SEC Info℠  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Opko Health, Inc. – ‘10-Q’ for 6/30/22 – ‘XML’

On:  Thursday, 8/4/22, at 4:27pm ET   ·   For:  6/30/22   ·   Accession #:  944809-22-38   ·   File #:  1-33528

Previous ‘10-Q’:  ‘10-Q’ on 5/9/22 for 3/31/22   ·   Next:  ‘10-Q’ on 11/8/22 for 9/30/22   ·   Latest:  ‘10-Q’ on 11/6/23 for 9/30/23   ·   2 References:   

Find Words in Filings emoji
 		  in    Show  and   ↓Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

 8/04/22  Opko Health, Inc.                 10-Q        6/30/22   86:12M

Quarterly Report   —   Form 10-Q

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML   2.60M 
 2: EX-31.1     Certification -- §302 - SOA'02                      HTML     26K 
 3: EX-31.2     Certification -- §302 - SOA'02                      HTML     26K 
 4: EX-32.1     Certification -- §906 - SOA'02                      HTML     23K 
 5: EX-32.2     Certification -- §906 - SOA'02                      HTML     23K 
11: R1          Cover Page                                          HTML     75K 
12: R2          Condensed Consolidated Balance Sheets               HTML    148K 
13: R3          Condensed Consolidated Balance Sheets               HTML     30K 
                (Parenthetical)                                                  
14: R4          Condensed Consolidated Statements of Operations     HTML    116K 
15: R5          Condensed Consolidated Statements of Comprehensive  HTML     43K 
                Income (Loss)                                                    
16: R6          Consolidated Statements of Equity                   HTML    128K 
17: R7          Condensed Consolidated Statements of Cash Flows     HTML    140K 
18: R8          Business and Organization                           HTML     38K 
19: R9          Impact of COVID-19                                  HTML     27K 
20: R10         Summary of Significant Accounting Policies          HTML     60K 
21: R11         Earnings (Loss) Per Share                           HTML     28K 
22: R12         Composition of Certain Financial Statement          HTML    108K 
                Captions                                                         
23: R13         Acquisitions and Investments                        HTML     68K 
24: R14         Debt                                                HTML    114K 
25: R15         Accumulated Other Comprehensive Loss                HTML     29K 
26: R16         Fair Value Measurements                             HTML     87K 
27: R17         Derivative Contracts                                HTML     44K 
28: R18         Related Party Transactions                          HTML     31K 
29: R19         Commitments and Contingencies                       HTML     35K 
30: R20         Revenue Recognition                                 HTML    128K 
31: R21         Strategic Alliances                                 HTML     46K 
32: R22         Segments                                            HTML    116K 
33: R23         Leases                                              HTML    110K 
34: R24         Subsequent Events                                   HTML     29K 
35: R25         Summary of Significant Accounting Policies          HTML    112K 
                (Policies)                                                       
36: R26         Composition of Certain Financial Statement          HTML    110K 
                Captions (Tables)                                                
37: R27         Acquisitions and Investments (Tables)               HTML     58K 
38: R28         Debt (Tables)                                       HTML     97K 
39: R29         Accumulated Other Comprehensive Loss (Tables)       HTML     29K 
40: R30         Fair Value Measurements (Tables)                    HTML     97K 
41: R31         Derivative Contracts (Tables)                       HTML     45K 
42: R32         Revenue Recognition (Tables)                        HTML    106K 
43: R33         Segments (Tables)                                   HTML    112K 
44: R34         Leases (Tables)                                     HTML     80K 
45: R35         Business and Organization (Details)                 HTML     88K 
46: R36         Impact of COVID-19 (Details)                        HTML     38K 
47: R37         Summary of Significant Accounting Policies          HTML    144K 
                (Details)                                                        
48: R38         Earnings (Loss) Per Share (Details)                 HTML     33K 
49: R39         Composition of Certain Financial Statement          HTML    121K 
                Captions (Details)                                               
50: R40         Composition of Certain Financial Statement          HTML     67K 
                Captions - Narrative (Details)                                   
51: R41         Composition of Certain Financial Statement          HTML     82K 
                Captions - Changes in Goodwill (Details)                         
52: R42         Acquisitions and Investments - Narrative (Details)  HTML    187K 
53: R43         Acquisitions and Investments - Schedule of          HTML     48K 
                Preliminary Purchase Price Allocation and                        
                Estimated Fair Value of Assets Acquired and                      
                Liabilities Assumed (Details)                                    
54: R44         Acquisitions and Investments - Summary of           HTML     42K 
                Investments (Details)                                            
55: R45         Acquisitions and Investments - Schedule of Net      HTML     29K 
                Gains and Losses on Equity Securities (Details)                  
56: R46         Debt - Schedule of Debt (Details)                   HTML     49K 
57: R47         Debt - Narrative (Details)                          HTML    241K 
58: R48         Debt - Schedule of Notes (Details)                  HTML     57K 
59: R49         Debt - Lines of Credit (Details)                    HTML     68K 
60: R50         Debt - Notes Payable and Other Debt (Details)       HTML     32K 
61: R51         Accumulated Other Comprehensive Loss (Details)      HTML     33K 
62: R52         Fair Value Measurements - Assets And Liabilities    HTML     63K 
                Measured At Fair Value (Details)                                 
63: R53         Fair Value Measurements - Carrying Amount and       HTML     34K 
                Estimated Fair Value of Long-Term Debt (Details)                 
64: R54         Fair Value Measurements - Level 3 Reconciliation    HTML     32K 
                (Details)                                                        
65: R55         Fair Value Measurements - Narrative (Details)       HTML     29K 
66: R56         Derivative Contracts - Balance Sheet Component      HTML     32K 
                (Details)                                                        
67: R57         Derivative Contracts - Derivative Gains (Losses)    HTML     30K 
                (Details)                                                        
68: R58         Related Party Transactions (Details)                HTML     94K 
69: R59         Commitments and Contingencies (Details)             HTML     47K 
70: R60         Revenue Recognition - Narrative (Details)           HTML     58K 
71: R61         Revenue Recognition - Schedule of Disaggregation    HTML     39K 
                of Revenue (Details)                                             
72: R62         Revenue Recognition - Schedule of Product Sales     HTML     53K 
                Allowances and Accruals (Details)                                
73: R63         Revenue Recognition - Changes in Contractual        HTML     27K 
                Liabilities Balance (Details)                                    
74: R64         Strategic Alliances (Details)                       HTML    136K 
75: R65         Segments - Narrative (Details)                      HTML     38K 
76: R66         Segments - Operations and Assets Information        HTML    102K 
                (Details)                                                        
77: R67         Leases - Lease Assets and Liabilities (Details)     HTML     52K 
78: R68         Leases - Lease Liability Maturity (Details)         HTML     61K 
79: R69         Leases - Narrative (Details)                        HTML     29K 
80: R70         Leases - Lease Cash Flow Information (Details)      HTML     30K 
81: R71         Subsequent Events (Details)                         HTML     36K 
84: XML         IDEA XML File -- Filing Summary                      XML    153K 
82: XML         XBRL Instance -- opk-20220630_htm                    XML   3.42M 
83: EXCEL       IDEA Workbook of Financial Reports                  XLSX    236K 
 7: EX-101.CAL  XBRL Calculations -- opk-20220630_cal                XML    245K 
 8: EX-101.DEF  XBRL Definitions -- opk-20220630_def                 XML   1.13M 
 9: EX-101.LAB  XBRL Labels -- opk-20220630_lab                      XML   2.41M 
10: EX-101.PRE  XBRL Presentations -- opk-20220630_pre               XML   1.49M 
 6: EX-101.SCH  XBRL Schema -- opk-20220630                          XSD    235K 
85: JSON        XBRL Instance as JSON Data -- MetaLinks              558±   822K 
86: ZIP         XBRL Zipped Folder -- 0000944809-22-000038-xbrl      Zip    633K

‘XML’   —   XBRL Instance — opk-20220630_htm

This Document is an XBRL XML File.

                                                                                                                                                                                
<?xml version="1.0" encoding="windows-1252"?>
<xbrl xml:lang="en-US" xmlns="http://www.xbrl.org/2003/instance" xmlns:country="http://xbrl.sec.gov/country/2022" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:opk="http://www.opko.com/20220630" xmlns:srt="http://fasb.org/srt/2022" xmlns:stpr="http://xbrl.sec.gov/stpr/2022" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<link:schemaRef xlink:href="opk-20220630.xsd" xlink:type="simple"/>
<context id="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
</entity>
<period>
<startDate> 2022-01-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="if0ded23553894a6a81063564257cdecd_I20220728">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
</entity>
<period>
<instant> 2022-07-28 </instant>
</period>
</context>
<context id="i4768f885851b49f986857a2a956f9162_I20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
</entity>
<period>
<instant> 2022-06-30 </instant>
</period>
</context>
<context id="i7e0f479bead144b0bdbcc71082db627b_I20211231">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
</entity>
<period>
<instant> 2021-12-31 </instant>
</period>
</context>
<context id="idf5be29147e94b809d0f3f67415ce0b1_D20220401-20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> us-gaap:ServiceMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-04-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="i3f3fc0cd0f02481481f1bb2345313999_D20210401-20210630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> us-gaap:ServiceMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-04-01 </startDate>
<endDate> 2021-06-30 </endDate>
</period>
</context>
<context id="i8b5aa09d29044d42bbfdc68d86a7e9a3_D20220101-20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> us-gaap:ServiceMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-01-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="i80b516e519b848f8a55bf1affb1fc020_D20210101-20210630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> us-gaap:ServiceMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-01-01 </startDate>
<endDate> 2021-06-30 </endDate>
</period>
</context>
<context id="if2238695b80a4a5f903fa54aa9e93ad7_D20220401-20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> us-gaap:ProductMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-04-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="ie9994295e2b2433795782a98077e22b5_D20210401-20210630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> us-gaap:ProductMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-04-01 </startDate>
<endDate> 2021-06-30 </endDate>
</period>
</context>
<context id="ib67a5f67884e4812a29dfbb65739778f_D20220101-20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> us-gaap:ProductMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-01-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="ia894264b8eea4bb0bd7d5a5dbc6ab9cd_D20210101-20210630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> us-gaap:ProductMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-01-01 </startDate>
<endDate> 2021-06-30 </endDate>
</period>
</context>
<context id="i2dbee62a623a4004a055434064bcdd46_D20220401-20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> opk:TransferOfIntellectualPropertyAndOtherMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-04-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="ia406b4879e9a4c2cadf973464d173c63_D20210401-20210630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> opk:TransferOfIntellectualPropertyAndOtherMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-04-01 </startDate>
<endDate> 2021-06-30 </endDate>
</period>
</context>
<context id="i504cf7154fff4123a500b2c26e04b6d9_D20220101-20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> opk:TransferOfIntellectualPropertyAndOtherMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-01-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="i32f2af0f2c1f4fee9b8639b2a0a7823b_D20210101-20210630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> opk:TransferOfIntellectualPropertyAndOtherMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-01-01 </startDate>
<endDate> 2021-06-30 </endDate>
</period>
</context>
<context id="i50aa2eea9a6446b6ad796d994509b1ad_D20220401-20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
</entity>
<period>
<startDate> 2022-04-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="if2a6207b6732465a921fe019a2a0f048_D20210401-20210630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
</entity>
<period>
<startDate> 2021-04-01 </startDate>
<endDate> 2021-06-30 </endDate>
</period>
</context>
<context id="i420e18e30084498a98510d48880063cd_D20210101-20210630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
</entity>
<period>
<startDate> 2021-01-01 </startDate>
<endDate> 2021-06-30 </endDate>
</period>
</context>
<context id="ie2ff5bb5f07c499aaa06f6f056723e2c_I20220331">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:CommonStockMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-03-31 </instant>
</period>
</context>
<context id="i9f2f310772cd4969a9bbdfb8c1c1bbf3_I20220331">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:TreasuryStockCommonMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-03-31 </instant>
</period>
</context>
<context id="i0c4dbaeee76c4337aab5500d767e1256_I20220331">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:AdditionalPaidInCapitalMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-03-31 </instant>
</period>
</context>
<context id="ifdb3df35acec413390cf60a1882c1ef9_I20220331">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:AccumulatedOtherComprehensiveIncomeMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-03-31 </instant>
</period>
</context>
<context id="i02d914e3e4754dfb90ffeb3e875dafdc_I20220331">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:RetainedEarningsMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-03-31 </instant>
</period>
</context>
<context id="ia9d8bbd1bb63472cb5580794fcfd8d33_I20220331">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
</entity>
<period>
<instant> 2022-03-31 </instant>
</period>
</context>
<context id="i04265b97ae4d49c797e0d0c55d843b90_D20220401-20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:AdditionalPaidInCapitalMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-04-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="iaddb92ee4a114eabb5c91ad635bf57f9_D20220401-20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:CommonStockMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-04-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="i7a3911d30cbc481998e3a5e0ab35ef79_D20220101-20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:CommonStockMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-01-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="iab350db377af4e68a4340919d2588400_D20220101-20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:AdditionalPaidInCapitalMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-01-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="i664e18092df94016a53d7b26841156a6_D20220401-20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:RetainedEarningsMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-04-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="i2f1e3a13d9e14974875975db079fd6f7_D20220401-20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:AccumulatedOtherComprehensiveIncomeMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-04-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="i85b7b1dbd04b4d3dbdaf6cb62cfc1665_I20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:CommonStockMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-06-30 </instant>
</period>
</context>
<context id="i3d5e060c68554a45962ea3a454384d02_I20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:TreasuryStockCommonMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-06-30 </instant>
</period>
</context>
<context id="i2a9555033f9c450cbd0cc0880f75dc69_I20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:AdditionalPaidInCapitalMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-06-30 </instant>
</period>
</context>
<context id="ie6ee77a745aa4015ad63d4f83040b0ed_I20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:AccumulatedOtherComprehensiveIncomeMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-06-30 </instant>
</period>
</context>
<context id="i9c7451fa56834bd59e76c58725d6590e_I20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:RetainedEarningsMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-06-30 </instant>
</period>
</context>
<context id="if69a9cfe200e450cac0564cfe636999d_I20211231">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:CommonStockMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2021-12-31 </instant>
</period>
</context>
<context id="i546a45246f83450caa3bdc0deb70f492_I20211231">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:TreasuryStockCommonMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2021-12-31 </instant>
</period>
</context>
<context id="i5ad35185d82b4d4b99658d6774a96349_I20211231">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:AdditionalPaidInCapitalMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2021-12-31 </instant>
</period>
</context>
<context id="ife171a124ce1417497c82a77ed3eb5c1_I20211231">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:AccumulatedOtherComprehensiveIncomeMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2021-12-31 </instant>
</period>
</context>
<context id="i07949398dbdd4852aa632d1f6516a009_I20211231">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:RetainedEarningsMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2021-12-31 </instant>
</period>
</context>
<context id="i6a367dd12b2e4f7192222dd2acfea35b_D20210101-20211231">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
</entity>
<period>
<startDate> 2021-01-01 </startDate>
<endDate> 2021-12-31 </endDate>
</period>
</context>
<context id="i21bf2c09312540c1a07d30824acd00af_I20211231">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis"> srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:AdditionalPaidInCapitalMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2021-12-31 </instant>
</period>
</context>
<context id="i0dd0c4b91d444de595bbd9d4c50f2a9c_I20211231">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis"> srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:RetainedEarningsMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2021-12-31 </instant>
</period>
</context>
<context id="i006ef26eeb91481d9d77c8e447b45a9d_I20211231">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis"> srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2021-12-31 </instant>
</period>
</context>
<context id="i56def4b76e0c4f9490d4c998c5a81918_D20220101-20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:RetainedEarningsMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-01-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="ibd58c29336894d95b5c9f39da70bfb30_D20220101-20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:AccumulatedOtherComprehensiveIncomeMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-01-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="i6c23a090b00b43c693b6d7f3d82b7be5_I20210331">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:CommonStockMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2021-03-31 </instant>
</period>
</context>
<context id="idc0a96aeba8b4919ab01f8ffc72b120a_I20210331">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:TreasuryStockCommonMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2021-03-31 </instant>
</period>
</context>
<context id="i62721db31d084926bae68f12928c12cd_I20210331">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:AdditionalPaidInCapitalMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2021-03-31 </instant>
</period>
</context>
<context id="ife540768ebf747979501881c139e0199_I20210331">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:AccumulatedOtherComprehensiveIncomeMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2021-03-31 </instant>
</period>
</context>
<context id="i357c7263e308459fafefe5433b54fde6_I20210331">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:RetainedEarningsMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2021-03-31 </instant>
</period>
</context>
<context id="iaa0c2c8c10d745ddaed78dfdd05335a0_I20210331">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
</entity>
<period>
<instant> 2021-03-31 </instant>
</period>
</context>
<context id="i6534ba238d994a90a6ea2f8387180ed8_D20210401-20210630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:AdditionalPaidInCapitalMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-04-01 </startDate>
<endDate> 2021-06-30 </endDate>
</period>
</context>
<context id="ie9dea1cfa0a040fca270b1ad597208aa_D20210401-20210630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:CommonStockMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-04-01 </startDate>
<endDate> 2021-06-30 </endDate>
</period>
</context>
<context id="i540203ee7d9442bea99bfbcbb845e88f_D20210401-20210630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:TreasuryStockCommonMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-04-01 </startDate>
<endDate> 2021-06-30 </endDate>
</period>
</context>
<context id="icdc099a3a96e47fba17c75b489504342_D20210401-20210630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:RetainedEarningsMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-04-01 </startDate>
<endDate> 2021-06-30 </endDate>
</period>
</context>
<context id="i0099598db9a54ff2be5a195f8bc7fafc_D20210401-20210630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:AccumulatedOtherComprehensiveIncomeMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-04-01 </startDate>
<endDate> 2021-06-30 </endDate>
</period>
</context>
<context id="i03e9eec1af7a46b5b2a8d119f418c07a_I20210630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:CommonStockMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2021-06-30 </instant>
</period>
</context>
<context id="icf579a7819844358809a652fbc83e308_I20210630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:TreasuryStockCommonMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2021-06-30 </instant>
</period>
</context>
<context id="i4d00d14adfc9448eb9e40866c713eb77_I20210630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:AdditionalPaidInCapitalMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2021-06-30 </instant>
</period>
</context>
<context id="i0c9b6e37c03b4ddab0b2471c8b70170a_I20210630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:AccumulatedOtherComprehensiveIncomeMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2021-06-30 </instant>
</period>
</context>
<context id="i7ca34897162343b08c9c9b25987fec26_I20210630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:RetainedEarningsMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2021-06-30 </instant>
</period>
</context>
<context id="i724677ce94b849699e6f5d548e33e1c7_I20210630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
</entity>
<period>
<instant> 2021-06-30 </instant>
</period>
</context>
<context id="ide0454f45282433aa644418ea11e2575_I20201231">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:CommonStockMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2020-12-31 </instant>
</period>
</context>
<context id="iee4648dd0f8f48e3aa02b39beacbac0d_I20201231">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:TreasuryStockCommonMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2020-12-31 </instant>
</period>
</context>
<context id="idec58d7abdf042679d88f31b2a910419_I20201231">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:AdditionalPaidInCapitalMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2020-12-31 </instant>
</period>
</context>
<context id="i96ef84d006064e0e82ea3344fe36540e_I20201231">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:AccumulatedOtherComprehensiveIncomeMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2020-12-31 </instant>
</period>
</context>
<context id="i720743b66e81454d8b52b679ad4ee1c3_I20201231">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:RetainedEarningsMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2020-12-31 </instant>
</period>
</context>
<context id="if51f06301fcf486db26eb226e027928f_I20201231">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
</entity>
<period>
<instant> 2020-12-31 </instant>
</period>
</context>
<context id="ia2e25bc253ba4254b83e569ae311af76_D20210101-20210630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:AdditionalPaidInCapitalMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-01-01 </startDate>
<endDate> 2021-06-30 </endDate>
</period>
</context>
<context id="i526a0f2934a64759b86957f5ac4057e7_D20210101-20210630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:CommonStockMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-01-01 </startDate>
<endDate> 2021-06-30 </endDate>
</period>
</context>
<context id="ibf1ef60ea3774e0482c1fc882047daa5_D20210101-20210630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:TreasuryStockCommonMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-01-01 </startDate>
<endDate> 2021-06-30 </endDate>
</period>
</context>
<context id="i3b4c93677d4045f4aab1f7094a56e88f_D20210101-20210630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:RetainedEarningsMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-01-01 </startDate>
<endDate> 2021-06-30 </endDate>
</period>
</context>
<context id="i2f1219e2e5e14486b523df300416bca8_D20210101-20210630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:AccumulatedOtherComprehensiveIncomeMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-01-01 </startDate>
<endDate> 2021-06-30 </endDate>
</period>
</context>
<context id="i3f7969e9854b45dfa1c0bba3df71fb1f_D20220509-20220509">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis"> opk:ModeXTherapeuticsIncMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-05-09 </startDate>
<endDate> 2022-05-09 </endDate>
</period>
</context>
<context id="ic131f974c00a4170a9cffd5b1edf89a2_D20220509-20220509">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis"> opk:ModeXTherapeuticsIncMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis"> us-gaap:CommonStockMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-05-09 </startDate>
<endDate> 2022-05-09 </endDate>
</period>
</context>
<context id="i20b9a56ee2dc4a508f7dfc81c0b8817c_I20220509">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis"> opk:ModeXTherapeuticsIncMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-05-09 </instant>
</period>
</context>
<context id="ifd33c3c2d74b47d984dc6f4de745b77a_I20220509">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis"> opk:ModeXTherapeuticsIncMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis"> opk:FormerStockholdersMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-05-09 </instant>
</period>
</context>
<context id="if656c6b905904d278cbc8c9215fcebd3_I20220509">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis"> us-gaap:CommonStockMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-05-09 </instant>
</period>
</context>
<context id="ibde59da9b1054f718e54290fcabbdad7_D20220429-20220429">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis"> opk:DetectGenomixMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="dei:LegalEntityAxis"> opk:Sema4Member </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-04-29 </startDate>
<endDate> 2022-04-29 </endDate>
</period>
</context>
<context id="i6b6b004d382d4a789347b7f3a93c6395_I20220429">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis"> opk:DetectGenomixMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis"> us-gaap:CommonClassAMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="dei:LegalEntityAxis"> opk:Sema4Member </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-04-29 </instant>
</period>
</context>
<context id="i030741997068424c9b6f6d32294debfc_D20220401-20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis"> opk:DetectGenomixMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="dei:LegalEntityAxis"> opk:Sema4Member </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-04-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="i609801dc869a46daa0f7c9d9d02d6f49_D20220429-20220429">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis"> opk:DetectGenomixMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="opk:MilestoneConsiderationAxis"> opk:MilestoneConsiderationTrancheOneMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-04-29 </startDate>
<endDate> 2022-04-29 </endDate>
</period>
</context>
<context id="ie8068b4750fa4a7bb7fd57b976f255bb_D20220429-20220429">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis"> opk:DetectGenomixMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="opk:MilestoneConsiderationAxis"> opk:MilestoneConsiderationTrancheTwoMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-04-29 </startDate>
<endDate> 2022-04-29 </endDate>
</period>
</context>
<context id="i4154180b9991448a838549649e73ab2d_I20220429">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis"> opk:DetectGenomixMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="dei:LegalEntityAxis"> opk:Sema4Member </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-04-29 </instant>
</period>
</context>
<context id="ib756cb650b5d46b5b7e407c80f59f34c_D20220101-20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="opk:TestingTypeAxis"> opk:RoutineClinicalTestMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-01-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="ic362a16dc89d4be3aa8eabf5fbcb4e30_D20220101-20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> opk:COVID19TestingMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis"> us-gaap:SalesRevenueNetMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis"> opk:COVID19TestingRevenueConcentrationRiskMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-01-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="i3f42af92d53c4588aba3e030054466b3_D20220101-20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> opk:COVID19TestingMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis"> us-gaap:AccountsReceivableMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis"> opk:COVID19TestingRevenueConcentrationRiskMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-01-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="icf88bd5dcf6d4a0b85df429b936bc0a1_I20211231">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis"> opk:DetectGenomixMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2021-12-31 </instant>
</period>
</context>
<context id="ie5402e1f07514e1bbc3dc38a49ae64dc_I20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis"> us-gaap:InProcessResearchAndDevelopmentMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-06-30 </instant>
</period>
</context>
<context id="if9075d5a9ceb4b15b07bfe556bbd0c3d_I20211231">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis"> us-gaap:InProcessResearchAndDevelopmentMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2021-12-31 </instant>
</period>
</context>
<context id="ib6bd9208c33c495395b98878d167a208_I20220331">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis"> us-gaap:InProcessResearchAndDevelopmentMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-03-31 </instant>
</period>
</context>
<context id="i8db165b77cc14b43a5ed53019cb00903_I20220331">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis"> opk:OPKOBiologicsMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-03-31 </instant>
</period>
</context>
<context id="i857711861e3f4bdb99db993663f74933_D20220101-20220331">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis"> us-gaap:InProcessResearchAndDevelopmentMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-01-01 </startDate>
<endDate> 2022-03-31 </endDate>
</period>
</context>
<context id="i92a3787eaa4c447ba84018ceceb9fff4_D20220101-20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:RangeAxis"> srt:MinimumMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-01-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="ic9f8abbc7eb944728e6c73cbef4ed54b_D20220101-20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:RangeAxis"> srt:MaximumMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-01-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="if4edb8311d3245ffa6aa3e152841f740_D20220101-20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis"> us-gaap:SoftwareAndSoftwareDevelopmentCostsMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-01-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="i6c4c12cfaf654e6eba27bca6bbb6f0a2_D20220101-20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:RangeAxis"> srt:MinimumMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis"> us-gaap:MachineryAndEquipmentMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-01-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="i2bdb327cb90347a5b1f640b34210ad62_D20220101-20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:RangeAxis"> srt:MaximumMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis"> us-gaap:MachineryAndEquipmentMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-01-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="i4c6ce3bcddc64838bc68ab64e28d03b5_D20220101-20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:RangeAxis"> srt:MinimumMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis"> us-gaap:FurnitureAndFixturesMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-01-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="icca08e8f63304c8698a98aaf9728303a_D20220101-20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:RangeAxis"> srt:MaximumMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis"> us-gaap:FurnitureAndFixturesMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-01-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="i40519de475434efa8c8f7e22b2a90ad9_D20220101-20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:RangeAxis"> srt:MinimumMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis"> us-gaap:BuildingAndBuildingImprovementsMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-01-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="icc3cd5b1940645259e869b5987e7c58a_D20220101-20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:RangeAxis"> srt:MaximumMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis"> us-gaap:BuildingAndBuildingImprovementsMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-01-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="ibc2797b8a71545248bf6e9025c48fcea_D20220101-20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:RangeAxis"> srt:MinimumMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis"> opk:AutomobilesandAircraftMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-01-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="ie7460091cf914c17bad1d941a24eecd9_D20220101-20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:RangeAxis"> srt:MaximumMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis"> opk:AutomobilesandAircraftMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-01-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="i074ad3ab2fbc48e790a2f7ebd43d2654_D20220630-20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:MajorCustomersAxis"> opk:FederalAndStateGovernmentsMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis"> us-gaap:AccountsReceivableMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis"> us-gaap:CreditConcentrationRiskMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-06-30 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="ic084989e42dc4a328176af80fcd08cb6_D20211231-20211231">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:MajorCustomersAxis"> opk:FederalAndStateGovernmentsMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis"> us-gaap:AccountsReceivableMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis"> us-gaap:CreditConcentrationRiskMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-12-31 </startDate>
<endDate> 2021-12-31 </endDate>
</period>
</context>
<context id="ia42b878f8f7c44eba4081c0c9a6be8d4_D20220630-20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:MajorCustomersAxis"> opk:StatesCitiesAndOtherMunicipalitiesMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis"> us-gaap:AccountsReceivableMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis"> us-gaap:GeographicConcentrationRiskMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-06-30 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="i44506d274f524d98bdf40e6b66b3b24e_D20211231-20211231">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:MajorCustomersAxis"> opk:StatesCitiesAndOtherMunicipalitiesMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis"> us-gaap:AccountsReceivableMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis"> us-gaap:GeographicConcentrationRiskMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-12-31 </startDate>
<endDate> 2021-12-31 </endDate>
</period>
</context>
<context id="ie7d78c03dcab4eae8faa63dcc6ae568e_D20220630-20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:MajorCustomersAxis"> opk:IndividualPatientsMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis"> us-gaap:AccountsReceivableMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis"> us-gaap:CustomerConcentrationRiskMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-06-30 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="i47c3284d560b4139b840d84cac215356_D20211231-20211231">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:MajorCustomersAxis"> opk:IndividualPatientsMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis"> us-gaap:AccountsReceivableMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis"> us-gaap:CustomerConcentrationRiskMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-12-31 </startDate>
<endDate> 2021-12-31 </endDate>
</period>
</context>
<context id="ie684d614568d45eb9bcce4fd63aa5077_I20220101">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis"> srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-01-01 </instant>
</period>
</context>
<context id="i17f6d7edfe2d4cfd97bd8bf85038b376_I20220101">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis"> srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:RetainedEarningsMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-01-01 </instant>
</period>
</context>
<context id="i2e013f06489447d0b09e5fcc88390e38_I20220101">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis"> srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:AdditionalPaidInCapitalMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-01-01 </instant>
</period>
</context>
<context id="ia10339d1deab4c91bf080650d80c7631_D20220401-20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"> us-gaap:CommonStockMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-04-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="i6e3c55b9c2a14112975c5b8a52ac0caa_D20210401-20210630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"> us-gaap:CommonStockMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-04-01 </startDate>
<endDate> 2021-06-30 </endDate>
</period>
</context>
<context id="ibc41d5877b14449aa18a19384d5641f8_D20220101-20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"> us-gaap:CommonStockMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-01-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="ib655e82b41ba4c9e8fa2842c43bfc319_D20210101-20210630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"> us-gaap:CommonStockMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-01-01 </startDate>
<endDate> 2021-06-30 </endDate>
</period>
</context>
<context id="ieb4fbf8f73d74de3ba4c91c86dd30023_I20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis"> us-gaap:CustomerRelationshipsMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-06-30 </instant>
</period>
</context>
<context id="i400904118190489b9d136dc11e2ccda3_I20211231">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis"> us-gaap:CustomerRelationshipsMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2021-12-31 </instant>
</period>
</context>
<context id="ic3cb8ffea8d547949eb6aa52d46711fe_I20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis"> us-gaap:TechnologyBasedIntangibleAssetsMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-06-30 </instant>
</period>
</context>
<context id="iebfc97ece41a4b8cb182968e19d1ef8c_I20211231">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis"> us-gaap:TechnologyBasedIntangibleAssetsMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2021-12-31 </instant>
</period>
</context>
<context id="i6803460117304737a13c6361b1284236_I20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis"> us-gaap:TradeNamesMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-06-30 </instant>
</period>
</context>
<context id="i0da5d41367d949c5a55dacd926dc2ba2_I20211231">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis"> us-gaap:TradeNamesMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2021-12-31 </instant>
</period>
</context>
<context id="ib2711e90c49d49278c0d28e6b0f2e233_I20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis"> us-gaap:NoncompeteAgreementsMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-06-30 </instant>
</period>
</context>
<context id="ief8b941f9e054e76848ef6a37277ab26_I20211231">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis"> us-gaap:NoncompeteAgreementsMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2021-12-31 </instant>
</period>
</context>
<context id="i05ef0a805a084776833a76c87ba0305d_I20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis"> us-gaap:LicensingAgreementsMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-06-30 </instant>
</period>
</context>
<context id="ib765c87c2fad4924a6a49a613b15fcf4_I20211231">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis"> us-gaap:LicensingAgreementsMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2021-12-31 </instant>
</period>
</context>
<context id="i7c0bc677b4664ebeac10693cdd91f43f_I20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis"> opk:ProductRegistrationsMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-06-30 </instant>
</period>
</context>
<context id="i702cce6c83684198821efd01ee1b9297_I20211231">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis"> opk:ProductRegistrationsMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2021-12-31 </instant>
</period>
</context>
<context id="ibac862a1a0e649dcb81d43591cd0d8d2_I20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis"> us-gaap:OtherIntangibleAssetsMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-06-30 </instant>
</period>
</context>
<context id="i968cd31428a64336a08f3bef10b29016_I20211231">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis"> us-gaap:OtherIntangibleAssetsMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2021-12-31 </instant>
</period>
</context>
<context id="i961111bfd3ae4d1786f3b644dfaed15f_D20220101-20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:RangeAxis"> srt:MinimumMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis"> us-gaap:DevelopedTechnologyRightsMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-01-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="i3891a855bcc64f0199be6de69911de91_D20220101-20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:RangeAxis"> srt:MaximumMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis"> us-gaap:DevelopedTechnologyRightsMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-01-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="ib8154ad8782c4825a297a4cb81b36e53_D20220101-20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:RangeAxis"> srt:MinimumMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis"> us-gaap:CustomerRelationshipsMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-01-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="ife2c9d6b8b8e418092c5956c4a0d03b6_D20220101-20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:RangeAxis"> srt:MaximumMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis"> us-gaap:CustomerRelationshipsMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-01-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="i61ac88df138d4017af162d9e836d38cb_D20220101-20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:RangeAxis"> srt:MinimumMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis"> us-gaap:ProductMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-01-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="i48e5f9c0fe4f420f8a4b344acfe545aa_D20220101-20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:RangeAxis"> srt:MaximumMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis"> us-gaap:ProductMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-01-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="ib06c7ba653fe4abe830ffc75779c7675_D20220101-20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis"> opk:CovenantsNotToCompeteMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-01-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="i0a9715dd8aa045569b32c5151bd4fe07_D20220101-20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:RangeAxis"> srt:MinimumMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis"> us-gaap:TradeNamesMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-01-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="i6731e6058ad24d159fc46e1db9045567_D20220101-20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:RangeAxis"> srt:MaximumMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis"> us-gaap:TradeNamesMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-01-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="ic3e0c38984e046c89b487d9fcf35517f_D20220101-20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:RangeAxis"> srt:MinimumMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis"> us-gaap:OtherIntangibleAssetsMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-01-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="id67de6a8442540ca96b8c68ada9e9d68_D20220101-20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:RangeAxis"> srt:MaximumMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis"> us-gaap:OtherIntangibleAssetsMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-01-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="ic7bc1c143261409d885f640ef938f1d0_I20220101">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis"> opk:CURNAMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis"> opk:PharmaceuticalMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-01-01 </instant>
</period>
</context>
<context id="ia43ace2974434cfcbeef89c8f5e7d477_I20211231">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis"> opk:CURNAMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis"> opk:PharmaceuticalMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2021-12-31 </instant>
</period>
</context>
<context id="ib1e13f80600d48f5a2c0e620b18ecabc_D20220101-20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis"> opk:CURNAMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis"> opk:PharmaceuticalMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-01-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="i5c4e1553e63444f18dce0e26ba559b82_I20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis"> opk:CURNAMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis"> opk:PharmaceuticalMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-06-30 </instant>
</period>
</context>
<context id="i565df68659b544e8b4f6c9442ca781fa_I20220101">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis"> opk:EirGenPharmaLimitedMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis"> opk:PharmaceuticalMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-01-01 </instant>
</period>
</context>
<context id="i431e318a0b5744f7baf11d068ead714b_I20211231">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis"> opk:EirGenPharmaLimitedMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis"> opk:PharmaceuticalMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2021-12-31 </instant>
</period>
</context>
<context id="if721914b6f354b41a9c707a8e5b76bf5_D20220101-20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis"> opk:EirGenPharmaLimitedMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis"> opk:PharmaceuticalMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-01-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="ie12b186fde19404faaed8e391ad1be7b_I20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis"> opk:EirGenPharmaLimitedMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis"> opk:PharmaceuticalMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-06-30 </instant>
</period>
</context>
<context id="i6131f768521c46428c444dd24756c742_I20220101">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis"> opk:FineTechMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis"> opk:PharmaceuticalMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-01-01 </instant>
</period>
</context>
<context id="i3ade77f9eaed4faabb37aeea4dce9d1b_I20211231">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis"> opk:FineTechMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis"> opk:PharmaceuticalMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2021-12-31 </instant>
</period>
</context>
<context id="i5c49745088b24c95a89e2e762044ccfe_D20220101-20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis"> opk:FineTechMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis"> opk:PharmaceuticalMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-01-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="ia31f3729b6794f729d55bc77509bbbb7_I20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis"> opk:FineTechMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis"> opk:PharmaceuticalMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-06-30 </instant>
</period>
</context>
<context id="i14362d9426824546a785459ecd0f7d21_I20220101">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis"> opk:ModeXTherapeuticsIncMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis"> opk:PharmaceuticalMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-01-01 </instant>
</period>
</context>
<context id="ic2c80ed446f94b9583d235b0ade0e583_I20211231">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis"> opk:ModeXTherapeuticsIncMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis"> opk:PharmaceuticalMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2021-12-31 </instant>
</period>
</context>
<context id="i4f33dc4c2e62444caaa86ebd36c79a27_D20220101-20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis"> opk:ModeXTherapeuticsIncMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis"> opk:PharmaceuticalMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-01-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="i5a29a6dcd3ad4c4d8ff6bdd54a4c0b60_I20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis"> opk:ModeXTherapeuticsIncMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis"> opk:PharmaceuticalMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-06-30 </instant>
</period>
</context>
<context id="ib35528f5c5454a948cd6fb7e53765880_I20220101">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis"> opk:OPKOBiologicsMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis"> opk:PharmaceuticalMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-01-01 </instant>
</period>
</context>
<context id="i147d9d98661e469bad1d656ac661d91f_I20211231">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis"> opk:OPKOBiologicsMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis"> opk:PharmaceuticalMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2021-12-31 </instant>
</period>
</context>
<context id="i9729c8b5a4004014942b75fdb603ea37_D20220101-20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis"> opk:OPKOBiologicsMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis"> opk:PharmaceuticalMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-01-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="id06e40979d754019aa484803caa7f019_I20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis"> opk:OPKOBiologicsMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis"> opk:PharmaceuticalMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-06-30 </instant>
</period>
</context>
<context id="i2d369c9e071a4a38b68a6d96269c8133_I20220101">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis"> opk:OpkoChileMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis"> opk:PharmaceuticalMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-01-01 </instant>
</period>
</context>
<context id="ib62f4ad40b5146e392e1a619721dbbdb_I20211231">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis"> opk:OpkoChileMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis"> opk:PharmaceuticalMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2021-12-31 </instant>
</period>
</context>
<context id="i91c921c5b67341828846ffb04a7f80d9_D20220101-20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis"> opk:OpkoChileMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis"> opk:PharmaceuticalMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-01-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="i490840fae40842cea71fdef8ce82a092_I20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis"> opk:OpkoChileMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis"> opk:PharmaceuticalMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-06-30 </instant>
</period>
</context>
<context id="i5c052fb6706048a38d2aa1f882ca5aa2_I20220101">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis"> opk:OPKOHealthEuropeMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis"> opk:PharmaceuticalMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-01-01 </instant>
</period>
</context>
<context id="ib7bb6a376a704d538179220f0aa9b673_I20211231">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis"> opk:OPKOHealthEuropeMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis"> opk:PharmaceuticalMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2021-12-31 </instant>
</period>
</context>
<context id="i02428274068d40bab70f37770fd40790_D20220101-20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis"> opk:OPKOHealthEuropeMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis"> opk:PharmaceuticalMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-01-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="i2d6a8e21d27a4daf877bb4ecd8e0f614_I20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis"> opk:OPKOHealthEuropeMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis"> opk:PharmaceuticalMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-06-30 </instant>
</period>
</context>
<context id="ie4ef700c25704bf78c7ff5c0ef6e2865_I20220101">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis"> opk:OPKOMexicoMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis"> opk:PharmaceuticalMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-01-01 </instant>
</period>
</context>
<context id="i19b751f2797a42a491b5a1d58941004c_I20211231">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis"> opk:OPKOMexicoMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis"> opk:PharmaceuticalMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2021-12-31 </instant>
</period>
</context>
<context id="i339582850da64817ac38b9219b61629e_D20220101-20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis"> opk:OPKOMexicoMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis"> opk:PharmaceuticalMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-01-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="ib62eb1ef6c404c7caf4166948d600d5b_I20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis"> opk:OPKOMexicoMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis"> opk:PharmaceuticalMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-06-30 </instant>
</period>
</context>
<context id="i07b0e87b09674c2ab0a8274ca50186f2_I20220101">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis"> opk:TransitionTherapeuticsInc.Member </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis"> opk:PharmaceuticalMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-01-01 </instant>
</period>
</context>
<context id="id2a4499b4f584b83947dfac0c12ea970_I20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis"> opk:TransitionTherapeuticsInc.Member </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis"> opk:PharmaceuticalMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-06-30 </instant>
</period>
</context>
<context id="i87df713daadf4da1acb681f3f77bdda7_D20220101-20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis"> opk:TransitionTherapeuticsInc.Member </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis"> opk:PharmaceuticalMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-01-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="i58c951942dcd46acb2b73f9457ce547c_I20220101">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis"> opk:BioReferenceMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis"> opk:DiagnosticsMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-01-01 </instant>
</period>
</context>
<context id="ia94af80a4c1b4fbc945badd9a1e4110f_I20211231">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis"> opk:BioReferenceMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis"> opk:DiagnosticsMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2021-12-31 </instant>
</period>
</context>
<context id="ib3c4407658c242e09207819ecbf0fedd_D20220101-20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis"> opk:BioReferenceMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis"> opk:DiagnosticsMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-01-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="iba2ce9ca3c1a46e4ace10af9e34b42a4_I20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis"> opk:BioReferenceMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis"> opk:DiagnosticsMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-06-30 </instant>
</period>
</context>
<context id="i5e1ecf3783924742b8005c8a29489617_I20220101">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis"> opk:OpkoDiagnosticsMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis"> opk:DiagnosticsMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-01-01 </instant>
</period>
</context>
<context id="i57378aa975644b29a7508b9513481d2f_I20211231">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis"> opk:OpkoDiagnosticsMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis"> opk:DiagnosticsMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2021-12-31 </instant>
</period>
</context>
<context id="ia00f75d5e5c540f9bed132290ac08971_D20220101-20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis"> opk:OpkoDiagnosticsMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis"> opk:DiagnosticsMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-01-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="id34a68b0949c484c8f91ca4af64492ae_I20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis"> opk:OpkoDiagnosticsMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis"> opk:DiagnosticsMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-06-30 </instant>
</period>
</context>
<context id="i6416188cab214728bec613abff1f00a5_I20220101">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
</entity>
<period>
<instant> 2022-01-01 </instant>
</period>
</context>
<context id="i0b9eb2f94272480b89af2aa6b63016bb_I20220509">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis"> opk:ModeXTherapeuticsIncMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis"> us-gaap:CommonStockMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-05-09 </instant>
</period>
</context>
<context id="i6e2ebcd18c6c468fb98cfa2b81b9e1d9_I20220509">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis"> opk:ModeXTherapeuticsIncMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis"> us-gaap:InProcessResearchAndDevelopmentMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-05-09 </instant>
</period>
</context>
<context id="i90e63abdd08541478caeee0f59f6fdf3_D20220509-20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis"> opk:ModeXTherapeuticsIncMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-05-09 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="iccb7ebf892d04d5bad4a79423d427821_I20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"> opk:PharmsynthezMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-06-30 </instant>
</period>
</context>
<context id="ibd144d9728004cf9863b6ae5054c6f3b_I20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"> opk:CocrystalMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-06-30 </instant>
</period>
</context>
<context id="i7f3e1c36b68e4b9297d3edcfa497c422_I20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"> opk:NonInvasiveMonitoringSystemsInc.Member </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-06-30 </instant>
</period>
</context>
<context id="i638893db4b744380bbf4fe4b1c4c34cb_I20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"> opk:NeovascMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-06-30 </instant>
</period>
</context>
<context id="ica61dbae6de944cbb0951857c4df1f1c_I20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"> opk:BioCardiaInc.Member </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-06-30 </instant>
</period>
</context>
<context id="ifa84a7bed2a34798be0401c8ebf24f2a_I20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"> opk:XeneticBiosciencesInc.Member </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-06-30 </instant>
</period>
</context>
<context id="i4aa0e748cf164fbebe8ea96fb98f0800_D20220101-20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"> opk:LeaderMedMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-01-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="i5d3db5074ab44b5da5cab50b5f82d089_I20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis"> us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-06-30 </instant>
</period>
</context>
<context id="i4cd739f3c8454b12b43d9bfab3d579a6_D20220101-20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis"> us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-01-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="i6ae7d1b97af640af87dab463fe02505b_I20211231">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis"> us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2021-12-31 </instant>
</period>
</context>
<context id="i092ce7932d9a4163958cb0a85b249a9e_D20210101-20211231">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis"> us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-01-01 </startDate>
<endDate> 2021-12-31 </endDate>
</period>
</context>
<context id="i8345c838c79a4bebb30e85822ef0d853_I20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis"> us-gaap:CommonClassAMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="dei:LegalEntityAxis"> opk:Sema4Member </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-06-30 </instant>
</period>
</context>
<context id="i62aaadeeb2eb492c9122db4484c06757_I20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"> opk:Sema4Member </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="dei:LegalEntityAxis"> opk:Sema4Member </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-06-30 </instant>
</period>
</context>
<context id="i0963066211524c049a2a49beb703d496_D20220429-20220429">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"> opk:Sema4Member </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-04-29 </startDate>
<endDate> 2022-04-29 </endDate>
</period>
</context>
<context id="if288f21de13c4cfb8202fe2552824c40_I20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"> opk:PhioPharmaceuticalsMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-06-30 </instant>
</period>
</context>
<context id="ic60a15d1f2b446899dd153a240f07d47_I20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"> opk:VBIVaccinesIncMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-06-30 </instant>
</period>
</context>
<context id="iedf7653609334b3e8f1f1e53eb7904f3_I20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"> opk:ChromaDexMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-06-30 </instant>
</period>
</context>
<context id="i4b9df4ff9c4d4da3ad49058716ae72e7_I20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"> opk:EloxxPharmaceuticalsMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-06-30 </instant>
</period>
</context>
<context id="i4e74a1253b194022be7043a4114032da_I20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"> opk:CAMP4Member </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-06-30 </instant>
</period>
</context>
<context id="i01da602732d248f58f9f4c22841acc82_I20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"> opk:HealthSnapMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-06-30 </instant>
</period>
</context>
<context id="i141dcc1c0b4a4b869a95068b3e96b2d7_I20211231">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"> opk:BioCardiaInc.Member </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2021-12-31 </instant>
</period>
</context>
<context id="i088e1c2b87224f69a5e28490a4d4c18b_I20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"> opk:InCellDxIncMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-06-30 </instant>
</period>
</context>
<context id="ife44f423be0e44ba9c693b730c6ecddf_D20210914-20210914">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:CounterpartyNameAxis"> opk:LeaderMedMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="srt:OwnershipAxis"> opk:LeaderMedJointVentureMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis"> us-gaap:CorporateJointVentureMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-09-14 </startDate>
<endDate> 2021-09-14 </endDate>
</period>
</context>
<context id="i1d617d723c3b4354a0819a2ba6169cbe_I20210914">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:CounterpartyNameAxis"> opk:LeaderMedMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="srt:OwnershipAxis"> opk:LeaderMedJointVentureMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis"> us-gaap:CorporateJointVentureMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2021-09-14 </instant>
</period>
</context>
<context id="i9df475336f4742019be80be30aa8e211_D20210914-20210914">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:CounterpartyNameAxis"> opk:LeaderMedMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="srt:OwnershipAxis"> opk:LeaderMedJointVentureMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> opk:TransferOfIntellectualPropertyAndOtherMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis"> us-gaap:CorporateJointVentureMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-09-14 </startDate>
<endDate> 2021-09-14 </endDate>
</period>
</context>
<context id="i2ba27a001dea4cc59d62f4a7ffee8b4f_I20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis"> us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"> opk:ZebraMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis"> us-gaap:SeriesAPreferredStockMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-06-30 </instant>
</period>
</context>
<context id="i3b7a2e82c132485bba44954c33dc0a80_D20220101-20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis"> us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"> opk:ZebraMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis"> us-gaap:RestrictedStockMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-01-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="i0044bb7665294ec49393bbdcb93e676c_I20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis"> us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"> opk:ZebraMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-06-30 </instant>
</period>
</context>
<context id="i151ab0dd04b3481fb9699222fcf20168_I20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis"> opk:ConvertibleSeniorNotesDue2025Member </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis"> us-gaap:ConvertibleDebtMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-06-30 </instant>
</period>
</context>
<context id="i4efdf654d84c4d7688276f9207347029_I20211231">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis"> opk:ConvertibleSeniorNotesDue2025Member </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis"> us-gaap:ConvertibleDebtMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2021-12-31 </instant>
</period>
</context>
<context id="i545b69ea550943f383e91660d1351a32_I20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis"> opk:A5ConvertibleNotesMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis"> us-gaap:ConvertibleDebtMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-06-30 </instant>
</period>
</context>
<context id="id441ab2a289c4a5d92325001746be946_I20211231">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis"> opk:A5ConvertibleNotesMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis"> us-gaap:ConvertibleDebtMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2021-12-31 </instant>
</period>
</context>
<context id="iaa9313f365864c73929898dbbfd8cc12_I20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis"> opk:NotesDueFebruary12033Member </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis"> us-gaap:ConvertibleNotesPayableMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-06-30 </instant>
</period>
</context>
<context id="i5e346875c2a14be79c94a0ea3d5b0ec1_I20211231">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis"> opk:NotesDueFebruary12033Member </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis"> us-gaap:ConvertibleNotesPayableMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2021-12-31 </instant>
</period>
</context>
<context id="ic9f69debfc1749da97c5998f7384fdc1_I20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis"> us-gaap:RevolvingCreditFacilityMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis"> opk:NewCreditAgreementMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis"> us-gaap:LineOfCreditMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-06-30 </instant>
</period>
</context>
<context id="id62e921fa70e48b8bcd0517e930bbf99_I20211231">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis"> us-gaap:RevolvingCreditFacilityMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis"> opk:NewCreditAgreementMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis"> us-gaap:LineOfCreditMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2021-12-31 </instant>
</period>
</context>
<context id="ic0a23d2a2b9748de8fc661ffee37ea8e_I20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis"> us-gaap:LineOfCreditMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-06-30 </instant>
</period>
</context>
<context id="ifc4a073257294a89b0fae4e5d964a900_I20211231">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis"> us-gaap:LineOfCreditMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2021-12-31 </instant>
</period>
</context>
<context id="ia01691970d624340948847c83273440d_I20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis"> us-gaap:NotesPayableOtherPayablesMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-06-30 </instant>
</period>
</context>
<context id="i6c8fc69a7d8d49cf8d3016e333b33f00_I20211231">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis"> us-gaap:NotesPayableOtherPayablesMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2021-12-31 </instant>
</period>
</context>
<context id="i2bc99c77452b4f53ba5c749761fbfb98_I20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis"> opk:ConvertibleNotesMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-06-30 </instant>
</period>
</context>
<context id="i286b350a85e94dbda1c1fbe93da8ec3f_I20211231">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis"> opk:ConvertibleNotesMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2021-12-31 </instant>
</period>
</context>
<context id="i08bce415af5648368d40c1e9504721af_I20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis"> opk:LineOfCreditAndNotesAndLoansPayableCurrentMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-06-30 </instant>
</period>
</context>
<context id="i2f7ea3469cb440b494ef76cac5c2e8b7_I20211231">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis"> opk:LineOfCreditAndNotesAndLoansPayableCurrentMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2021-12-31 </instant>
</period>
</context>
<context id="i9527c584ee6e460bb59b851ee6b2385d_I20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis"> us-gaap:OtherNoncurrentLiabilitiesMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-06-30 </instant>
</period>
</context>
<context id="icd2fa1bdbc054e5ca0d1119b9283489e_I20211231">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis"> us-gaap:OtherNoncurrentLiabilitiesMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2021-12-31 </instant>
</period>
</context>
<context id="i074565638db14b50ae97acdfc5c6aeaf_I20190228">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis"> opk:ConvertibleSeniorNotesDue2025Member </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis"> us-gaap:ConvertibleDebtMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2019-02-28 </instant>
</period>
</context>
<context id="iacae9f4f1fed4a7d9cbb734bd178394b_I20190228">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis"> us-gaap:ConvertibleDebtMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2019-02-28 </instant>
</period>
</context>
<context id="ic7549257a4ef4d1a96574093d9e6df03_D20190201-20190228">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:RangeAxis"> srt:MinimumMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis"> opk:ConvertibleSeniorNotesDue2025Member </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis"> us-gaap:DebtInstrumentRedemptionPeriodOneMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis"> us-gaap:ConvertibleDebtMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2019-02-01 </startDate>
<endDate> 2019-02-28 </endDate>
</period>
</context>
<context id="i8494b4ff6e2f4657b1504a0722acf6ce_D20190201-20190228">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:RangeAxis"> srt:MaximumMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis"> opk:ConvertibleSeniorNotesDue2025Member </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis"> us-gaap:DebtInstrumentRedemptionPeriodOneMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis"> us-gaap:ConvertibleDebtMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2019-02-01 </startDate>
<endDate> 2019-02-28 </endDate>
</period>
</context>
<context id="ia36206cec58a422eafdbb64775321560_D20190201-20190228">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis"> opk:ConvertibleSeniorNotesDue2025Member </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis"> us-gaap:DebtInstrumentRedemptionPeriodOneMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis"> us-gaap:ConvertibleDebtMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2019-02-01 </startDate>
<endDate> 2019-02-28 </endDate>
</period>
</context>
<context id="ibfa24f105ca34a13bfb968d16a59e767_D20190201-20190228">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:RangeAxis"> srt:MinimumMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis"> opk:ConvertibleSeniorNotesDue2025Member </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis"> us-gaap:DebtInstrumentRedemptionPeriodTwoMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis"> us-gaap:ConvertibleDebtMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2019-02-01 </startDate>
<endDate> 2019-02-28 </endDate>
</period>
</context>
<context id="ieea8bcf2f45a48698e5815a155f81004_D20190201-20190228">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:RangeAxis"> srt:MaximumMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis"> opk:ConvertibleSeniorNotesDue2025Member </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis"> us-gaap:DebtInstrumentRedemptionPeriodTwoMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis"> us-gaap:ConvertibleDebtMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2019-02-01 </startDate>
<endDate> 2019-02-28 </endDate>
</period>
</context>
<context id="ie3d1c7fac426448cb3f3648f46054f60_D20190201-20190228">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis"> opk:ConvertibleSeniorNotesDue2025Member </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis"> us-gaap:DebtInstrumentRedemptionPeriodTwoMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis"> us-gaap:ConvertibleDebtMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2019-02-01 </startDate>
<endDate> 2019-02-28 </endDate>
</period>
</context>
<context id="i7dcec7dfdeae4be998d97f1b318f9433_D20220101-20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis"> opk:ConvertibleSeniorNotesDue2025Member </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis"> us-gaap:DebtInstrumentRedemptionPeriodThreeMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis"> us-gaap:ConvertibleDebtMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-01-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="i22f25b04b85c4d44bbe55e3c2bf93530_D20220101-20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:RangeAxis"> srt:MinimumMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis"> opk:ConvertibleSeniorNotesDue2025Member </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis"> us-gaap:DebtInstrumentRedemptionPeriodThreeMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis"> us-gaap:ConvertibleDebtMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-01-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="i2df390f6e40342238875ab8db49600de_D20220101-20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:RangeAxis"> srt:MaximumMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis"> opk:ConvertibleSeniorNotesDue2025Member </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis"> us-gaap:DebtInstrumentRedemptionPeriodThreeMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis"> us-gaap:ConvertibleDebtMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-01-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="i04b77a20c73249288e12d7cc6ab35d1e_D20210501-20210531">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis"> opk:ConvertibleSeniorNotesDue2025Member </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis"> us-gaap:ConvertibleDebtMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-05-01 </startDate>
<endDate> 2021-05-31 </endDate>
</period>
</context>
<context id="ic07e78aa482c4bbc874a70c2e542f37e_D20220101-20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis"> opk:ConvertibleSeniorNotesDue2025Member </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis"> us-gaap:ConvertibleDebtMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-01-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="i5fc13571b11d4722895953bcfbe46938_D20210101-20211231">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis"> opk:ConvertibleSeniorNotesDue2025Member </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis"> us-gaap:ConvertibleDebtMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-01-01 </startDate>
<endDate> 2021-12-31 </endDate>
</period>
</context>
<context id="i066796790696499cb2b9834b409c969e_I20211231">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis"> us-gaap:SeniorNotesMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2021-12-31 </instant>
</period>
</context>
<context id="i40a7fd1ae9844d22adbba23face78713_D20220101-20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis"> us-gaap:SeniorNotesMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-01-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="icf03735524d949168f73504e648fc104_I20211231">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis"> srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis"> us-gaap:AccountingStandardsUpdate202006Member </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis"> us-gaap:SeniorNotesMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2021-12-31 </instant>
</period>
</context>
<context id="i2f8779c083c44285914f38702ee04ee0_I20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis"> us-gaap:SeniorNotesMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-06-30 </instant>
</period>
</context>
<context id="ib1eb3cc9d65e4d7d91eacb3270347554_I20180228">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis"> opk:A5ConvertibleNotesMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis"> us-gaap:ConvertibleDebtMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2018-02-28 </instant>
</period>
</context>
<context id="i40ed7e7b6fdb443f812627efa4fbe8b7_D20180201-20180228">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis"> opk:A5ConvertibleNotesMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis"> us-gaap:ConvertibleDebtMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2018-02-01 </startDate>
<endDate> 2018-02-28 </endDate>
</period>
</context>
<context id="i5e2069d0507747518c38c942dba9afb2_I20130130">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis"> opk:NotesDueFebruary12033Member </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis"> us-gaap:SeniorNotesMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2013-01-30 </instant>
</period>
</context>
<context id="i9ea765d456714acaa37e12d880184a34_D20130130-20130130">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis"> opk:NotesDueFebruary12033Member </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis"> us-gaap:SeniorNotesMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2013-01-30 </startDate>
<endDate> 2013-01-30 </endDate>
</period>
</context>
<context id="i3998285cf79345bf85e2e3c20bed4e2b_D20130101-20161231">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis"> opk:NotesDueFebruary12033Member </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis"> us-gaap:ConvertibleDebtMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2013-01-01 </startDate>
<endDate> 2016-12-31 </endDate>
</period>
</context>
<context id="i6ed1d5ceb104456c81e7bea1dc044cd5_D20130101-20161231">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis"> opk:NotesDueFebruary12033Member </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis"> us-gaap:ConvertibleDebtMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis"> us-gaap:CommonStockMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2013-01-01 </startDate>
<endDate> 2016-12-31 </endDate>
</period>
</context>
<context id="id987f0ef8a464c24a3e364f9b084a2db_I20190201">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis"> opk:NotesDueFebruary12033Member </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis"> us-gaap:ConvertibleNotesPayableMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2019-02-01 </instant>
</period>
</context>
<context id="i8137f42862c24bce826ee0380e613886_D20130101-20130131">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis"> opk:NotesDueFebruary12033Member </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis"> us-gaap:ConvertibleNotesPayableMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2013-01-01 </startDate>
<endDate> 2013-01-31 </endDate>
</period>
</context>
<context id="i533360515fa240e397a47831e256567b_I20151130">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis"> us-gaap:RevolvingCreditFacilityMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis"> opk:NewCreditAgreementMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis"> us-gaap:LineOfCreditMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2015-11-30 </instant>
</period>
</context>
<context id="ia43ec42737404e39a71e997f75a42a7d_I20151130">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis"> us-gaap:BridgeLoanMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis"> opk:NewCreditAgreementMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis"> us-gaap:LineOfCreditMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2015-11-30 </instant>
</period>
</context>
<context id="i88d19b39fa04431a872085f065eb25f7_I20151130">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis"> us-gaap:LetterOfCreditMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis"> opk:NewCreditAgreementMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis"> us-gaap:LineOfCreditMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2015-11-30 </instant>
</period>
</context>
<context id="ic515d09273fb4eb9a043d9e55756833a_D20151101-20151130">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis"> us-gaap:RevolvingCreditFacilityMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis"> opk:NewCreditAgreementMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis"> us-gaap:LineOfCreditMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:VariableRateAxis"> us-gaap:LondonInterbankOfferedRateLIBORMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2015-11-01 </startDate>
<endDate> 2015-11-30 </endDate>
</period>
</context>
<context id="i2546e962b7a444f49aae29ce581c6605_D20151101-20151130">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis"> us-gaap:RevolvingCreditFacilityMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis"> opk:NewCreditAgreementMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis"> us-gaap:LineOfCreditMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:VariableRateAxis"> opk:LondonInterbankOfferedRateLIBORFirstTwelveMonthsMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2015-11-01 </startDate>
<endDate> 2015-11-30 </endDate>
</period>
</context>
<context id="ib337a97b28244b6f8323a94c9849538c_D20151101-20151130">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis"> us-gaap:RevolvingCreditFacilityMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis"> opk:NewCreditAgreementMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis"> us-gaap:LineOfCreditMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:VariableRateAxis"> opk:LondonInterbankOfferedRateLIBORFirstTwelveMonthsAdjustedforEurocurrencyLiabilitiesMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2015-11-01 </startDate>
<endDate> 2015-11-30 </endDate>
</period>
</context>
<context id="if7609ec898974cd2bb37b42f63ea1c14_D20151101-20151130">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis"> us-gaap:RevolvingCreditFacilityMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis"> opk:NewCreditAgreementMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis"> us-gaap:LineOfCreditMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="opk:LineOfCreditFacilityRevolvingCommitmentAxis"> opk:LineOfCreditFacility50OrMoreOfRevolvingCommitmentMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2015-11-01 </startDate>
<endDate> 2015-11-30 </endDate>
</period>
</context>
<context id="i90097e8f2e3d48f39d40078004a70570_D20151101-20151130">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis"> us-gaap:RevolvingCreditFacilityMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis"> opk:NewCreditAgreementMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis"> us-gaap:LineOfCreditMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="opk:LineOfCreditFacilityRevolvingCommitmentAxis"> opk:LineOfCreditFacilityLessThanOrEqualTo50OfRevolvingCommitmentMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2015-11-01 </startDate>
<endDate> 2015-11-30 </endDate>
</period>
</context>
<context id="ib66e75fd6c1047b58f966338304821dd_I20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis"> opk:BioReferenceMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-06-30 </instant>
</period>
</context>
<context id="i56807793c69c4ec9a634208091e94279_I20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis"> opk:JPMorganChaseMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-06-30 </instant>
</period>
</context>
<context id="i2344a50075bf4971aa6e540623c2c620_I20211231">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis"> opk:JPMorganChaseMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2021-12-31 </instant>
</period>
</context>
<context id="ice0af0cb7369458d8f7c448eba85ffeb_I20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis"> opk:ItauBankMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-06-30 </instant>
</period>
</context>
<context id="i49ecd9df98ab40aaa2b8d33dd8ee5c51_I20211231">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis"> opk:ItauBankMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2021-12-31 </instant>
</period>
</context>
<context id="i52523bea912c40b9938f4d706c10e999_I20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis"> opk:BankOfChileMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-06-30 </instant>
</period>
</context>
<context id="i52c0ae43e5d24cc68b9582d04cb605f9_I20211231">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis"> opk:BankOfChileMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2021-12-31 </instant>
</period>
</context>
<context id="i60b61041434f419394d47f328f70ec2c_I20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis"> opk:BiceBankMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-06-30 </instant>
</period>
</context>
<context id="i16d500ea31cb4f2789f1f3ef7ec22d7e_I20211231">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis"> opk:BiceBankMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2021-12-31 </instant>
</period>
</context>
<context id="ie72f8d56489f4905a1971d13983ffac7_I20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis"> opk:ScotiabankMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-06-30 </instant>
</period>
</context>
<context id="i255535a8ace24b70829bdf68bfe2e690_I20211231">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis"> opk:ScotiabankMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2021-12-31 </instant>
</period>
</context>
<context id="i1a1f3fd7481e4dd6a1c53610266dcf0a_I20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis"> opk:SantanderBankMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-06-30 </instant>
</period>
</context>
<context id="i2712915f41d44376bdc9fd4e0d28de41_I20211231">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis"> opk:SantanderBankMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2021-12-31 </instant>
</period>
</context>
<context id="ib70c4920bea74eeca7f56555043a32a3_I20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis"> opk:SecurityMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-06-30 </instant>
</period>
</context>
<context id="ide3f5554e53c4dab98cc2c73c680f90f_I20211231">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis"> opk:SecurityMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2021-12-31 </instant>
</period>
</context>
<context id="id66fd4396bb54240a254a860ef3e5240_I20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis"> opk:EstadoBankMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-06-30 </instant>
</period>
</context>
<context id="ib8c7ae40d2d749828e9af1f579d12fb2_I20211231">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis"> opk:EstadoBankMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2021-12-31 </instant>
</period>
</context>
<context id="i5637acfcd63249cd82d7154c4c0f12f0_I20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis"> opk:BCIBankMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-06-30 </instant>
</period>
</context>
<context id="id1567ec7311643dd88397949786c9b43_I20211231">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis"> opk:BCIBankMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2021-12-31 </instant>
</period>
</context>
<context id="ie2ccd76b30e140c48c99c770483b6f5c_I20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis"> opk:Corpbanca1Member </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-06-30 </instant>
</period>
</context>
<context id="ie3458844527444f38fbe8ba9edb158c6_I20211231">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis"> opk:Corpbanca1Member </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2021-12-31 </instant>
</period>
</context>
<context id="id58289e26ef94850ac4a7fc7f7ebd663_I20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis"> opk:InternationalBankMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-06-30 </instant>
</period>
</context>
<context id="i04b9f66f168143bd90f0da006fed8821_I20211231">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis"> opk:InternationalBankMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2021-12-31 </instant>
</period>
</context>
<context id="i1718a3744fce467e9d6d675f095bd492_I20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis"> opk:ConsoorcioBankMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-06-30 </instant>
</period>
</context>
<context id="i6ba73a1704414fdb8410cf207c73c0c1_I20211231">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis"> opk:ConsoorcioBankMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2021-12-31 </instant>
</period>
</context>
<context id="i05bc4a7a182945a580aa3920bde0e0b3_I20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis"> opk:BancoDeSabadellMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-06-30 </instant>
</period>
</context>
<context id="i6783b43b6eb6425fa7d452652473e794_I20211231">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis"> opk:BancoDeSabadellMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2021-12-31 </instant>
</period>
</context>
<context id="i597fd23d185f4f11835243b671f72ad8_I20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis"> opk:SantanderBank2Member </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-06-30 </instant>
</period>
</context>
<context id="i6b5d01d98bd541cd86e2d77e9037086a_I20211231">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis"> opk:SantanderBank2Member </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2021-12-31 </instant>
</period>
</context>
<context id="i5ed93df026694b52bdb270cb2e2bba15_I20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis"> opk:NotesPayableAndOtherLongTermLiabilitiesMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-06-30 </instant>
</period>
</context>
<context id="i393cb528c2304024a2d3dab1c70aa562_I20211231">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis"> opk:NotesPayableAndOtherLongTermLiabilitiesMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2021-12-31 </instant>
</period>
</context>
<context id="i28c749cd61f5444e8a8e514d12554ce0_I20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:RangeAxis"> srt:MinimumMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis"> opk:OPKOHealthEuropeMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-06-30 </instant>
</period>
</context>
<context id="i15d550a3788a46098959eb013a63ace4_I20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:RangeAxis"> srt:MaximumMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis"> opk:OPKOHealthEuropeMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-06-30 </instant>
</period>
</context>
<context id="if8ff0b6e8f3a4561b6661e6b9d97aaea_I20211231">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis"> opk:OPKOHealthEuropeMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2021-12-31 </instant>
</period>
</context>
<context id="i092cd0d4f9f24c7e85aa4253a35b7074_I20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis"> opk:OPKOHealthEuropeMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-06-30 </instant>
</period>
</context>
<context id="id0f2d83dfceb4643b6689cb2c3735e7c_D20190201-20190228">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis"> opk:ConvertibleSeniorNotesDue2025Member </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis"> us-gaap:ConvertibleDebtMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2019-02-01 </startDate>
<endDate> 2019-02-28 </endDate>
</period>
</context>
<context id="i303bb35bf09d4dc7856750f6db40b282_I20211231">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:AccumulatedTranslationAdjustmentMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2021-12-31 </instant>
</period>
</context>
<context id="i8653f039aac143078e56b57e5a08417b_D20220101-20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:AccumulatedTranslationAdjustmentMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-01-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="if3554448f2d343a8844430991e28c3a6_I20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:AccumulatedTranslationAdjustmentMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-06-30 </instant>
</period>
</context>
<context id="ibfea464ded6448aca552adef980e0da4_I20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis"> us-gaap:FairValueInputsLevel1Member </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-06-30 </instant>
</period>
</context>
<context id="i72fd1c49a8474b988e35665a53082217_I20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis"> us-gaap:FairValueInputsLevel2Member </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-06-30 </instant>
</period>
</context>
<context id="i0fc88df2a18e4450acfcd643aba9ccf2_I20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis"> us-gaap:FairValueInputsLevel3Member </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-06-30 </instant>
</period>
</context>
<context id="ie0dc6128eb0c40be9f94448bec95076d_I20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis"> us-gaap:FairValueInputsLevel1Member </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis"> us-gaap:EquitySecuritiesMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-06-30 </instant>
</period>
</context>
<context id="i9a020d7596b24ac89b62d0eb67e8c866_I20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis"> us-gaap:FairValueInputsLevel2Member </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis"> us-gaap:EquitySecuritiesMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-06-30 </instant>
</period>
</context>
<context id="i6d3eb36da42c4da58345c85c97b23dd6_I20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis"> us-gaap:FairValueInputsLevel3Member </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis"> us-gaap:EquitySecuritiesMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-06-30 </instant>
</period>
</context>
<context id="i76b9d049162140ef8b8eabf4c02dfee2_I20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis"> us-gaap:EquitySecuritiesMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-06-30 </instant>
</period>
</context>
<context id="i224bb3923e45495e9ce69f0beac16ec0_I20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis"> us-gaap:FairValueInputsLevel1Member </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis"> us-gaap:ForwardContractsMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-06-30 </instant>
</period>
</context>
<context id="i37f76838f367409e8e4e168dcd0a01d0_I20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis"> us-gaap:FairValueInputsLevel2Member </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis"> us-gaap:ForwardContractsMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-06-30 </instant>
</period>
</context>
<context id="i4f45baa5bfd249ffbb20b64a82f05cbf_I20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis"> us-gaap:FairValueInputsLevel3Member </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis"> us-gaap:ForwardContractsMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-06-30 </instant>
</period>
</context>
<context id="i6c79f94c7c804d89a36e480b424e57c0_I20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis"> us-gaap:ForwardContractsMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-06-30 </instant>
</period>
</context>
<context id="i6a5748dbc7a446c1964b3d4f2f126e82_I20211231">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis"> us-gaap:FairValueInputsLevel1Member </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2021-12-31 </instant>
</period>
</context>
<context id="i88bc132bdde94d76820fbb0d52c10d79_I20211231">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis"> us-gaap:FairValueInputsLevel2Member </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2021-12-31 </instant>
</period>
</context>
<context id="i582ac628f05e4953b9ccd2fab6e714a6_I20211231">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis"> us-gaap:FairValueInputsLevel3Member </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2021-12-31 </instant>
</period>
</context>
<context id="i36a7a2d12b9748f2aca5ab5d89b03eb6_I20211231">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis"> us-gaap:FairValueInputsLevel1Member </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis"> us-gaap:EquitySecuritiesMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2021-12-31 </instant>
</period>
</context>
<context id="i55ec0a6131f24494b7123673340c96ce_I20211231">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis"> us-gaap:FairValueInputsLevel2Member </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis"> us-gaap:EquitySecuritiesMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2021-12-31 </instant>
</period>
</context>
<context id="i1fd3c9f461504a349a8f742d36f61319_I20211231">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis"> us-gaap:FairValueInputsLevel3Member </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis"> us-gaap:EquitySecuritiesMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2021-12-31 </instant>
</period>
</context>
<context id="i70ea49e1b5564a3999a159525ab40e66_I20211231">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis"> us-gaap:EquitySecuritiesMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2021-12-31 </instant>
</period>
</context>
<context id="ie9a939f96724436881465c6a9d817aef_I20211231">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis"> us-gaap:FairValueInputsLevel1Member </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis"> us-gaap:ForwardContractsMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2021-12-31 </instant>
</period>
</context>
<context id="iae1118f31b46442ab3feff33e0fe8bec_I20211231">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis"> us-gaap:FairValueInputsLevel2Member </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis"> us-gaap:ForwardContractsMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2021-12-31 </instant>
</period>
</context>
<context id="iacfe781a9cc44b3ca00b4513c457db51_I20211231">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis"> us-gaap:FairValueInputsLevel3Member </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis"> us-gaap:ForwardContractsMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2021-12-31 </instant>
</period>
</context>
<context id="ie3e8b63088884c56bcfc29948f65e463_I20211231">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis"> us-gaap:ForwardContractsMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2021-12-31 </instant>
</period>
</context>
<context id="ia33981192edd41b59027684f379a1ab3_I20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis"> us-gaap:CarryingReportedAmountFairValueDisclosureMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis"> us-gaap:ConvertibleNotesPayableMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-06-30 </instant>
</period>
</context>
<context id="i28b0014b24b8439fa52208ad6b809311_I20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis"> us-gaap:ConvertibleNotesPayableMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-06-30 </instant>
</period>
</context>
<context id="i06767b8ced884b4ca516f64257f3a9f5_I20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis"> us-gaap:FairValueInputsLevel1Member </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis"> us-gaap:ConvertibleNotesPayableMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-06-30 </instant>
</period>
</context>
<context id="ia6da14e46e95405a8e44c6fba822c6a4_I20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis"> us-gaap:FairValueInputsLevel2Member </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis"> us-gaap:ConvertibleNotesPayableMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-06-30 </instant>
</period>
</context>
<context id="i8d292d3ca8cd41e4aeaa2d9ee4f153ba_I20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis"> us-gaap:FairValueInputsLevel3Member </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis"> us-gaap:ConvertibleNotesPayableMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-06-30 </instant>
</period>
</context>
<context id="i59e36a43bbbe44558e75fc9e6cfa6012_I20211231">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis"> opk:ContingentConsiderationMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2021-12-31 </instant>
</period>
</context>
<context id="i65a0b049acb747c29820329d4e8557c9_D20220101-20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis"> opk:ContingentConsiderationMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-01-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="i6d6bd1d1a436445e9d4d16e321631499_I20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis"> opk:ContingentConsiderationMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-06-30 </instant>
</period>
</context>
<context id="i9f2a6258e98049439883dbcb99e01f29_I20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis"> us-gaap:AccruedLiabilitiesMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-06-30 </instant>
</period>
</context>
<context id="i65efe3dd9bdc415c805cfd2726799008_I20211231">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis"> us-gaap:AccruedLiabilitiesMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2021-12-31 </instant>
</period>
</context>
<context id="ib02175831f164aafbfaa698c482e0a71_I20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis"> us-gaap:InvestmentsMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis"> us-gaap:StockOptionMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis"> us-gaap:NondesignatedMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-06-30 </instant>
</period>
</context>
<context id="i75d42ed8c77d46dc983e5330c62b3740_I20211231">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis"> us-gaap:InvestmentsMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis"> us-gaap:StockOptionMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis"> us-gaap:NondesignatedMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2021-12-31 </instant>
</period>
</context>
<context id="i215af1b905a347d8ac401994928e236c_I20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis"> opk:PrepaidExpensesandOtherCurrentAssetsAccruedExpensesMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis"> us-gaap:ForwardContractsMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis"> us-gaap:NondesignatedMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-06-30 </instant>
</period>
</context>
<context id="i9a6eb9ed46e64435be8fba557735d4d7_I20211231">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis"> opk:PrepaidExpensesandOtherCurrentAssetsAccruedExpensesMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis"> us-gaap:ForwardContractsMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis"> us-gaap:NondesignatedMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2021-12-31 </instant>
</period>
</context>
<context id="i9fe4947833b24a4ca64cc0f859ec1795_D20220401-20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis"> us-gaap:StockOptionMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis"> us-gaap:NondesignatedMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-04-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="i57ec4d548aff49f3b1f854d388eb755a_D20210401-20210630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis"> us-gaap:StockOptionMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis"> us-gaap:NondesignatedMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-04-01 </startDate>
<endDate> 2021-06-30 </endDate>
</period>
</context>
<context id="ie2a3239bdd9d4c728245bea98e009d26_D20220101-20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis"> us-gaap:StockOptionMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis"> us-gaap:NondesignatedMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-01-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="i4316d86be62847d29b15b6cebf47ae09_D20210101-20210630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis"> us-gaap:StockOptionMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis"> us-gaap:NondesignatedMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-01-01 </startDate>
<endDate> 2021-06-30 </endDate>
</period>
</context>
<context id="ia55be08871dc4a009ceb35ae7fb8f266_D20220401-20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis"> us-gaap:ForwardContractsMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis"> us-gaap:NondesignatedMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-04-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="i9bf8a7f7eb234ea5a19f7687de9e9813_D20210401-20210630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis"> us-gaap:ForwardContractsMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis"> us-gaap:NondesignatedMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-04-01 </startDate>
<endDate> 2021-06-30 </endDate>
</period>
</context>
<context id="if20244744d774e6398b6bae428452264_D20220101-20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis"> us-gaap:ForwardContractsMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis"> us-gaap:NondesignatedMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-01-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="i2aced1f8a06c428bb238f003fd83ae71_D20210101-20210630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis"> us-gaap:ForwardContractsMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis"> us-gaap:NondesignatedMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-01-01 </startDate>
<endDate> 2021-06-30 </endDate>
</period>
</context>
<context id="iee6e65958638450585afc60d10fbd82b_D20220401-20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis"> us-gaap:NondesignatedMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-04-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="ie4f941de7d37464b935e1e24982cf735_D20210401-20210630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis"> us-gaap:NondesignatedMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-04-01 </startDate>
<endDate> 2021-06-30 </endDate>
</period>
</context>
<context id="i3e4dd7f6b70f47caa8ffd853fab9de85_D20220101-20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis"> us-gaap:NondesignatedMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-01-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="if0247590b7594ea9a15bd401f6de3a00_D20210101-20210630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis"> us-gaap:NondesignatedMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-01-01 </startDate>
<endDate> 2021-06-30 </endDate>
</period>
</context>
<context id="ia7a3c018e543418cafcd9447f550bae3_D20200801-20200831">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis"> us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"> opk:DetectGenomixMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2020-08-01 </startDate>
<endDate> 2020-08-31 </endDate>
</period>
</context>
<context id="i0d7891d8150144dd97ca108bf7292e46_I20200831">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis"> us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"> opk:DetectGenomixMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2020-08-31 </instant>
</period>
</context>
<context id="i4017b4d7760c4bf599661ff8eca425ac_D20200801-20200831">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis"> us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"> opk:DetectGenomixMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="dei:LegalEntityAxis"> opk:MednaxServicesIncMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2020-08-01 </startDate>
<endDate> 2020-08-31 </endDate>
</period>
</context>
<context id="idf1a2a8d8a014959b4fbfdb9c285551d_I20200831">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis"> us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"> opk:DetectGenomixMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="dei:LegalEntityAxis"> opk:MednaxServicesIncMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2020-08-31 </instant>
</period>
</context>
<context id="i6b2fc03757264304b6d7b20379ad54df_D20220101-20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis"> opk:DetectGenomixMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-01-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="id6c8824b84b940149de9701215df8749_I20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis"> opk:DetectGenomixMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-06-30 </instant>
</period>
</context>
<context id="if907ce6e11c94b43a96b7cfe0ea19f49_I20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis"> opk:SharesReceivedUponClosingofXeneticTransactionMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis"> srt:DirectorMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-06-30 </instant>
</period>
</context>
<context id="i16b541229b024da08f7daa48c380124d_D20220101-20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"> opk:ZebraMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-01-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="i64c7c96871b341d99d80d66a62fbcdf5_I20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"> opk:ChromadexCorporationMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-06-30 </instant>
</period>
</context>
<context id="i822b73267c824562bdff0073abf69c90_I20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"> opk:NIMSMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-06-30 </instant>
</period>
</context>
<context id="i9943940092354c79b00f75f6a1a4d840_I20190801">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis"> opk:FrostRealEstateHoldingsLLCMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2019-08-01 </instant>
</period>
</context>
<context id="i338cafba600248e69d11f39d67c116f5_D20220101-20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis"> opk:BeckmanCoulterMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-01-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="i7a7dbbd3653743e989676feff6ad0792_D20220101-20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis"> opk:IntegratedDNATechnologiesIncMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-01-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="i5355afa387de46198fcac5ce089f240e_D20220101-20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis"> opk:LeicaMicrosystemsIncMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-01-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="i47726716d3bd4c8593b1d488649813a3_D20220101-20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:LitigationCaseAxis"> opk:CivilInvestigativeDemandsMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis"> us-gaap:SettledLitigationMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-01-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="i7e1df4373dd046b89578b1be8e91e5ea_I20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:LitigationCaseAxis"> opk:CivilInvestigativeDemandsMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis"> us-gaap:SettledLitigationMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-06-30 </instant>
</period>
</context>
<context id="icc3fe055809a40779843b63725072220_I20211231">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:LitigationCaseAxis"> opk:CivilInvestigativeDemandsMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis"> us-gaap:SettledLitigationMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2021-12-31 </instant>
</period>
</context>
<context id="if50ac22ea363492e8881a12b69f412df_I20190405">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:LitigationCaseAxis"> opk:ChanceryCourtOfDelawareVsCompanyMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis"> us-gaap:SettledLitigationMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2019-04-05 </instant>
</period>
</context>
<context id="i834a9a4eb5f145048be6d98d14a1f2d0_D20210101-20210131">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:LitigationCaseAxis"> opk:ChanceryCourtOfDelawareVsCompanyMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis"> us-gaap:SettledLitigationMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-01-01 </startDate>
<endDate> 2021-01-31 </endDate>
</period>
</context>
<context id="i557a3a4d196441c3b5affd3d0bb5e05e_D20200922-20200922">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:LitigationCaseAxis"> opk:SouthernDistrictOfNewYorkVsBioReferenceMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis"> us-gaap:SettledLitigationMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2020-09-22 </startDate>
<endDate> 2020-09-22 </endDate>
</period>
</context>
<context id="i6bb5c2adbf0542a3aca179aa23bb6ae7_D20220401-20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> opk:HealthInsurersMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-04-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="idc2dbc0d17014b3b852db13d3e1a4057_D20210401-20210630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> opk:HealthInsurersMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-04-01 </startDate>
<endDate> 2021-06-30 </endDate>
</period>
</context>
<context id="ic2e7e867f4b44c73ac8edb9086cbf1af_D20220101-20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> opk:HealthInsurersMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-01-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="i4f0143a4a10e47a4ba818e759bfb700d_D20210101-20210630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> opk:HealthInsurersMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-01-01 </startDate>
<endDate> 2021-06-30 </endDate>
</period>
</context>
<context id="ia7f60d6c17c74ef0aea353cfcb26e682_D20220401-20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> opk:GovernmentPayersMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-04-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="ie851abf1a45b4637b3015e54ab1c0454_D20210401-20210630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> opk:GovernmentPayersMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-04-01 </startDate>
<endDate> 2021-06-30 </endDate>
</period>
</context>
<context id="ic5af5a8651384732a5e6104062d9073e_D20220101-20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> opk:GovernmentPayersMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-01-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="i6ba426be3e6248f6a2f174a0369b8b19_D20210101-20210630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> opk:GovernmentPayersMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-01-01 </startDate>
<endDate> 2021-06-30 </endDate>
</period>
</context>
<context id="i1ab1365924f1495b8be46a46d65c2278_D20220401-20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> opk:ClientPayersMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-04-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="ia7b1375110964abc93b30e830fa5b992_D20210401-20210630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> opk:ClientPayersMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-04-01 </startDate>
<endDate> 2021-06-30 </endDate>
</period>
</context>
<context id="i14984c435d404fafbacb8be50aebf8ff_D20220101-20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> opk:ClientPayersMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-01-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="i042dff45e2104ae1833cb6868607adf0_D20210101-20210630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> opk:ClientPayersMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-01-01 </startDate>
<endDate> 2021-06-30 </endDate>
</period>
</context>
<context id="ib56a9313041e44fab2a2830a8b058ec3_D20220401-20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> opk:PatientsMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-04-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="ie2d7cbc3727d4b6f8a7e93840976603b_D20210401-20210630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> opk:PatientsMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-04-01 </startDate>
<endDate> 2021-06-30 </endDate>
</period>
</context>
<context id="i0e3cfc7a7a4f4555a055e51ca671291c_D20220101-20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> opk:PatientsMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-01-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="i26b22c38d09e4e989bfde7f05a03aa9d_D20210101-20210630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> opk:PatientsMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-01-01 </startDate>
<endDate> 2021-06-30 </endDate>
</period>
</context>
<context id="if8f23b3b6d824e96b4de7bfae5af2e49_D20220401-20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> opk:RayaldeeMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-04-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="ibe1ed031e1284ea7821dad180688ecc8_D20220101-20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> opk:RayaldeeMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-01-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="i564e75108a164e5aa777de7fd2247e9b_D20210401-20210630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> opk:RayaldeeMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-04-01 </startDate>
<endDate> 2021-06-30 </endDate>
</period>
</context>
<context id="ia33f8e8ebe3940b9a6803c8dfd6f8d8f_D20210101-20210630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> opk:RayaldeeMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-01-01 </startDate>
<endDate> 2021-06-30 </endDate>
</period>
</context>
<context id="ic1087ac8d7514474b2cac40fdc6bce07_I20220331">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> opk:RayaldeeMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis"> opk:ChargebacksDiscountsRebatesAndFeesMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-03-31 </instant>
</period>
</context>
<context id="iccdfcf68105c4872a57cb3412df9b1eb_I20220331">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> opk:RayaldeeMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis"> opk:GovernmentalMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-03-31 </instant>
</period>
</context>
<context id="i8345f727b97746f4b228735fddfc5c08_I20220331">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> opk:RayaldeeMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis"> opk:SalesReturnsMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-03-31 </instant>
</period>
</context>
<context id="ie710435ef69c4a1a8c49d15fc6acce34_I20220331">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> opk:RayaldeeMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-03-31 </instant>
</period>
</context>
<context id="i48e11b8eeace403f82bfd20fb1c0b226_D20220401-20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> opk:RayaldeeMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis"> opk:ChargebacksDiscountsRebatesAndFeesMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-04-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="i9192452aae374b5b8060a5f9b4a10f7c_D20220401-20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> opk:RayaldeeMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis"> opk:GovernmentalMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-04-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="i45442e11dab0461d9e9ecd4e3dbe877c_D20220401-20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> opk:RayaldeeMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis"> opk:SalesReturnsMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-04-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="i8450d55aab1847daa919e89902d7e12b_I20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> opk:RayaldeeMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis"> opk:ChargebacksDiscountsRebatesAndFeesMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-06-30 </instant>
</period>
</context>
<context id="i4d6fe13bb5ea4edd9ac036805619ec63_I20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> opk:RayaldeeMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis"> opk:GovernmentalMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-06-30 </instant>
</period>
</context>
<context id="idd9e352e5df04547a80bc7424fa123c0_I20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> opk:RayaldeeMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis"> opk:SalesReturnsMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-06-30 </instant>
</period>
</context>
<context id="i77e5ed43e89b438ba48256bf157d2827_I20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> opk:RayaldeeMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-06-30 </instant>
</period>
</context>
<context id="ie6ed48530fc54f78a4c9d3dab331d6ee_I20211231">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> opk:RayaldeeMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis"> opk:ChargebacksDiscountsRebatesAndFeesMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2021-12-31 </instant>
</period>
</context>
<context id="i17b67f61ce8b41ee922405c19c92394f_I20211231">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> opk:RayaldeeMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis"> opk:GovernmentalMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2021-12-31 </instant>
</period>
</context>
<context id="i51774ab1ca0f413aadcd0edf0cbeef64_I20211231">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> opk:RayaldeeMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis"> opk:SalesReturnsMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2021-12-31 </instant>
</period>
</context>
<context id="icce105d5b0ba43438ae9521fa03df5f4_I20211231">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> opk:RayaldeeMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2021-12-31 </instant>
</period>
</context>
<context id="i2c9cbb57ea79457c9cda0bbd7952fe4e_D20220101-20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> opk:RayaldeeMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis"> opk:ChargebacksDiscountsRebatesAndFeesMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-01-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="ia1d6d63f2e0c4327a51f20037d56e598_D20220101-20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> opk:RayaldeeMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis"> opk:GovernmentalMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-01-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="id0ae536198124007a138924bb2785af2_D20220101-20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> opk:RayaldeeMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis"> opk:SalesReturnsMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-01-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="ib1a0d40d77bd4e56a647aee31b3fe14d_I20210331">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> opk:RayaldeeMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis"> opk:ChargebacksDiscountsRebatesAndFeesMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2021-03-31 </instant>
</period>
</context>
<context id="if6ae0f23b98f4df9a60f04854a743234_I20210331">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> opk:RayaldeeMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis"> opk:GovernmentalMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2021-03-31 </instant>
</period>
</context>
<context id="ifd5482e2bc32410fbb7288435951888b_I20210331">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> opk:RayaldeeMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis"> opk:SalesReturnsMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2021-03-31 </instant>
</period>
</context>
<context id="i2d850dbda35d4530baf0f0a13b7f8692_I20210331">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> opk:RayaldeeMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2021-03-31 </instant>
</period>
</context>
<context id="i642c89b963764feeb85667307d3f80f9_D20210401-20210630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> opk:RayaldeeMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis"> opk:ChargebacksDiscountsRebatesAndFeesMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-04-01 </startDate>
<endDate> 2021-06-30 </endDate>
</period>
</context>
<context id="i96dc7f6dbba346e684fb855b1e0e93a0_D20210401-20210630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> opk:RayaldeeMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis"> opk:GovernmentalMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-04-01 </startDate>
<endDate> 2021-06-30 </endDate>
</period>
</context>
<context id="ibc5a694894544ec183e96c6e03276765_D20210401-20210630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> opk:RayaldeeMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis"> opk:SalesReturnsMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-04-01 </startDate>
<endDate> 2021-06-30 </endDate>
</period>
</context>
<context id="i6f90e15c7d5b44cf8e02d2e5edaf7e46_I20210630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> opk:RayaldeeMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis"> opk:ChargebacksDiscountsRebatesAndFeesMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2021-06-30 </instant>
</period>
</context>
<context id="ide0b5e05384b4a9ab9b3b8347df937c9_I20210630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> opk:RayaldeeMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis"> opk:GovernmentalMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2021-06-30 </instant>
</period>
</context>
<context id="i531a7c098ac44b75ac7b3a46c34b6c3c_I20210630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> opk:RayaldeeMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis"> opk:SalesReturnsMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2021-06-30 </instant>
</period>
</context>
<context id="i4036f7150eba4a0ea41bb7f703001989_I20210630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> opk:RayaldeeMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2021-06-30 </instant>
</period>
</context>
<context id="i5830191e5eb8467d9591373c448d909d_I20201231">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> opk:RayaldeeMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis"> opk:ChargebacksDiscountsRebatesAndFeesMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2020-12-31 </instant>
</period>
</context>
<context id="if3f8c9be18594f1fb1986265d45d0995_I20201231">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> opk:RayaldeeMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis"> opk:GovernmentalMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2020-12-31 </instant>
</period>
</context>
<context id="if10c9dad621f41f4a9fa3879ae3e8d8e_I20201231">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> opk:RayaldeeMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis"> opk:SalesReturnsMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2020-12-31 </instant>
</period>
</context>
<context id="i15f7393e7e034cd58a3084cd59485b60_I20201231">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> opk:RayaldeeMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2020-12-31 </instant>
</period>
</context>
<context id="i340df3deb1144777bab4f9be295ee50a_D20210101-20210630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> opk:RayaldeeMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis"> opk:ChargebacksDiscountsRebatesAndFeesMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-01-01 </startDate>
<endDate> 2021-06-30 </endDate>
</period>
</context>
<context id="ia9fd561b004d41d78905c8c99e7b8a69_D20210101-20210630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> opk:RayaldeeMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis"> opk:GovernmentalMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-01-01 </startDate>
<endDate> 2021-06-30 </endDate>
</period>
</context>
<context id="i227c10653be445e0b26f1e13bea67679_D20210101-20210630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> opk:RayaldeeMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis"> opk:SalesReturnsMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-01-01 </startDate>
<endDate> 2021-06-30 </endDate>
</period>
</context>
<context id="i12f96520f0de445889e85c1dcc4a5537_D20220401-20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:CounterpartyNameAxis"> opk:PfizerMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> opk:TransferOfIntellectualPropertyAndOtherMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis"> us-gaap:ProductMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-04-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="i304ac2eceb1c429fbab5ca387b688dd3_D20220101-20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:CounterpartyNameAxis"> opk:PfizerMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> opk:TransferOfIntellectualPropertyAndOtherMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis"> us-gaap:ProductMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-01-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="ic2d25e88030844d6a45bcc6dd738ee08_D20220101-20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:CounterpartyNameAxis"> opk:ViforFreseniusMedicalCarePharmaLtdMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> opk:TransferOfIntellectualPropertyAndOtherMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis"> us-gaap:ProductMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-01-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="if52d9a96555d4b6a9061cd14d69ebbca_D20210401-20210630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:CounterpartyNameAxis"> opk:PfizerMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> opk:TransferOfIntellectualPropertyAndOtherMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis"> us-gaap:ProductMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-04-01 </startDate>
<endDate> 2021-06-30 </endDate>
</period>
</context>
<context id="icd5b0c4e08564d34af78f3a6a18a7869_D20210101-20210630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:CounterpartyNameAxis"> opk:PfizerMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> opk:TransferOfIntellectualPropertyAndOtherMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis"> us-gaap:ProductMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-01-01 </startDate>
<endDate> 2021-06-30 </endDate>
</period>
</context>
<context id="ia0ce8c6ac0e84c49b0f1d84de3584480_D20220101-20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:CounterpartyNameAxis"> opk:NicoyaMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-01-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="icd13b5cdff764ac1b6da33756463ad81_D20210101-20211231">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:CounterpartyNameAxis"> opk:LeaderMedMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="srt:OwnershipAxis"> opk:LeaderMedJointVentureMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> opk:TransferOfIntellectualPropertyAndOtherMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis"> us-gaap:CorporateJointVentureMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-01-01 </startDate>
<endDate> 2021-12-31 </endDate>
</period>
</context>
<context id="i5701e9389a3b45f09bc25710565808e4_D20210706-20210706">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:CounterpartyNameAxis"> opk:CAMP4Member </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> opk:TransferOfIntellectualPropertyAndOtherMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-07-06 </startDate>
<endDate> 2021-07-06 </endDate>
</period>
</context>
<context id="i66c40505624f4271a9330c0a7af1652b_D20210706-20210706">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:CounterpartyNameAxis"> opk:CAMP4Member </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-07-06 </startDate>
<endDate> 2021-07-06 </endDate>
</period>
</context>
<context id="i04b1fea4c63a4013a107d1f6e8c2b898_D20210706-20210706">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:CounterpartyNameAxis"> opk:CAMP4Member </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> opk:DravetSyndromeProductsMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-07-06 </startDate>
<endDate> 2021-07-06 </endDate>
</period>
</context>
<context id="i09e19371951f43cc9dc8c74c84e2251c_D20210706-20210706">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:CounterpartyNameAxis"> opk:CAMP4Member </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> opk:NonDravetSyndromeProductsMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-07-06 </startDate>
<endDate> 2021-07-06 </endDate>
</period>
</context>
<context id="icdd8457f597346fca02a9a713337a3a0_D20210618-20210618">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:CounterpartyNameAxis"> opk:NicoyaMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-06-18 </startDate>
<endDate> 2021-06-18 </endDate>
</period>
</context>
<context id="ic13084132a834365a6e31b71c6450cc0_D20210618-20210618">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:CounterpartyNameAxis"> opk:NicoyaMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="opk:MilestoneAxis"> opk:PhaseThreeInitiationMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-06-18 </startDate>
<endDate> 2021-06-18 </endDate>
</period>
</context>
<context id="ic7b48d7ef14a4478b86806c11aae1766_D20210618-20210618">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:CounterpartyNameAxis"> opk:NicoyaMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="opk:MilestoneAxis"> opk:RegulatoryAndDevelopmentMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-06-18 </startDate>
<endDate> 2021-06-18 </endDate>
</period>
</context>
<context id="i0528eeb931cb48febe1e55ac6c2120ea_D20200505-20200505">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> opk:TransferOfIntellectualPropertyAndOtherMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis"> us-gaap:ProductMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2020-05-05 </startDate>
<endDate> 2020-05-05 </endDate>
</period>
</context>
<context id="i242ab26482294826b358ac46a25dc0de_D20200505-20200505">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:CounterpartyNameAxis"> opk:EirGenPharmaLimitedMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> opk:RegulatoryMilestonesMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2020-05-05 </startDate>
<endDate> 2020-05-05 </endDate>
</period>
</context>
<context id="i919d82ffaa2242fab66ebd562eb3b0b8_D20200505-20200505">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:CounterpartyNameAxis"> opk:EirGenPharmaLimitedMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> opk:SalesMilestonesMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2020-05-05 </startDate>
<endDate> 2020-05-05 </endDate>
</period>
</context>
<context id="i7e6ec43259f2432fac1dab4a788f474c_D20160501-20160531">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:CounterpartyNameAxis"> opk:ViforFreseniusMedicalCarePharmaLtdMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> opk:ExclusiveOptionMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2016-05-01 </startDate>
<endDate> 2016-05-31 </endDate>
</period>
</context>
<context id="ibeccc485dd5f4f1f9697ea28a6c31669_D20220401-20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:CounterpartyNameAxis"> opk:PfizerMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis"> us-gaap:ProductMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-04-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="i6b34b696fb8f49d6a2693caeeef93ba5_D20191021-20191021">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:CounterpartyNameAxis"> opk:PfizerMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis"> us-gaap:ProductMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2019-10-21 </startDate>
<endDate> 2019-10-21 </endDate>
</period>
</context>
<context id="ia376fcbbc1d54e0abbe47b991bd1ca15_D20150101-20150131">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:CounterpartyNameAxis"> opk:PfizerMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis"> us-gaap:ProductMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2015-01-01 </startDate>
<endDate> 2015-01-31 </endDate>
</period>
</context>
<context id="i4a877793ea6e40bcb4412fb871d8a4a6_D20150101-20150131">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:CounterpartyNameAxis"> opk:PfizerMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="srt:RangeAxis"> srt:MinimumMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis"> us-gaap:ProductMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2015-01-01 </startDate>
<endDate> 2015-01-31 </endDate>
</period>
</context>
<context id="i1e36deb038794b318844f6bf06c5a436_D20150101-20150131">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:CounterpartyNameAxis"> opk:PfizerMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="srt:RangeAxis"> srt:MaximumMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis"> us-gaap:ProductMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2015-01-01 </startDate>
<endDate> 2015-01-31 </endDate>
</period>
</context>
<context id="i6744a2487a2a4da4bd87bdb6700db729_D20150101-20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:CounterpartyNameAxis"> opk:PfizerMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis"> us-gaap:ProductMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2015-01-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="id76c5069be644220983f7e66c6dc51c4_D20220101-20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis"> us-gaap:IntersegmentEliminationMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-01-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="id81dc8b2bd404b568174fdb62e57917a_D20220401-20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis"> us-gaap:OperatingSegmentsMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> us-gaap:ServiceMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis"> opk:PharmaceuticalMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-04-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="i33bb3aa9d57f4468993f60c3d830894d_D20210401-20210630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis"> us-gaap:OperatingSegmentsMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> us-gaap:ServiceMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis"> opk:PharmaceuticalMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-04-01 </startDate>
<endDate> 2021-06-30 </endDate>
</period>
</context>
<context id="ie9c4962f367a4a68b8a8f28ed7d49d6d_D20220101-20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis"> us-gaap:OperatingSegmentsMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> us-gaap:ServiceMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis"> opk:PharmaceuticalMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-01-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="ie63cc25623604f1193acdc474450358c_D20210101-20210630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis"> us-gaap:OperatingSegmentsMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> us-gaap:ServiceMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis"> opk:PharmaceuticalMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-01-01 </startDate>
<endDate> 2021-06-30 </endDate>
</period>
</context>
<context id="i0e5138f6fdda4c458a34b95b545a8605_D20220401-20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis"> us-gaap:OperatingSegmentsMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> us-gaap:ServiceMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis"> opk:DiagnosticsMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-04-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="if590b0262e2c4555bb7bf92a24775d9a_D20210401-20210630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis"> us-gaap:OperatingSegmentsMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> us-gaap:ServiceMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis"> opk:DiagnosticsMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-04-01 </startDate>
<endDate> 2021-06-30 </endDate>
</period>
</context>
<context id="i3f090dc87cae49b09a37d54a17fdab88_D20220101-20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis"> us-gaap:OperatingSegmentsMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> us-gaap:ServiceMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis"> opk:DiagnosticsMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-01-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="idab50ba28b814a40b2fec95f4c955688_D20210101-20210630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis"> us-gaap:OperatingSegmentsMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> us-gaap:ServiceMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis"> opk:DiagnosticsMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-01-01 </startDate>
<endDate> 2021-06-30 </endDate>
</period>
</context>
<context id="i477488176c1a43798f507e64450a4728_D20220401-20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis"> us-gaap:CorporateNonSegmentMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> us-gaap:ServiceMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-04-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="i2d9c598c7d6440bd90adc66fc4563e7a_D20210401-20210630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis"> us-gaap:CorporateNonSegmentMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> us-gaap:ServiceMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-04-01 </startDate>
<endDate> 2021-06-30 </endDate>
</period>
</context>
<context id="idcf14c4cdb9e480cab7cf4394d1ebefd_D20220101-20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis"> us-gaap:CorporateNonSegmentMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> us-gaap:ServiceMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-01-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="id668f805e3494978b808ca3a5edae187_D20210101-20210630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis"> us-gaap:CorporateNonSegmentMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> us-gaap:ServiceMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-01-01 </startDate>
<endDate> 2021-06-30 </endDate>
</period>
</context>
<context id="iaf914158d38b4cdd9b64cc48fe6941e7_D20220401-20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis"> us-gaap:OperatingSegmentsMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> us-gaap:ProductMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis"> opk:PharmaceuticalMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-04-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="i5df0e8ab75c84f8b9d413b10a337a431_D20210401-20210630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis"> us-gaap:OperatingSegmentsMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> us-gaap:ProductMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis"> opk:PharmaceuticalMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-04-01 </startDate>
<endDate> 2021-06-30 </endDate>
</period>
</context>
<context id="i30f11fb9d1c8437f8f8cec1e76f2db37_D20220101-20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis"> us-gaap:OperatingSegmentsMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> us-gaap:ProductMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis"> opk:PharmaceuticalMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-01-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="i143e53c0033b4a5aa1cc3194a84e2ba5_D20210101-20210630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis"> us-gaap:OperatingSegmentsMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> us-gaap:ProductMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis"> opk:PharmaceuticalMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-01-01 </startDate>
<endDate> 2021-06-30 </endDate>
</period>
</context>
<context id="i47c6f21fd59f4c408b59de9ac7a7f482_D20220401-20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis"> us-gaap:OperatingSegmentsMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> us-gaap:ProductMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis"> opk:DiagnosticsMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-04-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="i38e2d74e7a5746139ec93cdf2caaa373_D20210401-20210630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis"> us-gaap:OperatingSegmentsMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> us-gaap:ProductMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis"> opk:DiagnosticsMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-04-01 </startDate>
<endDate> 2021-06-30 </endDate>
</period>
</context>
<context id="ie12b9c2d9c4e403fa1ad251ba931d7c2_D20220101-20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis"> us-gaap:OperatingSegmentsMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> us-gaap:ProductMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis"> opk:DiagnosticsMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-01-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="i1d13f5bd721944f586124a6e82d9b758_D20210101-20210630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis"> us-gaap:OperatingSegmentsMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> us-gaap:ProductMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis"> opk:DiagnosticsMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-01-01 </startDate>
<endDate> 2021-06-30 </endDate>
</period>
</context>
<context id="i63babcfc181b470d90de1cc42164afdc_D20220401-20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis"> us-gaap:CorporateNonSegmentMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> us-gaap:ProductMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-04-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="i358ba31eb83948c3b5ba3c16bc6031b1_D20210401-20210630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis"> us-gaap:CorporateNonSegmentMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> us-gaap:ProductMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-04-01 </startDate>
<endDate> 2021-06-30 </endDate>
</period>
</context>
<context id="ie80ebdf1ac004a0fbc6f8158b6409b28_D20220101-20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis"> us-gaap:CorporateNonSegmentMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> us-gaap:ProductMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-01-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="i687618916e7f41789dc16990c9d03470_D20210101-20210630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis"> us-gaap:CorporateNonSegmentMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> us-gaap:ProductMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-01-01 </startDate>
<endDate> 2021-06-30 </endDate>
</period>
</context>
<context id="ic0587d2cd33b40af8987451f56f4aa29_D20220401-20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis"> us-gaap:OperatingSegmentsMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> opk:TransferOfIntellectualPropertyAndOtherMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis"> opk:PharmaceuticalMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-04-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="icfe2fb47c0064a28a23505dd76762dcf_D20210401-20210630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis"> us-gaap:OperatingSegmentsMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> opk:TransferOfIntellectualPropertyAndOtherMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis"> opk:PharmaceuticalMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-04-01 </startDate>
<endDate> 2021-06-30 </endDate>
</period>
</context>
<context id="ifb617d99ae244ec3b284b078d19e6d36_D20220101-20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis"> us-gaap:OperatingSegmentsMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> opk:TransferOfIntellectualPropertyAndOtherMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis"> opk:PharmaceuticalMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-01-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="ic5a6747ed795423d89d2f37e93c1ca03_D20210101-20210630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis"> us-gaap:OperatingSegmentsMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> opk:TransferOfIntellectualPropertyAndOtherMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis"> opk:PharmaceuticalMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-01-01 </startDate>
<endDate> 2021-06-30 </endDate>
</period>
</context>
<context id="i64bf1c05f86346148dfa9e35e5ff6f4f_D20220401-20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis"> us-gaap:OperatingSegmentsMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> opk:TransferOfIntellectualPropertyAndOtherMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis"> opk:DiagnosticsMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-04-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="i58965460c46b4eb0b0466c3a3733f92f_D20210401-20210630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis"> us-gaap:OperatingSegmentsMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> opk:TransferOfIntellectualPropertyAndOtherMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis"> opk:DiagnosticsMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-04-01 </startDate>
<endDate> 2021-06-30 </endDate>
</period>
</context>
<context id="icc4efd4200064acd9f3e6a3fbda11da1_D20220101-20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis"> us-gaap:OperatingSegmentsMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> opk:TransferOfIntellectualPropertyAndOtherMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis"> opk:DiagnosticsMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-01-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="i42fd684665a6467db64af378fa447780_D20210101-20210630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis"> us-gaap:OperatingSegmentsMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> opk:TransferOfIntellectualPropertyAndOtherMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis"> opk:DiagnosticsMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-01-01 </startDate>
<endDate> 2021-06-30 </endDate>
</period>
</context>
<context id="ib7415debee114057bb13f6ad72b27bab_D20220401-20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis"> us-gaap:CorporateNonSegmentMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> opk:TransferOfIntellectualPropertyAndOtherMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-04-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="i6731b7acc16d4873b3c7bcf4e8ea381e_D20210401-20210630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis"> us-gaap:CorporateNonSegmentMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> opk:TransferOfIntellectualPropertyAndOtherMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-04-01 </startDate>
<endDate> 2021-06-30 </endDate>
</period>
</context>
<context id="i4103386cd19941e088e1dd35c635673e_D20220101-20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis"> us-gaap:CorporateNonSegmentMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> opk:TransferOfIntellectualPropertyAndOtherMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-01-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="ic201d669422e446186ae5521d4bf67b4_D20210101-20210630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis"> us-gaap:CorporateNonSegmentMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> opk:TransferOfIntellectualPropertyAndOtherMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-01-01 </startDate>
<endDate> 2021-06-30 </endDate>
</period>
</context>
<context id="i957434db983c4190b847e4637fef04f9_D20220401-20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis"> us-gaap:OperatingSegmentsMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis"> opk:PharmaceuticalMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-04-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="i96ca08fd8d9945cb99bcf89ed9b4cd72_D20210401-20210630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis"> us-gaap:OperatingSegmentsMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis"> opk:PharmaceuticalMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-04-01 </startDate>
<endDate> 2021-06-30 </endDate>
</period>
</context>
<context id="i041fd017f3924fc3800fd697bfd128d1_D20220101-20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis"> us-gaap:OperatingSegmentsMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis"> opk:PharmaceuticalMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-01-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="i4b4c0e12ce634eecbb1e11e846d447b5_D20210101-20210630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis"> us-gaap:OperatingSegmentsMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis"> opk:PharmaceuticalMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-01-01 </startDate>
<endDate> 2021-06-30 </endDate>
</period>
</context>
<context id="i7fde44ebde9341789ddff40144143c2f_D20220401-20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis"> us-gaap:OperatingSegmentsMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis"> opk:DiagnosticsMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-04-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="icce0e81024e2406b803d4529ed0c015c_D20210401-20210630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis"> us-gaap:OperatingSegmentsMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis"> opk:DiagnosticsMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-04-01 </startDate>
<endDate> 2021-06-30 </endDate>
</period>
</context>
<context id="ia5c9d668ef7340748d80ff87edaf4173_D20220101-20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis"> us-gaap:OperatingSegmentsMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis"> opk:DiagnosticsMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-01-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="i21b7f98f9a12463da100915dc502484b_D20210101-20210630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis"> us-gaap:OperatingSegmentsMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis"> opk:DiagnosticsMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-01-01 </startDate>
<endDate> 2021-06-30 </endDate>
</period>
</context>
<context id="i8c23b2342c5f4f99bbfd7e108dea19ec_D20220401-20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis"> us-gaap:CorporateNonSegmentMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-04-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="ib557e685194f428ea1c938b7ea46759d_D20210401-20210630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis"> us-gaap:CorporateNonSegmentMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-04-01 </startDate>
<endDate> 2021-06-30 </endDate>
</period>
</context>
<context id="i0828e7ef8a584b5b8ff47b0f0506ad32_D20220101-20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis"> us-gaap:CorporateNonSegmentMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-01-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="i49a8829d28bd44178eb1108e0ef77637_D20210101-20210630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis"> us-gaap:CorporateNonSegmentMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-01-01 </startDate>
<endDate> 2021-06-30 </endDate>
</period>
</context>
<context id="i0dd68860a1a146e597f3770be5653eb1_D20220401-20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis"> country:US </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-04-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="ie9fa8a7fa3bd4c838a417101afd89478_D20210401-20210630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis"> country:US </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-04-01 </startDate>
<endDate> 2021-06-30 </endDate>
</period>
</context>
<context id="i7206f4294559439da9e04af14912ea95_D20220101-20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis"> country:US </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-01-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="i4e306ebc1a4841ccb1a9a48201229d45_D20210101-20210630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis"> country:US </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-01-01 </startDate>
<endDate> 2021-06-30 </endDate>
</period>
</context>
<context id="ic7edf2f37b144b5b98cbd8824f6e8284_D20220401-20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis"> country:IE </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-04-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="i559f4f01f3f54b08aa1043b5256116a6_D20210401-20210630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis"> country:IE </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-04-01 </startDate>
<endDate> 2021-06-30 </endDate>
</period>
</context>
<context id="i23061402e7ce43fe9914532b20d7ae5b_D20220101-20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis"> country:IE </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-01-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="ibd7b1018233641c5b70bfa7cac55e364_D20210101-20210630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis"> country:IE </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-01-01 </startDate>
<endDate> 2021-06-30 </endDate>
</period>
</context>
<context id="i8dac6979b49c411b86a6cb7570c61721_D20220401-20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis"> country:CL </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-04-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="ieffe8ce34d68444b965ba0946cec3044_D20210401-20210630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis"> country:CL </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-04-01 </startDate>
<endDate> 2021-06-30 </endDate>
</period>
</context>
<context id="ie5ffa3525ae44756824f1afcc5fd1ae5_D20220101-20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis"> country:CL </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-01-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="i64298a8ce6294c5690549751d5987f73_D20210101-20210630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis"> country:CL </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-01-01 </startDate>
<endDate> 2021-06-30 </endDate>
</period>
</context>
<context id="i7aa5b108802144fe8eb984c17fe037fd_D20220401-20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis"> country:ES </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-04-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="i041fa117876d43e49ec1c4ed358d285c_D20210401-20210630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis"> country:ES </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-04-01 </startDate>
<endDate> 2021-06-30 </endDate>
</period>
</context>
<context id="i9904c2a5cd304f36be9a34e8057e705c_D20220101-20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis"> country:ES </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-01-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="i69cccf9eda114612893f98381b1b9ad4_D20210101-20210630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis"> country:ES </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-01-01 </startDate>
<endDate> 2021-06-30 </endDate>
</period>
</context>
<context id="i52877188041549d1b37d940b442390a0_D20220401-20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis"> country:IL </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-04-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="i9019381f808348f6ad7cfc9e735c809d_D20210401-20210630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis"> country:IL </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-04-01 </startDate>
<endDate> 2021-06-30 </endDate>
</period>
</context>
<context id="ie8a826331d5041c9bdeca1a432bb4357_D20220101-20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis"> country:IL </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-01-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="i0dee503c427a4762a66dfd2b2d3935f9_D20210101-20210630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis"> country:IL </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-01-01 </startDate>
<endDate> 2021-06-30 </endDate>
</period>
</context>
<context id="i3e6c38e0293e4599bb8e99803d1d651a_D20220401-20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis"> country:MX </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-04-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="i562959c388b94bf9bf9ab9007634c7ad_D20210401-20210630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis"> country:MX </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-04-01 </startDate>
<endDate> 2021-06-30 </endDate>
</period>
</context>
<context id="i758f56d85bcf452b9cf2e86887b92cd9_D20220101-20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis"> country:MX </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-01-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="i780db68c2bb843e3bf05d5ed66b1e04c_D20210101-20210630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis"> country:MX </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-01-01 </startDate>
<endDate> 2021-06-30 </endDate>
</period>
</context>
<context id="iee88e88ad393482c9fc5f2515351701d_D20220401-20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis"> opk:OtherCountriesMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-04-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="i1e8f0ff787414bcb9de2b88966bcfc3f_D20210401-20210630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis"> opk:OtherCountriesMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-04-01 </startDate>
<endDate> 2021-06-30 </endDate>
</period>
</context>
<context id="ie3a530a9b17f4c679451829961773739_D20220101-20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis"> opk:OtherCountriesMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-01-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="iec818c36643649748e099a09b924ca36_D20210101-20210630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis"> opk:OtherCountriesMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-01-01 </startDate>
<endDate> 2021-06-30 </endDate>
</period>
</context>
<context id="i932964789b874d07b8eb7aa207be7426_I20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis"> us-gaap:OperatingSegmentsMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis"> opk:PharmaceuticalMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-06-30 </instant>
</period>
</context>
<context id="id98380ff851c4e8c863f5e14df564350_I20211231">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis"> us-gaap:OperatingSegmentsMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis"> opk:PharmaceuticalMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2021-12-31 </instant>
</period>
</context>
<context id="i3e0f809fdadc46b8bd186df746a3bd3c_I20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis"> us-gaap:OperatingSegmentsMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis"> opk:DiagnosticsMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-06-30 </instant>
</period>
</context>
<context id="ifd9c316e7e6345e8b7856cd774fb64c3_I20211231">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis"> us-gaap:OperatingSegmentsMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis"> opk:DiagnosticsMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2021-12-31 </instant>
</period>
</context>
<context id="i1411dda547cd4a0ebd23a90a746f9e70_I20220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis"> us-gaap:CorporateNonSegmentMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-06-30 </instant>
</period>
</context>
<context id="i265cf472105c4444a2536dc3fa84c305_I20211231">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis"> us-gaap:CorporateNonSegmentMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2021-12-31 </instant>
</period>
</context>
<context id="iaaab35e2a69742aba58b3bce061ca59d_D20220714-20220714">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis"> us-gaap:SettledLitigationMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis"> us-gaap:SubsequentEventMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-07-14 </startDate>
<endDate> 2022-07-14 </endDate>
</period>
</context>
<context id="i159bb5353b604ef8bcf714d747bd6227_I20220714">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis"> us-gaap:SettledLitigationMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis"> us-gaap:SubsequentEventMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-07-14 </instant>
</period>
</context>
<context id="if1f7b317f2664ce48cd8bed9f09bd628_D20220714-20220714">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis"> country:US </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis"> us-gaap:SettledLitigationMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis"> us-gaap:SubsequentEventMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-07-14 </startDate>
<endDate> 2022-07-14 </endDate>
</period>
</context>
<context id="i7fc497baca3b45b883c778a446f221b4_D20220714-20220714">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis"> stpr:MA </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis"> us-gaap:SettledLitigationMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis"> us-gaap:SubsequentEventMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-07-14 </startDate>
<endDate> 2022-07-14 </endDate>
</period>
</context>
<context id="if38b8c04509b49968e85bee0a732b229_D20220714-20220714">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis"> stpr:CT </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis"> us-gaap:SettledLitigationMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis"> us-gaap:SubsequentEventMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-07-14 </startDate>
<endDate> 2022-07-14 </endDate>
</period>
</context>
<context id="idd10fd8a8e37462facbaef8483be3234_D20220714-20220714">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000944809 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis"> us-gaap:SubsequentEventMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-07-14 </startDate>
<endDate> 2022-07-14 </endDate>
</period>
</context>
<unit id="shares">
<measure> shares </measure>
</unit>
<unit id="usd">
<measure> iso4217:USD </measure>
</unit>
<unit id="usdPerShare">
<divide>
<unitNumerator>
<measure> iso4217:USD </measure>
</unitNumerator>
<unitDenominator>
<measure> shares </measure>
</unitDenominator>
</divide>
</unit>
<unit id="employee">
<measure> opk:employee </measure>
</unit>
<unit id="number">
<measure> pure </measure>
</unit>
<unit id="segment">
<measure> opk:segment </measure>
</unit>
<unit id="day">
<measure> opk:day </measure>
</unit>
<unit id="institution">
<measure> opk:institution </measure>
</unit>
<unit id="sqft">
<measure> utr:sqft </measure>
</unit>
<dei:EntityCentralIndexKey contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml80L2ZyYWc6NmZlZWNiMjQxMjMyNGQ4ZTk2ZGQzZGRmNDgyZDg2YWIvdGFibGU6YTM0N2Q2OTAzY2UwNDc4YzgxMTA3ZWEzYjRhNzk4NzIvdGFibGVyYW5nZTphMzQ3ZDY5MDNjZTA0NzhjODExMDdlYTNiNGE3OTg3Ml8yLTEtMS0xLTQ4MTY0_5a3f9f02-deb8-4035-b53c-4cc7554f0ec0"> 0000944809 </dei:EntityCentralIndexKey>
<dei:AmendmentFlag contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml80L2ZyYWc6NmZlZWNiMjQxMjMyNGQ4ZTk2ZGQzZGRmNDgyZDg2YWIvdGFibGU6YTM0N2Q2OTAzY2UwNDc4YzgxMTA3ZWEzYjRhNzk4NzIvdGFibGVyYW5nZTphMzQ3ZDY5MDNjZTA0NzhjODExMDdlYTNiNGE3OTg3Ml8zLTEtMS0xLTQ4MTY0_3f4ac5e0-4259-435d-865b-600800a78cbd"> false </dei:AmendmentFlag>
<dei:DocumentFiscalYearFocus contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml80L2ZyYWc6NmZlZWNiMjQxMjMyNGQ4ZTk2ZGQzZGRmNDgyZDg2YWIvdGFibGU6YTM0N2Q2OTAzY2UwNDc4YzgxMTA3ZWEzYjRhNzk4NzIvdGFibGVyYW5nZTphMzQ3ZDY5MDNjZTA0NzhjODExMDdlYTNiNGE3OTg3Ml80LTEtMS0xLTQ4MTY0_162fe003-17f1-47ff-a8ed-5e5d2237f7f0"> 2022 </dei:DocumentFiscalYearFocus>
<dei:DocumentFiscalPeriodFocus contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml80L2ZyYWc6NmZlZWNiMjQxMjMyNGQ4ZTk2ZGQzZGRmNDgyZDg2YWIvdGFibGU6YTM0N2Q2OTAzY2UwNDc4YzgxMTA3ZWEzYjRhNzk4NzIvdGFibGVyYW5nZTphMzQ3ZDY5MDNjZTA0NzhjODExMDdlYTNiNGE3OTg3Ml81LTEtMS0xLTQ4MTY0_083e2212-c9cf-4ded-8a06-ae1065211d75"> Q2 </dei:DocumentFiscalPeriodFocus>
<dei:CurrentFiscalYearEndDate contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml80L2ZyYWc6NmZlZWNiMjQxMjMyNGQ4ZTk2ZGQzZGRmNDgyZDg2YWIvdGFibGU6YTM0N2Q2OTAzY2UwNDc4YzgxMTA3ZWEzYjRhNzk4NzIvdGFibGVyYW5nZTphMzQ3ZDY5MDNjZTA0NzhjODExMDdlYTNiNGE3OTg3Ml82LTEtMS0xLTQ4MTY0_a8ed60b0-72aa-484f-ac25-bba2cdaf2460"> --12-31 </dei:CurrentFiscalYearEndDate>
<us-gaap:AccountingStandardsUpdateExtensibleList contextRef="i6a367dd12b2e4f7192222dd2acfea35b_D20210101-20211231" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zMS9mcmFnOmVhOTkwNjc5MjQ2MTQ0MTVhZjY5OGNjNDIwZWZiYjZlL3RhYmxlOmE5MThjMTEyZWYyODQ3YzlhYWQ3MjZkNWMyZDZhNDAyL3RhYmxlcmFuZ2U6YTkxOGMxMTJlZjI4NDdjOWFhZDcyNmQ1YzJkNmE0MDJfNS0wLTEtMS01MjkxMw_6f23a997-b3a4-40c2-aaac-98acf5dbe0f6"> http://fasb.org/us-gaap/2022#AccountingStandardsUpdate202006Member </us-gaap:AccountingStandardsUpdateExtensibleList>
<us-gaap:DebtInstrumentConvertibleConversionRatio1 contextRef="id0f2d83dfceb4643b6689cb2c3735e7c_D20190201-20190228" decimals="7" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml82MS9mcmFnOmRmN2IwMjFhMWRmZTQ2ZmI4MzYyOGQxOGFmMGE0NTQyL3RhYmxlOjk1MjNjYTVkM2FiMzRmZDg5OTQ1ZWExOGY1Y2U5MDcxL3RhYmxlcmFuZ2U6OTUyM2NhNWQzYWIzNGZkODk5NDVlYTE4ZjVjZTkwNzFfMy0xLTEtMS00ODE2NA_36f5c85a-6fd0-481a-9885-87127750c7b1" unitRef="number"> 0.2367424 </us-gaap:DebtInstrumentConvertibleConversionRatio1>
<us-gaap:FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList contextRef="i4768f885851b49f986857a2a956f9162_I20220630" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84OC9mcmFnOmYwYmRmNjU2NjU4ODRlZTRhODlhNGU1NTA2ZDk4YTBhL3RhYmxlOmFhNTZiZTdkNzE4YjQ2OTE5ODAzYjE5YTg1NjA4ZWRhL3RhYmxlcmFuZ2U6YWE1NmJlN2Q3MThiNDY5MTk4MDNiMTlhODU2MDhlZGFfMy0wLTEtMS00ODE2NA_9c5b9bae-c0e0-43d9-ba85-b128a4c8eafa"> http://fasb.org/us-gaap/2022#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization </us-gaap:FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList>
<dei:DocumentType contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8xL2ZyYWc6Njc3YTJhZjk4NTM2NDA1ZDkzYmQwNmRhYTA4ZGVhZDUvdGV4dHJlZ2lvbjo2NzdhMmFmOTg1MzY0MDVkOTNiZDA2ZGFhMDhkZWFkNV8xODY5_46ab31e6-12be-456a-9bb8-a56d3da5bfab"> 10-Q </dei:DocumentType>
<dei:DocumentQuarterlyReport contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8xL2ZyYWc6Njc3YTJhZjk4NTM2NDA1ZDkzYmQwNmRhYTA4ZGVhZDUvdGFibGU6ODBmNjRmZTNhMzRmNDkxZjhjODNhY2QwNTEzZTVjMTUvdGFibGVyYW5nZTo4MGY2NGZlM2EzNGY0OTFmOGM4M2FjZDA1MTNlNWMxNV8wLTAtMS0xLTQ4MTY0_3c8fa913-c002-40f4-b867-bdd269bc65f5"> true </dei:DocumentQuarterlyReport>
<dei:DocumentPeriodEndDate contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8xL2ZyYWc6Njc3YTJhZjk4NTM2NDA1ZDkzYmQwNmRhYTA4ZGVhZDUvdGV4dHJlZ2lvbjo2NzdhMmFmOTg1MzY0MDVkOTNiZDA2ZGFhMDhkZWFkNV8xMzQ_4b09c52b-0fd6-410b-a8fb-32626185b4e1"> 2022-06-30 </dei:DocumentPeriodEndDate>
<dei:DocumentTransitionReport contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8xL2ZyYWc6Njc3YTJhZjk4NTM2NDA1ZDkzYmQwNmRhYTA4ZGVhZDUvdGFibGU6ZWRkOTUxZjRiZDc0NDRmZmJiNDFlZmZmMTNiYmU5ZDEvdGFibGVyYW5nZTplZGQ5NTFmNGJkNzQ0NGZmYmI0MWVmZmYxM2JiZTlkMV8wLTAtMS0xLTQ4MTY0_0be9e9e8-a0dc-4b53-a9f8-49f6dd95b2c9"> false </dei:DocumentTransitionReport>
<dei:EntityFileNumber contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8xL2ZyYWc6Njc3YTJhZjk4NTM2NDA1ZDkzYmQwNmRhYTA4ZGVhZDUvdGV4dHJlZ2lvbjo2NzdhMmFmOTg1MzY0MDVkOTNiZDA2ZGFhMDhkZWFkNV8xODcw_457977b0-c346-42e9-a459-d7074a126c5d"> 001-33528 </dei:EntityFileNumber>
<dei:EntityRegistrantName contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8xL2ZyYWc6Njc3YTJhZjk4NTM2NDA1ZDkzYmQwNmRhYTA4ZGVhZDUvdGV4dHJlZ2lvbjo2NzdhMmFmOTg1MzY0MDVkOTNiZDA2ZGFhMDhkZWFkNV8xODcx_8c0aa1fd-742f-4935-ae30-2866e52caa91"> OPKO Health, Inc. </dei:EntityRegistrantName>
<dei:EntityIncorporationStateCountryCode contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8xL2ZyYWc6Njc3YTJhZjk4NTM2NDA1ZDkzYmQwNmRhYTA4ZGVhZDUvdGFibGU6OGIxN2NkMDViZjE1NGE5YmE5MmM3YjlhOWZkZDc1YjUvdGFibGVyYW5nZTo4YjE3Y2QwNWJmMTU0YTliYTkyYzdiOWE5ZmRkNzViNV8wLTAtMS0xLTQ4MTY0_8f380353-7fee-4a3d-a344-500831ab4c83"> DE </dei:EntityIncorporationStateCountryCode>
<dei:EntityTaxIdentificationNumber contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8xL2ZyYWc6Njc3YTJhZjk4NTM2NDA1ZDkzYmQwNmRhYTA4ZGVhZDUvdGFibGU6OGIxN2NkMDViZjE1NGE5YmE5MmM3YjlhOWZkZDc1YjUvdGFibGVyYW5nZTo4YjE3Y2QwNWJmMTU0YTliYTkyYzdiOWE5ZmRkNzViNV8wLTItMS0xLTQ4MTY0_d907ad49-4acd-476d-95a4-de8b9d357067"> 75-2402409 </dei:EntityTaxIdentificationNumber>
<dei:EntityAddressAddressLine1 contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8xL2ZyYWc6Njc3YTJhZjk4NTM2NDA1ZDkzYmQwNmRhYTA4ZGVhZDUvdGFibGU6NWI5NzNjZmI1MGRhNDllNjhiMWE5ZjRiYmNhN2JlZTQvdGFibGVyYW5nZTo1Yjk3M2NmYjUwZGE0OWU2OGIxYTlmNGJiY2E3YmVlNF8wLTAtMS0xLTQ4MTY0_d9a81123-b361-4465-9456-8ac1d9484bc1"> 4400 Biscayne Blvd. </dei:EntityAddressAddressLine1>
<dei:EntityAddressCityOrTown contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8xL2ZyYWc6Njc3YTJhZjk4NTM2NDA1ZDkzYmQwNmRhYTA4ZGVhZDUvdGFibGU6NWI5NzNjZmI1MGRhNDllNjhiMWE5ZjRiYmNhN2JlZTQvdGFibGVyYW5nZTo1Yjk3M2NmYjUwZGE0OWU2OGIxYTlmNGJiY2E3YmVlNF8xLTAtMS0xLTQ4MTY0_d9c5870d-a35d-41fb-b4cc-64736f9eff07"> Miami </dei:EntityAddressCityOrTown>
<dei:EntityAddressStateOrProvince contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8xL2ZyYWc6Njc3YTJhZjk4NTM2NDA1ZDkzYmQwNmRhYTA4ZGVhZDUvdGFibGU6NWI5NzNjZmI1MGRhNDllNjhiMWE5ZjRiYmNhN2JlZTQvdGFibGVyYW5nZTo1Yjk3M2NmYjUwZGE0OWU2OGIxYTlmNGJiY2E3YmVlNF8xLTEtMS0xLTQ4MTY0_0496b024-f7cb-47aa-9ec3-3fbcf8bac515"> FL </dei:EntityAddressStateOrProvince>
<dei:EntityAddressPostalZipCode contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8xL2ZyYWc6Njc3YTJhZjk4NTM2NDA1ZDkzYmQwNmRhYTA4ZGVhZDUvdGFibGU6NWI5NzNjZmI1MGRhNDllNjhiMWE5ZjRiYmNhN2JlZTQvdGFibGVyYW5nZTo1Yjk3M2NmYjUwZGE0OWU2OGIxYTlmNGJiY2E3YmVlNF8xLTItMS0xLTQ4MTY0_21ca9595-e175-4479-87a0-49fd43c7b967"> 33137 </dei:EntityAddressPostalZipCode>
<dei:CityAreaCode contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8xL2ZyYWc6Njc3YTJhZjk4NTM2NDA1ZDkzYmQwNmRhYTA4ZGVhZDUvdGFibGU6NWI5NzNjZmI1MGRhNDllNjhiMWE5ZjRiYmNhN2JlZTQvdGFibGVyYW5nZTo1Yjk3M2NmYjUwZGE0OWU2OGIxYTlmNGJiY2E3YmVlNF80LTAtMS0xLTQ4MTY0_e7feaa6b-3311-40d1-9ec7-f9cd95162b9c"> (305) </dei:CityAreaCode>
<dei:LocalPhoneNumber contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8xL2ZyYWc6Njc3YTJhZjk4NTM2NDA1ZDkzYmQwNmRhYTA4ZGVhZDUvdGFibGU6NWI5NzNjZmI1MGRhNDllNjhiMWE5ZjRiYmNhN2JlZTQvdGFibGVyYW5nZTo1Yjk3M2NmYjUwZGE0OWU2OGIxYTlmNGJiY2E3YmVlNF80LTEtMS0xLTQ4MTY0_b538267c-b888-4edb-9d62-f7ae120113a8"> 575-4100 </dei:LocalPhoneNumber>
<dei:Security12bTitle contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8xL2ZyYWc6Njc3YTJhZjk4NTM2NDA1ZDkzYmQwNmRhYTA4ZGVhZDUvdGFibGU6NjQ5YWM3NzY4YWQzNDFhM2I2NDM5NDBmMzM2MWQzYzAvdGFibGVyYW5nZTo2NDlhYzc3NjhhZDM0MWEzYjY0Mzk0MGYzMzYxZDNjMF8xLTAtMS0xLTQ4MTY0_c4caa2bb-d9ac-4df2-93e2-8790a4dd1056"> Common Stock, par value $0.01 per share </dei:Security12bTitle>
<dei:TradingSymbol contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8xL2ZyYWc6Njc3YTJhZjk4NTM2NDA1ZDkzYmQwNmRhYTA4ZGVhZDUvdGFibGU6NjQ5YWM3NzY4YWQzNDFhM2I2NDM5NDBmMzM2MWQzYzAvdGFibGVyYW5nZTo2NDlhYzc3NjhhZDM0MWEzYjY0Mzk0MGYzMzYxZDNjMF8xLTEtMS0xLTQ4MTY0_4d7e18e3-572d-4263-a74b-65090ca7c233"> OPK </dei:TradingSymbol>
<dei:SecurityExchangeName contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8xL2ZyYWc6Njc3YTJhZjk4NTM2NDA1ZDkzYmQwNmRhYTA4ZGVhZDUvdGFibGU6NjQ5YWM3NzY4YWQzNDFhM2I2NDM5NDBmMzM2MWQzYzAvdGFibGVyYW5nZTo2NDlhYzc3NjhhZDM0MWEzYjY0Mzk0MGYzMzYxZDNjMF8xLTItMS0xLTQ4MTY0_3ea560a8-0e84-4741-9b47-b85f367ef002"> NASDAQ </dei:SecurityExchangeName>
<dei:EntityCurrentReportingStatus contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8xL2ZyYWc6Njc3YTJhZjk4NTM2NDA1ZDkzYmQwNmRhYTA4ZGVhZDUvdGV4dHJlZ2lvbjo2NzdhMmFmOTg1MzY0MDVkOTNiZDA2ZGFhMDhkZWFkNV8xODY2_10a77f29-6279-43cd-9499-3362ae907b12"> Yes </dei:EntityCurrentReportingStatus>
<dei:EntityInteractiveDataCurrent contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8xL2ZyYWc6Njc3YTJhZjk4NTM2NDA1ZDkzYmQwNmRhYTA4ZGVhZDUvdGV4dHJlZ2lvbjo2NzdhMmFmOTg1MzY0MDVkOTNiZDA2ZGFhMDhkZWFkNV8xODY3_2e962790-38d0-492b-8770-3cf2a3f113d2"> Yes </dei:EntityInteractiveDataCurrent>
<dei:EntityFilerCategory contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8xL2ZyYWc6Njc3YTJhZjk4NTM2NDA1ZDkzYmQwNmRhYTA4ZGVhZDUvdGFibGU6NjUyYTFlMjdiMDRlNGQ0ZmJlNmU4NDI3OGRlNjIxYWYvdGFibGVyYW5nZTo2NTJhMWUyN2IwNGU0ZDRmYmU2ZTg0Mjc4ZGU2MjFhZl8wLTAtMS0xLTQ4MTY0_6418c79e-2d8f-4807-a487-0d0d704ccd70"> Large Accelerated Filer </dei:EntityFilerCategory>
<dei:EntitySmallBusiness contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8xL2ZyYWc6Njc3YTJhZjk4NTM2NDA1ZDkzYmQwNmRhYTA4ZGVhZDUvdGFibGU6NjUyYTFlMjdiMDRlNGQ0ZmJlNmU4NDI3OGRlNjIxYWYvdGFibGVyYW5nZTo2NTJhMWUyN2IwNGU0ZDRmYmU2ZTg0Mjc4ZGU2MjFhZl8xLTMtMS0xLTQ4MTY0_98877663-98e1-4096-baaa-e3efb9f138e7"> false </dei:EntitySmallBusiness>
<dei:EntityEmergingGrowthCompany contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8xL2ZyYWc6Njc3YTJhZjk4NTM2NDA1ZDkzYmQwNmRhYTA4ZGVhZDUvdGFibGU6NjUyYTFlMjdiMDRlNGQ0ZmJlNmU4NDI3OGRlNjIxYWYvdGFibGVyYW5nZTo2NTJhMWUyN2IwNGU0ZDRmYmU2ZTg0Mjc4ZGU2MjFhZl8yLTMtMS0xLTQ4MTY0_c23e0466-973b-44f1-bec7-4d3bc421d5a0"> false </dei:EntityEmergingGrowthCompany>
<dei:EntityShellCompany contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8xL2ZyYWc6Njc3YTJhZjk4NTM2NDA1ZDkzYmQwNmRhYTA4ZGVhZDUvdGV4dHJlZ2lvbjo2NzdhMmFmOTg1MzY0MDVkOTNiZDA2ZGFhMDhkZWFkNV8xODY4_ae708faa-29d7-49ec-ac0e-a6bd14bac127"> false </dei:EntityShellCompany>
<dei:EntityCommonStockSharesOutstanding contextRef="if0ded23553894a6a81063564257cdecd_I20220728" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8xL2ZyYWc6Njc3YTJhZjk4NTM2NDA1ZDkzYmQwNmRhYTA4ZGVhZDUvdGV4dHJlZ2lvbjo2NzdhMmFmOTg1MzY0MDVkOTNiZDA2ZGFhMDhkZWFkNV8xODI5_340c1658-4f08-407c-8c39-4580167b2403" unitRef="shares"> 771959579 </dei:EntityCommonStockSharesOutstanding>
<us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="i4768f885851b49f986857a2a956f9162_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8xOS9mcmFnOjBjZmQ0MjVhZGFhOTQ3NmZhYjRiZjkzMTA5N2Y3Yjg2L3RhYmxlOmViODM4NGY0NzMwZjQ3Mjk4YzZjOWE4YmE2NmU3NmU5L3RhYmxlcmFuZ2U6ZWI4Mzg0ZjQ3MzBmNDcyOThjNmM5YThiYTY2ZTc2ZTlfMy0xLTEtMS00ODE2NA_f0484fcf-3eb0-42d0-825d-8bf253f6800e" unitRef="usd"> 210458000 </us-gaap:CashAndCashEquivalentsAtCarryingValue>
<us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="i7e0f479bead144b0bdbcc71082db627b_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8xOS9mcmFnOjBjZmQ0MjVhZGFhOTQ3NmZhYjRiZjkzMTA5N2Y3Yjg2L3RhYmxlOmViODM4NGY0NzMwZjQ3Mjk4YzZjOWE4YmE2NmU3NmU5L3RhYmxlcmFuZ2U6ZWI4Mzg0ZjQ3MzBmNDcyOThjNmM5YThiYTY2ZTc2ZTlfMy0zLTEtMS00ODE2NA_337bfba4-f80c-4df7-9cad-d8baba7d4497" unitRef="usd"> 134710000 </us-gaap:CashAndCashEquivalentsAtCarryingValue>
<us-gaap:AccountsReceivableNetCurrent contextRef="i4768f885851b49f986857a2a956f9162_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8xOS9mcmFnOjBjZmQ0MjVhZGFhOTQ3NmZhYjRiZjkzMTA5N2Y3Yjg2L3RhYmxlOmViODM4NGY0NzMwZjQ3Mjk4YzZjOWE4YmE2NmU3NmU5L3RhYmxlcmFuZ2U6ZWI4Mzg0ZjQ3MzBmNDcyOThjNmM5YThiYTY2ZTc2ZTlfNS0xLTEtMS00ODE2NA_45fb5a3a-eb60-4415-a9ce-7289b9ac0b0e" unitRef="usd"> 158425000 </us-gaap:AccountsReceivableNetCurrent>
<us-gaap:AccountsReceivableNetCurrent contextRef="i7e0f479bead144b0bdbcc71082db627b_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8xOS9mcmFnOjBjZmQ0MjVhZGFhOTQ3NmZhYjRiZjkzMTA5N2Y3Yjg2L3RhYmxlOmViODM4NGY0NzMwZjQ3Mjk4YzZjOWE4YmE2NmU3NmU5L3RhYmxlcmFuZ2U6ZWI4Mzg0ZjQ3MzBmNDcyOThjNmM5YThiYTY2ZTc2ZTlfNS0zLTEtMS00ODE2NA_d29ece3e-953b-43a2-ab73-845f5e5de7d3" unitRef="usd"> 259637000 </us-gaap:AccountsReceivableNetCurrent>
<us-gaap:InventoryNet contextRef="i4768f885851b49f986857a2a956f9162_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8xOS9mcmFnOjBjZmQ0MjVhZGFhOTQ3NmZhYjRiZjkzMTA5N2Y3Yjg2L3RhYmxlOmViODM4NGY0NzMwZjQ3Mjk4YzZjOWE4YmE2NmU3NmU5L3RhYmxlcmFuZ2U6ZWI4Mzg0ZjQ3MzBmNDcyOThjNmM5YThiYTY2ZTc2ZTlfNi0xLTEtMS00ODE2NA_aa6fbdf1-6f68-4536-ac59-c561e6c04713" unitRef="usd"> 83306000 </us-gaap:InventoryNet>
<us-gaap:InventoryNet contextRef="i7e0f479bead144b0bdbcc71082db627b_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8xOS9mcmFnOjBjZmQ0MjVhZGFhOTQ3NmZhYjRiZjkzMTA5N2Y3Yjg2L3RhYmxlOmViODM4NGY0NzMwZjQ3Mjk4YzZjOWE4YmE2NmU3NmU5L3RhYmxlcmFuZ2U6ZWI4Mzg0ZjQ3MzBmNDcyOThjNmM5YThiYTY2ZTc2ZTlfNi0zLTEtMS00ODE2NA_36064ffb-4028-4b37-94be-a055385275a6" unitRef="usd"> 86502000 </us-gaap:InventoryNet>
<us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="i4768f885851b49f986857a2a956f9162_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8xOS9mcmFnOjBjZmQ0MjVhZGFhOTQ3NmZhYjRiZjkzMTA5N2Y3Yjg2L3RhYmxlOmViODM4NGY0NzMwZjQ3Mjk4YzZjOWE4YmE2NmU3NmU5L3RhYmxlcmFuZ2U6ZWI4Mzg0ZjQ3MzBmNDcyOThjNmM5YThiYTY2ZTc2ZTlfNy0xLTEtMS00ODE2NA_f42deaa9-c7ba-4542-84c0-1e7e7dd3a96a" unitRef="usd"> 42563000 </us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
<us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="i7e0f479bead144b0bdbcc71082db627b_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8xOS9mcmFnOjBjZmQ0MjVhZGFhOTQ3NmZhYjRiZjkzMTA5N2Y3Yjg2L3RhYmxlOmViODM4NGY0NzMwZjQ3Mjk4YzZjOWE4YmE2NmU3NmU5L3RhYmxlcmFuZ2U6ZWI4Mzg0ZjQ3MzBmNDcyOThjNmM5YThiYTY2ZTc2ZTlfNy0zLTEtMS00ODE2NA_cc4ba999-7acc-44ba-bec6-a6637a087a8f" unitRef="usd"> 27170000 </us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
<us-gaap:AssetsHeldForSaleNotPartOfDisposalGroup contextRef="i4768f885851b49f986857a2a956f9162_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8xOS9mcmFnOjBjZmQ0MjVhZGFhOTQ3NmZhYjRiZjkzMTA5N2Y3Yjg2L3RhYmxlOmViODM4NGY0NzMwZjQ3Mjk4YzZjOWE4YmE2NmU3NmU5L3RhYmxlcmFuZ2U6ZWI4Mzg0ZjQ3MzBmNDcyOThjNmM5YThiYTY2ZTc2ZTlfOC0xLTEtMS00ODE2NA_0a5d4129-0a9b-4ba7-9f3f-1aac0154bb88" unitRef="usd"> 0 </us-gaap:AssetsHeldForSaleNotPartOfDisposalGroup>
<us-gaap:AssetsHeldForSaleNotPartOfDisposalGroup contextRef="i7e0f479bead144b0bdbcc71082db627b_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8xOS9mcmFnOjBjZmQ0MjVhZGFhOTQ3NmZhYjRiZjkzMTA5N2Y3Yjg2L3RhYmxlOmViODM4NGY0NzMwZjQ3Mjk4YzZjOWE4YmE2NmU3NmU5L3RhYmxlcmFuZ2U6ZWI4Mzg0ZjQ3MzBmNDcyOThjNmM5YThiYTY2ZTc2ZTlfOC0zLTEtMS00ODE2NA_c127d902-aafe-4934-9c3b-b26de01f9180" unitRef="usd"> 314994000 </us-gaap:AssetsHeldForSaleNotPartOfDisposalGroup>
<us-gaap:AssetsCurrent contextRef="i4768f885851b49f986857a2a956f9162_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8xOS9mcmFnOjBjZmQ0MjVhZGFhOTQ3NmZhYjRiZjkzMTA5N2Y3Yjg2L3RhYmxlOmViODM4NGY0NzMwZjQ3Mjk4YzZjOWE4YmE2NmU3NmU5L3RhYmxlcmFuZ2U6ZWI4Mzg0ZjQ3MzBmNDcyOThjNmM5YThiYTY2ZTc2ZTlfOS0xLTEtMS00ODE2NA_8183b321-d699-41c4-b5fc-e8fe62d9eb90" unitRef="usd"> 494752000 </us-gaap:AssetsCurrent>
<us-gaap:AssetsCurrent contextRef="i7e0f479bead144b0bdbcc71082db627b_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8xOS9mcmFnOjBjZmQ0MjVhZGFhOTQ3NmZhYjRiZjkzMTA5N2Y3Yjg2L3RhYmxlOmViODM4NGY0NzMwZjQ3Mjk4YzZjOWE4YmE2NmU3NmU5L3RhYmxlcmFuZ2U6ZWI4Mzg0ZjQ3MzBmNDcyOThjNmM5YThiYTY2ZTc2ZTlfOS0zLTEtMS00ODE2NA_3ecea6ce-6862-48ae-ac77-e4564f97bab6" unitRef="usd"> 823013000 </us-gaap:AssetsCurrent>
<us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization contextRef="i4768f885851b49f986857a2a956f9162_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8xOS9mcmFnOjBjZmQ0MjVhZGFhOTQ3NmZhYjRiZjkzMTA5N2Y3Yjg2L3RhYmxlOmViODM4NGY0NzMwZjQ3Mjk4YzZjOWE4YmE2NmU3NmU5L3RhYmxlcmFuZ2U6ZWI4Mzg0ZjQ3MzBmNDcyOThjNmM5YThiYTY2ZTc2ZTlfMTAtMS0xLTEtNDgxNjQ_e9160ba0-8372-4ef7-86a6-42429cac8111" unitRef="usd"> 78601000 </us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization>
<us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization contextRef="i7e0f479bead144b0bdbcc71082db627b_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8xOS9mcmFnOjBjZmQ0MjVhZGFhOTQ3NmZhYjRiZjkzMTA5N2Y3Yjg2L3RhYmxlOmViODM4NGY0NzMwZjQ3Mjk4YzZjOWE4YmE2NmU3NmU5L3RhYmxlcmFuZ2U6ZWI4Mzg0ZjQ3MzBmNDcyOThjNmM5YThiYTY2ZTc2ZTlfMTAtMy0xLTEtNDgxNjQ_51465068-beed-43b2-acc6-57bcbb577fe9" unitRef="usd"> 79727000 </us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization>
<us-gaap:FiniteLivedIntangibleAssetsNet contextRef="i4768f885851b49f986857a2a956f9162_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8xOS9mcmFnOjBjZmQ0MjVhZGFhOTQ3NmZhYjRiZjkzMTA5N2Y3Yjg2L3RhYmxlOmViODM4NGY0NzMwZjQ3Mjk4YzZjOWE4YmE2NmU3NmU5L3RhYmxlcmFuZ2U6ZWI4Mzg0ZjQ3MzBmNDcyOThjNmM5YThiYTY2ZTc2ZTlfMTEtMS0xLTEtNDgxNjQ_b750648d-5be7-4162-bde9-9f5ee0852869" unitRef="usd"> 862409000 </us-gaap:FiniteLivedIntangibleAssetsNet>
<us-gaap:FiniteLivedIntangibleAssetsNet contextRef="i7e0f479bead144b0bdbcc71082db627b_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8xOS9mcmFnOjBjZmQ0MjVhZGFhOTQ3NmZhYjRiZjkzMTA5N2Y3Yjg2L3RhYmxlOmViODM4NGY0NzMwZjQ3Mjk4YzZjOWE4YmE2NmU3NmU5L3RhYmxlcmFuZ2U6ZWI4Mzg0ZjQ3MzBmNDcyOThjNmM5YThiYTY2ZTc2ZTlfMTEtMy0xLTEtNDgxNjQ_d02a218c-fe5e-4f33-bd33-1408fef46242" unitRef="usd"> 321683000 </us-gaap:FiniteLivedIntangibleAssetsNet>
<opk:InProcessResearchandDevelopment contextRef="i4768f885851b49f986857a2a956f9162_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8xOS9mcmFnOjBjZmQ0MjVhZGFhOTQ3NmZhYjRiZjkzMTA5N2Y3Yjg2L3RhYmxlOmViODM4NGY0NzMwZjQ3Mjk4YzZjOWE4YmE2NmU3NmU5L3RhYmxlcmFuZ2U6ZWI4Mzg0ZjQ3MzBmNDcyOThjNmM5YThiYTY2ZTc2ZTlfMTItMS0xLTEtNDgxNjQ_62499806-f63c-4ff2-b7b8-08a3de12dc9c" unitRef="usd"> 195000000 </opk:InProcessResearchandDevelopment>
<opk:InProcessResearchandDevelopment contextRef="i7e0f479bead144b0bdbcc71082db627b_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8xOS9mcmFnOjBjZmQ0MjVhZGFhOTQ3NmZhYjRiZjkzMTA5N2Y3Yjg2L3RhYmxlOmViODM4NGY0NzMwZjQ3Mjk4YzZjOWE4YmE2NmU3NmU5L3RhYmxlcmFuZ2U6ZWI4Mzg0ZjQ3MzBmNDcyOThjNmM5YThiYTY2ZTc2ZTlfMTItMy0xLTEtNDgxNjQ_d92f6576-f514-4b26-bbf8-e9fe19df8d27" unitRef="usd"> 590200000 </opk:InProcessResearchandDevelopment>
<us-gaap:Goodwill contextRef="i4768f885851b49f986857a2a956f9162_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8xOS9mcmFnOjBjZmQ0MjVhZGFhOTQ3NmZhYjRiZjkzMTA5N2Y3Yjg2L3RhYmxlOmViODM4NGY0NzMwZjQ3Mjk4YzZjOWE4YmE2NmU3NmU5L3RhYmxlcmFuZ2U6ZWI4Mzg0ZjQ3MzBmNDcyOThjNmM5YThiYTY2ZTc2ZTlfMTMtMS0xLTEtNDgxNjQ_9ac05915-676f-4019-9c1e-ec53e7c03843" unitRef="usd"> 578845000 </us-gaap:Goodwill>
<us-gaap:Goodwill contextRef="i7e0f479bead144b0bdbcc71082db627b_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8xOS9mcmFnOjBjZmQ0MjVhZGFhOTQ3NmZhYjRiZjkzMTA5N2Y3Yjg2L3RhYmxlOmViODM4NGY0NzMwZjQ3Mjk4YzZjOWE4YmE2NmU3NmU5L3RhYmxlcmFuZ2U6ZWI4Mzg0ZjQ3MzBmNDcyOThjNmM5YThiYTY2ZTc2ZTlfMTMtMy0xLTEtNDgxNjQ_85fbeff3-4bd5-4f76-908b-a9c1fdd51e5b" unitRef="usd"> 520601000 </us-gaap:Goodwill>
<us-gaap:LongTermInvestments contextRef="i4768f885851b49f986857a2a956f9162_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8xOS9mcmFnOjBjZmQ0MjVhZGFhOTQ3NmZhYjRiZjkzMTA5N2Y3Yjg2L3RhYmxlOmViODM4NGY0NzMwZjQ3Mjk4YzZjOWE4YmE2NmU3NmU5L3RhYmxlcmFuZ2U6ZWI4Mzg0ZjQ3MzBmNDcyOThjNmM5YThiYTY2ZTc2ZTlfMTQtMS0xLTEtNDgxNjQ_dbd4128a-0579-4667-95d5-883d2aadaa18" unitRef="usd"> 108685000 </us-gaap:LongTermInvestments>
<us-gaap:LongTermInvestments contextRef="i7e0f479bead144b0bdbcc71082db627b_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8xOS9mcmFnOjBjZmQ0MjVhZGFhOTQ3NmZhYjRiZjkzMTA5N2Y3Yjg2L3RhYmxlOmViODM4NGY0NzMwZjQ3Mjk4YzZjOWE4YmE2NmU3NmU5L3RhYmxlcmFuZ2U6ZWI4Mzg0ZjQ3MzBmNDcyOThjNmM5YThiYTY2ZTc2ZTlfMTQtMy0xLTEtNDgxNjQ_fb0a7514-4beb-4350-87d0-0f00b4495894" unitRef="usd"> 10729000 </us-gaap:LongTermInvestments>
<us-gaap:OperatingLeaseRightOfUseAsset contextRef="i4768f885851b49f986857a2a956f9162_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8xOS9mcmFnOjBjZmQ0MjVhZGFhOTQ3NmZhYjRiZjkzMTA5N2Y3Yjg2L3RhYmxlOmViODM4NGY0NzMwZjQ3Mjk4YzZjOWE4YmE2NmU3NmU5L3RhYmxlcmFuZ2U6ZWI4Mzg0ZjQ3MzBmNDcyOThjNmM5YThiYTY2ZTc2ZTlfMTUtMS0xLTEtNDgxNjQ_f4713b9f-5093-45b3-a1de-32fff81849e3" unitRef="usd"> 42412000 </us-gaap:OperatingLeaseRightOfUseAsset>
<us-gaap:OperatingLeaseRightOfUseAsset contextRef="i7e0f479bead144b0bdbcc71082db627b_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8xOS9mcmFnOjBjZmQ0MjVhZGFhOTQ3NmZhYjRiZjkzMTA5N2Y3Yjg2L3RhYmxlOmViODM4NGY0NzMwZjQ3Mjk4YzZjOWE4YmE2NmU3NmU5L3RhYmxlcmFuZ2U6ZWI4Mzg0ZjQ3MzBmNDcyOThjNmM5YThiYTY2ZTc2ZTlfMTUtMy0xLTEtNDgxNjQ_3654b45c-f05d-4f71-9426-3fc48a4f2846" unitRef="usd"> 44228000 </us-gaap:OperatingLeaseRightOfUseAsset>
<us-gaap:OtherAssetsNoncurrent contextRef="i4768f885851b49f986857a2a956f9162_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8xOS9mcmFnOjBjZmQ0MjVhZGFhOTQ3NmZhYjRiZjkzMTA5N2Y3Yjg2L3RhYmxlOmViODM4NGY0NzMwZjQ3Mjk4YzZjOWE4YmE2NmU3NmU5L3RhYmxlcmFuZ2U6ZWI4Mzg0ZjQ3MzBmNDcyOThjNmM5YThiYTY2ZTc2ZTlfMTYtMS0xLTEtNDgxNjQ_5172c2a0-ef41-4695-859f-ab3f13e3afd1" unitRef="usd"> 8898000 </us-gaap:OtherAssetsNoncurrent>
<us-gaap:OtherAssetsNoncurrent contextRef="i7e0f479bead144b0bdbcc71082db627b_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8xOS9mcmFnOjBjZmQ0MjVhZGFhOTQ3NmZhYjRiZjkzMTA5N2Y3Yjg2L3RhYmxlOmViODM4NGY0NzMwZjQ3Mjk4YzZjOWE4YmE2NmU3NmU5L3RhYmxlcmFuZ2U6ZWI4Mzg0ZjQ3MzBmNDcyOThjNmM5YThiYTY2ZTc2ZTlfMTYtMy0xLTEtNDgxNjQ_1fb6a297-c921-4b1c-a74c-4d4335f45cc1" unitRef="usd"> 9534000 </us-gaap:OtherAssetsNoncurrent>
<us-gaap:Assets contextRef="i4768f885851b49f986857a2a956f9162_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8xOS9mcmFnOjBjZmQ0MjVhZGFhOTQ3NmZhYjRiZjkzMTA5N2Y3Yjg2L3RhYmxlOmViODM4NGY0NzMwZjQ3Mjk4YzZjOWE4YmE2NmU3NmU5L3RhYmxlcmFuZ2U6ZWI4Mzg0ZjQ3MzBmNDcyOThjNmM5YThiYTY2ZTc2ZTlfMTctMS0xLTEtNDgxNjQ_87c8b6ca-34b0-4f48-b484-302f61e7c51c" unitRef="usd"> 2369602000 </us-gaap:Assets>
<us-gaap:Assets contextRef="i7e0f479bead144b0bdbcc71082db627b_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8xOS9mcmFnOjBjZmQ0MjVhZGFhOTQ3NmZhYjRiZjkzMTA5N2Y3Yjg2L3RhYmxlOmViODM4NGY0NzMwZjQ3Mjk4YzZjOWE4YmE2NmU3NmU5L3RhYmxlcmFuZ2U6ZWI4Mzg0ZjQ3MzBmNDcyOThjNmM5YThiYTY2ZTc2ZTlfMTctMy0xLTEtNDgxNjQ_6ed03b61-5e87-4bcd-b2d9-b01e58df18a0" unitRef="usd"> 2399715000 </us-gaap:Assets>
<us-gaap:AccountsPayableCurrent contextRef="i4768f885851b49f986857a2a956f9162_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8xOS9mcmFnOjBjZmQ0MjVhZGFhOTQ3NmZhYjRiZjkzMTA5N2Y3Yjg2L3RhYmxlOmViODM4NGY0NzMwZjQ3Mjk4YzZjOWE4YmE2NmU3NmU5L3RhYmxlcmFuZ2U6ZWI4Mzg0ZjQ3MzBmNDcyOThjNmM5YThiYTY2ZTc2ZTlfMjAtMS0xLTEtNDgxNjQ_5bc747a9-b862-44bc-87be-f5c390672225" unitRef="usd"> 56107000 </us-gaap:AccountsPayableCurrent>
<us-gaap:AccountsPayableCurrent contextRef="i7e0f479bead144b0bdbcc71082db627b_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8xOS9mcmFnOjBjZmQ0MjVhZGFhOTQ3NmZhYjRiZjkzMTA5N2Y3Yjg2L3RhYmxlOmViODM4NGY0NzMwZjQ3Mjk4YzZjOWE4YmE2NmU3NmU5L3RhYmxlcmFuZ2U6ZWI4Mzg0ZjQ3MzBmNDcyOThjNmM5YThiYTY2ZTc2ZTlfMjAtMy0xLTEtNDgxNjQ_21349e79-2c14-4f43-a2e2-86f2a0ea1258" unitRef="usd"> 82040000 </us-gaap:AccountsPayableCurrent>
<us-gaap:AccruedLiabilitiesCurrent contextRef="i4768f885851b49f986857a2a956f9162_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8xOS9mcmFnOjBjZmQ0MjVhZGFhOTQ3NmZhYjRiZjkzMTA5N2Y3Yjg2L3RhYmxlOmViODM4NGY0NzMwZjQ3Mjk4YzZjOWE4YmE2NmU3NmU5L3RhYmxlcmFuZ2U6ZWI4Mzg0ZjQ3MzBmNDcyOThjNmM5YThiYTY2ZTc2ZTlfMjEtMS0xLTEtNDgxNjQ_5be00ea4-4e8d-4c9d-a78c-3b59ff62f978" unitRef="usd"> 128254000 </us-gaap:AccruedLiabilitiesCurrent>
<us-gaap:AccruedLiabilitiesCurrent contextRef="i7e0f479bead144b0bdbcc71082db627b_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8xOS9mcmFnOjBjZmQ0MjVhZGFhOTQ3NmZhYjRiZjkzMTA5N2Y3Yjg2L3RhYmxlOmViODM4NGY0NzMwZjQ3Mjk4YzZjOWE4YmE2NmU3NmU5L3RhYmxlcmFuZ2U6ZWI4Mzg0ZjQ3MzBmNDcyOThjNmM5YThiYTY2ZTc2ZTlfMjEtMy0xLTEtNDgxNjQ_3f639ec9-8981-4012-99d2-a52b3770a537" unitRef="usd"> 193493000 </us-gaap:AccruedLiabilitiesCurrent>
<us-gaap:OperatingLeaseLiabilityCurrent contextRef="i4768f885851b49f986857a2a956f9162_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8xOS9mcmFnOjBjZmQ0MjVhZGFhOTQ3NmZhYjRiZjkzMTA5N2Y3Yjg2L3RhYmxlOmViODM4NGY0NzMwZjQ3Mjk4YzZjOWE4YmE2NmU3NmU5L3RhYmxlcmFuZ2U6ZWI4Mzg0ZjQ3MzBmNDcyOThjNmM5YThiYTY2ZTc2ZTlfMjItMS0xLTEtNDgxNjQ_927846cc-2c06-4bd9-8d34-77e5131da50d" unitRef="usd"> 12122000 </us-gaap:OperatingLeaseLiabilityCurrent>
<us-gaap:OperatingLeaseLiabilityCurrent contextRef="i7e0f479bead144b0bdbcc71082db627b_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8xOS9mcmFnOjBjZmQ0MjVhZGFhOTQ3NmZhYjRiZjkzMTA5N2Y3Yjg2L3RhYmxlOmViODM4NGY0NzMwZjQ3Mjk4YzZjOWE4YmE2NmU3NmU5L3RhYmxlcmFuZ2U6ZWI4Mzg0ZjQ3MzBmNDcyOThjNmM5YThiYTY2ZTc2ZTlfMjItMy0xLTEtNDgxNjQ_214b7eb1-1b54-4478-83c0-2274fea162e1" unitRef="usd"> 11624000 </us-gaap:OperatingLeaseLiabilityCurrent>
<us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent contextRef="i4768f885851b49f986857a2a956f9162_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8xOS9mcmFnOjBjZmQ0MjVhZGFhOTQ3NmZhYjRiZjkzMTA5N2Y3Yjg2L3RhYmxlOmViODM4NGY0NzMwZjQ3Mjk4YzZjOWE4YmE2NmU3NmU5L3RhYmxlcmFuZ2U6ZWI4Mzg0ZjQ3MzBmNDcyOThjNmM5YThiYTY2ZTc2ZTlfMjMtMS0xLTEtNDgxNjQ_346f0ad2-6518-4aac-b609-8045988b1be8" unitRef="usd"> 0 </us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent>
<us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent contextRef="i7e0f479bead144b0bdbcc71082db627b_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8xOS9mcmFnOjBjZmQ0MjVhZGFhOTQ3NmZhYjRiZjkzMTA5N2Y3Yjg2L3RhYmxlOmViODM4NGY0NzMwZjQ3Mjk4YzZjOWE4YmE2NmU3NmU5L3RhYmxlcmFuZ2U6ZWI4Mzg0ZjQ3MzBmNDcyOThjNmM5YThiYTY2ZTc2ZTlfMjMtMy0xLTEtNDgxNjQ_36a97fc8-721f-4abd-8c29-6db6d222a47e" unitRef="usd"> 28156000 </us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent>
<us-gaap:LinesOfCreditCurrent contextRef="i4768f885851b49f986857a2a956f9162_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8xOS9mcmFnOjBjZmQ0MjVhZGFhOTQ3NmZhYjRiZjkzMTA5N2Y3Yjg2L3RhYmxlOmViODM4NGY0NzMwZjQ3Mjk4YzZjOWE4YmE2NmU3NmU5L3RhYmxlcmFuZ2U6ZWI4Mzg0ZjQ3MzBmNDcyOThjNmM5YThiYTY2ZTc2ZTlfMjQtMS0xLTEtNDgxNjQ_1d73e47a-fe43-40ae-af20-e8ba41fc894a" unitRef="usd"> 18989000 </us-gaap:LinesOfCreditCurrent>
<us-gaap:LinesOfCreditCurrent contextRef="i7e0f479bead144b0bdbcc71082db627b_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8xOS9mcmFnOjBjZmQ0MjVhZGFhOTQ3NmZhYjRiZjkzMTA5N2Y3Yjg2L3RhYmxlOmViODM4NGY0NzMwZjQ3Mjk4YzZjOWE4YmE2NmU3NmU5L3RhYmxlcmFuZ2U6ZWI4Mzg0ZjQ3MzBmNDcyOThjNmM5YThiYTY2ZTc2ZTlfMjQtMy0xLTEtNDgxNjQ_2ba48dfc-4537-4dab-8788-a047deb722ef" unitRef="usd"> 14695000 </us-gaap:LinesOfCreditCurrent>
<us-gaap:LiabilitiesCurrent contextRef="i4768f885851b49f986857a2a956f9162_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8xOS9mcmFnOjBjZmQ0MjVhZGFhOTQ3NmZhYjRiZjkzMTA5N2Y3Yjg2L3RhYmxlOmViODM4NGY0NzMwZjQ3Mjk4YzZjOWE4YmE2NmU3NmU5L3RhYmxlcmFuZ2U6ZWI4Mzg0ZjQ3MzBmNDcyOThjNmM5YThiYTY2ZTc2ZTlfMjUtMS0xLTEtNDgxNjQ_5b55c375-e0b1-435e-a446-c94c2f6a3ca4" unitRef="usd"> 215472000 </us-gaap:LiabilitiesCurrent>
<us-gaap:LiabilitiesCurrent contextRef="i7e0f479bead144b0bdbcc71082db627b_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8xOS9mcmFnOjBjZmQ0MjVhZGFhOTQ3NmZhYjRiZjkzMTA5N2Y3Yjg2L3RhYmxlOmViODM4NGY0NzMwZjQ3Mjk4YzZjOWE4YmE2NmU3NmU5L3RhYmxlcmFuZ2U6ZWI4Mzg0ZjQ3MzBmNDcyOThjNmM5YThiYTY2ZTc2ZTlfMjUtMy0xLTEtNDgxNjQ_732acb2b-f18e-4106-89c0-5a94789b1dfb" unitRef="usd"> 330008000 </us-gaap:LiabilitiesCurrent>
<us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="i4768f885851b49f986857a2a956f9162_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8xOS9mcmFnOjBjZmQ0MjVhZGFhOTQ3NmZhYjRiZjkzMTA5N2Y3Yjg2L3RhYmxlOmViODM4NGY0NzMwZjQ3Mjk4YzZjOWE4YmE2NmU3NmU5L3RhYmxlcmFuZ2U6ZWI4Mzg0ZjQ3MzBmNDcyOThjNmM5YThiYTY2ZTc2ZTlfMjYtMS0xLTEtNDgxNjQ_aa1d937b-d8b9-4605-ba48-117235d9ec5d" unitRef="usd"> 30876000 </us-gaap:OperatingLeaseLiabilityNoncurrent>
<us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="i7e0f479bead144b0bdbcc71082db627b_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8xOS9mcmFnOjBjZmQ0MjVhZGFhOTQ3NmZhYjRiZjkzMTA5N2Y3Yjg2L3RhYmxlOmViODM4NGY0NzMwZjQ3Mjk4YzZjOWE4YmE2NmU3NmU5L3RhYmxlcmFuZ2U6ZWI4Mzg0ZjQ3MzBmNDcyOThjNmM5YThiYTY2ZTc2ZTlfMjYtMy0xLTEtNDgxNjQ_589914c2-684f-4b6f-b610-8082bd84b301" unitRef="usd"> 33097000 </us-gaap:OperatingLeaseLiabilityNoncurrent>
<us-gaap:ConvertibleLongTermNotesPayable contextRef="i4768f885851b49f986857a2a956f9162_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8xOS9mcmFnOjBjZmQ0MjVhZGFhOTQ3NmZhYjRiZjkzMTA5N2Y3Yjg2L3RhYmxlOmViODM4NGY0NzMwZjQ3Mjk4YzZjOWE4YmE2NmU3NmU5L3RhYmxlcmFuZ2U6ZWI4Mzg0ZjQ3MzBmNDcyOThjNmM5YThiYTY2ZTc2ZTlfMjctMS0xLTEtNDgxNjQ_324ab175-f248-4486-a2a6-d47eca1ee2d6" unitRef="usd"> 211477000 </us-gaap:ConvertibleLongTermNotesPayable>
<us-gaap:ConvertibleLongTermNotesPayable contextRef="i7e0f479bead144b0bdbcc71082db627b_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8xOS9mcmFnOjBjZmQ0MjVhZGFhOTQ3NmZhYjRiZjkzMTA5N2Y3Yjg2L3RhYmxlOmViODM4NGY0NzMwZjQ3Mjk4YzZjOWE4YmE2NmU3NmU5L3RhYmxlcmFuZ2U6ZWI4Mzg0ZjQ3MzBmNDcyOThjNmM5YThiYTY2ZTc2ZTlfMjctMy0xLTEtNDgxNjQ_f0cc45a1-836d-4d2b-9014-13b8b9e9bf86" unitRef="usd"> 187935000 </us-gaap:ConvertibleLongTermNotesPayable>
<us-gaap:DeferredIncomeTaxLiabilitiesNet contextRef="i4768f885851b49f986857a2a956f9162_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8xOS9mcmFnOjBjZmQ0MjVhZGFhOTQ3NmZhYjRiZjkzMTA5N2Y3Yjg2L3RhYmxlOmViODM4NGY0NzMwZjQ3Mjk4YzZjOWE4YmE2NmU3NmU5L3RhYmxlcmFuZ2U6ZWI4Mzg0ZjQ3MzBmNDcyOThjNmM5YThiYTY2ZTc2ZTlfMjgtMS0xLTEtNDgxNjQ_19f264e8-c3db-4bf0-a1c3-acea37138fb5" unitRef="usd"> 176741000 </us-gaap:DeferredIncomeTaxLiabilitiesNet>
<us-gaap:DeferredIncomeTaxLiabilitiesNet contextRef="i7e0f479bead144b0bdbcc71082db627b_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8xOS9mcmFnOjBjZmQ0MjVhZGFhOTQ3NmZhYjRiZjkzMTA5N2Y3Yjg2L3RhYmxlOmViODM4NGY0NzMwZjQ3Mjk4YzZjOWE4YmE2NmU3NmU5L3RhYmxlcmFuZ2U6ZWI4Mzg0ZjQ3MzBmNDcyOThjNmM5YThiYTY2ZTc2ZTlfMjgtMy0xLTEtNDgxNjQ_4f0994db-824d-4667-bb61-d3e3a12c26f7" unitRef="usd"> 148487000 </us-gaap:DeferredIncomeTaxLiabilitiesNet>
<us-gaap:OtherLiabilitiesNoncurrent contextRef="i4768f885851b49f986857a2a956f9162_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8xOS9mcmFnOjBjZmQ0MjVhZGFhOTQ3NmZhYjRiZjkzMTA5N2Y3Yjg2L3RhYmxlOmViODM4NGY0NzMwZjQ3Mjk4YzZjOWE4YmE2NmU3NmU5L3RhYmxlcmFuZ2U6ZWI4Mzg0ZjQ3MzBmNDcyOThjNmM5YThiYTY2ZTc2ZTlfMjktMS0xLTEtNDgxNjQ_866503e6-93e9-403c-be46-046fe5a88284" unitRef="usd"> 16237000 </us-gaap:OtherLiabilitiesNoncurrent>
<us-gaap:OtherLiabilitiesNoncurrent contextRef="i7e0f479bead144b0bdbcc71082db627b_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8xOS9mcmFnOjBjZmQ0MjVhZGFhOTQ3NmZhYjRiZjkzMTA5N2Y3Yjg2L3RhYmxlOmViODM4NGY0NzMwZjQ3Mjk4YzZjOWE4YmE2NmU3NmU5L3RhYmxlcmFuZ2U6ZWI4Mzg0ZjQ3MzBmNDcyOThjNmM5YThiYTY2ZTc2ZTlfMjktMy0xLTEtNDgxNjQ_40e0dc8c-5670-499e-92c1-ab7bd035f87d" unitRef="usd"> 15062000 </us-gaap:OtherLiabilitiesNoncurrent>
<us-gaap:LiabilitiesNoncurrent contextRef="i4768f885851b49f986857a2a956f9162_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8xOS9mcmFnOjBjZmQ0MjVhZGFhOTQ3NmZhYjRiZjkzMTA5N2Y3Yjg2L3RhYmxlOmViODM4NGY0NzMwZjQ3Mjk4YzZjOWE4YmE2NmU3NmU5L3RhYmxlcmFuZ2U6ZWI4Mzg0ZjQ3MzBmNDcyOThjNmM5YThiYTY2ZTc2ZTlfMzAtMS0xLTEtNDgxNjQ_864f3d52-af0e-4e02-a609-7e560f33a2f6" unitRef="usd"> 435331000 </us-gaap:LiabilitiesNoncurrent>
<us-gaap:LiabilitiesNoncurrent contextRef="i7e0f479bead144b0bdbcc71082db627b_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8xOS9mcmFnOjBjZmQ0MjVhZGFhOTQ3NmZhYjRiZjkzMTA5N2Y3Yjg2L3RhYmxlOmViODM4NGY0NzMwZjQ3Mjk4YzZjOWE4YmE2NmU3NmU5L3RhYmxlcmFuZ2U6ZWI4Mzg0ZjQ3MzBmNDcyOThjNmM5YThiYTY2ZTc2ZTlfMzAtMy0xLTEtNDgxNjQ_a1c717f2-3e72-4b1b-9f89-eea8eec81d95" unitRef="usd"> 384581000 </us-gaap:LiabilitiesNoncurrent>
<us-gaap:Liabilities contextRef="i4768f885851b49f986857a2a956f9162_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8xOS9mcmFnOjBjZmQ0MjVhZGFhOTQ3NmZhYjRiZjkzMTA5N2Y3Yjg2L3RhYmxlOmViODM4NGY0NzMwZjQ3Mjk4YzZjOWE4YmE2NmU3NmU5L3RhYmxlcmFuZ2U6ZWI4Mzg0ZjQ3MzBmNDcyOThjNmM5YThiYTY2ZTc2ZTlfMzEtMS0xLTEtNDgxNjQ_a82128cf-2221-47c9-b348-dbbca34ea3cf" unitRef="usd"> 650803000 </us-gaap:Liabilities>
<us-gaap:Liabilities contextRef="i7e0f479bead144b0bdbcc71082db627b_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8xOS9mcmFnOjBjZmQ0MjVhZGFhOTQ3NmZhYjRiZjkzMTA5N2Y3Yjg2L3RhYmxlOmViODM4NGY0NzMwZjQ3Mjk4YzZjOWE4YmE2NmU3NmU5L3RhYmxlcmFuZ2U6ZWI4Mzg0ZjQ3MzBmNDcyOThjNmM5YThiYTY2ZTc2ZTlfMzEtMy0xLTEtNDgxNjQ_dc3db848-3975-4fb5-a2fb-bd9f6ec2cf85" unitRef="usd"> 714589000 </us-gaap:Liabilities>
<us-gaap:CommonStockParOrStatedValuePerShare contextRef="i7e0f479bead144b0bdbcc71082db627b_I20211231" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8xOS9mcmFnOjBjZmQ0MjVhZGFhOTQ3NmZhYjRiZjkzMTA5N2Y3Yjg2L3RhYmxlOmViODM4NGY0NzMwZjQ3Mjk4YzZjOWE4YmE2NmU3NmU5L3RhYmxlcmFuZ2U6ZWI4Mzg0ZjQ3MzBmNDcyOThjNmM5YThiYTY2ZTc2ZTlfMzctMC0xLTEtNDgxNjQvdGV4dHJlZ2lvbjpjMzU1ODEyNzYyY2I0MjkwOGJiMjdkNzc1NmRiMzU5MV8xOQ_3d682adb-9ef3-4038-9f7d-60a5e94a17f6" unitRef="usdPerShare"> 0.01 </us-gaap:CommonStockParOrStatedValuePerShare>
<us-gaap:CommonStockParOrStatedValuePerShare contextRef="i4768f885851b49f986857a2a956f9162_I20220630" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8xOS9mcmFnOjBjZmQ0MjVhZGFhOTQ3NmZhYjRiZjkzMTA5N2Y3Yjg2L3RhYmxlOmViODM4NGY0NzMwZjQ3Mjk4YzZjOWE4YmE2NmU3NmU5L3RhYmxlcmFuZ2U6ZWI4Mzg0ZjQ3MzBmNDcyOThjNmM5YThiYTY2ZTc2ZTlfMzctMC0xLTEtNDgxNjQvdGV4dHJlZ2lvbjpjMzU1ODEyNzYyY2I0MjkwOGJiMjdkNzc1NmRiMzU5MV8xOQ_eac6b5ee-69b4-4a82-b222-a9ae67ea33f7" unitRef="usdPerShare"> 0.01 </us-gaap:CommonStockParOrStatedValuePerShare>
<us-gaap:CommonStockSharesAuthorized contextRef="i4768f885851b49f986857a2a956f9162_I20220630" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8xOS9mcmFnOjBjZmQ0MjVhZGFhOTQ3NmZhYjRiZjkzMTA5N2Y3Yjg2L3RhYmxlOmViODM4NGY0NzMwZjQ3Mjk4YzZjOWE4YmE2NmU3NmU5L3RhYmxlcmFuZ2U6ZWI4Mzg0ZjQ3MzBmNDcyOThjNmM5YThiYTY2ZTc2ZTlfMzctMC0xLTEtNDgxNjQvdGV4dHJlZ2lvbjpjMzU1ODEyNzYyY2I0MjkwOGJiMjdkNzc1NmRiMzU5MV8zMw_4c7c0d16-8510-45b3-ae25-d232c32e30aa" unitRef="shares"> 1000000000 </us-gaap:CommonStockSharesAuthorized>
<us-gaap:CommonStockSharesAuthorized contextRef="i7e0f479bead144b0bdbcc71082db627b_I20211231" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8xOS9mcmFnOjBjZmQ0MjVhZGFhOTQ3NmZhYjRiZjkzMTA5N2Y3Yjg2L3RhYmxlOmViODM4NGY0NzMwZjQ3Mjk4YzZjOWE4YmE2NmU3NmU5L3RhYmxlcmFuZ2U6ZWI4Mzg0ZjQ3MzBmNDcyOThjNmM5YThiYTY2ZTc2ZTlfMzctMC0xLTEtNDgxNjQvdGV4dHJlZ2lvbjpjMzU1ODEyNzYyY2I0MjkwOGJiMjdkNzc1NmRiMzU5MV8zMw_a27958b0-3621-4948-b64a-afa0d46b37cf" unitRef="shares"> 1000000000 </us-gaap:CommonStockSharesAuthorized>
<us-gaap:CommonStockSharesIssued contextRef="i4768f885851b49f986857a2a956f9162_I20220630" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8xOS9mcmFnOjBjZmQ0MjVhZGFhOTQ3NmZhYjRiZjkzMTA5N2Y3Yjg2L3RhYmxlOmViODM4NGY0NzMwZjQ3Mjk4YzZjOWE4YmE2NmU3NmU5L3RhYmxlcmFuZ2U6ZWI4Mzg0ZjQ3MzBmNDcyOThjNmM5YThiYTY2ZTc2ZTlfMzctMC0xLTEtNDgxNjQvdGV4dHJlZ2lvbjpjMzU1ODEyNzYyY2I0MjkwOGJiMjdkNzc1NmRiMzU5MV81NQ_fcf43f9d-6ad8-411c-b8dc-37243323bd78" unitRef="shares"> 780591681 </us-gaap:CommonStockSharesIssued>
<us-gaap:CommonStockSharesIssued contextRef="i7e0f479bead144b0bdbcc71082db627b_I20211231" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8xOS9mcmFnOjBjZmQ0MjVhZGFhOTQ3NmZhYjRiZjkzMTA5N2Y3Yjg2L3RhYmxlOmViODM4NGY0NzMwZjQ3Mjk4YzZjOWE4YmE2NmU3NmU5L3RhYmxlcmFuZ2U6ZWI4Mzg0ZjQ3MzBmNDcyOThjNmM5YThiYTY2ZTc2ZTlfMzctMC0xLTEtNDgxNjQvdGV4dHJlZ2lvbjpjMzU1ODEyNzYyY2I0MjkwOGJiMjdkNzc1NmRiMzU5MV82Mg_7b5f0adc-a36b-42cc-adeb-ad32641b97b9" unitRef="shares"> 690082283 </us-gaap:CommonStockSharesIssued>
<us-gaap:CommonStockValue contextRef="i4768f885851b49f986857a2a956f9162_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8xOS9mcmFnOjBjZmQ0MjVhZGFhOTQ3NmZhYjRiZjkzMTA5N2Y3Yjg2L3RhYmxlOmViODM4NGY0NzMwZjQ3Mjk4YzZjOWE4YmE2NmU3NmU5L3RhYmxlcmFuZ2U6ZWI4Mzg0ZjQ3MzBmNDcyOThjNmM5YThiYTY2ZTc2ZTlfMzctMS0xLTEtNDgxNjQ_957d61bb-a037-4d81-9d65-ea0fe4f2da1c" unitRef="usd"> 7806000 </us-gaap:CommonStockValue>
<us-gaap:CommonStockValue contextRef="i7e0f479bead144b0bdbcc71082db627b_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8xOS9mcmFnOjBjZmQ0MjVhZGFhOTQ3NmZhYjRiZjkzMTA5N2Y3Yjg2L3RhYmxlOmViODM4NGY0NzMwZjQ3Mjk4YzZjOWE4YmE2NmU3NmU5L3RhYmxlcmFuZ2U6ZWI4Mzg0ZjQ3MzBmNDcyOThjNmM5YThiYTY2ZTc2ZTlfMzctMy0xLTEtNDgxNjQ_e6bb4047-9cf6-46e1-9558-3ebe8c5aad12" unitRef="usd"> 6901000 </us-gaap:CommonStockValue>
<us-gaap:TreasuryStockCommonShares contextRef="i4768f885851b49f986857a2a956f9162_I20220630" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8xOS9mcmFnOjBjZmQ0MjVhZGFhOTQ3NmZhYjRiZjkzMTA5N2Y3Yjg2L3RhYmxlOmViODM4NGY0NzMwZjQ3Mjk4YzZjOWE4YmE2NmU3NmU5L3RhYmxlcmFuZ2U6ZWI4Mzg0ZjQ3MzBmNDcyOThjNmM5YThiYTY2ZTc2ZTlfMzgtMC0xLTEtNDgxNjQvdGV4dHJlZ2lvbjpmMTgyNWZlYzE5MWY0NGE5YWIyNzBlMDJjMDQ0YTIxMV8yMQ_51ed69c2-c793-4a30-b4a6-dc825eed788f" unitRef="shares"> 8655082 </us-gaap:TreasuryStockCommonShares>
<us-gaap:TreasuryStockCommonValue contextRef="i4768f885851b49f986857a2a956f9162_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8xOS9mcmFnOjBjZmQ0MjVhZGFhOTQ3NmZhYjRiZjkzMTA5N2Y3Yjg2L3RhYmxlOmViODM4NGY0NzMwZjQ3Mjk4YzZjOWE4YmE2NmU3NmU5L3RhYmxlcmFuZ2U6ZWI4Mzg0ZjQ3MzBmNDcyOThjNmM5YThiYTY2ZTc2ZTlfMzgtMS0xLTEtNDgxNjQ_e92f31dc-749b-4d00-aec2-d54e155cef9d" unitRef="usd"> 1791000 </us-gaap:TreasuryStockCommonValue>
<us-gaap:TreasuryStockCommonValue contextRef="i7e0f479bead144b0bdbcc71082db627b_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8xOS9mcmFnOjBjZmQ0MjVhZGFhOTQ3NmZhYjRiZjkzMTA5N2Y3Yjg2L3RhYmxlOmViODM4NGY0NzMwZjQ3Mjk4YzZjOWE4YmE2NmU3NmU5L3RhYmxlcmFuZ2U6ZWI4Mzg0ZjQ3MzBmNDcyOThjNmM5YThiYTY2ZTc2ZTlfMzgtMy0xLTEtNDgxNjQ_288a0611-b812-498f-9475-eccc097727f4" unitRef="usd"> 1791000 </us-gaap:TreasuryStockCommonValue>
<us-gaap:AdditionalPaidInCapital contextRef="i4768f885851b49f986857a2a956f9162_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8xOS9mcmFnOjBjZmQ0MjVhZGFhOTQ3NmZhYjRiZjkzMTA5N2Y3Yjg2L3RhYmxlOmViODM4NGY0NzMwZjQ3Mjk4YzZjOWE4YmE2NmU3NmU5L3RhYmxlcmFuZ2U6ZWI4Mzg0ZjQ3MzBmNDcyOThjNmM5YThiYTY2ZTc2ZTlfMzktMS0xLTEtNDgxNjQ_216b3907-6a54-4f45-8c64-90fd50e3631d" unitRef="usd"> 3413556000 </us-gaap:AdditionalPaidInCapital>
<us-gaap:AdditionalPaidInCapital contextRef="i7e0f479bead144b0bdbcc71082db627b_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8xOS9mcmFnOjBjZmQ0MjVhZGFhOTQ3NmZhYjRiZjkzMTA5N2Y3Yjg2L3RhYmxlOmViODM4NGY0NzMwZjQ3Mjk4YzZjOWE4YmE2NmU3NmU5L3RhYmxlcmFuZ2U6ZWI4Mzg0ZjQ3MzBmNDcyOThjNmM5YThiYTY2ZTc2ZTlfMzktMy0xLTEtNDgxNjQ_40ef6a83-2c14-4626-8490-ecacce73df89" unitRef="usd"> 3222487000 </us-gaap:AdditionalPaidInCapital>
<us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="i4768f885851b49f986857a2a956f9162_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8xOS9mcmFnOjBjZmQ0MjVhZGFhOTQ3NmZhYjRiZjkzMTA5N2Y3Yjg2L3RhYmxlOmViODM4NGY0NzMwZjQ3Mjk4YzZjOWE4YmE2NmU3NmU5L3RhYmxlcmFuZ2U6ZWI4Mzg0ZjQ3MzBmNDcyOThjNmM5YThiYTY2ZTc2ZTlfNDAtMS0xLTEtNDgxNjQ_aae16335-8274-4cd0-80a9-25bad364fdfd" unitRef="usd"> -49171000 </us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
<us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="i7e0f479bead144b0bdbcc71082db627b_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8xOS9mcmFnOjBjZmQ0MjVhZGFhOTQ3NmZhYjRiZjkzMTA5N2Y3Yjg2L3RhYmxlOmViODM4NGY0NzMwZjQ3Mjk4YzZjOWE4YmE2NmU3NmU5L3RhYmxlcmFuZ2U6ZWI4Mzg0ZjQ3MzBmNDcyOThjNmM5YThiYTY2ZTc2ZTlfNDAtMy0xLTEtNDgxNjQ_951dbd74-864b-48c7-815a-517a8654b311" unitRef="usd"> -30495000 </us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
<us-gaap:RetainedEarningsAccumulatedDeficit contextRef="i4768f885851b49f986857a2a956f9162_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8xOS9mcmFnOjBjZmQ0MjVhZGFhOTQ3NmZhYjRiZjkzMTA5N2Y3Yjg2L3RhYmxlOmViODM4NGY0NzMwZjQ3Mjk4YzZjOWE4YmE2NmU3NmU5L3RhYmxlcmFuZ2U6ZWI4Mzg0ZjQ3MzBmNDcyOThjNmM5YThiYTY2ZTc2ZTlfNDEtMS0xLTEtNDgxNjQ_2083f25b-cfad-419b-a13c-5e1a70203ba2" unitRef="usd"> -1651601000 </us-gaap:RetainedEarningsAccumulatedDeficit>
<us-gaap:RetainedEarningsAccumulatedDeficit contextRef="i7e0f479bead144b0bdbcc71082db627b_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8xOS9mcmFnOjBjZmQ0MjVhZGFhOTQ3NmZhYjRiZjkzMTA5N2Y3Yjg2L3RhYmxlOmViODM4NGY0NzMwZjQ3Mjk4YzZjOWE4YmE2NmU3NmU5L3RhYmxlcmFuZ2U6ZWI4Mzg0ZjQ3MzBmNDcyOThjNmM5YThiYTY2ZTc2ZTlfNDEtMy0xLTEtNDgxNjQ_d05a0d66-dfb3-4a00-bd2d-7a313fc11eff" unitRef="usd"> -1511976000 </us-gaap:RetainedEarningsAccumulatedDeficit>
<us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="i4768f885851b49f986857a2a956f9162_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8xOS9mcmFnOjBjZmQ0MjVhZGFhOTQ3NmZhYjRiZjkzMTA5N2Y3Yjg2L3RhYmxlOmViODM4NGY0NzMwZjQ3Mjk4YzZjOWE4YmE2NmU3NmU5L3RhYmxlcmFuZ2U6ZWI4Mzg0ZjQ3MzBmNDcyOThjNmM5YThiYTY2ZTc2ZTlfNDQtMS0xLTEtNDgxNjQ_bccc395b-99c2-4dd0-a1e0-d0add21982f4" unitRef="usd"> 1718799000 </us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
<us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="i7e0f479bead144b0bdbcc71082db627b_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8xOS9mcmFnOjBjZmQ0MjVhZGFhOTQ3NmZhYjRiZjkzMTA5N2Y3Yjg2L3RhYmxlOmViODM4NGY0NzMwZjQ3Mjk4YzZjOWE4YmE2NmU3NmU5L3RhYmxlcmFuZ2U6ZWI4Mzg0ZjQ3MzBmNDcyOThjNmM5YThiYTY2ZTc2ZTlfNDQtMy0xLTEtNDgxNjQ_06a43c2c-d23b-4b04-96e8-7df4909866e7" unitRef="usd"> 1685126000 </us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
<us-gaap:LiabilitiesAndStockholdersEquity contextRef="i4768f885851b49f986857a2a956f9162_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8xOS9mcmFnOjBjZmQ0MjVhZGFhOTQ3NmZhYjRiZjkzMTA5N2Y3Yjg2L3RhYmxlOmViODM4NGY0NzMwZjQ3Mjk4YzZjOWE4YmE2NmU3NmU5L3RhYmxlcmFuZ2U6ZWI4Mzg0ZjQ3MzBmNDcyOThjNmM5YThiYTY2ZTc2ZTlfNDUtMS0xLTEtNDgxNjQ_96613416-0557-45fc-8388-afc68cf3b0a8" unitRef="usd"> 2369602000 </us-gaap:LiabilitiesAndStockholdersEquity>
<us-gaap:LiabilitiesAndStockholdersEquity contextRef="i7e0f479bead144b0bdbcc71082db627b_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8xOS9mcmFnOjBjZmQ0MjVhZGFhOTQ3NmZhYjRiZjkzMTA5N2Y3Yjg2L3RhYmxlOmViODM4NGY0NzMwZjQ3Mjk4YzZjOWE4YmE2NmU3NmU5L3RhYmxlcmFuZ2U6ZWI4Mzg0ZjQ3MzBmNDcyOThjNmM5YThiYTY2ZTc2ZTlfNDUtMy0xLTEtNDgxNjQ_1638f27a-2b11-4d07-8aef-4c850c4919ae" unitRef="usd"> 2399715000 </us-gaap:LiabilitiesAndStockholdersEquity>
<us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="idf5be29147e94b809d0f3f67415ce0b1_D20220401-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8yNS9mcmFnOmM4YjY5YzZiOTg5NjQ4ZmJhOWQyZTRlOGExMWE5M2ZkL3RhYmxlOjc3NWVhZjBhNWVhOTRmOThhYzY3M2ZjNDk0MjcyNDFjL3RhYmxlcmFuZ2U6Nzc1ZWFmMGE1ZWE5NGY5OGFjNjczZmM0OTQyNzI0MWNfMy0xLTEtMS00ODE2NA_4826e79a-e01d-4c6d-a6b3-04dbf6daad6c" unitRef="usd"> 186804000 </us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
<us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="i3f3fc0cd0f02481481f1bb2345313999_D20210401-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8yNS9mcmFnOmM4YjY5YzZiOTg5NjQ4ZmJhOWQyZTRlOGExMWE5M2ZkL3RhYmxlOjc3NWVhZjBhNWVhOTRmOThhYzY3M2ZjNDk0MjcyNDFjL3RhYmxlcmFuZ2U6Nzc1ZWFmMGE1ZWE5NGY5OGFjNjczZmM0OTQyNzI0MWNfMy0zLTEtMS00ODE2NA_1a8841d6-3391-420f-b2c9-97b431ceeeb5" unitRef="usd"> 397197000 </us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
<us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="i8b5aa09d29044d42bbfdc68d86a7e9a3_D20220101-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8yNS9mcmFnOmM4YjY5YzZiOTg5NjQ4ZmJhOWQyZTRlOGExMWE5M2ZkL3RhYmxlOjc3NWVhZjBhNWVhOTRmOThhYzY3M2ZjNDk0MjcyNDFjL3RhYmxlcmFuZ2U6Nzc1ZWFmMGE1ZWE5NGY5OGFjNjczZmM0OTQyNzI0MWNfMy01LTEtMS00ODE2NA_4fcf15b5-22d7-45b5-814b-aebb70865ccc" unitRef="usd"> 473402000 </us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
<us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="i80b516e519b848f8a55bf1affb1fc020_D20210101-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8yNS9mcmFnOmM4YjY5YzZiOTg5NjQ4ZmJhOWQyZTRlOGExMWE5M2ZkL3RhYmxlOjc3NWVhZjBhNWVhOTRmOThhYzY3M2ZjNDk0MjcyNDFjL3RhYmxlcmFuZ2U6Nzc1ZWFmMGE1ZWE5NGY5OGFjNjczZmM0OTQyNzI0MWNfMy03LTEtMS00ODE2NA_f0d660ee-558a-4aa5-b4e2-201f425cf48a" unitRef="usd"> 904149000 </us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
<us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="if2238695b80a4a5f903fa54aa9e93ad7_D20220401-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8yNS9mcmFnOmM4YjY5YzZiOTg5NjQ4ZmJhOWQyZTRlOGExMWE5M2ZkL3RhYmxlOjc3NWVhZjBhNWVhOTRmOThhYzY3M2ZjNDk0MjcyNDFjL3RhYmxlcmFuZ2U6Nzc1ZWFmMGE1ZWE5NGY5OGFjNjczZmM0OTQyNzI0MWNfNC0xLTEtMS00ODE2NA_574e5d14-1c7f-436a-aeae-20f7ed5a236c" unitRef="usd"> 35892000 </us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
<us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="ie9994295e2b2433795782a98077e22b5_D20210401-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8yNS9mcmFnOmM4YjY5YzZiOTg5NjQ4ZmJhOWQyZTRlOGExMWE5M2ZkL3RhYmxlOjc3NWVhZjBhNWVhOTRmOThhYzY3M2ZjNDk0MjcyNDFjL3RhYmxlcmFuZ2U6Nzc1ZWFmMGE1ZWE5NGY5OGFjNjczZmM0OTQyNzI0MWNfNC0zLTEtMS00ODE2NA_3eb77a97-3c87-41ef-951c-17a5dacd0fc0" unitRef="usd"> 35663000 </us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
<us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="ib67a5f67884e4812a29dfbb65739778f_D20220101-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8yNS9mcmFnOmM4YjY5YzZiOTg5NjQ4ZmJhOWQyZTRlOGExMWE5M2ZkL3RhYmxlOjc3NWVhZjBhNWVhOTRmOThhYzY3M2ZjNDk0MjcyNDFjL3RhYmxlcmFuZ2U6Nzc1ZWFmMGE1ZWE5NGY5OGFjNjczZmM0OTQyNzI0MWNfNC01LTEtMS00ODE2NA_bbea30db-0780-4143-b1e1-67a461e27700" unitRef="usd"> 72550000 </us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
<us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="ia894264b8eea4bb0bd7d5a5dbc6ab9cd_D20210101-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8yNS9mcmFnOmM4YjY5YzZiOTg5NjQ4ZmJhOWQyZTRlOGExMWE5M2ZkL3RhYmxlOjc3NWVhZjBhNWVhOTRmOThhYzY3M2ZjNDk0MjcyNDFjL3RhYmxlcmFuZ2U6Nzc1ZWFmMGE1ZWE5NGY5OGFjNjczZmM0OTQyNzI0MWNfNC03LTEtMS00ODE2NA_9fb5e5e8-6ed9-461f-aac3-b119ffb084b4" unitRef="usd"> 69608000 </us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
<us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="i2dbee62a623a4004a055434064bcdd46_D20220401-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8yNS9mcmFnOmM4YjY5YzZiOTg5NjQ4ZmJhOWQyZTRlOGExMWE5M2ZkL3RhYmxlOjc3NWVhZjBhNWVhOTRmOThhYzY3M2ZjNDk0MjcyNDFjL3RhYmxlcmFuZ2U6Nzc1ZWFmMGE1ZWE5NGY5OGFjNjczZmM0OTQyNzI0MWNfNS0xLTEtMS00ODE2NA_19565673-94ae-4a0e-866f-b138aae6c18b" unitRef="usd"> 87197000 </us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
<us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="ia406b4879e9a4c2cadf973464d173c63_D20210401-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8yNS9mcmFnOmM4YjY5YzZiOTg5NjQ4ZmJhOWQyZTRlOGExMWE5M2ZkL3RhYmxlOjc3NWVhZjBhNWVhOTRmOThhYzY3M2ZjNDk0MjcyNDFjL3RhYmxlcmFuZ2U6Nzc1ZWFmMGE1ZWE5NGY5OGFjNjczZmM0OTQyNzI0MWNfNS0zLTEtMS00ODE2NA_0586f019-5a09-4545-90c9-ae7de7f691ad" unitRef="usd"> 9548000 </us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
<us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="i504cf7154fff4123a500b2c26e04b6d9_D20220101-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8yNS9mcmFnOmM4YjY5YzZiOTg5NjQ4ZmJhOWQyZTRlOGExMWE5M2ZkL3RhYmxlOjc3NWVhZjBhNWVhOTRmOThhYzY3M2ZjNDk0MjcyNDFjL3RhYmxlcmFuZ2U6Nzc1ZWFmMGE1ZWE5NGY5OGFjNjczZmM0OTQyNzI0MWNfNS01LTEtMS00ODE2NA_d3b1b654-234f-4330-b1b2-abc689ce7d66" unitRef="usd"> 93159000 </us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
<us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="i32f2af0f2c1f4fee9b8639b2a0a7823b_D20210101-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8yNS9mcmFnOmM4YjY5YzZiOTg5NjQ4ZmJhOWQyZTRlOGExMWE5M2ZkL3RhYmxlOjc3NWVhZjBhNWVhOTRmOThhYzY3M2ZjNDk0MjcyNDFjL3RhYmxlcmFuZ2U6Nzc1ZWFmMGE1ZWE5NGY5OGFjNjczZmM0OTQyNzI0MWNfNS03LTEtMS00ODE2NA_6cf35908-9aef-428f-bf9f-92ab23cdf98e" unitRef="usd"> 13816000 </us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
<us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="i50aa2eea9a6446b6ad796d994509b1ad_D20220401-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8yNS9mcmFnOmM4YjY5YzZiOTg5NjQ4ZmJhOWQyZTRlOGExMWE5M2ZkL3RhYmxlOjc3NWVhZjBhNWVhOTRmOThhYzY3M2ZjNDk0MjcyNDFjL3RhYmxlcmFuZ2U6Nzc1ZWFmMGE1ZWE5NGY5OGFjNjczZmM0OTQyNzI0MWNfNi0xLTEtMS00ODE2NA_031a03bd-52b9-4063-a13a-40074b2c81b5" unitRef="usd"> 309893000 </us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
<us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="if2a6207b6732465a921fe019a2a0f048_D20210401-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8yNS9mcmFnOmM4YjY5YzZiOTg5NjQ4ZmJhOWQyZTRlOGExMWE5M2ZkL3RhYmxlOjc3NWVhZjBhNWVhOTRmOThhYzY3M2ZjNDk0MjcyNDFjL3RhYmxlcmFuZ2U6Nzc1ZWFmMGE1ZWE5NGY5OGFjNjczZmM0OTQyNzI0MWNfNi0zLTEtMS00ODE2NA_efc55d4f-2a35-476c-9dec-7d65acb6bf20" unitRef="usd"> 442408000 </us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
<us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8yNS9mcmFnOmM4YjY5YzZiOTg5NjQ4ZmJhOWQyZTRlOGExMWE5M2ZkL3RhYmxlOjc3NWVhZjBhNWVhOTRmOThhYzY3M2ZjNDk0MjcyNDFjL3RhYmxlcmFuZ2U6Nzc1ZWFmMGE1ZWE5NGY5OGFjNjczZmM0OTQyNzI0MWNfNi01LTEtMS00ODE2NA_81225c4b-474a-42f6-acb2-1ad96f413885" unitRef="usd"> 639111000 </us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
<us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="i420e18e30084498a98510d48880063cd_D20210101-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8yNS9mcmFnOmM4YjY5YzZiOTg5NjQ4ZmJhOWQyZTRlOGExMWE5M2ZkL3RhYmxlOjc3NWVhZjBhNWVhOTRmOThhYzY3M2ZjNDk0MjcyNDFjL3RhYmxlcmFuZ2U6Nzc1ZWFmMGE1ZWE5NGY5OGFjNjczZmM0OTQyNzI0MWNfNi03LTEtMS00ODE2NA_22bb690d-edcf-46a1-8b3c-055f774769af" unitRef="usd"> 987573000 </us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
<us-gaap:CostOfGoodsAndServicesSold contextRef="idf5be29147e94b809d0f3f67415ce0b1_D20220401-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8yNS9mcmFnOmM4YjY5YzZiOTg5NjQ4ZmJhOWQyZTRlOGExMWE5M2ZkL3RhYmxlOjc3NWVhZjBhNWVhOTRmOThhYzY3M2ZjNDk0MjcyNDFjL3RhYmxlcmFuZ2U6Nzc1ZWFmMGE1ZWE5NGY5OGFjNjczZmM0OTQyNzI0MWNfOC0xLTEtMS00ODE2NA_b05de358-7917-4374-bc53-441c9871c895" unitRef="usd"> 171836000 </us-gaap:CostOfGoodsAndServicesSold>
<us-gaap:CostOfGoodsAndServicesSold contextRef="i3f3fc0cd0f02481481f1bb2345313999_D20210401-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8yNS9mcmFnOmM4YjY5YzZiOTg5NjQ4ZmJhOWQyZTRlOGExMWE5M2ZkL3RhYmxlOjc3NWVhZjBhNWVhOTRmOThhYzY3M2ZjNDk0MjcyNDFjL3RhYmxlcmFuZ2U6Nzc1ZWFmMGE1ZWE5NGY5OGFjNjczZmM0OTQyNzI0MWNfOC0zLTEtMS00ODE2NA_ff88829a-9037-4afc-a582-13eea41d1ae6" unitRef="usd"> 267807000 </us-gaap:CostOfGoodsAndServicesSold>
<us-gaap:CostOfGoodsAndServicesSold contextRef="i8b5aa09d29044d42bbfdc68d86a7e9a3_D20220101-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8yNS9mcmFnOmM4YjY5YzZiOTg5NjQ4ZmJhOWQyZTRlOGExMWE5M2ZkL3RhYmxlOjc3NWVhZjBhNWVhOTRmOThhYzY3M2ZjNDk0MjcyNDFjL3RhYmxlcmFuZ2U6Nzc1ZWFmMGE1ZWE5NGY5OGFjNjczZmM0OTQyNzI0MWNfOC01LTEtMS00ODE2NA_7f2a2a6c-a5ef-415d-9502-d7783e5d2105" unitRef="usd"> 393039000 </us-gaap:CostOfGoodsAndServicesSold>
<us-gaap:CostOfGoodsAndServicesSold contextRef="i80b516e519b848f8a55bf1affb1fc020_D20210101-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8yNS9mcmFnOmM4YjY5YzZiOTg5NjQ4ZmJhOWQyZTRlOGExMWE5M2ZkL3RhYmxlOjc3NWVhZjBhNWVhOTRmOThhYzY3M2ZjNDk0MjcyNDFjL3RhYmxlcmFuZ2U6Nzc1ZWFmMGE1ZWE5NGY5OGFjNjczZmM0OTQyNzI0MWNfOC03LTEtMS00ODE2NA_d547db15-68c0-4473-837a-8c833d5ab03e" unitRef="usd"> 607235000 </us-gaap:CostOfGoodsAndServicesSold>
<us-gaap:CostOfGoodsAndServicesSold contextRef="if2238695b80a4a5f903fa54aa9e93ad7_D20220401-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8yNS9mcmFnOmM4YjY5YzZiOTg5NjQ4ZmJhOWQyZTRlOGExMWE5M2ZkL3RhYmxlOjc3NWVhZjBhNWVhOTRmOThhYzY3M2ZjNDk0MjcyNDFjL3RhYmxlcmFuZ2U6Nzc1ZWFmMGE1ZWE5NGY5OGFjNjczZmM0OTQyNzI0MWNfOS0xLTEtMS00ODE2NA_cab2d82d-899a-44c8-a8dc-4dc24fad9bc3" unitRef="usd"> 22475000 </us-gaap:CostOfGoodsAndServicesSold>
<us-gaap:CostOfGoodsAndServicesSold contextRef="ie9994295e2b2433795782a98077e22b5_D20210401-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8yNS9mcmFnOmM4YjY5YzZiOTg5NjQ4ZmJhOWQyZTRlOGExMWE5M2ZkL3RhYmxlOjc3NWVhZjBhNWVhOTRmOThhYzY3M2ZjNDk0MjcyNDFjL3RhYmxlcmFuZ2U6Nzc1ZWFmMGE1ZWE5NGY5OGFjNjczZmM0OTQyNzI0MWNfOS0zLTEtMS00ODE2NA_eca7af64-e186-410a-ad2c-ed0ac38ad96b" unitRef="usd"> 25101000 </us-gaap:CostOfGoodsAndServicesSold>
<us-gaap:CostOfGoodsAndServicesSold contextRef="ib67a5f67884e4812a29dfbb65739778f_D20220101-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8yNS9mcmFnOmM4YjY5YzZiOTg5NjQ4ZmJhOWQyZTRlOGExMWE5M2ZkL3RhYmxlOjc3NWVhZjBhNWVhOTRmOThhYzY3M2ZjNDk0MjcyNDFjL3RhYmxlcmFuZ2U6Nzc1ZWFmMGE1ZWE5NGY5OGFjNjczZmM0OTQyNzI0MWNfOS01LTEtMS00ODE2NA_0034ca45-b302-4311-9790-4f8e58f93404" unitRef="usd"> 45147000 </us-gaap:CostOfGoodsAndServicesSold>
<us-gaap:CostOfGoodsAndServicesSold contextRef="ia894264b8eea4bb0bd7d5a5dbc6ab9cd_D20210101-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8yNS9mcmFnOmM4YjY5YzZiOTg5NjQ4ZmJhOWQyZTRlOGExMWE5M2ZkL3RhYmxlOjc3NWVhZjBhNWVhOTRmOThhYzY3M2ZjNDk0MjcyNDFjL3RhYmxlcmFuZ2U6Nzc1ZWFmMGE1ZWE5NGY5OGFjNjczZmM0OTQyNzI0MWNfOS03LTEtMS00ODE2NA_5c04d205-238e-4506-8be7-e449ba18e6a7" unitRef="usd"> 49179000 </us-gaap:CostOfGoodsAndServicesSold>
<us-gaap:SellingGeneralAndAdministrativeExpense contextRef="i50aa2eea9a6446b6ad796d994509b1ad_D20220401-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8yNS9mcmFnOmM4YjY5YzZiOTg5NjQ4ZmJhOWQyZTRlOGExMWE5M2ZkL3RhYmxlOjc3NWVhZjBhNWVhOTRmOThhYzY3M2ZjNDk0MjcyNDFjL3RhYmxlcmFuZ2U6Nzc1ZWFmMGE1ZWE5NGY5OGFjNjczZmM0OTQyNzI0MWNfMTEtMS0xLTEtNDgxNjQ_61402886-c18f-400b-8e02-521e2d37be6b" unitRef="usd"> 101464000 </us-gaap:SellingGeneralAndAdministrativeExpense>
<us-gaap:SellingGeneralAndAdministrativeExpense contextRef="if2a6207b6732465a921fe019a2a0f048_D20210401-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8yNS9mcmFnOmM4YjY5YzZiOTg5NjQ4ZmJhOWQyZTRlOGExMWE5M2ZkL3RhYmxlOjc3NWVhZjBhNWVhOTRmOThhYzY3M2ZjNDk0MjcyNDFjL3RhYmxlcmFuZ2U6Nzc1ZWFmMGE1ZWE5NGY5OGFjNjczZmM0OTQyNzI0MWNfMTEtMy0xLTEtNDgxNjQ_75791e36-ec0a-4035-9100-644175f2e74a" unitRef="usd"> 113236000 </us-gaap:SellingGeneralAndAdministrativeExpense>
<us-gaap:SellingGeneralAndAdministrativeExpense contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8yNS9mcmFnOmM4YjY5YzZiOTg5NjQ4ZmJhOWQyZTRlOGExMWE5M2ZkL3RhYmxlOjc3NWVhZjBhNWVhOTRmOThhYzY3M2ZjNDk0MjcyNDFjL3RhYmxlcmFuZ2U6Nzc1ZWFmMGE1ZWE5NGY5OGFjNjczZmM0OTQyNzI0MWNfMTEtNS0xLTEtNDgxNjQ_95505580-ed59-44b8-acf7-305571b7da96" unitRef="usd"> 219000000 </us-gaap:SellingGeneralAndAdministrativeExpense>
<us-gaap:SellingGeneralAndAdministrativeExpense contextRef="i420e18e30084498a98510d48880063cd_D20210101-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8yNS9mcmFnOmM4YjY5YzZiOTg5NjQ4ZmJhOWQyZTRlOGExMWE5M2ZkL3RhYmxlOjc3NWVhZjBhNWVhOTRmOThhYzY3M2ZjNDk0MjcyNDFjL3RhYmxlcmFuZ2U6Nzc1ZWFmMGE1ZWE5NGY5OGFjNjczZmM0OTQyNzI0MWNfMTEtNy0xLTEtNDgxNjQ_0588b3a8-7992-402e-b4cd-2a454ce61996" unitRef="usd"> 225522000 </us-gaap:SellingGeneralAndAdministrativeExpense>
<us-gaap:ResearchAndDevelopmentExpense contextRef="i50aa2eea9a6446b6ad796d994509b1ad_D20220401-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8yNS9mcmFnOmM4YjY5YzZiOTg5NjQ4ZmJhOWQyZTRlOGExMWE5M2ZkL3RhYmxlOjc3NWVhZjBhNWVhOTRmOThhYzY3M2ZjNDk0MjcyNDFjL3RhYmxlcmFuZ2U6Nzc1ZWFmMGE1ZWE5NGY5OGFjNjczZmM0OTQyNzI0MWNfMTItMS0xLTEtNDgxNjQ_6899a58f-17ee-48f1-ae08-d6c3210ca103" unitRef="usd"> 17254000 </us-gaap:ResearchAndDevelopmentExpense>
<us-gaap:ResearchAndDevelopmentExpense contextRef="if2a6207b6732465a921fe019a2a0f048_D20210401-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8yNS9mcmFnOmM4YjY5YzZiOTg5NjQ4ZmJhOWQyZTRlOGExMWE5M2ZkL3RhYmxlOjc3NWVhZjBhNWVhOTRmOThhYzY3M2ZjNDk0MjcyNDFjL3RhYmxlcmFuZ2U6Nzc1ZWFmMGE1ZWE5NGY5OGFjNjczZmM0OTQyNzI0MWNfMTItMy0xLTEtNDgxNjQ_d0ca76fb-4b79-40c3-bd12-4d9f0ae757f0" unitRef="usd"> 18222000 </us-gaap:ResearchAndDevelopmentExpense>
<us-gaap:ResearchAndDevelopmentExpense contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8yNS9mcmFnOmM4YjY5YzZiOTg5NjQ4ZmJhOWQyZTRlOGExMWE5M2ZkL3RhYmxlOjc3NWVhZjBhNWVhOTRmOThhYzY3M2ZjNDk0MjcyNDFjL3RhYmxlcmFuZ2U6Nzc1ZWFmMGE1ZWE5NGY5OGFjNjczZmM0OTQyNzI0MWNfMTItNS0xLTEtNDgxNjQ_609fd117-275c-414d-983b-19afc25f01a9" unitRef="usd"> 35566000 </us-gaap:ResearchAndDevelopmentExpense>
<us-gaap:ResearchAndDevelopmentExpense contextRef="i420e18e30084498a98510d48880063cd_D20210101-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8yNS9mcmFnOmM4YjY5YzZiOTg5NjQ4ZmJhOWQyZTRlOGExMWE5M2ZkL3RhYmxlOjc3NWVhZjBhNWVhOTRmOThhYzY3M2ZjNDk0MjcyNDFjL3RhYmxlcmFuZ2U6Nzc1ZWFmMGE1ZWE5NGY5OGFjNjczZmM0OTQyNzI0MWNfMTItNy0xLTEtNDgxNjQ_2118e539-3f84-4fa6-b09c-c7f6af6e9b13" unitRef="usd"> 37537000 </us-gaap:ResearchAndDevelopmentExpense>
<us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1 contextRef="i50aa2eea9a6446b6ad796d994509b1ad_D20220401-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8yNS9mcmFnOmM4YjY5YzZiOTg5NjQ4ZmJhOWQyZTRlOGExMWE5M2ZkL3RhYmxlOjc3NWVhZjBhNWVhOTRmOThhYzY3M2ZjNDk0MjcyNDFjL3RhYmxlcmFuZ2U6Nzc1ZWFmMGE1ZWE5NGY5OGFjNjczZmM0OTQyNzI0MWNfMTQtMS0xLTEtNDgxNjQ_6b252f1f-335e-464c-96d3-e8283a19b23b" unitRef="usd"> 175000 </us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
<us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1 contextRef="if2a6207b6732465a921fe019a2a0f048_D20210401-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8yNS9mcmFnOmM4YjY5YzZiOTg5NjQ4ZmJhOWQyZTRlOGExMWE5M2ZkL3RhYmxlOjc3NWVhZjBhNWVhOTRmOThhYzY3M2ZjNDk0MjcyNDFjL3RhYmxlcmFuZ2U6Nzc1ZWFmMGE1ZWE5NGY5OGFjNjczZmM0OTQyNzI0MWNfMTQtMy0xLTEtNDgxNjQ_c226a6d6-c479-4cee-b87c-348c1df86b19" unitRef="usd"> -103000 </us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
<us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1 contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8yNS9mcmFnOmM4YjY5YzZiOTg5NjQ4ZmJhOWQyZTRlOGExMWE5M2ZkL3RhYmxlOjc3NWVhZjBhNWVhOTRmOThhYzY3M2ZjNDk0MjcyNDFjL3RhYmxlcmFuZ2U6Nzc1ZWFmMGE1ZWE5NGY5OGFjNjczZmM0OTQyNzI0MWNfMTQtNS0xLTEtNDgxNjQ_98a446c2-3430-4a38-8b52-bf5e0cee5602" unitRef="usd"> 69000 </us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
<us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1 contextRef="i420e18e30084498a98510d48880063cd_D20210101-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8yNS9mcmFnOmM4YjY5YzZiOTg5NjQ4ZmJhOWQyZTRlOGExMWE5M2ZkL3RhYmxlOjc3NWVhZjBhNWVhOTRmOThhYzY3M2ZjNDk0MjcyNDFjL3RhYmxlcmFuZ2U6Nzc1ZWFmMGE1ZWE5NGY5OGFjNjczZmM0OTQyNzI0MWNfMTQtNy0xLTEtNDgxNjQ_5f7d09cc-c338-45dd-ab17-f872249e97c6" unitRef="usd"> -1059000 </us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
<us-gaap:AmortizationOfIntangibleAssets contextRef="i50aa2eea9a6446b6ad796d994509b1ad_D20220401-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8yNS9mcmFnOmM4YjY5YzZiOTg5NjQ4ZmJhOWQyZTRlOGExMWE5M2ZkL3RhYmxlOjc3NWVhZjBhNWVhOTRmOThhYzY3M2ZjNDk0MjcyNDFjL3RhYmxlcmFuZ2U6Nzc1ZWFmMGE1ZWE5NGY5OGFjNjczZmM0OTQyNzI0MWNfMTUtMS0xLTEtNDgxNjQ_e00a612d-b91f-4acf-b06e-1ebab3ffeabd" unitRef="usd"> 22793000 </us-gaap:AmortizationOfIntangibleAssets>
<us-gaap:AmortizationOfIntangibleAssets contextRef="if2a6207b6732465a921fe019a2a0f048_D20210401-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8yNS9mcmFnOmM4YjY5YzZiOTg5NjQ4ZmJhOWQyZTRlOGExMWE5M2ZkL3RhYmxlOjc3NWVhZjBhNWVhOTRmOThhYzY3M2ZjNDk0MjcyNDFjL3RhYmxlcmFuZ2U6Nzc1ZWFmMGE1ZWE5NGY5OGFjNjczZmM0OTQyNzI0MWNfMTUtMy0xLTEtNDgxNjQ_3da2c689-ff05-4ed2-96d3-3747cd3ab545" unitRef="usd"> 12574000 </us-gaap:AmortizationOfIntangibleAssets>
<us-gaap:AmortizationOfIntangibleAssets contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8yNS9mcmFnOmM4YjY5YzZiOTg5NjQ4ZmJhOWQyZTRlOGExMWE5M2ZkL3RhYmxlOjc3NWVhZjBhNWVhOTRmOThhYzY3M2ZjNDk0MjcyNDFjL3RhYmxlcmFuZ2U6Nzc1ZWFmMGE1ZWE5NGY5OGFjNjczZmM0OTQyNzI0MWNfMTUtNS0xLTEtNDgxNjQ_6bad9442-8258-4efb-ba85-66e332e52480" unitRef="usd"> 44818000 </us-gaap:AmortizationOfIntangibleAssets>
<us-gaap:AmortizationOfIntangibleAssets contextRef="i420e18e30084498a98510d48880063cd_D20210101-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8yNS9mcmFnOmM4YjY5YzZiOTg5NjQ4ZmJhOWQyZTRlOGExMWE5M2ZkL3RhYmxlOjc3NWVhZjBhNWVhOTRmOThhYzY3M2ZjNDk0MjcyNDFjL3RhYmxlcmFuZ2U6Nzc1ZWFmMGE1ZWE5NGY5OGFjNjczZmM0OTQyNzI0MWNfMTUtNy0xLTEtNDgxNjQ_5f12bcb8-4c17-4a89-9dfa-7c439c4d3bd9" unitRef="usd"> 25151000 </us-gaap:AmortizationOfIntangibleAssets>
<us-gaap:GainLossOnSaleOfInvestments contextRef="i50aa2eea9a6446b6ad796d994509b1ad_D20220401-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8yNS9mcmFnOmM4YjY5YzZiOTg5NjQ4ZmJhOWQyZTRlOGExMWE5M2ZkL3RhYmxlOjc3NWVhZjBhNWVhOTRmOThhYzY3M2ZjNDk0MjcyNDFjL3RhYmxlcmFuZ2U6Nzc1ZWFmMGE1ZWE5NGY5OGFjNjczZmM0OTQyNzI0MWNfMTYtMS0xLTEtNDgxNjQ_805914d1-3229-4d9b-a8f6-f6887e90ec73" unitRef="usd"> 15365000 </us-gaap:GainLossOnSaleOfInvestments>
<us-gaap:GainLossOnSaleOfInvestments contextRef="if2a6207b6732465a921fe019a2a0f048_D20210401-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8yNS9mcmFnOmM4YjY5YzZiOTg5NjQ4ZmJhOWQyZTRlOGExMWE5M2ZkL3RhYmxlOjc3NWVhZjBhNWVhOTRmOThhYzY3M2ZjNDk0MjcyNDFjL3RhYmxlcmFuZ2U6Nzc1ZWFmMGE1ZWE5NGY5OGFjNjczZmM0OTQyNzI0MWNfMTYtMy0xLTEtNDgxNjQ_ec3a432a-5304-4776-8b25-a1f68a9e5db1" unitRef="usd"> 0 </us-gaap:GainLossOnSaleOfInvestments>
<us-gaap:GainLossOnSaleOfInvestments contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8yNS9mcmFnOmM4YjY5YzZiOTg5NjQ4ZmJhOWQyZTRlOGExMWE5M2ZkL3RhYmxlOjc3NWVhZjBhNWVhOTRmOThhYzY3M2ZjNDk0MjcyNDFjL3RhYmxlcmFuZ2U6Nzc1ZWFmMGE1ZWE5NGY5OGFjNjczZmM0OTQyNzI0MWNfMTYtNS0xLTEtNDgxNjQ_06e4b850-b98f-4e9b-951f-d4e44809783c" unitRef="usd"> 15365000 </us-gaap:GainLossOnSaleOfInvestments>
<us-gaap:GainLossOnSaleOfInvestments contextRef="i420e18e30084498a98510d48880063cd_D20210101-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8yNS9mcmFnOmM4YjY5YzZiOTg5NjQ4ZmJhOWQyZTRlOGExMWE5M2ZkL3RhYmxlOjc3NWVhZjBhNWVhOTRmOThhYzY3M2ZjNDk0MjcyNDFjL3RhYmxlcmFuZ2U6Nzc1ZWFmMGE1ZWE5NGY5OGFjNjczZmM0OTQyNzI0MWNfMTYtNy0xLTEtNDgxNjQ_d2eedcca-ede3-45f2-8152-b612041a5354" unitRef="usd"> 0 </us-gaap:GainLossOnSaleOfInvestments>
<us-gaap:OperatingExpenses contextRef="i50aa2eea9a6446b6ad796d994509b1ad_D20220401-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8yNS9mcmFnOmM4YjY5YzZiOTg5NjQ4ZmJhOWQyZTRlOGExMWE5M2ZkL3RhYmxlOjc3NWVhZjBhNWVhOTRmOThhYzY3M2ZjNDk0MjcyNDFjL3RhYmxlcmFuZ2U6Nzc1ZWFmMGE1ZWE5NGY5OGFjNjczZmM0OTQyNzI0MWNfMTctMS0xLTEtNDgxNjQ_32364943-fefd-4447-b26c-11f059a9499d" unitRef="usd"> 320632000 </us-gaap:OperatingExpenses>
<us-gaap:OperatingExpenses contextRef="if2a6207b6732465a921fe019a2a0f048_D20210401-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8yNS9mcmFnOmM4YjY5YzZiOTg5NjQ4ZmJhOWQyZTRlOGExMWE5M2ZkL3RhYmxlOjc3NWVhZjBhNWVhOTRmOThhYzY3M2ZjNDk0MjcyNDFjL3RhYmxlcmFuZ2U6Nzc1ZWFmMGE1ZWE5NGY5OGFjNjczZmM0OTQyNzI0MWNfMTctMy0xLTEtNDgxNjQ_6206ee0a-9638-42ae-b85b-b4494e704d84" unitRef="usd"> 436837000 </us-gaap:OperatingExpenses>
<us-gaap:OperatingExpenses contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8yNS9mcmFnOmM4YjY5YzZiOTg5NjQ4ZmJhOWQyZTRlOGExMWE5M2ZkL3RhYmxlOjc3NWVhZjBhNWVhOTRmOThhYzY3M2ZjNDk0MjcyNDFjL3RhYmxlcmFuZ2U6Nzc1ZWFmMGE1ZWE5NGY5OGFjNjczZmM0OTQyNzI0MWNfMTctNS0xLTEtNDgxNjQ_802968b2-6e60-46e3-9f2e-e6b428466548" unitRef="usd"> 722275000 </us-gaap:OperatingExpenses>
<us-gaap:OperatingExpenses contextRef="i420e18e30084498a98510d48880063cd_D20210101-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8yNS9mcmFnOmM4YjY5YzZiOTg5NjQ4ZmJhOWQyZTRlOGExMWE5M2ZkL3RhYmxlOjc3NWVhZjBhNWVhOTRmOThhYzY3M2ZjNDk0MjcyNDFjL3RhYmxlcmFuZ2U6Nzc1ZWFmMGE1ZWE5NGY5OGFjNjczZmM0OTQyNzI0MWNfMTctNy0xLTEtNDgxNjQ_0810f1a4-05f1-4bcb-aff8-bc01eaae1fa2" unitRef="usd"> 943565000 </us-gaap:OperatingExpenses>
<us-gaap:OperatingIncomeLoss contextRef="i50aa2eea9a6446b6ad796d994509b1ad_D20220401-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8yNS9mcmFnOmM4YjY5YzZiOTg5NjQ4ZmJhOWQyZTRlOGExMWE5M2ZkL3RhYmxlOjc3NWVhZjBhNWVhOTRmOThhYzY3M2ZjNDk0MjcyNDFjL3RhYmxlcmFuZ2U6Nzc1ZWFmMGE1ZWE5NGY5OGFjNjczZmM0OTQyNzI0MWNfMTgtMS0xLTEtNDgxNjQ_56befe11-25bc-46e5-84b9-008ecba5a15d" unitRef="usd"> -10739000 </us-gaap:OperatingIncomeLoss>
<us-gaap:OperatingIncomeLoss contextRef="if2a6207b6732465a921fe019a2a0f048_D20210401-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8yNS9mcmFnOmM4YjY5YzZiOTg5NjQ4ZmJhOWQyZTRlOGExMWE5M2ZkL3RhYmxlOjc3NWVhZjBhNWVhOTRmOThhYzY3M2ZjNDk0MjcyNDFjL3RhYmxlcmFuZ2U6Nzc1ZWFmMGE1ZWE5NGY5OGFjNjczZmM0OTQyNzI0MWNfMTgtMy0xLTEtNDgxNjQ_8be4e00a-4cdc-41eb-be7d-0f27bef5354a" unitRef="usd"> 5571000 </us-gaap:OperatingIncomeLoss>
<us-gaap:OperatingIncomeLoss contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8yNS9mcmFnOmM4YjY5YzZiOTg5NjQ4ZmJhOWQyZTRlOGExMWE5M2ZkL3RhYmxlOjc3NWVhZjBhNWVhOTRmOThhYzY3M2ZjNDk0MjcyNDFjL3RhYmxlcmFuZ2U6Nzc1ZWFmMGE1ZWE5NGY5OGFjNjczZmM0OTQyNzI0MWNfMTgtNS0xLTEtNDgxNjQ_c1cfa937-680c-41b4-8aeb-2418686d0d94" unitRef="usd"> -83164000 </us-gaap:OperatingIncomeLoss>
<us-gaap:OperatingIncomeLoss contextRef="i420e18e30084498a98510d48880063cd_D20210101-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8yNS9mcmFnOmM4YjY5YzZiOTg5NjQ4ZmJhOWQyZTRlOGExMWE5M2ZkL3RhYmxlOjc3NWVhZjBhNWVhOTRmOThhYzY3M2ZjNDk0MjcyNDFjL3RhYmxlcmFuZ2U6Nzc1ZWFmMGE1ZWE5NGY5OGFjNjczZmM0OTQyNzI0MWNfMTgtNy0xLTEtNDgxNjQ_367072bb-1ba3-4040-bb68-6a63efdcad04" unitRef="usd"> 44008000 </us-gaap:OperatingIncomeLoss>
<opk:InterestIncomeNonoperating contextRef="i50aa2eea9a6446b6ad796d994509b1ad_D20220401-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8yNS9mcmFnOmM4YjY5YzZiOTg5NjQ4ZmJhOWQyZTRlOGExMWE5M2ZkL3RhYmxlOjc3NWVhZjBhNWVhOTRmOThhYzY3M2ZjNDk0MjcyNDFjL3RhYmxlcmFuZ2U6Nzc1ZWFmMGE1ZWE5NGY5OGFjNjczZmM0OTQyNzI0MWNfMjAtMS0xLTEtNDgxNjQ_364d3161-3857-4e71-9189-94299b9cd0a7" unitRef="usd"> 161000 </opk:InterestIncomeNonoperating>
<opk:InterestIncomeNonoperating contextRef="if2a6207b6732465a921fe019a2a0f048_D20210401-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8yNS9mcmFnOmM4YjY5YzZiOTg5NjQ4ZmJhOWQyZTRlOGExMWE5M2ZkL3RhYmxlOjc3NWVhZjBhNWVhOTRmOThhYzY3M2ZjNDk0MjcyNDFjL3RhYmxlcmFuZ2U6Nzc1ZWFmMGE1ZWE5NGY5OGFjNjczZmM0OTQyNzI0MWNfMjAtMy0xLTEtNDgxNjQ_febb5cc1-67c2-4749-98d8-28a9638668e8" unitRef="usd"> 6000 </opk:InterestIncomeNonoperating>
<opk:InterestIncomeNonoperating contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8yNS9mcmFnOmM4YjY5YzZiOTg5NjQ4ZmJhOWQyZTRlOGExMWE5M2ZkL3RhYmxlOjc3NWVhZjBhNWVhOTRmOThhYzY3M2ZjNDk0MjcyNDFjL3RhYmxlcmFuZ2U6Nzc1ZWFmMGE1ZWE5NGY5OGFjNjczZmM0OTQyNzI0MWNfMjAtNS0xLTEtNDgxNjQ_890f692e-0bb1-4fe5-b760-ee1504e552b0" unitRef="usd"> 171000 </opk:InterestIncomeNonoperating>
<opk:InterestIncomeNonoperating contextRef="i420e18e30084498a98510d48880063cd_D20210101-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8yNS9mcmFnOmM4YjY5YzZiOTg5NjQ4ZmJhOWQyZTRlOGExMWE5M2ZkL3RhYmxlOjc3NWVhZjBhNWVhOTRmOThhYzY3M2ZjNDk0MjcyNDFjL3RhYmxlcmFuZ2U6Nzc1ZWFmMGE1ZWE5NGY5OGFjNjczZmM0OTQyNzI0MWNfMjAtNy0xLTEtNDgxNjQ_5c79e070-3263-447f-bb26-88f3b607feaa" unitRef="usd"> 12000 </opk:InterestIncomeNonoperating>
<opk:InterestExpenseNonoperating contextRef="i50aa2eea9a6446b6ad796d994509b1ad_D20220401-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8yNS9mcmFnOmM4YjY5YzZiOTg5NjQ4ZmJhOWQyZTRlOGExMWE5M2ZkL3RhYmxlOjc3NWVhZjBhNWVhOTRmOThhYzY3M2ZjNDk0MjcyNDFjL3RhYmxlcmFuZ2U6Nzc1ZWFmMGE1ZWE5NGY5OGFjNjczZmM0OTQyNzI0MWNfMjEtMS0xLTEtNDgxNjQ_cfb32709-7524-4527-a8bd-13263bb23eef" unitRef="usd"> 3075000 </opk:InterestExpenseNonoperating>
<opk:InterestExpenseNonoperating contextRef="if2a6207b6732465a921fe019a2a0f048_D20210401-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8yNS9mcmFnOmM4YjY5YzZiOTg5NjQ4ZmJhOWQyZTRlOGExMWE5M2ZkL3RhYmxlOjc3NWVhZjBhNWVhOTRmOThhYzY3M2ZjNDk0MjcyNDFjL3RhYmxlcmFuZ2U6Nzc1ZWFmMGE1ZWE5NGY5OGFjNjczZmM0OTQyNzI0MWNfMjEtMy0xLTEtNDgxNjQ_3a537378-af66-4f46-80f9-980261735684" unitRef="usd"> 4887000 </opk:InterestExpenseNonoperating>
<opk:InterestExpenseNonoperating contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8yNS9mcmFnOmM4YjY5YzZiOTg5NjQ4ZmJhOWQyZTRlOGExMWE5M2ZkL3RhYmxlOjc3NWVhZjBhNWVhOTRmOThhYzY3M2ZjNDk0MjcyNDFjL3RhYmxlcmFuZ2U6Nzc1ZWFmMGE1ZWE5NGY5OGFjNjczZmM0OTQyNzI0MWNfMjEtNS0xLTEtNDgxNjQ_6a74304d-9efe-4180-8e2b-466df8bc40f7" unitRef="usd"> 5737000 </opk:InterestExpenseNonoperating>
<opk:InterestExpenseNonoperating contextRef="i420e18e30084498a98510d48880063cd_D20210101-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8yNS9mcmFnOmM4YjY5YzZiOTg5NjQ4ZmJhOWQyZTRlOGExMWE5M2ZkL3RhYmxlOjc3NWVhZjBhNWVhOTRmOThhYzY3M2ZjNDk0MjcyNDFjL3RhYmxlcmFuZ2U6Nzc1ZWFmMGE1ZWE5NGY5OGFjNjczZmM0OTQyNzI0MWNfMjEtNy0xLTEtNDgxNjQ_0ed5f247-9a13-4253-b1d4-78d2029cf745" unitRef="usd"> 10282000 </opk:InterestExpenseNonoperating>
<us-gaap:GainLossOnDerivativeInstrumentsNetPretax contextRef="i50aa2eea9a6446b6ad796d994509b1ad_D20220401-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8yNS9mcmFnOmM4YjY5YzZiOTg5NjQ4ZmJhOWQyZTRlOGExMWE5M2ZkL3RhYmxlOjc3NWVhZjBhNWVhOTRmOThhYzY3M2ZjNDk0MjcyNDFjL3RhYmxlcmFuZ2U6Nzc1ZWFmMGE1ZWE5NGY5OGFjNjczZmM0OTQyNzI0MWNfMjItMS0xLTEtNDgxNjQ_5f54584e-5c65-4509-b148-0dfa43f94447" unitRef="usd"> 338000 </us-gaap:GainLossOnDerivativeInstrumentsNetPretax>
<us-gaap:GainLossOnDerivativeInstrumentsNetPretax contextRef="if2a6207b6732465a921fe019a2a0f048_D20210401-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8yNS9mcmFnOmM4YjY5YzZiOTg5NjQ4ZmJhOWQyZTRlOGExMWE5M2ZkL3RhYmxlOjc3NWVhZjBhNWVhOTRmOThhYzY3M2ZjNDk0MjcyNDFjL3RhYmxlcmFuZ2U6Nzc1ZWFmMGE1ZWE5NGY5OGFjNjczZmM0OTQyNzI0MWNfMjItMy0xLTEtNDgxNjQ_bcb5154b-452a-4065-8b9e-f007d9688592" unitRef="usd"> -272000 </us-gaap:GainLossOnDerivativeInstrumentsNetPretax>
<us-gaap:GainLossOnDerivativeInstrumentsNetPretax contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8yNS9mcmFnOmM4YjY5YzZiOTg5NjQ4ZmJhOWQyZTRlOGExMWE5M2ZkL3RhYmxlOjc3NWVhZjBhNWVhOTRmOThhYzY3M2ZjNDk0MjcyNDFjL3RhYmxlcmFuZ2U6Nzc1ZWFmMGE1ZWE5NGY5OGFjNjczZmM0OTQyNzI0MWNfMjItNS0xLTEtNDgxNjQ_b5613e5d-7582-48d7-98e7-d152f6bb9f9f" unitRef="usd"> 206000 </us-gaap:GainLossOnDerivativeInstrumentsNetPretax>
<us-gaap:GainLossOnDerivativeInstrumentsNetPretax contextRef="i420e18e30084498a98510d48880063cd_D20210101-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8yNS9mcmFnOmM4YjY5YzZiOTg5NjQ4ZmJhOWQyZTRlOGExMWE5M2ZkL3RhYmxlOjc3NWVhZjBhNWVhOTRmOThhYzY3M2ZjNDk0MjcyNDFjL3RhYmxlcmFuZ2U6Nzc1ZWFmMGE1ZWE5NGY5OGFjNjczZmM0OTQyNzI0MWNfMjItNy0xLTEtNDgxNjQ_32f30960-969f-4179-8351-faa5bdc5d13d" unitRef="usd"> -711000 </us-gaap:GainLossOnDerivativeInstrumentsNetPretax>
<us-gaap:OtherNonoperatingIncomeExpense contextRef="i50aa2eea9a6446b6ad796d994509b1ad_D20220401-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8yNS9mcmFnOmM4YjY5YzZiOTg5NjQ4ZmJhOWQyZTRlOGExMWE5M2ZkL3RhYmxlOjc3NWVhZjBhNWVhOTRmOThhYzY3M2ZjNDk0MjcyNDFjL3RhYmxlcmFuZ2U6Nzc1ZWFmMGE1ZWE5NGY5OGFjNjczZmM0OTQyNzI0MWNfMjMtMS0xLTEtNDgxNjQ_d4a151dd-75b1-4f5d-9cec-ec2899e8534a" unitRef="usd"> -72997000 </us-gaap:OtherNonoperatingIncomeExpense>
<us-gaap:OtherNonoperatingIncomeExpense contextRef="if2a6207b6732465a921fe019a2a0f048_D20210401-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8yNS9mcmFnOmM4YjY5YzZiOTg5NjQ4ZmJhOWQyZTRlOGExMWE5M2ZkL3RhYmxlOjc3NWVhZjBhNWVhOTRmOThhYzY3M2ZjNDk0MjcyNDFjL3RhYmxlcmFuZ2U6Nzc1ZWFmMGE1ZWE5NGY5OGFjNjczZmM0OTQyNzI0MWNfMjMtMy0xLTEtNDgxNjQ_e7800003-f93d-43e9-90d0-f1d90acef08e" unitRef="usd"> -11783000 </us-gaap:OtherNonoperatingIncomeExpense>
<us-gaap:OtherNonoperatingIncomeExpense contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8yNS9mcmFnOmM4YjY5YzZiOTg5NjQ4ZmJhOWQyZTRlOGExMWE5M2ZkL3RhYmxlOjc3NWVhZjBhNWVhOTRmOThhYzY3M2ZjNDk0MjcyNDFjL3RhYmxlcmFuZ2U6Nzc1ZWFmMGE1ZWE5NGY5OGFjNjczZmM0OTQyNzI0MWNfMjMtNS0xLTEtNDgxNjQ_94ad3faa-02ba-4d1c-b01d-349567990f35" unitRef="usd"> -74439000 </us-gaap:OtherNonoperatingIncomeExpense>
<us-gaap:OtherNonoperatingIncomeExpense contextRef="i420e18e30084498a98510d48880063cd_D20210101-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8yNS9mcmFnOmM4YjY5YzZiOTg5NjQ4ZmJhOWQyZTRlOGExMWE5M2ZkL3RhYmxlOjc3NWVhZjBhNWVhOTRmOThhYzY3M2ZjNDk0MjcyNDFjL3RhYmxlcmFuZ2U6Nzc1ZWFmMGE1ZWE5NGY5OGFjNjczZmM0OTQyNzI0MWNfMjMtNy0xLTEtNDgxNjQ_75fd2793-936b-47fe-9239-2f5b4c4a2236" unitRef="usd"> -12711000 </us-gaap:OtherNonoperatingIncomeExpense>
<us-gaap:NonoperatingIncomeExpense contextRef="i50aa2eea9a6446b6ad796d994509b1ad_D20220401-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8yNS9mcmFnOmM4YjY5YzZiOTg5NjQ4ZmJhOWQyZTRlOGExMWE5M2ZkL3RhYmxlOjc3NWVhZjBhNWVhOTRmOThhYzY3M2ZjNDk0MjcyNDFjL3RhYmxlcmFuZ2U6Nzc1ZWFmMGE1ZWE5NGY5OGFjNjczZmM0OTQyNzI0MWNfMjQtMS0xLTEtNDgxNjQ_7be7a454-957d-4802-80b7-4af4ac343c9d" unitRef="usd"> -75572000 </us-gaap:NonoperatingIncomeExpense>
<us-gaap:NonoperatingIncomeExpense contextRef="if2a6207b6732465a921fe019a2a0f048_D20210401-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8yNS9mcmFnOmM4YjY5YzZiOTg5NjQ4ZmJhOWQyZTRlOGExMWE5M2ZkL3RhYmxlOjc3NWVhZjBhNWVhOTRmOThhYzY3M2ZjNDk0MjcyNDFjL3RhYmxlcmFuZ2U6Nzc1ZWFmMGE1ZWE5NGY5OGFjNjczZmM0OTQyNzI0MWNfMjQtMy0xLTEtNDgxNjQ_38dfb28b-fbeb-4572-b778-25404773c76a" unitRef="usd"> -16936000 </us-gaap:NonoperatingIncomeExpense>
<us-gaap:NonoperatingIncomeExpense contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8yNS9mcmFnOmM4YjY5YzZiOTg5NjQ4ZmJhOWQyZTRlOGExMWE5M2ZkL3RhYmxlOjc3NWVhZjBhNWVhOTRmOThhYzY3M2ZjNDk0MjcyNDFjL3RhYmxlcmFuZ2U6Nzc1ZWFmMGE1ZWE5NGY5OGFjNjczZmM0OTQyNzI0MWNfMjQtNS0xLTEtNDgxNjQ_62b85ee3-fe26-4b3b-a415-4648a41973dd" unitRef="usd"> -79799000 </us-gaap:NonoperatingIncomeExpense>
<us-gaap:NonoperatingIncomeExpense contextRef="i420e18e30084498a98510d48880063cd_D20210101-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8yNS9mcmFnOmM4YjY5YzZiOTg5NjQ4ZmJhOWQyZTRlOGExMWE5M2ZkL3RhYmxlOjc3NWVhZjBhNWVhOTRmOThhYzY3M2ZjNDk0MjcyNDFjL3RhYmxlcmFuZ2U6Nzc1ZWFmMGE1ZWE5NGY5OGFjNjczZmM0OTQyNzI0MWNfMjQtNy0xLTEtNDgxNjQ_b765f862-8157-4ed1-a104-74439f3f0d9b" unitRef="usd"> -23692000 </us-gaap:NonoperatingIncomeExpense>
<us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments contextRef="i50aa2eea9a6446b6ad796d994509b1ad_D20220401-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8yNS9mcmFnOmM4YjY5YzZiOTg5NjQ4ZmJhOWQyZTRlOGExMWE5M2ZkL3RhYmxlOjc3NWVhZjBhNWVhOTRmOThhYzY3M2ZjNDk0MjcyNDFjL3RhYmxlcmFuZ2U6Nzc1ZWFmMGE1ZWE5NGY5OGFjNjczZmM0OTQyNzI0MWNfMjUtMS0xLTEtNDgxNjQ_44a4ac3e-4117-48f5-8798-7b2b43429976" unitRef="usd"> -86312000 </us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
<us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments contextRef="if2a6207b6732465a921fe019a2a0f048_D20210401-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8yNS9mcmFnOmM4YjY5YzZiOTg5NjQ4ZmJhOWQyZTRlOGExMWE5M2ZkL3RhYmxlOjc3NWVhZjBhNWVhOTRmOThhYzY3M2ZjNDk0MjcyNDFjL3RhYmxlcmFuZ2U6Nzc1ZWFmMGE1ZWE5NGY5OGFjNjczZmM0OTQyNzI0MWNfMjUtMy0xLTEtNDgxNjQ_07515023-bd86-4153-8b61-41f83d916e3d" unitRef="usd"> -11365000 </us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
<us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8yNS9mcmFnOmM4YjY5YzZiOTg5NjQ4ZmJhOWQyZTRlOGExMWE5M2ZkL3RhYmxlOjc3NWVhZjBhNWVhOTRmOThhYzY3M2ZjNDk0MjcyNDFjL3RhYmxlcmFuZ2U6Nzc1ZWFmMGE1ZWE5NGY5OGFjNjczZmM0OTQyNzI0MWNfMjUtNS0xLTEtNDgxNjQ_03014f1e-6ad0-4a22-92be-acad1b926f03" unitRef="usd"> -162963000 </us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
<us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments contextRef="i420e18e30084498a98510d48880063cd_D20210101-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8yNS9mcmFnOmM4YjY5YzZiOTg5NjQ4ZmJhOWQyZTRlOGExMWE5M2ZkL3RhYmxlOjc3NWVhZjBhNWVhOTRmOThhYzY3M2ZjNDk0MjcyNDFjL3RhYmxlcmFuZ2U6Nzc1ZWFmMGE1ZWE5NGY5OGFjNjczZmM0OTQyNzI0MWNfMjUtNy0xLTEtNDgxNjQ_0de731cc-2681-4212-a1b5-53d2284b1460" unitRef="usd"> 20316000 </us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
<us-gaap:IncomeTaxExpenseBenefit contextRef="i50aa2eea9a6446b6ad796d994509b1ad_D20220401-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8yNS9mcmFnOmM4YjY5YzZiOTg5NjQ4ZmJhOWQyZTRlOGExMWE5M2ZkL3RhYmxlOjc3NWVhZjBhNWVhOTRmOThhYzY3M2ZjNDk0MjcyNDFjL3RhYmxlcmFuZ2U6Nzc1ZWFmMGE1ZWE5NGY5OGFjNjczZmM0OTQyNzI0MWNfMjYtMS0xLTEtNDgxNjQ_25646a45-2cdb-4433-8211-b09aa70cf691" unitRef="usd"> 15070000 </us-gaap:IncomeTaxExpenseBenefit>
<us-gaap:IncomeTaxExpenseBenefit contextRef="if2a6207b6732465a921fe019a2a0f048_D20210401-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8yNS9mcmFnOmM4YjY5YzZiOTg5NjQ4ZmJhOWQyZTRlOGExMWE5M2ZkL3RhYmxlOjc3NWVhZjBhNWVhOTRmOThhYzY3M2ZjNDk0MjcyNDFjL3RhYmxlcmFuZ2U6Nzc1ZWFmMGE1ZWE5NGY5OGFjNjczZmM0OTQyNzI0MWNfMjYtMy0xLTEtNDgxNjQ_e55a1a32-9d13-4f79-97c7-4f33deb8ef0e" unitRef="usd"> 4754000 </us-gaap:IncomeTaxExpenseBenefit>
<us-gaap:IncomeTaxExpenseBenefit contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8yNS9mcmFnOmM4YjY5YzZiOTg5NjQ4ZmJhOWQyZTRlOGExMWE5M2ZkL3RhYmxlOjc3NWVhZjBhNWVhOTRmOThhYzY3M2ZjNDk0MjcyNDFjL3RhYmxlcmFuZ2U6Nzc1ZWFmMGE1ZWE5NGY5OGFjNjczZmM0OTQyNzI0MWNfMjYtNS0xLTEtNDgxNjQ_fa8a60f9-3218-4c3c-b431-16b708654d25" unitRef="usd"> -6196000 </us-gaap:IncomeTaxExpenseBenefit>
<us-gaap:IncomeTaxExpenseBenefit contextRef="i420e18e30084498a98510d48880063cd_D20210101-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8yNS9mcmFnOmM4YjY5YzZiOTg5NjQ4ZmJhOWQyZTRlOGExMWE5M2ZkL3RhYmxlOjc3NWVhZjBhNWVhOTRmOThhYzY3M2ZjNDk0MjcyNDFjL3RhYmxlcmFuZ2U6Nzc1ZWFmMGE1ZWE5NGY5OGFjNjczZmM0OTQyNzI0MWNfMjYtNy0xLTEtNDgxNjQ_ddda506b-04d2-4604-93d4-7d5c27597479" unitRef="usd"> 5314000 </us-gaap:IncomeTaxExpenseBenefit>
<opk:IncomeLossFromContinuingOperationsBeforeInvestmentsInInvesteesExtraordinaryItemsNetOfTax contextRef="i50aa2eea9a6446b6ad796d994509b1ad_D20220401-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8yNS9mcmFnOmM4YjY5YzZiOTg5NjQ4ZmJhOWQyZTRlOGExMWE5M2ZkL3RhYmxlOjc3NWVhZjBhNWVhOTRmOThhYzY3M2ZjNDk0MjcyNDFjL3RhYmxlcmFuZ2U6Nzc1ZWFmMGE1ZWE5NGY5OGFjNjczZmM0OTQyNzI0MWNfMjctMS0xLTEtNDgxNjQ_d169680c-75b8-4b51-a504-96d2468189ab" unitRef="usd"> -101382000 </opk:IncomeLossFromContinuingOperationsBeforeInvestmentsInInvesteesExtraordinaryItemsNetOfTax>
<opk:IncomeLossFromContinuingOperationsBeforeInvestmentsInInvesteesExtraordinaryItemsNetOfTax contextRef="if2a6207b6732465a921fe019a2a0f048_D20210401-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8yNS9mcmFnOmM4YjY5YzZiOTg5NjQ4ZmJhOWQyZTRlOGExMWE5M2ZkL3RhYmxlOjc3NWVhZjBhNWVhOTRmOThhYzY3M2ZjNDk0MjcyNDFjL3RhYmxlcmFuZ2U6Nzc1ZWFmMGE1ZWE5NGY5OGFjNjczZmM0OTQyNzI0MWNfMjctMy0xLTEtNDgxNjQ_cfe1b60b-3a57-4745-a4da-d64da0ee0a84" unitRef="usd"> -16119000 </opk:IncomeLossFromContinuingOperationsBeforeInvestmentsInInvesteesExtraordinaryItemsNetOfTax>
<opk:IncomeLossFromContinuingOperationsBeforeInvestmentsInInvesteesExtraordinaryItemsNetOfTax contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8yNS9mcmFnOmM4YjY5YzZiOTg5NjQ4ZmJhOWQyZTRlOGExMWE5M2ZkL3RhYmxlOjc3NWVhZjBhNWVhOTRmOThhYzY3M2ZjNDk0MjcyNDFjL3RhYmxlcmFuZ2U6Nzc1ZWFmMGE1ZWE5NGY5OGFjNjczZmM0OTQyNzI0MWNfMjctNS0xLTEtNDgxNjQ_8a3ccfd8-3957-456a-b9a1-df05f0841300" unitRef="usd"> -156766000 </opk:IncomeLossFromContinuingOperationsBeforeInvestmentsInInvesteesExtraordinaryItemsNetOfTax>
<opk:IncomeLossFromContinuingOperationsBeforeInvestmentsInInvesteesExtraordinaryItemsNetOfTax contextRef="i420e18e30084498a98510d48880063cd_D20210101-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8yNS9mcmFnOmM4YjY5YzZiOTg5NjQ4ZmJhOWQyZTRlOGExMWE5M2ZkL3RhYmxlOjc3NWVhZjBhNWVhOTRmOThhYzY3M2ZjNDk0MjcyNDFjL3RhYmxlcmFuZ2U6Nzc1ZWFmMGE1ZWE5NGY5OGFjNjczZmM0OTQyNzI0MWNfMjctNy0xLTEtNDgxNjQ_959442bb-1ad0-4b13-9a11-e243cb0d3e89" unitRef="usd"> 15002000 </opk:IncomeLossFromContinuingOperationsBeforeInvestmentsInInvesteesExtraordinaryItemsNetOfTax>
<us-gaap:IncomeLossFromEquityMethodInvestments contextRef="i50aa2eea9a6446b6ad796d994509b1ad_D20220401-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8yNS9mcmFnOmM4YjY5YzZiOTg5NjQ4ZmJhOWQyZTRlOGExMWE5M2ZkL3RhYmxlOjc3NWVhZjBhNWVhOTRmOThhYzY3M2ZjNDk0MjcyNDFjL3RhYmxlcmFuZ2U6Nzc1ZWFmMGE1ZWE5NGY5OGFjNjczZmM0OTQyNzI0MWNfMjgtMS0xLTEtNDgxNjQ_de19cfba-ee29-4143-8916-1ca1e68d0de9" unitRef="usd"> -268000 </us-gaap:IncomeLossFromEquityMethodInvestments>
<us-gaap:IncomeLossFromEquityMethodInvestments contextRef="if2a6207b6732465a921fe019a2a0f048_D20210401-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8yNS9mcmFnOmM4YjY5YzZiOTg5NjQ4ZmJhOWQyZTRlOGExMWE5M2ZkL3RhYmxlOjc3NWVhZjBhNWVhOTRmOThhYzY3M2ZjNDk0MjcyNDFjL3RhYmxlcmFuZ2U6Nzc1ZWFmMGE1ZWE5NGY5OGFjNjczZmM0OTQyNzI0MWNfMjgtMy0xLTEtNDgxNjQ_a029c7aa-754e-47f1-9ba3-624bf82f4e9e" unitRef="usd"> -67000 </us-gaap:IncomeLossFromEquityMethodInvestments>
<us-gaap:IncomeLossFromEquityMethodInvestments contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8yNS9mcmFnOmM4YjY5YzZiOTg5NjQ4ZmJhOWQyZTRlOGExMWE5M2ZkL3RhYmxlOjc3NWVhZjBhNWVhOTRmOThhYzY3M2ZjNDk0MjcyNDFjL3RhYmxlcmFuZ2U6Nzc1ZWFmMGE1ZWE5NGY5OGFjNjczZmM0OTQyNzI0MWNfMjgtNS0xLTEtNDgxNjQ_4dd8a518-d29e-4da7-8c51-2ff3d9afd484" unitRef="usd"> -316000 </us-gaap:IncomeLossFromEquityMethodInvestments>
<us-gaap:IncomeLossFromEquityMethodInvestments contextRef="i420e18e30084498a98510d48880063cd_D20210101-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8yNS9mcmFnOmM4YjY5YzZiOTg5NjQ4ZmJhOWQyZTRlOGExMWE5M2ZkL3RhYmxlOjc3NWVhZjBhNWVhOTRmOThhYzY3M2ZjNDk0MjcyNDFjL3RhYmxlcmFuZ2U6Nzc1ZWFmMGE1ZWE5NGY5OGFjNjczZmM0OTQyNzI0MWNfMjgtNy0xLTEtNDgxNjQ_5a14a400-ed9d-42e1-9074-f50f24de778b" unitRef="usd"> -110000 </us-gaap:IncomeLossFromEquityMethodInvestments>
<us-gaap:NetIncomeLoss contextRef="i50aa2eea9a6446b6ad796d994509b1ad_D20220401-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8yNS9mcmFnOmM4YjY5YzZiOTg5NjQ4ZmJhOWQyZTRlOGExMWE5M2ZkL3RhYmxlOjc3NWVhZjBhNWVhOTRmOThhYzY3M2ZjNDk0MjcyNDFjL3RhYmxlcmFuZ2U6Nzc1ZWFmMGE1ZWE5NGY5OGFjNjczZmM0OTQyNzI0MWNfMjktMS0xLTEtNDgxNjQ_bfb34926-1934-43a5-8635-c1b05680bd4a" unitRef="usd"> -101650000 </us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="if2a6207b6732465a921fe019a2a0f048_D20210401-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8yNS9mcmFnOmM4YjY5YzZiOTg5NjQ4ZmJhOWQyZTRlOGExMWE5M2ZkL3RhYmxlOjc3NWVhZjBhNWVhOTRmOThhYzY3M2ZjNDk0MjcyNDFjL3RhYmxlcmFuZ2U6Nzc1ZWFmMGE1ZWE5NGY5OGFjNjczZmM0OTQyNzI0MWNfMjktMy0xLTEtNDgxNjQ_0cdd8ae7-b5c4-412a-9255-29a3b7151c2b" unitRef="usd"> -16186000 </us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8yNS9mcmFnOmM4YjY5YzZiOTg5NjQ4ZmJhOWQyZTRlOGExMWE5M2ZkL3RhYmxlOjc3NWVhZjBhNWVhOTRmOThhYzY3M2ZjNDk0MjcyNDFjL3RhYmxlcmFuZ2U6Nzc1ZWFmMGE1ZWE5NGY5OGFjNjczZmM0OTQyNzI0MWNfMjktNS0xLTEtNDgxNjQ_67b0b910-b8de-44f5-8fd2-806e204197e1" unitRef="usd"> -157083000 </us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="i420e18e30084498a98510d48880063cd_D20210101-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8yNS9mcmFnOmM4YjY5YzZiOTg5NjQ4ZmJhOWQyZTRlOGExMWE5M2ZkL3RhYmxlOjc3NWVhZjBhNWVhOTRmOThhYzY3M2ZjNDk0MjcyNDFjL3RhYmxlcmFuZ2U6Nzc1ZWFmMGE1ZWE5NGY5OGFjNjczZmM0OTQyNzI0MWNfMjktNy0xLTEtNDgxNjQ_1c71dd0b-d646-499f-a6e2-75ce9292a170" unitRef="usd"> 14892000 </us-gaap:NetIncomeLoss>
<us-gaap:EarningsPerShareBasic contextRef="i50aa2eea9a6446b6ad796d994509b1ad_D20220401-20220630" decimals="2" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8yNS9mcmFnOmM4YjY5YzZiOTg5NjQ4ZmJhOWQyZTRlOGExMWE5M2ZkL3RhYmxlOjc3NWVhZjBhNWVhOTRmOThhYzY3M2ZjNDk0MjcyNDFjL3RhYmxlcmFuZ2U6Nzc1ZWFmMGE1ZWE5NGY5OGFjNjczZmM0OTQyNzI0MWNfMzktMS0xLTEtNDgxNjQ_3914b6dd-b551-45e7-bb4c-4cbb6176889f" unitRef="usdPerShare"> -0.14 </us-gaap:EarningsPerShareBasic>
<us-gaap:EarningsPerShareDiluted contextRef="i50aa2eea9a6446b6ad796d994509b1ad_D20220401-20220630" decimals="2" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8yNS9mcmFnOmM4YjY5YzZiOTg5NjQ4ZmJhOWQyZTRlOGExMWE5M2ZkL3RhYmxlOjc3NWVhZjBhNWVhOTRmOThhYzY3M2ZjNDk0MjcyNDFjL3RhYmxlcmFuZ2U6Nzc1ZWFmMGE1ZWE5NGY5OGFjNjczZmM0OTQyNzI0MWNfMzktMS0xLTEtNDgxNjQ_baf02c3d-a969-4329-83d5-566522ac17c4" unitRef="usdPerShare"> -0.14 </us-gaap:EarningsPerShareDiluted>
<us-gaap:EarningsPerShareDiluted contextRef="if2a6207b6732465a921fe019a2a0f048_D20210401-20210630" decimals="2" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8yNS9mcmFnOmM4YjY5YzZiOTg5NjQ4ZmJhOWQyZTRlOGExMWE5M2ZkL3RhYmxlOjc3NWVhZjBhNWVhOTRmOThhYzY3M2ZjNDk0MjcyNDFjL3RhYmxlcmFuZ2U6Nzc1ZWFmMGE1ZWE5NGY5OGFjNjczZmM0OTQyNzI0MWNfMzktMy0xLTEtNDgxNjQ_03772a38-6125-4100-8a01-e475854ca7bc" unitRef="usdPerShare"> -0.03 </us-gaap:EarningsPerShareDiluted>
<us-gaap:EarningsPerShareBasic contextRef="if2a6207b6732465a921fe019a2a0f048_D20210401-20210630" decimals="2" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8yNS9mcmFnOmM4YjY5YzZiOTg5NjQ4ZmJhOWQyZTRlOGExMWE5M2ZkL3RhYmxlOjc3NWVhZjBhNWVhOTRmOThhYzY3M2ZjNDk0MjcyNDFjL3RhYmxlcmFuZ2U6Nzc1ZWFmMGE1ZWE5NGY5OGFjNjczZmM0OTQyNzI0MWNfMzktMy0xLTEtNDgxNjQ_b14290ce-0211-4735-96e4-e13250f80c4c" unitRef="usdPerShare"> -0.03 </us-gaap:EarningsPerShareBasic>
<us-gaap:EarningsPerShareBasic contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" decimals="2" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8yNS9mcmFnOmM4YjY5YzZiOTg5NjQ4ZmJhOWQyZTRlOGExMWE5M2ZkL3RhYmxlOjc3NWVhZjBhNWVhOTRmOThhYzY3M2ZjNDk0MjcyNDFjL3RhYmxlcmFuZ2U6Nzc1ZWFmMGE1ZWE5NGY5OGFjNjczZmM0OTQyNzI0MWNfMzktNS0xLTEtNDgxNjQ_2910584d-f478-4f1b-9e9c-8cba5edfb676" unitRef="usdPerShare"> -0.23 </us-gaap:EarningsPerShareBasic>
<us-gaap:EarningsPerShareDiluted contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" decimals="2" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8yNS9mcmFnOmM4YjY5YzZiOTg5NjQ4ZmJhOWQyZTRlOGExMWE5M2ZkL3RhYmxlOjc3NWVhZjBhNWVhOTRmOThhYzY3M2ZjNDk0MjcyNDFjL3RhYmxlcmFuZ2U6Nzc1ZWFmMGE1ZWE5NGY5OGFjNjczZmM0OTQyNzI0MWNfMzktNS0xLTEtNDgxNjQ_d1df9402-f59c-428e-9929-71db517cef33" unitRef="usdPerShare"> -0.23 </us-gaap:EarningsPerShareDiluted>
<us-gaap:EarningsPerShareBasic contextRef="i420e18e30084498a98510d48880063cd_D20210101-20210630" decimals="2" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8yNS9mcmFnOmM4YjY5YzZiOTg5NjQ4ZmJhOWQyZTRlOGExMWE5M2ZkL3RhYmxlOjc3NWVhZjBhNWVhOTRmOThhYzY3M2ZjNDk0MjcyNDFjL3RhYmxlcmFuZ2U6Nzc1ZWFmMGE1ZWE5NGY5OGFjNjczZmM0OTQyNzI0MWNfMzktNy0xLTEtNDgxNjQ_21c00edd-9db0-40a3-8b6a-83e210f24bdd" unitRef="usdPerShare"> 0.02 </us-gaap:EarningsPerShareBasic>
<us-gaap:EarningsPerShareDiluted contextRef="i420e18e30084498a98510d48880063cd_D20210101-20210630" decimals="2" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8yNS9mcmFnOmM4YjY5YzZiOTg5NjQ4ZmJhOWQyZTRlOGExMWE5M2ZkL3RhYmxlOjc3NWVhZjBhNWVhOTRmOThhYzY3M2ZjNDk0MjcyNDFjL3RhYmxlcmFuZ2U6Nzc1ZWFmMGE1ZWE5NGY5OGFjNjczZmM0OTQyNzI0MWNfMzktNy0xLTEtNDgxNjQ_720ea5c3-e03d-494b-b080-e8d50cdc8ab1" unitRef="usdPerShare"> 0.02 </us-gaap:EarningsPerShareDiluted>
<us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="i50aa2eea9a6446b6ad796d994509b1ad_D20220401-20220630" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8yNS9mcmFnOmM4YjY5YzZiOTg5NjQ4ZmJhOWQyZTRlOGExMWE5M2ZkL3RhYmxlOjc3NWVhZjBhNWVhOTRmOThhYzY3M2ZjNDk0MjcyNDFjL3RhYmxlcmFuZ2U6Nzc1ZWFmMGE1ZWE5NGY5OGFjNjczZmM0OTQyNzI0MWNfNDEtMS0xLTEtNDgxNjQ_46f29acd-e250-446f-980e-f3bdadc00db2" unitRef="shares"> 712548661 </us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
<us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="i50aa2eea9a6446b6ad796d994509b1ad_D20220401-20220630" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8yNS9mcmFnOmM4YjY5YzZiOTg5NjQ4ZmJhOWQyZTRlOGExMWE5M2ZkL3RhYmxlOjc3NWVhZjBhNWVhOTRmOThhYzY3M2ZjNDk0MjcyNDFjL3RhYmxlcmFuZ2U6Nzc1ZWFmMGE1ZWE5NGY5OGFjNjczZmM0OTQyNzI0MWNfNDEtMS0xLTEtNDgxNjQ_69a27453-8012-4c4b-ac18-d3abf3f108d0" unitRef="shares"> 712548661 </us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
<us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="if2a6207b6732465a921fe019a2a0f048_D20210401-20210630" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8yNS9mcmFnOmM4YjY5YzZiOTg5NjQ4ZmJhOWQyZTRlOGExMWE5M2ZkL3RhYmxlOjc3NWVhZjBhNWVhOTRmOThhYzY3M2ZjNDk0MjcyNDFjL3RhYmxlcmFuZ2U6Nzc1ZWFmMGE1ZWE5NGY5OGFjNjczZmM0OTQyNzI0MWNfNDEtMy0xLTEtNDgxNjQ_5218a69b-73ab-4367-853d-61e530ed34c0" unitRef="shares"> 646996891 </us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
<us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="if2a6207b6732465a921fe019a2a0f048_D20210401-20210630" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8yNS9mcmFnOmM4YjY5YzZiOTg5NjQ4ZmJhOWQyZTRlOGExMWE5M2ZkL3RhYmxlOjc3NWVhZjBhNWVhOTRmOThhYzY3M2ZjNDk0MjcyNDFjL3RhYmxlcmFuZ2U6Nzc1ZWFmMGE1ZWE5NGY5OGFjNjczZmM0OTQyNzI0MWNfNDEtMy0xLTEtNDgxNjQ_e9d2bbec-4be5-49f7-a8b7-469b492f977e" unitRef="shares"> 646996891 </us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
<us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8yNS9mcmFnOmM4YjY5YzZiOTg5NjQ4ZmJhOWQyZTRlOGExMWE5M2ZkL3RhYmxlOjc3NWVhZjBhNWVhOTRmOThhYzY3M2ZjNDk0MjcyNDFjL3RhYmxlcmFuZ2U6Nzc1ZWFmMGE1ZWE5NGY5OGFjNjczZmM0OTQyNzI0MWNfNDEtNS0xLTEtNDgxNjQ_31d80a58-4dc9-4771-9682-59f3e1678fdc" unitRef="shares"> 686597899 </us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
<us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8yNS9mcmFnOmM4YjY5YzZiOTg5NjQ4ZmJhOWQyZTRlOGExMWE5M2ZkL3RhYmxlOjc3NWVhZjBhNWVhOTRmOThhYzY3M2ZjNDk0MjcyNDFjL3RhYmxlcmFuZ2U6Nzc1ZWFmMGE1ZWE5NGY5OGFjNjczZmM0OTQyNzI0MWNfNDEtNS0xLTEtNDgxNjQ_deaa6e57-4264-4c1b-8719-2a2fc49c54cc" unitRef="shares"> 686597899 </us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
<us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="i420e18e30084498a98510d48880063cd_D20210101-20210630" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8yNS9mcmFnOmM4YjY5YzZiOTg5NjQ4ZmJhOWQyZTRlOGExMWE5M2ZkL3RhYmxlOjc3NWVhZjBhNWVhOTRmOThhYzY3M2ZjNDk0MjcyNDFjL3RhYmxlcmFuZ2U6Nzc1ZWFmMGE1ZWE5NGY5OGFjNjczZmM0OTQyNzI0MWNfNDEtNy0xLTEtNDgxNjQ_36565cb5-2943-4f82-9416-62dc930ecc97" unitRef="shares"> 644001280 </us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
<us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="i420e18e30084498a98510d48880063cd_D20210101-20210630" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8yNS9mcmFnOmM4YjY5YzZiOTg5NjQ4ZmJhOWQyZTRlOGExMWE5M2ZkL3RhYmxlOjc3NWVhZjBhNWVhOTRmOThhYzY3M2ZjNDk0MjcyNDFjL3RhYmxlcmFuZ2U6Nzc1ZWFmMGE1ZWE5NGY5OGFjNjczZmM0OTQyNzI0MWNfNDEtNy0xLTEtNDgxNjQ_5dc44052-0d95-41e1-a693-7f4c83dac89d" unitRef="shares"> 644001280 </us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
<us-gaap:NetIncomeLoss contextRef="i50aa2eea9a6446b6ad796d994509b1ad_D20220401-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8yOC9mcmFnOjAwODAyNDc1NDc3YTRiZTg4ODAxNDYwNWU5OWMzM2Y2L3RhYmxlOjI5NWRiYzMwOTA0ZDQzMmY5YTdhYWFkMzA4NjdiYWE4L3RhYmxlcmFuZ2U6Mjk1ZGJjMzA5MDRkNDMyZjlhN2FhYWQzMDg2N2JhYThfMi0xLTEtMS00ODE2NA_70c75df4-e935-4d7d-9369-d54220a00923" unitRef="usd"> -101650000 </us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="if2a6207b6732465a921fe019a2a0f048_D20210401-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8yOC9mcmFnOjAwODAyNDc1NDc3YTRiZTg4ODAxNDYwNWU5OWMzM2Y2L3RhYmxlOjI5NWRiYzMwOTA0ZDQzMmY5YTdhYWFkMzA4NjdiYWE4L3RhYmxlcmFuZ2U6Mjk1ZGJjMzA5MDRkNDMyZjlhN2FhYWQzMDg2N2JhYThfMi0zLTEtMS00ODE2NA_aba34cbd-a9a8-4eb2-8944-2e9482978861" unitRef="usd"> -16186000 </us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8yOC9mcmFnOjAwODAyNDc1NDc3YTRiZTg4ODAxNDYwNWU5OWMzM2Y2L3RhYmxlOjI5NWRiYzMwOTA0ZDQzMmY5YTdhYWFkMzA4NjdiYWE4L3RhYmxlcmFuZ2U6Mjk1ZGJjMzA5MDRkNDMyZjlhN2FhYWQzMDg2N2JhYThfMi01LTEtMS00ODE2NA_a496ac33-ddf4-4634-bf61-bfddeb617db4" unitRef="usd"> -157083000 </us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="i420e18e30084498a98510d48880063cd_D20210101-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8yOC9mcmFnOjAwODAyNDc1NDc3YTRiZTg4ODAxNDYwNWU5OWMzM2Y2L3RhYmxlOjI5NWRiYzMwOTA0ZDQzMmY5YTdhYWFkMzA4NjdiYWE4L3RhYmxlcmFuZ2U6Mjk1ZGJjMzA5MDRkNDMyZjlhN2FhYWQzMDg2N2JhYThfMi03LTEtMS00ODE2NA_935e4675-2bda-48e8-86de-51bcbf9d7b94" unitRef="usd"> 14892000 </us-gaap:NetIncomeLoss>
<us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent contextRef="i50aa2eea9a6446b6ad796d994509b1ad_D20220401-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8yOC9mcmFnOjAwODAyNDc1NDc3YTRiZTg4ODAxNDYwNWU5OWMzM2Y2L3RhYmxlOjI5NWRiYzMwOTA0ZDQzMmY5YTdhYWFkMzA4NjdiYWE4L3RhYmxlcmFuZ2U6Mjk1ZGJjMzA5MDRkNDMyZjlhN2FhYWQzMDg2N2JhYThfNC0xLTEtMS00ODE2NA_d3982451-dc47-40d0-9494-fc3d02752a08" unitRef="usd"> -17756000 </us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
<us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent contextRef="if2a6207b6732465a921fe019a2a0f048_D20210401-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8yOC9mcmFnOjAwODAyNDc1NDc3YTRiZTg4ODAxNDYwNWU5OWMzM2Y2L3RhYmxlOjI5NWRiYzMwOTA0ZDQzMmY5YTdhYWFkMzA4NjdiYWE4L3RhYmxlcmFuZ2U6Mjk1ZGJjMzA5MDRkNDMyZjlhN2FhYWQzMDg2N2JhYThfNC0zLTEtMS00ODE2NA_e4051d94-ed40-4bb0-903d-7930bda5ad1c" unitRef="usd"> -9070000 </us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
<us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8yOC9mcmFnOjAwODAyNDc1NDc3YTRiZTg4ODAxNDYwNWU5OWMzM2Y2L3RhYmxlOjI5NWRiYzMwOTA0ZDQzMmY5YTdhYWFkMzA4NjdiYWE4L3RhYmxlcmFuZ2U6Mjk1ZGJjMzA5MDRkNDMyZjlhN2FhYWQzMDg2N2JhYThfNC01LTEtMS00ODE2NA_2ad74210-0f5e-4600-837c-6686d03bbf83" unitRef="usd"> -18676000 </us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
<us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent contextRef="i420e18e30084498a98510d48880063cd_D20210101-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8yOC9mcmFnOjAwODAyNDc1NDc3YTRiZTg4ODAxNDYwNWU5OWMzM2Y2L3RhYmxlOjI5NWRiYzMwOTA0ZDQzMmY5YTdhYWFkMzA4NjdiYWE4L3RhYmxlcmFuZ2U6Mjk1ZGJjMzA5MDRkNDMyZjlhN2FhYWQzMDg2N2JhYThfNC03LTEtMS00ODE2NA_46f4e440-3424-4159-ac33-818f57c3240f" unitRef="usd"> -9070000 </us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
<us-gaap:ComprehensiveIncomeNetOfTax contextRef="i50aa2eea9a6446b6ad796d994509b1ad_D20220401-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8yOC9mcmFnOjAwODAyNDc1NDc3YTRiZTg4ODAxNDYwNWU5OWMzM2Y2L3RhYmxlOjI5NWRiYzMwOTA0ZDQzMmY5YTdhYWFkMzA4NjdiYWE4L3RhYmxlcmFuZ2U6Mjk1ZGJjMzA5MDRkNDMyZjlhN2FhYWQzMDg2N2JhYThfOS0xLTEtMS00ODE2NA_1fdbfafd-ba66-4da0-8bc1-dd6f134ad696" unitRef="usd"> -119406000 </us-gaap:ComprehensiveIncomeNetOfTax>
<us-gaap:ComprehensiveIncomeNetOfTax contextRef="if2a6207b6732465a921fe019a2a0f048_D20210401-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8yOC9mcmFnOjAwODAyNDc1NDc3YTRiZTg4ODAxNDYwNWU5OWMzM2Y2L3RhYmxlOjI5NWRiYzMwOTA0ZDQzMmY5YTdhYWFkMzA4NjdiYWE4L3RhYmxlcmFuZ2U6Mjk1ZGJjMzA5MDRkNDMyZjlhN2FhYWQzMDg2N2JhYThfOS0zLTEtMS00ODE2NA_8bf26bea-6203-4ce0-96e1-c39a7a3ffac0" unitRef="usd"> -25256000 </us-gaap:ComprehensiveIncomeNetOfTax>
<us-gaap:ComprehensiveIncomeNetOfTax contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8yOC9mcmFnOjAwODAyNDc1NDc3YTRiZTg4ODAxNDYwNWU5OWMzM2Y2L3RhYmxlOjI5NWRiYzMwOTA0ZDQzMmY5YTdhYWFkMzA4NjdiYWE4L3RhYmxlcmFuZ2U6Mjk1ZGJjMzA5MDRkNDMyZjlhN2FhYWQzMDg2N2JhYThfOS01LTEtMS00ODE2NA_53073204-3b3f-46cb-a731-695acf7a0329" unitRef="usd"> -175759000 </us-gaap:ComprehensiveIncomeNetOfTax>
<us-gaap:ComprehensiveIncomeNetOfTax contextRef="i420e18e30084498a98510d48880063cd_D20210101-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8yOC9mcmFnOjAwODAyNDc1NDc3YTRiZTg4ODAxNDYwNWU5OWMzM2Y2L3RhYmxlOjI5NWRiYzMwOTA0ZDQzMmY5YTdhYWFkMzA4NjdiYWE4L3RhYmxlcmFuZ2U6Mjk1ZGJjMzA5MDRkNDMyZjlhN2FhYWQzMDg2N2JhYThfOS03LTEtMS00ODE2NA_050a4c23-c429-41d0-990d-7a16cb2818bb" unitRef="usd"> 5822000 </us-gaap:ComprehensiveIncomeNetOfTax>
<us-gaap:CommonStockSharesOutstanding contextRef="ie2ff5bb5f07c499aaa06f6f056723e2c_I20220331" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zMS9mcmFnOmVhOTkwNjc5MjQ2MTQ0MTVhZjY5OGNjNDIwZWZiYjZlL3RhYmxlOmMxNmQ4ODFkMzg0YzQzYWY4YzkxZGRlOTI1ZTBlMTU3L3RhYmxlcmFuZ2U6YzE2ZDg4MWQzODRjNDNhZjhjOTFkZGU5MjVlMGUxNTdfMi01LTEtMS00ODE2NA_6e2dbfee-916c-4e40-90c1-9e94733c3a33" unitRef="shares"> 690138033 </us-gaap:CommonStockSharesOutstanding>
<us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="ie2ff5bb5f07c499aaa06f6f056723e2c_I20220331" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zMS9mcmFnOmVhOTkwNjc5MjQ2MTQ0MTVhZjY5OGNjNDIwZWZiYjZlL3RhYmxlOmMxNmQ4ODFkMzg0YzQzYWY4YzkxZGRlOTI1ZTBlMTU3L3RhYmxlcmFuZ2U6YzE2ZDg4MWQzODRjNDNhZjhjOTFkZGU5MjVlMGUxNTdfMi03LTEtMS00ODE2NA_fac61564-5ee8-4d3a-89ae-d7560204a120" unitRef="usd"> 6901000 </us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
<us-gaap:TreasuryStockCommonShares contextRef="i9f2f310772cd4969a9bbdfb8c1c1bbf3_I20220331" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zMS9mcmFnOmVhOTkwNjc5MjQ2MTQ0MTVhZjY5OGNjNDIwZWZiYjZlL3RhYmxlOmMxNmQ4ODFkMzg0YzQzYWY4YzkxZGRlOTI1ZTBlMTU3L3RhYmxlcmFuZ2U6YzE2ZDg4MWQzODRjNDNhZjhjOTFkZGU5MjVlMGUxNTdfMi05LTEtMS00ODE2NA_792a1b1f-f6b1-496e-a28d-d6f3affd5787" unitRef="shares"> 8655082 </us-gaap:TreasuryStockCommonShares>
<us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="i9f2f310772cd4969a9bbdfb8c1c1bbf3_I20220331" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zMS9mcmFnOmVhOTkwNjc5MjQ2MTQ0MTVhZjY5OGNjNDIwZWZiYjZlL3RhYmxlOmMxNmQ4ODFkMzg0YzQzYWY4YzkxZGRlOTI1ZTBlMTU3L3RhYmxlcmFuZ2U6YzE2ZDg4MWQzODRjNDNhZjhjOTFkZGU5MjVlMGUxNTdfMi0xMS0xLTEtNDgxNjQ_397a9ee0-f69d-41c3-ae01-263b32a00294" unitRef="usd"> -1791000 </us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
<us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="i0c4dbaeee76c4337aab5500d767e1256_I20220331" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zMS9mcmFnOmVhOTkwNjc5MjQ2MTQ0MTVhZjY5OGNjNDIwZWZiYjZlL3RhYmxlOmMxNmQ4ODFkMzg0YzQzYWY4YzkxZGRlOTI1ZTBlMTU3L3RhYmxlcmFuZ2U6YzE2ZDg4MWQzODRjNDNhZjhjOTFkZGU5MjVlMGUxNTdfMi0xMy0xLTEtNDgxNjQ_1587b86e-fe31-4ca7-ae21-109a1570d6f1" unitRef="usd"> 3191139000 </us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
<us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="ifdb3df35acec413390cf60a1882c1ef9_I20220331" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zMS9mcmFnOmVhOTkwNjc5MjQ2MTQ0MTVhZjY5OGNjNDIwZWZiYjZlL3RhYmxlOmMxNmQ4ODFkMzg0YzQzYWY4YzkxZGRlOTI1ZTBlMTU3L3RhYmxlcmFuZ2U6YzE2ZDg4MWQzODRjNDNhZjhjOTFkZGU5MjVlMGUxNTdfMi0xNS0xLTEtNDgxNjQ_5de41207-45e9-46c4-9a09-112265e483aa" unitRef="usd"> -31415000 </us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
<us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="i02d914e3e4754dfb90ffeb3e875dafdc_I20220331" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zMS9mcmFnOmVhOTkwNjc5MjQ2MTQ0MTVhZjY5OGNjNDIwZWZiYjZlL3RhYmxlOmMxNmQ4ODFkMzg0YzQzYWY4YzkxZGRlOTI1ZTBlMTU3L3RhYmxlcmFuZ2U6YzE2ZDg4MWQzODRjNDNhZjhjOTFkZGU5MjVlMGUxNTdfMi0xNy0xLTEtNDgxNjQ_5ac164b1-3940-4d2e-ad35-30a501e562bb" unitRef="usd"> -1549951000 </us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
<us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="ia9d8bbd1bb63472cb5580794fcfd8d33_I20220331" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zMS9mcmFnOmVhOTkwNjc5MjQ2MTQ0MTVhZjY5OGNjNDIwZWZiYjZlL3RhYmxlOmMxNmQ4ODFkMzg0YzQzYWY4YzkxZGRlOTI1ZTBlMTU3L3RhYmxlcmFuZ2U6YzE2ZDg4MWQzODRjNDNhZjhjOTFkZGU5MjVlMGUxNTdfMi0yMS0xLTEtNDgxNjQ_d17b7a43-ac65-405a-b652-80b098a9fb2a" unitRef="usd"> 1614884000 </us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
<us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="i04265b97ae4d49c797e0d0c55d843b90_D20220401-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zMS9mcmFnOmVhOTkwNjc5MjQ2MTQ0MTVhZjY5OGNjNDIwZWZiYjZlL3RhYmxlOmMxNmQ4ODFkMzg0YzQzYWY4YzkxZGRlOTI1ZTBlMTU3L3RhYmxlcmFuZ2U6YzE2ZDg4MWQzODRjNDNhZjhjOTFkZGU5MjVlMGUxNTdfMy0xMy0xLTEtNDgxNjQ_56fb6110-50a4-4d33-afcd-8157f6946619" unitRef="usd"> 4308000 </us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
<us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="i50aa2eea9a6446b6ad796d994509b1ad_D20220401-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zMS9mcmFnOmVhOTkwNjc5MjQ2MTQ0MTVhZjY5OGNjNDIwZWZiYjZlL3RhYmxlOmMxNmQ4ODFkMzg0YzQzYWY4YzkxZGRlOTI1ZTBlMTU3L3RhYmxlcmFuZ2U6YzE2ZDg4MWQzODRjNDNhZjhjOTFkZGU5MjVlMGUxNTdfMy0yMS0xLTEtNDgxNjQ_65621f1f-5981-4c5f-a313-91223378e63d" unitRef="usd"> 4308000 </us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
<us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="iaddb92ee4a114eabb5c91ad635bf57f9_D20220401-20220630" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zMS9mcmFnOmVhOTkwNjc5MjQ2MTQ0MTVhZjY5OGNjNDIwZWZiYjZlL3RhYmxlOmMxNmQ4ODFkMzg0YzQzYWY4YzkxZGRlOTI1ZTBlMTU3L3RhYmxlcmFuZ2U6YzE2ZDg4MWQzODRjNDNhZjhjOTFkZGU5MjVlMGUxNTdfNC01LTEtMS00ODE2NA_93ce793d-a322-4112-babe-a95a2ae08473" unitRef="shares"> 546337 </us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
<us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="iaddb92ee4a114eabb5c91ad635bf57f9_D20220401-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zMS9mcmFnOmVhOTkwNjc5MjQ2MTQ0MTVhZjY5OGNjNDIwZWZiYjZlL3RhYmxlOmMxNmQ4ODFkMzg0YzQzYWY4YzkxZGRlOTI1ZTBlMTU3L3RhYmxlcmFuZ2U6YzE2ZDg4MWQzODRjNDNhZjhjOTFkZGU5MjVlMGUxNTdfNC03LTEtMS00ODE2NA_b1733d1f-f627-40e9-b09a-f47c8d1b2645" unitRef="usd"> 6000 </us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
<us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="i04265b97ae4d49c797e0d0c55d843b90_D20220401-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zMS9mcmFnOmVhOTkwNjc5MjQ2MTQ0MTVhZjY5OGNjNDIwZWZiYjZlL3RhYmxlOmMxNmQ4ODFkMzg0YzQzYWY4YzkxZGRlOTI1ZTBlMTU3L3RhYmxlcmFuZ2U6YzE2ZDg4MWQzODRjNDNhZjhjOTFkZGU5MjVlMGUxNTdfNC0xMy0xLTEtNDgxNjQ_b596d56c-182a-438a-a7d5-0877e89b4066" unitRef="usd"> -366000 </us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
<us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="i50aa2eea9a6446b6ad796d994509b1ad_D20220401-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zMS9mcmFnOmVhOTkwNjc5MjQ2MTQ0MTVhZjY5OGNjNDIwZWZiYjZlL3RhYmxlOmMxNmQ4ODFkMzg0YzQzYWY4YzkxZGRlOTI1ZTBlMTU3L3RhYmxlcmFuZ2U6YzE2ZDg4MWQzODRjNDNhZjhjOTFkZGU5MjVlMGUxNTdfNC0yMS0xLTEtNDgxNjQ_fa9fbda6-a4e2-4af7-843f-daa2a1af75e8" unitRef="usd"> -360000 </us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
<us-gaap:StockIssuedDuringPeriodSharesAcquisitions contextRef="i7a3911d30cbc481998e3a5e0ab35ef79_D20220101-20220630" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zMS9mcmFnOmVhOTkwNjc5MjQ2MTQ0MTVhZjY5OGNjNDIwZWZiYjZlL3RhYmxlOmMxNmQ4ODFkMzg0YzQzYWY4YzkxZGRlOTI1ZTBlMTU3L3RhYmxlcmFuZ2U6YzE2ZDg4MWQzODRjNDNhZjhjOTFkZGU5MjVlMGUxNTdfNy01LTEtMS01NTI3NA_9aacc8e1-c9f9-4218-a396-c052eb69cc6a" unitRef="shares"> 89907311 </us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
<us-gaap:StockIssuedDuringPeriodValueAcquisitions contextRef="i7a3911d30cbc481998e3a5e0ab35ef79_D20220101-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zMS9mcmFnOmVhOTkwNjc5MjQ2MTQ0MTVhZjY5OGNjNDIwZWZiYjZlL3RhYmxlOmMxNmQ4ODFkMzg0YzQzYWY4YzkxZGRlOTI1ZTBlMTU3L3RhYmxlcmFuZ2U6YzE2ZDg4MWQzODRjNDNhZjhjOTFkZGU5MjVlMGUxNTdfNy03LTEtMS01NTI3NA_5baa138d-30bf-4be1-ab8b-52341a224acd" unitRef="usd"> 899000 </us-gaap:StockIssuedDuringPeriodValueAcquisitions>
<us-gaap:StockIssuedDuringPeriodValueAcquisitions contextRef="iab350db377af4e68a4340919d2588400_D20220101-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zMS9mcmFnOmVhOTkwNjc5MjQ2MTQ0MTVhZjY5OGNjNDIwZWZiYjZlL3RhYmxlOmMxNmQ4ODFkMzg0YzQzYWY4YzkxZGRlOTI1ZTBlMTU3L3RhYmxlcmFuZ2U6YzE2ZDg4MWQzODRjNDNhZjhjOTFkZGU5MjVlMGUxNTdfNy0xMy0xLTEtNTUyNzQ_d2f794ac-818d-46de-87b7-bd98787a1bad" unitRef="usd"> 218475000 </us-gaap:StockIssuedDuringPeriodValueAcquisitions>
<us-gaap:StockIssuedDuringPeriodValueAcquisitions contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zMS9mcmFnOmVhOTkwNjc5MjQ2MTQ0MTVhZjY5OGNjNDIwZWZiYjZlL3RhYmxlOmMxNmQ4ODFkMzg0YzQzYWY4YzkxZGRlOTI1ZTBlMTU3L3RhYmxlcmFuZ2U6YzE2ZDg4MWQzODRjNDNhZjhjOTFkZGU5MjVlMGUxNTdfNy0yMS0xLTEtNTUyNzQ_d60a45a4-8141-4339-a550-9c6048793734" unitRef="usd"> 219374000 </us-gaap:StockIssuedDuringPeriodValueAcquisitions>
<us-gaap:NetIncomeLoss contextRef="i664e18092df94016a53d7b26841156a6_D20220401-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zMS9mcmFnOmVhOTkwNjc5MjQ2MTQ0MTVhZjY5OGNjNDIwZWZiYjZlL3RhYmxlOmMxNmQ4ODFkMzg0YzQzYWY4YzkxZGRlOTI1ZTBlMTU3L3RhYmxlcmFuZ2U6YzE2ZDg4MWQzODRjNDNhZjhjOTFkZGU5MjVlMGUxNTdfNy0xNy0xLTEtNDgxNjQ_b6d9b45f-5d17-4cc0-af4f-e061974bc442" unitRef="usd"> -101650000 </us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="i50aa2eea9a6446b6ad796d994509b1ad_D20220401-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zMS9mcmFnOmVhOTkwNjc5MjQ2MTQ0MTVhZjY5OGNjNDIwZWZiYjZlL3RhYmxlOmMxNmQ4ODFkMzg0YzQzYWY4YzkxZGRlOTI1ZTBlMTU3L3RhYmxlcmFuZ2U6YzE2ZDg4MWQzODRjNDNhZjhjOTFkZGU5MjVlMGUxNTdfNy0yMS0xLTEtNDgxNjQ_9eab9fa7-7fb7-4daa-81be-1f74db2ec658" unitRef="usd"> -101650000 </us-gaap:NetIncomeLoss>
<us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="i2f1e3a13d9e14974875975db079fd6f7_D20220401-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zMS9mcmFnOmVhOTkwNjc5MjQ2MTQ0MTVhZjY5OGNjNDIwZWZiYjZlL3RhYmxlOmMxNmQ4ODFkMzg0YzQzYWY4YzkxZGRlOTI1ZTBlMTU3L3RhYmxlcmFuZ2U6YzE2ZDg4MWQzODRjNDNhZjhjOTFkZGU5MjVlMGUxNTdfOC0xNS0xLTEtNDgxNjQ_64ac549b-8f80-4cf2-a655-f6699f69cc66" unitRef="usd"> -17756000 </us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
<us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="i50aa2eea9a6446b6ad796d994509b1ad_D20220401-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zMS9mcmFnOmVhOTkwNjc5MjQ2MTQ0MTVhZjY5OGNjNDIwZWZiYjZlL3RhYmxlOmMxNmQ4ODFkMzg0YzQzYWY4YzkxZGRlOTI1ZTBlMTU3L3RhYmxlcmFuZ2U6YzE2ZDg4MWQzODRjNDNhZjhjOTFkZGU5MjVlMGUxNTdfOC0yMS0xLTEtNDgxNjQ_00324273-c128-4034-b8ad-d0df78c8a2ba" unitRef="usd"> -17756000 </us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
<us-gaap:CommonStockSharesOutstanding contextRef="i85b7b1dbd04b4d3dbdaf6cb62cfc1665_I20220630" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zMS9mcmFnOmVhOTkwNjc5MjQ2MTQ0MTVhZjY5OGNjNDIwZWZiYjZlL3RhYmxlOmMxNmQ4ODFkMzg0YzQzYWY4YzkxZGRlOTI1ZTBlMTU3L3RhYmxlcmFuZ2U6YzE2ZDg4MWQzODRjNDNhZjhjOTFkZGU5MjVlMGUxNTdfOS01LTEtMS00ODE2NA_2b3ffbd4-9fe0-4c1e-a35e-9261ae5ac3cd" unitRef="shares"> 780591681 </us-gaap:CommonStockSharesOutstanding>
<us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="i85b7b1dbd04b4d3dbdaf6cb62cfc1665_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zMS9mcmFnOmVhOTkwNjc5MjQ2MTQ0MTVhZjY5OGNjNDIwZWZiYjZlL3RhYmxlOmMxNmQ4ODFkMzg0YzQzYWY4YzkxZGRlOTI1ZTBlMTU3L3RhYmxlcmFuZ2U6YzE2ZDg4MWQzODRjNDNhZjhjOTFkZGU5MjVlMGUxNTdfOS03LTEtMS00ODE2NA_95175c73-aef6-4bb0-9b90-14fcee9e2e5e" unitRef="usd"> 7806000 </us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
<us-gaap:TreasuryStockCommonShares contextRef="i3d5e060c68554a45962ea3a454384d02_I20220630" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zMS9mcmFnOmVhOTkwNjc5MjQ2MTQ0MTVhZjY5OGNjNDIwZWZiYjZlL3RhYmxlOmMxNmQ4ODFkMzg0YzQzYWY4YzkxZGRlOTI1ZTBlMTU3L3RhYmxlcmFuZ2U6YzE2ZDg4MWQzODRjNDNhZjhjOTFkZGU5MjVlMGUxNTdfOS05LTEtMS00ODE2NA_86094da1-2eeb-48ce-89eb-1a326dc525b4" unitRef="shares"> 8655082 </us-gaap:TreasuryStockCommonShares>
<us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="i3d5e060c68554a45962ea3a454384d02_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zMS9mcmFnOmVhOTkwNjc5MjQ2MTQ0MTVhZjY5OGNjNDIwZWZiYjZlL3RhYmxlOmMxNmQ4ODFkMzg0YzQzYWY4YzkxZGRlOTI1ZTBlMTU3L3RhYmxlcmFuZ2U6YzE2ZDg4MWQzODRjNDNhZjhjOTFkZGU5MjVlMGUxNTdfOS0xMS0xLTEtNDgxNjQ_07231572-f144-448e-9052-39c33f364625" unitRef="usd"> -1791000 </us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
<us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="i2a9555033f9c450cbd0cc0880f75dc69_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zMS9mcmFnOmVhOTkwNjc5MjQ2MTQ0MTVhZjY5OGNjNDIwZWZiYjZlL3RhYmxlOmMxNmQ4ODFkMzg0YzQzYWY4YzkxZGRlOTI1ZTBlMTU3L3RhYmxlcmFuZ2U6YzE2ZDg4MWQzODRjNDNhZjhjOTFkZGU5MjVlMGUxNTdfOS0xMy0xLTEtNDgxNjQ_9ee2348c-fe62-4a6d-ba5b-6b95ce2bd067" unitRef="usd"> 3413556000 </us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
<us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="ie6ee77a745aa4015ad63d4f83040b0ed_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zMS9mcmFnOmVhOTkwNjc5MjQ2MTQ0MTVhZjY5OGNjNDIwZWZiYjZlL3RhYmxlOmMxNmQ4ODFkMzg0YzQzYWY4YzkxZGRlOTI1ZTBlMTU3L3RhYmxlcmFuZ2U6YzE2ZDg4MWQzODRjNDNhZjhjOTFkZGU5MjVlMGUxNTdfOS0xNS0xLTEtNDgxNjQ_a1dfbab0-fd81-42a5-82c5-e89c766156fd" unitRef="usd"> -49171000 </us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
<us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="i9c7451fa56834bd59e76c58725d6590e_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zMS9mcmFnOmVhOTkwNjc5MjQ2MTQ0MTVhZjY5OGNjNDIwZWZiYjZlL3RhYmxlOmMxNmQ4ODFkMzg0YzQzYWY4YzkxZGRlOTI1ZTBlMTU3L3RhYmxlcmFuZ2U6YzE2ZDg4MWQzODRjNDNhZjhjOTFkZGU5MjVlMGUxNTdfOS0xNy0xLTEtNDgxNjQ_03b9b793-0c84-49d0-b100-10c5dbc51440" unitRef="usd"> -1651601000 </us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
<us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="i4768f885851b49f986857a2a956f9162_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zMS9mcmFnOmVhOTkwNjc5MjQ2MTQ0MTVhZjY5OGNjNDIwZWZiYjZlL3RhYmxlOmMxNmQ4ODFkMzg0YzQzYWY4YzkxZGRlOTI1ZTBlMTU3L3RhYmxlcmFuZ2U6YzE2ZDg4MWQzODRjNDNhZjhjOTFkZGU5MjVlMGUxNTdfOS0yMS0xLTEtNDgxNjQ_090b6fd3-bfcf-4507-be17-3513622da564" unitRef="usd"> 1718799000 </us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
<us-gaap:CommonStockSharesOutstanding contextRef="if69a9cfe200e450cac0564cfe636999d_I20211231" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zMS9mcmFnOmVhOTkwNjc5MjQ2MTQ0MTVhZjY5OGNjNDIwZWZiYjZlL3RhYmxlOmE5MThjMTEyZWYyODQ3YzlhYWQ3MjZkNWMyZDZhNDAyL3RhYmxlcmFuZ2U6YTkxOGMxMTJlZjI4NDdjOWFhZDcyNmQ1YzJkNmE0MDJfMi01LTEtMS00ODI2NQ_b17bbbcc-ea9c-456a-bbcc-9f70cb753854" unitRef="shares"> 690082283 </us-gaap:CommonStockSharesOutstanding>
<us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="if69a9cfe200e450cac0564cfe636999d_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zMS9mcmFnOmVhOTkwNjc5MjQ2MTQ0MTVhZjY5OGNjNDIwZWZiYjZlL3RhYmxlOmE5MThjMTEyZWYyODQ3YzlhYWQ3MjZkNWMyZDZhNDAyL3RhYmxlcmFuZ2U6YTkxOGMxMTJlZjI4NDdjOWFhZDcyNmQ1YzJkNmE0MDJfMi03LTEtMS00ODI2NQ_9b3b2c4d-4c91-44ec-bf84-b3603e3453da" unitRef="usd"> 6901000 </us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
<us-gaap:TreasuryStockCommonShares contextRef="i546a45246f83450caa3bdc0deb70f492_I20211231" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zMS9mcmFnOmVhOTkwNjc5MjQ2MTQ0MTVhZjY5OGNjNDIwZWZiYjZlL3RhYmxlOmE5MThjMTEyZWYyODQ3YzlhYWQ3MjZkNWMyZDZhNDAyL3RhYmxlcmFuZ2U6YTkxOGMxMTJlZjI4NDdjOWFhZDcyNmQ1YzJkNmE0MDJfMi05LTEtMS00ODI2NQ_cc1492c6-5cfd-4427-9ec5-5d9434d1ffd1" unitRef="shares"> 8655082 </us-gaap:TreasuryStockCommonShares>
<us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="i546a45246f83450caa3bdc0deb70f492_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zMS9mcmFnOmVhOTkwNjc5MjQ2MTQ0MTVhZjY5OGNjNDIwZWZiYjZlL3RhYmxlOmE5MThjMTEyZWYyODQ3YzlhYWQ3MjZkNWMyZDZhNDAyL3RhYmxlcmFuZ2U6YTkxOGMxMTJlZjI4NDdjOWFhZDcyNmQ1YzJkNmE0MDJfMi0xMS0xLTEtNDgyNjU_19dfdf32-9fd5-45a3-b808-138a9fc539dd" unitRef="usd"> -1791000 </us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
<us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="i5ad35185d82b4d4b99658d6774a96349_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zMS9mcmFnOmVhOTkwNjc5MjQ2MTQ0MTVhZjY5OGNjNDIwZWZiYjZlL3RhYmxlOmE5MThjMTEyZWYyODQ3YzlhYWQ3MjZkNWMyZDZhNDAyL3RhYmxlcmFuZ2U6YTkxOGMxMTJlZjI4NDdjOWFhZDcyNmQ1YzJkNmE0MDJfMi0xMy0xLTEtNDgyNjU_adf6a28a-48e7-4332-af19-40abe19d8421" unitRef="usd"> 3222487000 </us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
<us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="ife171a124ce1417497c82a77ed3eb5c1_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zMS9mcmFnOmVhOTkwNjc5MjQ2MTQ0MTVhZjY5OGNjNDIwZWZiYjZlL3RhYmxlOmE5MThjMTEyZWYyODQ3YzlhYWQ3MjZkNWMyZDZhNDAyL3RhYmxlcmFuZ2U6YTkxOGMxMTJlZjI4NDdjOWFhZDcyNmQ1YzJkNmE0MDJfMi0xNS0xLTEtNDgyNjU_850bbc46-83a4-4208-8a35-c61dc2b4da8d" unitRef="usd"> -30495000 </us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
<us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="i07949398dbdd4852aa632d1f6516a009_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zMS9mcmFnOmVhOTkwNjc5MjQ2MTQ0MTVhZjY5OGNjNDIwZWZiYjZlL3RhYmxlOmE5MThjMTEyZWYyODQ3YzlhYWQ3MjZkNWMyZDZhNDAyL3RhYmxlcmFuZ2U6YTkxOGMxMTJlZjI4NDdjOWFhZDcyNmQ1YzJkNmE0MDJfMi0xNy0xLTEtNDgyNjU_3c074314-8a17-4b67-9d1a-badb233d4bf2" unitRef="usd"> -1511976000 </us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
<us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="i7e0f479bead144b0bdbcc71082db627b_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zMS9mcmFnOmVhOTkwNjc5MjQ2MTQ0MTVhZjY5OGNjNDIwZWZiYjZlL3RhYmxlOmE5MThjMTEyZWYyODQ3YzlhYWQ3MjZkNWMyZDZhNDAyL3RhYmxlcmFuZ2U6YTkxOGMxMTJlZjI4NDdjOWFhZDcyNmQ1YzJkNmE0MDJfMi0yMS0xLTEtNDgyNjU_4a9155e5-9f6d-429d-ae9f-78b30544f711" unitRef="usd"> 1685126000 </us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
<us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="iab350db377af4e68a4340919d2588400_D20220101-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zMS9mcmFnOmVhOTkwNjc5MjQ2MTQ0MTVhZjY5OGNjNDIwZWZiYjZlL3RhYmxlOmE5MThjMTEyZWYyODQ3YzlhYWQ3MjZkNWMyZDZhNDAyL3RhYmxlcmFuZ2U6YTkxOGMxMTJlZjI4NDdjOWFhZDcyNmQ1YzJkNmE0MDJfMy0xMy0xLTEtNDgyNjU_597ca182-0d66-4f3e-9390-c52e9e97249d" unitRef="usd"> 11925000 </us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
<us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zMS9mcmFnOmVhOTkwNjc5MjQ2MTQ0MTVhZjY5OGNjNDIwZWZiYjZlL3RhYmxlOmE5MThjMTEyZWYyODQ3YzlhYWQ3MjZkNWMyZDZhNDAyL3RhYmxlcmFuZ2U6YTkxOGMxMTJlZjI4NDdjOWFhZDcyNmQ1YzJkNmE0MDJfMy0yMS0xLTEtNDgyNjU_f0923568-ce60-4446-8919-2b56db0b9358" unitRef="usd"> 11925000 </us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
<us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="i7a3911d30cbc481998e3a5e0ab35ef79_D20220101-20220630" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zMS9mcmFnOmVhOTkwNjc5MjQ2MTQ0MTVhZjY5OGNjNDIwZWZiYjZlL3RhYmxlOmE5MThjMTEyZWYyODQ3YzlhYWQ3MjZkNWMyZDZhNDAyL3RhYmxlcmFuZ2U6YTkxOGMxMTJlZjI4NDdjOWFhZDcyNmQ1YzJkNmE0MDJfNC01LTEtMS00ODI2NQ_396534f6-97dc-433e-937f-de60ea455f4e" unitRef="shares"> 602087 </us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
<us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="i7a3911d30cbc481998e3a5e0ab35ef79_D20220101-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zMS9mcmFnOmVhOTkwNjc5MjQ2MTQ0MTVhZjY5OGNjNDIwZWZiYjZlL3RhYmxlOmE5MThjMTEyZWYyODQ3YzlhYWQ3MjZkNWMyZDZhNDAyL3RhYmxlcmFuZ2U6YTkxOGMxMTJlZjI4NDdjOWFhZDcyNmQ1YzJkNmE0MDJfNC03LTEtMS00ODI2NQ_151c1da7-000d-48af-86b6-5de3744b6097" unitRef="usd"> 6000 </us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
<us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="iab350db377af4e68a4340919d2588400_D20220101-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zMS9mcmFnOmVhOTkwNjc5MjQ2MTQ0MTVhZjY5OGNjNDIwZWZiYjZlL3RhYmxlOmE5MThjMTEyZWYyODQ3YzlhYWQ3MjZkNWMyZDZhNDAyL3RhYmxlcmFuZ2U6YTkxOGMxMTJlZjI4NDdjOWFhZDcyNmQ1YzJkNmE0MDJfNC0xMy0xLTEtNDgyNjU_f1d0a05e-706e-48e7-bd17-d995d8e5390e" unitRef="usd"> -231000 </us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
<us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zMS9mcmFnOmVhOTkwNjc5MjQ2MTQ0MTVhZjY5OGNjNDIwZWZiYjZlL3RhYmxlOmE5MThjMTEyZWYyODQ3YzlhYWQ3MjZkNWMyZDZhNDAyL3RhYmxlcmFuZ2U6YTkxOGMxMTJlZjI4NDdjOWFhZDcyNmQ1YzJkNmE0MDJfNC0yMS0xLTEtNDgyNjU_cdeb5588-fd17-48f2-895d-dd2b41fb8ddc" unitRef="usd"> -225000 </us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
<us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="i21bf2c09312540c1a07d30824acd00af_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zMS9mcmFnOmVhOTkwNjc5MjQ2MTQ0MTVhZjY5OGNjNDIwZWZiYjZlL3RhYmxlOmE5MThjMTEyZWYyODQ3YzlhYWQ3MjZkNWMyZDZhNDAyL3RhYmxlcmFuZ2U6YTkxOGMxMTJlZjI4NDdjOWFhZDcyNmQ1YzJkNmE0MDJfNS0xMy0xLTEtNDgyNjU_e7ef089c-9b7e-42e6-b096-fff763b75615" unitRef="usd"> -39100000 </us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
<us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="i0dd0c4b91d444de595bbd9d4c50f2a9c_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zMS9mcmFnOmVhOTkwNjc5MjQ2MTQ0MTVhZjY5OGNjNDIwZWZiYjZlL3RhYmxlOmE5MThjMTEyZWYyODQ3YzlhYWQ3MjZkNWMyZDZhNDAyL3RhYmxlcmFuZ2U6YTkxOGMxMTJlZjI4NDdjOWFhZDcyNmQ1YzJkNmE0MDJfNS0xNy0xLTEtNDgyNjU_dca802ca-7280-4457-a44d-75f55f913374" unitRef="usd"> 17458000 </us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
<us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="i006ef26eeb91481d9d77c8e447b45a9d_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zMS9mcmFnOmVhOTkwNjc5MjQ2MTQ0MTVhZjY5OGNjNDIwZWZiYjZlL3RhYmxlOmE5MThjMTEyZWYyODQ3YzlhYWQ3MjZkNWMyZDZhNDAyL3RhYmxlcmFuZ2U6YTkxOGMxMTJlZjI4NDdjOWFhZDcyNmQ1YzJkNmE0MDJfNS0yMS0xLTEtNDgyNjU_148d0470-ccbe-4d9a-9401-c9683c83603b" unitRef="usd"> -21642000 </us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
<us-gaap:StockIssuedDuringPeriodSharesAcquisitions contextRef="i7a3911d30cbc481998e3a5e0ab35ef79_D20220101-20220630" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zMS9mcmFnOmVhOTkwNjc5MjQ2MTQ0MTVhZjY5OGNjNDIwZWZiYjZlL3RhYmxlOmE5MThjMTEyZWYyODQ3YzlhYWQ3MjZkNWMyZDZhNDAyL3RhYmxlcmFuZ2U6YTkxOGMxMTJlZjI4NDdjOWFhZDcyNmQ1YzJkNmE0MDJfNy01LTEtMS01NTI4NA_b3a5fe41-dc6e-4b3c-9c13-d90b6433828c" unitRef="shares"> 89907311 </us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
<us-gaap:StockIssuedDuringPeriodValueAcquisitions contextRef="i7a3911d30cbc481998e3a5e0ab35ef79_D20220101-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zMS9mcmFnOmVhOTkwNjc5MjQ2MTQ0MTVhZjY5OGNjNDIwZWZiYjZlL3RhYmxlOmE5MThjMTEyZWYyODQ3YzlhYWQ3MjZkNWMyZDZhNDAyL3RhYmxlcmFuZ2U6YTkxOGMxMTJlZjI4NDdjOWFhZDcyNmQ1YzJkNmE0MDJfNy03LTEtMS01NTI4NA_963a0c63-2e5b-49b3-a2d4-50b2ffbd224a" unitRef="usd"> 899000 </us-gaap:StockIssuedDuringPeriodValueAcquisitions>
<us-gaap:StockIssuedDuringPeriodValueAcquisitions contextRef="iab350db377af4e68a4340919d2588400_D20220101-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zMS9mcmFnOmVhOTkwNjc5MjQ2MTQ0MTVhZjY5OGNjNDIwZWZiYjZlL3RhYmxlOmE5MThjMTEyZWYyODQ3YzlhYWQ3MjZkNWMyZDZhNDAyL3RhYmxlcmFuZ2U6YTkxOGMxMTJlZjI4NDdjOWFhZDcyNmQ1YzJkNmE0MDJfNy0xMy0xLTEtNTUyODQ_33a9fd2b-ab29-442d-a10b-a5b9c17ba6bc" unitRef="usd"> 218475000 </us-gaap:StockIssuedDuringPeriodValueAcquisitions>
<us-gaap:StockIssuedDuringPeriodValueAcquisitions contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zMS9mcmFnOmVhOTkwNjc5MjQ2MTQ0MTVhZjY5OGNjNDIwZWZiYjZlL3RhYmxlOmE5MThjMTEyZWYyODQ3YzlhYWQ3MjZkNWMyZDZhNDAyL3RhYmxlcmFuZ2U6YTkxOGMxMTJlZjI4NDdjOWFhZDcyNmQ1YzJkNmE0MDJfNy0yMS0xLTEtNTUyODQ_6601657b-610d-4557-b5f9-4f76b7206e21" unitRef="usd"> 219374000 </us-gaap:StockIssuedDuringPeriodValueAcquisitions>
<us-gaap:NetIncomeLoss contextRef="i56def4b76e0c4f9490d4c998c5a81918_D20220101-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zMS9mcmFnOmVhOTkwNjc5MjQ2MTQ0MTVhZjY5OGNjNDIwZWZiYjZlL3RhYmxlOmE5MThjMTEyZWYyODQ3YzlhYWQ3MjZkNWMyZDZhNDAyL3RhYmxlcmFuZ2U6YTkxOGMxMTJlZjI4NDdjOWFhZDcyNmQ1YzJkNmE0MDJfNy0xNy0xLTEtNDgyNjU_001089a8-7416-431e-ba29-f8b10256be24" unitRef="usd"> -157083000 </us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zMS9mcmFnOmVhOTkwNjc5MjQ2MTQ0MTVhZjY5OGNjNDIwZWZiYjZlL3RhYmxlOmE5MThjMTEyZWYyODQ3YzlhYWQ3MjZkNWMyZDZhNDAyL3RhYmxlcmFuZ2U6YTkxOGMxMTJlZjI4NDdjOWFhZDcyNmQ1YzJkNmE0MDJfNy0yMS0xLTEtNDgyNjU_9c572699-b775-4d20-8d20-3d03411b387c" unitRef="usd"> -157083000 </us-gaap:NetIncomeLoss>
<us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="ibd58c29336894d95b5c9f39da70bfb30_D20220101-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zMS9mcmFnOmVhOTkwNjc5MjQ2MTQ0MTVhZjY5OGNjNDIwZWZiYjZlL3RhYmxlOmE5MThjMTEyZWYyODQ3YzlhYWQ3MjZkNWMyZDZhNDAyL3RhYmxlcmFuZ2U6YTkxOGMxMTJlZjI4NDdjOWFhZDcyNmQ1YzJkNmE0MDJfOC0xNS0xLTEtNDgyNjU_1547c4c4-5e93-4204-83d0-93e4a05e4a0a" unitRef="usd"> -18676000 </us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
<us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zMS9mcmFnOmVhOTkwNjc5MjQ2MTQ0MTVhZjY5OGNjNDIwZWZiYjZlL3RhYmxlOmE5MThjMTEyZWYyODQ3YzlhYWQ3MjZkNWMyZDZhNDAyL3RhYmxlcmFuZ2U6YTkxOGMxMTJlZjI4NDdjOWFhZDcyNmQ1YzJkNmE0MDJfOC0yMS0xLTEtNDgyNjU_ce49b8d6-992d-4e34-a042-a16a6b14817f" unitRef="usd"> -18676000 </us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
<us-gaap:CommonStockSharesOutstanding contextRef="i85b7b1dbd04b4d3dbdaf6cb62cfc1665_I20220630" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zMS9mcmFnOmVhOTkwNjc5MjQ2MTQ0MTVhZjY5OGNjNDIwZWZiYjZlL3RhYmxlOmE5MThjMTEyZWYyODQ3YzlhYWQ3MjZkNWMyZDZhNDAyL3RhYmxlcmFuZ2U6YTkxOGMxMTJlZjI4NDdjOWFhZDcyNmQ1YzJkNmE0MDJfOS01LTEtMS00ODI2NQ_871d3be5-b025-4218-b825-b2533444e2cd" unitRef="shares"> 780591681 </us-gaap:CommonStockSharesOutstanding>
<us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="i85b7b1dbd04b4d3dbdaf6cb62cfc1665_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zMS9mcmFnOmVhOTkwNjc5MjQ2MTQ0MTVhZjY5OGNjNDIwZWZiYjZlL3RhYmxlOmE5MThjMTEyZWYyODQ3YzlhYWQ3MjZkNWMyZDZhNDAyL3RhYmxlcmFuZ2U6YTkxOGMxMTJlZjI4NDdjOWFhZDcyNmQ1YzJkNmE0MDJfOS03LTEtMS00ODI2NQ_8ede3360-d998-4cd7-a9a1-6a6f6bed7f44" unitRef="usd"> 7806000 </us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
<us-gaap:TreasuryStockCommonShares contextRef="i3d5e060c68554a45962ea3a454384d02_I20220630" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zMS9mcmFnOmVhOTkwNjc5MjQ2MTQ0MTVhZjY5OGNjNDIwZWZiYjZlL3RhYmxlOmE5MThjMTEyZWYyODQ3YzlhYWQ3MjZkNWMyZDZhNDAyL3RhYmxlcmFuZ2U6YTkxOGMxMTJlZjI4NDdjOWFhZDcyNmQ1YzJkNmE0MDJfOS05LTEtMS00ODI2NQ_1f70cae8-40a2-4c1e-8ce3-cea4e9f28b93" unitRef="shares"> 8655082 </us-gaap:TreasuryStockCommonShares>
<us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="i3d5e060c68554a45962ea3a454384d02_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zMS9mcmFnOmVhOTkwNjc5MjQ2MTQ0MTVhZjY5OGNjNDIwZWZiYjZlL3RhYmxlOmE5MThjMTEyZWYyODQ3YzlhYWQ3MjZkNWMyZDZhNDAyL3RhYmxlcmFuZ2U6YTkxOGMxMTJlZjI4NDdjOWFhZDcyNmQ1YzJkNmE0MDJfOS0xMS0xLTEtNDgyNjU_d843de34-d632-43db-b4cf-3a29bb43e1a0" unitRef="usd"> -1791000 </us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
<us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="i2a9555033f9c450cbd0cc0880f75dc69_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zMS9mcmFnOmVhOTkwNjc5MjQ2MTQ0MTVhZjY5OGNjNDIwZWZiYjZlL3RhYmxlOmE5MThjMTEyZWYyODQ3YzlhYWQ3MjZkNWMyZDZhNDAyL3RhYmxlcmFuZ2U6YTkxOGMxMTJlZjI4NDdjOWFhZDcyNmQ1YzJkNmE0MDJfOS0xMy0xLTEtNDgyNjU_4dbaf495-1918-4c6d-b346-70339b2db2a8" unitRef="usd"> 3413556000 </us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
<us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="ie6ee77a745aa4015ad63d4f83040b0ed_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zMS9mcmFnOmVhOTkwNjc5MjQ2MTQ0MTVhZjY5OGNjNDIwZWZiYjZlL3RhYmxlOmE5MThjMTEyZWYyODQ3YzlhYWQ3MjZkNWMyZDZhNDAyL3RhYmxlcmFuZ2U6YTkxOGMxMTJlZjI4NDdjOWFhZDcyNmQ1YzJkNmE0MDJfOS0xNS0xLTEtNDgyNjU_5383e14c-201c-4c68-acba-c53152205eae" unitRef="usd"> -49171000 </us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
<us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="i9c7451fa56834bd59e76c58725d6590e_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zMS9mcmFnOmVhOTkwNjc5MjQ2MTQ0MTVhZjY5OGNjNDIwZWZiYjZlL3RhYmxlOmE5MThjMTEyZWYyODQ3YzlhYWQ3MjZkNWMyZDZhNDAyL3RhYmxlcmFuZ2U6YTkxOGMxMTJlZjI4NDdjOWFhZDcyNmQ1YzJkNmE0MDJfOS0xNy0xLTEtNDgyNjU_c40ec701-55c1-4ce7-a989-25b022808c5c" unitRef="usd"> -1651601000 </us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
<us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="i4768f885851b49f986857a2a956f9162_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zMS9mcmFnOmVhOTkwNjc5MjQ2MTQ0MTVhZjY5OGNjNDIwZWZiYjZlL3RhYmxlOmE5MThjMTEyZWYyODQ3YzlhYWQ3MjZkNWMyZDZhNDAyL3RhYmxlcmFuZ2U6YTkxOGMxMTJlZjI4NDdjOWFhZDcyNmQ1YzJkNmE0MDJfOS0yMS0xLTEtNDgyNjU_6ca49863-1396-4672-89be-c3f4c70ffeac" unitRef="usd"> 1718799000 </us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
<us-gaap:CommonStockSharesOutstanding contextRef="i6c23a090b00b43c693b6d7f3d82b7be5_I20210331" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zMS9mcmFnOmVhOTkwNjc5MjQ2MTQ0MTVhZjY5OGNjNDIwZWZiYjZlL3RhYmxlOjE5ZWI1ODQ4OTE5MzQ4MjNiNGM3MDIzNjU4ZjZiZGQ4L3RhYmxlcmFuZ2U6MTllYjU4NDg5MTkzNDgyM2I0YzcwMjM2NThmNmJkZDhfMi01LTEtMS00ODE2NA_a101d4e1-8245-4fdd-9f97-111d5da2411a" unitRef="shares"> 670703076 </us-gaap:CommonStockSharesOutstanding>
<us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="i6c23a090b00b43c693b6d7f3d82b7be5_I20210331" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zMS9mcmFnOmVhOTkwNjc5MjQ2MTQ0MTVhZjY5OGNjNDIwZWZiYjZlL3RhYmxlOjE5ZWI1ODQ4OTE5MzQ4MjNiNGM3MDIzNjU4ZjZiZGQ4L3RhYmxlcmFuZ2U6MTllYjU4NDg5MTkzNDgyM2I0YzcwMjM2NThmNmJkZDhfMi03LTEtMS00ODE2NA_78125e02-3012-4bdb-bdb8-faf0c9406427" unitRef="usd"> 6707000 </us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
<us-gaap:TreasuryStockCommonShares contextRef="idc0a96aeba8b4919ab01f8ffc72b120a_I20210331" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zMS9mcmFnOmVhOTkwNjc5MjQ2MTQ0MTVhZjY5OGNjNDIwZWZiYjZlL3RhYmxlOjE5ZWI1ODQ4OTE5MzQ4MjNiNGM3MDIzNjU4ZjZiZGQ4L3RhYmxlcmFuZ2U6MTllYjU4NDg5MTkzNDgyM2I0YzcwMjM2NThmNmJkZDhfMi05LTEtMS00ODE2NA_d64d7d56-d82b-4583-b1af-c724b2486629" unitRef="shares"> 549907 </us-gaap:TreasuryStockCommonShares>
<us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="idc0a96aeba8b4919ab01f8ffc72b120a_I20210331" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zMS9mcmFnOmVhOTkwNjc5MjQ2MTQ0MTVhZjY5OGNjNDIwZWZiYjZlL3RhYmxlOjE5ZWI1ODQ4OTE5MzQ4MjNiNGM3MDIzNjU4ZjZiZGQ4L3RhYmxlcmFuZ2U6MTllYjU4NDg5MTkzNDgyM2I0YzcwMjM2NThmNmJkZDhfMi0xMS0xLTEtNDgxNjQ_6c91aa84-cfac-411d-8841-595230f50263" unitRef="usd"> -1791000 </us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
<us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="i62721db31d084926bae68f12928c12cd_I20210331" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zMS9mcmFnOmVhOTkwNjc5MjQ2MTQ0MTVhZjY5OGNjNDIwZWZiYjZlL3RhYmxlOjE5ZWI1ODQ4OTE5MzQ4MjNiNGM3MDIzNjU4ZjZiZGQ4L3RhYmxlcmFuZ2U6MTllYjU4NDg5MTkzNDgyM2I0YzcwMjM2NThmNmJkZDhfMi0xMy0xLTEtNDgxNjQ_28005137-2b6c-4159-a2e3-49d5b8ff7bb7" unitRef="usd"> 3155648000 </us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
<us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="ife540768ebf747979501881c139e0199_I20210331" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zMS9mcmFnOmVhOTkwNjc5MjQ2MTQ0MTVhZjY5OGNjNDIwZWZiYjZlL3RhYmxlOjE5ZWI1ODQ4OTE5MzQ4MjNiNGM3MDIzNjU4ZjZiZGQ4L3RhYmxlcmFuZ2U6MTllYjU4NDg5MTkzNDgyM2I0YzcwMjM2NThmNmJkZDhfMi0xNS0xLTEtNDgxNjQ_33f6b791-1601-4b0c-9adf-0fac9cfad946" unitRef="usd"> -13295000 </us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
<us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="i357c7263e308459fafefe5433b54fde6_I20210331" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zMS9mcmFnOmVhOTkwNjc5MjQ2MTQ0MTVhZjY5OGNjNDIwZWZiYjZlL3RhYmxlOjE5ZWI1ODQ4OTE5MzQ4MjNiNGM3MDIzNjU4ZjZiZGQ4L3RhYmxlcmFuZ2U6MTllYjU4NDg5MTkzNDgyM2I0YzcwMjM2NThmNmJkZDhfMi0xNy0xLTEtNDgxNjQ_ad5d0bc9-2825-448c-a766-775736083fb3" unitRef="usd"> -1450755000 </us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
<us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="iaa0c2c8c10d745ddaed78dfdd05335a0_I20210331" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zMS9mcmFnOmVhOTkwNjc5MjQ2MTQ0MTVhZjY5OGNjNDIwZWZiYjZlL3RhYmxlOjE5ZWI1ODQ4OTE5MzQ4MjNiNGM3MDIzNjU4ZjZiZGQ4L3RhYmxlcmFuZ2U6MTllYjU4NDg5MTkzNDgyM2I0YzcwMjM2NThmNmJkZDhfMi0yMS0xLTEtNDgxNjQ_c1e38804-2843-495b-9219-a5b179d1b6ac" unitRef="usd"> 1696514000 </us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
<us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="i6534ba238d994a90a6ea2f8387180ed8_D20210401-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zMS9mcmFnOmVhOTkwNjc5MjQ2MTQ0MTVhZjY5OGNjNDIwZWZiYjZlL3RhYmxlOjE5ZWI1ODQ4OTE5MzQ4MjNiNGM3MDIzNjU4ZjZiZGQ4L3RhYmxlcmFuZ2U6MTllYjU4NDg5MTkzNDgyM2I0YzcwMjM2NThmNmJkZDhfMy0xMy0xLTEtNDgxNjQ_d24e13a9-98d3-4cba-88e1-aa1c5efa41a6" unitRef="usd"> 3460000 </us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
<us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="if2a6207b6732465a921fe019a2a0f048_D20210401-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zMS9mcmFnOmVhOTkwNjc5MjQ2MTQ0MTVhZjY5OGNjNDIwZWZiYjZlL3RhYmxlOjE5ZWI1ODQ4OTE5MzQ4MjNiNGM3MDIzNjU4ZjZiZGQ4L3RhYmxlcmFuZ2U6MTllYjU4NDg5MTkzNDgyM2I0YzcwMjM2NThmNmJkZDhfMy0yMS0xLTEtNDgxNjQ_535a2e5a-0952-431f-929f-c936e9468013" unitRef="usd"> 3460000 </us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
<us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="ie9dea1cfa0a040fca270b1ad597208aa_D20210401-20210630" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zMS9mcmFnOmVhOTkwNjc5MjQ2MTQ0MTVhZjY5OGNjNDIwZWZiYjZlL3RhYmxlOjE5ZWI1ODQ4OTE5MzQ4MjNiNGM3MDIzNjU4ZjZiZGQ4L3RhYmxlcmFuZ2U6MTllYjU4NDg5MTkzNDgyM2I0YzcwMjM2NThmNmJkZDhfNC01LTEtMS00ODE2NA_9a85a915-b214-4c5d-8886-df89ddd328f0" unitRef="shares"> 63625 </us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
<us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="ie9dea1cfa0a040fca270b1ad597208aa_D20210401-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zMS9mcmFnOmVhOTkwNjc5MjQ2MTQ0MTVhZjY5OGNjNDIwZWZiYjZlL3RhYmxlOjE5ZWI1ODQ4OTE5MzQ4MjNiNGM3MDIzNjU4ZjZiZGQ4L3RhYmxlcmFuZ2U6MTllYjU4NDg5MTkzNDgyM2I0YzcwMjM2NThmNmJkZDhfNC03LTEtMS00ODE2NA_f13fd6df-ffb0-46d4-8fd2-a1f9e024b238" unitRef="usd"> 1000 </us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
<us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="i6534ba238d994a90a6ea2f8387180ed8_D20210401-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zMS9mcmFnOmVhOTkwNjc5MjQ2MTQ0MTVhZjY5OGNjNDIwZWZiYjZlL3RhYmxlOjE5ZWI1ODQ4OTE5MzQ4MjNiNGM3MDIzNjU4ZjZiZGQ4L3RhYmxlcmFuZ2U6MTllYjU4NDg5MTkzNDgyM2I0YzcwMjM2NThmNmJkZDhfNC0xMy0xLTEtNDgxNjQ_58eb610f-9d0c-4e65-9d75-86b776b2c394" unitRef="usd"> 158000 </us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
<us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="if2a6207b6732465a921fe019a2a0f048_D20210401-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zMS9mcmFnOmVhOTkwNjc5MjQ2MTQ0MTVhZjY5OGNjNDIwZWZiYjZlL3RhYmxlOjE5ZWI1ODQ4OTE5MzQ4MjNiNGM3MDIzNjU4ZjZiZGQ4L3RhYmxlcmFuZ2U6MTllYjU4NDg5MTkzNDgyM2I0YzcwMjM2NThmNmJkZDhfNC0yMS0xLTEtNDgxNjQ_45a98dd4-3c92-4deb-9115-037aad7d4ba8" unitRef="usd"> 159000 </us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
<us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities contextRef="ie9dea1cfa0a040fca270b1ad597208aa_D20210401-20210630" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zMS9mcmFnOmVhOTkwNjc5MjQ2MTQ0MTVhZjY5OGNjNDIwZWZiYjZlL3RhYmxlOjE5ZWI1ODQ4OTE5MzQ4MjNiNGM3MDIzNjU4ZjZiZGQ4L3RhYmxlcmFuZ2U6MTllYjU4NDg5MTkzNDgyM2I0YzcwMjM2NThmNmJkZDhfNi01LTEtMS00ODE2NA_3158c150-c236-43f0-8015-c0b033e13688" unitRef="shares"> 19051270 </us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
<us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities contextRef="ie9dea1cfa0a040fca270b1ad597208aa_D20210401-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zMS9mcmFnOmVhOTkwNjc5MjQ2MTQ0MTVhZjY5OGNjNDIwZWZiYjZlL3RhYmxlOjE5ZWI1ODQ4OTE5MzQ4MjNiNGM3MDIzNjU4ZjZiZGQ4L3RhYmxlcmFuZ2U6MTllYjU4NDg5MTkzNDgyM2I0YzcwMjM2NThmNmJkZDhfNi03LTEtMS00ODE2NA_8dd985dd-5d64-40f3-b599-40f9906d8a4e" unitRef="usd"> 190000 </us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
<us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities contextRef="i540203ee7d9442bea99bfbcbb845e88f_D20210401-20210630" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zMS9mcmFnOmVhOTkwNjc5MjQ2MTQ0MTVhZjY5OGNjNDIwZWZiYjZlL3RhYmxlOjE5ZWI1ODQ4OTE5MzQ4MjNiNGM3MDIzNjU4ZjZiZGQ4L3RhYmxlcmFuZ2U6MTllYjU4NDg5MTkzNDgyM2I0YzcwMjM2NThmNmJkZDhfNi05LTEtMS00ODE2NA_0dae9a83-83de-48ee-8835-791916af842c" unitRef="shares"> -8105175 </us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
<us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities contextRef="i6534ba238d994a90a6ea2f8387180ed8_D20210401-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zMS9mcmFnOmVhOTkwNjc5MjQ2MTQ0MTVhZjY5OGNjNDIwZWZiYjZlL3RhYmxlOjE5ZWI1ODQ4OTE5MzQ4MjNiNGM3MDIzNjU4ZjZiZGQ4L3RhYmxlcmFuZ2U6MTllYjU4NDg5MTkzNDgyM2I0YzcwMjM2NThmNmJkZDhfNi0xMy0xLTEtNDgxNjQ_3487a758-1223-4437-9716-eccc278558b5" unitRef="usd"> 55085000 </us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
<us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities contextRef="if2a6207b6732465a921fe019a2a0f048_D20210401-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zMS9mcmFnOmVhOTkwNjc5MjQ2MTQ0MTVhZjY5OGNjNDIwZWZiYjZlL3RhYmxlOjE5ZWI1ODQ4OTE5MzQ4MjNiNGM3MDIzNjU4ZjZiZGQ4L3RhYmxlcmFuZ2U6MTllYjU4NDg5MTkzNDgyM2I0YzcwMjM2NThmNmJkZDhfNi0yMS0xLTEtNDgxNjQ_262a4dad-9f74-42c9-a168-1fa62e7cb653" unitRef="usd"> 55275000 </us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
<us-gaap:NetIncomeLoss contextRef="icdc099a3a96e47fba17c75b489504342_D20210401-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zMS9mcmFnOmVhOTkwNjc5MjQ2MTQ0MTVhZjY5OGNjNDIwZWZiYjZlL3RhYmxlOjE5ZWI1ODQ4OTE5MzQ4MjNiNGM3MDIzNjU4ZjZiZGQ4L3RhYmxlcmFuZ2U6MTllYjU4NDg5MTkzNDgyM2I0YzcwMjM2NThmNmJkZDhfNy0xNy0xLTEtNDgxNjQ_26a334ea-3ae0-4005-b2a5-a5e9ef0db7f0" unitRef="usd"> -16186000 </us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="if2a6207b6732465a921fe019a2a0f048_D20210401-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zMS9mcmFnOmVhOTkwNjc5MjQ2MTQ0MTVhZjY5OGNjNDIwZWZiYjZlL3RhYmxlOjE5ZWI1ODQ4OTE5MzQ4MjNiNGM3MDIzNjU4ZjZiZGQ4L3RhYmxlcmFuZ2U6MTllYjU4NDg5MTkzNDgyM2I0YzcwMjM2NThmNmJkZDhfNy0yMS0xLTEtNDgxNjQ_e803468c-ae14-4679-90a9-594eb3ebb93a" unitRef="usd"> -16186000 </us-gaap:NetIncomeLoss>
<us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="i0099598db9a54ff2be5a195f8bc7fafc_D20210401-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zMS9mcmFnOmVhOTkwNjc5MjQ2MTQ0MTVhZjY5OGNjNDIwZWZiYjZlL3RhYmxlOjE5ZWI1ODQ4OTE5MzQ4MjNiNGM3MDIzNjU4ZjZiZGQ4L3RhYmxlcmFuZ2U6MTllYjU4NDg5MTkzNDgyM2I0YzcwMjM2NThmNmJkZDhfOC0xNS0xLTEtNDgxNjQ_fced32f7-2308-4545-a549-7774e8ec1ec7" unitRef="usd"> 3363000 </us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
<us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="if2a6207b6732465a921fe019a2a0f048_D20210401-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zMS9mcmFnOmVhOTkwNjc5MjQ2MTQ0MTVhZjY5OGNjNDIwZWZiYjZlL3RhYmxlOjE5ZWI1ODQ4OTE5MzQ4MjNiNGM3MDIzNjU4ZjZiZGQ4L3RhYmxlcmFuZ2U6MTllYjU4NDg5MTkzNDgyM2I0YzcwMjM2NThmNmJkZDhfOC0yMS0xLTEtNDgxNjQ_2d5b55a7-8736-4881-8db7-f75ddbbcb6a3" unitRef="usd"> 3363000 </us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
<us-gaap:CommonStockSharesOutstanding contextRef="i03e9eec1af7a46b5b2a8d119f418c07a_I20210630" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zMS9mcmFnOmVhOTkwNjc5MjQ2MTQ0MTVhZjY5OGNjNDIwZWZiYjZlL3RhYmxlOjE5ZWI1ODQ4OTE5MzQ4MjNiNGM3MDIzNjU4ZjZiZGQ4L3RhYmxlcmFuZ2U6MTllYjU4NDg5MTkzNDgyM2I0YzcwMjM2NThmNmJkZDhfOS01LTEtMS00ODE2NA_0e9db366-5eb1-42d4-adf4-ee0bca0be13f" unitRef="shares"> 689817971 </us-gaap:CommonStockSharesOutstanding>
<us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="i03e9eec1af7a46b5b2a8d119f418c07a_I20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zMS9mcmFnOmVhOTkwNjc5MjQ2MTQ0MTVhZjY5OGNjNDIwZWZiYjZlL3RhYmxlOjE5ZWI1ODQ4OTE5MzQ4MjNiNGM3MDIzNjU4ZjZiZGQ4L3RhYmxlcmFuZ2U6MTllYjU4NDg5MTkzNDgyM2I0YzcwMjM2NThmNmJkZDhfOS03LTEtMS00ODE2NA_fba5f099-6e69-49f4-9878-a1641dfdde9d" unitRef="usd"> 6898000 </us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
<us-gaap:TreasuryStockCommonShares contextRef="icf579a7819844358809a652fbc83e308_I20210630" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zMS9mcmFnOmVhOTkwNjc5MjQ2MTQ0MTVhZjY5OGNjNDIwZWZiYjZlL3RhYmxlOjE5ZWI1ODQ4OTE5MzQ4MjNiNGM3MDIzNjU4ZjZiZGQ4L3RhYmxlcmFuZ2U6MTllYjU4NDg5MTkzNDgyM2I0YzcwMjM2NThmNmJkZDhfOS05LTEtMS00ODE2NA_20993d0f-3bfc-457a-902e-8547da9bd667" unitRef="shares"> 8655082 </us-gaap:TreasuryStockCommonShares>
<us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="icf579a7819844358809a652fbc83e308_I20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zMS9mcmFnOmVhOTkwNjc5MjQ2MTQ0MTVhZjY5OGNjNDIwZWZiYjZlL3RhYmxlOjE5ZWI1ODQ4OTE5MzQ4MjNiNGM3MDIzNjU4ZjZiZGQ4L3RhYmxlcmFuZ2U6MTllYjU4NDg5MTkzNDgyM2I0YzcwMjM2NThmNmJkZDhfOS0xMS0xLTEtNDgxNjQ_a8831157-9039-45b5-b674-0430d2b6fa45" unitRef="usd"> -1791000 </us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
<us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="i4d00d14adfc9448eb9e40866c713eb77_I20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zMS9mcmFnOmVhOTkwNjc5MjQ2MTQ0MTVhZjY5OGNjNDIwZWZiYjZlL3RhYmxlOjE5ZWI1ODQ4OTE5MzQ4MjNiNGM3MDIzNjU4ZjZiZGQ4L3RhYmxlcmFuZ2U6MTllYjU4NDg5MTkzNDgyM2I0YzcwMjM2NThmNmJkZDhfOS0xMy0xLTEtNDgxNjQ_82865120-c535-4223-bb0b-b671189e0ff3" unitRef="usd"> 3214351000 </us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
<us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="i0c9b6e37c03b4ddab0b2471c8b70170a_I20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zMS9mcmFnOmVhOTkwNjc5MjQ2MTQ0MTVhZjY5OGNjNDIwZWZiYjZlL3RhYmxlOjE5ZWI1ODQ4OTE5MzQ4MjNiNGM3MDIzNjU4ZjZiZGQ4L3RhYmxlcmFuZ2U6MTllYjU4NDg5MTkzNDgyM2I0YzcwMjM2NThmNmJkZDhfOS0xNS0xLTEtNDgxNjQ_c8394b3e-34f1-42f1-8e11-aceff4f762a4" unitRef="usd"> -9932000 </us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
<us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="i7ca34897162343b08c9c9b25987fec26_I20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zMS9mcmFnOmVhOTkwNjc5MjQ2MTQ0MTVhZjY5OGNjNDIwZWZiYjZlL3RhYmxlOjE5ZWI1ODQ4OTE5MzQ4MjNiNGM3MDIzNjU4ZjZiZGQ4L3RhYmxlcmFuZ2U6MTllYjU4NDg5MTkzNDgyM2I0YzcwMjM2NThmNmJkZDhfOS0xNy0xLTEtNDgxNjQ_1f808bbc-9c62-4aed-9474-d141ff2ea43d" unitRef="usd"> -1466941000 </us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
<us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="i724677ce94b849699e6f5d548e33e1c7_I20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zMS9mcmFnOmVhOTkwNjc5MjQ2MTQ0MTVhZjY5OGNjNDIwZWZiYjZlL3RhYmxlOjE5ZWI1ODQ4OTE5MzQ4MjNiNGM3MDIzNjU4ZjZiZGQ4L3RhYmxlcmFuZ2U6MTllYjU4NDg5MTkzNDgyM2I0YzcwMjM2NThmNmJkZDhfOS0yMS0xLTEtNDgxNjQ_6ae737c4-d859-4b99-b411-9d2d5702bf6a" unitRef="usd"> 1742585000 </us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
<us-gaap:CommonStockSharesOutstanding contextRef="ide0454f45282433aa644418ea11e2575_I20201231" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zMS9mcmFnOmVhOTkwNjc5MjQ2MTQ0MTVhZjY5OGNjNDIwZWZiYjZlL3RhYmxlOjZjZjgwN2U4NjVlNTQ0ZDJiY2EyNzM2NjQ1MmU5MWU1L3RhYmxlcmFuZ2U6NmNmODA3ZTg2NWU1NDRkMmJjYTI3MzY2NDUyZTkxZTVfMi01LTEtMS00ODMxNw_d0dff2af-9810-4193-9f1c-b7c8d900a9e5" unitRef="shares"> 670585576 </us-gaap:CommonStockSharesOutstanding>
<us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="ide0454f45282433aa644418ea11e2575_I20201231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zMS9mcmFnOmVhOTkwNjc5MjQ2MTQ0MTVhZjY5OGNjNDIwZWZiYjZlL3RhYmxlOjZjZjgwN2U4NjVlNTQ0ZDJiY2EyNzM2NjQ1MmU5MWU1L3RhYmxlcmFuZ2U6NmNmODA3ZTg2NWU1NDRkMmJjYTI3MzY2NDUyZTkxZTVfMi03LTEtMS00ODMxNw_e0fdbb32-12f3-4081-9d36-7f35a702ea9d" unitRef="usd"> 6706000 </us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
<us-gaap:TreasuryStockCommonShares contextRef="iee4648dd0f8f48e3aa02b39beacbac0d_I20201231" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zMS9mcmFnOmVhOTkwNjc5MjQ2MTQ0MTVhZjY5OGNjNDIwZWZiYjZlL3RhYmxlOjZjZjgwN2U4NjVlNTQ0ZDJiY2EyNzM2NjQ1MmU5MWU1L3RhYmxlcmFuZ2U6NmNmODA3ZTg2NWU1NDRkMmJjYTI3MzY2NDUyZTkxZTVfMi05LTEtMS00ODMxNw_3ddd8669-89c8-472c-b45f-f92a0614ff4c" unitRef="shares"> 549907 </us-gaap:TreasuryStockCommonShares>
<us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="iee4648dd0f8f48e3aa02b39beacbac0d_I20201231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zMS9mcmFnOmVhOTkwNjc5MjQ2MTQ0MTVhZjY5OGNjNDIwZWZiYjZlL3RhYmxlOjZjZjgwN2U4NjVlNTQ0ZDJiY2EyNzM2NjQ1MmU5MWU1L3RhYmxlcmFuZ2U6NmNmODA3ZTg2NWU1NDRkMmJjYTI3MzY2NDUyZTkxZTVfMi0xMS0xLTEtNDgzMTc_0ed4993f-4b28-4e45-b8ca-04dc9dcdbbad" unitRef="usd"> -1791000 </us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
<us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="idec58d7abdf042679d88f31b2a910419_I20201231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zMS9mcmFnOmVhOTkwNjc5MjQ2MTQ0MTVhZjY5OGNjNDIwZWZiYjZlL3RhYmxlOjZjZjgwN2U4NjVlNTQ0ZDJiY2EyNzM2NjQ1MmU5MWU1L3RhYmxlcmFuZ2U6NmNmODA3ZTg2NWU1NDRkMmJjYTI3MzY2NDUyZTkxZTVfMi0xMy0xLTEtNDgzMTc_9200cb39-a254-4b7a-a15d-9aa6526c362a" unitRef="usd"> 3152694000 </us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
<us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="i96ef84d006064e0e82ea3344fe36540e_I20201231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zMS9mcmFnOmVhOTkwNjc5MjQ2MTQ0MTVhZjY5OGNjNDIwZWZiYjZlL3RhYmxlOjZjZjgwN2U4NjVlNTQ0ZDJiY2EyNzM2NjQ1MmU5MWU1L3RhYmxlcmFuZ2U6NmNmODA3ZTg2NWU1NDRkMmJjYTI3MzY2NDUyZTkxZTVfMi0xNS0xLTEtNDgzMTc_5fb26dd4-9a44-4abd-9edb-fdf6c5f2c0fc" unitRef="usd"> -4225000 </us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
<us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="i720743b66e81454d8b52b679ad4ee1c3_I20201231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zMS9mcmFnOmVhOTkwNjc5MjQ2MTQ0MTVhZjY5OGNjNDIwZWZiYjZlL3RhYmxlOjZjZjgwN2U4NjVlNTQ0ZDJiY2EyNzM2NjQ1MmU5MWU1L3RhYmxlcmFuZ2U6NmNmODA3ZTg2NWU1NDRkMmJjYTI3MzY2NDUyZTkxZTVfMi0xNy0xLTEtNDgzMTc_bcee4fbd-0464-470a-9df0-b303cbb738a5" unitRef="usd"> -1481833000 </us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
<us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="if51f06301fcf486db26eb226e027928f_I20201231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zMS9mcmFnOmVhOTkwNjc5MjQ2MTQ0MTVhZjY5OGNjNDIwZWZiYjZlL3RhYmxlOjZjZjgwN2U4NjVlNTQ0ZDJiY2EyNzM2NjQ1MmU5MWU1L3RhYmxlcmFuZ2U6NmNmODA3ZTg2NWU1NDRkMmJjYTI3MzY2NDUyZTkxZTVfMi0yMS0xLTEtNDgzMTc_a3f29d8b-d24d-4a0b-9182-04ef70154517" unitRef="usd"> 1671551000 </us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
<us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="ia2e25bc253ba4254b83e569ae311af76_D20210101-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zMS9mcmFnOmVhOTkwNjc5MjQ2MTQ0MTVhZjY5OGNjNDIwZWZiYjZlL3RhYmxlOjZjZjgwN2U4NjVlNTQ0ZDJiY2EyNzM2NjQ1MmU5MWU1L3RhYmxlcmFuZ2U6NmNmODA3ZTg2NWU1NDRkMmJjYTI3MzY2NDUyZTkxZTVfMy0xMy0xLTEtNDgzMTc_5aac10e3-3fb3-48d1-86fe-81079058e777" unitRef="usd"> 6107000 </us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
<us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="i420e18e30084498a98510d48880063cd_D20210101-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zMS9mcmFnOmVhOTkwNjc5MjQ2MTQ0MTVhZjY5OGNjNDIwZWZiYjZlL3RhYmxlOjZjZjgwN2U4NjVlNTQ0ZDJiY2EyNzM2NjQ1MmU5MWU1L3RhYmxlcmFuZ2U6NmNmODA3ZTg2NWU1NDRkMmJjYTI3MzY2NDUyZTkxZTVfMy0yMS0xLTEtNDgzMTc_96557361-bffa-4749-a462-c7e130ceb7a8" unitRef="usd"> 6107000 </us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
<us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="i526a0f2934a64759b86957f5ac4057e7_D20210101-20210630" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zMS9mcmFnOmVhOTkwNjc5MjQ2MTQ0MTVhZjY5OGNjNDIwZWZiYjZlL3RhYmxlOjZjZjgwN2U4NjVlNTQ0ZDJiY2EyNzM2NjQ1MmU5MWU1L3RhYmxlcmFuZ2U6NmNmODA3ZTg2NWU1NDRkMmJjYTI3MzY2NDUyZTkxZTVfNC01LTEtMS00ODMxNw_dbcd180b-e8ed-4bdc-bfcb-c044c7e15257" unitRef="shares"> 181125 </us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
<us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="i526a0f2934a64759b86957f5ac4057e7_D20210101-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zMS9mcmFnOmVhOTkwNjc5MjQ2MTQ0MTVhZjY5OGNjNDIwZWZiYjZlL3RhYmxlOjZjZjgwN2U4NjVlNTQ0ZDJiY2EyNzM2NjQ1MmU5MWU1L3RhYmxlcmFuZ2U6NmNmODA3ZTg2NWU1NDRkMmJjYTI3MzY2NDUyZTkxZTVfNC03LTEtMS00ODMxNw_f9597066-d157-4419-8f8d-c9692eb381bf" unitRef="usd"> 2000 </us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
<us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="ia2e25bc253ba4254b83e569ae311af76_D20210101-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zMS9mcmFnOmVhOTkwNjc5MjQ2MTQ0MTVhZjY5OGNjNDIwZWZiYjZlL3RhYmxlOjZjZjgwN2U4NjVlNTQ0ZDJiY2EyNzM2NjQ1MmU5MWU1L3RhYmxlcmFuZ2U6NmNmODA3ZTg2NWU1NDRkMmJjYTI3MzY2NDUyZTkxZTVfNC0xMy0xLTEtNDgzMTc_1c425067-6c8f-4dac-af41-83194d4ac280" unitRef="usd"> 465000 </us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
<us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="i420e18e30084498a98510d48880063cd_D20210101-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zMS9mcmFnOmVhOTkwNjc5MjQ2MTQ0MTVhZjY5OGNjNDIwZWZiYjZlL3RhYmxlOjZjZjgwN2U4NjVlNTQ0ZDJiY2EyNzM2NjQ1MmU5MWU1L3RhYmxlcmFuZ2U6NmNmODA3ZTg2NWU1NDRkMmJjYTI3MzY2NDUyZTkxZTVfNC0yMS0xLTEtNDgzMTc_d51e26c4-2de0-4e81-aa8e-d138cf1f2382" unitRef="usd"> 467000 </us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
<us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities contextRef="i526a0f2934a64759b86957f5ac4057e7_D20210101-20210630" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zMS9mcmFnOmVhOTkwNjc5MjQ2MTQ0MTVhZjY5OGNjNDIwZWZiYjZlL3RhYmxlOjZjZjgwN2U4NjVlNTQ0ZDJiY2EyNzM2NjQ1MmU5MWU1L3RhYmxlcmFuZ2U6NmNmODA3ZTg2NWU1NDRkMmJjYTI3MzY2NDUyZTkxZTVfNi01LTEtMS00ODMxNw_878a1cc2-03e2-42fb-bc21-03d2fce756c0" unitRef="shares"> 19051270 </us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
<us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities contextRef="i526a0f2934a64759b86957f5ac4057e7_D20210101-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zMS9mcmFnOmVhOTkwNjc5MjQ2MTQ0MTVhZjY5OGNjNDIwZWZiYjZlL3RhYmxlOjZjZjgwN2U4NjVlNTQ0ZDJiY2EyNzM2NjQ1MmU5MWU1L3RhYmxlcmFuZ2U6NmNmODA3ZTg2NWU1NDRkMmJjYTI3MzY2NDUyZTkxZTVfNi03LTEtMS00ODMxNw_139862d1-eaf5-4079-84f7-7bf250e539b9" unitRef="usd"> 190000 </us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
<us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities contextRef="ibf1ef60ea3774e0482c1fc882047daa5_D20210101-20210630" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zMS9mcmFnOmVhOTkwNjc5MjQ2MTQ0MTVhZjY5OGNjNDIwZWZiYjZlL3RhYmxlOjZjZjgwN2U4NjVlNTQ0ZDJiY2EyNzM2NjQ1MmU5MWU1L3RhYmxlcmFuZ2U6NmNmODA3ZTg2NWU1NDRkMmJjYTI3MzY2NDUyZTkxZTVfNi05LTEtMS00ODMxNw_e0d3034d-471d-4aae-b10b-50ce0ea85e6f" unitRef="shares"> -8105175 </us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
<us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities contextRef="ia2e25bc253ba4254b83e569ae311af76_D20210101-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zMS9mcmFnOmVhOTkwNjc5MjQ2MTQ0MTVhZjY5OGNjNDIwZWZiYjZlL3RhYmxlOjZjZjgwN2U4NjVlNTQ0ZDJiY2EyNzM2NjQ1MmU5MWU1L3RhYmxlcmFuZ2U6NmNmODA3ZTg2NWU1NDRkMmJjYTI3MzY2NDUyZTkxZTVfNi0xMy0xLTEtNDgzMTc_304dd8b6-43be-452e-90d0-c094db03339a" unitRef="usd"> 55085000 </us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
<us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities contextRef="i420e18e30084498a98510d48880063cd_D20210101-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zMS9mcmFnOmVhOTkwNjc5MjQ2MTQ0MTVhZjY5OGNjNDIwZWZiYjZlL3RhYmxlOjZjZjgwN2U4NjVlNTQ0ZDJiY2EyNzM2NjQ1MmU5MWU1L3RhYmxlcmFuZ2U6NmNmODA3ZTg2NWU1NDRkMmJjYTI3MzY2NDUyZTkxZTVfNi0yMS0xLTEtNDgzMTc_46134ed6-b0af-49aa-baad-67de482d217c" unitRef="usd"> 55275000 </us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
<us-gaap:NetIncomeLoss contextRef="i3b4c93677d4045f4aab1f7094a56e88f_D20210101-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zMS9mcmFnOmVhOTkwNjc5MjQ2MTQ0MTVhZjY5OGNjNDIwZWZiYjZlL3RhYmxlOjZjZjgwN2U4NjVlNTQ0ZDJiY2EyNzM2NjQ1MmU5MWU1L3RhYmxlcmFuZ2U6NmNmODA3ZTg2NWU1NDRkMmJjYTI3MzY2NDUyZTkxZTVfNy0xNy0xLTEtNDgzMTc_1f6fbf1a-85c4-411c-a643-0ab1b544db35" unitRef="usd"> 14892000 </us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="i420e18e30084498a98510d48880063cd_D20210101-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zMS9mcmFnOmVhOTkwNjc5MjQ2MTQ0MTVhZjY5OGNjNDIwZWZiYjZlL3RhYmxlOjZjZjgwN2U4NjVlNTQ0ZDJiY2EyNzM2NjQ1MmU5MWU1L3RhYmxlcmFuZ2U6NmNmODA3ZTg2NWU1NDRkMmJjYTI3MzY2NDUyZTkxZTVfNy0yMS0xLTEtNDgzMTc_10a0b2a5-5f08-4145-8296-cad5d1c8430a" unitRef="usd"> 14892000 </us-gaap:NetIncomeLoss>
<us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="i2f1219e2e5e14486b523df300416bca8_D20210101-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zMS9mcmFnOmVhOTkwNjc5MjQ2MTQ0MTVhZjY5OGNjNDIwZWZiYjZlL3RhYmxlOjZjZjgwN2U4NjVlNTQ0ZDJiY2EyNzM2NjQ1MmU5MWU1L3RhYmxlcmFuZ2U6NmNmODA3ZTg2NWU1NDRkMmJjYTI3MzY2NDUyZTkxZTVfOC0xNS0xLTEtNDgzMTc_d8823d0a-bd0a-4e38-b3a2-b6e0be4828c0" unitRef="usd"> -5707000 </us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
<us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="i420e18e30084498a98510d48880063cd_D20210101-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zMS9mcmFnOmVhOTkwNjc5MjQ2MTQ0MTVhZjY5OGNjNDIwZWZiYjZlL3RhYmxlOjZjZjgwN2U4NjVlNTQ0ZDJiY2EyNzM2NjQ1MmU5MWU1L3RhYmxlcmFuZ2U6NmNmODA3ZTg2NWU1NDRkMmJjYTI3MzY2NDUyZTkxZTVfOC0yMS0xLTEtNDgzMTc_6f9e3567-df3d-4aa6-be5f-48e928e9d513" unitRef="usd"> -5707000 </us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
<us-gaap:CommonStockSharesOutstanding contextRef="i03e9eec1af7a46b5b2a8d119f418c07a_I20210630" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zMS9mcmFnOmVhOTkwNjc5MjQ2MTQ0MTVhZjY5OGNjNDIwZWZiYjZlL3RhYmxlOjZjZjgwN2U4NjVlNTQ0ZDJiY2EyNzM2NjQ1MmU5MWU1L3RhYmxlcmFuZ2U6NmNmODA3ZTg2NWU1NDRkMmJjYTI3MzY2NDUyZTkxZTVfOS01LTEtMS00ODMxNw_4592227e-50e1-41bc-a19e-e66bf5cabfda" unitRef="shares"> 689817971 </us-gaap:CommonStockSharesOutstanding>
<us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="i03e9eec1af7a46b5b2a8d119f418c07a_I20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zMS9mcmFnOmVhOTkwNjc5MjQ2MTQ0MTVhZjY5OGNjNDIwZWZiYjZlL3RhYmxlOjZjZjgwN2U4NjVlNTQ0ZDJiY2EyNzM2NjQ1MmU5MWU1L3RhYmxlcmFuZ2U6NmNmODA3ZTg2NWU1NDRkMmJjYTI3MzY2NDUyZTkxZTVfOS03LTEtMS00ODMxNw_e087e8e7-2156-4d32-9b44-5288c9826a46" unitRef="usd"> 6898000 </us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
<us-gaap:TreasuryStockCommonShares contextRef="icf579a7819844358809a652fbc83e308_I20210630" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zMS9mcmFnOmVhOTkwNjc5MjQ2MTQ0MTVhZjY5OGNjNDIwZWZiYjZlL3RhYmxlOjZjZjgwN2U4NjVlNTQ0ZDJiY2EyNzM2NjQ1MmU5MWU1L3RhYmxlcmFuZ2U6NmNmODA3ZTg2NWU1NDRkMmJjYTI3MzY2NDUyZTkxZTVfOS05LTEtMS00ODMxNw_b74afa74-bafa-4e8e-86c5-c24a00cf4c42" unitRef="shares"> 8655082 </us-gaap:TreasuryStockCommonShares>
<us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="icf579a7819844358809a652fbc83e308_I20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zMS9mcmFnOmVhOTkwNjc5MjQ2MTQ0MTVhZjY5OGNjNDIwZWZiYjZlL3RhYmxlOjZjZjgwN2U4NjVlNTQ0ZDJiY2EyNzM2NjQ1MmU5MWU1L3RhYmxlcmFuZ2U6NmNmODA3ZTg2NWU1NDRkMmJjYTI3MzY2NDUyZTkxZTVfOS0xMS0xLTEtNDgzMTc_f2a912cb-c7b7-483c-b2de-f8aca471ec72" unitRef="usd"> -1791000 </us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
<us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="i4d00d14adfc9448eb9e40866c713eb77_I20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zMS9mcmFnOmVhOTkwNjc5MjQ2MTQ0MTVhZjY5OGNjNDIwZWZiYjZlL3RhYmxlOjZjZjgwN2U4NjVlNTQ0ZDJiY2EyNzM2NjQ1MmU5MWU1L3RhYmxlcmFuZ2U6NmNmODA3ZTg2NWU1NDRkMmJjYTI3MzY2NDUyZTkxZTVfOS0xMy0xLTEtNDgzMTc_917fa3a9-2ba3-4ac6-bcd3-5acb970f2015" unitRef="usd"> 3214351000 </us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
<us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="i0c9b6e37c03b4ddab0b2471c8b70170a_I20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zMS9mcmFnOmVhOTkwNjc5MjQ2MTQ0MTVhZjY5OGNjNDIwZWZiYjZlL3RhYmxlOjZjZjgwN2U4NjVlNTQ0ZDJiY2EyNzM2NjQ1MmU5MWU1L3RhYmxlcmFuZ2U6NmNmODA3ZTg2NWU1NDRkMmJjYTI3MzY2NDUyZTkxZTVfOS0xNS0xLTEtNDgzMTc_8663ba37-7bcd-4431-bf96-8b067201f489" unitRef="usd"> -9932000 </us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
<us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="i7ca34897162343b08c9c9b25987fec26_I20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zMS9mcmFnOmVhOTkwNjc5MjQ2MTQ0MTVhZjY5OGNjNDIwZWZiYjZlL3RhYmxlOjZjZjgwN2U4NjVlNTQ0ZDJiY2EyNzM2NjQ1MmU5MWU1L3RhYmxlcmFuZ2U6NmNmODA3ZTg2NWU1NDRkMmJjYTI3MzY2NDUyZTkxZTVfOS0xNy0xLTEtNDgzMTc_25307576-3ff0-48f8-89e9-320ea03919c0" unitRef="usd"> -1466941000 </us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
<us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="i724677ce94b849699e6f5d548e33e1c7_I20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zMS9mcmFnOmVhOTkwNjc5MjQ2MTQ0MTVhZjY5OGNjNDIwZWZiYjZlL3RhYmxlOjZjZjgwN2U4NjVlNTQ0ZDJiY2EyNzM2NjQ1MmU5MWU1L3RhYmxlcmFuZ2U6NmNmODA3ZTg2NWU1NDRkMmJjYTI3MzY2NDUyZTkxZTVfOS0yMS0xLTEtNDgzMTc_3415ab76-b08b-4e83-b1d4-bf061045bfc7" unitRef="usd"> 1742585000 </us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
<us-gaap:NetIncomeLoss contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zNC9mcmFnOmI4NjIzMGRmZGUzNjQ0OThiOTY5MDg1ZmY4MTZlNjc1L3RhYmxlOjQ1NDBiNWI4YjhlZTQ3Mjc4Yjc5NzJkY2ZhMDM5OWU2L3RhYmxlcmFuZ2U6NDU0MGI1YjhiOGVlNDcyNzhiNzk3MmRjZmEwMzk5ZTZfMy0xLTEtMS00ODE2NA_06d122d6-4ee4-402e-bf87-9e4482782922" unitRef="usd"> -157083000 </us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="i420e18e30084498a98510d48880063cd_D20210101-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zNC9mcmFnOmI4NjIzMGRmZGUzNjQ0OThiOTY5MDg1ZmY4MTZlNjc1L3RhYmxlOjQ1NDBiNWI4YjhlZTQ3Mjc4Yjc5NzJkY2ZhMDM5OWU2L3RhYmxlcmFuZ2U6NDU0MGI1YjhiOGVlNDcyNzhiNzk3MmRjZmEwMzk5ZTZfMy0zLTEtMS00ODE2NA_b15173ea-5688-4689-9e6e-ae492ec087df" unitRef="usd"> 14892000 </us-gaap:NetIncomeLoss>
<us-gaap:DepreciationDepletionAndAmortization contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zNC9mcmFnOmI4NjIzMGRmZGUzNjQ0OThiOTY5MDg1ZmY4MTZlNjc1L3RhYmxlOjQ1NDBiNWI4YjhlZTQ3Mjc4Yjc5NzJkY2ZhMDM5OWU2L3RhYmxlcmFuZ2U6NDU0MGI1YjhiOGVlNDcyNzhiNzk3MmRjZmEwMzk5ZTZfNi0xLTEtMS00ODE2NA_529d1a9a-5e4a-44b2-a793-ce2ed4d05199" unitRef="usd"> 55809000 </us-gaap:DepreciationDepletionAndAmortization>
<us-gaap:DepreciationDepletionAndAmortization contextRef="i420e18e30084498a98510d48880063cd_D20210101-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zNC9mcmFnOmI4NjIzMGRmZGUzNjQ0OThiOTY5MDg1ZmY4MTZlNjc1L3RhYmxlOjQ1NDBiNWI4YjhlZTQ3Mjc4Yjc5NzJkY2ZhMDM5OWU2L3RhYmxlcmFuZ2U6NDU0MGI1YjhiOGVlNDcyNzhiNzk3MmRjZmEwMzk5ZTZfNi0zLTEtMS00ODE2NA_8cf54c57-5f21-4f11-83e7-16377b147c0c" unitRef="usd"> 40561000 </us-gaap:DepreciationDepletionAndAmortization>
<us-gaap:PaidInKindInterest contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zNC9mcmFnOmI4NjIzMGRmZGUzNjQ0OThiOTY5MDg1ZmY4MTZlNjc1L3RhYmxlOjQ1NDBiNWI4YjhlZTQ3Mjc4Yjc5NzJkY2ZhMDM5OWU2L3RhYmxlcmFuZ2U6NDU0MGI1YjhiOGVlNDcyNzhiNzk3MmRjZmEwMzk5ZTZfNy0xLTEtMS00ODE2NA_77f67df2-4c68-4ea7-ac3f-5d5968ec6af4" unitRef="usd"> 1364000 </us-gaap:PaidInKindInterest>
<us-gaap:PaidInKindInterest contextRef="i420e18e30084498a98510d48880063cd_D20210101-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zNC9mcmFnOmI4NjIzMGRmZGUzNjQ0OThiOTY5MDg1ZmY4MTZlNjc1L3RhYmxlOjQ1NDBiNWI4YjhlZTQ3Mjc4Yjc5NzJkY2ZhMDM5OWU2L3RhYmxlcmFuZ2U6NDU0MGI1YjhiOGVlNDcyNzhiNzk3MmRjZmEwMzk5ZTZfNy0zLTEtMS00ODE2NA_62dc8dbb-857f-4187-84de-8f36b1092538" unitRef="usd"> 4981000 </us-gaap:PaidInKindInterest>
<us-gaap:AmortizationOfFinancingCosts contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zNC9mcmFnOmI4NjIzMGRmZGUzNjQ0OThiOTY5MDg1ZmY4MTZlNjc1L3RhYmxlOjQ1NDBiNWI4YjhlZTQ3Mjc4Yjc5NzJkY2ZhMDM5OWU2L3RhYmxlcmFuZ2U6NDU0MGI1YjhiOGVlNDcyNzhiNzk3MmRjZmEwMzk5ZTZfOC0xLTEtMS00ODE2NA_5bcdd819-9055-45ee-b587-2ef15bc5070e" unitRef="usd"> 569000 </us-gaap:AmortizationOfFinancingCosts>
<us-gaap:AmortizationOfFinancingCosts contextRef="i420e18e30084498a98510d48880063cd_D20210101-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zNC9mcmFnOmI4NjIzMGRmZGUzNjQ0OThiOTY5MDg1ZmY4MTZlNjc1L3RhYmxlOjQ1NDBiNWI4YjhlZTQ3Mjc4Yjc5NzJkY2ZhMDM5OWU2L3RhYmxlcmFuZ2U6NDU0MGI1YjhiOGVlNDcyNzhiNzk3MmRjZmEwMzk5ZTZfOC0zLTEtMS00ODE2NA_c3f97dd2-9cea-4f26-847e-4e7059ffd331" unitRef="usd"> 424000 </us-gaap:AmortizationOfFinancingCosts>
<us-gaap:IncomeLossFromEquityMethodInvestments contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zNC9mcmFnOmI4NjIzMGRmZGUzNjQ0OThiOTY5MDg1ZmY4MTZlNjc1L3RhYmxlOjQ1NDBiNWI4YjhlZTQ3Mjc4Yjc5NzJkY2ZhMDM5OWU2L3RhYmxlcmFuZ2U6NDU0MGI1YjhiOGVlNDcyNzhiNzk3MmRjZmEwMzk5ZTZfMTAtMS0xLTEtNDgxNjQ_68a647a2-3d06-4095-bef1-01a2983c7cb2" unitRef="usd"> -316000 </us-gaap:IncomeLossFromEquityMethodInvestments>
<us-gaap:IncomeLossFromEquityMethodInvestments contextRef="i420e18e30084498a98510d48880063cd_D20210101-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zNC9mcmFnOmI4NjIzMGRmZGUzNjQ0OThiOTY5MDg1ZmY4MTZlNjc1L3RhYmxlOjQ1NDBiNWI4YjhlZTQ3Mjc4Yjc5NzJkY2ZhMDM5OWU2L3RhYmxlcmFuZ2U6NDU0MGI1YjhiOGVlNDcyNzhiNzk3MmRjZmEwMzk5ZTZfMTAtMy0xLTEtNDgxNjQ_bee70635-5c83-471b-a630-95042603ad66" unitRef="usd"> -110000 </us-gaap:IncomeLossFromEquityMethodInvestments>
<us-gaap:ShareBasedCompensation contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zNC9mcmFnOmI4NjIzMGRmZGUzNjQ0OThiOTY5MDg1ZmY4MTZlNjc1L3RhYmxlOjQ1NDBiNWI4YjhlZTQ3Mjc4Yjc5NzJkY2ZhMDM5OWU2L3RhYmxlcmFuZ2U6NDU0MGI1YjhiOGVlNDcyNzhiNzk3MmRjZmEwMzk5ZTZfMTEtMS0xLTEtNDgxNjQ_a36ed481-fde5-4269-95c9-c7c4a380a4dd" unitRef="usd"> 11925000 </us-gaap:ShareBasedCompensation>
<us-gaap:ShareBasedCompensation contextRef="i420e18e30084498a98510d48880063cd_D20210101-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zNC9mcmFnOmI4NjIzMGRmZGUzNjQ0OThiOTY5MDg1ZmY4MTZlNjc1L3RhYmxlOjQ1NDBiNWI4YjhlZTQ3Mjc4Yjc5NzJkY2ZhMDM5OWU2L3RhYmxlcmFuZ2U6NDU0MGI1YjhiOGVlNDcyNzhiNzk3MmRjZmEwMzk5ZTZfMTEtMy0xLTEtNDgxNjQ_5d6a578f-c40b-4098-a89d-8ef55c11984a" unitRef="usd"> 6107000 </us-gaap:ShareBasedCompensation>
<us-gaap:GainLossOnDispositionOfAssets1 contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zNC9mcmFnOmI4NjIzMGRmZGUzNjQ0OThiOTY5MDg1ZmY4MTZlNjc1L3RhYmxlOjQ1NDBiNWI4YjhlZTQ3Mjc4Yjc5NzJkY2ZhMDM5OWU2L3RhYmxlcmFuZ2U6NDU0MGI1YjhiOGVlNDcyNzhiNzk3MmRjZmEwMzk5ZTZfMTUtMS0xLTEtNDgxNjQ_83112d51-0d25-4077-953a-897e1d354473" unitRef="usd"> 477000 </us-gaap:GainLossOnDispositionOfAssets1>
<us-gaap:GainLossOnDispositionOfAssets1 contextRef="i420e18e30084498a98510d48880063cd_D20210101-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zNC9mcmFnOmI4NjIzMGRmZGUzNjQ0OThiOTY5MDg1ZmY4MTZlNjc1L3RhYmxlOjQ1NDBiNWI4YjhlZTQ3Mjc4Yjc5NzJkY2ZhMDM5OWU2L3RhYmxlcmFuZ2U6NDU0MGI1YjhiOGVlNDcyNzhiNzk3MmRjZmEwMzk5ZTZfMTUtMy0xLTEtNDgxNjQ_44704bed-db54-4c45-b6d7-feabbb3395bb" unitRef="usd"> 3146000 </us-gaap:GainLossOnDispositionOfAssets1>
<opk:GainLossOnConversionOfDebt contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zNC9mcmFnOmI4NjIzMGRmZGUzNjQ0OThiOTY5MDg1ZmY4MTZlNjc1L3RhYmxlOjQ1NDBiNWI4YjhlZTQ3Mjc4Yjc5NzJkY2ZhMDM5OWU2L3RhYmxlcmFuZ2U6NDU0MGI1YjhiOGVlNDcyNzhiNzk3MmRjZmEwMzk5ZTZfMTYtMS0xLTEtNDgxNjQ_a3016f01-182d-42b8-a14a-a7df4711300a" unitRef="usd"> 0 </opk:GainLossOnConversionOfDebt>
<opk:GainLossOnConversionOfDebt contextRef="i420e18e30084498a98510d48880063cd_D20210101-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zNC9mcmFnOmI4NjIzMGRmZGUzNjQ0OThiOTY5MDg1ZmY4MTZlNjc1L3RhYmxlOjQ1NDBiNWI4YjhlZTQ3Mjc4Yjc5NzJkY2ZhMDM5OWU2L3RhYmxlcmFuZ2U6NDU0MGI1YjhiOGVlNDcyNzhiNzk3MmRjZmEwMzk5ZTZfMTYtMy0xLTEtNDgxNjQ_e9e94d1b-ecdc-4c20-a228-8fee061bd5d5" unitRef="usd"> -11111000 </opk:GainLossOnConversionOfDebt>
<opk:IncreaseDecreaseInEquitySecuritiesFVNIAndDerivativeInstruments contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zNC9mcmFnOmI4NjIzMGRmZGUzNjQ0OThiOTY5MDg1ZmY4MTZlNjc1L3RhYmxlOjQ1NDBiNWI4YjhlZTQ3Mjc4Yjc5NzJkY2ZhMDM5OWU2L3RhYmxlcmFuZ2U6NDU0MGI1YjhiOGVlNDcyNzhiNzk3MmRjZmEwMzk5ZTZfMTgtMS0xLTEtNDgxNjQ_4ac0213f-fc11-45d0-87c5-081b1369c7a6" unitRef="usd"> -73724000 </opk:IncreaseDecreaseInEquitySecuritiesFVNIAndDerivativeInstruments>
<opk:IncreaseDecreaseInEquitySecuritiesFVNIAndDerivativeInstruments contextRef="i420e18e30084498a98510d48880063cd_D20210101-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zNC9mcmFnOmI4NjIzMGRmZGUzNjQ0OThiOTY5MDg1ZmY4MTZlNjc1L3RhYmxlOjQ1NDBiNWI4YjhlZTQ3Mjc4Yjc5NzJkY2ZhMDM5OWU2L3RhYmxlcmFuZ2U6NDU0MGI1YjhiOGVlNDcyNzhiNzk3MmRjZmEwMzk5ZTZfMTgtMy0xLTEtNDgxNjQ_251c7e06-1c56-4734-b90a-ab22baaf6eb7" unitRef="usd"> -873000 </opk:IncreaseDecreaseInEquitySecuritiesFVNIAndDerivativeInstruments>
<us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1 contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zNC9mcmFnOmI4NjIzMGRmZGUzNjQ0OThiOTY5MDg1ZmY4MTZlNjc1L3RhYmxlOjQ1NDBiNWI4YjhlZTQ3Mjc4Yjc5NzJkY2ZhMDM5OWU2L3RhYmxlcmFuZ2U6NDU0MGI1YjhiOGVlNDcyNzhiNzk3MmRjZmEwMzk5ZTZfMjAtMS0xLTEtNDgxNjQ_d91408c3-924f-4486-bed8-d22a227a90f8" unitRef="usd"> 69000 </us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
<us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1 contextRef="i420e18e30084498a98510d48880063cd_D20210101-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zNC9mcmFnOmI4NjIzMGRmZGUzNjQ0OThiOTY5MDg1ZmY4MTZlNjc1L3RhYmxlOjQ1NDBiNWI4YjhlZTQ3Mjc4Yjc5NzJkY2ZhMDM5OWU2L3RhYmxlcmFuZ2U6NDU0MGI1YjhiOGVlNDcyNzhiNzk3MmRjZmEwMzk5ZTZfMjAtMy0xLTEtNDgxNjQ_fe25df9e-02de-4bf1-bf3a-5e91a4e21c7d" unitRef="usd"> -1059000 </us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
<us-gaap:GainLossOnSaleOfInvestments contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zNC9mcmFnOmI4NjIzMGRmZGUzNjQ0OThiOTY5MDg1ZmY4MTZlNjc1L3RhYmxlOjQ1NDBiNWI4YjhlZTQ3Mjc4Yjc5NzJkY2ZhMDM5OWU2L3RhYmxlcmFuZ2U6NDU0MGI1YjhiOGVlNDcyNzhiNzk3MmRjZmEwMzk5ZTZfMjEtMS0xLTEtNDgxNjQ_26068f8d-9cae-4225-ab83-1ad053de6b61" unitRef="usd"> 15365000 </us-gaap:GainLossOnSaleOfInvestments>
<us-gaap:GainLossOnSaleOfInvestments contextRef="i420e18e30084498a98510d48880063cd_D20210101-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zNC9mcmFnOmI4NjIzMGRmZGUzNjQ0OThiOTY5MDg1ZmY4MTZlNjc1L3RhYmxlOjQ1NDBiNWI4YjhlZTQ3Mjc4Yjc5NzJkY2ZhMDM5OWU2L3RhYmxlcmFuZ2U6NDU0MGI1YjhiOGVlNDcyNzhiNzk3MmRjZmEwMzk5ZTZfMjEtMy0xLTEtNDgxNjQ_8e14ed12-f5dd-4dec-b4e4-0beaf497703f" unitRef="usd"> 0 </us-gaap:GainLossOnSaleOfInvestments>
<us-gaap:DeferredIncomeTaxExpenseBenefit contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zNC9mcmFnOmI4NjIzMGRmZGUzNjQ0OThiOTY5MDg1ZmY4MTZlNjc1L3RhYmxlOjQ1NDBiNWI4YjhlZTQ3Mjc4Yjc5NzJkY2ZhMDM5OWU2L3RhYmxlcmFuZ2U6NDU0MGI1YjhiOGVlNDcyNzhiNzk3MmRjZmEwMzk5ZTZfMjQtMS0xLTEtNDgxNjQ_c6feff7d-1ab9-4264-bf89-a2bea4ab65e4" unitRef="usd"> -8942000 </us-gaap:DeferredIncomeTaxExpenseBenefit>
<us-gaap:DeferredIncomeTaxExpenseBenefit contextRef="i420e18e30084498a98510d48880063cd_D20210101-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zNC9mcmFnOmI4NjIzMGRmZGUzNjQ0OThiOTY5MDg1ZmY4MTZlNjc1L3RhYmxlOjQ1NDBiNWI4YjhlZTQ3Mjc4Yjc5NzJkY2ZhMDM5OWU2L3RhYmxlcmFuZ2U6NDU0MGI1YjhiOGVlNDcyNzhiNzk3MmRjZmEwMzk5ZTZfMjQtMy0xLTEtNDgxNjQ_6fe734a5-ba4b-41f5-b5d8-db1be8cfab23" unitRef="usd"> 2479000 </us-gaap:DeferredIncomeTaxExpenseBenefit>
<us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zNC9mcmFnOmI4NjIzMGRmZGUzNjQ0OThiOTY5MDg1ZmY4MTZlNjc1L3RhYmxlOjQ1NDBiNWI4YjhlZTQ3Mjc4Yjc5NzJkY2ZhMDM5OWU2L3RhYmxlcmFuZ2U6NDU0MGI1YjhiOGVlNDcyNzhiNzk3MmRjZmEwMzk5ZTZfMjYtMS0xLTEtNDgxNjQ_f5702807-1a74-452e-b047-6ffbd836a9b7" unitRef="usd"> -95864000 </us-gaap:IncreaseDecreaseInAccountsReceivable>
<us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="i420e18e30084498a98510d48880063cd_D20210101-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zNC9mcmFnOmI4NjIzMGRmZGUzNjQ0OThiOTY5MDg1ZmY4MTZlNjc1L3RhYmxlOjQ1NDBiNWI4YjhlZTQ3Mjc4Yjc5NzJkY2ZhMDM5OWU2L3RhYmxlcmFuZ2U6NDU0MGI1YjhiOGVlNDcyNzhiNzk3MmRjZmEwMzk5ZTZfMjYtMy0xLTEtNDgxNjQ_daf4e350-62f1-4012-a349-c3d5b6b85089" unitRef="usd"> -20352000 </us-gaap:IncreaseDecreaseInAccountsReceivable>
<us-gaap:IncreaseDecreaseInInventories contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zNC9mcmFnOmI4NjIzMGRmZGUzNjQ0OThiOTY5MDg1ZmY4MTZlNjc1L3RhYmxlOjQ1NDBiNWI4YjhlZTQ3Mjc4Yjc5NzJkY2ZhMDM5OWU2L3RhYmxlcmFuZ2U6NDU0MGI1YjhiOGVlNDcyNzhiNzk3MmRjZmEwMzk5ZTZfMjctMS0xLTEtNDgxNjQ_ba2a9bae-30f4-4569-adc0-92febb957580" unitRef="usd"> -2864000 </us-gaap:IncreaseDecreaseInInventories>
<us-gaap:IncreaseDecreaseInInventories contextRef="i420e18e30084498a98510d48880063cd_D20210101-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zNC9mcmFnOmI4NjIzMGRmZGUzNjQ0OThiOTY5MDg1ZmY4MTZlNjc1L3RhYmxlOjQ1NDBiNWI4YjhlZTQ3Mjc4Yjc5NzJkY2ZhMDM5OWU2L3RhYmxlcmFuZ2U6NDU0MGI1YjhiOGVlNDcyNzhiNzk3MmRjZmEwMzk5ZTZfMjctMy0xLTEtNDgxNjQ_8c60fa59-96dc-4d77-9308-c4077a9d2386" unitRef="usd"> 3817000 </us-gaap:IncreaseDecreaseInInventories>
<us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zNC9mcmFnOmI4NjIzMGRmZGUzNjQ0OThiOTY5MDg1ZmY4MTZlNjc1L3RhYmxlOjQ1NDBiNWI4YjhlZTQ3Mjc4Yjc5NzJkY2ZhMDM5OWU2L3RhYmxlcmFuZ2U6NDU0MGI1YjhiOGVlNDcyNzhiNzk3MmRjZmEwMzk5ZTZfMjgtMS0xLTEtNDgxNjQ_247fb91c-b5a9-4fbb-8034-9b36b8f54059" unitRef="usd"> 6502000 </us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
<us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="i420e18e30084498a98510d48880063cd_D20210101-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zNC9mcmFnOmI4NjIzMGRmZGUzNjQ0OThiOTY5MDg1ZmY4MTZlNjc1L3RhYmxlOjQ1NDBiNWI4YjhlZTQ3Mjc4Yjc5NzJkY2ZhMDM5OWU2L3RhYmxlcmFuZ2U6NDU0MGI1YjhiOGVlNDcyNzhiNzk3MmRjZmEwMzk5ZTZfMjgtMy0xLTEtNDgxNjQ_2093ff01-3638-4656-a9df-fd51a73cdaf6" unitRef="usd"> 13904000 </us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
<us-gaap:IncreaseDecreaseInOtherOperatingAssets contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zNC9mcmFnOmI4NjIzMGRmZGUzNjQ0OThiOTY5MDg1ZmY4MTZlNjc1L3RhYmxlOjQ1NDBiNWI4YjhlZTQ3Mjc4Yjc5NzJkY2ZhMDM5OWU2L3RhYmxlcmFuZ2U6NDU0MGI1YjhiOGVlNDcyNzhiNzk3MmRjZmEwMzk5ZTZfMjktMS0xLTEtNDgxNjQ_2c9cbbfe-71b0-4dd2-871a-17def72107e7" unitRef="usd"> 260000 </us-gaap:IncreaseDecreaseInOtherOperatingAssets>
<us-gaap:IncreaseDecreaseInOtherOperatingAssets contextRef="i420e18e30084498a98510d48880063cd_D20210101-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zNC9mcmFnOmI4NjIzMGRmZGUzNjQ0OThiOTY5MDg1ZmY4MTZlNjc1L3RhYmxlOjQ1NDBiNWI4YjhlZTQ3Mjc4Yjc5NzJkY2ZhMDM5OWU2L3RhYmxlcmFuZ2U6NDU0MGI1YjhiOGVlNDcyNzhiNzk3MmRjZmEwMzk5ZTZfMjktMy0xLTEtNDgxNjQ_d19a1e8e-b9bd-4b2d-a6ef-8e2b9436d071" unitRef="usd"> -1388000 </us-gaap:IncreaseDecreaseInOtherOperatingAssets>
<us-gaap:IncreaseDecreaseInAccountsPayable contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zNC9mcmFnOmI4NjIzMGRmZGUzNjQ0OThiOTY5MDg1ZmY4MTZlNjc1L3RhYmxlOjQ1NDBiNWI4YjhlZTQ3Mjc4Yjc5NzJkY2ZhMDM5OWU2L3RhYmxlcmFuZ2U6NDU0MGI1YjhiOGVlNDcyNzhiNzk3MmRjZmEwMzk5ZTZfMzAtMS0xLTEtNDgxNjQ_1f4be3fa-29cf-4bc3-b468-b443415b2d07" unitRef="usd"> -19508000 </us-gaap:IncreaseDecreaseInAccountsPayable>
<us-gaap:IncreaseDecreaseInAccountsPayable contextRef="i420e18e30084498a98510d48880063cd_D20210101-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zNC9mcmFnOmI4NjIzMGRmZGUzNjQ0OThiOTY5MDg1ZmY4MTZlNjc1L3RhYmxlOjQ1NDBiNWI4YjhlZTQ3Mjc4Yjc5NzJkY2ZhMDM5OWU2L3RhYmxlcmFuZ2U6NDU0MGI1YjhiOGVlNDcyNzhiNzk3MmRjZmEwMzk5ZTZfMzAtMy0xLTEtNDgxNjQ_16417a7a-fa93-4169-8cdd-5df9654b8baf" unitRef="usd"> -11651000 </us-gaap:IncreaseDecreaseInAccountsPayable>
<opk:IncreaseDecreaseinForeignCurrencyMeasurement contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zNC9mcmFnOmI4NjIzMGRmZGUzNjQ0OThiOTY5MDg1ZmY4MTZlNjc1L3RhYmxlOjQ1NDBiNWI4YjhlZTQ3Mjc4Yjc5NzJkY2ZhMDM5OWU2L3RhYmxlcmFuZ2U6NDU0MGI1YjhiOGVlNDcyNzhiNzk3MmRjZmEwMzk5ZTZfMzEtMS0xLTEtNDgxNjQ_bf96ed47-69b3-4ba7-a8c6-ef6d4c92a6db" unitRef="usd"> 4295000 </opk:IncreaseDecreaseinForeignCurrencyMeasurement>
<opk:IncreaseDecreaseinForeignCurrencyMeasurement contextRef="i420e18e30084498a98510d48880063cd_D20210101-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zNC9mcmFnOmI4NjIzMGRmZGUzNjQ0OThiOTY5MDg1ZmY4MTZlNjc1L3RhYmxlOjQ1NDBiNWI4YjhlZTQ3Mjc4Yjc5NzJkY2ZhMDM5OWU2L3RhYmxlcmFuZ2U6NDU0MGI1YjhiOGVlNDcyNzhiNzk3MmRjZmEwMzk5ZTZfMzEtMy0xLTEtNDgxNjQ_fccd91b9-e192-4704-8ff0-c8f06089a8d1" unitRef="usd"> -2532000 </opk:IncreaseDecreaseinForeignCurrencyMeasurement>
<us-gaap:IncreaseDecreaseInContractWithCustomerLiability contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zNC9mcmFnOmI4NjIzMGRmZGUzNjQ0OThiOTY5MDg1ZmY4MTZlNjc1L3RhYmxlOjQ1NDBiNWI4YjhlZTQ3Mjc4Yjc5NzJkY2ZhMDM5OWU2L3RhYmxlcmFuZ2U6NDU0MGI1YjhiOGVlNDcyNzhiNzk3MmRjZmEwMzk5ZTZfMzItMS0xLTEtNDgxNjQ_c4b8f345-e318-4b00-aa75-6eb7f84d84ee" unitRef="usd"> -17000 </us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
<us-gaap:IncreaseDecreaseInContractWithCustomerLiability contextRef="i420e18e30084498a98510d48880063cd_D20210101-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zNC9mcmFnOmI4NjIzMGRmZGUzNjQ0OThiOTY5MDg1ZmY4MTZlNjc1L3RhYmxlOjQ1NDBiNWI4YjhlZTQ3Mjc4Yjc5NzJkY2ZhMDM5OWU2L3RhYmxlcmFuZ2U6NDU0MGI1YjhiOGVlNDcyNzhiNzk3MmRjZmEwMzk5ZTZfMzItMy0xLTEtNDgxNjQ_5c720104-2fe8-41ad-8812-ff4fb85831d0" unitRef="usd"> -7425000 </us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
<us-gaap:IncreaseDecreaseInAccruedLiabilities contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zNC9mcmFnOmI4NjIzMGRmZGUzNjQ0OThiOTY5MDg1ZmY4MTZlNjc1L3RhYmxlOjQ1NDBiNWI4YjhlZTQ3Mjc4Yjc5NzJkY2ZhMDM5OWU2L3RhYmxlcmFuZ2U6NDU0MGI1YjhiOGVlNDcyNzhiNzk3MmRjZmEwMzk5ZTZfMzMtMS0xLTEtNDgxNjQ_150a35b5-adf3-4f68-a521-5b1c9553e3c4" unitRef="usd"> -69978000 </us-gaap:IncreaseDecreaseInAccruedLiabilities>
<us-gaap:IncreaseDecreaseInAccruedLiabilities contextRef="i420e18e30084498a98510d48880063cd_D20210101-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zNC9mcmFnOmI4NjIzMGRmZGUzNjQ0OThiOTY5MDg1ZmY4MTZlNjc1L3RhYmxlOjQ1NDBiNWI4YjhlZTQ3Mjc4Yjc5NzJkY2ZhMDM5OWU2L3RhYmxlcmFuZ2U6NDU0MGI1YjhiOGVlNDcyNzhiNzk3MmRjZmEwMzk5ZTZfMzMtMy0xLTEtNDgxNjQ_42a162cd-7f97-41b7-a0e1-f72d818fc67a" unitRef="usd"> -49159000 </us-gaap:IncreaseDecreaseInAccruedLiabilities>
<us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zNC9mcmFnOmI4NjIzMGRmZGUzNjQ0OThiOTY5MDg1ZmY4MTZlNjc1L3RhYmxlOjQ1NDBiNWI4YjhlZTQ3Mjc4Yjc5NzJkY2ZhMDM5OWU2L3RhYmxlcmFuZ2U6NDU0MGI1YjhiOGVlNDcyNzhiNzk3MmRjZmEwMzk5ZTZfMzYtMS0xLTEtNDgxNjQ_a968470e-6e9b-421c-a077-79bd493b711f" unitRef="usd"> -31333000 </us-gaap:NetCashProvidedByUsedInOperatingActivities>
<us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="i420e18e30084498a98510d48880063cd_D20210101-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zNC9mcmFnOmI4NjIzMGRmZGUzNjQ0OThiOTY5MDg1ZmY4MTZlNjc1L3RhYmxlOjQ1NDBiNWI4YjhlZTQ3Mjc4Yjc5NzJkY2ZhMDM5OWU2L3RhYmxlcmFuZ2U6NDU0MGI1YjhiOGVlNDcyNzhiNzk3MmRjZmEwMzk5ZTZfMzYtMy0xLTEtNDgxNjQ_2859fff8-24b2-43fe-ba09-111bd6d59bad" unitRef="usd"> 10585000 </us-gaap:NetCashProvidedByUsedInOperatingActivities>
<us-gaap:ProceedsFromSaleMaturityAndCollectionsOfInvestments contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zNC9mcmFnOmI4NjIzMGRmZGUzNjQ0OThiOTY5MDg1ZmY4MTZlNjc1L3RhYmxlOjQ1NDBiNWI4YjhlZTQ3Mjc4Yjc5NzJkY2ZhMDM5OWU2L3RhYmxlcmFuZ2U6NDU0MGI1YjhiOGVlNDcyNzhiNzk3MmRjZmEwMzk5ZTZfMzktMS0xLTEtNDgxNjQ_f2bee80f-a4d6-44ac-ac48-90f108961058" unitRef="usd"> 0 </us-gaap:ProceedsFromSaleMaturityAndCollectionsOfInvestments>
<us-gaap:ProceedsFromSaleMaturityAndCollectionsOfInvestments contextRef="i420e18e30084498a98510d48880063cd_D20210101-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zNC9mcmFnOmI4NjIzMGRmZGUzNjQ0OThiOTY5MDg1ZmY4MTZlNjc1L3RhYmxlOjQ1NDBiNWI4YjhlZTQ3Mjc4Yjc5NzJkY2ZhMDM5OWU2L3RhYmxlcmFuZ2U6NDU0MGI1YjhiOGVlNDcyNzhiNzk3MmRjZmEwMzk5ZTZfMzktMy0xLTEtNDgxNjQ_9d07487c-4678-4e9f-ac34-e1afa10e9ca1" unitRef="usd"> 8079000 </us-gaap:ProceedsFromSaleMaturityAndCollectionsOfInvestments>
<us-gaap:ProceedsFromSaleOfEquityMethodInvestments contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zNC9mcmFnOmI4NjIzMGRmZGUzNjQ0OThiOTY5MDg1ZmY4MTZlNjc1L3RhYmxlOjQ1NDBiNWI4YjhlZTQ3Mjc4Yjc5NzJkY2ZhMDM5OWU2L3RhYmxlcmFuZ2U6NDU0MGI1YjhiOGVlNDcyNzhiNzk3MmRjZmEwMzk5ZTZfNDAtMS0xLTEtNTk4MjY_d3cc5bf2-9f7f-48e5-84f5-01ba1ca4970a" unitRef="usd"> 115423000 </us-gaap:ProceedsFromSaleOfEquityMethodInvestments>
<us-gaap:ProceedsFromSaleOfEquityMethodInvestments contextRef="i420e18e30084498a98510d48880063cd_D20210101-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zNC9mcmFnOmI4NjIzMGRmZGUzNjQ0OThiOTY5MDg1ZmY4MTZlNjc1L3RhYmxlOjQ1NDBiNWI4YjhlZTQ3Mjc4Yjc5NzJkY2ZhMDM5OWU2L3RhYmxlcmFuZ2U6NDU0MGI1YjhiOGVlNDcyNzhiNzk3MmRjZmEwMzk5ZTZfNDAtMy0xLTEtNTk5MDc_7d199bb1-de98-4bcf-bc25-896c8e7ce1a7" unitRef="usd"> 0 </us-gaap:ProceedsFromSaleOfEquityMethodInvestments>
<us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zNC9mcmFnOmI4NjIzMGRmZGUzNjQ0OThiOTY5MDg1ZmY4MTZlNjc1L3RhYmxlOjQ1NDBiNWI4YjhlZTQ3Mjc4Yjc5NzJkY2ZhMDM5OWU2L3RhYmxlcmFuZ2U6NDU0MGI1YjhiOGVlNDcyNzhiNzk3MmRjZmEwMzk5ZTZfNDAtMS0xLTEtNDgxNjQ_e2c3449d-fb17-47a9-b8c4-a6b347df546a" unitRef="usd"> 2071000 </us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
<us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired contextRef="i420e18e30084498a98510d48880063cd_D20210101-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zNC9mcmFnOmI4NjIzMGRmZGUzNjQ0OThiOTY5MDg1ZmY4MTZlNjc1L3RhYmxlOjQ1NDBiNWI4YjhlZTQ3Mjc4Yjc5NzJkY2ZhMDM5OWU2L3RhYmxlcmFuZ2U6NDU0MGI1YjhiOGVlNDcyNzhiNzk3MmRjZmEwMzk5ZTZfNDAtMy0xLTEtNDgxNjQ_250b8d18-a9ae-49a3-9829-8a6b6aa77193" unitRef="usd"> 0 </us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
<us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zNC9mcmFnOmI4NjIzMGRmZGUzNjQ0OThiOTY5MDg1ZmY4MTZlNjc1L3RhYmxlOjQ1NDBiNWI4YjhlZTQ3Mjc4Yjc5NzJkY2ZhMDM5OWU2L3RhYmxlcmFuZ2U6NDU0MGI1YjhiOGVlNDcyNzhiNzk3MmRjZmEwMzk5ZTZfNDMtMS0xLTEtNDgxNjQ_2a926a17-1ae8-4eea-8140-22653ad62288" unitRef="usd"> 870000 </us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
<us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment contextRef="i420e18e30084498a98510d48880063cd_D20210101-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zNC9mcmFnOmI4NjIzMGRmZGUzNjQ0OThiOTY5MDg1ZmY4MTZlNjc1L3RhYmxlOjQ1NDBiNWI4YjhlZTQ3Mjc4Yjc5NzJkY2ZhMDM5OWU2L3RhYmxlcmFuZ2U6NDU0MGI1YjhiOGVlNDcyNzhiNzk3MmRjZmEwMzk5ZTZfNDMtMy0xLTEtNDgxNjQ_b0954bd5-afd9-4861-bd11-45a2226b5f88" unitRef="usd"> 165000 </us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
<us-gaap:PaymentsToAcquireProductiveAssets contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zNC9mcmFnOmI4NjIzMGRmZGUzNjQ0OThiOTY5MDg1ZmY4MTZlNjc1L3RhYmxlOjQ1NDBiNWI4YjhlZTQ3Mjc4Yjc5NzJkY2ZhMDM5OWU2L3RhYmxlcmFuZ2U6NDU0MGI1YjhiOGVlNDcyNzhiNzk3MmRjZmEwMzk5ZTZfNDUtMS0xLTEtNDgxNjQ_3b97f778-de2c-4ec2-b409-05a1bf244e2a" unitRef="usd"> 10630000 </us-gaap:PaymentsToAcquireProductiveAssets>
<us-gaap:PaymentsToAcquireProductiveAssets contextRef="i420e18e30084498a98510d48880063cd_D20210101-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zNC9mcmFnOmI4NjIzMGRmZGUzNjQ0OThiOTY5MDg1ZmY4MTZlNjc1L3RhYmxlOjQ1NDBiNWI4YjhlZTQ3Mjc4Yjc5NzJkY2ZhMDM5OWU2L3RhYmxlcmFuZ2U6NDU0MGI1YjhiOGVlNDcyNzhiNzk3MmRjZmEwMzk5ZTZfNDUtMy0xLTEtNDgxNjQ_075db05e-ff25-4b37-96a1-ecacc6dbe425" unitRef="usd"> 18192000 </us-gaap:PaymentsToAcquireProductiveAssets>
<us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zNC9mcmFnOmI4NjIzMGRmZGUzNjQ0OThiOTY5MDg1ZmY4MTZlNjc1L3RhYmxlOjQ1NDBiNWI4YjhlZTQ3Mjc4Yjc5NzJkY2ZhMDM5OWU2L3RhYmxlcmFuZ2U6NDU0MGI1YjhiOGVlNDcyNzhiNzk3MmRjZmEwMzk5ZTZfNDYtMS0xLTEtNDgxNjQ_e357414d-52ed-44e4-8aa4-7cbe65afad5b" unitRef="usd"> 103592000 </us-gaap:NetCashProvidedByUsedInInvestingActivities>
<us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="i420e18e30084498a98510d48880063cd_D20210101-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zNC9mcmFnOmI4NjIzMGRmZGUzNjQ0OThiOTY5MDg1ZmY4MTZlNjc1L3RhYmxlOjQ1NDBiNWI4YjhlZTQ3Mjc4Yjc5NzJkY2ZhMDM5OWU2L3RhYmxlcmFuZ2U6NDU0MGI1YjhiOGVlNDcyNzhiNzk3MmRjZmEwMzk5ZTZfNDYtMy0xLTEtNDgxNjQ_620fd1a4-6db1-43b4-8a65-787784967b7e" unitRef="usd"> -9948000 </us-gaap:NetCashProvidedByUsedInInvestingActivities>
<us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zNC9mcmFnOmI4NjIzMGRmZGUzNjQ0OThiOTY5MDg1ZmY4MTZlNjc1L3RhYmxlOjQ1NDBiNWI4YjhlZTQ3Mjc4Yjc5NzJkY2ZhMDM5OWU2L3RhYmxlcmFuZ2U6NDU0MGI1YjhiOGVlNDcyNzhiNzk3MmRjZmEwMzk5ZTZfNTAtMS0xLTEtNDgxNjQ_6871ab79-db61-4040-983f-9126f7620a3c" unitRef="usd"> 1000 </us-gaap:ProceedsFromIssuanceOfCommonStock>
<us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="i420e18e30084498a98510d48880063cd_D20210101-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zNC9mcmFnOmI4NjIzMGRmZGUzNjQ0OThiOTY5MDg1ZmY4MTZlNjc1L3RhYmxlOjQ1NDBiNWI4YjhlZTQ3Mjc4Yjc5NzJkY2ZhMDM5OWU2L3RhYmxlcmFuZ2U6NDU0MGI1YjhiOGVlNDcyNzhiNzk3MmRjZmEwMzk5ZTZfNTAtMy0xLTEtNDgxNjQ_c009dbe8-7a7d-4289-b526-43751cbe364d" unitRef="usd"> 0 </us-gaap:ProceedsFromIssuanceOfCommonStock>
<opk:ProceedsFromStockOptionsExercisedNetOfTaxWithholdings contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zNC9mcmFnOmI4NjIzMGRmZGUzNjQ0OThiOTY5MDg1ZmY4MTZlNjc1L3RhYmxlOjQ1NDBiNWI4YjhlZTQ3Mjc4Yjc5NzJkY2ZhMDM5OWU2L3RhYmxlcmFuZ2U6NDU0MGI1YjhiOGVlNDcyNzhiNzk3MmRjZmEwMzk5ZTZfNTEtMS0xLTEtNDgxNjQ_fc4113ac-fcd7-4bdf-b9b4-d18c81c889bf" unitRef="usd"> -225000 </opk:ProceedsFromStockOptionsExercisedNetOfTaxWithholdings>
<opk:ProceedsFromStockOptionsExercisedNetOfTaxWithholdings contextRef="i420e18e30084498a98510d48880063cd_D20210101-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zNC9mcmFnOmI4NjIzMGRmZGUzNjQ0OThiOTY5MDg1ZmY4MTZlNjc1L3RhYmxlOjQ1NDBiNWI4YjhlZTQ3Mjc4Yjc5NzJkY2ZhMDM5OWU2L3RhYmxlcmFuZ2U6NDU0MGI1YjhiOGVlNDcyNzhiNzk3MmRjZmEwMzk5ZTZfNTEtMy0xLTEtNDgxNjQ_7dffe330-20b0-4ca8-9c83-844bee08b4bb" unitRef="usd"> 465000 </opk:ProceedsFromStockOptionsExercisedNetOfTaxWithholdings>
<us-gaap:ProceedsFromLinesOfCredit contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zNC9mcmFnOmI4NjIzMGRmZGUzNjQ0OThiOTY5MDg1ZmY4MTZlNjc1L3RhYmxlOjQ1NDBiNWI4YjhlZTQ3Mjc4Yjc5NzJkY2ZhMDM5OWU2L3RhYmxlcmFuZ2U6NDU0MGI1YjhiOGVlNDcyNzhiNzk3MmRjZmEwMzk5ZTZfNTQtMS0xLTEtNDgxNjQ_5a4197ac-0ca2-45d3-8638-33be3534997a" unitRef="usd"> 684467000 </us-gaap:ProceedsFromLinesOfCredit>
<us-gaap:ProceedsFromLinesOfCredit contextRef="i420e18e30084498a98510d48880063cd_D20210101-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zNC9mcmFnOmI4NjIzMGRmZGUzNjQ0OThiOTY5MDg1ZmY4MTZlNjc1L3RhYmxlOjQ1NDBiNWI4YjhlZTQ3Mjc4Yjc5NzJkY2ZhMDM5OWU2L3RhYmxlcmFuZ2U6NDU0MGI1YjhiOGVlNDcyNzhiNzk3MmRjZmEwMzk5ZTZfNTQtMy0xLTEtNDgxNjQ_d82a3e38-d951-4b3c-8b8f-2625745d667f" unitRef="usd"> 982797000 </us-gaap:ProceedsFromLinesOfCredit>
<us-gaap:RepaymentsOfLinesOfCredit contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zNC9mcmFnOmI4NjIzMGRmZGUzNjQ0OThiOTY5MDg1ZmY4MTZlNjc1L3RhYmxlOjQ1NDBiNWI4YjhlZTQ3Mjc4Yjc5NzJkY2ZhMDM5OWU2L3RhYmxlcmFuZ2U6NDU0MGI1YjhiOGVlNDcyNzhiNzk3MmRjZmEwMzk5ZTZfNTUtMS0xLTEtNDgxNjQ_507adbfe-311e-440e-89b5-37c051b5bcc0" unitRef="usd"> 679860000 </us-gaap:RepaymentsOfLinesOfCredit>
<us-gaap:RepaymentsOfLinesOfCredit contextRef="i420e18e30084498a98510d48880063cd_D20210101-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zNC9mcmFnOmI4NjIzMGRmZGUzNjQ0OThiOTY5MDg1ZmY4MTZlNjc1L3RhYmxlOjQ1NDBiNWI4YjhlZTQ3Mjc4Yjc5NzJkY2ZhMDM5OWU2L3RhYmxlcmFuZ2U6NDU0MGI1YjhiOGVlNDcyNzhiNzk3MmRjZmEwMzk5ZTZfNTUtMy0xLTEtNDgxNjQ_5b673426-76bc-40a9-9b25-68e76da4b4f9" unitRef="usd"> 990190000 </us-gaap:RepaymentsOfLinesOfCredit>
<us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zNC9mcmFnOmI4NjIzMGRmZGUzNjQ0OThiOTY5MDg1ZmY4MTZlNjc1L3RhYmxlOjQ1NDBiNWI4YjhlZTQ3Mjc4Yjc5NzJkY2ZhMDM5OWU2L3RhYmxlcmFuZ2U6NDU0MGI1YjhiOGVlNDcyNzhiNzk3MmRjZmEwMzk5ZTZfNTktMS0xLTEtNDgxNjQ_25d23f99-30b3-4ce0-b015-820fb5de508b" unitRef="usd"> 4383000 </us-gaap:NetCashProvidedByUsedInFinancingActivities>
<us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="i420e18e30084498a98510d48880063cd_D20210101-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zNC9mcmFnOmI4NjIzMGRmZGUzNjQ0OThiOTY5MDg1ZmY4MTZlNjc1L3RhYmxlOjQ1NDBiNWI4YjhlZTQ3Mjc4Yjc5NzJkY2ZhMDM5OWU2L3RhYmxlcmFuZ2U6NDU0MGI1YjhiOGVlNDcyNzhiNzk3MmRjZmEwMzk5ZTZfNTktMy0xLTEtNDgxNjQ_2f45b7a7-006c-4a4e-b0f1-dd554bf8fdb6" unitRef="usd"> -6928000 </us-gaap:NetCashProvidedByUsedInFinancingActivities>
<us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zNC9mcmFnOmI4NjIzMGRmZGUzNjQ0OThiOTY5MDg1ZmY4MTZlNjc1L3RhYmxlOjQ1NDBiNWI4YjhlZTQ3Mjc4Yjc5NzJkY2ZhMDM5OWU2L3RhYmxlcmFuZ2U6NDU0MGI1YjhiOGVlNDcyNzhiNzk3MmRjZmEwMzk5ZTZfNjAtMS0xLTEtNDgxNjQ_332cf415-e1fa-4b7e-8139-196c02014967" unitRef="usd"> -894000 </us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
<us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="i420e18e30084498a98510d48880063cd_D20210101-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zNC9mcmFnOmI4NjIzMGRmZGUzNjQ0OThiOTY5MDg1ZmY4MTZlNjc1L3RhYmxlOjQ1NDBiNWI4YjhlZTQ3Mjc4Yjc5NzJkY2ZhMDM5OWU2L3RhYmxlcmFuZ2U6NDU0MGI1YjhiOGVlNDcyNzhiNzk3MmRjZmEwMzk5ZTZfNjAtMy0xLTEtNDgxNjQ_2fd391a3-39ff-450c-94b2-709360b8cd27" unitRef="usd"> -163000 </us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
<us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zNC9mcmFnOmI4NjIzMGRmZGUzNjQ0OThiOTY5MDg1ZmY4MTZlNjc1L3RhYmxlOjQ1NDBiNWI4YjhlZTQ3Mjc4Yjc5NzJkY2ZhMDM5OWU2L3RhYmxlcmFuZ2U6NDU0MGI1YjhiOGVlNDcyNzhiNzk3MmRjZmEwMzk5ZTZfNjEtMS0xLTEtNDgxNjQ_abd9638d-5041-494e-8afd-397083d053dc" unitRef="usd"> 75748000 </us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
<us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="i420e18e30084498a98510d48880063cd_D20210101-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zNC9mcmFnOmI4NjIzMGRmZGUzNjQ0OThiOTY5MDg1ZmY4MTZlNjc1L3RhYmxlOjQ1NDBiNWI4YjhlZTQ3Mjc4Yjc5NzJkY2ZhMDM5OWU2L3RhYmxlcmFuZ2U6NDU0MGI1YjhiOGVlNDcyNzhiNzk3MmRjZmEwMzk5ZTZfNjEtMy0xLTEtNDgxNjQ_7b60e472-da92-4e1a-a671-b32271294871" unitRef="usd"> -6454000 </us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
<us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="i7e0f479bead144b0bdbcc71082db627b_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zNC9mcmFnOmI4NjIzMGRmZGUzNjQ0OThiOTY5MDg1ZmY4MTZlNjc1L3RhYmxlOjQ1NDBiNWI4YjhlZTQ3Mjc4Yjc5NzJkY2ZhMDM5OWU2L3RhYmxlcmFuZ2U6NDU0MGI1YjhiOGVlNDcyNzhiNzk3MmRjZmEwMzk5ZTZfNjItMS0xLTEtNDgxNjQ_b6559470-fc62-4701-9caa-3e9d21b1bb3a" unitRef="usd"> 134710000 </us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
<us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="if51f06301fcf486db26eb226e027928f_I20201231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zNC9mcmFnOmI4NjIzMGRmZGUzNjQ0OThiOTY5MDg1ZmY4MTZlNjc1L3RhYmxlOjQ1NDBiNWI4YjhlZTQ3Mjc4Yjc5NzJkY2ZhMDM5OWU2L3RhYmxlcmFuZ2U6NDU0MGI1YjhiOGVlNDcyNzhiNzk3MmRjZmEwMzk5ZTZfNjItMy0xLTEtNDgxNjQ_5d4d1886-5405-42af-8fd0-827e7cfbdd80" unitRef="usd"> 72211000 </us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
<us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="i4768f885851b49f986857a2a956f9162_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zNC9mcmFnOmI4NjIzMGRmZGUzNjQ0OThiOTY5MDg1ZmY4MTZlNjc1L3RhYmxlOjQ1NDBiNWI4YjhlZTQ3Mjc4Yjc5NzJkY2ZhMDM5OWU2L3RhYmxlcmFuZ2U6NDU0MGI1YjhiOGVlNDcyNzhiNzk3MmRjZmEwMzk5ZTZfNjMtMS0xLTEtNDgxNjQ_e4381f4d-3a9c-4eb5-90bb-ecc1d461bb6b" unitRef="usd"> 210458000 </us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
<us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="i724677ce94b849699e6f5d548e33e1c7_I20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zNC9mcmFnOmI4NjIzMGRmZGUzNjQ0OThiOTY5MDg1ZmY4MTZlNjc1L3RhYmxlOjQ1NDBiNWI4YjhlZTQ3Mjc4Yjc5NzJkY2ZhMDM5OWU2L3RhYmxlcmFuZ2U6NDU0MGI1YjhiOGVlNDcyNzhiNzk3MmRjZmEwMzk5ZTZfNjMtMy0xLTEtNDgxNjQ_06274deb-f0c9-4c22-86b8-807765c8676f" unitRef="usd"> 65757000 </us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
<us-gaap:InterestPaidNet contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zNC9mcmFnOmI4NjIzMGRmZGUzNjQ0OThiOTY5MDg1ZmY4MTZlNjc1L3RhYmxlOjQ1NDBiNWI4YjhlZTQ3Mjc4Yjc5NzJkY2ZhMDM5OWU2L3RhYmxlcmFuZ2U6NDU0MGI1YjhiOGVlNDcyNzhiNzk3MmRjZmEwMzk5ZTZfNjUtMS0xLTEtNDgxNjQ_1ae67638-815d-45e7-8810-46a8867e2876" unitRef="usd"> 3554000 </us-gaap:InterestPaidNet>
<us-gaap:InterestPaidNet contextRef="i420e18e30084498a98510d48880063cd_D20210101-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zNC9mcmFnOmI4NjIzMGRmZGUzNjQ0OThiOTY5MDg1ZmY4MTZlNjc1L3RhYmxlOjQ1NDBiNWI4YjhlZTQ3Mjc4Yjc5NzJkY2ZhMDM5OWU2L3RhYmxlcmFuZ2U6NDU0MGI1YjhiOGVlNDcyNzhiNzk3MmRjZmEwMzk5ZTZfNjUtMy0xLTEtNDgxNjQ_95157cd4-8489-4f98-944e-f2e9a5e61855" unitRef="usd"> 4883000 </us-gaap:InterestPaidNet>
<us-gaap:IncomeTaxesPaidNet contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zNC9mcmFnOmI4NjIzMGRmZGUzNjQ0OThiOTY5MDg1ZmY4MTZlNjc1L3RhYmxlOjQ1NDBiNWI4YjhlZTQ3Mjc4Yjc5NzJkY2ZhMDM5OWU2L3RhYmxlcmFuZ2U6NDU0MGI1YjhiOGVlNDcyNzhiNzk3MmRjZmEwMzk5ZTZfNjYtMS0xLTEtNDgxNjQ_556d3976-de61-4f17-8e7d-dfeaa8eb1b6b" unitRef="usd"> 4647000 </us-gaap:IncomeTaxesPaidNet>
<us-gaap:IncomeTaxesPaidNet contextRef="i420e18e30084498a98510d48880063cd_D20210101-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zNC9mcmFnOmI4NjIzMGRmZGUzNjQ0OThiOTY5MDg1ZmY4MTZlNjc1L3RhYmxlOjQ1NDBiNWI4YjhlZTQ3Mjc4Yjc5NzJkY2ZhMDM5OWU2L3RhYmxlcmFuZ2U6NDU0MGI1YjhiOGVlNDcyNzhiNzk3MmRjZmEwMzk5ZTZfNjYtMy0xLTEtNDgxNjQ_2a0d80cf-a1aa-4abc-af83-131b5a237978" unitRef="usd"> 3690000 </us-gaap:IncomeTaxesPaidNet>
<us-gaap:DebtConversionConvertedInstrumentAmount1 contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zNC9mcmFnOmI4NjIzMGRmZGUzNjQ0OThiOTY5MDg1ZmY4MTZlNjc1L3RhYmxlOjQ1NDBiNWI4YjhlZTQ3Mjc4Yjc5NzJkY2ZhMDM5OWU2L3RhYmxlcmFuZ2U6NDU0MGI1YjhiOGVlNDcyNzhiNzk3MmRjZmEwMzk5ZTZfNzQtMS0xLTEtNDgxNjQ_dbb7573c-f3f9-44f1-9c16-53192d1100b5" unitRef="usd"> 0 </us-gaap:DebtConversionConvertedInstrumentAmount1>
<us-gaap:DebtConversionConvertedInstrumentAmount1 contextRef="i420e18e30084498a98510d48880063cd_D20210101-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zNC9mcmFnOmI4NjIzMGRmZGUzNjQ0OThiOTY5MDg1ZmY4MTZlNjc1L3RhYmxlOjQ1NDBiNWI4YjhlZTQ3Mjc4Yjc5NzJkY2ZhMDM5OWU2L3RhYmxlcmFuZ2U6NDU0MGI1YjhiOGVlNDcyNzhiNzk3MmRjZmEwMzk5ZTZfNzQtMy0xLTEtNDgxNjQ_eebce395-179d-40d9-8f96-72bbb7d342db" unitRef="usd"> 68775000 </us-gaap:DebtConversionConvertedInstrumentAmount1>
<opk:CommonStockWarrantsNetExercised contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zNC9mcmFnOmI4NjIzMGRmZGUzNjQ0OThiOTY5MDg1ZmY4MTZlNjc1L3RhYmxlOjQ1NDBiNWI4YjhlZTQ3Mjc4Yjc5NzJkY2ZhMDM5OWU2L3RhYmxlcmFuZ2U6NDU0MGI1YjhiOGVlNDcyNzhiNzk3MmRjZmEwMzk5ZTZfNzUtMS0xLTEtNDgxNjQ_3ab71ccd-d5f3-418e-8aaa-62a2262f2e56" unitRef="usd"> 655000 </opk:CommonStockWarrantsNetExercised>
<opk:CommonStockWarrantsNetExercised contextRef="i420e18e30084498a98510d48880063cd_D20210101-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zNC9mcmFnOmI4NjIzMGRmZGUzNjQ0OThiOTY5MDg1ZmY4MTZlNjc1L3RhYmxlOjQ1NDBiNWI4YjhlZTQ3Mjc4Yjc5NzJkY2ZhMDM5OWU2L3RhYmxlcmFuZ2U6NDU0MGI1YjhiOGVlNDcyNzhiNzk3MmRjZmEwMzk5ZTZfNzUtMy0xLTEtNDgxNjQ_d81e98ee-221d-4814-8d00-1978d9741679" unitRef="usd"> 0 </opk:CommonStockWarrantsNetExercised>
<us-gaap:StockIssued1 contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zNC9mcmFnOmI4NjIzMGRmZGUzNjQ0OThiOTY5MDg1ZmY4MTZlNjc1L3RhYmxlOjQ1NDBiNWI4YjhlZTQ3Mjc4Yjc5NzJkY2ZhMDM5OWU2L3RhYmxlcmFuZ2U6NDU0MGI1YjhiOGVlNDcyNzhiNzk3MmRjZmEwMzk5ZTZfODctMS0xLTEtNTcxNjU_cf271359-58c3-4160-a433-7c5930fe8079" unitRef="usd"> 219374000 </us-gaap:StockIssued1>
<us-gaap:StockIssued1 contextRef="i420e18e30084498a98510d48880063cd_D20210101-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zNC9mcmFnOmI4NjIzMGRmZGUzNjQ0OThiOTY5MDg1ZmY4MTZlNjc1L3RhYmxlOjQ1NDBiNWI4YjhlZTQ3Mjc4Yjc5NzJkY2ZhMDM5OWU2L3RhYmxlcmFuZ2U6NDU0MGI1YjhiOGVlNDcyNzhiNzk3MmRjZmEwMzk5ZTZfODctMy0xLTEtNTcxNjU_cb46d10b-17ec-43e1-a213-b1f7737d572b" unitRef="usd"> 0 </us-gaap:StockIssued1>
<us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zNC9mcmFnOmI4NjIzMGRmZGUzNjQ0OThiOTY5MDg1ZmY4MTZlNjc1L3RhYmxlOjQ1NDBiNWI4YjhlZTQ3Mjc4Yjc5NzJkY2ZhMDM5OWU2L3RhYmxlcmFuZ2U6NDU0MGI1YjhiOGVlNDcyNzhiNzk3MmRjZmEwMzk5ZTZfODktMS0xLTEtNTk5MDk_21717b94-f508-428f-925f-6f7340eb7844" unitRef="usd"> 172000000 </us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable>
<us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable contextRef="i420e18e30084498a98510d48880063cd_D20210101-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml8zNC9mcmFnOmI4NjIzMGRmZGUzNjQ0OThiOTY5MDg1ZmY4MTZlNjc1L3RhYmxlOjQ1NDBiNWI4YjhlZTQ3Mjc4Yjc5NzJkY2ZhMDM5OWU2L3RhYmxlcmFuZ2U6NDU0MGI1YjhiOGVlNDcyNzhiNzk3MmRjZmEwMzk5ZTZfODktMy0xLTEtNTk5MDk_c8e61c45-77e0-4f34-a370-e7653c5af132" unitRef="usd"> 0 </us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable>
<us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml80MC9mcmFnOjRmNmVmODRmOGFiYTQ4MmQ4M2E3ZTg5MjM3NmRmZmIzL3RleHRyZWdpb246NGY2ZWY4NGY4YWJhNDgyZDgzYTdlODkyMzc2ZGZmYjNfNjA1NA_757d439c-7417-4b5b-a7ba-5d4adfc878f2">
BUSINESS AND ORGANIZATION<div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a diversified healthcare company that seeks to establish industry-leading positions in large and rapidly growing medical markets. Our diagnostics business includes BioReference Health, LLC, formerly known as BioReference Laboratories, Inc. (“BioReference”), one of the nation’s largest full service laboratories with an almost 250-person sales and marketing team to drive growth and leverage new products. Our pharmaceutical business features </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Rayaldee</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, a U.S. Food and Drug Administration (“FDA”) approved treatment for secondary hyperparathyroidism (“SHPT”) in adults with stage 3 or 4 chronic kidney disease (“CKD”) and vitamin D insufficiency and a pipeline of products in various stages of development. Our leading product in development is Somatrogon (hGH-CTP), a once-weekly human growth hormone for which we have partnered with Pfizer, Inc. (“Pfizer”) and successfully completed a phase 3 study in August 2019. Regulatory applications for Somatrogon (hGH-CTP) have been submitted to the applicable regulatory bodies for review in several countries around the world. In February 2022, the European Commission granted marketing authorization in the European Union for Somatrogon (hGH-CTP) under the brand name NGENLA® to treat children and adolescents from as young as three years of age with growth disturbance due to insufficient secretion of growth hormone, and we recently received pricing approval in Germany. In January 2022, the Ministry of Health, Labour and Welfare in Japan approved NGENLA® (Somatrogon) for the long-term treatment of pediatric patients who have growth failure due to an inadequate secretion of endogenous growth hormone and we recently received pricing approval. In October 2021, Health Canada approved NGENLA® for the long-term treatment of pediatric patients who have growth hormone deficiency, and Australia’s Therapeutic Goods Administration approved NGENLA® for the long-term treatment of pediatric patients with growth disturbance due to insufficient secretion of growth hormone. Pfizer submitted the initial Biologics License Application (“BLA”) with the FDA for approval of Somatrogon (hGH-CTP) in the United States and received a Complete Response Letter in January 2022. Pfizer and OPKO are evaluating the FDA’s comments and will work with the agency to determine the best path forward for Somatrogon (hGH-CTP) in the United States. We are incorporated in Delaware, and our principal executive offices are located in leased offices in Miami, Florida. </span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Through BioReference, we provide laboratory testing services, primarily to customers in the larger metropolitan areas in New York, New Jersey, Florida, Texas, Maryland, California, Pennsylvania, Delaware, Washington, DC, Illinois and Massachusetts, as well as to customers in a number of other states. We offer a comprehensive test menu of clinical diagnostics for blood, urine and tissue analysis. This includes hematology, clinical chemistry, immunoassay, infectious diseases, serology, hormones, and toxicology assays, as well as Pap smear, anatomic pathology (biopsies) and other types of tissue analysis. We market our laboratory testing services directly to physicians, geneticists, hospitals, clinics, correctional and other health facilities. </span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We operate established pharmaceutical platforms in Ireland, Chile, Spain, and Mexico, which are generating revenue and from which we expect to generate positive cash flow and facilitate future market entry for our products currently in development. In addition, we have a development and commercial supply pharmaceutical company and a global supply chain operation and holding company in Ireland. We own a specialty active pharmaceutical ingredients (“APIs”) manufacturer in Israel, which we expect will facilitate the development of our pipeline of molecules and compounds for our proprietary molecular diagnostic and therapeutic products.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our research and development activities are primarily performed at facilities in Woburn, MA, Waterford, Ireland, Kiryat Gat, Israel, and Barcelona, Spain.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 9, 2022 (the “Closing Date”), the Company entered into an Agreement and Plan of Merger (the “ModeX Merger Agreement”) with Orca Acquisition Sub, Inc., a Delaware corporation and wholly owned subsidiary of the Company (“Merger Sub”), ModeX Therapeutics, Inc., a Delaware corporation (“ModeX”) and Gary J. Nabel, solely in his capacity as sellers’ representative, pursuant to which Merger Sub merged with and into ModeX (the “ModeX Merger”), with ModeX surviving the ModeX Merger as a wholly owned subsidiary of the Company. The Company paid the entirety of the $300.0 million purchase price pursuant to the issuance of an aggregate of 89,907,310 shares (the “Consideration Shares”) of the Company’s common stock, par value $0.01 per share (“Common Stock”), to the former stockholders of ModeX (the “Selling Stockholders”), of which 10% of such shares were deposited in a twelve-month escrow for purposes of satisfying the potential indemnity obligations of the Selling Stockholders under the ModeX Merger Agreement. Additionally, the Company issued equity awards to ModeX employees in an amount equal to $12.4 million, which was deducted from the consideration payable on the Closing Date. If any of such awards are forfeited or otherwise remain unvested on the four-year anniversary of the Closing Date, up to $2.6 million shares of Common Stock (valued at the same price used for determining the number of Consideration Shares issuable upon consummation of the ModeX Merger) may be distributed pro rata to ModeX’s former stockholders in respect of such forfeited or unvested awards. Shares of Common Stock with respect to such potential distribution have been escrowed and will remain escrowed for such four-year period. For accounting purposes, the shares were valued at $219.4 million, based on </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the closing price per share of our Common Stock of $2.44 as reported by NASDAQ Global Select Market (“NASDAQ”) on the Closing Date. </span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In connection with the ModeX Merger, the Company appointed Elias A. Zerhouni, M.D., Gary J. Nabel, M.D., PhD., and Alexis Borisy to the Board of Directors of the Company (the “Board”), with Dr. Zerhouni serving as Vice Chair. Elizabeth Nabel, one of the founders of ModeX, was appointed as the Company’s new Chief Medical Officer. Dr. Gary J. Nabel has been named the Chief Executive Officer of ModeX and Chief Innovation Officer of the Company and Dr. Elias A.Zerhouni has been named the President of the Company.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with the ModeX Merger Agreement, Dr. Phillip Frost, the Company’s Chief Executive Officer and Chairman of the Board, Dr. Jane Hsiao, the Company’s Chief Technical Officer and a Director, and Frost Gamma Investments Trust (“FGIT”), a trust controlled by Dr. Frost, entered into a lockup and voting agreement, together with the Company (the “ModeX Lockup and Voting Agreement”), pursuant to which: (i) FGIT has agreed that, for a period of four years immediately following the Closing Date, it will not sell or otherwise transfer its shares of Common Stock, subject to certain customary exceptions; and (ii) Drs. Frost and Hsiao agreed that, for as long as Dr. Elias A. Zerhouni or Dr. Gary J. Nabel remains an employee of the Company or ModeX, Drs. Frost and Hsiao will vote, or cause to be voted, all of their respective shares of Common Stock in favor of such person’s election to the Board. Additionally, in accordance with the ModeX Merger Agreement, certain recipients of the Consideration Shares, holding in aggregate approximately 88.0% of the Consideration Shares, agreed not to sell or otherwise transfer their respective Consideration Shares for a period of four years immediately following the Closing Date on the same terms as contained in the ModeX Lockup and Voting Agreement.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 14, 2022, the Company entered into an Agreement and Plan of Merger and Reorganization (the “GeneDx Merger Agreement”) with Sema4 Holdings Corp., a Delaware corporation (“Sema4”), pursuant to which Sema4 acquired the Company’s former subsidiary, GeneDx LLC, (f/k/a GeneDx, Inc. “GeneDx”), (the “GeneDx Transaction”) in a transaction that closed on April 29, 2022 (the “GeneDx Closing”). </span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon the GeneDx Closing, Sema4 paid to the Company aggregate consideration of $150 million in cash (before deduction of transaction expenses and other customary purchase price adjustments), together with 80.0 million shares (the “Closing Shares”) of Sema4’s Class A common stock, par value $0.0001 per share (“Sema4 Common Stock”). Additionally, Sema4 has agreed to pay the Company up to an additional $150 million, which may be paid in Sema4 Common Stock, cash or a combination thereof in Sema4’s discretion, subject to GeneDx achieving certain revenue targets for the fiscal years ending December 31, 2022 and 2023 (the “Milestone Consideration”). Based on the closing price of Sema4 Common Stock on April 29, 2022, the total upfront consideration was approximately $322 million, and the total aggregate consideration, including the potential Milestone Consideration, was approximately $447 million. We recognized a gain of $15.4 million on the sale of GeneDx during the second quarter of 2022.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the transactions contemplated by the GeneDx Merger Agreement, on January 14, 2022, the Company entered into a Shareholder Agreement (the “Sema4 Shareholder Agreement”) with Sema4, pursuant to which the Company has agreed to, among other things, be subject to a lock-up period with respect to its shares of Sema4 Common Stock, which expires on April 29, 2024 with respect to the Closing Shares, and, if earned and received, would extend for periods of one-year and six-months following the issuance of shares, cash or a combination thereof, in respect of the first and second potential Milestone Consideration payments, respectively.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Pursuant to the GeneDx Merger Agreement, the Company designated, and Sema4 nominated for election an individual to serve on the board of directors of Sema4, and such nominee was elected by Sema4’s stockholders to serve as a director until Sema4’s 2024 annual meeting of stockholders. In addition, the Company has further agreed to certain standstill provisions whereby, subject to certain exceptions, it is obligated to refrain from taking certain actions with respect to the Sema4 Common Stock. The Company has also agreed to vote its shares of Sema4 Common Stock in accordance with the recommendations of Sema4’s board of directors for so long as it continues to hold at least 5% of the outstanding shares of Sema4 Common Stock. Further, Sema4 has also granted the Company certain customary shelf, piggyback and demand registration rights that require Sema4 to register the Company’s Sema4 Lock-Up Shares for resale under the Securities Act. OPKO’s intention is that we will no longer have a designee serving on Sema4’s board of directors upon the expiration of the Sema4 Lock-Up Period. As such, OPKO is not actively participating in the policy-making process of Sema4.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2021, GeneDx met the held-for-sale accounting criteria and, its related assets and liabilities are classified as held for sale in the consolidated balance sheet. GeneDx was included in our diagnostics segment as of December 31, 2021.</span></div>
</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
<opk:NumberofSalesEmployees contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" decimals="-1" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml80MC9mcmFnOjRmNmVmODRmOGFiYTQ4MmQ4M2E3ZTg5MjM3NmRmZmIzL3RleHRyZWdpb246NGY2ZWY4NGY4YWJhNDgyZDgzYTdlODkyMzc2ZGZmYjNfMzcy_2ffb9d79-fcd6-4018-8c52-579cd3404414" unitRef="employee"> 250 </opk:NumberofSalesEmployees>
<us-gaap:BusinessCombinationConsiderationTransferred1 contextRef="i3f7969e9854b45dfa1c0bba3df71fb1f_D20220509-20220509" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml80MC9mcmFnOjRmNmVmODRmOGFiYTQ4MmQ4M2E3ZTg5MjM3NmRmZmIzL3RleHRyZWdpb246NGY2ZWY4NGY4YWJhNDgyZDgzYTdlODkyMzc2ZGZmYjNfMzg0ODI5MDcyNjk0Ng_f2cea548-7087-44b5-a1ad-9322222e39c0" unitRef="usd"> 300000000 </us-gaap:BusinessCombinationConsiderationTransferred1>
<us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued contextRef="ic131f974c00a4170a9cffd5b1edf89a2_D20220509-20220509" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml80MC9mcmFnOjRmNmVmODRmOGFiYTQ4MmQ4M2E3ZTg5MjM3NmRmZmIzL3RleHRyZWdpb246NGY2ZWY4NGY4YWJhNDgyZDgzYTdlODkyMzc2ZGZmYjNfMzg0ODI5MDcyNjk3Mw_570cd399-b138-4a10-9fa5-ed94e2a09147" unitRef="shares"> 89907310 </us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
<us-gaap:CommonStockParOrStatedValuePerShare contextRef="i20b9a56ee2dc4a508f7dfc81c0b8817c_I20220509" decimals="2" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml80MC9mcmFnOjRmNmVmODRmOGFiYTQ4MmQ4M2E3ZTg5MjM3NmRmZmIzL3RleHRyZWdpb246NGY2ZWY4NGY4YWJhNDgyZDgzYTdlODkyMzc2ZGZmYjNfMzg0ODI5MDcyNjk4NQ_644c8304-28fc-464f-b588-f619e5323563" unitRef="usdPerShare"> 0.01 </us-gaap:CommonStockParOrStatedValuePerShare>
<opk:BusinessAcquisitionPercentOfSharesDepositedInEscrow contextRef="i20b9a56ee2dc4a508f7dfc81c0b8817c_I20220509" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml80MC9mcmFnOjRmNmVmODRmOGFiYTQ4MmQ4M2E3ZTg5MjM3NmRmZmIzL3RleHRyZWdpb246NGY2ZWY4NGY4YWJhNDgyZDgzYTdlODkyMzc2ZGZmYjNfMzg0ODI5MDczNjI3Mw_ef62ec0b-3eb1-4b49-b33d-e58d634d715c" unitRef="number"> 0.10 </opk:BusinessAcquisitionPercentOfSharesDepositedInEscrow>
<opk:BusinessAcquisitionEscrowDepositTerm contextRef="i3f7969e9854b45dfa1c0bba3df71fb1f_D20220509-20220509" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml80MC9mcmFnOjRmNmVmODRmOGFiYTQ4MmQ4M2E3ZTg5MjM3NmRmZmIzL3RleHRyZWdpb246NGY2ZWY4NGY4YWJhNDgyZDgzYTdlODkyMzc2ZGZmYjNfMzg0ODI5MDcyNzAyNA_91ae3c8a-0009-4541-858d-e475d23e02a3"> P12M </opk:BusinessAcquisitionEscrowDepositTerm>
<us-gaap:BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned contextRef="i20b9a56ee2dc4a508f7dfc81c0b8817c_I20220509" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml80MC9mcmFnOjRmNmVmODRmOGFiYTQ4MmQ4M2E3ZTg5MjM3NmRmZmIzL3RleHRyZWdpb246NGY2ZWY4NGY4YWJhNDgyZDgzYTdlODkyMzc2ZGZmYjNfMzg0ODI5MDcyNzAzOA_ebc9421c-323d-4165-829f-b41df306392c" unitRef="usd"> 12400000 </us-gaap:BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned>
<opk:BusinessAcquisitionEquityInterestIssuedOrIssuablePeriodFollowingClosingDate contextRef="i3f7969e9854b45dfa1c0bba3df71fb1f_D20220509-20220509" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml80MC9mcmFnOjRmNmVmODRmOGFiYTQ4MmQ4M2E3ZTg5MjM3NmRmZmIzL3RleHRyZWdpb246NGY2ZWY4NGY4YWJhNDgyZDgzYTdlODkyMzc2ZGZmYjNfMzg0ODI5MDczNjI2OA_7f2e2421-ac07-44c0-81d6-a1cb60877b57"> P4Y </opk:BusinessAcquisitionEquityInterestIssuedOrIssuablePeriodFollowingClosingDate>
<us-gaap:BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned contextRef="ifd33c3c2d74b47d984dc6f4de745b77a_I20220509" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml80MC9mcmFnOjRmNmVmODRmOGFiYTQ4MmQ4M2E3ZTg5MjM3NmRmZmIzL3RleHRyZWdpb246NGY2ZWY4NGY4YWJhNDgyZDgzYTdlODkyMzc2ZGZmYjNfMzg0ODI5MDcyNzA4NA_746878c0-54b4-4147-b52a-c354ccafc32a" unitRef="usd"> 2600000 </us-gaap:BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned>
<opk:BusinessAcquisitionEscrowPeriod contextRef="i3f7969e9854b45dfa1c0bba3df71fb1f_D20220509-20220509" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml80MC9mcmFnOjRmNmVmODRmOGFiYTQ4MmQ4M2E3ZTg5MjM3NmRmZmIzL3RleHRyZWdpb246NGY2ZWY4NGY4YWJhNDgyZDgzYTdlODkyMzc2ZGZmYjNfMzg0ODI5MDczNjI2OQ_69e7d315-9bd2-422c-8d51-ccbfc98b9724"> P4Y </opk:BusinessAcquisitionEscrowPeriod>
<us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable contextRef="ic131f974c00a4170a9cffd5b1edf89a2_D20220509-20220509" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml80MC9mcmFnOjRmNmVmODRmOGFiYTQ4MmQ4M2E3ZTg5MjM3NmRmZmIzL3RleHRyZWdpb246NGY2ZWY4NGY4YWJhNDgyZDgzYTdlODkyMzc2ZGZmYjNfMzg0ODI5MDcyNzA2OA_793b80a1-3615-4e48-9f7a-db1db89565ed" unitRef="usd"> 219400000 </us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable>
<us-gaap:SharePrice contextRef="if656c6b905904d278cbc8c9215fcebd3_I20220509" decimals="2" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml80MC9mcmFnOjRmNmVmODRmOGFiYTQ4MmQ4M2E3ZTg5MjM3NmRmZmIzL3RleHRyZWdpb246NGY2ZWY4NGY4YWJhNDgyZDgzYTdlODkyMzc2ZGZmYjNfMzg0ODI5MDcyNzEwNA_64f0ff4e-7b31-42ee-bf65-c6c9a140d30c" unitRef="usdPerShare"> 2.44 </us-gaap:SharePrice>
<opk:BusinessAcquisitionLockupAndVotingAgreementPeriodFollowingClosingDate contextRef="i3f7969e9854b45dfa1c0bba3df71fb1f_D20220509-20220509" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml80MC9mcmFnOjRmNmVmODRmOGFiYTQ4MmQ4M2E3ZTg5MjM3NmRmZmIzL3RleHRyZWdpb246NGY2ZWY4NGY4YWJhNDgyZDgzYTdlODkyMzc2ZGZmYjNfMzg0ODI5MDczNjIzNA_c880327d-85fa-4563-a466-1633d1d99e36"> P4Y </opk:BusinessAcquisitionLockupAndVotingAgreementPeriodFollowingClosingDate>
<opk:BusinessAcquisitionPercentageOfConsiderationSharesHeld contextRef="i3f7969e9854b45dfa1c0bba3df71fb1f_D20220509-20220509" decimals="3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml80MC9mcmFnOjRmNmVmODRmOGFiYTQ4MmQ4M2E3ZTg5MjM3NmRmZmIzL3RleHRyZWdpb246NGY2ZWY4NGY4YWJhNDgyZDgzYTdlODkyMzc2ZGZmYjNfMzg0ODI5MDcyNzE1NA_48216c2f-eb56-42a7-9b73-0cb70635bad1" unitRef="number"> 0.880 </opk:BusinessAcquisitionPercentageOfConsiderationSharesHeld>
<opk:BusinessAcquisitionLockupAndVotingAgreementPeriodFollowingClosingDate contextRef="i3f7969e9854b45dfa1c0bba3df71fb1f_D20220509-20220509" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml80MC9mcmFnOjRmNmVmODRmOGFiYTQ4MmQ4M2E3ZTg5MjM3NmRmZmIzL3RleHRyZWdpb246NGY2ZWY4NGY4YWJhNDgyZDgzYTdlODkyMzc2ZGZmYjNfMzg0ODI5MDczNjI1MQ_a878174b-f0e0-49c6-8127-a1b6c78ea629"> P4Y </opk:BusinessAcquisitionLockupAndVotingAgreementPeriodFollowingClosingDate>
<us-gaap:PaymentsToAcquireBusinessesGross contextRef="ibde59da9b1054f718e54290fcabbdad7_D20220429-20220429" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml80MC9mcmFnOjRmNmVmODRmOGFiYTQ4MmQ4M2E3ZTg5MjM3NmRmZmIzL3RleHRyZWdpb246NGY2ZWY4NGY4YWJhNDgyZDgzYTdlODkyMzc2ZGZmYjNfNDYxNA_bdf9081a-8bbd-43b4-9693-cf46ae6099c3" unitRef="usd"> 150000000 </us-gaap:PaymentsToAcquireBusinessesGross>
<us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued contextRef="ibde59da9b1054f718e54290fcabbdad7_D20220429-20220429" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml80MC9mcmFnOjRmNmVmODRmOGFiYTQ4MmQ4M2E3ZTg5MjM3NmRmZmIzL3RleHRyZWdpb246NGY2ZWY4NGY4YWJhNDgyZDgzYTdlODkyMzc2ZGZmYjNfNDY1NQ_08a5c4e5-63ec-48b3-95f5-942ca2e43812" unitRef="shares"> 80000000 </us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
<us-gaap:CommonStockParOrStatedValuePerShare contextRef="i6b6b004d382d4a789347b7f3a93c6395_I20220429" decimals="4" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml80MC9mcmFnOjRmNmVmODRmOGFiYTQ4MmQ4M2E3ZTg5MjM3NmRmZmIzL3RleHRyZWdpb246NGY2ZWY4NGY4YWJhNDgyZDgzYTdlODkyMzc2ZGZmYjNfMzg0ODI5MDcyNzE2MQ_64b74c1e-80de-4e15-9d15-e4956d83dca1" unitRef="usdPerShare"> 0.0001 </us-gaap:CommonStockParOrStatedValuePerShare>
<opk:BusinessCombinationConsiderationTransferredRevenueBasedMilestonePayments contextRef="ibde59da9b1054f718e54290fcabbdad7_D20220429-20220429" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml80MC9mcmFnOjRmNmVmODRmOGFiYTQ4MmQ4M2E3ZTg5MjM3NmRmZmIzL3RleHRyZWdpb246NGY2ZWY4NGY4YWJhNDgyZDgzYTdlODkyMzc2ZGZmYjNfNDc0Ng_fe64f115-3fc9-4dc3-aa0e-67d71e156b0c" unitRef="usd"> 150000000 </opk:BusinessCombinationConsiderationTransferredRevenueBasedMilestonePayments>
<opk:BusinessCombinationUpfrontConsiderationTransferred contextRef="ibde59da9b1054f718e54290fcabbdad7_D20220429-20220429" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml80MC9mcmFnOjRmNmVmODRmOGFiYTQ4MmQ4M2E3ZTg5MjM3NmRmZmIzL3RleHRyZWdpb246NGY2ZWY4NGY4YWJhNDgyZDgzYTdlODkyMzc2ZGZmYjNfNTA2NQ_04a4fc1f-098d-44a8-b5a9-a32e6275a932" unitRef="usd"> 322000000 </opk:BusinessCombinationUpfrontConsiderationTransferred>
<us-gaap:BusinessCombinationConsiderationTransferred1 contextRef="ibde59da9b1054f718e54290fcabbdad7_D20220429-20220429" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml80MC9mcmFnOjRmNmVmODRmOGFiYTQ4MmQ4M2E3ZTg5MjM3NmRmZmIzL3RleHRyZWdpb246NGY2ZWY4NGY4YWJhNDgyZDgzYTdlODkyMzc2ZGZmYjNfNTE1NQ_7c606881-574f-4bac-8af8-22eac5e9f3f5" unitRef="usd"> 447000000 </us-gaap:BusinessCombinationConsiderationTransferred1>
<us-gaap:GainLossOnSaleOfInvestments contextRef="i030741997068424c9b6f6d32294debfc_D20220401-20220630" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml80MC9mcmFnOjRmNmVmODRmOGFiYTQ4MmQ4M2E3ZTg5MjM3NmRmZmIzL3RleHRyZWdpb246NGY2ZWY4NGY4YWJhNDgyZDgzYTdlODkyMzc2ZGZmYjNfMjE5OTAyMzI4NTI2Nw_fe25fb4a-75cd-4cc4-a07d-95ec5d2c1290" unitRef="usd"> 15400000 </us-gaap:GainLossOnSaleOfInvestments>
<opk:BusinessAcquisitionShareholderAgreementExtensionPeriod contextRef="i609801dc869a46daa0f7c9d9d02d6f49_D20220429-20220429" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml80MC9mcmFnOjRmNmVmODRmOGFiYTQ4MmQ4M2E3ZTg5MjM3NmRmZmIzL3RleHRyZWdpb246NGY2ZWY4NGY4YWJhNDgyZDgzYTdlODkyMzc2ZGZmYjNfMzg0ODI5MDczNjI3MA_b703c2ed-aca4-4e07-9ac8-228c3fbdc79a"> P1Y </opk:BusinessAcquisitionShareholderAgreementExtensionPeriod>
<opk:BusinessAcquisitionShareholderAgreementExtensionPeriod contextRef="ie8068b4750fa4a7bb7fd57b976f255bb_D20220429-20220429" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml80MC9mcmFnOjRmNmVmODRmOGFiYTQ4MmQ4M2E3ZTg5MjM3NmRmZmIzL3RleHRyZWdpb246NGY2ZWY4NGY4YWJhNDgyZDgzYTdlODkyMzc2ZGZmYjNfMzg0ODI5MDczNjI3MQ_ed62caa9-ad8d-4dd3-8241-ef099c719958"> P6M </opk:BusinessAcquisitionShareholderAgreementExtensionPeriod>
<opk:BusinessAcquisitionOutstandingSharesHeldPercentage contextRef="i4154180b9991448a838549649e73ab2d_I20220429" decimals="2" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml80MC9mcmFnOjRmNmVmODRmOGFiYTQ4MmQ4M2E3ZTg5MjM3NmRmZmIzL3RleHRyZWdpb246NGY2ZWY4NGY4YWJhNDgyZDgzYTdlODkyMzc2ZGZmYjNfMTY0OTI2NzQ3MTY2Mg_62c6f9bc-86ae-4a72-9875-771cc859a4ef" unitRef="number"> 0.05 </opk:BusinessAcquisitionOutstandingSharesHeldPercentage>
<us-gaap:UnusualOrInfrequentItemsDisclosureTextBlock contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml80My9mcmFnOjgzMGUyNWVhMjcxZTQ1MzViODg2MTk0YjQyMzQ1YTcyL3RleHRyZWdpb246ODMwZTI1ZWEyNzFlNDUzNWI4ODYxOTRiNDIzNDVhNzJfMzMxNg_c99cb331-c17c-45c7-b69b-82fc83b98c00">
IMPACT OF COVID-19<div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We continue to be a part of the coordinated public and private sector response to SARS-CoV-2, a novel strain of coronavirus, referred to as COVID-19. There continues to be a high level of uncertainty relating to how the pandemic will evolve, how governments and consumers will react, progress on the distribution of vaccines and whether the pandemic will have a longer-term effect on the healthcare industry and patient habits. BioReference is providing COVID-19 solutions, including diagnostic molecular testing and serology antibody testing, to meet the testing needs of its customers, including physicians, health systems, long-term care facilities, governments, schools, employers, professional sports teams and entertainment venues, as well as the general public through relationships with retail pharmacy chains.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Since the pandemic began in the U.S., we have invested in testing capabilities and infrastructure to meet demand for our molecular and antibody testing for COVID-19. Throughout the pandemic, we have managed our company-wide lab operations specimen acquisition, logistics, procurement, customer service, and initiatives to manage our cost structure to match the ever changing COVID-19 testing volumes and to manage efficiency gains in our core clinical lines of business. We anticipate that COVID-19 will continue to impact our business in 2022 and, overall, we expect COVID-19 test demand to continue to decline in 2022 as compared to 2021.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Revenue from services for the six months ended June 30, 2022 decreased by $430.7 million as compared to 2021 due to lower COVID-19 testing volumes. Excluding COVID-19 test volumes, for the six months ended June 30, 2022, routine clinical test volume decreased 26.2% as compared to volumes for the six months ended June 30, 2021.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In March 2022, the U.S. Health Resources and Services Administration ("HRSA") informed providers that, after March 22, 2022, it would stop accepting claims for testing and treatment for uninsured individuals under the HRSA COVID-19 Uninsured Program and that claims submitted prior to that date would be subject to eligibility and availability of funds. For the six months ended June 30, 2022, revenue for testing of uninsured individuals under the HRSA COVID-19 Uninsured Program represented approximately 5.7% of our COVID-19 testing revenue. As of June 30, 2022, less than 2% of our net accounts receivable was associated with claims for reimbursement for COVID-19 testing of uninsured individuals. Although we believe that our estimates for contractual allowances and patient price concessions are appropriate, actual results could differ from those estimates.</span></div>
</us-gaap:UnusualOrInfrequentItemsDisclosureTextBlock>
<opk:IncreaseDecreaseInRevenueFromContractWithCustomerExcludingAssessedTax contextRef="i8b5aa09d29044d42bbfdc68d86a7e9a3_D20220101-20220630" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml80My9mcmFnOjgzMGUyNWVhMjcxZTQ1MzViODg2MTk0YjQyMzQ1YTcyL3RleHRyZWdpb246ODMwZTI1ZWEyNzFlNDUzNWI4ODYxOTRiNDIzNDVhNzJfNTQ5NzU1ODI4NjM5_acc873a4-0e36-4a9c-a4fd-f9340a8ad5ee" unitRef="usd"> -430700000 </opk:IncreaseDecreaseInRevenueFromContractWithCustomerExcludingAssessedTax>
<opk:ChangeInTestingVolumePercent contextRef="ib756cb650b5d46b5b7e407c80f59f34c_D20220101-20220630" decimals="3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml80My9mcmFnOjgzMGUyNWVhMjcxZTQ1MzViODg2MTk0YjQyMzQ1YTcyL3RleHRyZWdpb246ODMwZTI1ZWEyNzFlNDUzNWI4ODYxOTRiNDIzNDVhNzJfMjE5OTAyMzI3MTQxNQ_359ec63d-c951-49e1-8384-80505d08d937" unitRef="number"> 0.262 </opk:ChangeInTestingVolumePercent>
<us-gaap:ConcentrationRiskPercentage1 contextRef="ic362a16dc89d4be3aa8eabf5fbcb4e30_D20220101-20220630" decimals="3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml80My9mcmFnOjgzMGUyNWVhMjcxZTQ1MzViODg2MTk0YjQyMzQ1YTcyL3RleHRyZWdpb246ODMwZTI1ZWEyNzFlNDUzNWI4ODYxOTRiNDIzNDVhNzJfMjE5OTAyMzI3MTQzNA_38d95dfc-93a3-4a16-b670-529ff4d2f0b6" unitRef="number"> 0.057 </us-gaap:ConcentrationRiskPercentage1>
<us-gaap:ConcentrationRiskPercentage1 contextRef="i3f42af92d53c4588aba3e030054466b3_D20220101-20220630" decimals="2" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml80My9mcmFnOjgzMGUyNWVhMjcxZTQ1MzViODg2MTk0YjQyMzQ1YTcyL3RleHRyZWdpb246ODMwZTI1ZWEyNzFlNDUzNWI4ODYxOTRiNDIzNDVhNzJfMjE5OTAyMzI3MTQyNQ_5162c10a-40a4-46ba-89bc-f4ecc49f9ad3" unitRef="number"> 0.02 </us-gaap:ConcentrationRiskPercentage1>
<us-gaap:SignificantAccountingPoliciesTextBlock contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml80Ni9mcmFnOjI2MmUyZTgzNjZhNTQzNDc4MmNhYTY3NzJmOGUwM2JiL3RleHRyZWdpb246MjYyZTJlODM2NmE1NDM0NzgyY2FhNjc3MmY4ZTAzYmJfMjQ3OTg_09681278-c369-4f91-88cb-c7087ee9ef33">
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES<div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Basis of presentation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The accompanying unaudited Condensed Consolidated Financial Statements have been prepared in accordance with accounting principles generally accepted in the U.S. (“GAAP”) and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all information and notes required by GAAP for complete financial statements. In the opinion of management, all adjustments (consisting of only normal recurring adjustments or adjustments otherwise disclosed herein) considered necessary to present fairly the Company’s results of operations, financial position and cash flows have been made. The results of operations and cash flows for the six months ended June 30, 2022 are not necessarily indicative of the results of operations and cash flows that may be reported for the remainder of 2022 or any other future periods. The unaudited Condensed Consolidated Financial Statements should be read in conjunction with the audited Consolidated Financial Statements and the Notes to Consolidated Financial Statements included in our Annual Report on Form 10-K for the year ended December 31, 2021. </span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Principles of consolidation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The accompanying unaudited Condensed Consolidated Financial Statements include the accounts of OPKO Health, Inc. and our wholly-owned subsidiaries. All intercompany accounts and transactions are eliminated in consolidation. </span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Use of estimates</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ significantly from these estimates.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash and cash equivalents</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Cash and cash equivalents include short-term, interest-bearing instruments with original maturities of 90 days or less at the date of purchase. We also consider all highly liquid investments with original maturities at the date of purchase of 90 days or less as cash equivalents. These investments include money markets, bank deposits, certificates of deposit and U.S. treasury securities. </span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Inventories</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Inventories are valued at the lower of cost and net realizable value. Cost is determined by the first-in, first-out method. We consider such factors as the amount of inventory on hand, estimated time required to sell such inventories, remaining shelf-life, and current market conditions to determine whether inventories are stated at the lower of cost and net realizable value. Inventories at our diagnostics segment consist primarily of purchased laboratory supplies, which are used in our testing laboratories. Inventory obsolescence expense for the three and six months ended June 30, 2022 was $0.3 million and $1.0 million, respectively. Inventory obsolescence expense for the three and six months ended June 30, 2021 was $0.9 million and $3.9 million, respectively.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Goodwill and intangible assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Goodwill represents the difference between the purchase price and the estimated fair value of the net assets acquired accounted for by the acquisition method of accounting. Refer to Note 5. Goodwill, in-process research and development (“IPR&D”) and other intangible assets acquired in business combinations, licensing and other transactions was $1.6 billion and $1.4 billion, respectively, at June 30, 2022 and December 31, 2021.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assets acquired and liabilities assumed in business combinations, licensing and other transactions are generally recognized at the date of acquisition at their respective fair values. Any excess of the purchase price over the estimated fair values of the net assets acquired is recognized as goodwill. At acquisition, we generally determine the fair value of intangible assets, including IPR&D, using the “income method.”</span></div><div style="margin-bottom:5pt;margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subsequent to their acquisition, goodwill and indefinite lived intangible assets are tested at least annually as of October 1 for impairment, or when events or changes in circumstances indicate it is more likely than not that the carrying amount of such assets may not be recoverable.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Estimating the fair value of a reporting unit for goodwill impairment is highly sensitive to changes in projections and assumptions and changes in assumptions could potentially lead to impairment. We perform sensitivity analyses around our assumptions in order to assess the reasonableness of the assumptions and the results of our testing. Ultimately, potential changes in these assumptions may impact the estimated fair value of a reporting unit and result in an impairment if the fair value of such reporting unit is less than its carrying value. Goodwill was $578.8 million and $520.6 million, respectively, at June 30, 2022 and December 31, 2021. At December 31, 2021, Assets held for sale include $151.8 million of goodwill related to GeneDx. </span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net intangible assets other than goodwill was $1,057.4 million and $911.9 million, including IPR&D of $195.0 million and $590.2 million at June 30, 2022 and December 31, 2021, respectively. Intangible assets are highly vulnerable to impairment charges, particularly newly acquired assets for recently launched products and IPR&D. Considering the high risk nature of research and development and the industry’s success rate of bringing developmental compounds to market, IPR&D impairment charges may occur in future periods. Estimating the fair value of IPR&D for potential impairment is highly sensitive to changes in projections and assumptions and changes in assumptions could potentially lead to impairment.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon obtaining regulatory approval, IPR&D assets are then accounted for as a finite-lived intangible asset and amortized on a straight-line basis over its estimated useful life. If the project is abandoned, the IPR&D asset is charged to expense. Finite lived intangible assets are tested for impairment when events or changes in circumstances indicate it is more likely than not that the carrying amount of such assets may not be recoverable. The testing includes a comparison of the carrying amount of the asset to its estimated undiscounted future cash flows expected to be generated by the asset. If the carrying amount of an asset exceeds its estimated undiscounted future cash flows, then an impairment charge is recognized for the amount by which the carrying amount of the asset exceeds the fair value of the asset.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that our estimates and assumptions in testing goodwill and other intangible assets, including IPR&D, for</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">impairment are reasonable and otherwise consistent with assumptions that marketplace participants would use in their estimates</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of fair value. However, if future results are not consistent with our estimates and assumptions, including as a result of the</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">COVID-19 global pandemic, then we may be exposed to additional impairment charges, which could be material. Pfizer submitted the initial BLA with the FDA for approval of Somatrogon (hGH-CTP) in the United States and Pfizer received a Complete Response Letter in January 2022. Pfizer and OPKO are evaluating the FDA’s comments and will work with the agency to determine the best path forward for Somatrogon (hGH-CTP) in the United States.</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first quarter of 2022, we reclassified $590.0 million of IPR&D related to Somatrogon (hGH-CTP) from IPR&D in our Condensed Consolidated Balance Sheet upon the approval of NGENLA (Somatrogon) in Europe and Japan. The assets will be amortized on a straight-line basis over their estimated useful life of approximately 12 years.</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We amortize intangible assets with definite lives on a straight-line basis over their estimated useful lives, ranging from 3 to 20 years. We use the straight-line method of amortization as there is no reliably determinable pattern in which the economic benefits of our intangible assets are consumed or otherwise used up. Amortization expense was $44.8 million and $25.2 million for the six months ended June 30, 2022 and 2021, respectively.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair value measurements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The carrying amounts of our cash and cash equivalents, accounts receivable, accounts payable and short-term debt approximate their fair value due to the short-term maturities of these instruments. Investments that are considered equity securities as of June 30, 2022 and December 31, 2021 are predominately carried at fair value. Our debt under the Credit Agreement (as defined below) approximates fair value due to the variable rate of interest applicable to such debt.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In evaluating the fair value information, considerable judgment is required to interpret the market data used to develop the estimates. The use of different market assumptions and/or different valuation techniques may have a material effect on the </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">estimated fair value amounts. Accordingly, the estimates of fair value presented herein may not be indicative of the amounts that could be realized in a current market exchange. Refer to Note 9.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingent consideration</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Each period we revalue the contingent consideration obligations associated with certain prior acquisitions to their fair value and record increases in the fair value as contingent consideration expense and decreases in the fair value as a reduction in contingent consideration expense. Changes in contingent consideration result from changes in the assumptions regarding probabilities of successful achievement of related milestones, the estimated timing in which the milestones are achieved and the discount rate used to estimate the fair value of the liability. Contingent consideration may change significantly as our development programs progress, revenue estimates evolve and additional data is obtained, impacting our assumptions. The assumptions used in estimating fair value require significant judgment. The use of different assumptions and judgments could result in a materially different estimate of fair value which may have a material impact on our results from operations and financial position.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Derivative financial instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. We record derivative financial instruments on our Condensed Consolidated Balance Sheet at their fair value and recognize the changes in the fair value in our Condensed Consolidated Statement of Operations when they occur, the only exception being derivatives that qualify as hedges. For the derivative instrument to qualify as a hedge, we are required to meet strict hedge effectiveness and contemporaneous documentation requirements at the initiation of the hedge and assess the hedge effectiveness on an ongoing basis over the life of the hedge. At June 30, 2022 and December 31, 2021, our foreign currency forward contracts held to economically hedge inventory purchases did not meet the documentation requirements to be designated as hedges. Accordingly, we recognized all changes in the fair values of our derivatives instruments, net, in our Condensed Consolidated Statement of Operations. Refer to Note 10.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Property, plant and equipment</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Property, plant and equipment are recorded at cost or fair value if acquired in a business combination. Depreciation is provided using the straight-line method over the estimated useful lives of the assets and includes amortization expense for assets capitalized under finance leases. The estimated useful lives by asset class are as follows: software - 3 years, machinery, medical and other equipment - 5-8 years, furniture and fixtures - 5-12 years, leasehold improvements - the lesser of their useful life or the lease term, buildings and improvements - 10-40 years, and automobiles - 3-5 years. Expenditures for repairs and maintenance are charged to expense as incurred. Assets held under finance leases are included within Property, plant and equipment, net in our Consolidated Balance Sheets and are amortized over the shorter of their useful lives or the expected term of their related leases. Depreciation expense was $5.2 million and $11.0 million for the three and six months ended June 30, 2022, respectively. Depreciation expense was $8.0 million and $15.4 million for three and six months ended June 30, 2021, respectively.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Impairment of long-lived assets. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-lived assets, such as property and equipment and assets held for sale, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to estimated undiscounted future cash flows expected to be generated by the asset. If the carrying amount of an asset exceeds its estimated future cash flows, then an impairment charge is recognized for the amount by which the carrying amount of the asset exceeds the fair value of the asset.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income taxes.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Income taxes are accounted for under the asset-and-liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and the respective tax bases and for operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in operations in the period that includes the enactment date. We periodically evaluate the realizability of our net deferred tax assets. Our tax accruals are analyzed periodically and adjustments are made as events occur to warrant such adjustment. Valuation allowances on certain U.S. deferred tax assets and non-U.S. deferred tax assets are established, because realization of these tax benefits through future taxable income does not meet the more-likely-than-not threshold.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We operate in various countries and tax jurisdictions globally.  For interim reporting purposes, we record income taxes based on the expected effective income tax rate, taking into consideration year to date and global forecasted tax results.  For the six months ended June 30, 2022, the tax rate differed from the U.S. federal statutory rate of 21% primarily due to the valuation allowance against certain U.S. and non-U.S. deferred tax assets, the relative mix in earnings and losses in the U.S. versus foreign tax jurisdictions, and the impact of certain discrete tax events and operating results in tax jurisdictions which do not result in a tax benefit.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue recognition</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. We recognize revenue when a customer obtains control of promised goods or services in accordance with Accounting Standards Codification Topic 606, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue from Contracts with Customers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (“Topic 606”). The amount of revenue that is recorded reflects the consideration that we expect to receive in exchange for those goods or services. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We apply the following five-step model in order to determine this amount: (i) identify the contract(s) with a customer; (ii) identify the performance obligations in the contract; (iii) determine the transaction price; (iv) allocate the transaction price to the performance obligations in the contract; and (v) recognize revenue when (or as) we satisfy a performance obligation. </span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We apply the five-step model to contracts when it is probable that we will collect the consideration we are entitled to in exchange for the goods or services we transfer to the customer. At contract inception, once the contract is determined to be within the scope of Topic 606, we review the contract to determine which performance obligations we must deliver and which of these performance obligations are distinct. We recognize as revenue the amount of the transaction price that is allocated to the respective performance obligation when the performance obligation is satisfied or as it is satisfied. For a complete discussion of accounting for Revenues from services, Revenues from products and Revenue from transfer of intellectual property and other, refer to Note 13.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Concentration of credit risk and allowance for credit losses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Financial instruments that potentially subject us to concentrations of credit risk consist primarily of accounts receivable. Substantially all of our accounts receivable are with either companies in the healthcare industry or patients. However, credit risk is limited due to the number of our clients as well as their dispersion across many different geographic regions.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While we have receivables due from federal and state governmental agencies, we do not believe that such receivables represent a credit risk because the related healthcare programs are funded by federal and state governments, and payment is primarily dependent upon submitting appropriate documentation. On June 30, 2022 and December 31, 2021, receivable balances (net of explicit and implicit price concessions) from Medicare and Medicaid were 12% and 6%, respectively, of our consolidated Accounts receivable, net. On June 30, 2022 and December 31, 2021, receivable balances (net of explicit and implicit price concessions) due directly from states, cities and other municipalities, specifically related to our real-time reverse-transcription polymerase chain reaction (real-time RT-PCR) assay to detect COVID-19, were 3.9% and 4.1% of our consolidated accounts receivable, net, respectively. </span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The portion of our accounts receivable due from individual patients comprises the largest portion of credit risk. At June 30, 2022 and December 31, 2021, receivables due from patients represented approximately 2.3% and 0.7%, respectively, of our consolidated Accounts receivable, net. </span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We assess the collectability of accounts receivable balances by considering factors such as historical collection experience, customer credit worthiness, the age of accounts receivable balances, regulatory changes and current economic conditions and trends that may affect a customer’s ability to pay. Actual results could differ from those estimates. The allowance for credit losses was $6.8 million and $1.8 million at June 30, 2022 and December 31, 2021, respectively. The credit loss expense for the three and six months ended June 30, 2022 was $0.1 million and $0.2 million, respectively. The credit loss expense for the three and six months ended June 30, 2021 was $0.3 million and $0.6 million, respectively.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Equity-based compensation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. We measure the cost of services received in exchange for an award of equity instruments based on the grant-date fair value of the award. That cost is recognized in the Condensed Consolidated Statement of Operations over the period during which an employee is required to provide service in exchange for the award. We record excess tax benefits realized from the exercise of stock options as cash flows from operations. For the three and six months ended June 30, 2022 we recorded $4.3 million and $11.9 million, respectively, of equity-based compensation expense. For the three and six months ended June 30, 2021 we recorded $3.5 million and $6.1 million, respectively, of equity-based compensation expense.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Research and development expenses. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development expenses include external and internal expenses. External expenses include clinical and non-clinical activities performed by contract research organizations, lab services, purchases of drug and diagnostic product materials and manufacturing development costs. Research and development employee-related expenses include salaries, benefits and equity-based compensation expense. Other internal research and development expenses are incurred to support overall research and development activities and include expenses related to general overhead and facilities. We expense these costs in the period in which they are incurred. We estimate our liabilities for research and development expenses in order to match the recognition of expenses to the period in which the actual services are received. As such, accrued liabilities related to third party research and development activities are recognized based upon our estimate of services received and degree of completion of the services in accordance with the specific third party contract.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development expense includes costs for in-process research and development projects acquired in asset acquisitions which have not reached technological feasibility, and which have no alternative future use. For in-process research and development projects acquired in business combinations, the in-process research and development project is capitalized and evaluated for impairment until the development process has been completed. Once the development process has been completed the asset will be amortized over its remaining estimated useful life.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Segment reporting</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Our chief operating decision-maker (“CODM”) is Phillip Frost, M.D., our Chairman and Chief Executive Officer. Our CODM reviews our operating results and operating plans and makes resource allocation decisions on a Company-wide or aggregate basis. We manage our operations in two reportable segments, pharmaceutical and diagnostics. The pharmaceutical segment consists of our pharmaceutical operations in Chile, Mexico, Ireland, Israel and Spain, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Rayaldee</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> product sales and our pharmaceutical research and development. The diagnostics segment primarily consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. There are no significant inter-segment sales. We evaluate the performance of each segment based on operating profit or loss. There is no inter-segment allocation of interest expense or income taxes. Refer to Note 15.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Shipping and handling costs. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not charge customers for shipping and handling costs. Shipping and handling costs are classified as Cost of revenues in the Condensed Consolidated Statement of Operations.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Foreign currency translation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The financial statements of certain of our foreign operations are measured using the local currency as the functional currency. The local currency assets and liabilities are generally translated at the rate of exchange to the U.S. dollar on the balance sheet date and the local currency revenues and expenses are translated at average rates of exchange to the U.S. dollar during the reporting periods. Foreign currency transaction gains (losses) have been reflected as a component of Other income (expense), net within the Condensed Consolidated Statement of Operations and foreign currency translation gains (losses) have been included as a component of the Condensed Consolidated Statement of Comprehensive Income (Loss). During the three and six months ended June 30, 2022, we recorded $0.8 million and $1.8 million, respectively of transaction losses. During the three and six months ended June 30, 2021, we recorded $(0.4) million and $4.4 million, respectively, of transaction gains and losses.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Variable interest entities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The consolidation of a variable interest entity (“VIE”) is required when an enterprise has a controlling financial interest. A controlling financial interest in a VIE will have both of the following characteristics: (a) the power to direct the activities of a VIE that most significantly impact the VIE’s economic performance and (b) the obligation to absorb losses of the VIE that could potentially be significant to the VIE. Refer to Note 6.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. We have made strategic investments in development stage and emerging companies. We record these investments as equity method investments or as equity securities based on our percentage of ownership and whether we have significant influence over the operations of the investees. For investments classified under the equity method of accounting, we record our proportionate share of their losses in Losses from investments in investees in our Condensed Consolidated Statement of Operations. Refer to Note 6. For investments classified as equity securities, we record changes in their fair value as Other income (expense) in our Condensed Consolidated Statement of Operations based on their closing price per share at the end of each reporting period, unless the equity security does not have a readily determinable fair value. Refer to Note 6.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recently adopted accounting pronouncements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, the FASB issued ASU No. 2020-06, “Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity's Own Equity (Subtopic 815-40).” ASU 2020-06 simplifies the accounting for convertible instruments by reducing the number of accounting models for convertible debt instruments and convertible preferred stock. The ASU is effective for public entities for fiscal years beginning after December 15, 2021, with early adoption permitted. As required, we adopted ASU 2020-06 on January 1, 2022 and used the modified retrospective approach for all convertible debt instruments at the beginning of the period of adoptions. Results for reporting periods beginning January 1, 2022 are presented under ASU 2020-06, while prior period amounts were not adjusted and continue to be reported in accordance with historic accounting guidance. </span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the modified approach, entities will apply the guidance to all financial instruments that are outstanding as of the beginning of the year of adoption with the cumulative effect recognized as an adjustment to the opening balance of retained earnings. ASU 2020-06 eliminates the cash conversion and beneficial conversion feature models in ASC 470-20 that require an issuer of certain convertible debt and preferred stock to separately account for embedded conversion features as a component of equity. The adoption of ASU 2020-06 at January 1, 2022 resulted in an increase of the Convertible notes of $21.6 million, a reduction of the Accumulated deficit of $17.5 million and a reduction of Additional paid-in capital of $39.1 million.</span></div>
</us-gaap:SignificantAccountingPoliciesTextBlock>
<us-gaap:BasisOfAccountingPolicyPolicyTextBlock contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml80Ni9mcmFnOjI2MmUyZTgzNjZhNTQzNDc4MmNhYTY3NzJmOGUwM2JiL3RleHRyZWdpb246MjYyZTJlODM2NmE1NDM0NzgyY2FhNjc3MmY4ZTAzYmJfMjQ3MzI_a8acedc4-abcf-4a96-884d-24e106019397"> Basis of presentation. The accompanying unaudited Condensed Consolidated Financial Statements have been prepared in accordance with accounting principles generally accepted in the U.S. (“GAAP”) and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all information and notes required by GAAP for complete financial statements. In the opinion of management, all adjustments (consisting of only normal recurring adjustments or adjustments otherwise disclosed herein) considered necessary to present fairly the Company’s results of operations, financial position and cash flows have been made. The results of operations and cash flows for the six months ended June 30, 2022 are not necessarily indicative of the results of operations and cash flows that may be reported for the remainder of 2022 or any other future periods. The unaudited Condensed Consolidated Financial Statements should be read in conjunction with the audited Consolidated Financial Statements and the Notes to Consolidated Financial Statements included in our Annual Report on Form 10-K for the year ended December 31, 2021. </us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
<us-gaap:ConsolidationPolicyTextBlock contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml80Ni9mcmFnOjI2MmUyZTgzNjZhNTQzNDc4MmNhYTY3NzJmOGUwM2JiL3RleHRyZWdpb246MjYyZTJlODM2NmE1NDM0NzgyY2FhNjc3MmY4ZTAzYmJfMjQ3ODE_ab38ee57-28b1-4e70-995f-61224ccb6f58"> Principles of consolidation. The accompanying unaudited Condensed Consolidated Financial Statements include the accounts of OPKO Health, Inc. and our wholly-owned subsidiaries. All intercompany accounts and transactions are eliminated in consolidation. </us-gaap:ConsolidationPolicyTextBlock>
<us-gaap:UseOfEstimates contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml80Ni9mcmFnOjI2MmUyZTgzNjZhNTQzNDc4MmNhYTY3NzJmOGUwM2JiL3RleHRyZWdpb246MjYyZTJlODM2NmE1NDM0NzgyY2FhNjc3MmY4ZTAzYmJfMjQ3NzM_2b219086-5f54-4f46-857b-216087629c99">
<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Use of estimates</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ significantly from these estimates.</span>
</us-gaap:UseOfEstimates>
<us-gaap:CashAndCashEquivalentsPolicyTextBlock contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml80Ni9mcmFnOjI2MmUyZTgzNjZhNTQzNDc4MmNhYTY3NzJmOGUwM2JiL3RleHRyZWdpb246MjYyZTJlODM2NmE1NDM0NzgyY2FhNjc3MmY4ZTAzYmJfMjQ4NTE_77b16443-8933-4a94-b9c2-cef3bc0979d7"> Cash and cash equivalents. Cash and cash equivalents include short-term, interest-bearing instruments with original maturities of 90 days or less at the date of purchase. We also consider all highly liquid investments with original maturities at the date of purchase of 90 days or less as cash equivalents. These investments include money markets, bank deposits, certificates of deposit and U.S. treasury securities. </us-gaap:CashAndCashEquivalentsPolicyTextBlock>
<us-gaap:InventoryPolicyTextBlock contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml80Ni9mcmFnOjI2MmUyZTgzNjZhNTQzNDc4MmNhYTY3NzJmOGUwM2JiL3RleHRyZWdpb246MjYyZTJlODM2NmE1NDM0NzgyY2FhNjc3MmY4ZTAzYmJfMjQ3MTc_0bfe5fe7-0a9a-493d-9d88-fa0a6c7c0dec"> Inventories. Inventories are valued at the lower of cost and net realizable value. Cost is determined by the first-in, first-out method. We consider such factors as the amount of inventory on hand, estimated time required to sell such inventories, remaining shelf-life, and current market conditions to determine whether inventories are stated at the lower of cost and net realizable value. Inventories at our diagnostics segment consist primarily of purchased laboratory supplies, which are used in our testing laboratories. </us-gaap:InventoryPolicyTextBlock>
<us-gaap:InventoryWriteDown contextRef="i50aa2eea9a6446b6ad796d994509b1ad_D20220401-20220630" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml80Ni9mcmFnOjI2MmUyZTgzNjZhNTQzNDc4MmNhYTY3NzJmOGUwM2JiL3RleHRyZWdpb246MjYyZTJlODM2NmE1NDM0NzgyY2FhNjc3MmY4ZTAzYmJfMjg4MQ_75c9f675-c7b3-4fb3-8aad-b875d06eb6e2" unitRef="usd"> 300000 </us-gaap:InventoryWriteDown>
<us-gaap:InventoryWriteDown contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml80Ni9mcmFnOjI2MmUyZTgzNjZhNTQzNDc4MmNhYTY3NzJmOGUwM2JiL3RleHRyZWdpb246MjYyZTJlODM2NmE1NDM0NzgyY2FhNjc3MmY4ZTAzYmJfMjE5OTAyMzI4MDYxNQ_01371781-836e-416b-913d-b7cf49521be4" unitRef="usd"> 1000000 </us-gaap:InventoryWriteDown>
<us-gaap:InventoryWriteDown contextRef="if2a6207b6732465a921fe019a2a0f048_D20210401-20210630" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml80Ni9mcmFnOjI2MmUyZTgzNjZhNTQzNDc4MmNhYTY3NzJmOGUwM2JiL3RleHRyZWdpb246MjYyZTJlODM2NmE1NDM0NzgyY2FhNjc3MmY4ZTAzYmJfMjg4OA_c5d289c2-33a1-4d40-b272-e6bac9944910" unitRef="usd"> 900000 </us-gaap:InventoryWriteDown>
<us-gaap:InventoryWriteDown contextRef="i420e18e30084498a98510d48880063cd_D20210101-20210630" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml80Ni9mcmFnOjI2MmUyZTgzNjZhNTQzNDc4MmNhYTY3NzJmOGUwM2JiL3RleHRyZWdpb246MjYyZTJlODM2NmE1NDM0NzgyY2FhNjc3MmY4ZTAzYmJfMjE5OTAyMzI4MDY0OA_9f7bb30a-3c27-4092-bd8b-f90d9be48453" unitRef="usd"> 3900000 </us-gaap:InventoryWriteDown>
<us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml80Ni9mcmFnOjI2MmUyZTgzNjZhNTQzNDc4MmNhYTY3NzJmOGUwM2JiL3RleHRyZWdpb246MjYyZTJlODM2NmE1NDM0NzgyY2FhNjc3MmY4ZTAzYmJfMjQ4MzY_7ac2b001-fbbd-454c-945e-8a7ab152c553">
<div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Goodwill and intangible assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Goodwill represents the difference between the purchase price and the estimated fair value of the net assets acquired accounted for by the acquisition method of accounting. Refer to Note 5. Goodwill, in-process research and development (“IPR&D”) and other intangible assets acquired in business combinations, licensing and other transactions was $1.6 billion and $1.4 billion, respectively, at June 30, 2022 and December 31, 2021.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assets acquired and liabilities assumed in business combinations, licensing and other transactions are generally recognized at the date of acquisition at their respective fair values. Any excess of the purchase price over the estimated fair values of the net assets acquired is recognized as goodwill. At acquisition, we generally determine the fair value of intangible assets, including IPR&D, using the “income method.”</span></div><div style="margin-bottom:5pt;margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subsequent to their acquisition, goodwill and indefinite lived intangible assets are tested at least annually as of October 1 for impairment, or when events or changes in circumstances indicate it is more likely than not that the carrying amount of such assets may not be recoverable.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Estimating the fair value of a reporting unit for goodwill impairment is highly sensitive to changes in projections and assumptions and changes in assumptions could potentially lead to impairment. We perform sensitivity analyses around our assumptions in order to assess the reasonableness of the assumptions and the results of our testing. Ultimately, potential changes in these assumptions may impact the estimated fair value of a reporting unit and result in an impairment if the fair value of such reporting unit is less than its carrying value. Goodwill was $578.8 million and $520.6 million, respectively, at June 30, 2022 and December 31, 2021. At December 31, 2021, Assets held for sale include $151.8 million of goodwill related to GeneDx. </span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net intangible assets other than goodwill was $1,057.4 million and $911.9 million, including IPR&D of $195.0 million and $590.2 million at June 30, 2022 and December 31, 2021, respectively. Intangible assets are highly vulnerable to impairment charges, particularly newly acquired assets for recently launched products and IPR&D. Considering the high risk nature of research and development and the industry’s success rate of bringing developmental compounds to market, IPR&D impairment charges may occur in future periods. Estimating the fair value of IPR&D for potential impairment is highly sensitive to changes in projections and assumptions and changes in assumptions could potentially lead to impairment.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon obtaining regulatory approval, IPR&D assets are then accounted for as a finite-lived intangible asset and amortized on a straight-line basis over its estimated useful life. If the project is abandoned, the IPR&D asset is charged to expense. Finite lived intangible assets are tested for impairment when events or changes in circumstances indicate it is more likely than not that the carrying amount of such assets may not be recoverable. The testing includes a comparison of the carrying amount of the asset to its estimated undiscounted future cash flows expected to be generated by the asset. If the carrying amount of an asset exceeds its estimated undiscounted future cash flows, then an impairment charge is recognized for the amount by which the carrying amount of the asset exceeds the fair value of the asset.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that our estimates and assumptions in testing goodwill and other intangible assets, including IPR&D, for</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">impairment are reasonable and otherwise consistent with assumptions that marketplace participants would use in their estimates</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of fair value. However, if future results are not consistent with our estimates and assumptions, including as a result of the</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">COVID-19 global pandemic, then we may be exposed to additional impairment charges, which could be material. Pfizer submitted the initial BLA with the FDA for approval of Somatrogon (hGH-CTP) in the United States and Pfizer received a Complete Response Letter in January 2022. Pfizer and OPKO are evaluating the FDA’s comments and will work with the agency to determine the best path forward for Somatrogon (hGH-CTP) in the United States.</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first quarter of 2022, we reclassified $590.0 million of IPR&D related to Somatrogon (hGH-CTP) from IPR&D in our Condensed Consolidated Balance Sheet upon the approval of NGENLA (Somatrogon) in Europe and Japan. The assets will be amortized on a straight-line basis over their estimated useful life of approximately 12 years.</span></div>We amortize intangible assets with definite lives on a straight-line basis over their estimated useful lives, ranging from 3 to 20 years. We use the straight-line method of amortization as there is no reliably determinable pattern in which the economic benefits of our intangible assets are consumed or otherwise used up.
</us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock>
<opk:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedGoodwillandIntangibleAssets contextRef="i4768f885851b49f986857a2a956f9162_I20220630" decimals="-8" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml80Ni9mcmFnOjI2MmUyZTgzNjZhNTQzNDc4MmNhYTY3NzJmOGUwM2JiL3RleHRyZWdpb246MjYyZTJlODM2NmE1NDM0NzgyY2FhNjc3MmY4ZTAzYmJfMzI4Nw_925b5aa7-f2ad-4a4e-8c20-e0fed652ad3c" unitRef="usd"> 1600000000 </opk:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedGoodwillandIntangibleAssets>
<opk:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedGoodwillandIntangibleAssets contextRef="i7e0f479bead144b0bdbcc71082db627b_I20211231" decimals="-8" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml80Ni9mcmFnOjI2MmUyZTgzNjZhNTQzNDc4MmNhYTY3NzJmOGUwM2JiL3RleHRyZWdpb246MjYyZTJlODM2NmE1NDM0NzgyY2FhNjc3MmY4ZTAzYmJfMjE5OTAyMzI4MDY5Mw_5cdb443d-861b-41ec-8bd6-6001f9bf19bb" unitRef="usd"> 1400000000 </opk:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedGoodwillandIntangibleAssets>
<us-gaap:Goodwill contextRef="i4768f885851b49f986857a2a956f9162_I20220630" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml80Ni9mcmFnOjI2MmUyZTgzNjZhNTQzNDc4MmNhYTY3NzJmOGUwM2JiL3RleHRyZWdpb246MjYyZTJlODM2NmE1NDM0NzgyY2FhNjc3MmY4ZTAzYmJfNDAzMQ_4d987f14-8eba-4bb3-a966-adc73cb53df9" unitRef="usd"> 578800000 </us-gaap:Goodwill>
<us-gaap:Goodwill contextRef="i7e0f479bead144b0bdbcc71082db627b_I20211231" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml80Ni9mcmFnOjI2MmUyZTgzNjZhNTQzNDc4MmNhYTY3NzJmOGUwM2JiL3RleHRyZWdpb246MjYyZTJlODM2NmE1NDM0NzgyY2FhNjc3MmY4ZTAzYmJfNDAzOA_0fd84233-e72a-4424-851a-81d1fd49be35" unitRef="usd"> 520600000 </us-gaap:Goodwill>
<us-gaap:Goodwill contextRef="icf88bd5dcf6d4a0b85df429b936bc0a1_I20211231" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml80Ni9mcmFnOjI2MmUyZTgzNjZhNTQzNDc4MmNhYTY3NzJmOGUwM2JiL3RleHRyZWdpb246MjYyZTJlODM2NmE1NDM0NzgyY2FhNjc3MmY4ZTAzYmJfNDEwMA_7b0a334e-f1bf-445d-a938-7b80b4e1fc03" unitRef="usd"> 151800000 </us-gaap:Goodwill>
<us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill contextRef="i4768f885851b49f986857a2a956f9162_I20220630" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml80Ni9mcmFnOjI2MmUyZTgzNjZhNTQzNDc4MmNhYTY3NzJmOGUwM2JiL3RleHRyZWdpb246MjYyZTJlODM2NmE1NDM0NzgyY2FhNjc3MmY4ZTAzYmJfNDczMg_0abab14e-2d5b-4ac0-b13a-cd4758fd36f5" unitRef="usd"> 1057400000 </us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
<us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill contextRef="i7e0f479bead144b0bdbcc71082db627b_I20211231" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml80Ni9mcmFnOjI2MmUyZTgzNjZhNTQzNDc4MmNhYTY3NzJmOGUwM2JiL3RleHRyZWdpb246MjYyZTJlODM2NmE1NDM0NzgyY2FhNjc3MmY4ZTAzYmJfNDczOQ_07acd403-2b44-4996-a298-4a198a45bd32" unitRef="usd"> 911900000 </us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
<us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill contextRef="ie5402e1f07514e1bbc3dc38a49ae64dc_I20220630" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml80Ni9mcmFnOjI2MmUyZTgzNjZhNTQzNDc4MmNhYTY3NzJmOGUwM2JiL3RleHRyZWdpb246MjYyZTJlODM2NmE1NDM0NzgyY2FhNjc3MmY4ZTAzYmJfMjE5OTAyMzI4MzcyOQ_1bd84244-8f97-4b4e-ac14-a63190ff8616" unitRef="usd"> 195000000 </us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
<us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill contextRef="if9075d5a9ceb4b15b07bfe556bbd0c3d_I20211231" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml80Ni9mcmFnOjI2MmUyZTgzNjZhNTQzNDc4MmNhYTY3NzJmOGUwM2JiL3RleHRyZWdpb246MjYyZTJlODM2NmE1NDM0NzgyY2FhNjc3MmY4ZTAzYmJfNDc2Mg_d9bec9e0-1b42-40fd-b435-e743400429aa" unitRef="usd"> 590200000 </us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
<us-gaap:FiniteLivedIntangibleAssetsNet contextRef="ib6bd9208c33c495395b98878d167a208_I20220331" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml80Ni9mcmFnOjI2MmUyZTgzNjZhNTQzNDc4MmNhYTY3NzJmOGUwM2JiL3RleHRyZWdpb246MjYyZTJlODM2NmE1NDM0NzgyY2FhNjc3MmY4ZTAzYmJfNjk4Nw_1ac237c1-6718-450f-9a61-f53d3508ff65" unitRef="usd"> 590000000 </us-gaap:FiniteLivedIntangibleAssetsNet>
<opk:InProcessResearchandDevelopment contextRef="i8db165b77cc14b43a5ed53019cb00903_I20220331" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml80Ni9mcmFnOjI2MmUyZTgzNjZhNTQzNDc4MmNhYTY3NzJmOGUwM2JiL3RleHRyZWdpb246MjYyZTJlODM2NmE1NDM0NzgyY2FhNjc3MmY4ZTAzYmJfNjk4Nw_2e378d69-abfb-4ee8-aa27-e8cd374261ef" unitRef="usd"> 590000000 </opk:InProcessResearchandDevelopment>
<us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="i857711861e3f4bdb99db993663f74933_D20220101-20220331" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml80Ni9mcmFnOjI2MmUyZTgzNjZhNTQzNDc4MmNhYTY3NzJmOGUwM2JiL3RleHRyZWdpb246MjYyZTJlODM2NmE1NDM0NzgyY2FhNjc3MmY4ZTAzYmJfNzI1Mg_382bd85a-f302-4f62-b6eb-30af2ac063e2"> P12Y </us-gaap:FiniteLivedIntangibleAssetUsefulLife>
<us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="i92a3787eaa4c447ba84018ceceb9fff4_D20220101-20220630" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml80Ni9mcmFnOjI2MmUyZTgzNjZhNTQzNDc4MmNhYTY3NzJmOGUwM2JiL3RleHRyZWdpb246MjYyZTJlODM2NmE1NDM0NzgyY2FhNjc3MmY4ZTAzYmJfNzM4NQ_211a7366-5c4f-49d6-a6b4-e9b3dbc3180d"> P3Y </us-gaap:FiniteLivedIntangibleAssetUsefulLife>
<us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="ic9f8abbc7eb944728e6c73cbef4ed54b_D20220101-20220630" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml80Ni9mcmFnOjI2MmUyZTgzNjZhNTQzNDc4MmNhYTY3NzJmOGUwM2JiL3RleHRyZWdpb246MjYyZTJlODM2NmE1NDM0NzgyY2FhNjc3MmY4ZTAzYmJfNzM5MQ_abc6a618-1939-4460-b1c3-ebd0b21bafdc"> P20Y </us-gaap:FiniteLivedIntangibleAssetUsefulLife>
<us-gaap:AmortizationOfIntangibleAssets contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml80Ni9mcmFnOjI2MmUyZTgzNjZhNTQzNDc4MmNhYTY3NzJmOGUwM2JiL3RleHRyZWdpb246MjYyZTJlODM2NmE1NDM0NzgyY2FhNjc3MmY4ZTAzYmJfNzYxMg_35b05be2-5bd9-4091-a12b-42cedf8a07c1" unitRef="usd"> 44800000 </us-gaap:AmortizationOfIntangibleAssets>
<us-gaap:AmortizationOfIntangibleAssets contextRef="i420e18e30084498a98510d48880063cd_D20210101-20210630" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml80Ni9mcmFnOjI2MmUyZTgzNjZhNTQzNDc4MmNhYTY3NzJmOGUwM2JiL3RleHRyZWdpb246MjYyZTJlODM2NmE1NDM0NzgyY2FhNjc3MmY4ZTAzYmJfNzYxOQ_69884714-4388-4329-b6f2-8e2f41afc3c7" unitRef="usd"> 25200000 </us-gaap:AmortizationOfIntangibleAssets>
<us-gaap:FairValueMeasurementPolicyPolicyTextBlock contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml80Ni9mcmFnOjI2MmUyZTgzNjZhNTQzNDc4MmNhYTY3NzJmOGUwM2JiL3RleHRyZWdpb246MjYyZTJlODM2NmE1NDM0NzgyY2FhNjc3MmY4ZTAzYmJfMjQ3ODY_8de1ab3a-b553-46eb-9b02-fbcde18c3984">
<div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair value measurements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The carrying amounts of our cash and cash equivalents, accounts receivable, accounts payable and short-term debt approximate their fair value due to the short-term maturities of these instruments. Investments that are considered equity securities as of June 30, 2022 and December 31, 2021 are predominately carried at fair value. Our debt under the Credit Agreement (as defined below) approximates fair value due to the variable rate of interest applicable to such debt.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In evaluating the fair value information, considerable judgment is required to interpret the market data used to develop the estimates. The use of different market assumptions and/or different valuation techniques may have a material effect on the </span></div>estimated fair value amounts. Accordingly, the estimates of fair value presented herein may not be indicative of the amounts that could be realized in a current market exchange.
</us-gaap:FairValueMeasurementPolicyPolicyTextBlock>
<us-gaap:BusinessCombinationsPolicy contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml80Ni9mcmFnOjI2MmUyZTgzNjZhNTQzNDc4MmNhYTY3NzJmOGUwM2JiL3RleHRyZWdpb246MjYyZTJlODM2NmE1NDM0NzgyY2FhNjc3MmY4ZTAzYmJfMjQ3NjY_570f641c-7e42-435e-81c7-788a3bafa4e6">
<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingent consideration</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Each period we revalue the contingent consideration obligations associated with certain prior acquisitions to their fair value and record increases in the fair value as contingent consideration expense and decreases in the fair value as a reduction in contingent consideration expense. Changes in contingent consideration result from changes in the assumptions regarding probabilities of successful achievement of related milestones, the estimated timing in which the milestones are achieved and the discount rate used to estimate the fair value of the liability. Contingent consideration may change significantly as our development programs progress, revenue estimates evolve and additional data is obtained, impacting our assumptions. The assumptions used in estimating fair value require significant judgment. The use of different assumptions and judgments could result in a materially different estimate of fair value which may have a material impact on our results from operations and financial position.</span>
</us-gaap:BusinessCombinationsPolicy>
<us-gaap:DerivativesPolicyTextBlock contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml80Ni9mcmFnOjI2MmUyZTgzNjZhNTQzNDc4MmNhYTY3NzJmOGUwM2JiL3RleHRyZWdpb246MjYyZTJlODM2NmE1NDM0NzgyY2FhNjc3MmY4ZTAzYmJfMjQ3Mjk_4373880f-42a5-4095-8d3e-7363b9c3481f"> Derivative financial instruments. We record derivative financial instruments on our Condensed Consolidated Balance Sheet at their fair value and recognize the changes in the fair value in our Condensed Consolidated Statement of Operations when they occur, the only exception being derivatives that qualify as hedges. For the derivative instrument to qualify as a hedge, we are required to meet strict hedge effectiveness and contemporaneous documentation requirements at the initiation of the hedge and assess the hedge effectiveness on an ongoing basis over the life of the hedge. At June 30, 2022 and December 31, 2021, our foreign currency forward contracts held to economically hedge inventory purchases did not meet the documentation requirements to be designated as hedges. Accordingly, we recognized all changes in the fair values of our derivatives instruments, net, in our Condensed Consolidated Statement of Operations. </us-gaap:DerivativesPolicyTextBlock>
<us-gaap:PropertyPlantAndEquipmentPolicyTextBlock contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml80Ni9mcmFnOjI2MmUyZTgzNjZhNTQzNDc4MmNhYTY3NzJmOGUwM2JiL3RleHRyZWdpb246MjYyZTJlODM2NmE1NDM0NzgyY2FhNjc3MmY4ZTAzYmJfMjQ3MjI_420c774f-8c01-431a-b2d4-1804e6411ed9"> Property, plant and equipment. Property, plant and equipment are recorded at cost or fair value if acquired in a business combination. Depreciation is provided using the straight-line method over the estimated useful lives of the assets and includes amortization expense for assets capitalized under finance leases. The estimated useful lives by asset class are as follows: software - 3 years, machinery, medical and other equipment - 5-8 years, furniture and fixtures - 5-12 years, leasehold improvements - the lesser of their useful life or the lease term, buildings and improvements - 10-40 years, and automobiles - 3-5 years. Expenditures for repairs and maintenance are charged to expense as incurred. Assets held under finance leases are included within Property, plant and equipment, net in our Consolidated Balance Sheets and are amortized over the shorter of their useful lives or the expected term of their related leases. </us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
<us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="if4edb8311d3245ffa6aa3e152841f740_D20220101-20220630" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml80Ni9mcmFnOjI2MmUyZTgzNjZhNTQzNDc4MmNhYTY3NzJmOGUwM2JiL3RleHRyZWdpb246MjYyZTJlODM2NmE1NDM0NzgyY2FhNjc3MmY4ZTAzYmJfMTA5NDI_3394d450-cc8f-4fd4-98ec-7e4edc654c37"> P3Y </us-gaap:PropertyPlantAndEquipmentUsefulLife>
<us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="i6c4c12cfaf654e6eba27bca6bbb6f0a2_D20220101-20220630" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml80Ni9mcmFnOjI2MmUyZTgzNjZhNTQzNDc4MmNhYTY3NzJmOGUwM2JiL3RleHRyZWdpb246MjYyZTJlODM2NmE1NDM0NzgyY2FhNjc3MmY4ZTAzYmJfMTA5OTM_3828be07-57d9-48f0-8e69-f45df215871f"> P5Y </us-gaap:PropertyPlantAndEquipmentUsefulLife>
<us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="i2bdb327cb90347a5b1f640b34210ad62_D20220101-20220630" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml80Ni9mcmFnOjI2MmUyZTgzNjZhNTQzNDc4MmNhYTY3NzJmOGUwM2JiL3RleHRyZWdpb246MjYyZTJlODM2NmE1NDM0NzgyY2FhNjc3MmY4ZTAzYmJfMTA5OTY_1fab9ee1-d370-48dd-b8fa-56680cd0098d"> P8Y </us-gaap:PropertyPlantAndEquipmentUsefulLife>
<us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="i4c6ce3bcddc64838bc68ab64e28d03b5_D20220101-20220630" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml80Ni9mcmFnOjI2MmUyZTgzNjZhNTQzNDc4MmNhYTY3NzJmOGUwM2JiL3RleHRyZWdpb246MjYyZTJlODM2NmE1NDM0NzgyY2FhNjc3MmY4ZTAzYmJfMTEwMzE_8a7d5c97-16eb-401f-8f66-fb4388a70b1a"> P5Y </us-gaap:PropertyPlantAndEquipmentUsefulLife>
<us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="icca08e8f63304c8698a98aaf9728303a_D20220101-20220630" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml80Ni9mcmFnOjI2MmUyZTgzNjZhNTQzNDc4MmNhYTY3NzJmOGUwM2JiL3RleHRyZWdpb246MjYyZTJlODM2NmE1NDM0NzgyY2FhNjc3MmY4ZTAzYmJfMTEwMzQ_c0c42179-bce1-42a8-9a82-b43985c68705"> P12Y </us-gaap:PropertyPlantAndEquipmentUsefulLife>
<us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="i40519de475434efa8c8f7e22b2a90ad9_D20220101-20220630" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml80Ni9mcmFnOjI2MmUyZTgzNjZhNTQzNDc4MmNhYTY3NzJmOGUwM2JiL3RleHRyZWdpb246MjYyZTJlODM2NmE1NDM0NzgyY2FhNjc3MmY4ZTAzYmJfMTExNDk_63443279-c285-4c07-9360-f1a97fb4f6d6"> P10Y </us-gaap:PropertyPlantAndEquipmentUsefulLife>
<us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="icc3cd5b1940645259e869b5987e7c58a_D20220101-20220630" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml80Ni9mcmFnOjI2MmUyZTgzNjZhNTQzNDc4MmNhYTY3NzJmOGUwM2JiL3RleHRyZWdpb246MjYyZTJlODM2NmE1NDM0NzgyY2FhNjc3MmY4ZTAzYmJfMTExNTI_94a0ff3c-686e-42dd-ae50-20eb7e69e14b"> P40Y </us-gaap:PropertyPlantAndEquipmentUsefulLife>
<us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="ibc2797b8a71545248bf6e9025c48fcea_D20220101-20220630" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml80Ni9mcmFnOjI2MmUyZTgzNjZhNTQzNDc4MmNhYTY3NzJmOGUwM2JiL3RleHRyZWdpb246MjYyZTJlODM2NmE1NDM0NzgyY2FhNjc3MmY4ZTAzYmJfMTExODA_712291c2-fd71-421b-86b7-9f32b0713a3a"> P3Y </us-gaap:PropertyPlantAndEquipmentUsefulLife>
<us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="ie7460091cf914c17bad1d941a24eecd9_D20220101-20220630" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml80Ni9mcmFnOjI2MmUyZTgzNjZhNTQzNDc4MmNhYTY3NzJmOGUwM2JiL3RleHRyZWdpb246MjYyZTJlODM2NmE1NDM0NzgyY2FhNjc3MmY4ZTAzYmJfMTExODM_0a22875c-2210-4352-80bc-81bde9ff4a9b"> P5Y </us-gaap:PropertyPlantAndEquipmentUsefulLife>
<us-gaap:Depreciation contextRef="i50aa2eea9a6446b6ad796d994509b1ad_D20220401-20220630" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml80Ni9mcmFnOjI2MmUyZTgzNjZhNTQzNDc4MmNhYTY3NzJmOGUwM2JiL3RleHRyZWdpb246MjYyZTJlODM2NmE1NDM0NzgyY2FhNjc3MmY4ZTAzYmJfMTEyOTc_7cb54b3e-aafe-4753-8f8f-2b9d2ffe698e" unitRef="usd"> 5200000 </us-gaap:Depreciation>
<us-gaap:Depreciation contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml80Ni9mcmFnOjI2MmUyZTgzNjZhNTQzNDc4MmNhYTY3NzJmOGUwM2JiL3RleHRyZWdpb246MjYyZTJlODM2NmE1NDM0NzgyY2FhNjc3MmY4ZTAzYmJfMjE5OTAyMzI4MjUxMA_4a77d02b-ef4e-493b-9688-ee5496279105" unitRef="usd"> 11000000 </us-gaap:Depreciation>
<us-gaap:Depreciation contextRef="if2a6207b6732465a921fe019a2a0f048_D20210401-20210630" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml80Ni9mcmFnOjI2MmUyZTgzNjZhNTQzNDc4MmNhYTY3NzJmOGUwM2JiL3RleHRyZWdpb246MjYyZTJlODM2NmE1NDM0NzgyY2FhNjc3MmY4ZTAzYmJfMTEzMDQ_abac0c51-7192-453f-aced-a76e64106f60" unitRef="usd"> 8000000 </us-gaap:Depreciation>
<us-gaap:Depreciation contextRef="i420e18e30084498a98510d48880063cd_D20210101-20210630" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml80Ni9mcmFnOjI2MmUyZTgzNjZhNTQzNDc4MmNhYTY3NzJmOGUwM2JiL3RleHRyZWdpb246MjYyZTJlODM2NmE1NDM0NzgyY2FhNjc3MmY4ZTAzYmJfMjE5OTAyMzI4MjQ5Ng_d67d2542-9d56-47f2-81ba-77c37e2ef6bb" unitRef="usd"> 15400000 </us-gaap:Depreciation>
<us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml80Ni9mcmFnOjI2MmUyZTgzNjZhNTQzNDc4MmNhYTY3NzJmOGUwM2JiL3RleHRyZWdpb246MjYyZTJlODM2NmE1NDM0NzgyY2FhNjc3MmY4ZTAzYmJfMjQ3MTg_b6424090-9146-4a72-acfa-85a8e8ef44d4">
<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Impairment of long-lived assets. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-lived assets, such as property and equipment and assets held for sale, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to estimated undiscounted future cash flows expected to be generated by the asset. If the carrying amount of an asset exceeds its estimated future cash flows, then an impairment charge is recognized for the amount by which the carrying amount of the asset exceeds the fair value of the asset.</span>
</us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock>
<us-gaap:IncomeTaxPolicyTextBlock contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml80Ni9mcmFnOjI2MmUyZTgzNjZhNTQzNDc4MmNhYTY3NzJmOGUwM2JiL3RleHRyZWdpb246MjYyZTJlODM2NmE1NDM0NzgyY2FhNjc3MmY4ZTAzYmJfMjQ3NTc_e214f320-cf33-4a4e-8eb2-25cd107e4732">
<div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income taxes.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Income taxes are accounted for under the asset-and-liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and the respective tax bases and for operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in operations in the period that includes the enactment date. We periodically evaluate the realizability of our net deferred tax assets. Our tax accruals are analyzed periodically and adjustments are made as events occur to warrant such adjustment. Valuation allowances on certain U.S. deferred tax assets and non-U.S. deferred tax assets are established, because realization of these tax benefits through future taxable income does not meet the more-likely-than-not threshold.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We operate in various countries and tax jurisdictions globally.  For interim reporting purposes, we record income taxes based on the expected effective income tax rate, taking into consideration year to date and global forecasted tax results.  For the six months ended June 30, 2022, the tax rate differed from the U.S. federal statutory rate of 21% primarily due to the valuation allowance against certain U.S. and non-U.S. deferred tax assets, the relative mix in earnings and losses in the U.S. versus foreign tax jurisdictions, and the impact of certain discrete tax events and operating results in tax jurisdictions which do not result in a tax benefit.</span></div>
</us-gaap:IncomeTaxPolicyTextBlock>
<us-gaap:RevenueFromContractWithCustomerPolicyTextBlock contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml80Ni9mcmFnOjI2MmUyZTgzNjZhNTQzNDc4MmNhYTY3NzJmOGUwM2JiL3RleHRyZWdpb246MjYyZTJlODM2NmE1NDM0NzgyY2FhNjc3MmY4ZTAzYmJfMjQ3MTk_da183f47-021e-4069-993a-c20839dd7240">
<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue recognition</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. We recognize revenue when a customer obtains control of promised goods or services in accordance with Accounting Standards Codification Topic 606, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue from Contracts with Customers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (“Topic 606”). The amount of revenue that is recorded reflects the consideration that we expect to receive in exchange for those goods or services. </span>We apply the following five-step model in order to determine this amount: (i) identify the contract(s) with a customer; (ii) identify the performance obligations in the contract; (iii) determine the transaction price; (iv) allocate the transaction price to the performance obligations in the contract; and (v) recognize revenue when (or as) we satisfy a performance obligation. We apply the five-step model to contracts when it is probable that we will collect the consideration we are entitled to in exchange for the goods or services we transfer to the customer. At contract inception, once the contract is determined to be within the scope of Topic 606, we review the contract to determine which performance obligations we must deliver and which of these performance obligations are distinct. We recognize as revenue the amount of the transaction price that is allocated to the respective performance obligation when the performance obligation is satisfied or as it is satisfied.<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Shipping and handling costs. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not charge customers for shipping and handling costs. Shipping and handling costs are classified as Cost of revenues in the Condensed Consolidated Statement of Operations.</span>
</us-gaap:RevenueFromContractWithCustomerPolicyTextBlock>
<us-gaap:ConcentrationRiskCreditRisk contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml80Ni9mcmFnOjI2MmUyZTgzNjZhNTQzNDc4MmNhYTY3NzJmOGUwM2JiL3RleHRyZWdpb246MjYyZTJlODM2NmE1NDM0NzgyY2FhNjc3MmY4ZTAzYmJfMjQ3NDU_38e8d09c-8a35-43e7-a5db-d868110b5e9d">
<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Concentration of credit risk and allowance for credit losses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Financial instruments that potentially subject us to concentrations of credit risk consist primarily of accounts receivable. Substantially all of our accounts receivable are with either companies in the healthcare industry or patients. However, credit risk is limited due to the number of our clients as well as their dispersion across many different geographic regions.</span>While we have receivables due from federal and state governmental agencies, we do not believe that such receivables represent a credit risk because the related healthcare programs are funded by federal and state governments, and payment is primarily dependent upon submitting appropriate documentation.
</us-gaap:ConcentrationRiskCreditRisk>
<us-gaap:ConcentrationRiskPercentage1 contextRef="i074ad3ab2fbc48e790a2f7ebd43d2654_D20220630-20220630" decimals="2" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml80Ni9mcmFnOjI2MmUyZTgzNjZhNTQzNDc4MmNhYTY3NzJmOGUwM2JiL3RleHRyZWdpb246MjYyZTJlODM2NmE1NDM0NzgyY2FhNjc3MmY4ZTAzYmJfMTYzNDk_7c1084a3-2b2a-47a6-9d8c-5f55a6577162" unitRef="number"> 0.12 </us-gaap:ConcentrationRiskPercentage1>
<us-gaap:ConcentrationRiskPercentage1 contextRef="ic084989e42dc4a328176af80fcd08cb6_D20211231-20211231" decimals="2" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml80Ni9mcmFnOjI2MmUyZTgzNjZhNTQzNDc4MmNhYTY3NzJmOGUwM2JiL3RleHRyZWdpb246MjYyZTJlODM2NmE1NDM0NzgyY2FhNjc3MmY4ZTAzYmJfMTYzNTY_d15c377a-d36a-4f28-a894-2fd9b9c1a988" unitRef="number"> 0.06 </us-gaap:ConcentrationRiskPercentage1>
<us-gaap:ConcentrationRiskPercentage1 contextRef="ia42b878f8f7c44eba4081c0c9a6be8d4_D20220630-20220630" decimals="3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml80Ni9mcmFnOjI2MmUyZTgzNjZhNTQzNDc4MmNhYTY3NzJmOGUwM2JiL3RleHRyZWdpb246MjYyZTJlODM2NmE1NDM0NzgyY2FhNjc3MmY4ZTAzYmJfMTY2OTg_afa744c9-87bb-4f5a-9687-50d1a5bc56f8" unitRef="number"> 0.039 </us-gaap:ConcentrationRiskPercentage1>
<us-gaap:ConcentrationRiskPercentage1 contextRef="i44506d274f524d98bdf40e6b66b3b24e_D20211231-20211231" decimals="3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml80Ni9mcmFnOjI2MmUyZTgzNjZhNTQzNDc4MmNhYTY3NzJmOGUwM2JiL3RleHRyZWdpb246MjYyZTJlODM2NmE1NDM0NzgyY2FhNjc3MmY4ZTAzYmJfMTY3MDU_d8a556b9-c4ed-4d60-95bc-d055b4619351" unitRef="number"> 0.041 </us-gaap:ConcentrationRiskPercentage1>
<us-gaap:ConcentrationRiskPercentage1 contextRef="ie7d78c03dcab4eae8faa63dcc6ae568e_D20220630-20220630" decimals="3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml80Ni9mcmFnOjI2MmUyZTgzNjZhNTQzNDc4MmNhYTY3NzJmOGUwM2JiL3RleHRyZWdpb246MjYyZTJlODM2NmE1NDM0NzgyY2FhNjc3MmY4ZTAzYmJfMTY5NTQ_eca87890-caf0-419f-8e9a-9f7ba43fd297" unitRef="number"> 0.023 </us-gaap:ConcentrationRiskPercentage1>
<us-gaap:ConcentrationRiskPercentage1 contextRef="i47c3284d560b4139b840d84cac215356_D20211231-20211231" decimals="3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml80Ni9mcmFnOjI2MmUyZTgzNjZhNTQzNDc4MmNhYTY3NzJmOGUwM2JiL3RleHRyZWdpb246MjYyZTJlODM2NmE1NDM0NzgyY2FhNjc3MmY4ZTAzYmJfMTY5NjE_f036059b-4a77-44ec-9f1c-2cbf5948501d" unitRef="number"> 0.007 </us-gaap:ConcentrationRiskPercentage1>
<us-gaap:ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml80Ni9mcmFnOjI2MmUyZTgzNjZhNTQzNDc4MmNhYTY3NzJmOGUwM2JiL3RleHRyZWdpb246MjYyZTJlODM2NmE1NDM0NzgyY2FhNjc3MmY4ZTAzYmJfMjQ4MDI_f788a2e6-b4f9-485f-b347-950dc4c9d2e7"> We assess the collectability of accounts receivable balances by considering factors such as historical collection experience, customer credit worthiness, the age of accounts receivable balances, regulatory changes and current economic conditions and trends that may affect a customer’s ability to pay. Actual results could differ from those estimates. </us-gaap:ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy>
<us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent contextRef="i4768f885851b49f986857a2a956f9162_I20220630" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml80Ni9mcmFnOjI2MmUyZTgzNjZhNTQzNDc4MmNhYTY3NzJmOGUwM2JiL3RleHRyZWdpb246MjYyZTJlODM2NmE1NDM0NzgyY2FhNjc3MmY4ZTAzYmJfMTc0MTc_7c4a6bc6-a143-4cab-a430-d4a5a04c5488" unitRef="usd"> 6800000 </us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
<us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent contextRef="i7e0f479bead144b0bdbcc71082db627b_I20211231" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml80Ni9mcmFnOjI2MmUyZTgzNjZhNTQzNDc4MmNhYTY3NzJmOGUwM2JiL3RleHRyZWdpb246MjYyZTJlODM2NmE1NDM0NzgyY2FhNjc3MmY4ZTAzYmJfMTc0MjQ_89653869-0ca1-4175-88b0-0672999c5009" unitRef="usd"> 1800000 </us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
<us-gaap:ProvisionForDoubtfulAccounts contextRef="i50aa2eea9a6446b6ad796d994509b1ad_D20220401-20220630" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml80Ni9mcmFnOjI2MmUyZTgzNjZhNTQzNDc4MmNhYTY3NzJmOGUwM2JiL3RleHRyZWdpb246MjYyZTJlODM2NmE1NDM0NzgyY2FhNjc3MmY4ZTAzYmJfMTc1MDQ_9338f415-cf95-4a00-932e-e5f42a0333f9" unitRef="usd"> 100000 </us-gaap:ProvisionForDoubtfulAccounts>
<us-gaap:ProvisionForDoubtfulAccounts contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml80Ni9mcmFnOjI2MmUyZTgzNjZhNTQzNDc4MmNhYTY3NzJmOGUwM2JiL3RleHRyZWdpb246MjYyZTJlODM2NmE1NDM0NzgyY2FhNjc3MmY4ZTAzYmJfMjE5OTAyMzI4MjgxNQ_b9f76f0b-1ec8-4eec-9b2a-a0cb3c869ea1" unitRef="usd"> 200000 </us-gaap:ProvisionForDoubtfulAccounts>
<us-gaap:ProvisionForDoubtfulAccounts contextRef="if2a6207b6732465a921fe019a2a0f048_D20210401-20210630" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml80Ni9mcmFnOjI2MmUyZTgzNjZhNTQzNDc4MmNhYTY3NzJmOGUwM2JiL3RleHRyZWdpb246MjYyZTJlODM2NmE1NDM0NzgyY2FhNjc3MmY4ZTAzYmJfMTc1MTE_420661ad-adac-44c8-9e74-f733934953dc" unitRef="usd"> 300000 </us-gaap:ProvisionForDoubtfulAccounts>
<us-gaap:ProvisionForDoubtfulAccounts contextRef="i420e18e30084498a98510d48880063cd_D20210101-20210630" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml80Ni9mcmFnOjI2MmUyZTgzNjZhNTQzNDc4MmNhYTY3NzJmOGUwM2JiL3RleHRyZWdpb246MjYyZTJlODM2NmE1NDM0NzgyY2FhNjc3MmY4ZTAzYmJfMjE5OTAyMzI4MjgwMQ_24eb1d15-3ceb-405d-8250-764585c343bf" unitRef="usd"> 600000 </us-gaap:ProvisionForDoubtfulAccounts>
<us-gaap:CompensationRelatedCostsPolicyTextBlock contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml80Ni9mcmFnOjI2MmUyZTgzNjZhNTQzNDc4MmNhYTY3NzJmOGUwM2JiL3RleHRyZWdpb246MjYyZTJlODM2NmE1NDM0NzgyY2FhNjc3MmY4ZTAzYmJfMjQ4NTk_c9746ec6-3715-47b7-8da8-0a42e51a5aac"> Equity-based compensation. We measure the cost of services received in exchange for an award of equity instruments based on the grant-date fair value of the award. That cost is recognized in the Condensed Consolidated Statement of Operations over the period during which an employee is required to provide service in exchange for the award. We record excess tax benefits realized from the exercise of stock options as cash flows from operations. </us-gaap:CompensationRelatedCostsPolicyTextBlock>
<us-gaap:AllocatedShareBasedCompensationExpense contextRef="i50aa2eea9a6446b6ad796d994509b1ad_D20220401-20220630" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml80Ni9mcmFnOjI2MmUyZTgzNjZhNTQzNDc4MmNhYTY3NzJmOGUwM2JiL3RleHRyZWdpb246MjYyZTJlODM2NmE1NDM0NzgyY2FhNjc3MmY4ZTAzYmJfMjE5OTAyMzI4MzQzNQ_1c672ae6-11f6-49c3-ad27-2a2f2862df47" unitRef="usd"> 4300000 </us-gaap:AllocatedShareBasedCompensationExpense>
<us-gaap:AllocatedShareBasedCompensationExpense contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml80Ni9mcmFnOjI2MmUyZTgzNjZhNTQzNDc4MmNhYTY3NzJmOGUwM2JiL3RleHRyZWdpb246MjYyZTJlODM2NmE1NDM0NzgyY2FhNjc3MmY4ZTAzYmJfMjE5OTAyMzI4MzQyOQ_b0c40e27-8b49-4524-baa2-40dea8c9bcd2" unitRef="usd"> 11900000 </us-gaap:AllocatedShareBasedCompensationExpense>
<us-gaap:AllocatedShareBasedCompensationExpense contextRef="if2a6207b6732465a921fe019a2a0f048_D20210401-20210630" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml80Ni9mcmFnOjI2MmUyZTgzNjZhNTQzNDc4MmNhYTY3NzJmOGUwM2JiL3RleHRyZWdpb246MjYyZTJlODM2NmE1NDM0NzgyY2FhNjc3MmY4ZTAzYmJfMjE5OTAyMzI4MzQyMg_0b6e1fdc-d200-4849-9f87-35609ca74941" unitRef="usd"> 3500000 </us-gaap:AllocatedShareBasedCompensationExpense>
<us-gaap:AllocatedShareBasedCompensationExpense contextRef="i420e18e30084498a98510d48880063cd_D20210101-20210630" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml80Ni9mcmFnOjI2MmUyZTgzNjZhNTQzNDc4MmNhYTY3NzJmOGUwM2JiL3RleHRyZWdpb246MjYyZTJlODM2NmE1NDM0NzgyY2FhNjc3MmY4ZTAzYmJfMjE5OTAyMzI4MzQ0Mg_520b9554-5cfd-4ccc-a3ae-1e8fb5038238" unitRef="usd"> 6100000 </us-gaap:AllocatedShareBasedCompensationExpense>
<us-gaap:ResearchAndDevelopmentExpensePolicy contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml80Ni9mcmFnOjI2MmUyZTgzNjZhNTQzNDc4MmNhYTY3NzJmOGUwM2JiL3RleHRyZWdpb246MjYyZTJlODM2NmE1NDM0NzgyY2FhNjc3MmY4ZTAzYmJfMjQ4NjQ_39eec779-72be-4734-a8cc-656e091fdf07">
<div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Research and development expenses. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development expenses include external and internal expenses. External expenses include clinical and non-clinical activities performed by contract research organizations, lab services, purchases of drug and diagnostic product materials and manufacturing development costs. Research and development employee-related expenses include salaries, benefits and equity-based compensation expense. Other internal research and development expenses are incurred to support overall research and development activities and include expenses related to general overhead and facilities. We expense these costs in the period in which they are incurred. We estimate our liabilities for research and development expenses in order to match the recognition of expenses to the period in which the actual services are received. As such, accrued liabilities related to third party research and development activities are recognized based upon our estimate of services received and degree of completion of the services in accordance with the specific third party contract.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development expense includes costs for in-process research and development projects acquired in asset acquisitions which have not reached technological feasibility, and which have no alternative future use. For in-process research and development projects acquired in business combinations, the in-process research and development project is capitalized and evaluated for impairment until the development process has been completed. Once the development process has been completed the asset will be amortized over its remaining estimated useful life.</span></div>
</us-gaap:ResearchAndDevelopmentExpensePolicy>
<us-gaap:SegmentReportingPolicyPolicyTextBlock contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml80Ni9mcmFnOjI2MmUyZTgzNjZhNTQzNDc4MmNhYTY3NzJmOGUwM2JiL3RleHRyZWdpb246MjYyZTJlODM2NmE1NDM0NzgyY2FhNjc3MmY4ZTAzYmJfMjQ4NTA_cd04e2ac-9429-4100-b509-f231eb5b9ddf">
<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Segment reporting</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Our chief operating decision-maker (“CODM”) is Phillip Frost, M.D., our Chairman and Chief Executive Officer. Our CODM reviews our operating results and operating plans and makes resource allocation decisions on a Company-wide or aggregate basis. We manage our operations in two reportable segments, pharmaceutical and diagnostics. The pharmaceutical segment consists of our pharmaceutical operations in Chile, Mexico, Ireland, Israel and Spain, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Rayaldee</span> product sales and our pharmaceutical research and development. The diagnostics segment primarily consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. There are no significant inter-segment sales. We evaluate the performance of each segment based on operating profit or loss. There is no inter-segment allocation of interest expense or income taxes.
</us-gaap:SegmentReportingPolicyPolicyTextBlock>
<us-gaap:NumberOfReportableSegments contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml80Ni9mcmFnOjI2MmUyZTgzNjZhNTQzNDc4MmNhYTY3NzJmOGUwM2JiL3RleHRyZWdpb246MjYyZTJlODM2NmE1NDM0NzgyY2FhNjc3MmY4ZTAzYmJfMjAwMzk_e73409f5-12f5-42e5-b75a-5c46dee84ee2" unitRef="segment"> 2 </us-gaap:NumberOfReportableSegments>
<us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml80Ni9mcmFnOjI2MmUyZTgzNjZhNTQzNDc4MmNhYTY3NzJmOGUwM2JiL3RleHRyZWdpb246MjYyZTJlODM2NmE1NDM0NzgyY2FhNjc3MmY4ZTAzYmJfMjQ4Njg_dad96ef6-8d09-4ffe-b825-b16ade93bb94"> Foreign currency translation. The financial statements of certain of our foreign operations are measured using the local currency as the functional currency. The local currency assets and liabilities are generally translated at the rate of exchange to the U.S. dollar on the balance sheet date and the local currency revenues and expenses are translated at average rates of exchange to the U.S. dollar during the reporting periods. Foreign currency transaction gains (losses) have been reflected as a component of Other income (expense), net within the Condensed Consolidated Statement of Operations and foreign currency translation gains (losses) have been included as a component of the Condensed Consolidated Statement of Comprehensive Income (Loss). </us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock>
<us-gaap:ForeignCurrencyTransactionGainLossBeforeTax contextRef="i50aa2eea9a6446b6ad796d994509b1ad_D20220401-20220630" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml80Ni9mcmFnOjI2MmUyZTgzNjZhNTQzNDc4MmNhYTY3NzJmOGUwM2JiL3RleHRyZWdpb246MjYyZTJlODM2NmE1NDM0NzgyY2FhNjc3MmY4ZTAzYmJfMjE2Nzg_bdc2b423-1e50-460a-ab36-60bb50373112" unitRef="usd"> 800000 </us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
<us-gaap:ForeignCurrencyTransactionGainLossBeforeTax contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml80Ni9mcmFnOjI2MmUyZTgzNjZhNTQzNDc4MmNhYTY3NzJmOGUwM2JiL3RleHRyZWdpb246MjYyZTJlODM2NmE1NDM0NzgyY2FhNjc3MmY4ZTAzYmJfMjE5OTAyMzI4MzEyOQ_54527e1f-1b9e-4192-b62f-de676d86bcc7" unitRef="usd"> 1800000 </us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
<us-gaap:ForeignCurrencyTransactionGainLossBeforeTax contextRef="if2a6207b6732465a921fe019a2a0f048_D20210401-20210630" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml80Ni9mcmFnOjI2MmUyZTgzNjZhNTQzNDc4MmNhYTY3NzJmOGUwM2JiL3RleHRyZWdpb246MjYyZTJlODM2NmE1NDM0NzgyY2FhNjc3MmY4ZTAzYmJfMjE2ODU_39cced70-736c-4d1c-93df-c8e0586d5141" unitRef="usd"> -400000 </us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
<us-gaap:ForeignCurrencyTransactionGainLossBeforeTax contextRef="i420e18e30084498a98510d48880063cd_D20210101-20210630" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml80Ni9mcmFnOjI2MmUyZTgzNjZhNTQzNDc4MmNhYTY3NzJmOGUwM2JiL3RleHRyZWdpb246MjYyZTJlODM2NmE1NDM0NzgyY2FhNjc3MmY4ZTAzYmJfMjE5OTAyMzI4MzM5Mw_cd36f378-54ee-4ae1-861d-84439008843f" unitRef="usd"> 4400000 </us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
<us-gaap:ConsolidationVariableInterestEntityPolicy contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml80Ni9mcmFnOjI2MmUyZTgzNjZhNTQzNDc4MmNhYTY3NzJmOGUwM2JiL3RleHRyZWdpb246MjYyZTJlODM2NmE1NDM0NzgyY2FhNjc3MmY4ZTAzYmJfMjQ3MTQ_c640a272-ebf9-4b21-8dd4-ba010f14c075"> Variable interest entities. The consolidation of a variable interest entity (“VIE”) is required when an enterprise has a controlling financial interest. A controlling financial interest in a VIE will have both of the following characteristics: (a) the power to direct the activities of a VIE that most significantly impact the VIE’s economic performance and (b) the obligation to absorb losses of the VIE that could potentially be significant to the VIE. </us-gaap:ConsolidationVariableInterestEntityPolicy>
<us-gaap:InvestmentPolicyTextBlock contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml80Ni9mcmFnOjI2MmUyZTgzNjZhNTQzNDc4MmNhYTY3NzJmOGUwM2JiL3RleHRyZWdpb246MjYyZTJlODM2NmE1NDM0NzgyY2FhNjc3MmY4ZTAzYmJfMjQ3Mzc_76c7ea34-ed1f-45f7-8f4c-e42dcc47859f"> Investments. We have made strategic investments in development stage and emerging companies. We record these investments as equity method investments or as equity securities based on our percentage of ownership and whether we have significant influence over the operations of the investees. For investments classified under the equity method of accounting, we record our proportionate share of their losses in Losses from investments in investees in our Condensed Consolidated Statement of Operations. Refer to Note 6. For investments classified as equity securities, we record changes in their fair value as Other income (expense) in our Condensed Consolidated Statement of Operations based on their closing price per share at the end of each reporting period, unless the equity security does not have a readily determinable fair value. </us-gaap:InvestmentPolicyTextBlock>
<us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml80Ni9mcmFnOjI2MmUyZTgzNjZhNTQzNDc4MmNhYTY3NzJmOGUwM2JiL3RleHRyZWdpb246MjYyZTJlODM2NmE1NDM0NzgyY2FhNjc3MmY4ZTAzYmJfMjQ3MTU_b352f6c7-e316-4136-8e86-8b737dfdfcbc">
<div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recently adopted accounting pronouncements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, the FASB issued ASU No. 2020-06, “Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity's Own Equity (Subtopic 815-40).” ASU 2020-06 simplifies the accounting for convertible instruments by reducing the number of accounting models for convertible debt instruments and convertible preferred stock. The ASU is effective for public entities for fiscal years beginning after December 15, 2021, with early adoption permitted. As required, we adopted ASU 2020-06 on January 1, 2022 and used the modified retrospective approach for all convertible debt instruments at the beginning of the period of adoptions. Results for reporting periods beginning January 1, 2022 are presented under ASU 2020-06, while prior period amounts were not adjusted and continue to be reported in accordance with historic accounting guidance. </span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the modified approach, entities will apply the guidance to all financial instruments that are outstanding as of the beginning of the year of adoption with the cumulative effect recognized as an adjustment to the opening balance of retained earnings. ASU 2020-06 eliminates the cash conversion and beneficial conversion feature models in ASC 470-20 that require an issuer of certain convertible debt and preferred stock to separately account for embedded conversion features as a component of equity. The adoption of ASU 2020-06 at January 1, 2022 resulted in an increase of the Convertible notes of $21.6 million, a reduction of the Accumulated deficit of $17.5 million and a reduction of Additional paid-in capital of $39.1 million.</span></div>
</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
<us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="ie684d614568d45eb9bcce4fd63aa5077_I20220101" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml80Ni9mcmFnOjI2MmUyZTgzNjZhNTQzNDc4MmNhYTY3NzJmOGUwM2JiL3RleHRyZWdpb246MjYyZTJlODM2NmE1NDM0NzgyY2FhNjc3MmY4ZTAzYmJfMjQ2MDc_418e4e63-d602-4c0e-98f2-451e333c03b9" unitRef="usd"> 21600000 </us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
<us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="i17f6d7edfe2d4cfd97bd8bf85038b376_I20220101" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml80Ni9mcmFnOjI2MmUyZTgzNjZhNTQzNDc4MmNhYTY3NzJmOGUwM2JiL3RleHRyZWdpb246MjYyZTJlODM2NmE1NDM0NzgyY2FhNjc3MmY4ZTAzYmJfMjQ2NTM_c6279bed-c5ba-49f4-9508-4984555c49ad" unitRef="usd"> 17500000 </us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
<us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="i2e013f06489447d0b09e5fcc88390e38_I20220101" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml80Ni9mcmFnOjI2MmUyZTgzNjZhNTQzNDc4MmNhYTY3NzJmOGUwM2JiL3RleHRyZWdpb246MjYyZTJlODM2NmE1NDM0NzgyY2FhNjc3MmY4ZTAzYmJfMjQ3MDU_2bb8a987-aeba-4ed8-b586-44b53e1e9bb1" unitRef="usd"> -39100000 </us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
<us-gaap:EarningsPerShareTextBlock contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml80OS9mcmFnOmJjMjdiMDA4MjA1NDQ5Mzg4MWMxMjg5YzBlMzgwNTU1L3RleHRyZWdpb246YmMyN2IwMDgyMDU0NDkzODgxYzEyODljMGUzODA1NTVfMjQxMg_b3d17061-f73f-4cdf-b11c-a4d2fb78fe06">
EARNINGS (LOSS) PER SHAREBasic income (loss) per share is computed by dividing our net income (loss) by the weighted average number of shares of our Common Stock outstanding during the period. Shares of Common Stock outstanding under the share lending arrangement entered into in conjunction with the 2025 Notes (as defined in Note 7) are excluded from the calculation of basic and diluted earnings per share because the borrower of the shares is required under the share lending arrangement to refund any dividends <div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">paid on the shares lent. Refer to Note 7. For diluted earnings per share, the dilutive impact of stock options and warrants is determined by applying the “treasury stock” method. The dilutive impact of the 2033 Senior Notes, the 2023 Convertible Notes and the 2025 Notes (each, as defined and discussed in Note 7) has been considered using the “if converted” method. For periods in which their effect would be antidilutive, no effect is given to Common Stock issuable under outstanding options or warrants or the potentially dilutive shares issuable pursuant to the 2033 Senior Notes, the 2023 Convertible Notes and the 2025 Notes in the dilutive computation. </span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> A total of 56,605,791 and 64,292,882 potential shares of Common Stock were excluded from the calculation of diluted net loss per share for the three months ended June 30, 2022, and 2021, respectively, because their inclusion would be antidilutive. A total of 57,016,847 and 69,861,689 potential shares of Common Stock were excluded from the calculation of diluted net loss per share for the six months ended June 30, 2022, and 2021, respectively, because their inclusion would be antidilutive. A full presentation of diluted earnings per share has not been provided because the required adjustments to the numerator and denominator resulted in diluted earnings per share equivalent to basic earnings per share.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended June 30, 2022, an aggregate of 789,063 options and warrants to purchase shares of our Common Stock were exercised, resulting in the issuance of 546,337 shares of Common Stock. Of the 789,063 options and warrants exercised, 242,726 shares of Common Stock were surrendered in lieu of a cash payment via the net exercise feature of such instruments.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the six months ended June 30, 2022, an aggregate of 844,813 options and warrants to purchase shares of our Common Stock were exercised, resulting in the issuance of 602,087 shares of Common Stock. Of the 844,813 options and warrants exercised, 242,726 shares of Common Stock were surrendered in lieu of a cash payment via the net exercise feature of such instruments.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended June 30, 2021, an aggregate of 63,625 options or warrants to purchase shares of our Common Stock were exercised, resulting in the issuance of 63,625 shares of Common Stock. Of the 63,625 options and warrants exercised, no shares of Common Stock were surrendered in lieu of a cash payment via the net exercise feature of such instruments.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the six months ended June 30, 2021, an aggregate of 181,125 options or warrants to purchase shares of our Common Stock were exercised, resulting in the issuance of 181,125 shares of Common Stock. Of the 181,125 options and warrants exercised, no shares of Common Stock were surrendered in lieu of a cash payment via the net exercise feature of such instruments.</span></div>
</us-gaap:EarningsPerShareTextBlock>
<us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="ia10339d1deab4c91bf080650d80c7631_D20220401-20220630" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml80OS9mcmFnOmJjMjdiMDA4MjA1NDQ5Mzg4MWMxMjg5YzBlMzgwNTU1L3RleHRyZWdpb246YmMyN2IwMDgyMDU0NDkzODgxYzEyODljMGUzODA1NTVfMjE5OTAyMzI1ODIxNA_acbdb5dd-ef40-4c08-9d94-4f330072befb" unitRef="shares"> 56605791 </us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
<us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="i6e3c55b9c2a14112975c5b8a52ac0caa_D20210401-20210630" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml80OS9mcmFnOmJjMjdiMDA4MjA1NDQ5Mzg4MWMxMjg5YzBlMzgwNTU1L3RleHRyZWdpb246YmMyN2IwMDgyMDU0NDkzODgxYzEyODljMGUzODA1NTVfMjE5OTAyMzI1OTE4NA_008e78d9-51a9-4739-895b-06d3c08e71e4" unitRef="shares"> 64292882 </us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
<us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="ibc41d5877b14449aa18a19384d5641f8_D20220101-20220630" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml80OS9mcmFnOmJjMjdiMDA4MjA1NDQ5Mzg4MWMxMjg5YzBlMzgwNTU1L3RleHRyZWdpb246YmMyN2IwMDgyMDU0NDkzODgxYzEyODljMGUzODA1NTVfMTI0OA_b5eee855-5332-4fd7-a360-a61f8782a74c" unitRef="shares"> 57016847 </us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
<us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="ib655e82b41ba4c9e8fa2842c43bfc319_D20210101-20210630" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml80OS9mcmFnOmJjMjdiMDA4MjA1NDQ5Mzg4MWMxMjg5YzBlMzgwNTU1L3RleHRyZWdpb246YmMyN2IwMDgyMDU0NDkzODgxYzEyODljMGUzODA1NTVfMjE5OTAyMzI1OTE4OA_1cbe864c-51d3-4509-906e-4c2f0c829a0c" unitRef="shares"> 69861689 </us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
<opk:StockIssuedDuringPeriodSharesStockOptionsandWarrantsExercised contextRef="i50aa2eea9a6446b6ad796d994509b1ad_D20220401-20220630" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml80OS9mcmFnOmJjMjdiMDA4MjA1NDQ5Mzg4MWMxMjg5YzBlMzgwNTU1L3RleHRyZWdpb246YmMyN2IwMDgyMDU0NDkzODgxYzEyODljMGUzODA1NTVfMjE5OTAyMzI1ODU5MQ_deb164d6-76cb-49a6-b033-3ca6413265c7" unitRef="shares"> 789063 </opk:StockIssuedDuringPeriodSharesStockOptionsandWarrantsExercised>
<opk:StockIssuedDuringPeriodSharesStockOptionsandWarrantsExercisedNetofSharesSurrenderedinLieuofCashPayment contextRef="i50aa2eea9a6446b6ad796d994509b1ad_D20220401-20220630" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml80OS9mcmFnOmJjMjdiMDA4MjA1NDQ5Mzg4MWMxMjg5YzBlMzgwNTU1L3RleHRyZWdpb246YmMyN2IwMDgyMDU0NDkzODgxYzEyODljMGUzODA1NTVfMjE5OTAyMzI1ODU5NQ_70553781-3b26-4aba-87a7-04e507c9ae3e" unitRef="shares"> 546337 </opk:StockIssuedDuringPeriodSharesStockOptionsandWarrantsExercisedNetofSharesSurrenderedinLieuofCashPayment>
<opk:StockIssuedDuringPeriodSharesStockOptionsandWarrantsExercised contextRef="i50aa2eea9a6446b6ad796d994509b1ad_D20220401-20220630" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml80OS9mcmFnOmJjMjdiMDA4MjA1NDQ5Mzg4MWMxMjg5YzBlMzgwNTU1L3RleHRyZWdpb246YmMyN2IwMDgyMDU0NDkzODgxYzEyODljMGUzODA1NTVfMjE5OTAyMzI1ODU5OQ_deb164d6-76cb-49a6-b033-3ca6413265c7" unitRef="shares"> 789063 </opk:StockIssuedDuringPeriodSharesStockOptionsandWarrantsExercised>
<opk:SharesSurrenderedInLieuOfCashPayment contextRef="i50aa2eea9a6446b6ad796d994509b1ad_D20220401-20220630" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml80OS9mcmFnOmJjMjdiMDA4MjA1NDQ5Mzg4MWMxMjg5YzBlMzgwNTU1L3RleHRyZWdpb246YmMyN2IwMDgyMDU0NDkzODgxYzEyODljMGUzODA1NTVfMjE5OTAyMzI1ODYxNg_1733ba47-e0a1-46ac-a8d7-9012a2097e81" unitRef="shares"> 242726 </opk:SharesSurrenderedInLieuOfCashPayment>
<opk:StockIssuedDuringPeriodSharesStockOptionsandWarrantsExercised contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml80OS9mcmFnOmJjMjdiMDA4MjA1NDQ5Mzg4MWMxMjg5YzBlMzgwNTU1L3RleHRyZWdpb246YmMyN2IwMDgyMDU0NDkzODgxYzEyODljMGUzODA1NTVfMTY2OQ_30cc554b-fc2d-4117-98c8-518e941654c8" unitRef="shares"> 844813 </opk:StockIssuedDuringPeriodSharesStockOptionsandWarrantsExercised>
<opk:StockIssuedDuringPeriodSharesStockOptionsandWarrantsExercisedNetofSharesSurrenderedinLieuofCashPayment contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml80OS9mcmFnOmJjMjdiMDA4MjA1NDQ5Mzg4MWMxMjg5YzBlMzgwNTU1L3RleHRyZWdpb246YmMyN2IwMDgyMDU0NDkzODgxYzEyODljMGUzODA1NTVfMTgwMw_e496e98e-58cf-47f4-b42e-031f7ca21d04" unitRef="shares"> 602087 </opk:StockIssuedDuringPeriodSharesStockOptionsandWarrantsExercisedNetofSharesSurrenderedinLieuofCashPayment>
<opk:StockIssuedDuringPeriodSharesStockOptionsandWarrantsExercised contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml80OS9mcmFnOmJjMjdiMDA4MjA1NDQ5Mzg4MWMxMjg5YzBlMzgwNTU1L3RleHRyZWdpb246YmMyN2IwMDgyMDU0NDkzODgxYzEyODljMGUzODA1NTVfMTgzOA_30cc554b-fc2d-4117-98c8-518e941654c8" unitRef="shares"> 844813 </opk:StockIssuedDuringPeriodSharesStockOptionsandWarrantsExercised>
<opk:SharesSurrenderedInLieuOfCashPayment contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml80OS9mcmFnOmJjMjdiMDA4MjA1NDQ5Mzg4MWMxMjg5YzBlMzgwNTU1L3RleHRyZWdpb246YmMyN2IwMDgyMDU0NDkzODgxYzEyODljMGUzODA1NTVfMjE5OTAyMzI1OTE3OA_536b7126-360e-4b8e-81b5-901d9c0f287b" unitRef="shares"> 242726 </opk:SharesSurrenderedInLieuOfCashPayment>
<opk:StockIssuedDuringPeriodSharesStockOptionsandWarrantsExercised contextRef="if2a6207b6732465a921fe019a2a0f048_D20210401-20210630" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml80OS9mcmFnOmJjMjdiMDA4MjA1NDQ5Mzg4MWMxMjg5YzBlMzgwNTU1L3RleHRyZWdpb246YmMyN2IwMDgyMDU0NDkzODgxYzEyODljMGUzODA1NTVfMjE5OTAyMzI1OTA1Ng_0ae11867-280e-4f0c-a4da-67b0ff35e3a1" unitRef="shares"> 63625 </opk:StockIssuedDuringPeriodSharesStockOptionsandWarrantsExercised>
<opk:StockIssuedDuringPeriodSharesStockOptionsandWarrantsExercisedNetofSharesSurrenderedinLieuofCashPayment contextRef="if2a6207b6732465a921fe019a2a0f048_D20210401-20210630" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml80OS9mcmFnOmJjMjdiMDA4MjA1NDQ5Mzg4MWMxMjg5YzBlMzgwNTU1L3RleHRyZWdpb246YmMyN2IwMDgyMDU0NDkzODgxYzEyODljMGUzODA1NTVfMjE5OTAyMzI1OTA3OA_631029c4-56eb-45f5-9f31-9f346ed79096" unitRef="shares"> 63625 </opk:StockIssuedDuringPeriodSharesStockOptionsandWarrantsExercisedNetofSharesSurrenderedinLieuofCashPayment>
<opk:StockIssuedDuringPeriodSharesStockOptionsandWarrantsExercised contextRef="if2a6207b6732465a921fe019a2a0f048_D20210401-20210630" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml80OS9mcmFnOmJjMjdiMDA4MjA1NDQ5Mzg4MWMxMjg5YzBlMzgwNTU1L3RleHRyZWdpb246YmMyN2IwMDgyMDU0NDkzODgxYzEyODljMGUzODA1NTVfMjE5OTAyMzI1OTA4Mg_0ae11867-280e-4f0c-a4da-67b0ff35e3a1" unitRef="shares"> 63625 </opk:StockIssuedDuringPeriodSharesStockOptionsandWarrantsExercised>
<opk:SharesSurrenderedInLieuOfCashPayment contextRef="if2a6207b6732465a921fe019a2a0f048_D20210401-20210630" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml80OS9mcmFnOmJjMjdiMDA4MjA1NDQ5Mzg4MWMxMjg5YzBlMzgwNTU1L3RleHRyZWdpb246YmMyN2IwMDgyMDU0NDkzODgxYzEyODljMGUzODA1NTVfMjE5OTAyMzI1OTA4Ng_9e498698-d23c-4fe0-b56f-901e7ad1223d" unitRef="shares"> 0 </opk:SharesSurrenderedInLieuOfCashPayment>
<opk:StockIssuedDuringPeriodSharesStockOptionsandWarrantsExercised contextRef="i420e18e30084498a98510d48880063cd_D20210101-20210630" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml80OS9mcmFnOmJjMjdiMDA4MjA1NDQ5Mzg4MWMxMjg5YzBlMzgwNTU1L3RleHRyZWdpb246YmMyN2IwMDgyMDU0NDkzODgxYzEyODljMGUzODA1NTVfMjE5OTAyMzI1OTE2MA_6c1d16ac-3111-408d-8a1b-4b30df0e939d" unitRef="shares"> 181125 </opk:StockIssuedDuringPeriodSharesStockOptionsandWarrantsExercised>
<opk:StockIssuedDuringPeriodSharesStockOptionsandWarrantsExercisedNetofSharesSurrenderedinLieuofCashPayment contextRef="i420e18e30084498a98510d48880063cd_D20210101-20210630" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml80OS9mcmFnOmJjMjdiMDA4MjA1NDQ5Mzg4MWMxMjg5YzBlMzgwNTU1L3RleHRyZWdpb246YmMyN2IwMDgyMDU0NDkzODgxYzEyODljMGUzODA1NTVfMjE5OTAyMzI1OTE2NA_6ad9c323-f971-48a1-b4f4-3dd593432f53" unitRef="shares"> 181125 </opk:StockIssuedDuringPeriodSharesStockOptionsandWarrantsExercisedNetofSharesSurrenderedinLieuofCashPayment>
<opk:StockIssuedDuringPeriodSharesStockOptionsandWarrantsExercised contextRef="i420e18e30084498a98510d48880063cd_D20210101-20210630" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml80OS9mcmFnOmJjMjdiMDA4MjA1NDQ5Mzg4MWMxMjg5YzBlMzgwNTU1L3RleHRyZWdpb246YmMyN2IwMDgyMDU0NDkzODgxYzEyODljMGUzODA1NTVfMjE5OTAyMzI1OTE2OA_6c1d16ac-3111-408d-8a1b-4b30df0e939d" unitRef="shares"> 181125 </opk:StockIssuedDuringPeriodSharesStockOptionsandWarrantsExercised>
<opk:SharesSurrenderedInLieuOfCashPayment contextRef="i420e18e30084498a98510d48880063cd_D20210101-20210630" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml80OS9mcmFnOmJjMjdiMDA4MjA1NDQ5Mzg4MWMxMjg5YzBlMzgwNTU1L3RleHRyZWdpb246YmMyN2IwMDgyMDU0NDkzODgxYzEyODljMGUzODA1NTVfMjE5OTAyMzI1OTE3Mg_7571db15-8ea7-4362-ae24-4154cfbc960a" unitRef="shares"> 0 </opk:SharesSurrenderedInLieuOfCashPayment>
<us-gaap:SupplementalBalanceSheetDisclosuresTextBlock contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81Mi9mcmFnOjQ0NzlmZjNiYTAyNzRkYWE5ZDBiZTRjMmRmNDlhYzE0L3RleHRyZWdpb246NDQ3OWZmM2JhMDI3NGRhYTlkMGJlNGMyZGY0OWFjMTRfMTkyNA_99b53748-5bfb-4fbf-b039-511a88db5dac">
COMPOSITION OF CERTAIN FINANCIAL STATEMENT CAPTIONS<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.958%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.005%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.007%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">June 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable, net:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">165,226 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">261,476 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: allowance for credit losses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,801)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,839)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">158,425 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">259,637 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories, net:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consumable supplies</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,054 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,447 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished products</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,321 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,107 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in-process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,892 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,615 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,256 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,112 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: inventory reserve</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,217)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,779)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83,306 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86,502 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets and prepaid expenses:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Taxes recoverable</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,442 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,598 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,324 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,641 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid insurance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,166 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,383 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other receivables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,273 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">353 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,358 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,195 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,563 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,170 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets, net:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">311,864 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">314,823 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technologies</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">822,323 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">246,101 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade names</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,735 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,770 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Covenants not to compete</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,907 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,920 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Licenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,873 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,766 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product registrations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,440 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,995 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,755 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,128 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: accumulated amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(352,488)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(320,820)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">862,409 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">321,683 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory received but not invoiced</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,853 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,446 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commitments and contingencies</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,745 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,819 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,368 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,939 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">257 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">258 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Clinical trials</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,245 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,867 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">487 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">487 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases short-term</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,625 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,257 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Professional fees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,116 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,121 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,558 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,299 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128,254 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">193,493 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.958%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.005%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.007%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">June 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,416 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,350 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgages and other debts payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,680 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,224 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases long-term</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,588 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,924 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">192 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">208 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,361 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,356 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,237 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,062 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:4pt;text-indent:22.5pt"><span><br/></span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our intangible assets and goodwill relate principally to our completed acquisitions of OPKO Renal, OPKO Biologics, EirGen, BioReference and ModeX. We amortize intangible assets with definite lives on a straight-line basis over their estimated useful lives. The estimated useful lives by asset class are as follows: technologies - 7-17 years, customer relationships - 7-20 years, product registrations - 7-10 years, covenants not to compete - 5 years, trade names - 5-10 years, other 9-13 years. We do not anticipate capitalizing the cost of product registration renewals, rather we expect to expense these costs, as incurred. Our goodwill is not tax deductible for income tax purposes in any jurisdiction in which we operate.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2021, GeneDx met the held-for-sale accounting criteria and its related assets and liabilities were recognized at the lower of carrying value or fair value less costs to sell in the consolidated balance sheet. In addition, at December 31, 2021, Assets held for sale included $151.8 million of goodwill related to GeneDx. </span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first quarter of 2022, we reclassified $590.0 million of IPR&D related to Somatrogon from IPR&D in our Condensed Consolidated Balance Sheet upon the approval of NGENLA (Somatrogon) in Europe and Japan. The assets will be amortized on a straight-line basis over their estimated useful life of approximately 12 years. Other changes in value of the intangible assets and goodwill during the six months ended June 30, 2022 and 2021 were primarily due to foreign currency fluctuations between the Chilean Peso, and the Euro against the U.S. dollar. </span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the changes in Goodwill by reporting unit during the six months ended June 30, 2022.</span></div><div style="margin-top:14pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.076%"><tr><td style="width:1.0%"/><td style="width:28.869%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.906%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.906%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:12.906%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.906%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.907%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gross goodwill at January 1</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cumulative impairment at January 1</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Acquisitions and dispositions</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign exchange and other</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at June 30</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pharmaceuticals</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CURNA</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,827 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4,827)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">Rayaldee</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">86,554 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(6,652)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">79,902 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">FineTech</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11,698 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(11,698)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ModeX</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">65,786 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">65,786 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">OPKO Biologics</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">139,784 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">139,784 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">OPKO Chile</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,760 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(301)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,459 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">OPKO Health Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,478 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(589)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,889 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">OPKO Mexico</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">100 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(100)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Transition Therapeutics</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,421 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3,421)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Diagnostics</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">BioReference</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">434,809 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(151,784)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">283,025 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">OPKO Diagnostics</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17,977 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(17,977)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">710,408 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(38,023)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(85,998)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(7,542)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">578,845 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div>
</us-gaap:SupplementalBalanceSheetDisclosuresTextBlock>
<opk:CompositionOfCertainFinancialStatementCaptionsTableTextBlock contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81Mi9mcmFnOjQ0NzlmZjNiYTAyNzRkYWE5ZDBiZTRjMmRmNDlhYzE0L3RleHRyZWdpb246NDQ3OWZmM2JhMDI3NGRhYTlkMGJlNGMyZGY0OWFjMTRfMTkwNQ_d825286e-baba-4eb4-b1ff-4ed78121304b">
<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.958%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.005%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.007%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">June 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable, net:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">165,226 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">261,476 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: allowance for credit losses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,801)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,839)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">158,425 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">259,637 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories, net:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consumable supplies</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,054 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,447 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished products</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,321 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,107 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in-process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,892 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,615 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,256 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,112 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: inventory reserve</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,217)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,779)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83,306 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86,502 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets and prepaid expenses:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Taxes recoverable</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,442 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,598 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,324 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,641 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid insurance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,166 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,383 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other receivables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,273 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">353 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,358 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,195 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,563 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,170 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets, net:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">311,864 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">314,823 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technologies</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">822,323 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">246,101 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade names</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,735 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,770 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Covenants not to compete</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,907 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,920 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Licenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,873 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,766 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product registrations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,440 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,995 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,755 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,128 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: accumulated amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(352,488)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(320,820)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">862,409 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">321,683 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory received but not invoiced</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,853 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,446 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commitments and contingencies</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,745 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,819 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,368 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,939 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">257 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">258 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Clinical trials</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,245 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,867 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">487 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">487 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases short-term</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,625 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,257 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Professional fees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,116 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,121 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,558 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,299 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128,254 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">193,493 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.958%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.005%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.007%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">June 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,416 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,350 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgages and other debts payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,680 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,224 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases long-term</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,588 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,924 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">192 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">208 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,361 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,356 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,237 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,062 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table>
</opk:CompositionOfCertainFinancialStatementCaptionsTableTextBlock>
<us-gaap:AccountsReceivableGrossCurrent contextRef="i4768f885851b49f986857a2a956f9162_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81Mi9mcmFnOjQ0NzlmZjNiYTAyNzRkYWE5ZDBiZTRjMmRmNDlhYzE0L3RhYmxlOjcxYjQyZGU1OThjYTRiNDE5YzIzYzU1MzgxMzllMmQ4L3RhYmxlcmFuZ2U6NzFiNDJkZTU5OGNhNGI0MTljMjNjNTUzODEzOWUyZDhfMi0xLTEtMS00ODE2NA_30009dca-a9d4-4617-809e-9655eb13c0ac" unitRef="usd"> 165226000 </us-gaap:AccountsReceivableGrossCurrent>
<us-gaap:AccountsReceivableGrossCurrent contextRef="i7e0f479bead144b0bdbcc71082db627b_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81Mi9mcmFnOjQ0NzlmZjNiYTAyNzRkYWE5ZDBiZTRjMmRmNDlhYzE0L3RhYmxlOjcxYjQyZGU1OThjYTRiNDE5YzIzYzU1MzgxMzllMmQ4L3RhYmxlcmFuZ2U6NzFiNDJkZTU5OGNhNGI0MTljMjNjNTUzODEzOWUyZDhfMi0zLTEtMS00ODE2NA_26da0165-8c41-4684-91d7-b71e5f00dae4" unitRef="usd"> 261476000 </us-gaap:AccountsReceivableGrossCurrent>
<us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent contextRef="i4768f885851b49f986857a2a956f9162_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81Mi9mcmFnOjQ0NzlmZjNiYTAyNzRkYWE5ZDBiZTRjMmRmNDlhYzE0L3RhYmxlOjcxYjQyZGU1OThjYTRiNDE5YzIzYzU1MzgxMzllMmQ4L3RhYmxlcmFuZ2U6NzFiNDJkZTU5OGNhNGI0MTljMjNjNTUzODEzOWUyZDhfMy0xLTEtMS00ODE2NA_60bfbecb-9a9e-4b79-91cd-0cffa16cda8b" unitRef="usd"> 6801000 </us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
<us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent contextRef="i7e0f479bead144b0bdbcc71082db627b_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81Mi9mcmFnOjQ0NzlmZjNiYTAyNzRkYWE5ZDBiZTRjMmRmNDlhYzE0L3RhYmxlOjcxYjQyZGU1OThjYTRiNDE5YzIzYzU1MzgxMzllMmQ4L3RhYmxlcmFuZ2U6NzFiNDJkZTU5OGNhNGI0MTljMjNjNTUzODEzOWUyZDhfMy0zLTEtMS00ODE2NA_8bd439a8-a3bf-49b3-a260-fe1a096be2b5" unitRef="usd"> 1839000 </us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
<us-gaap:AccountsReceivableNetCurrent contextRef="i4768f885851b49f986857a2a956f9162_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81Mi9mcmFnOjQ0NzlmZjNiYTAyNzRkYWE5ZDBiZTRjMmRmNDlhYzE0L3RhYmxlOjcxYjQyZGU1OThjYTRiNDE5YzIzYzU1MzgxMzllMmQ4L3RhYmxlcmFuZ2U6NzFiNDJkZTU5OGNhNGI0MTljMjNjNTUzODEzOWUyZDhfNC0xLTEtMS00ODE2NA_24907329-5061-4f93-8381-5fa213615145" unitRef="usd"> 158425000 </us-gaap:AccountsReceivableNetCurrent>
<us-gaap:AccountsReceivableNetCurrent contextRef="i7e0f479bead144b0bdbcc71082db627b_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81Mi9mcmFnOjQ0NzlmZjNiYTAyNzRkYWE5ZDBiZTRjMmRmNDlhYzE0L3RhYmxlOjcxYjQyZGU1OThjYTRiNDE5YzIzYzU1MzgxMzllMmQ4L3RhYmxlcmFuZ2U6NzFiNDJkZTU5OGNhNGI0MTljMjNjNTUzODEzOWUyZDhfNC0zLTEtMS00ODE2NA_fe7d00b6-1197-429f-ac9a-dd8947e5b928" unitRef="usd"> 259637000 </us-gaap:AccountsReceivableNetCurrent>
<us-gaap:OtherInventorySupplies contextRef="i4768f885851b49f986857a2a956f9162_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81Mi9mcmFnOjQ0NzlmZjNiYTAyNzRkYWE5ZDBiZTRjMmRmNDlhYzE0L3RhYmxlOjcxYjQyZGU1OThjYTRiNDE5YzIzYzU1MzgxMzllMmQ4L3RhYmxlcmFuZ2U6NzFiNDJkZTU5OGNhNGI0MTljMjNjNTUzODEzOWUyZDhfNi0xLTEtMS00ODE2NA_ae35bcd5-1956-45c0-bcca-ae14328b4ba6" unitRef="usd"> 37054000 </us-gaap:OtherInventorySupplies>
<us-gaap:OtherInventorySupplies contextRef="i7e0f479bead144b0bdbcc71082db627b_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81Mi9mcmFnOjQ0NzlmZjNiYTAyNzRkYWE5ZDBiZTRjMmRmNDlhYzE0L3RhYmxlOjcxYjQyZGU1OThjYTRiNDE5YzIzYzU1MzgxMzllMmQ4L3RhYmxlcmFuZ2U6NzFiNDJkZTU5OGNhNGI0MTljMjNjNTUzODEzOWUyZDhfNi0zLTEtMS00ODE2NA_3438e014-5c32-4e2f-b1c6-3f45901c729d" unitRef="usd"> 39447000 </us-gaap:OtherInventorySupplies>
<us-gaap:InventoryFinishedGoods contextRef="i4768f885851b49f986857a2a956f9162_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81Mi9mcmFnOjQ0NzlmZjNiYTAyNzRkYWE5ZDBiZTRjMmRmNDlhYzE0L3RhYmxlOjcxYjQyZGU1OThjYTRiNDE5YzIzYzU1MzgxMzllMmQ4L3RhYmxlcmFuZ2U6NzFiNDJkZTU5OGNhNGI0MTljMjNjNTUzODEzOWUyZDhfNy0xLTEtMS00ODE2NA_d6cf8069-289a-439d-aa9f-76f18c402bfc" unitRef="usd"> 42321000 </us-gaap:InventoryFinishedGoods>
<us-gaap:InventoryFinishedGoods contextRef="i7e0f479bead144b0bdbcc71082db627b_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81Mi9mcmFnOjQ0NzlmZjNiYTAyNzRkYWE5ZDBiZTRjMmRmNDlhYzE0L3RhYmxlOjcxYjQyZGU1OThjYTRiNDE5YzIzYzU1MzgxMzllMmQ4L3RhYmxlcmFuZ2U6NzFiNDJkZTU5OGNhNGI0MTljMjNjNTUzODEzOWUyZDhfNy0zLTEtMS00ODE2NA_967715bb-8fd6-4e4c-ab69-cc4358bb39c6" unitRef="usd"> 44107000 </us-gaap:InventoryFinishedGoods>
<us-gaap:InventoryWorkInProcess contextRef="i4768f885851b49f986857a2a956f9162_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81Mi9mcmFnOjQ0NzlmZjNiYTAyNzRkYWE5ZDBiZTRjMmRmNDlhYzE0L3RhYmxlOjcxYjQyZGU1OThjYTRiNDE5YzIzYzU1MzgxMzllMmQ4L3RhYmxlcmFuZ2U6NzFiNDJkZTU5OGNhNGI0MTljMjNjNTUzODEzOWUyZDhfOC0xLTEtMS00ODE2NA_973aae71-d7e1-4405-9bad-b9531be469eb" unitRef="usd"> 1892000 </us-gaap:InventoryWorkInProcess>
<us-gaap:InventoryWorkInProcess contextRef="i7e0f479bead144b0bdbcc71082db627b_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81Mi9mcmFnOjQ0NzlmZjNiYTAyNzRkYWE5ZDBiZTRjMmRmNDlhYzE0L3RhYmxlOjcxYjQyZGU1OThjYTRiNDE5YzIzYzU1MzgxMzllMmQ4L3RhYmxlcmFuZ2U6NzFiNDJkZTU5OGNhNGI0MTljMjNjNTUzODEzOWUyZDhfOC0zLTEtMS00ODE2NA_44d58400-a2f0-4127-a184-19081b5b9339" unitRef="usd"> 1615000 </us-gaap:InventoryWorkInProcess>
<us-gaap:InventoryRawMaterials contextRef="i4768f885851b49f986857a2a956f9162_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81Mi9mcmFnOjQ0NzlmZjNiYTAyNzRkYWE5ZDBiZTRjMmRmNDlhYzE0L3RhYmxlOjcxYjQyZGU1OThjYTRiNDE5YzIzYzU1MzgxMzllMmQ4L3RhYmxlcmFuZ2U6NzFiNDJkZTU5OGNhNGI0MTljMjNjNTUzODEzOWUyZDhfOS0xLTEtMS00ODE2NA_66304bf7-2cd2-4156-a437-81d67c0f7d70" unitRef="usd"> 7256000 </us-gaap:InventoryRawMaterials>
<us-gaap:InventoryRawMaterials contextRef="i7e0f479bead144b0bdbcc71082db627b_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81Mi9mcmFnOjQ0NzlmZjNiYTAyNzRkYWE5ZDBiZTRjMmRmNDlhYzE0L3RhYmxlOjcxYjQyZGU1OThjYTRiNDE5YzIzYzU1MzgxMzllMmQ4L3RhYmxlcmFuZ2U6NzFiNDJkZTU5OGNhNGI0MTljMjNjNTUzODEzOWUyZDhfOS0zLTEtMS00ODE2NA_2686e106-43c2-4658-9a19-c5fcba6108c3" unitRef="usd"> 6112000 </us-gaap:InventoryRawMaterials>
<us-gaap:InventoryValuationReserves contextRef="i4768f885851b49f986857a2a956f9162_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81Mi9mcmFnOjQ0NzlmZjNiYTAyNzRkYWE5ZDBiZTRjMmRmNDlhYzE0L3RhYmxlOjcxYjQyZGU1OThjYTRiNDE5YzIzYzU1MzgxMzllMmQ4L3RhYmxlcmFuZ2U6NzFiNDJkZTU5OGNhNGI0MTljMjNjNTUzODEzOWUyZDhfMTAtMS0xLTEtNDgxNjQ_73d40cd8-54a9-4551-82d3-f14be882af95" unitRef="usd"> 5217000 </us-gaap:InventoryValuationReserves>
<us-gaap:InventoryValuationReserves contextRef="i7e0f479bead144b0bdbcc71082db627b_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81Mi9mcmFnOjQ0NzlmZjNiYTAyNzRkYWE5ZDBiZTRjMmRmNDlhYzE0L3RhYmxlOjcxYjQyZGU1OThjYTRiNDE5YzIzYzU1MzgxMzllMmQ4L3RhYmxlcmFuZ2U6NzFiNDJkZTU5OGNhNGI0MTljMjNjNTUzODEzOWUyZDhfMTAtMy0xLTEtNDgxNjQ_65ea26b8-d074-405a-b015-9fa72865329e" unitRef="usd"> 4779000 </us-gaap:InventoryValuationReserves>
<us-gaap:InventoryNet contextRef="i4768f885851b49f986857a2a956f9162_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81Mi9mcmFnOjQ0NzlmZjNiYTAyNzRkYWE5ZDBiZTRjMmRmNDlhYzE0L3RhYmxlOjcxYjQyZGU1OThjYTRiNDE5YzIzYzU1MzgxMzllMmQ4L3RhYmxlcmFuZ2U6NzFiNDJkZTU5OGNhNGI0MTljMjNjNTUzODEzOWUyZDhfMTEtMS0xLTEtNDgxNjQ_c9e3848c-7acb-4de4-a0b5-6a5b76d3a099" unitRef="usd"> 83306000 </us-gaap:InventoryNet>
<us-gaap:InventoryNet contextRef="i7e0f479bead144b0bdbcc71082db627b_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81Mi9mcmFnOjQ0NzlmZjNiYTAyNzRkYWE5ZDBiZTRjMmRmNDlhYzE0L3RhYmxlOjcxYjQyZGU1OThjYTRiNDE5YzIzYzU1MzgxMzllMmQ4L3RhYmxlcmFuZ2U6NzFiNDJkZTU5OGNhNGI0MTljMjNjNTUzODEzOWUyZDhfMTEtMy0xLTEtNDgxNjQ_c1e21623-fd7c-4fec-9b71-8f0ae8bf3365" unitRef="usd"> 86502000 </us-gaap:InventoryNet>
<opk:TaxesRecoverableCurrent contextRef="i4768f885851b49f986857a2a956f9162_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81Mi9mcmFnOjQ0NzlmZjNiYTAyNzRkYWE5ZDBiZTRjMmRmNDlhYzE0L3RhYmxlOjcxYjQyZGU1OThjYTRiNDE5YzIzYzU1MzgxMzllMmQ4L3RhYmxlcmFuZ2U6NzFiNDJkZTU5OGNhNGI0MTljMjNjNTUzODEzOWUyZDhfMTMtMS0xLTEtNDgxNjQ_4b28e36f-394e-4dc8-ae7e-ca1a49927168" unitRef="usd"> 5442000 </opk:TaxesRecoverableCurrent>
<opk:TaxesRecoverableCurrent contextRef="i7e0f479bead144b0bdbcc71082db627b_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81Mi9mcmFnOjQ0NzlmZjNiYTAyNzRkYWE5ZDBiZTRjMmRmNDlhYzE0L3RhYmxlOjcxYjQyZGU1OThjYTRiNDE5YzIzYzU1MzgxMzllMmQ4L3RhYmxlcmFuZ2U6NzFiNDJkZTU5OGNhNGI0MTljMjNjNTUzODEzOWUyZDhfMTMtMy0xLTEtNDgxNjQ_362c03fa-591d-4122-9577-b0727ff7bd8d" unitRef="usd"> 5598000 </opk:TaxesRecoverableCurrent>
<us-gaap:Supplies contextRef="i4768f885851b49f986857a2a956f9162_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81Mi9mcmFnOjQ0NzlmZjNiYTAyNzRkYWE5ZDBiZTRjMmRmNDlhYzE0L3RhYmxlOjcxYjQyZGU1OThjYTRiNDE5YzIzYzU1MzgxMzllMmQ4L3RhYmxlcmFuZ2U6NzFiNDJkZTU5OGNhNGI0MTljMjNjNTUzODEzOWUyZDhfMTQtMS0xLTEtNDgxNjQ_03608caf-38a5-4db7-a8e8-b03c7aeec4f7" unitRef="usd"> 12324000 </us-gaap:Supplies>
<us-gaap:Supplies contextRef="i7e0f479bead144b0bdbcc71082db627b_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81Mi9mcmFnOjQ0NzlmZjNiYTAyNzRkYWE5ZDBiZTRjMmRmNDlhYzE0L3RhYmxlOjcxYjQyZGU1OThjYTRiNDE5YzIzYzU1MzgxMzllMmQ4L3RhYmxlcmFuZ2U6NzFiNDJkZTU5OGNhNGI0MTljMjNjNTUzODEzOWUyZDhfMTQtMy0xLTEtNDgxNjQ_7ee0338b-3658-4763-954f-74c50122284f" unitRef="usd"> 10641000 </us-gaap:Supplies>
<us-gaap:PrepaidInsurance contextRef="i4768f885851b49f986857a2a956f9162_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81Mi9mcmFnOjQ0NzlmZjNiYTAyNzRkYWE5ZDBiZTRjMmRmNDlhYzE0L3RhYmxlOjcxYjQyZGU1OThjYTRiNDE5YzIzYzU1MzgxMzllMmQ4L3RhYmxlcmFuZ2U6NzFiNDJkZTU5OGNhNGI0MTljMjNjNTUzODEzOWUyZDhfMTgtMS0xLTEtNDgxNjQ_3fc65541-44fb-4010-8a3d-e96260a55209" unitRef="usd"> 7166000 </us-gaap:PrepaidInsurance>
<us-gaap:PrepaidInsurance contextRef="i7e0f479bead144b0bdbcc71082db627b_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81Mi9mcmFnOjQ0NzlmZjNiYTAyNzRkYWE5ZDBiZTRjMmRmNDlhYzE0L3RhYmxlOjcxYjQyZGU1OThjYTRiNDE5YzIzYzU1MzgxMzllMmQ4L3RhYmxlcmFuZ2U6NzFiNDJkZTU5OGNhNGI0MTljMjNjNTUzODEzOWUyZDhfMTgtMy0xLTEtNDgxNjQ_0e643baf-4bb1-4fc1-a4a4-d6b36fb6c637" unitRef="usd"> 4383000 </us-gaap:PrepaidInsurance>
<us-gaap:AccountsAndOtherReceivablesNetCurrent contextRef="i4768f885851b49f986857a2a956f9162_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81Mi9mcmFnOjQ0NzlmZjNiYTAyNzRkYWE5ZDBiZTRjMmRmNDlhYzE0L3RhYmxlOjcxYjQyZGU1OThjYTRiNDE5YzIzYzU1MzgxMzllMmQ4L3RhYmxlcmFuZ2U6NzFiNDJkZTU5OGNhNGI0MTljMjNjNTUzODEzOWUyZDhfMTktMS0xLTEtNDgxNjQ_a7d3f160-6860-4505-bde2-47760533e6e1" unitRef="usd"> 11273000 </us-gaap:AccountsAndOtherReceivablesNetCurrent>
<us-gaap:AccountsAndOtherReceivablesNetCurrent contextRef="i7e0f479bead144b0bdbcc71082db627b_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81Mi9mcmFnOjQ0NzlmZjNiYTAyNzRkYWE5ZDBiZTRjMmRmNDlhYzE0L3RhYmxlOjcxYjQyZGU1OThjYTRiNDE5YzIzYzU1MzgxMzllMmQ4L3RhYmxlcmFuZ2U6NzFiNDJkZTU5OGNhNGI0MTljMjNjNTUzODEzOWUyZDhfMTktMy0xLTEtNDgxNjQ_35b3dfa2-5e2c-45b6-a989-4fa273b9468d" unitRef="usd"> 353000 </us-gaap:AccountsAndOtherReceivablesNetCurrent>
<us-gaap:OtherAssetsCurrent contextRef="i4768f885851b49f986857a2a956f9162_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81Mi9mcmFnOjQ0NzlmZjNiYTAyNzRkYWE5ZDBiZTRjMmRmNDlhYzE0L3RhYmxlOjcxYjQyZGU1OThjYTRiNDE5YzIzYzU1MzgxMzllMmQ4L3RhYmxlcmFuZ2U6NzFiNDJkZTU5OGNhNGI0MTljMjNjNTUzODEzOWUyZDhfMjAtMS0xLTEtNDgxNjQ_d8b9044e-0bdc-4f4d-a506-efcdd322c372" unitRef="usd"> 6358000 </us-gaap:OtherAssetsCurrent>
<us-gaap:OtherAssetsCurrent contextRef="i7e0f479bead144b0bdbcc71082db627b_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81Mi9mcmFnOjQ0NzlmZjNiYTAyNzRkYWE5ZDBiZTRjMmRmNDlhYzE0L3RhYmxlOjcxYjQyZGU1OThjYTRiNDE5YzIzYzU1MzgxMzllMmQ4L3RhYmxlcmFuZ2U6NzFiNDJkZTU5OGNhNGI0MTljMjNjNTUzODEzOWUyZDhfMjAtMy0xLTEtNDgxNjQ_b9f055a2-465f-4133-97cc-f56cc43af5d8" unitRef="usd"> 6195000 </us-gaap:OtherAssetsCurrent>
<us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="i4768f885851b49f986857a2a956f9162_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81Mi9mcmFnOjQ0NzlmZjNiYTAyNzRkYWE5ZDBiZTRjMmRmNDlhYzE0L3RhYmxlOjcxYjQyZGU1OThjYTRiNDE5YzIzYzU1MzgxMzllMmQ4L3RhYmxlcmFuZ2U6NzFiNDJkZTU5OGNhNGI0MTljMjNjNTUzODEzOWUyZDhfMjEtMS0xLTEtNDgxNjQ_f4c79fc7-62ed-4bbe-a399-b9fc8d106a88" unitRef="usd"> 42563000 </us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
<us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="i7e0f479bead144b0bdbcc71082db627b_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81Mi9mcmFnOjQ0NzlmZjNiYTAyNzRkYWE5ZDBiZTRjMmRmNDlhYzE0L3RhYmxlOjcxYjQyZGU1OThjYTRiNDE5YzIzYzU1MzgxMzllMmQ4L3RhYmxlcmFuZ2U6NzFiNDJkZTU5OGNhNGI0MTljMjNjNTUzODEzOWUyZDhfMjEtMy0xLTEtNDgxNjQ_0206182a-aaba-451f-b29c-b1ea3064d6a5" unitRef="usd"> 27170000 </us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
<us-gaap:FiniteLivedIntangibleAssetsGross contextRef="ieb4fbf8f73d74de3ba4c91c86dd30023_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81Mi9mcmFnOjQ0NzlmZjNiYTAyNzRkYWE5ZDBiZTRjMmRmNDlhYzE0L3RhYmxlOjcxYjQyZGU1OThjYTRiNDE5YzIzYzU1MzgxMzllMmQ4L3RhYmxlcmFuZ2U6NzFiNDJkZTU5OGNhNGI0MTljMjNjNTUzODEzOWUyZDhfMjMtMS0xLTEtNDgxNjQ_ee33599c-1f83-4db3-8482-0b7569dcd96a" unitRef="usd"> 311864000 </us-gaap:FiniteLivedIntangibleAssetsGross>
<us-gaap:FiniteLivedIntangibleAssetsGross contextRef="i400904118190489b9d136dc11e2ccda3_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81Mi9mcmFnOjQ0NzlmZjNiYTAyNzRkYWE5ZDBiZTRjMmRmNDlhYzE0L3RhYmxlOjcxYjQyZGU1OThjYTRiNDE5YzIzYzU1MzgxMzllMmQ4L3RhYmxlcmFuZ2U6NzFiNDJkZTU5OGNhNGI0MTljMjNjNTUzODEzOWUyZDhfMjMtMy0xLTEtNDgxNjQ_a5503d32-0285-46dd-9103-3400c4b5eb75" unitRef="usd"> 314823000 </us-gaap:FiniteLivedIntangibleAssetsGross>
<us-gaap:FiniteLivedIntangibleAssetsGross contextRef="ic3cb8ffea8d547949eb6aa52d46711fe_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81Mi9mcmFnOjQ0NzlmZjNiYTAyNzRkYWE5ZDBiZTRjMmRmNDlhYzE0L3RhYmxlOjcxYjQyZGU1OThjYTRiNDE5YzIzYzU1MzgxMzllMmQ4L3RhYmxlcmFuZ2U6NzFiNDJkZTU5OGNhNGI0MTljMjNjNTUzODEzOWUyZDhfMjQtMS0xLTEtNDgxNjQ_0f580113-49f9-498a-b84e-22fd09540ee2" unitRef="usd"> 822323000 </us-gaap:FiniteLivedIntangibleAssetsGross>
<us-gaap:FiniteLivedIntangibleAssetsGross contextRef="iebfc97ece41a4b8cb182968e19d1ef8c_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81Mi9mcmFnOjQ0NzlmZjNiYTAyNzRkYWE5ZDBiZTRjMmRmNDlhYzE0L3RhYmxlOjcxYjQyZGU1OThjYTRiNDE5YzIzYzU1MzgxMzllMmQ4L3RhYmxlcmFuZ2U6NzFiNDJkZTU5OGNhNGI0MTljMjNjNTUzODEzOWUyZDhfMjQtMy0xLTEtNDgxNjQ_bd171492-b131-4796-8181-d648b7e4091f" unitRef="usd"> 246101000 </us-gaap:FiniteLivedIntangibleAssetsGross>
<us-gaap:FiniteLivedIntangibleAssetsGross contextRef="i6803460117304737a13c6361b1284236_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81Mi9mcmFnOjQ0NzlmZjNiYTAyNzRkYWE5ZDBiZTRjMmRmNDlhYzE0L3RhYmxlOjcxYjQyZGU1OThjYTRiNDE5YzIzYzU1MzgxMzllMmQ4L3RhYmxlcmFuZ2U6NzFiNDJkZTU5OGNhNGI0MTljMjNjNTUzODEzOWUyZDhfMjUtMS0xLTEtNDgxNjQ_4c4085b4-f0b4-42fb-9a4e-c222b9c5ddb2" unitRef="usd"> 49735000 </us-gaap:FiniteLivedIntangibleAssetsGross>
<us-gaap:FiniteLivedIntangibleAssetsGross contextRef="i0da5d41367d949c5a55dacd926dc2ba2_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81Mi9mcmFnOjQ0NzlmZjNiYTAyNzRkYWE5ZDBiZTRjMmRmNDlhYzE0L3RhYmxlOjcxYjQyZGU1OThjYTRiNDE5YzIzYzU1MzgxMzllMmQ4L3RhYmxlcmFuZ2U6NzFiNDJkZTU5OGNhNGI0MTljMjNjNTUzODEzOWUyZDhfMjUtMy0xLTEtNDgxNjQ_feeb7caa-3a01-4331-a3b4-a9a64a7e26c6" unitRef="usd"> 49770000 </us-gaap:FiniteLivedIntangibleAssetsGross>
<us-gaap:FiniteLivedIntangibleAssetsGross contextRef="ib2711e90c49d49278c0d28e6b0f2e233_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81Mi9mcmFnOjQ0NzlmZjNiYTAyNzRkYWE5ZDBiZTRjMmRmNDlhYzE0L3RhYmxlOjcxYjQyZGU1OThjYTRiNDE5YzIzYzU1MzgxMzllMmQ4L3RhYmxlcmFuZ2U6NzFiNDJkZTU5OGNhNGI0MTljMjNjNTUzODEzOWUyZDhfMjctMS0xLTEtNDgxNjQ_4a70ba5a-eab0-4662-afff-7b467a092e63" unitRef="usd"> 12907000 </us-gaap:FiniteLivedIntangibleAssetsGross>
<us-gaap:FiniteLivedIntangibleAssetsGross contextRef="ief8b941f9e054e76848ef6a37277ab26_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81Mi9mcmFnOjQ0NzlmZjNiYTAyNzRkYWE5ZDBiZTRjMmRmNDlhYzE0L3RhYmxlOjcxYjQyZGU1OThjYTRiNDE5YzIzYzU1MzgxMzllMmQ4L3RhYmxlcmFuZ2U6NzFiNDJkZTU5OGNhNGI0MTljMjNjNTUzODEzOWUyZDhfMjctMy0xLTEtNDgxNjQ_bec2c3c1-a586-473a-8c5f-ebdbab5714e6" unitRef="usd"> 12920000 </us-gaap:FiniteLivedIntangibleAssetsGross>
<us-gaap:FiniteLivedIntangibleAssetsGross contextRef="i05ef0a805a084776833a76c87ba0305d_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81Mi9mcmFnOjQ0NzlmZjNiYTAyNzRkYWE5ZDBiZTRjMmRmNDlhYzE0L3RhYmxlOjcxYjQyZGU1OThjYTRiNDE5YzIzYzU1MzgxMzllMmQ4L3RhYmxlcmFuZ2U6NzFiNDJkZTU5OGNhNGI0MTljMjNjNTUzODEzOWUyZDhfMjgtMS0xLTEtNDgxNjQ_03a25fcb-a13f-4cb1-9e7d-cf4ec32b120b" unitRef="usd"> 5873000 </us-gaap:FiniteLivedIntangibleAssetsGross>
<us-gaap:FiniteLivedIntangibleAssetsGross contextRef="ib765c87c2fad4924a6a49a613b15fcf4_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81Mi9mcmFnOjQ0NzlmZjNiYTAyNzRkYWE5ZDBiZTRjMmRmNDlhYzE0L3RhYmxlOjcxYjQyZGU1OThjYTRiNDE5YzIzYzU1MzgxMzllMmQ4L3RhYmxlcmFuZ2U6NzFiNDJkZTU5OGNhNGI0MTljMjNjNTUzODEzOWUyZDhfMjgtMy0xLTEtNDgxNjQ_b4f5f6fc-6766-425b-a4b6-980f034ad684" unitRef="usd"> 5766000 </us-gaap:FiniteLivedIntangibleAssetsGross>
<us-gaap:FiniteLivedIntangibleAssetsGross contextRef="i7c0bc677b4664ebeac10693cdd91f43f_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81Mi9mcmFnOjQ0NzlmZjNiYTAyNzRkYWE5ZDBiZTRjMmRmNDlhYzE0L3RhYmxlOjcxYjQyZGU1OThjYTRiNDE5YzIzYzU1MzgxMzllMmQ4L3RhYmxlcmFuZ2U6NzFiNDJkZTU5OGNhNGI0MTljMjNjNTUzODEzOWUyZDhfMjktMS0xLTEtNDgxNjQ_1e15e3d1-0470-4ed0-942f-e93651d730b3" unitRef="usd"> 6440000 </us-gaap:FiniteLivedIntangibleAssetsGross>
<us-gaap:FiniteLivedIntangibleAssetsGross contextRef="i702cce6c83684198821efd01ee1b9297_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81Mi9mcmFnOjQ0NzlmZjNiYTAyNzRkYWE5ZDBiZTRjMmRmNDlhYzE0L3RhYmxlOjcxYjQyZGU1OThjYTRiNDE5YzIzYzU1MzgxMzllMmQ4L3RhYmxlcmFuZ2U6NzFiNDJkZTU5OGNhNGI0MTljMjNjNTUzODEzOWUyZDhfMjktMy0xLTEtNDgxNjQ_89460f8d-2227-43de-8e2f-8b457a16b0af" unitRef="usd"> 6995000 </us-gaap:FiniteLivedIntangibleAssetsGross>
<us-gaap:FiniteLivedIntangibleAssetsGross contextRef="ibac862a1a0e649dcb81d43591cd0d8d2_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81Mi9mcmFnOjQ0NzlmZjNiYTAyNzRkYWE5ZDBiZTRjMmRmNDlhYzE0L3RhYmxlOjcxYjQyZGU1OThjYTRiNDE5YzIzYzU1MzgxMzllMmQ4L3RhYmxlcmFuZ2U6NzFiNDJkZTU5OGNhNGI0MTljMjNjNTUzODEzOWUyZDhfMzAtMS0xLTEtNDgxNjQ_a6f6d407-c3bc-429e-ab40-6f3a31f48d24" unitRef="usd"> 5755000 </us-gaap:FiniteLivedIntangibleAssetsGross>
<us-gaap:FiniteLivedIntangibleAssetsGross contextRef="i968cd31428a64336a08f3bef10b29016_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81Mi9mcmFnOjQ0NzlmZjNiYTAyNzRkYWE5ZDBiZTRjMmRmNDlhYzE0L3RhYmxlOjcxYjQyZGU1OThjYTRiNDE5YzIzYzU1MzgxMzllMmQ4L3RhYmxlcmFuZ2U6NzFiNDJkZTU5OGNhNGI0MTljMjNjNTUzODEzOWUyZDhfMzAtMy0xLTEtNDgxNjQ_72f35098-1164-47f8-96d4-18583e58ffca" unitRef="usd"> 6128000 </us-gaap:FiniteLivedIntangibleAssetsGross>
<us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="i4768f885851b49f986857a2a956f9162_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81Mi9mcmFnOjQ0NzlmZjNiYTAyNzRkYWE5ZDBiZTRjMmRmNDlhYzE0L3RhYmxlOjcxYjQyZGU1OThjYTRiNDE5YzIzYzU1MzgxMzllMmQ4L3RhYmxlcmFuZ2U6NzFiNDJkZTU5OGNhNGI0MTljMjNjNTUzODEzOWUyZDhfMzEtMS0xLTEtNDgxNjQ_9dbee2d3-0907-437b-8732-be22ca63a24e" unitRef="usd"> 352488000 </us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
<us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="i7e0f479bead144b0bdbcc71082db627b_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81Mi9mcmFnOjQ0NzlmZjNiYTAyNzRkYWE5ZDBiZTRjMmRmNDlhYzE0L3RhYmxlOjcxYjQyZGU1OThjYTRiNDE5YzIzYzU1MzgxMzllMmQ4L3RhYmxlcmFuZ2U6NzFiNDJkZTU5OGNhNGI0MTljMjNjNTUzODEzOWUyZDhfMzEtMy0xLTEtNDgxNjQ_9429c575-fbc7-4b82-89de-10a1eba774bb" unitRef="usd"> 320820000 </us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
<us-gaap:FiniteLivedIntangibleAssetsNet contextRef="i4768f885851b49f986857a2a956f9162_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81Mi9mcmFnOjQ0NzlmZjNiYTAyNzRkYWE5ZDBiZTRjMmRmNDlhYzE0L3RhYmxlOjcxYjQyZGU1OThjYTRiNDE5YzIzYzU1MzgxMzllMmQ4L3RhYmxlcmFuZ2U6NzFiNDJkZTU5OGNhNGI0MTljMjNjNTUzODEzOWUyZDhfMzItMS0xLTEtNDgxNjQ_586a577d-89aa-4997-9a5f-c937e5cbaefd" unitRef="usd"> 862409000 </us-gaap:FiniteLivedIntangibleAssetsNet>
<us-gaap:FiniteLivedIntangibleAssetsNet contextRef="i7e0f479bead144b0bdbcc71082db627b_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81Mi9mcmFnOjQ0NzlmZjNiYTAyNzRkYWE5ZDBiZTRjMmRmNDlhYzE0L3RhYmxlOjcxYjQyZGU1OThjYTRiNDE5YzIzYzU1MzgxMzllMmQ4L3RhYmxlcmFuZ2U6NzFiNDJkZTU5OGNhNGI0MTljMjNjNTUzODEzOWUyZDhfMzItMy0xLTEtNDgxNjQ_1423f5a7-d84f-43f8-bfde-424fd536f5eb" unitRef="usd"> 321683000 </us-gaap:FiniteLivedIntangibleAssetsNet>
<opk:InventoryReceivedNotInvoicedCurrent contextRef="i4768f885851b49f986857a2a956f9162_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81Mi9mcmFnOjQ0NzlmZjNiYTAyNzRkYWE5ZDBiZTRjMmRmNDlhYzE0L3RhYmxlOjcxYjQyZGU1OThjYTRiNDE5YzIzYzU1MzgxMzllMmQ4L3RhYmxlcmFuZ2U6NzFiNDJkZTU5OGNhNGI0MTljMjNjNTUzODEzOWUyZDhfMzQtMS0xLTEtNDgxNjQ_e9510140-0835-464a-95c6-9cece3f8942d" unitRef="usd"> 18853000 </opk:InventoryReceivedNotInvoicedCurrent>
<opk:InventoryReceivedNotInvoicedCurrent contextRef="i7e0f479bead144b0bdbcc71082db627b_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81Mi9mcmFnOjQ0NzlmZjNiYTAyNzRkYWE5ZDBiZTRjMmRmNDlhYzE0L3RhYmxlOjcxYjQyZGU1OThjYTRiNDE5YzIzYzU1MzgxMzllMmQ4L3RhYmxlcmFuZ2U6NzFiNDJkZTU5OGNhNGI0MTljMjNjNTUzODEzOWUyZDhfMzQtMy0xLTEtNDgxNjQ_4e4672ca-7b8a-4f6d-bbff-082e7bd82197" unitRef="usd"> 40446000 </opk:InventoryReceivedNotInvoicedCurrent>
<opk:AccruedCommitmentsandContingenciesCurrent contextRef="i4768f885851b49f986857a2a956f9162_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81Mi9mcmFnOjQ0NzlmZjNiYTAyNzRkYWE5ZDBiZTRjMmRmNDlhYzE0L3RhYmxlOjcxYjQyZGU1OThjYTRiNDE5YzIzYzU1MzgxMzllMmQ4L3RhYmxlcmFuZ2U6NzFiNDJkZTU5OGNhNGI0MTljMjNjNTUzODEzOWUyZDhfMzUtMS0xLTEtNDgxNjQ_bab3474a-380a-497a-8e61-37c676d839fb" unitRef="usd"> 12745000 </opk:AccruedCommitmentsandContingenciesCurrent>
<opk:AccruedCommitmentsandContingenciesCurrent contextRef="i7e0f479bead144b0bdbcc71082db627b_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81Mi9mcmFnOjQ0NzlmZjNiYTAyNzRkYWE5ZDBiZTRjMmRmNDlhYzE0L3RhYmxlOjcxYjQyZGU1OThjYTRiNDE5YzIzYzU1MzgxMzllMmQ4L3RhYmxlcmFuZ2U6NzFiNDJkZTU5OGNhNGI0MTljMjNjNTUzODEzOWUyZDhfMzUtMy0xLTEtNDgxNjQ_1b1d6d5b-174b-4ef9-b6ce-0121fa0fe23f" unitRef="usd"> 27819000 </opk:AccruedCommitmentsandContingenciesCurrent>
<us-gaap:AccruedEmployeeBenefitsCurrent contextRef="i4768f885851b49f986857a2a956f9162_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81Mi9mcmFnOjQ0NzlmZjNiYTAyNzRkYWE5ZDBiZTRjMmRmNDlhYzE0L3RhYmxlOjcxYjQyZGU1OThjYTRiNDE5YzIzYzU1MzgxMzllMmQ4L3RhYmxlcmFuZ2U6NzFiNDJkZTU5OGNhNGI0MTljMjNjNTUzODEzOWUyZDhfMzYtMS0xLTEtNDgxNjQ_386e9dac-9921-4c41-86d1-1dd189f182fc" unitRef="usd"> 34368000 </us-gaap:AccruedEmployeeBenefitsCurrent>
<us-gaap:AccruedEmployeeBenefitsCurrent contextRef="i7e0f479bead144b0bdbcc71082db627b_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81Mi9mcmFnOjQ0NzlmZjNiYTAyNzRkYWE5ZDBiZTRjMmRmNDlhYzE0L3RhYmxlOjcxYjQyZGU1OThjYTRiNDE5YzIzYzU1MzgxMzllMmQ4L3RhYmxlcmFuZ2U6NzFiNDJkZTU5OGNhNGI0MTljMjNjNTUzODEzOWUyZDhfMzYtMy0xLTEtNDgxNjQ_e43a9ff2-7d09-4348-b117-6a4437bbbbea" unitRef="usd"> 45939000 </us-gaap:AccruedEmployeeBenefitsCurrent>
<us-gaap:ContractWithCustomerLiabilityCurrent contextRef="i4768f885851b49f986857a2a956f9162_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81Mi9mcmFnOjQ0NzlmZjNiYTAyNzRkYWE5ZDBiZTRjMmRmNDlhYzE0L3RhYmxlOjcxYjQyZGU1OThjYTRiNDE5YzIzYzU1MzgxMzllMmQ4L3RhYmxlcmFuZ2U6NzFiNDJkZTU5OGNhNGI0MTljMjNjNTUzODEzOWUyZDhfMzctMS0xLTEtNDgxNjQ_2cc6083f-acf3-4d67-a85d-796a2c014be0" unitRef="usd"> 257000 </us-gaap:ContractWithCustomerLiabilityCurrent>
<us-gaap:ContractWithCustomerLiabilityCurrent contextRef="i7e0f479bead144b0bdbcc71082db627b_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81Mi9mcmFnOjQ0NzlmZjNiYTAyNzRkYWE5ZDBiZTRjMmRmNDlhYzE0L3RhYmxlOjcxYjQyZGU1OThjYTRiNDE5YzIzYzU1MzgxMzllMmQ4L3RhYmxlcmFuZ2U6NzFiNDJkZTU5OGNhNGI0MTljMjNjNTUzODEzOWUyZDhfMzctMy0xLTEtNDgxNjQ_5b5bcb74-6c23-41b8-b9ce-b1a3b3383739" unitRef="usd"> 258000 </us-gaap:ContractWithCustomerLiabilityCurrent>
<opk:AccruedClinicalTrialsCurrent contextRef="i4768f885851b49f986857a2a956f9162_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81Mi9mcmFnOjQ0NzlmZjNiYTAyNzRkYWE5ZDBiZTRjMmRmNDlhYzE0L3RhYmxlOjcxYjQyZGU1OThjYTRiNDE5YzIzYzU1MzgxMzllMmQ4L3RhYmxlcmFuZ2U6NzFiNDJkZTU5OGNhNGI0MTljMjNjNTUzODEzOWUyZDhfMzgtMS0xLTEtNDgxNjQ_cb0e56fe-2928-4676-9c84-2ecf9c9434a4" unitRef="usd"> 4245000 </opk:AccruedClinicalTrialsCurrent>
<opk:AccruedClinicalTrialsCurrent contextRef="i7e0f479bead144b0bdbcc71082db627b_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81Mi9mcmFnOjQ0NzlmZjNiYTAyNzRkYWE5ZDBiZTRjMmRmNDlhYzE0L3RhYmxlOjcxYjQyZGU1OThjYTRiNDE5YzIzYzU1MzgxMzllMmQ4L3RhYmxlcmFuZ2U6NzFiNDJkZTU5OGNhNGI0MTljMjNjNTUzODEzOWUyZDhfMzgtMy0xLTEtNDgxNjQ_bb0128f8-f1be-463a-934f-7885a6133ee7" unitRef="usd"> 4867000 </opk:AccruedClinicalTrialsCurrent>
<us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent contextRef="i4768f885851b49f986857a2a956f9162_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81Mi9mcmFnOjQ0NzlmZjNiYTAyNzRkYWE5ZDBiZTRjMmRmNDlhYzE0L3RhYmxlOjcxYjQyZGU1OThjYTRiNDE5YzIzYzU1MzgxMzllMmQ4L3RhYmxlcmFuZ2U6NzFiNDJkZTU5OGNhNGI0MTljMjNjNTUzODEzOWUyZDhfNDAtMS0xLTEtNDgxNjQ_764c13a3-1d50-47ed-af2a-83fe287f4d6e" unitRef="usd"> 487000 </us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent>
<us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent contextRef="i7e0f479bead144b0bdbcc71082db627b_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81Mi9mcmFnOjQ0NzlmZjNiYTAyNzRkYWE5ZDBiZTRjMmRmNDlhYzE0L3RhYmxlOjcxYjQyZGU1OThjYTRiNDE5YzIzYzU1MzgxMzllMmQ4L3RhYmxlcmFuZ2U6NzFiNDJkZTU5OGNhNGI0MTljMjNjNTUzODEzOWUyZDhfNDAtMy0xLTEtNDgxNjQ_3239fe0b-40ab-4c54-a20c-9720ec655136" unitRef="usd"> 487000 </us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent>
<us-gaap:FinanceLeaseLiabilityCurrent contextRef="i4768f885851b49f986857a2a956f9162_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81Mi9mcmFnOjQ0NzlmZjNiYTAyNzRkYWE5ZDBiZTRjMmRmNDlhYzE0L3RhYmxlOjcxYjQyZGU1OThjYTRiNDE5YzIzYzU1MzgxMzllMmQ4L3RhYmxlcmFuZ2U6NzFiNDJkZTU5OGNhNGI0MTljMjNjNTUzODEzOWUyZDhfNDEtMS0xLTEtNDgxNjQ_46193171-fc66-45dc-b6e2-ffdd77017795" unitRef="usd"> 2625000 </us-gaap:FinanceLeaseLiabilityCurrent>
<us-gaap:FinanceLeaseLiabilityCurrent contextRef="i7e0f479bead144b0bdbcc71082db627b_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81Mi9mcmFnOjQ0NzlmZjNiYTAyNzRkYWE5ZDBiZTRjMmRmNDlhYzE0L3RhYmxlOjcxYjQyZGU1OThjYTRiNDE5YzIzYzU1MzgxMzllMmQ4L3RhYmxlcmFuZ2U6NzFiNDJkZTU5OGNhNGI0MTljMjNjNTUzODEzOWUyZDhfNDEtMy0xLTEtNDgxNjQ_a5c6083d-1a2d-428a-a1c8-b107daa0d18d" unitRef="usd"> 2257000 </us-gaap:FinanceLeaseLiabilityCurrent>
<us-gaap:AccruedProfessionalFeesCurrent contextRef="i4768f885851b49f986857a2a956f9162_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81Mi9mcmFnOjQ0NzlmZjNiYTAyNzRkYWE5ZDBiZTRjMmRmNDlhYzE0L3RhYmxlOjcxYjQyZGU1OThjYTRiNDE5YzIzYzU1MzgxMzllMmQ4L3RhYmxlcmFuZ2U6NzFiNDJkZTU5OGNhNGI0MTljMjNjNTUzODEzOWUyZDhfNDMtMS0xLTEtNDgxNjQ_65d8b415-ca99-4383-8812-54403c5d57d3" unitRef="usd"> 4116000 </us-gaap:AccruedProfessionalFeesCurrent>
<us-gaap:AccruedProfessionalFeesCurrent contextRef="i7e0f479bead144b0bdbcc71082db627b_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81Mi9mcmFnOjQ0NzlmZjNiYTAyNzRkYWE5ZDBiZTRjMmRmNDlhYzE0L3RhYmxlOjcxYjQyZGU1OThjYTRiNDE5YzIzYzU1MzgxMzllMmQ4L3RhYmxlcmFuZ2U6NzFiNDJkZTU5OGNhNGI0MTljMjNjNTUzODEzOWUyZDhfNDMtMy0xLTEtNDgxNjQ_969ca95a-c452-4df2-9e8d-00687a6533f5" unitRef="usd"> 2121000 </us-gaap:AccruedProfessionalFeesCurrent>
<us-gaap:OtherAccruedLiabilitiesCurrent contextRef="i4768f885851b49f986857a2a956f9162_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81Mi9mcmFnOjQ0NzlmZjNiYTAyNzRkYWE5ZDBiZTRjMmRmNDlhYzE0L3RhYmxlOjcxYjQyZGU1OThjYTRiNDE5YzIzYzU1MzgxMzllMmQ4L3RhYmxlcmFuZ2U6NzFiNDJkZTU5OGNhNGI0MTljMjNjNTUzODEzOWUyZDhfNDYtMS0xLTEtNDgxNjQ_ce79a191-ef4a-472e-a8b9-25439245b6e2" unitRef="usd"> 50558000 </us-gaap:OtherAccruedLiabilitiesCurrent>
<us-gaap:OtherAccruedLiabilitiesCurrent contextRef="i7e0f479bead144b0bdbcc71082db627b_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81Mi9mcmFnOjQ0NzlmZjNiYTAyNzRkYWE5ZDBiZTRjMmRmNDlhYzE0L3RhYmxlOjcxYjQyZGU1OThjYTRiNDE5YzIzYzU1MzgxMzllMmQ4L3RhYmxlcmFuZ2U6NzFiNDJkZTU5OGNhNGI0MTljMjNjNTUzODEzOWUyZDhfNDYtMy0xLTEtNDgxNjQ_847b5e12-0125-4dda-8d16-5e7b1e5324c6" unitRef="usd"> 69299000 </us-gaap:OtherAccruedLiabilitiesCurrent>
<us-gaap:AccruedLiabilitiesCurrent contextRef="i4768f885851b49f986857a2a956f9162_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81Mi9mcmFnOjQ0NzlmZjNiYTAyNzRkYWE5ZDBiZTRjMmRmNDlhYzE0L3RhYmxlOjcxYjQyZGU1OThjYTRiNDE5YzIzYzU1MzgxMzllMmQ4L3RhYmxlcmFuZ2U6NzFiNDJkZTU5OGNhNGI0MTljMjNjNTUzODEzOWUyZDhfNDctMS0xLTEtNDgxNjQ_1ab63545-090a-4e98-96db-73601bbc3270" unitRef="usd"> 128254000 </us-gaap:AccruedLiabilitiesCurrent>
<us-gaap:AccruedLiabilitiesCurrent contextRef="i7e0f479bead144b0bdbcc71082db627b_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81Mi9mcmFnOjQ0NzlmZjNiYTAyNzRkYWE5ZDBiZTRjMmRmNDlhYzE0L3RhYmxlOjcxYjQyZGU1OThjYTRiNDE5YzIzYzU1MzgxMzllMmQ4L3RhYmxlcmFuZ2U6NzFiNDJkZTU5OGNhNGI0MTljMjNjNTUzODEzOWUyZDhfNDctMy0xLTEtNDgxNjQ_40b7d3a7-0424-41d8-83ff-e86b61a04118" unitRef="usd"> 193493000 </us-gaap:AccruedLiabilitiesCurrent>
<us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent contextRef="i4768f885851b49f986857a2a956f9162_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81Mi9mcmFnOjQ0NzlmZjNiYTAyNzRkYWE5ZDBiZTRjMmRmNDlhYzE0L3RhYmxlOjcxYjQyZGU1OThjYTRiNDE5YzIzYzU1MzgxMzllMmQ4L3RhYmxlcmFuZ2U6NzFiNDJkZTU5OGNhNGI0MTljMjNjNTUzODEzOWUyZDhfNTEtMS0xLTEtNDgxNjQ_d3acd72a-f9a1-4f1b-b613-43e53db83457" unitRef="usd"> 2416000 </us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent>
<us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent contextRef="i7e0f479bead144b0bdbcc71082db627b_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81Mi9mcmFnOjQ0NzlmZjNiYTAyNzRkYWE5ZDBiZTRjMmRmNDlhYzE0L3RhYmxlOjcxYjQyZGU1OThjYTRiNDE5YzIzYzU1MzgxMzllMmQ4L3RhYmxlcmFuZ2U6NzFiNDJkZTU5OGNhNGI0MTljMjNjNTUzODEzOWUyZDhfNTEtMy0xLTEtNDgxNjQ_13ca8664-3854-4643-9e93-f7b3f03208d5" unitRef="usd"> 2350000 </us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent>
<us-gaap:OtherLongTermDebtNoncurrent contextRef="i4768f885851b49f986857a2a956f9162_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81Mi9mcmFnOjQ0NzlmZjNiYTAyNzRkYWE5ZDBiZTRjMmRmNDlhYzE0L3RhYmxlOjcxYjQyZGU1OThjYTRiNDE5YzIzYzU1MzgxMzllMmQ4L3RhYmxlcmFuZ2U6NzFiNDJkZTU5OGNhNGI0MTljMjNjNTUzODEzOWUyZDhfNTMtMS0xLTEtNDgxNjQ_9a7be54b-d69b-48ca-afd8-2f14f3ce8bc1" unitRef="usd"> 1680000 </us-gaap:OtherLongTermDebtNoncurrent>
<us-gaap:OtherLongTermDebtNoncurrent contextRef="i7e0f479bead144b0bdbcc71082db627b_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81Mi9mcmFnOjQ0NzlmZjNiYTAyNzRkYWE5ZDBiZTRjMmRmNDlhYzE0L3RhYmxlOjcxYjQyZGU1OThjYTRiNDE5YzIzYzU1MzgxMzllMmQ4L3RhYmxlcmFuZ2U6NzFiNDJkZTU5OGNhNGI0MTljMjNjNTUzODEzOWUyZDhfNTMtMy0xLTEtNDgxNjQ_53274ad6-c157-4d55-bb59-3f1215994a83" unitRef="usd"> 2224000 </us-gaap:OtherLongTermDebtNoncurrent>
<us-gaap:FinanceLeaseLiabilityNoncurrent contextRef="i4768f885851b49f986857a2a956f9162_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81Mi9mcmFnOjQ0NzlmZjNiYTAyNzRkYWE5ZDBiZTRjMmRmNDlhYzE0L3RhYmxlOjcxYjQyZGU1OThjYTRiNDE5YzIzYzU1MzgxMzllMmQ4L3RhYmxlcmFuZ2U6NzFiNDJkZTU5OGNhNGI0MTljMjNjNTUzODEzOWUyZDhfNTQtMS0xLTEtNDgxNjQ_c466d457-c307-4bee-82c1-d90a9260fae2" unitRef="usd"> 4588000 </us-gaap:FinanceLeaseLiabilityNoncurrent>
<us-gaap:FinanceLeaseLiabilityNoncurrent contextRef="i7e0f479bead144b0bdbcc71082db627b_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81Mi9mcmFnOjQ0NzlmZjNiYTAyNzRkYWE5ZDBiZTRjMmRmNDlhYzE0L3RhYmxlOjcxYjQyZGU1OThjYTRiNDE5YzIzYzU1MzgxMzllMmQ4L3RhYmxlcmFuZ2U6NzFiNDJkZTU5OGNhNGI0MTljMjNjNTUzODEzOWUyZDhfNTQtMy0xLTEtNDgxNjQ_2a1737f3-60ca-4297-84eb-1c3c5cfdb86e" unitRef="usd"> 2924000 </us-gaap:FinanceLeaseLiabilityNoncurrent>
<us-gaap:ContractWithCustomerLiabilityNoncurrent contextRef="i4768f885851b49f986857a2a956f9162_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81Mi9mcmFnOjQ0NzlmZjNiYTAyNzRkYWE5ZDBiZTRjMmRmNDlhYzE0L3RhYmxlOjcxYjQyZGU1OThjYTRiNDE5YzIzYzU1MzgxMzllMmQ4L3RhYmxlcmFuZ2U6NzFiNDJkZTU5OGNhNGI0MTljMjNjNTUzODEzOWUyZDhfNTUtMS0xLTEtNDgxNjQ_4dcf882b-7165-4193-87c2-c3986b3dc5f6" unitRef="usd"> 192000 </us-gaap:ContractWithCustomerLiabilityNoncurrent>
<us-gaap:ContractWithCustomerLiabilityNoncurrent contextRef="i7e0f479bead144b0bdbcc71082db627b_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81Mi9mcmFnOjQ0NzlmZjNiYTAyNzRkYWE5ZDBiZTRjMmRmNDlhYzE0L3RhYmxlOjcxYjQyZGU1OThjYTRiNDE5YzIzYzU1MzgxMzllMmQ4L3RhYmxlcmFuZ2U6NzFiNDJkZTU5OGNhNGI0MTljMjNjNTUzODEzOWUyZDhfNTUtMy0xLTEtNDgxNjQ_92f26996-a7b4-401f-beee-445a36db65a5" unitRef="usd"> 208000 </us-gaap:ContractWithCustomerLiabilityNoncurrent>
<us-gaap:OtherLiabilitiesAndDeferredRevenueNoncurrent contextRef="i4768f885851b49f986857a2a956f9162_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81Mi9mcmFnOjQ0NzlmZjNiYTAyNzRkYWE5ZDBiZTRjMmRmNDlhYzE0L3RhYmxlOjcxYjQyZGU1OThjYTRiNDE5YzIzYzU1MzgxMzllMmQ4L3RhYmxlcmFuZ2U6NzFiNDJkZTU5OGNhNGI0MTljMjNjNTUzODEzOWUyZDhfNTYtMS0xLTEtNDgxNjQ_8af693a7-ac2e-4c2b-a991-59e5d9fd6b60" unitRef="usd"> 7361000 </us-gaap:OtherLiabilitiesAndDeferredRevenueNoncurrent>
<us-gaap:OtherLiabilitiesAndDeferredRevenueNoncurrent contextRef="i7e0f479bead144b0bdbcc71082db627b_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81Mi9mcmFnOjQ0NzlmZjNiYTAyNzRkYWE5ZDBiZTRjMmRmNDlhYzE0L3RhYmxlOjcxYjQyZGU1OThjYTRiNDE5YzIzYzU1MzgxMzllMmQ4L3RhYmxlcmFuZ2U6NzFiNDJkZTU5OGNhNGI0MTljMjNjNTUzODEzOWUyZDhfNTYtMy0xLTEtNDgxNjQ_f31a383c-7d5b-4a8e-a652-46b9d4c6881d" unitRef="usd"> 7356000 </us-gaap:OtherLiabilitiesAndDeferredRevenueNoncurrent>
<us-gaap:OtherLiabilitiesNoncurrent contextRef="i4768f885851b49f986857a2a956f9162_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81Mi9mcmFnOjQ0NzlmZjNiYTAyNzRkYWE5ZDBiZTRjMmRmNDlhYzE0L3RhYmxlOjcxYjQyZGU1OThjYTRiNDE5YzIzYzU1MzgxMzllMmQ4L3RhYmxlcmFuZ2U6NzFiNDJkZTU5OGNhNGI0MTljMjNjNTUzODEzOWUyZDhfNTctMS0xLTEtNDgxNjQ_0d094ec5-6171-4d31-88c7-1ff46c3f4b79" unitRef="usd"> 16237000 </us-gaap:OtherLiabilitiesNoncurrent>
<us-gaap:OtherLiabilitiesNoncurrent contextRef="i7e0f479bead144b0bdbcc71082db627b_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81Mi9mcmFnOjQ0NzlmZjNiYTAyNzRkYWE5ZDBiZTRjMmRmNDlhYzE0L3RhYmxlOjcxYjQyZGU1OThjYTRiNDE5YzIzYzU1MzgxMzllMmQ4L3RhYmxlcmFuZ2U6NzFiNDJkZTU5OGNhNGI0MTljMjNjNTUzODEzOWUyZDhfNTctMy0xLTEtNDgxNjQ_a1b076b8-bd96-4f6d-9c07-d7d7b4efaeb4" unitRef="usd"> 15062000 </us-gaap:OtherLiabilitiesNoncurrent>
<us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife contextRef="i961111bfd3ae4d1786f3b644dfaed15f_D20220101-20220630" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81Mi9mcmFnOjQ0NzlmZjNiYTAyNzRkYWE5ZDBiZTRjMmRmNDlhYzE0L3RleHRyZWdpb246NDQ3OWZmM2JhMDI3NGRhYTlkMGJlNGMyZGY0OWFjMTRfMzkz_3a533488-5b38-4c4f-b9e4-759f8cec58ac"> P7Y </us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
<us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife contextRef="i3891a855bcc64f0199be6de69911de91_D20220101-20220630" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81Mi9mcmFnOjQ0NzlmZjNiYTAyNzRkYWE5ZDBiZTRjMmRmNDlhYzE0L3RleHRyZWdpb246NDQ3OWZmM2JhMDI3NGRhYTlkMGJlNGMyZGY0OWFjMTRfMzk2_b7f0d450-2d67-42d6-8857-c618027cd455"> P17Y </us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
<us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife contextRef="ib8154ad8782c4825a297a4cb81b36e53_D20220101-20220630" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81Mi9mcmFnOjQ0NzlmZjNiYTAyNzRkYWE5ZDBiZTRjMmRmNDlhYzE0L3RleHRyZWdpb246NDQ3OWZmM2JhMDI3NGRhYTlkMGJlNGMyZGY0OWFjMTRfNDMx_c5dfd9be-4c3c-4513-905e-c0be26ebd402"> P7Y </us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
<us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife contextRef="ife2c9d6b8b8e418092c5956c4a0d03b6_D20220101-20220630" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81Mi9mcmFnOjQ0NzlmZjNiYTAyNzRkYWE5ZDBiZTRjMmRmNDlhYzE0L3RleHRyZWdpb246NDQ3OWZmM2JhMDI3NGRhYTlkMGJlNGMyZGY0OWFjMTRfNDM0_0d537178-f573-4b16-8e1e-eb18794bbd42"> P20Y </us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
<us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife contextRef="i61ac88df138d4017af162d9e836d38cb_D20220101-20220630" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81Mi9mcmFnOjQ0NzlmZjNiYTAyNzRkYWE5ZDBiZTRjMmRmNDlhYzE0L3RleHRyZWdpb246NDQ3OWZmM2JhMDI3NGRhYTlkMGJlNGMyZGY0OWFjMTRfNDY4_de30ff6b-c676-42ad-9768-769dccddeee8"> P7Y </us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
<us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife contextRef="i48e5f9c0fe4f420f8a4b344acfe545aa_D20220101-20220630" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81Mi9mcmFnOjQ0NzlmZjNiYTAyNzRkYWE5ZDBiZTRjMmRmNDlhYzE0L3RleHRyZWdpb246NDQ3OWZmM2JhMDI3NGRhYTlkMGJlNGMyZGY0OWFjMTRfNDcx_60360073-3095-4815-b721-3b6e763253b6"> P10Y </us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
<us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife contextRef="ib06c7ba653fe4abe830ffc75779c7675_D20220101-20220630" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81Mi9mcmFnOjQ0NzlmZjNiYTAyNzRkYWE5ZDBiZTRjMmRmNDlhYzE0L3RleHRyZWdpb246NDQ3OWZmM2JhMDI3NGRhYTlkMGJlNGMyZGY0OWFjMTRfNTA4_63e3f3b4-31b0-49e3-8f3f-5e0d34c5d8bc"> P5Y </us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
<us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife contextRef="i0a9715dd8aa045569b32c5151bd4fe07_D20220101-20220630" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81Mi9mcmFnOjQ0NzlmZjNiYTAyNzRkYWE5ZDBiZTRjMmRmNDlhYzE0L3RleHRyZWdpb246NDQ3OWZmM2JhMDI3NGRhYTlkMGJlNGMyZGY0OWFjMTRfNTMy_673b0696-9374-4f05-8da8-cca49e1f98d8"> P5Y </us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
<us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife contextRef="i6731e6058ad24d159fc46e1db9045567_D20220101-20220630" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81Mi9mcmFnOjQ0NzlmZjNiYTAyNzRkYWE5ZDBiZTRjMmRmNDlhYzE0L3RleHRyZWdpb246NDQ3OWZmM2JhMDI3NGRhYTlkMGJlNGMyZGY0OWFjMTRfNTM1_d496bdec-da2f-4c7e-be78-15c186694191"> P10Y </us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
<us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife contextRef="ic3e0c38984e046c89b487d9fcf35517f_D20220101-20220630" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81Mi9mcmFnOjQ0NzlmZjNiYTAyNzRkYWE5ZDBiZTRjMmRmNDlhYzE0L3RleHRyZWdpb246NDQ3OWZmM2JhMDI3NGRhYTlkMGJlNGMyZGY0OWFjMTRfNTUx_62ec4b44-e13d-46b4-bf78-9399eafe31c9"> P9Y </us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
<us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife contextRef="id67de6a8442540ca96b8c68ada9e9d68_D20220101-20220630" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81Mi9mcmFnOjQ0NzlmZjNiYTAyNzRkYWE5ZDBiZTRjMmRmNDlhYzE0L3RleHRyZWdpb246NDQ3OWZmM2JhMDI3NGRhYTlkMGJlNGMyZGY0OWFjMTRfNTU0_70d0b4a3-4f9c-411a-ba88-10eb00690a99"> P13Y </us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
<us-gaap:Goodwill contextRef="icf88bd5dcf6d4a0b85df429b936bc0a1_I20211231" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81Mi9mcmFnOjQ0NzlmZjNiYTAyNzRkYWE5ZDBiZTRjMmRmNDlhYzE0L3RleHRyZWdpb246NDQ3OWZmM2JhMDI3NGRhYTlkMGJlNGMyZGY0OWFjMTRfMTEyNw_7b0a334e-f1bf-445d-a938-7b80b4e1fc03" unitRef="usd"> 151800000 </us-gaap:Goodwill>
<us-gaap:FiniteLivedIntangibleAssetsNet contextRef="ib6bd9208c33c495395b98878d167a208_I20220331" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81Mi9mcmFnOjQ0NzlmZjNiYTAyNzRkYWE5ZDBiZTRjMmRmNDlhYzE0L3RleHRyZWdpb246NDQ3OWZmM2JhMDI3NGRhYTlkMGJlNGMyZGY0OWFjMTRfMTIwOA_1ac237c1-6718-450f-9a61-f53d3508ff65" unitRef="usd"> 590000000 </us-gaap:FiniteLivedIntangibleAssetsNet>
<opk:InProcessResearchandDevelopment contextRef="i8db165b77cc14b43a5ed53019cb00903_I20220331" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81Mi9mcmFnOjQ0NzlmZjNiYTAyNzRkYWE5ZDBiZTRjMmRmNDlhYzE0L3RleHRyZWdpb246NDQ3OWZmM2JhMDI3NGRhYTlkMGJlNGMyZGY0OWFjMTRfMTIwOA_2e378d69-abfb-4ee8-aa27-e8cd374261ef" unitRef="usd"> 590000000 </opk:InProcessResearchandDevelopment>
<us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="i857711861e3f4bdb99db993663f74933_D20220101-20220331" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81Mi9mcmFnOjQ0NzlmZjNiYTAyNzRkYWE5ZDBiZTRjMmRmNDlhYzE0L3RleHRyZWdpb246NDQ3OWZmM2JhMDI3NGRhYTlkMGJlNGMyZGY0OWFjMTRfMTQ2Mw_382bd85a-f302-4f62-b6eb-30af2ac063e2"> P12Y </us-gaap:FiniteLivedIntangibleAssetUsefulLife>
<us-gaap:ScheduleOfGoodwillTextBlock contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81Mi9mcmFnOjQ0NzlmZjNiYTAyNzRkYWE5ZDBiZTRjMmRmNDlhYzE0L3RleHRyZWdpb246NDQ3OWZmM2JhMDI3NGRhYTlkMGJlNGMyZGY0OWFjMTRfMTkwNw_d69bbdf7-401a-414c-bed6-f8f2641731ef">
<div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the changes in Goodwill by reporting unit during the six months ended June 30, 2022.</span></div><div style="margin-top:14pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.076%"><tr><td style="width:1.0%"/><td style="width:28.869%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.906%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.906%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:12.906%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.906%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.907%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gross goodwill at January 1</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cumulative impairment at January 1</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Acquisitions and dispositions</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign exchange and other</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at June 30</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pharmaceuticals</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CURNA</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,827 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4,827)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">Rayaldee</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">86,554 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(6,652)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">79,902 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">FineTech</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11,698 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(11,698)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ModeX</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">65,786 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">65,786 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">OPKO Biologics</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">139,784 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">139,784 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">OPKO Chile</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,760 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(301)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,459 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">OPKO Health Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,478 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(589)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,889 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">OPKO Mexico</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">100 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(100)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Transition Therapeutics</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,421 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3,421)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Diagnostics</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">BioReference</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">434,809 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(151,784)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">283,025 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">OPKO Diagnostics</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17,977 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(17,977)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">710,408 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(38,023)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(85,998)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(7,542)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">578,845 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div>
</us-gaap:ScheduleOfGoodwillTextBlock>
<us-gaap:Goodwill contextRef="ic7bc1c143261409d885f640ef938f1d0_I20220101" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81Mi9mcmFnOjQ0NzlmZjNiYTAyNzRkYWE5ZDBiZTRjMmRmNDlhYzE0L3RhYmxlOjRmMjY3ZWE5MzRiMTRkMGY4NTNmMzVkMDdkNGUyY2U1L3RhYmxlcmFuZ2U6NGYyNjdlYTkzNGIxNGQwZjg1M2YzNWQwN2Q0ZTJjZTVfMy0xLTEtMS00ODE2NA_8f08bbf7-4a25-47eb-b8cf-10fe155115de" unitRef="usd"> 4827000 </us-gaap:Goodwill>
<us-gaap:GoodwillImpairedAccumulatedImpairmentLoss contextRef="ia43ace2974434cfcbeef89c8f5e7d477_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81Mi9mcmFnOjQ0NzlmZjNiYTAyNzRkYWE5ZDBiZTRjMmRmNDlhYzE0L3RhYmxlOjRmMjY3ZWE5MzRiMTRkMGY4NTNmMzVkMDdkNGUyY2U1L3RhYmxlcmFuZ2U6NGYyNjdlYTkzNGIxNGQwZjg1M2YzNWQwN2Q0ZTJjZTVfMy0yLTEtMS00ODE2NA_dfa47c44-c5af-4b6a-b3c9-f057d88c73c9" unitRef="usd"> 4827000 </us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
<opk:GoodwillAcquiredDisposedOfDuringPeriod contextRef="ib1e13f80600d48f5a2c0e620b18ecabc_D20220101-20220630" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81Mi9mcmFnOjQ0NzlmZjNiYTAyNzRkYWE5ZDBiZTRjMmRmNDlhYzE0L3RhYmxlOjRmMjY3ZWE5MzRiMTRkMGY4NTNmMzVkMDdkNGUyY2U1L3RhYmxlcmFuZ2U6NGYyNjdlYTkzNGIxNGQwZjg1M2YzNWQwN2Q0ZTJjZTVfMy00LTEtMS01NjQzNw_004634da-96a1-44be-98f5-9a39731495ac" unitRef="usd" xsi:nil="true"/>
<us-gaap:GoodwillForeignCurrencyTranslationGainLoss contextRef="ib1e13f80600d48f5a2c0e620b18ecabc_D20220101-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81Mi9mcmFnOjQ0NzlmZjNiYTAyNzRkYWE5ZDBiZTRjMmRmNDlhYzE0L3RhYmxlOjRmMjY3ZWE5MzRiMTRkMGY4NTNmMzVkMDdkNGUyY2U1L3RhYmxlcmFuZ2U6NGYyNjdlYTkzNGIxNGQwZjg1M2YzNWQwN2Q0ZTJjZTVfMy00LTEtMS00ODE2NA_dfa7b88e-6f8e-4d9b-9746-662720b5712e" unitRef="usd"> 0 </us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
<us-gaap:Goodwill contextRef="i5c4e1553e63444f18dce0e26ba559b82_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81Mi9mcmFnOjQ0NzlmZjNiYTAyNzRkYWE5ZDBiZTRjMmRmNDlhYzE0L3RhYmxlOjRmMjY3ZWE5MzRiMTRkMGY4NTNmMzVkMDdkNGUyY2U1L3RhYmxlcmFuZ2U6NGYyNjdlYTkzNGIxNGQwZjg1M2YzNWQwN2Q0ZTJjZTVfMy01LTEtMS00ODE2NA_4a414098-9b0b-44ed-a04d-a9870af158d9" unitRef="usd"> 0 </us-gaap:Goodwill>
<us-gaap:Goodwill contextRef="i565df68659b544e8b4f6c9442ca781fa_I20220101" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81Mi9mcmFnOjQ0NzlmZjNiYTAyNzRkYWE5ZDBiZTRjMmRmNDlhYzE0L3RhYmxlOjRmMjY3ZWE5MzRiMTRkMGY4NTNmMzVkMDdkNGUyY2U1L3RhYmxlcmFuZ2U6NGYyNjdlYTkzNGIxNGQwZjg1M2YzNWQwN2Q0ZTJjZTVfNC0xLTEtMS00ODE2NA_854ed125-d75e-44af-8fac-e8e10ddeea0b" unitRef="usd"> 86554000 </us-gaap:Goodwill>
<us-gaap:GoodwillImpairedAccumulatedImpairmentLoss contextRef="i431e318a0b5744f7baf11d068ead714b_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81Mi9mcmFnOjQ0NzlmZjNiYTAyNzRkYWE5ZDBiZTRjMmRmNDlhYzE0L3RhYmxlOjRmMjY3ZWE5MzRiMTRkMGY4NTNmMzVkMDdkNGUyY2U1L3RhYmxlcmFuZ2U6NGYyNjdlYTkzNGIxNGQwZjg1M2YzNWQwN2Q0ZTJjZTVfNC0yLTEtMS00ODE2NA_3a9e9bcc-f132-4402-ab2c-772e01441fb1" unitRef="usd"> 0 </us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
<opk:GoodwillAcquiredDisposedOfDuringPeriod contextRef="if721914b6f354b41a9c707a8e5b76bf5_D20220101-20220630" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81Mi9mcmFnOjQ0NzlmZjNiYTAyNzRkYWE5ZDBiZTRjMmRmNDlhYzE0L3RhYmxlOjRmMjY3ZWE5MzRiMTRkMGY4NTNmMzVkMDdkNGUyY2U1L3RhYmxlcmFuZ2U6NGYyNjdlYTkzNGIxNGQwZjg1M2YzNWQwN2Q0ZTJjZTVfNC00LTEtMS01NjQzNw_06c70c18-cacd-451c-803c-a5438723920a" unitRef="usd" xsi:nil="true"/>
<us-gaap:GoodwillForeignCurrencyTranslationGainLoss contextRef="if721914b6f354b41a9c707a8e5b76bf5_D20220101-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81Mi9mcmFnOjQ0NzlmZjNiYTAyNzRkYWE5ZDBiZTRjMmRmNDlhYzE0L3RhYmxlOjRmMjY3ZWE5MzRiMTRkMGY4NTNmMzVkMDdkNGUyY2U1L3RhYmxlcmFuZ2U6NGYyNjdlYTkzNGIxNGQwZjg1M2YzNWQwN2Q0ZTJjZTVfNC00LTEtMS00ODE2NA_ad9f2311-2b61-481a-97b3-18cf66f6370a" unitRef="usd"> -6652000 </us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
<us-gaap:Goodwill contextRef="ie12b186fde19404faaed8e391ad1be7b_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81Mi9mcmFnOjQ0NzlmZjNiYTAyNzRkYWE5ZDBiZTRjMmRmNDlhYzE0L3RhYmxlOjRmMjY3ZWE5MzRiMTRkMGY4NTNmMzVkMDdkNGUyY2U1L3RhYmxlcmFuZ2U6NGYyNjdlYTkzNGIxNGQwZjg1M2YzNWQwN2Q0ZTJjZTVfNC01LTEtMS00ODE2NA_7eaf4dcf-6d63-4078-80a9-e8367abf331d" unitRef="usd"> 79902000 </us-gaap:Goodwill>
<us-gaap:Goodwill contextRef="i6131f768521c46428c444dd24756c742_I20220101" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81Mi9mcmFnOjQ0NzlmZjNiYTAyNzRkYWE5ZDBiZTRjMmRmNDlhYzE0L3RhYmxlOjRmMjY3ZWE5MzRiMTRkMGY4NTNmMzVkMDdkNGUyY2U1L3RhYmxlcmFuZ2U6NGYyNjdlYTkzNGIxNGQwZjg1M2YzNWQwN2Q0ZTJjZTVfNS0xLTEtMS00ODE2NA_cb550c4b-637d-477e-8968-0e1a431cb683" unitRef="usd"> 11698000 </us-gaap:Goodwill>
<us-gaap:GoodwillImpairedAccumulatedImpairmentLoss contextRef="i3ade77f9eaed4faabb37aeea4dce9d1b_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81Mi9mcmFnOjQ0NzlmZjNiYTAyNzRkYWE5ZDBiZTRjMmRmNDlhYzE0L3RhYmxlOjRmMjY3ZWE5MzRiMTRkMGY4NTNmMzVkMDdkNGUyY2U1L3RhYmxlcmFuZ2U6NGYyNjdlYTkzNGIxNGQwZjg1M2YzNWQwN2Q0ZTJjZTVfNS0yLTEtMS00ODE2NA_74f7402b-331c-44bf-b8e2-e2743897412c" unitRef="usd"> 11698000 </us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
<opk:GoodwillAcquiredDisposedOfDuringPeriod contextRef="i5c49745088b24c95a89e2e762044ccfe_D20220101-20220630" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81Mi9mcmFnOjQ0NzlmZjNiYTAyNzRkYWE5ZDBiZTRjMmRmNDlhYzE0L3RhYmxlOjRmMjY3ZWE5MzRiMTRkMGY4NTNmMzVkMDdkNGUyY2U1L3RhYmxlcmFuZ2U6NGYyNjdlYTkzNGIxNGQwZjg1M2YzNWQwN2Q0ZTJjZTVfNS00LTEtMS01NjQzNw_eb37b430-2a34-4973-9a89-99fe41b12009" unitRef="usd" xsi:nil="true"/>
<us-gaap:GoodwillForeignCurrencyTranslationGainLoss contextRef="i5c49745088b24c95a89e2e762044ccfe_D20220101-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81Mi9mcmFnOjQ0NzlmZjNiYTAyNzRkYWE5ZDBiZTRjMmRmNDlhYzE0L3RhYmxlOjRmMjY3ZWE5MzRiMTRkMGY4NTNmMzVkMDdkNGUyY2U1L3RhYmxlcmFuZ2U6NGYyNjdlYTkzNGIxNGQwZjg1M2YzNWQwN2Q0ZTJjZTVfNS00LTEtMS00ODE2NA_b86717f0-e02d-4edf-97f8-63a083575de9" unitRef="usd"> 0 </us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
<us-gaap:Goodwill contextRef="ia31f3729b6794f729d55bc77509bbbb7_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81Mi9mcmFnOjQ0NzlmZjNiYTAyNzRkYWE5ZDBiZTRjMmRmNDlhYzE0L3RhYmxlOjRmMjY3ZWE5MzRiMTRkMGY4NTNmMzVkMDdkNGUyY2U1L3RhYmxlcmFuZ2U6NGYyNjdlYTkzNGIxNGQwZjg1M2YzNWQwN2Q0ZTJjZTVfNS01LTEtMS00ODE2NA_45a515f4-8bef-43df-bb13-be48252aa66f" unitRef="usd"> 0 </us-gaap:Goodwill>
<us-gaap:Goodwill contextRef="i14362d9426824546a785459ecd0f7d21_I20220101" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81Mi9mcmFnOjQ0NzlmZjNiYTAyNzRkYWE5ZDBiZTRjMmRmNDlhYzE0L3RhYmxlOjRmMjY3ZWE5MzRiMTRkMGY4NTNmMzVkMDdkNGUyY2U1L3RhYmxlcmFuZ2U6NGYyNjdlYTkzNGIxNGQwZjg1M2YzNWQwN2Q0ZTJjZTVfNi0xLTEtMS01NDUzNQ_1d40383a-e18d-4ea0-8c09-d1a6be48c43b" unitRef="usd"> 0 </us-gaap:Goodwill>
<us-gaap:GoodwillImpairedAccumulatedImpairmentLoss contextRef="ic2c80ed446f94b9583d235b0ade0e583_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81Mi9mcmFnOjQ0NzlmZjNiYTAyNzRkYWE5ZDBiZTRjMmRmNDlhYzE0L3RhYmxlOjRmMjY3ZWE5MzRiMTRkMGY4NTNmMzVkMDdkNGUyY2U1L3RhYmxlcmFuZ2U6NGYyNjdlYTkzNGIxNGQwZjg1M2YzNWQwN2Q0ZTJjZTVfNi0yLTEtMS01NDU0Nw_c63b2be8-cf6c-468c-874f-a864d5228951" unitRef="usd"> 0 </us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
<opk:GoodwillAcquiredDisposedOfDuringPeriod contextRef="i4f33dc4c2e62444caaa86ebd36c79a27_D20220101-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81Mi9mcmFnOjQ0NzlmZjNiYTAyNzRkYWE5ZDBiZTRjMmRmNDlhYzE0L3RhYmxlOjRmMjY3ZWE5MzRiMTRkMGY4NTNmMzVkMDdkNGUyY2U1L3RhYmxlcmFuZ2U6NGYyNjdlYTkzNGIxNGQwZjg1M2YzNWQwN2Q0ZTJjZTVfNi00LTEtMS01NjQxNQ_ae70e9ab-f272-440b-8e46-ee51a07c69b9" unitRef="usd"> 65786000 </opk:GoodwillAcquiredDisposedOfDuringPeriod>
<us-gaap:GoodwillForeignCurrencyTranslationGainLoss contextRef="i4f33dc4c2e62444caaa86ebd36c79a27_D20220101-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81Mi9mcmFnOjQ0NzlmZjNiYTAyNzRkYWE5ZDBiZTRjMmRmNDlhYzE0L3RhYmxlOjRmMjY3ZWE5MzRiMTRkMGY4NTNmMzVkMDdkNGUyY2U1L3RhYmxlcmFuZ2U6NGYyNjdlYTkzNGIxNGQwZjg1M2YzNWQwN2Q0ZTJjZTVfNi00LTEtMS01NDU1Ng_51040607-36d3-438e-92ba-7634c5936fae" unitRef="usd"> 0 </us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
<us-gaap:Goodwill contextRef="i5a29a6dcd3ad4c4d8ff6bdd54a4c0b60_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81Mi9mcmFnOjQ0NzlmZjNiYTAyNzRkYWE5ZDBiZTRjMmRmNDlhYzE0L3RhYmxlOjRmMjY3ZWE5MzRiMTRkMGY4NTNmMzVkMDdkNGUyY2U1L3RhYmxlcmFuZ2U6NGYyNjdlYTkzNGIxNGQwZjg1M2YzNWQwN2Q0ZTJjZTVfNi01LTEtMS01NDU2NQ_56c14e6b-9e53-40c5-a1a6-675604196ae4" unitRef="usd"> 65786000 </us-gaap:Goodwill>
<us-gaap:Goodwill contextRef="ib35528f5c5454a948cd6fb7e53765880_I20220101" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81Mi9mcmFnOjQ0NzlmZjNiYTAyNzRkYWE5ZDBiZTRjMmRmNDlhYzE0L3RhYmxlOjRmMjY3ZWE5MzRiMTRkMGY4NTNmMzVkMDdkNGUyY2U1L3RhYmxlcmFuZ2U6NGYyNjdlYTkzNGIxNGQwZjg1M2YzNWQwN2Q0ZTJjZTVfNi0xLTEtMS00ODE2NA_ec10619c-ec56-4585-ab17-82f712d773cf" unitRef="usd"> 139784000 </us-gaap:Goodwill>
<us-gaap:GoodwillImpairedAccumulatedImpairmentLoss contextRef="i147d9d98661e469bad1d656ac661d91f_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81Mi9mcmFnOjQ0NzlmZjNiYTAyNzRkYWE5ZDBiZTRjMmRmNDlhYzE0L3RhYmxlOjRmMjY3ZWE5MzRiMTRkMGY4NTNmMzVkMDdkNGUyY2U1L3RhYmxlcmFuZ2U6NGYyNjdlYTkzNGIxNGQwZjg1M2YzNWQwN2Q0ZTJjZTVfNi0yLTEtMS00ODE2NA_8a97e53f-592e-49f6-b279-71c7b0c31313" unitRef="usd"> 0 </us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
<opk:GoodwillAcquiredDisposedOfDuringPeriod contextRef="i9729c8b5a4004014942b75fdb603ea37_D20220101-20220630" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81Mi9mcmFnOjQ0NzlmZjNiYTAyNzRkYWE5ZDBiZTRjMmRmNDlhYzE0L3RhYmxlOjRmMjY3ZWE5MzRiMTRkMGY4NTNmMzVkMDdkNGUyY2U1L3RhYmxlcmFuZ2U6NGYyNjdlYTkzNGIxNGQwZjg1M2YzNWQwN2Q0ZTJjZTVfNy00LTEtMS01NjQzNw_d71dc2f6-1b4e-4a88-8ab1-60e8c6cd0eec" unitRef="usd" xsi:nil="true"/>
<us-gaap:GoodwillForeignCurrencyTranslationGainLoss contextRef="i9729c8b5a4004014942b75fdb603ea37_D20220101-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81Mi9mcmFnOjQ0NzlmZjNiYTAyNzRkYWE5ZDBiZTRjMmRmNDlhYzE0L3RhYmxlOjRmMjY3ZWE5MzRiMTRkMGY4NTNmMzVkMDdkNGUyY2U1L3RhYmxlcmFuZ2U6NGYyNjdlYTkzNGIxNGQwZjg1M2YzNWQwN2Q0ZTJjZTVfNi00LTEtMS00ODE2NA_e7ca98c3-a44b-46df-abfa-1ece1b15a09d" unitRef="usd"> 0 </us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
<us-gaap:Goodwill contextRef="id06e40979d754019aa484803caa7f019_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81Mi9mcmFnOjQ0NzlmZjNiYTAyNzRkYWE5ZDBiZTRjMmRmNDlhYzE0L3RhYmxlOjRmMjY3ZWE5MzRiMTRkMGY4NTNmMzVkMDdkNGUyY2U1L3RhYmxlcmFuZ2U6NGYyNjdlYTkzNGIxNGQwZjg1M2YzNWQwN2Q0ZTJjZTVfNi01LTEtMS00ODE2NA_ccb53911-9e95-4205-acc1-e23a479c7781" unitRef="usd"> 139784000 </us-gaap:Goodwill>
<us-gaap:Goodwill contextRef="i2d369c9e071a4a38b68a6d96269c8133_I20220101" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81Mi9mcmFnOjQ0NzlmZjNiYTAyNzRkYWE5ZDBiZTRjMmRmNDlhYzE0L3RhYmxlOjRmMjY3ZWE5MzRiMTRkMGY4NTNmMzVkMDdkNGUyY2U1L3RhYmxlcmFuZ2U6NGYyNjdlYTkzNGIxNGQwZjg1M2YzNWQwN2Q0ZTJjZTVfNy0xLTEtMS00ODE2NA_79d30a74-4195-4f1d-b19a-05f8919dba8a" unitRef="usd"> 3760000 </us-gaap:Goodwill>
<us-gaap:GoodwillImpairedAccumulatedImpairmentLoss contextRef="ib62f4ad40b5146e392e1a619721dbbdb_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81Mi9mcmFnOjQ0NzlmZjNiYTAyNzRkYWE5ZDBiZTRjMmRmNDlhYzE0L3RhYmxlOjRmMjY3ZWE5MzRiMTRkMGY4NTNmMzVkMDdkNGUyY2U1L3RhYmxlcmFuZ2U6NGYyNjdlYTkzNGIxNGQwZjg1M2YzNWQwN2Q0ZTJjZTVfNy0yLTEtMS00ODE2NA_3d9cd896-6af9-4c8e-800f-1ace2439cf16" unitRef="usd"> 0 </us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
<opk:GoodwillAcquiredDisposedOfDuringPeriod contextRef="i91c921c5b67341828846ffb04a7f80d9_D20220101-20220630" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81Mi9mcmFnOjQ0NzlmZjNiYTAyNzRkYWE5ZDBiZTRjMmRmNDlhYzE0L3RhYmxlOjRmMjY3ZWE5MzRiMTRkMGY4NTNmMzVkMDdkNGUyY2U1L3RhYmxlcmFuZ2U6NGYyNjdlYTkzNGIxNGQwZjg1M2YzNWQwN2Q0ZTJjZTVfOC00LTEtMS01NjQzNw_64152781-d92f-4c02-8005-98da7d0e96e9" unitRef="usd" xsi:nil="true"/>
<us-gaap:GoodwillForeignCurrencyTranslationGainLoss contextRef="i91c921c5b67341828846ffb04a7f80d9_D20220101-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81Mi9mcmFnOjQ0NzlmZjNiYTAyNzRkYWE5ZDBiZTRjMmRmNDlhYzE0L3RhYmxlOjRmMjY3ZWE5MzRiMTRkMGY4NTNmMzVkMDdkNGUyY2U1L3RhYmxlcmFuZ2U6NGYyNjdlYTkzNGIxNGQwZjg1M2YzNWQwN2Q0ZTJjZTVfNy00LTEtMS00ODE2NA_d858782f-f82e-40b9-8ff7-5308c67f0585" unitRef="usd"> -301000 </us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
<us-gaap:Goodwill contextRef="i490840fae40842cea71fdef8ce82a092_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81Mi9mcmFnOjQ0NzlmZjNiYTAyNzRkYWE5ZDBiZTRjMmRmNDlhYzE0L3RhYmxlOjRmMjY3ZWE5MzRiMTRkMGY4NTNmMzVkMDdkNGUyY2U1L3RhYmxlcmFuZ2U6NGYyNjdlYTkzNGIxNGQwZjg1M2YzNWQwN2Q0ZTJjZTVfNy01LTEtMS00ODE2NA_ba34c6c5-79ed-4b8e-9553-f43233fa16a3" unitRef="usd"> 3459000 </us-gaap:Goodwill>
<us-gaap:Goodwill contextRef="i5c052fb6706048a38d2aa1f882ca5aa2_I20220101" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81Mi9mcmFnOjQ0NzlmZjNiYTAyNzRkYWE5ZDBiZTRjMmRmNDlhYzE0L3RhYmxlOjRmMjY3ZWE5MzRiMTRkMGY4NTNmMzVkMDdkNGUyY2U1L3RhYmxlcmFuZ2U6NGYyNjdlYTkzNGIxNGQwZjg1M2YzNWQwN2Q0ZTJjZTVfOC0xLTEtMS00ODE2NA_201a60c7-65bc-46d2-ab50-dab80114c191" unitRef="usd"> 7478000 </us-gaap:Goodwill>
<us-gaap:GoodwillImpairedAccumulatedImpairmentLoss contextRef="ib7bb6a376a704d538179220f0aa9b673_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81Mi9mcmFnOjQ0NzlmZjNiYTAyNzRkYWE5ZDBiZTRjMmRmNDlhYzE0L3RhYmxlOjRmMjY3ZWE5MzRiMTRkMGY4NTNmMzVkMDdkNGUyY2U1L3RhYmxlcmFuZ2U6NGYyNjdlYTkzNGIxNGQwZjg1M2YzNWQwN2Q0ZTJjZTVfOC0yLTEtMS00ODE2NA_43ae19c3-2e82-4013-8fca-b5e7924eb45a" unitRef="usd"> 0 </us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
<opk:GoodwillAcquiredDisposedOfDuringPeriod contextRef="i02428274068d40bab70f37770fd40790_D20220101-20220630" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81Mi9mcmFnOjQ0NzlmZjNiYTAyNzRkYWE5ZDBiZTRjMmRmNDlhYzE0L3RhYmxlOjRmMjY3ZWE5MzRiMTRkMGY4NTNmMzVkMDdkNGUyY2U1L3RhYmxlcmFuZ2U6NGYyNjdlYTkzNGIxNGQwZjg1M2YzNWQwN2Q0ZTJjZTVfOS00LTEtMS01NjQzNw_36aea7d3-8976-4627-8a53-8ab3cd41d5e6" unitRef="usd" xsi:nil="true"/>
<us-gaap:GoodwillForeignCurrencyTranslationGainLoss contextRef="i02428274068d40bab70f37770fd40790_D20220101-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81Mi9mcmFnOjQ0NzlmZjNiYTAyNzRkYWE5ZDBiZTRjMmRmNDlhYzE0L3RhYmxlOjRmMjY3ZWE5MzRiMTRkMGY4NTNmMzVkMDdkNGUyY2U1L3RhYmxlcmFuZ2U6NGYyNjdlYTkzNGIxNGQwZjg1M2YzNWQwN2Q0ZTJjZTVfOC00LTEtMS00ODE2NA_e0507c75-2824-4fd0-9f9d-81771f20563a" unitRef="usd"> -589000 </us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
<us-gaap:Goodwill contextRef="i2d6a8e21d27a4daf877bb4ecd8e0f614_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81Mi9mcmFnOjQ0NzlmZjNiYTAyNzRkYWE5ZDBiZTRjMmRmNDlhYzE0L3RhYmxlOjRmMjY3ZWE5MzRiMTRkMGY4NTNmMzVkMDdkNGUyY2U1L3RhYmxlcmFuZ2U6NGYyNjdlYTkzNGIxNGQwZjg1M2YzNWQwN2Q0ZTJjZTVfOC01LTEtMS00ODE2NA_da11a1a3-1bc2-4b65-82c4-612285707200" unitRef="usd"> 6889000 </us-gaap:Goodwill>
<us-gaap:Goodwill contextRef="ie4ef700c25704bf78c7ff5c0ef6e2865_I20220101" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81Mi9mcmFnOjQ0NzlmZjNiYTAyNzRkYWE5ZDBiZTRjMmRmNDlhYzE0L3RhYmxlOjRmMjY3ZWE5MzRiMTRkMGY4NTNmMzVkMDdkNGUyY2U1L3RhYmxlcmFuZ2U6NGYyNjdlYTkzNGIxNGQwZjg1M2YzNWQwN2Q0ZTJjZTVfOS0xLTEtMS00ODE2NA_884185dc-062b-4a99-b60d-b35729e8ffd7" unitRef="usd"> 100000 </us-gaap:Goodwill>
<us-gaap:GoodwillImpairedAccumulatedImpairmentLoss contextRef="i19b751f2797a42a491b5a1d58941004c_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81Mi9mcmFnOjQ0NzlmZjNiYTAyNzRkYWE5ZDBiZTRjMmRmNDlhYzE0L3RhYmxlOjRmMjY3ZWE5MzRiMTRkMGY4NTNmMzVkMDdkNGUyY2U1L3RhYmxlcmFuZ2U6NGYyNjdlYTkzNGIxNGQwZjg1M2YzNWQwN2Q0ZTJjZTVfOS0yLTEtMS00ODE2NA_563ed680-b412-45dc-91c4-0cca569fe385" unitRef="usd"> 100000 </us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
<opk:GoodwillAcquiredDisposedOfDuringPeriod contextRef="i339582850da64817ac38b9219b61629e_D20220101-20220630" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81Mi9mcmFnOjQ0NzlmZjNiYTAyNzRkYWE5ZDBiZTRjMmRmNDlhYzE0L3RhYmxlOjRmMjY3ZWE5MzRiMTRkMGY4NTNmMzVkMDdkNGUyY2U1L3RhYmxlcmFuZ2U6NGYyNjdlYTkzNGIxNGQwZjg1M2YzNWQwN2Q0ZTJjZTVfMTAtNC0xLTEtNTY0Mzc_725e0f52-ead4-4f75-9a7a-d981e0493e40" unitRef="usd" xsi:nil="true"/>
<us-gaap:GoodwillForeignCurrencyTranslationGainLoss contextRef="i339582850da64817ac38b9219b61629e_D20220101-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81Mi9mcmFnOjQ0NzlmZjNiYTAyNzRkYWE5ZDBiZTRjMmRmNDlhYzE0L3RhYmxlOjRmMjY3ZWE5MzRiMTRkMGY4NTNmMzVkMDdkNGUyY2U1L3RhYmxlcmFuZ2U6NGYyNjdlYTkzNGIxNGQwZjg1M2YzNWQwN2Q0ZTJjZTVfOS00LTEtMS00ODE2NA_b38fa9f5-8f8c-4a27-b92d-ffd4eb8150c7" unitRef="usd"> 0 </us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
<us-gaap:Goodwill contextRef="ib62eb1ef6c404c7caf4166948d600d5b_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81Mi9mcmFnOjQ0NzlmZjNiYTAyNzRkYWE5ZDBiZTRjMmRmNDlhYzE0L3RhYmxlOjRmMjY3ZWE5MzRiMTRkMGY4NTNmMzVkMDdkNGUyY2U1L3RhYmxlcmFuZ2U6NGYyNjdlYTkzNGIxNGQwZjg1M2YzNWQwN2Q0ZTJjZTVfOS01LTEtMS00ODE2NA_d140eef6-5ae2-44f8-8f56-b941c71f9c71" unitRef="usd"> 0 </us-gaap:Goodwill>
<us-gaap:Goodwill contextRef="i07b0e87b09674c2ab0a8274ca50186f2_I20220101" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81Mi9mcmFnOjQ0NzlmZjNiYTAyNzRkYWE5ZDBiZTRjMmRmNDlhYzE0L3RhYmxlOjRmMjY3ZWE5MzRiMTRkMGY4NTNmMzVkMDdkNGUyY2U1L3RhYmxlcmFuZ2U6NGYyNjdlYTkzNGIxNGQwZjg1M2YzNWQwN2Q0ZTJjZTVfMTAtMS0xLTEtNDgxNjQ_10f4eda3-b83a-4edf-bb65-2362d663ea33" unitRef="usd"> 3421000 </us-gaap:Goodwill>
<us-gaap:GoodwillImpairedAccumulatedImpairmentLoss contextRef="id2a4499b4f584b83947dfac0c12ea970_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81Mi9mcmFnOjQ0NzlmZjNiYTAyNzRkYWE5ZDBiZTRjMmRmNDlhYzE0L3RhYmxlOjRmMjY3ZWE5MzRiMTRkMGY4NTNmMzVkMDdkNGUyY2U1L3RhYmxlcmFuZ2U6NGYyNjdlYTkzNGIxNGQwZjg1M2YzNWQwN2Q0ZTJjZTVfMTAtMi0xLTEtNDgxNjQ_d72b3b79-91f9-4377-917a-a1bb1b483a6e" unitRef="usd"> 3421000 </us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
<opk:GoodwillAcquiredDisposedOfDuringPeriod contextRef="i87df713daadf4da1acb681f3f77bdda7_D20220101-20220630" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81Mi9mcmFnOjQ0NzlmZjNiYTAyNzRkYWE5ZDBiZTRjMmRmNDlhYzE0L3RhYmxlOjRmMjY3ZWE5MzRiMTRkMGY4NTNmMzVkMDdkNGUyY2U1L3RhYmxlcmFuZ2U6NGYyNjdlYTkzNGIxNGQwZjg1M2YzNWQwN2Q0ZTJjZTVfMTEtNC0xLTEtNTY0Mzc_3bd58e63-5398-47fe-a21c-36aaebc63d3a" unitRef="usd" xsi:nil="true"/>
<us-gaap:GoodwillForeignCurrencyTranslationGainLoss contextRef="i87df713daadf4da1acb681f3f77bdda7_D20220101-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81Mi9mcmFnOjQ0NzlmZjNiYTAyNzRkYWE5ZDBiZTRjMmRmNDlhYzE0L3RhYmxlOjRmMjY3ZWE5MzRiMTRkMGY4NTNmMzVkMDdkNGUyY2U1L3RhYmxlcmFuZ2U6NGYyNjdlYTkzNGIxNGQwZjg1M2YzNWQwN2Q0ZTJjZTVfMTAtNC0xLTEtNDgxNjQ_1ba7491a-36d8-4d82-a6d2-1f4eb9d49c90" unitRef="usd"> 0 </us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
<us-gaap:Goodwill contextRef="id2a4499b4f584b83947dfac0c12ea970_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81Mi9mcmFnOjQ0NzlmZjNiYTAyNzRkYWE5ZDBiZTRjMmRmNDlhYzE0L3RhYmxlOjRmMjY3ZWE5MzRiMTRkMGY4NTNmMzVkMDdkNGUyY2U1L3RhYmxlcmFuZ2U6NGYyNjdlYTkzNGIxNGQwZjg1M2YzNWQwN2Q0ZTJjZTVfMTAtNS0xLTEtNDgxNjQ_c2131146-8976-411f-a537-816aaf930b10" unitRef="usd"> 0 </us-gaap:Goodwill>
<us-gaap:Goodwill contextRef="i58c951942dcd46acb2b73f9457ce547c_I20220101" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81Mi9mcmFnOjQ0NzlmZjNiYTAyNzRkYWE5ZDBiZTRjMmRmNDlhYzE0L3RhYmxlOjRmMjY3ZWE5MzRiMTRkMGY4NTNmMzVkMDdkNGUyY2U1L3RhYmxlcmFuZ2U6NGYyNjdlYTkzNGIxNGQwZjg1M2YzNWQwN2Q0ZTJjZTVfMTMtMS0xLTEtNDgxNjQ_31dedcaf-e216-470a-9da5-855e19e8ba6f" unitRef="usd"> 434809000 </us-gaap:Goodwill>
<us-gaap:GoodwillImpairedAccumulatedImpairmentLoss contextRef="ia94af80a4c1b4fbc945badd9a1e4110f_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81Mi9mcmFnOjQ0NzlmZjNiYTAyNzRkYWE5ZDBiZTRjMmRmNDlhYzE0L3RhYmxlOjRmMjY3ZWE5MzRiMTRkMGY4NTNmMzVkMDdkNGUyY2U1L3RhYmxlcmFuZ2U6NGYyNjdlYTkzNGIxNGQwZjg1M2YzNWQwN2Q0ZTJjZTVfMTMtMi0xLTEtNDgxNjQ_ec9f4a09-4294-41a9-b4f8-8adc60e74a40" unitRef="usd"> 0 </us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
<opk:GoodwillAcquiredDisposedOfDuringPeriod contextRef="ib3c4407658c242e09207819ecbf0fedd_D20220101-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81Mi9mcmFnOjQ0NzlmZjNiYTAyNzRkYWE5ZDBiZTRjMmRmNDlhYzE0L3RhYmxlOjRmMjY3ZWE5MzRiMTRkMGY4NTNmMzVkMDdkNGUyY2U1L3RhYmxlcmFuZ2U6NGYyNjdlYTkzNGIxNGQwZjg1M2YzNWQwN2Q0ZTJjZTVfMTQtNC0xLTEtNTY0NDk_d3568533-869c-4ff0-b7ee-3245adc1f797" unitRef="usd"> -151784000 </opk:GoodwillAcquiredDisposedOfDuringPeriod>
<us-gaap:GoodwillForeignCurrencyTranslationGainLoss contextRef="ib3c4407658c242e09207819ecbf0fedd_D20220101-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81Mi9mcmFnOjQ0NzlmZjNiYTAyNzRkYWE5ZDBiZTRjMmRmNDlhYzE0L3RhYmxlOjRmMjY3ZWE5MzRiMTRkMGY4NTNmMzVkMDdkNGUyY2U1L3RhYmxlcmFuZ2U6NGYyNjdlYTkzNGIxNGQwZjg1M2YzNWQwN2Q0ZTJjZTVfMTMtNC0xLTEtNDgxNjQ_fdb0f1de-2694-460c-ac91-c4ddb6747651" unitRef="usd"> 0 </us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
<us-gaap:Goodwill contextRef="iba2ce9ca3c1a46e4ace10af9e34b42a4_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81Mi9mcmFnOjQ0NzlmZjNiYTAyNzRkYWE5ZDBiZTRjMmRmNDlhYzE0L3RhYmxlOjRmMjY3ZWE5MzRiMTRkMGY4NTNmMzVkMDdkNGUyY2U1L3RhYmxlcmFuZ2U6NGYyNjdlYTkzNGIxNGQwZjg1M2YzNWQwN2Q0ZTJjZTVfMTMtNS0xLTEtNDgxNjQ_df9b0a64-cf9f-4152-9b65-0a41f5ad64e8" unitRef="usd"> 283025000 </us-gaap:Goodwill>
<us-gaap:Goodwill contextRef="i5e1ecf3783924742b8005c8a29489617_I20220101" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81Mi9mcmFnOjQ0NzlmZjNiYTAyNzRkYWE5ZDBiZTRjMmRmNDlhYzE0L3RhYmxlOjRmMjY3ZWE5MzRiMTRkMGY4NTNmMzVkMDdkNGUyY2U1L3RhYmxlcmFuZ2U6NGYyNjdlYTkzNGIxNGQwZjg1M2YzNWQwN2Q0ZTJjZTVfMTQtMS0xLTEtNDgxNjQ_a0eeed6c-2418-4b25-94cd-0094c54ad86e" unitRef="usd"> 17977000 </us-gaap:Goodwill>
<us-gaap:GoodwillImpairedAccumulatedImpairmentLoss contextRef="i57378aa975644b29a7508b9513481d2f_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81Mi9mcmFnOjQ0NzlmZjNiYTAyNzRkYWE5ZDBiZTRjMmRmNDlhYzE0L3RhYmxlOjRmMjY3ZWE5MzRiMTRkMGY4NTNmMzVkMDdkNGUyY2U1L3RhYmxlcmFuZ2U6NGYyNjdlYTkzNGIxNGQwZjg1M2YzNWQwN2Q0ZTJjZTVfMTQtMi0xLTEtNDgxNjQ_1aeee28c-9613-4d17-8271-3ea3202dd802" unitRef="usd"> 17977000 </us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
<opk:GoodwillAcquiredDisposedOfDuringPeriod contextRef="ia00f75d5e5c540f9bed132290ac08971_D20220101-20220630" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81Mi9mcmFnOjQ0NzlmZjNiYTAyNzRkYWE5ZDBiZTRjMmRmNDlhYzE0L3RhYmxlOjRmMjY3ZWE5MzRiMTRkMGY4NTNmMzVkMDdkNGUyY2U1L3RhYmxlcmFuZ2U6NGYyNjdlYTkzNGIxNGQwZjg1M2YzNWQwN2Q0ZTJjZTVfMTUtNC0xLTEtNTY0NDk_960ed2bc-0318-4c8a-b20d-46005b366d5f" unitRef="usd" xsi:nil="true"/>
<us-gaap:GoodwillForeignCurrencyTranslationGainLoss contextRef="ia00f75d5e5c540f9bed132290ac08971_D20220101-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81Mi9mcmFnOjQ0NzlmZjNiYTAyNzRkYWE5ZDBiZTRjMmRmNDlhYzE0L3RhYmxlOjRmMjY3ZWE5MzRiMTRkMGY4NTNmMzVkMDdkNGUyY2U1L3RhYmxlcmFuZ2U6NGYyNjdlYTkzNGIxNGQwZjg1M2YzNWQwN2Q0ZTJjZTVfMTQtNC0xLTEtNDgxNjQ_57f9fc74-69b7-45e9-b340-afd7fe3a4625" unitRef="usd"> 0 </us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
<us-gaap:Goodwill contextRef="id34a68b0949c484c8f91ca4af64492ae_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81Mi9mcmFnOjQ0NzlmZjNiYTAyNzRkYWE5ZDBiZTRjMmRmNDlhYzE0L3RhYmxlOjRmMjY3ZWE5MzRiMTRkMGY4NTNmMzVkMDdkNGUyY2U1L3RhYmxlcmFuZ2U6NGYyNjdlYTkzNGIxNGQwZjg1M2YzNWQwN2Q0ZTJjZTVfMTQtNS0xLTEtNDgxNjQ_c1df2d74-425f-44c0-a131-683f537e02ce" unitRef="usd"> 0 </us-gaap:Goodwill>
<us-gaap:Goodwill contextRef="i6416188cab214728bec613abff1f00a5_I20220101" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81Mi9mcmFnOjQ0NzlmZjNiYTAyNzRkYWE5ZDBiZTRjMmRmNDlhYzE0L3RhYmxlOjRmMjY3ZWE5MzRiMTRkMGY4NTNmMzVkMDdkNGUyY2U1L3RhYmxlcmFuZ2U6NGYyNjdlYTkzNGIxNGQwZjg1M2YzNWQwN2Q0ZTJjZTVfMTUtMS0xLTEtNDgxNjQ_f56ba87c-3671-422c-9768-51ad7c4d503f" unitRef="usd"> 710408000 </us-gaap:Goodwill>
<us-gaap:GoodwillImpairedAccumulatedImpairmentLoss contextRef="i7e0f479bead144b0bdbcc71082db627b_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81Mi9mcmFnOjQ0NzlmZjNiYTAyNzRkYWE5ZDBiZTRjMmRmNDlhYzE0L3RhYmxlOjRmMjY3ZWE5MzRiMTRkMGY4NTNmMzVkMDdkNGUyY2U1L3RhYmxlcmFuZ2U6NGYyNjdlYTkzNGIxNGQwZjg1M2YzNWQwN2Q0ZTJjZTVfMTUtMi0xLTEtNDgxNjQ_31f8edfb-4aab-409e-b824-05b6640748aa" unitRef="usd"> 38023000 </us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
<opk:GoodwillAcquiredDisposedOfDuringPeriod contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81Mi9mcmFnOjQ0NzlmZjNiYTAyNzRkYWE5ZDBiZTRjMmRmNDlhYzE0L3RhYmxlOjRmMjY3ZWE5MzRiMTRkMGY4NTNmMzVkMDdkNGUyY2U1L3RhYmxlcmFuZ2U6NGYyNjdlYTkzNGIxNGQwZjg1M2YzNWQwN2Q0ZTJjZTVfMTYtNC0xLTEtNTY0NTY_072da6a3-0256-4e59-b876-3a3754fcc702" unitRef="usd"> -85998000 </opk:GoodwillAcquiredDisposedOfDuringPeriod>
<us-gaap:GoodwillForeignCurrencyTranslationGainLoss contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81Mi9mcmFnOjQ0NzlmZjNiYTAyNzRkYWE5ZDBiZTRjMmRmNDlhYzE0L3RhYmxlOjRmMjY3ZWE5MzRiMTRkMGY4NTNmMzVkMDdkNGUyY2U1L3RhYmxlcmFuZ2U6NGYyNjdlYTkzNGIxNGQwZjg1M2YzNWQwN2Q0ZTJjZTVfMTUtNC0xLTEtNDgxNjQ_8ae7a59c-e72c-47ae-89ff-a48cef11b74b" unitRef="usd"> -7542000 </us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
<us-gaap:Goodwill contextRef="i4768f885851b49f986857a2a956f9162_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81Mi9mcmFnOjQ0NzlmZjNiYTAyNzRkYWE5ZDBiZTRjMmRmNDlhYzE0L3RhYmxlOjRmMjY3ZWE5MzRiMTRkMGY4NTNmMzVkMDdkNGUyY2U1L3RhYmxlcmFuZ2U6NGYyNjdlYTkzNGIxNGQwZjg1M2YzNWQwN2Q0ZTJjZTVfMTUtNS0xLTEtNDgxNjQ_30b2681e-56ec-4755-9239-097bb16c2cde" unitRef="usd"> 578845000 </us-gaap:Goodwill>
<opk:BusinessCombinationAndInvestmentsDisclosureTextBlock contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81NS9mcmFnOjFjOWViMDlkMTM1MjRiNGNiYzE0ZDRjMjM3ZjE4MmExL3RleHRyZWdpb246MWM5ZWIwOWQxMzUyNGI0Y2JjMTRkNGMyMzdmMTgyYTFfNDM5ODA0NjUyNzQwOA_ec75d5c3-9d1e-42c4-8363-f77f21e26ca5">
ACQUISITIONS AND INVESTMENTS<div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ModeX Acquisition</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">On May 9, 2022, the Company entered into the ModeX Merger Agreement, pursuant to which ModeX survived the ModeX Merger as a wholly owned subsidiary of the Company. The Company paid the entirety of the $300.0 million purchase price pursuant to the issuance of the Consideration Shares to the former stockholders of ModeX. The Consideration Shares were valued at $219.4 million, based on the closing price per share of our Common Stock of $2.44 as reported by NASDAQ on the Closing Date. Included in the total purchase price of $221.7 million are $2.3 million of fully vested equity awards.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the preliminary purchase price allocation and the estimated fair value of the net assets acquired and liabilities assumed at the date of acquisition. The purchase price allocation for the ModeX transaction is preliminary pending completion of the fair value analysis of acquired assets and liabilities:</span></div><div style="margin-top:9pt;text-indent:24.75pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.666%"><tr><td style="width:1.0%"/><td style="width:85.502%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.437%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.661%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ModeX</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">218 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">554 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,046 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IPR&D assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">195,000 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65,786 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(202)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liability</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40,740)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total purchase price</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">221,662 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill from the acquisition of ModeX principally relates to intangible assets that do not qualify for separate recognition (for instance, ModeX's assembled workforce) and the deferred tax liability generated as a result of the transaction. Goodwill is not tax deductible for income tax purposes and was assigned to the pharmaceutical reporting segment.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our IPR&D assets will not be amortized until the underlying development programs are completed. Intangible assets are tested for impairment whenever events or changes in circumstances indicate that the carrying amount of such assets may not be recoverable, although IPR&D is required to be tested at least annually until the project is completed or abandoned. Upon obtaining regulatory approval, the IPR&D asset is then accounted for as a finite-lived intangible asset and amortized depending on pattern of future use.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue and Net income (loss) in the Condensed Consolidated Statement of Operations for the six months ended June 30, 2022 includes revenue and net loss of ModeX from the date of acquisition to the six months ended June 30, 2022 of $0.0 million and $1.1 million, respectively.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table reflects the accounting method, carrying value and underlying equity in net assets of our unconsolidated investments as of June 30, 2022 and December 31, 2021:</span></div><div style="margin-top:14pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.883%"><tr><td style="width:1.0%"/><td style="width:46.203%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.416%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.226%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.416%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.226%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.416%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.688%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.416%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.693%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">As of June 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">As of December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment type</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Investment Carrying Value</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Underlying Equity in Net Assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Investment Carrying Value</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Underlying Equity in Net Assets</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity method investments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">173 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,822 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">263 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,577 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable interest entity, equity method</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">797 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,417 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">816 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,043 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity method investments - FV option</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100,800 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,508 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,226 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities with no readily determinable fair value</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,396 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,408 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrants and options</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total carrying value of investments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108,685 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,729 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr></table></div><div style="margin-top:4pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:174%">Equity method investments</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our equity method investments, other than Sema4 disclosed below, consist of investments in Pharmsynthez (ownership 9%), Cocrystal Pharma, Inc. (“COCP”) (3%), Non-Invasive Monitoring Systems, Inc. (“NIMS”) (1%), Neovasc, Inc. (“Neovasc”) (1%), BioCardia, Inc. (“BioCardia”) (1%), Xenetic Biosciences, Inc. (“Xenetic”) (3%), and LeaderMed Health Group Limited (“LeaderMed”) (47%). The aggregate amount of assets, liabilities, and net losses of these equity method investees as of and for the six months ended June 30, 2022 were $212.4 million, $41.7 million, and $48.6 million, respectively. The aggregate amount of assets, liabilities, and net losses of our equity method investees as of and for the year ended December 31, 2021 were $223.6 million, $37.9 million, and $69.4 million, respectively. We have determined that we and/or our related parties have the ability to exercise significant influence over our equity method investments through our board representation and/or voting power. Accordingly, we account for our investment in these entities under the equity method and record our proportionate share of their losses in Loss from investments in investees in our Condensed Consolidated Statement of Operations. The aggregate value of our equity method investments based on the quoted market prices of their respective shares of common stock and the number of shares held by us as of June 30, 2022 and December 31, 2021 was $1.9 million and $4.5 million, respectively. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Equity method investments - FV option</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On April 29, 2022, the Company sold GeneDx to Sema4 in accordance with the terms of the GeneDx Merger Agreement, pursuant to which Sema4 paid to the Company aggregate consideration of $150.0 million in cash (before deduction of transaction expenses and other customary purchase price adjustments), together with the Closing Shares of Sema4 Common Stock. As of June 30, 2022, we held 80 million shares of Sema4’s Class A common stock, representing an approximate 21.2% ownership interest.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Pursuant to the GeneDx Merger Agreement, the Company designated, and Sema4 nominated for election an individual to serve on the board of directors of Sema4, and such nominee was elected by Sema4’s stockholders to serve as a director until Sema4’s 2024 annual meeting of stockholders. As a result, we have determined that the Company or our related parties can exercise significant influence over the investee through our board representation or voting power. However, our influence is restricted by the Sema4 Shareholder Agreement, pursuant to which we have agreed to vote our shares of Sema4 Common Stock in accordance with the recommendation of Sema4’s board of directors for so long as we continue to hold at least 5% of the outstanding shares of Sema4 Common Stock. Our sole ability to influence the policy-making process is through our board representation. However, because we hold only one out of eleven seats on Sema4’s board of directors, our intention is that we will no longer have a designee serving on Sema4’s board of directors upon the expiration of the Sema4 Lock-Up Period. As such, OPKO is not actively participating in the policy-making process of Sema4. We elected to we account for our investment in Sema4 under the equity method fair value option and record gains and losses from changes in fair value in other income (expense), net in our Condensed Consolidated Statement of Operations. For the three and six months ended June 30, 2022, we recognized $71.2 million in net losses for fair value changes in our Sema4 investment.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments in Equity Securities</span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our equity securities consist of investments in Phio Pharmaceuticals (“Phio”) (ownership 0.01%), VBI Vaccines Inc. (“VBI”) (1%), ChromaDex Corporation (“ChromaDex”) (0.1%), Eloxx Pharmaceuticals, Inc. (“Eloxx”) (1%), and CAMP4 Therapeutics Corporation (“CAMP4”) (2%) and HealthSnap, Inc. (7%). We have determined that our ownership, along with </span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">that of our related parties, does not provide us with significant influence over the operations of these investments. Accordingly, we account for our investment in these entities as equity securities, and we record changes in the fair value of these investments in Other income (expense) each reporting period when they have readily determinable fair value. Equity securities without a readily determinable fair value are adjusted to fair value when there is an observable price change. Net gains and losses on our equity securities for the six months ended June 30, 2022, and 2021 were as follows:</span></div><div style="margin-top:14pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.367%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.376%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">For the six months ended June 30</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in thousands)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Equity Securities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net gains and losses recognized during the period on equity securities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,718)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,408 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: Net gains realized during the period on equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,981)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unrealized net gains and losses recognized during the period on equity securities still held at the reporting date</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,718)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,573)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:4pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Sales of investments</span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gains (losses) included in earnings from sales of our investments are recorded in Other income (expense), net in our Condensed Consolidated Statement of Operations. The cost of securities sold is based on the specific identification method. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Warrants and options</span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to our equity method investments and equity securities, we hold options to purchase 47 thousand additional shares of BioCardia, all of which were vested as of June 30, 2022 and December 31, 2021, and 33 thousand and 0.7 million to purchase additional shares of COCP and InCellDx, respectively. We recorded the changes in the fair value of the options and warrants in Fair value changes of derivative instruments, net in our Condensed Consolidated Statement of Operations. We also recorded the fair value of the options and warrants in Investments, net in our Condensed Consolidated Balance Sheet. See further discussion of the Company’s options and warrants in Note 9 and Note 10.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments in variable interest entities</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have determined that we hold variable interests in LeaderMed and Zebra Biologics, Inc. (“Zebra”). We made this determination as a result of our assessment that they do not have sufficient resources to carry out their principal activities without additional financial support. </span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 14, 2021, we and LeaderMed, a pharmaceutical development company with operations based in Asia, announced the formation of a joint venture to develop, manufacture and commercialize two of OPKO’s clinical stage, long-acting drug products in Greater China and eight other Asian territories. Under the terms of the agreements, we have granted the joint venture exclusive rights to develop, manufacture and commercialize (a) OPK88003, an oxyntomodulin analog being developed for the treatment of obesity and diabetes, and (b) Factor VIIa-CTP, a novel long acting coagulation factor being developed to treat hemophilia, in exchange for 4,703 shares 47% ownership interest in the joint venture. In addition, we received an upfront payment of $1.0 million and will be reimbursed for clinical trial material and technical support we provide the joint venture.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In order to determine the primary beneficiary of the joint venture, we evaluated our investment and our related parties’ investment, as well as our investment combined with the related parties’ investment to identify if we had the power to direct the activities that most significantly impact the economic performance of the joint venture. Based on the capital structure, governing documents and overall business operations of the joint venture, we determined that, while a VIE, we do not have the power to direct the activities that most significantly impact the joint venture’s economic performance and do not have an obligation to fund expected losses. We did determine that we can significantly influence control of the joint venture through our board representation and voting power. Therefore, we have the ability to exercise significant influence over the joint venture’s operations and account for our investment in the joint venture under the equity method.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We own 1,260,000 shares of Zebra Series A-2 Preferred Stock and 900,000 shares of Zebra restricted common stock (ownership 29% at June 30, 2022). Zebra is a privately held biotechnology company focused on the discovery and development of biosuperior antibody therapeutics and complex drugs. Dr. Richard Lerner, M.D., a former member of our Board of Directors, is a founder of Zebra and, along with Dr. Frost, serves as a member of Zebra’s Board of Directors. </span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In order to determine the primary beneficiary of Zebra, we evaluated our investment and our related parties’ investment, as well as our investment combined with the related parties’ investment to identify if we had the power to direct the activities that most significantly impact the economic performance of Zebra. Based on the capital structure, governing documents and </span></div>overall business operations of Zebra, we determined that, while a VIE, we do not have the power to direct the activities that most significantly impact Zebra’s economic performance and have no obligation to fund expected losses. We determined, however, that we can significantly influence control of Zebra through our board representation and voting power. Therefore, we have the ability to exercise significant influence over Zebra’s operations and account for our investment in Zebra under the equity method.
</opk:BusinessCombinationAndInvestmentsDisclosureTextBlock>
<us-gaap:BusinessCombinationConsiderationTransferred1 contextRef="i3f7969e9854b45dfa1c0bba3df71fb1f_D20220509-20220509" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81NS9mcmFnOjFjOWViMDlkMTM1MjRiNGNiYzE0ZDRjMjM3ZjE4MmExL3RleHRyZWdpb246MWM5ZWIwOWQxMzUyNGI0Y2JjMTRkNGMyMzdmMTgyYTFfMzg0ODI5MDczMzM2NA_2f3cb1a6-9a1a-49f4-87ef-45265cbb3d26" unitRef="usd"> 300000000 </us-gaap:BusinessCombinationConsiderationTransferred1>
<us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable contextRef="ic131f974c00a4170a9cffd5b1edf89a2_D20220509-20220509" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81NS9mcmFnOjFjOWViMDlkMTM1MjRiNGNiYzE0ZDRjMjM3ZjE4MmExL3RleHRyZWdpb246MWM5ZWIwOWQxMzUyNGI0Y2JjMTRkNGMyMzdmMTgyYTFfMzg0ODI5MDczMzM5NQ_a3991c33-8d4e-415d-9b2f-be98b8dea4f1" unitRef="usd"> 219400000 </us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable>
<us-gaap:SharePrice contextRef="i0b9eb2f94272480b89af2aa6b63016bb_I20220509" decimals="2" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81NS9mcmFnOjFjOWViMDlkMTM1MjRiNGNiYzE0ZDRjMjM3ZjE4MmExL3RleHRyZWdpb246MWM5ZWIwOWQxMzUyNGI0Y2JjMTRkNGMyMzdmMTgyYTFfMzg0ODI5MDczMzQxNw_c7488305-50eb-4442-867a-75d8dca41f36" unitRef="usdPerShare"> 2.44 </us-gaap:SharePrice>
<us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet contextRef="i20b9a56ee2dc4a508f7dfc81c0b8817c_I20220509" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81NS9mcmFnOjFjOWViMDlkMTM1MjRiNGNiYzE0ZDRjMjM3ZjE4MmExL3RleHRyZWdpb246MWM5ZWIwOWQxMzUyNGI0Y2JjMTRkNGMyMzdmMTgyYTFfMjE5OTAyMzI5ODI5Ng_1e311241-4586-4982-925f-30c7253aceb3" unitRef="usd"> 221700000 </us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
<opk:BusinessCombinationConsiderationTransferredEquityInterestsIssued contextRef="i3f7969e9854b45dfa1c0bba3df71fb1f_D20220509-20220509" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81NS9mcmFnOjFjOWViMDlkMTM1MjRiNGNiYzE0ZDRjMjM3ZjE4MmExL3RleHRyZWdpb246MWM5ZWIwOWQxMzUyNGI0Y2JjMTRkNGMyMzdmMTgyYTFfMzg0ODI5MDc0MTY5Nw_14c62cf8-789a-4447-ab31-0c6cab764ddb" unitRef="usd"> 2300000 </opk:BusinessCombinationConsiderationTransferredEquityInterestsIssued>
<us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81NS9mcmFnOjFjOWViMDlkMTM1MjRiNGNiYzE0ZDRjMjM3ZjE4MmExL3RleHRyZWdpb246MWM5ZWIwOWQxMzUyNGI0Y2JjMTRkNGMyMzdmMTgyYTFfMzg0ODI5MDcxMzM4Mg_b0db5831-dc0b-4d27-9e78-da19d8a9bba5">
<div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the preliminary purchase price allocation and the estimated fair value of the net assets acquired and liabilities assumed at the date of acquisition. The purchase price allocation for the ModeX transaction is preliminary pending completion of the fair value analysis of acquired assets and liabilities:</span></div><div style="margin-top:9pt;text-indent:24.75pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.666%"><tr><td style="width:1.0%"/><td style="width:85.502%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.437%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.661%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ModeX</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">218 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">554 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,046 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IPR&D assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">195,000 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65,786 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(202)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liability</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40,740)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total purchase price</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">221,662 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>
</us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock>
<us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents contextRef="i20b9a56ee2dc4a508f7dfc81c0b8817c_I20220509" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81NS9mcmFnOjFjOWViMDlkMTM1MjRiNGNiYzE0ZDRjMjM3ZjE4MmExL3RhYmxlOmQzZDNmMTM2YWNiMjQwZDM5NjliMjNlYTQyMWZmYjRiL3RhYmxlcmFuZ2U6ZDNkM2YxMzZhY2IyNDBkMzk2OWIyM2VhNDIxZmZiNGJfMi0yLTEtMS01Mzg4OA_eb4ffe6d-1050-475b-9cd5-b0cd69c44dc9" unitRef="usd"> 218000 </us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents>
<us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets contextRef="i20b9a56ee2dc4a508f7dfc81c0b8817c_I20220509" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81NS9mcmFnOjFjOWViMDlkMTM1MjRiNGNiYzE0ZDRjMjM3ZjE4MmExL3RhYmxlOmQzZDNmMTM2YWNiMjQwZDM5NjliMjNlYTQyMWZmYjRiL3RhYmxlcmFuZ2U6ZDNkM2YxMzZhY2IyNDBkMzk2OWIyM2VhNDIxZmZiNGJfMy0yLTEtMS01Mzg4OA_c543b701-6844-4829-9e09-b18d7baaa829" unitRef="usd"> 554000 </us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets>
<us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment contextRef="i20b9a56ee2dc4a508f7dfc81c0b8817c_I20220509" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81NS9mcmFnOjFjOWViMDlkMTM1MjRiNGNiYzE0ZDRjMjM3ZjE4MmExL3RhYmxlOmQzZDNmMTM2YWNiMjQwZDM5NjliMjNlYTQyMWZmYjRiL3RhYmxlcmFuZ2U6ZDNkM2YxMzZhY2IyNDBkMzk2OWIyM2VhNDIxZmZiNGJfNC0yLTEtMS01Mzg4OA_453e54bb-2d9e-4362-bce4-3eb38c5d6af0" unitRef="usd"> 1046000 </us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
<us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles contextRef="i6e2ebcd18c6c468fb98cfa2b81b9e1d9_I20220509" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81NS9mcmFnOjFjOWViMDlkMTM1MjRiNGNiYzE0ZDRjMjM3ZjE4MmExL3RhYmxlOmQzZDNmMTM2YWNiMjQwZDM5NjliMjNlYTQyMWZmYjRiL3RhYmxlcmFuZ2U6ZDNkM2YxMzZhY2IyNDBkMzk2OWIyM2VhNDIxZmZiNGJfNS0yLTEtMS01Mzg4OA_c62da7fb-8c43-4273-b771-445b3ef925cc" unitRef="usd"> 195000000 </us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
<us-gaap:Goodwill contextRef="i20b9a56ee2dc4a508f7dfc81c0b8817c_I20220509" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81NS9mcmFnOjFjOWViMDlkMTM1MjRiNGNiYzE0ZDRjMjM3ZjE4MmExL3RhYmxlOmQzZDNmMTM2YWNiMjQwZDM5NjliMjNlYTQyMWZmYjRiL3RhYmxlcmFuZ2U6ZDNkM2YxMzZhY2IyNDBkMzk2OWIyM2VhNDIxZmZiNGJfNi0yLTEtMS01Mzg4OA_2c56b540-dad2-40d7-850d-c54b1b726581" unitRef="usd"> 65786000 </us-gaap:Goodwill>
<us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable contextRef="i20b9a56ee2dc4a508f7dfc81c0b8817c_I20220509" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81NS9mcmFnOjFjOWViMDlkMTM1MjRiNGNiYzE0ZDRjMjM3ZjE4MmExL3RhYmxlOmQzZDNmMTM2YWNiMjQwZDM5NjliMjNlYTQyMWZmYjRiL3RhYmxlcmFuZ2U6ZDNkM2YxMzZhY2IyNDBkMzk2OWIyM2VhNDIxZmZiNGJfNy0yLTEtMS01Mzg4OA_63f104f0-61e5-4f8b-9557-be8932d47b4c" unitRef="usd"> 202000 </us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable>
<us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities contextRef="i20b9a56ee2dc4a508f7dfc81c0b8817c_I20220509" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81NS9mcmFnOjFjOWViMDlkMTM1MjRiNGNiYzE0ZDRjMjM3ZjE4MmExL3RhYmxlOmQzZDNmMTM2YWNiMjQwZDM5NjliMjNlYTQyMWZmYjRiL3RhYmxlcmFuZ2U6ZDNkM2YxMzZhY2IyNDBkMzk2OWIyM2VhNDIxZmZiNGJfOC0yLTEtMS01NTk3Mw_17ee5391-7020-4175-9f34-d8bf83e929b7" unitRef="usd"> 40740000 </us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities>
<us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet contextRef="i20b9a56ee2dc4a508f7dfc81c0b8817c_I20220509" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81NS9mcmFnOjFjOWViMDlkMTM1MjRiNGNiYzE0ZDRjMjM3ZjE4MmExL3RhYmxlOmQzZDNmMTM2YWNiMjQwZDM5NjliMjNlYTQyMWZmYjRiL3RhYmxlcmFuZ2U6ZDNkM2YxMzZhY2IyNDBkMzk2OWIyM2VhNDIxZmZiNGJfOC0yLTEtMS01Mzg4OA_92571c26-833e-4fcd-85f1-db56f7beafe1" unitRef="usd"> 221662000 </us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
<us-gaap:BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual contextRef="i90e63abdd08541478caeee0f59f6fdf3_D20220509-20220630" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81NS9mcmFnOjFjOWViMDlkMTM1MjRiNGNiYzE0ZDRjMjM3ZjE4MmExL3RleHRyZWdpb246MWM5ZWIwOWQxMzUyNGI0Y2JjMTRkNGMyMzdmMTgyYTFfMzg0ODI5MDcxMzQyOA_03d730f3-5b9e-4c73-9434-d8c992abc32a" unitRef="usd"> 0 </us-gaap:BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual>
<us-gaap:BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual contextRef="i90e63abdd08541478caeee0f59f6fdf3_D20220509-20220630" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81NS9mcmFnOjFjOWViMDlkMTM1MjRiNGNiYzE0ZDRjMjM3ZjE4MmExL3RleHRyZWdpb246MWM5ZWIwOWQxMzUyNGI0Y2JjMTRkNGMyMzdmMTgyYTFfMzg0ODI5MDcxMzQ0Mg_5904d277-df58-4143-95c4-8be1efff1e77" unitRef="usd"> 1100000 </us-gaap:BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual>
<us-gaap:InvestmentTableTextBlock contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81NS9mcmFnOjFjOWViMDlkMTM1MjRiNGNiYzE0ZDRjMjM3ZjE4MmExL3RleHRyZWdpb246MWM5ZWIwOWQxMzUyNGI0Y2JjMTRkNGMyMzdmMTgyYTFfODg5Mg_a2d9483e-2ea7-4a7a-98d1-ed47ba57d280">
<div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table reflects the accounting method, carrying value and underlying equity in net assets of our unconsolidated investments as of June 30, 2022 and December 31, 2021:</span></div><div style="margin-top:14pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.883%"><tr><td style="width:1.0%"/><td style="width:46.203%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.416%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.226%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.416%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.226%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.416%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.688%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.416%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.693%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">As of June 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">As of December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment type</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Investment Carrying Value</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Underlying Equity in Net Assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Investment Carrying Value</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Underlying Equity in Net Assets</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity method investments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">173 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,822 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">263 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,577 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable interest entity, equity method</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">797 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,417 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">816 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,043 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity method investments - FV option</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100,800 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,508 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,226 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities with no readily determinable fair value</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,396 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,408 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrants and options</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total carrying value of investments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108,685 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,729 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr></table></div>
</us-gaap:InvestmentTableTextBlock>
<opk:EquityMethodInvestmentExcludingVariableInterestEntity contextRef="i4768f885851b49f986857a2a956f9162_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81NS9mcmFnOjFjOWViMDlkMTM1MjRiNGNiYzE0ZDRjMjM3ZjE4MmExL3RhYmxlOjQ5YzQxYTM5ODY3MDRiMDFhMDE1NTliMzg0NThlNDMxL3RhYmxlcmFuZ2U6NDljNDFhMzk4NjcwNGIwMWEwMTU1OWIzODQ1OGU0MzFfMi0yLTEtMS00ODE2NA_7f90188e-8fd5-49f7-9e24-5df3d8fde847" unitRef="usd"> 173000 </opk:EquityMethodInvestmentExcludingVariableInterestEntity>
<us-gaap:EquityMethodInvestmentUnderlyingEquityInNetAssets contextRef="i4768f885851b49f986857a2a956f9162_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81NS9mcmFnOjFjOWViMDlkMTM1MjRiNGNiYzE0ZDRjMjM3ZjE4MmExL3RhYmxlOjQ5YzQxYTM5ODY3MDRiMDFhMDE1NTliMzg0NThlNDMxL3RhYmxlcmFuZ2U6NDljNDFhMzk4NjcwNGIwMWEwMTU1OWIzODQ1OGU0MzFfMi00LTEtMS00ODE2NA_2a9656eb-1ce4-42d9-b204-4bfed4617d67" unitRef="usd"> 4822000 </us-gaap:EquityMethodInvestmentUnderlyingEquityInNetAssets>
<opk:EquityMethodInvestmentExcludingVariableInterestEntity contextRef="i7e0f479bead144b0bdbcc71082db627b_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81NS9mcmFnOjFjOWViMDlkMTM1MjRiNGNiYzE0ZDRjMjM3ZjE4MmExL3RhYmxlOjQ5YzQxYTM5ODY3MDRiMDFhMDE1NTliMzg0NThlNDMxL3RhYmxlcmFuZ2U6NDljNDFhMzk4NjcwNGIwMWEwMTU1OWIzODQ1OGU0MzFfMi02LTEtMS00ODE2NA_5adb1961-c61c-4dbe-ae73-939ade781216" unitRef="usd"> 263000 </opk:EquityMethodInvestmentExcludingVariableInterestEntity>
<us-gaap:EquityMethodInvestmentUnderlyingEquityInNetAssets contextRef="i7e0f479bead144b0bdbcc71082db627b_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81NS9mcmFnOjFjOWViMDlkMTM1MjRiNGNiYzE0ZDRjMjM3ZjE4MmExL3RhYmxlOjQ5YzQxYTM5ODY3MDRiMDFhMDE1NTliMzg0NThlNDMxL3RhYmxlcmFuZ2U6NDljNDFhMzk4NjcwNGIwMWEwMTU1OWIzODQ1OGU0MzFfMi04LTEtMS00ODE2NA_4702185c-2b78-4ed8-8dfe-68fcaa46246c" unitRef="usd"> 3577000 </us-gaap:EquityMethodInvestmentUnderlyingEquityInNetAssets>
<opk:EquityMethodInvestmentVariableInterestEntity contextRef="i4768f885851b49f986857a2a956f9162_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81NS9mcmFnOjFjOWViMDlkMTM1MjRiNGNiYzE0ZDRjMjM3ZjE4MmExL3RhYmxlOjQ5YzQxYTM5ODY3MDRiMDFhMDE1NTliMzg0NThlNDMxL3RhYmxlcmFuZ2U6NDljNDFhMzk4NjcwNGIwMWEwMTU1OWIzODQ1OGU0MzFfMy0yLTEtMS00ODE2NA_bb77cc7b-99b9-4dad-b893-b6ffe2e36799" unitRef="usd"> 797000 </opk:EquityMethodInvestmentVariableInterestEntity>
<opk:EquityMethodInvestmentVariableInterestEntityUnderlyingEquityInNetAssets contextRef="i4768f885851b49f986857a2a956f9162_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81NS9mcmFnOjFjOWViMDlkMTM1MjRiNGNiYzE0ZDRjMjM3ZjE4MmExL3RhYmxlOjQ5YzQxYTM5ODY3MDRiMDFhMDE1NTliMzg0NThlNDMxL3RhYmxlcmFuZ2U6NDljNDFhMzk4NjcwNGIwMWEwMTU1OWIzODQ1OGU0MzFfMy00LTEtMS00ODE2NA_69805671-6e8e-4803-9979-32efffdad94d" unitRef="usd"> 2417000 </opk:EquityMethodInvestmentVariableInterestEntityUnderlyingEquityInNetAssets>
<opk:EquityMethodInvestmentVariableInterestEntity contextRef="i7e0f479bead144b0bdbcc71082db627b_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81NS9mcmFnOjFjOWViMDlkMTM1MjRiNGNiYzE0ZDRjMjM3ZjE4MmExL3RhYmxlOjQ5YzQxYTM5ODY3MDRiMDFhMDE1NTliMzg0NThlNDMxL3RhYmxlcmFuZ2U6NDljNDFhMzk4NjcwNGIwMWEwMTU1OWIzODQ1OGU0MzFfMy02LTEtMS00ODE2NA_33fea629-1c64-4a67-b82a-29881c298611" unitRef="usd"> 816000 </opk:EquityMethodInvestmentVariableInterestEntity>
<opk:EquityMethodInvestmentVariableInterestEntityUnderlyingEquityInNetAssets contextRef="i7e0f479bead144b0bdbcc71082db627b_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81NS9mcmFnOjFjOWViMDlkMTM1MjRiNGNiYzE0ZDRjMjM3ZjE4MmExL3RhYmxlOjQ5YzQxYTM5ODY3MDRiMDFhMDE1NTliMzg0NThlNDMxL3RhYmxlcmFuZ2U6NDljNDFhMzk4NjcwNGIwMWEwMTU1OWIzODQ1OGU0MzFfMy04LTEtMS00ODE2NA_43d98312-29ff-4605-94ad-d55adf8651d4" unitRef="usd"> 3043000 </opk:EquityMethodInvestmentVariableInterestEntityUnderlyingEquityInNetAssets>
<us-gaap:EquityMethodInvestmentsFairValueDisclosure contextRef="i4768f885851b49f986857a2a956f9162_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81NS9mcmFnOjFjOWViMDlkMTM1MjRiNGNiYzE0ZDRjMjM3ZjE4MmExL3RhYmxlOjQ5YzQxYTM5ODY3MDRiMDFhMDE1NTliMzg0NThlNDMxL3RhYmxlcmFuZ2U6NDljNDFhMzk4NjcwNGIwMWEwMTU1OWIzODQ1OGU0MzFfNC0yLTEtMS01NDk4NQ_5af143c9-7f35-47fd-9b92-c37408b55659" unitRef="usd"> 100800000 </us-gaap:EquityMethodInvestmentsFairValueDisclosure>
<us-gaap:EquityMethodInvestmentsFairValueDisclosure contextRef="i7e0f479bead144b0bdbcc71082db627b_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81NS9mcmFnOjFjOWViMDlkMTM1MjRiNGNiYzE0ZDRjMjM3ZjE4MmExL3RhYmxlOjQ5YzQxYTM5ODY3MDRiMDFhMDE1NTliMzg0NThlNDMxL3RhYmxlcmFuZ2U6NDljNDFhMzk4NjcwNGIwMWEwMTU1OWIzODQ1OGU0MzFfNC02LTEtMS01NTk4MA_cc326005-85cf-423c-93f3-2d22cd072272" unitRef="usd"> 0 </us-gaap:EquityMethodInvestmentsFairValueDisclosure>
<us-gaap:EquitySecuritiesFvNi contextRef="i4768f885851b49f986857a2a956f9162_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81NS9mcmFnOjFjOWViMDlkMTM1MjRiNGNiYzE0ZDRjMjM3ZjE4MmExL3RhYmxlOjQ5YzQxYTM5ODY3MDRiMDFhMDE1NTliMzg0NThlNDMxL3RhYmxlcmFuZ2U6NDljNDFhMzk4NjcwNGIwMWEwMTU1OWIzODQ1OGU0MzFfNC0yLTEtMS00ODE2NA_73b2ba8e-1628-4b7a-a61f-7856d79bd7b8" unitRef="usd"> 1508000 </us-gaap:EquitySecuritiesFvNi>
<us-gaap:EquitySecuritiesFvNi contextRef="i7e0f479bead144b0bdbcc71082db627b_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81NS9mcmFnOjFjOWViMDlkMTM1MjRiNGNiYzE0ZDRjMjM3ZjE4MmExL3RhYmxlOjQ5YzQxYTM5ODY3MDRiMDFhMDE1NTliMzg0NThlNDMxL3RhYmxlcmFuZ2U6NDljNDFhMzk4NjcwNGIwMWEwMTU1OWIzODQ1OGU0MzFfNC02LTEtMS00ODE2NA_033c1db4-9212-40a7-80ac-d2c087c2032a" unitRef="usd"> 4226000 </us-gaap:EquitySecuritiesFvNi>
<us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount contextRef="i4768f885851b49f986857a2a956f9162_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81NS9mcmFnOjFjOWViMDlkMTM1MjRiNGNiYzE0ZDRjMjM3ZjE4MmExL3RhYmxlOjQ5YzQxYTM5ODY3MDRiMDFhMDE1NTliMzg0NThlNDMxL3RhYmxlcmFuZ2U6NDljNDFhMzk4NjcwNGIwMWEwMTU1OWIzODQ1OGU0MzFfNS0yLTEtMS00ODE2NA_b0563fe6-78ab-41cb-b835-12e57c5d8813" unitRef="usd"> 5396000 </us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount>
<us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount contextRef="i7e0f479bead144b0bdbcc71082db627b_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81NS9mcmFnOjFjOWViMDlkMTM1MjRiNGNiYzE0ZDRjMjM3ZjE4MmExL3RhYmxlOjQ5YzQxYTM5ODY3MDRiMDFhMDE1NTliMzg0NThlNDMxL3RhYmxlcmFuZ2U6NDljNDFhMzk4NjcwNGIwMWEwMTU1OWIzODQ1OGU0MzFfNS02LTEtMS00ODE2NA_6aeb2d1e-6638-412e-b2ea-f23d998574f1" unitRef="usd"> 5408000 </us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount>
<opk:StockOptionandWarrantInvestments contextRef="i4768f885851b49f986857a2a956f9162_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81NS9mcmFnOjFjOWViMDlkMTM1MjRiNGNiYzE0ZDRjMjM3ZjE4MmExL3RhYmxlOjQ5YzQxYTM5ODY3MDRiMDFhMDE1NTliMzg0NThlNDMxL3RhYmxlcmFuZ2U6NDljNDFhMzk4NjcwNGIwMWEwMTU1OWIzODQ1OGU0MzFfNi0yLTEtMS00ODE2NA_5155247e-496f-4919-8fd9-d9110b13a4c3" unitRef="usd"> 11000 </opk:StockOptionandWarrantInvestments>
<opk:StockOptionandWarrantInvestments contextRef="i7e0f479bead144b0bdbcc71082db627b_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81NS9mcmFnOjFjOWViMDlkMTM1MjRiNGNiYzE0ZDRjMjM3ZjE4MmExL3RhYmxlOjQ5YzQxYTM5ODY3MDRiMDFhMDE1NTliMzg0NThlNDMxL3RhYmxlcmFuZ2U6NDljNDFhMzk4NjcwNGIwMWEwMTU1OWIzODQ1OGU0MzFfNi02LTEtMS00ODE2NA_6af6312c-4349-43b8-b780-0ee7b9050a75" unitRef="usd"> 16000 </opk:StockOptionandWarrantInvestments>
<us-gaap:LongTermInvestments contextRef="i4768f885851b49f986857a2a956f9162_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81NS9mcmFnOjFjOWViMDlkMTM1MjRiNGNiYzE0ZDRjMjM3ZjE4MmExL3RhYmxlOjQ5YzQxYTM5ODY3MDRiMDFhMDE1NTliMzg0NThlNDMxL3RhYmxlcmFuZ2U6NDljNDFhMzk4NjcwNGIwMWEwMTU1OWIzODQ1OGU0MzFfNy0yLTEtMS00ODE2NA_89d0190b-d3b8-4be8-902c-7e1ab880666c" unitRef="usd"> 108685000 </us-gaap:LongTermInvestments>
<us-gaap:LongTermInvestments contextRef="i7e0f479bead144b0bdbcc71082db627b_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81NS9mcmFnOjFjOWViMDlkMTM1MjRiNGNiYzE0ZDRjMjM3ZjE4MmExL3RhYmxlOjQ5YzQxYTM5ODY3MDRiMDFhMDE1NTliMzg0NThlNDMxL3RhYmxlcmFuZ2U6NDljNDFhMzk4NjcwNGIwMWEwMTU1OWIzODQ1OGU0MzFfNy02LTEtMS00ODE2NA_1e55851e-e2b1-441a-8f67-b1b09e02754e" unitRef="usd"> 10729000 </us-gaap:LongTermInvestments>
<us-gaap:EquityMethodInvestmentOwnershipPercentage contextRef="iccb7ebf892d04d5bad4a79423d427821_I20220630" decimals="2" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81NS9mcmFnOjFjOWViMDlkMTM1MjRiNGNiYzE0ZDRjMjM3ZjE4MmExL3RleHRyZWdpb246MWM5ZWIwOWQxMzUyNGI0Y2JjMTRkNGMyMzdmMTgyYTFfMzEz_07556627-bb7c-4e15-bd8a-dc4dd3d80d4c" unitRef="number"> 0.09 </us-gaap:EquityMethodInvestmentOwnershipPercentage>
<us-gaap:EquityMethodInvestmentOwnershipPercentage contextRef="ibd144d9728004cf9863b6ae5054c6f3b_I20220630" decimals="2" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81NS9mcmFnOjFjOWViMDlkMTM1MjRiNGNiYzE0ZDRjMjM3ZjE4MmExL3RleHRyZWdpb246MWM5ZWIwOWQxMzUyNGI0Y2JjMTRkNGMyMzdmMTgyYTFfMzUx_0988d565-7245-4eba-b07c-61d9541c3b2f" unitRef="number"> 0.03 </us-gaap:EquityMethodInvestmentOwnershipPercentage>
<us-gaap:EquityMethodInvestmentOwnershipPercentage contextRef="i7f3e1c36b68e4b9297d3edcfa497c422_I20220630" decimals="2" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81NS9mcmFnOjFjOWViMDlkMTM1MjRiNGNiYzE0ZDRjMjM3ZjE4MmExL3RleHRyZWdpb246MWM5ZWIwOWQxMzUyNGI0Y2JjMTRkNGMyMzdmMTgyYTFfNDA0_814e6555-0af2-4597-a791-a59d71d6cdf6" unitRef="number"> 0.01 </us-gaap:EquityMethodInvestmentOwnershipPercentage>
<us-gaap:EquityMethodInvestmentOwnershipPercentage contextRef="i638893db4b744380bbf4fe4b1c4c34cb_I20220630" decimals="2" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81NS9mcmFnOjFjOWViMDlkMTM1MjRiNGNiYzE0ZDRjMjM3ZjE4MmExL3RleHRyZWdpb246MWM5ZWIwOWQxMzUyNGI0Y2JjMTRkNGMyMzdmMTgyYTFfNDM2_f8b0ed1d-9abf-4f2b-9241-f3a8a327d396" unitRef="number"> 0.01 </us-gaap:EquityMethodInvestmentOwnershipPercentage>
<us-gaap:EquityMethodInvestmentOwnershipPercentage contextRef="ica61dbae6de944cbb0951857c4df1f1c_I20220630" decimals="2" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81NS9mcmFnOjFjOWViMDlkMTM1MjRiNGNiYzE0ZDRjMjM3ZjE4MmExL3RleHRyZWdpb246MWM5ZWIwOWQxMzUyNGI0Y2JjMTRkNGMyMzdmMTgyYTFfNTA2_cf520093-0e70-4c36-a1c7-a7f731e1a10f" unitRef="number"> 0.01 </us-gaap:EquityMethodInvestmentOwnershipPercentage>
<us-gaap:EquityMethodInvestmentOwnershipPercentage contextRef="ifa84a7bed2a34798be0401c8ebf24f2a_I20220630" decimals="2" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81NS9mcmFnOjFjOWViMDlkMTM1MjRiNGNiYzE0ZDRjMjM3ZjE4MmExL3RleHRyZWdpb246MWM5ZWIwOWQxMzUyNGI0Y2JjMTRkNGMyMzdmMTgyYTFfNTUw_d463353b-bc41-4301-84b8-df914e3583e7" unitRef="number"> 0.03 </us-gaap:EquityMethodInvestmentOwnershipPercentage>
<us-gaap:VariableInterestEntityOwnershipPercentage contextRef="i4aa0e748cf164fbebe8ea96fb98f0800_D20220101-20220630" decimals="2" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81NS9mcmFnOjFjOWViMDlkMTM1MjRiNGNiYzE0ZDRjMjM3ZjE4MmExL3RleHRyZWdpb246MWM5ZWIwOWQxMzUyNGI0Y2JjMTRkNGMyMzdmMTgyYTFfNjA1_f619dc79-a14a-41df-a72a-49a476b08337" unitRef="number"> 0.47 </us-gaap:VariableInterestEntityOwnershipPercentage>
<us-gaap:Assets contextRef="i5d3db5074ab44b5da5cab50b5f82d089_I20220630" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81NS9mcmFnOjFjOWViMDlkMTM1MjRiNGNiYzE0ZDRjMjM3ZjE4MmExL3RleHRyZWdpb246MWM5ZWIwOWQxMzUyNGI0Y2JjMTRkNGMyMzdmMTgyYTFfNzI4_9372ae4d-03c6-4042-b753-76568bce1fac" unitRef="usd"> 212400000 </us-gaap:Assets>
<us-gaap:Liabilities contextRef="i5d3db5074ab44b5da5cab50b5f82d089_I20220630" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81NS9mcmFnOjFjOWViMDlkMTM1MjRiNGNiYzE0ZDRjMjM3ZjE4MmExL3RleHRyZWdpb246MWM5ZWIwOWQxMzUyNGI0Y2JjMTRkNGMyMzdmMTgyYTFfNzMy_09a2515c-f6c6-44a4-9253-576770de44b1" unitRef="usd"> 41700000 </us-gaap:Liabilities>
<us-gaap:ProfitLoss contextRef="i4cd739f3c8454b12b43d9bfab3d579a6_D20220101-20220630" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81NS9mcmFnOjFjOWViMDlkMTM1MjRiNGNiYzE0ZDRjMjM3ZjE4MmExL3RleHRyZWdpb246MWM5ZWIwOWQxMzUyNGI0Y2JjMTRkNGMyMzdmMTgyYTFfNzQw_21909b2c-6824-4ee9-8b33-40cbad1915ba" unitRef="usd"> -48600000 </us-gaap:ProfitLoss>
<us-gaap:Assets contextRef="i6ae7d1b97af640af87dab463fe02505b_I20211231" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81NS9mcmFnOjFjOWViMDlkMTM1MjRiNGNiYzE0ZDRjMjM3ZjE4MmExL3RleHRyZWdpb246MWM5ZWIwOWQxMzUyNGI0Y2JjMTRkNGMyMzdmMTgyYTFfOTAy_3c009d45-a697-4481-8a23-c17c4f8e6b7e" unitRef="usd"> 223600000 </us-gaap:Assets>
<us-gaap:Liabilities contextRef="i6ae7d1b97af640af87dab463fe02505b_I20211231" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81NS9mcmFnOjFjOWViMDlkMTM1MjRiNGNiYzE0ZDRjMjM3ZjE4MmExL3RleHRyZWdpb246MWM5ZWIwOWQxMzUyNGI0Y2JjMTRkNGMyMzdmMTgyYTFfOTA2_9debd67b-ced7-4c58-b1b8-0f492b6bc6cc" unitRef="usd"> 37900000 </us-gaap:Liabilities>
<us-gaap:ProfitLoss contextRef="i092ce7932d9a4163958cb0a85b249a9e_D20210101-20211231" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81NS9mcmFnOjFjOWViMDlkMTM1MjRiNGNiYzE0ZDRjMjM3ZjE4MmExL3RleHRyZWdpb246MWM5ZWIwOWQxMzUyNGI0Y2JjMTRkNGMyMzdmMTgyYTFfOTE0_66ea1dd6-4c96-4767-9c6d-fcd71f1aa879" unitRef="usd"> -69400000 </us-gaap:ProfitLoss>
<us-gaap:EquityMethodInvestmentQuotedMarketValue contextRef="i4768f885851b49f986857a2a956f9162_I20220630" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81NS9mcmFnOjFjOWViMDlkMTM1MjRiNGNiYzE0ZDRjMjM3ZjE4MmExL3RleHRyZWdpb246MWM5ZWIwOWQxMzUyNGI0Y2JjMTRkNGMyMzdmMTgyYTFfMTU0MQ_580de32f-52bb-4138-9c25-7e689f93559f" unitRef="usd"> 1900000 </us-gaap:EquityMethodInvestmentQuotedMarketValue>
<us-gaap:EquityMethodInvestmentQuotedMarketValue contextRef="i7e0f479bead144b0bdbcc71082db627b_I20211231" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81NS9mcmFnOjFjOWViMDlkMTM1MjRiNGNiYzE0ZDRjMjM3ZjE4MmExL3RleHRyZWdpb246MWM5ZWIwOWQxMzUyNGI0Y2JjMTRkNGMyMzdmMTgyYTFfMTU0OA_facc5b2c-7a2c-4232-ab02-b6bb4c222493" unitRef="usd"> 4500000 </us-gaap:EquityMethodInvestmentQuotedMarketValue>
<us-gaap:PaymentsToAcquireBusinessesGross contextRef="ibde59da9b1054f718e54290fcabbdad7_D20220429-20220429" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81NS9mcmFnOjFjOWViMDlkMTM1MjRiNGNiYzE0ZDRjMjM3ZjE4MmExL3RleHRyZWdpb246MWM5ZWIwOWQxMzUyNGI0Y2JjMTRkNGMyMzdmMTgyYTFfMzg0ODI5MDczMzQyNA_7aaa7205-00dc-47c0-a9bb-39e286a008fc" unitRef="usd"> 150000000 </us-gaap:PaymentsToAcquireBusinessesGross>
<us-gaap:InvestmentOwnedBalanceShares contextRef="i8345c838c79a4bebb30e85822ef0d853_I20220630" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81NS9mcmFnOjFjOWViMDlkMTM1MjRiNGNiYzE0ZDRjMjM3ZjE4MmExL3RleHRyZWdpb246MWM5ZWIwOWQxMzUyNGI0Y2JjMTRkNGMyMzdmMTgyYTFfMjE5OTAyMzI5Nzg5MA_8efe4bea-f677-4eea-849d-83a3d1917bab" unitRef="shares"> 80000000 </us-gaap:InvestmentOwnedBalanceShares>
<us-gaap:EquityMethodInvestmentOwnershipPercentage contextRef="i62aaadeeb2eb492c9122db4484c06757_I20220630" decimals="3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81NS9mcmFnOjFjOWViMDlkMTM1MjRiNGNiYzE0ZDRjMjM3ZjE4MmExL3RleHRyZWdpb246MWM5ZWIwOWQxMzUyNGI0Y2JjMTRkNGMyMzdmMTgyYTFfMzg0ODI5MDczMzQzOQ_4f1df506-ba8e-4033-aee6-fdce5555fd22" unitRef="number"> 0.212 </us-gaap:EquityMethodInvestmentOwnershipPercentage>
<opk:BusinessAcquisitionOutstandingSharesHeldPercentage contextRef="i4154180b9991448a838549649e73ab2d_I20220429" decimals="2" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81NS9mcmFnOjFjOWViMDlkMTM1MjRiNGNiYzE0ZDRjMjM3ZjE4MmExL3RleHRyZWdpb246MWM5ZWIwOWQxMzUyNGI0Y2JjMTRkNGMyMzdmMTgyYTFfMzg0ODI5MDc0MTY5Mw_31f51230-8f2d-4443-b7fb-41040aecf261" unitRef="number"> 0.05 </opk:BusinessAcquisitionOutstandingSharesHeldPercentage>
<us-gaap:EquitySecuritiesFvNiRealizedLoss contextRef="i0963066211524c049a2a49beb703d496_D20220429-20220429" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81NS9mcmFnOjFjOWViMDlkMTM1MjRiNGNiYzE0ZDRjMjM3ZjE4MmExL3RleHRyZWdpb246MWM5ZWIwOWQxMzUyNGI0Y2JjMTRkNGMyMzdmMTgyYTFfMjE5OTAyMzMwMDg4NA_22131b4d-c8b4-4cf6-a896-f2048f65557c" unitRef="usd"> 71200000 </us-gaap:EquitySecuritiesFvNiRealizedLoss>
<opk:EquitySecurityFVNIOwnershipPercent contextRef="if288f21de13c4cfb8202fe2552824c40_I20220630" decimals="4" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81NS9mcmFnOjFjOWViMDlkMTM1MjRiNGNiYzE0ZDRjMjM3ZjE4MmExL3RleHRyZWdpb246MWM5ZWIwOWQxMzUyNGI0Y2JjMTRkNGMyMzdmMTgyYTFfMTY4OQ_7c0d64d2-280a-4180-8a14-6d505717d4b5" unitRef="number"> 0.0001 </opk:EquitySecurityFVNIOwnershipPercent>
<opk:EquitySecurityFVNIOwnershipPercent contextRef="ic60a15d1f2b446899dd153a240f07d47_I20220630" decimals="2" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81NS9mcmFnOjFjOWViMDlkMTM1MjRiNGNiYzE0ZDRjMjM3ZjE4MmExL3RleHRyZWdpb246MWM5ZWIwOWQxMzUyNGI0Y2JjMTRkNGMyMzdmMTgyYTFfMTcyMQ_87ea9e29-6318-4bb8-bc0a-da8d47ac4baf" unitRef="number"> 0.01 </opk:EquitySecurityFVNIOwnershipPercent>
<opk:EquitySecurityFVNIOwnershipPercent contextRef="iedf7653609334b3e8f1f1e53eb7904f3_I20220630" decimals="3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81NS9mcmFnOjFjOWViMDlkMTM1MjRiNGNiYzE0ZDRjMjM3ZjE4MmExL3RleHRyZWdpb246MWM5ZWIwOWQxMzUyNGI0Y2JjMTRkNGMyMzdmMTgyYTFfMTc2Mw_6d876c55-179e-48fc-bdb9-4ad73197f940" unitRef="number"> 0.001 </opk:EquitySecurityFVNIOwnershipPercent>
<opk:EquitySecurityFVNIOwnershipPercent contextRef="i4b9df4ff9c4d4da3ad49058716ae72e7_I20220630" decimals="2" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81NS9mcmFnOjFjOWViMDlkMTM1MjRiNGNiYzE0ZDRjMjM3ZjE4MmExL3RleHRyZWdpb246MWM5ZWIwOWQxMzUyNGI0Y2JjMTRkNGMyMzdmMTgyYTFfMTgwNw_cf3f1c93-bbcd-480d-9cf2-ba1aff63845f" unitRef="number"> 0.01 </opk:EquitySecurityFVNIOwnershipPercent>
<opk:EquitySecurityFVNIOwnershipPercent contextRef="i4e74a1253b194022be7043a4114032da_I20220630" decimals="2" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81NS9mcmFnOjFjOWViMDlkMTM1MjRiNGNiYzE0ZDRjMjM3ZjE4MmExL3RleHRyZWdpb246MWM5ZWIwOWQxMzUyNGI0Y2JjMTRkNGMyMzdmMTgyYTFfMTg1OA_bdca4107-686f-44ef-9420-fd2d02945c41" unitRef="number"> 0.02 </opk:EquitySecurityFVNIOwnershipPercent>
<opk:EquitySecurityFVNIOwnershipPercent contextRef="i01da602732d248f58f9f4c22841acc82_I20220630" decimals="2" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81NS9mcmFnOjFjOWViMDlkMTM1MjRiNGNiYzE0ZDRjMjM3ZjE4MmExL3RleHRyZWdpb246MWM5ZWIwOWQxMzUyNGI0Y2JjMTRkNGMyMzdmMTgyYTFfMTg4NA_ceae59a3-35e4-4852-9861-e3b088bf14d2" unitRef="number"> 0.07 </opk:EquitySecurityFVNIOwnershipPercent>
<us-gaap:UnrealizedGainLossOnInvestmentsTableTextBlock contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81NS9mcmFnOjFjOWViMDlkMTM1MjRiNGNiYzE0ZDRjMjM3ZjE4MmExL3RleHRyZWdpb246MWM5ZWIwOWQxMzUyNGI0Y2JjMTRkNGMyMzdmMTgyYTFfODg3Ng_3285fbfd-db82-4558-ab03-f573e4f9ca0a">
Net gains and losses on our equity securities for the six months ended June 30, 2022, and 2021 were as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.367%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.376%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">For the six months ended June 30</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in thousands)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Equity Securities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net gains and losses recognized during the period on equity securities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,718)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,408 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: Net gains realized during the period on equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,981)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unrealized net gains and losses recognized during the period on equity securities still held at the reporting date</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,718)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,573)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table>
</us-gaap:UnrealizedGainLossOnInvestmentsTableTextBlock>
<us-gaap:EquitySecuritiesFvNiGainLoss contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81NS9mcmFnOjFjOWViMDlkMTM1MjRiNGNiYzE0ZDRjMjM3ZjE4MmExL3RhYmxlOjYyNTFhN2ZkZGY5ZTRiMWNiYzEwM2VjMDdiNjQ0ZmQzL3RhYmxlcmFuZ2U6NjI1MWE3ZmRkZjllNGIxY2JjMTAzZWMwN2I2NDRmZDNfMy0xLTEtMS00ODE2NA_f76f2ca3-350b-40ae-a926-0ad586ca2df8" unitRef="usd"> -2718000 </us-gaap:EquitySecuritiesFvNiGainLoss>
<us-gaap:EquitySecuritiesFvNiGainLoss contextRef="i420e18e30084498a98510d48880063cd_D20210101-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81NS9mcmFnOjFjOWViMDlkMTM1MjRiNGNiYzE0ZDRjMjM3ZjE4MmExL3RhYmxlOjYyNTFhN2ZkZGY5ZTRiMWNiYzEwM2VjMDdiNjQ0ZmQzL3RhYmxlcmFuZ2U6NjI1MWE3ZmRkZjllNGIxY2JjMTAzZWMwN2I2NDRmZDNfMy0zLTEtMS00ODE2NA_c9adbdd5-9936-4982-ba4d-2c6407e104ed" unitRef="usd"> 1408000 </us-gaap:EquitySecuritiesFvNiGainLoss>
<us-gaap:EquitySecuritiesFvNiRealizedGainLoss contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81NS9mcmFnOjFjOWViMDlkMTM1MjRiNGNiYzE0ZDRjMjM3ZjE4MmExL3RhYmxlOjYyNTFhN2ZkZGY5ZTRiMWNiYzEwM2VjMDdiNjQ0ZmQzL3RhYmxlcmFuZ2U6NjI1MWE3ZmRkZjllNGIxY2JjMTAzZWMwN2I2NDRmZDNfNC0xLTEtMS00ODE2NA_9a304e74-b9de-4f46-a954-1cd3ac1c671a" unitRef="usd"> 0 </us-gaap:EquitySecuritiesFvNiRealizedGainLoss>
<us-gaap:EquitySecuritiesFvNiRealizedGainLoss contextRef="i420e18e30084498a98510d48880063cd_D20210101-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81NS9mcmFnOjFjOWViMDlkMTM1MjRiNGNiYzE0ZDRjMjM3ZjE4MmExL3RhYmxlOjYyNTFhN2ZkZGY5ZTRiMWNiYzEwM2VjMDdiNjQ0ZmQzL3RhYmxlcmFuZ2U6NjI1MWE3ZmRkZjllNGIxY2JjMTAzZWMwN2I2NDRmZDNfNC0zLTEtMS00ODE2NA_265957a6-ceed-49d7-9d86-3ea1484dfd49" unitRef="usd"> 2981000 </us-gaap:EquitySecuritiesFvNiRealizedGainLoss>
<us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81NS9mcmFnOjFjOWViMDlkMTM1MjRiNGNiYzE0ZDRjMjM3ZjE4MmExL3RhYmxlOjYyNTFhN2ZkZGY5ZTRiMWNiYzEwM2VjMDdiNjQ0ZmQzL3RhYmxlcmFuZ2U6NjI1MWE3ZmRkZjllNGIxY2JjMTAzZWMwN2I2NDRmZDNfNS0xLTEtMS00ODE2NA_bd2d73d9-dda0-49e4-9f5d-6dad7bc13ca4" unitRef="usd"> -2718000 </us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss>
<us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss contextRef="i420e18e30084498a98510d48880063cd_D20210101-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81NS9mcmFnOjFjOWViMDlkMTM1MjRiNGNiYzE0ZDRjMjM3ZjE4MmExL3RhYmxlOjYyNTFhN2ZkZGY5ZTRiMWNiYzEwM2VjMDdiNjQ0ZmQzL3RhYmxlcmFuZ2U6NjI1MWE3ZmRkZjllNGIxY2JjMTAzZWMwN2I2NDRmZDNfNS0zLTEtMS00ODE2NA_f4e75108-2d71-48ff-9716-72572cb9ec49" unitRef="usd"> -1573000 </us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss>
<us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights contextRef="ica61dbae6de944cbb0951857c4df1f1c_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81NS9mcmFnOjFjOWViMDlkMTM1MjRiNGNiYzE0ZDRjMjM3ZjE4MmExL3RleHRyZWdpb246MWM5ZWIwOWQxMzUyNGI0Y2JjMTRkNGMyMzdmMTgyYTFfMjg5Ng_36ac7700-ba5b-45b0-b205-6baf32f53e83" unitRef="shares"> 47000 </us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
<us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights contextRef="i141dcc1c0b4a4b869a95068b3e96b2d7_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81NS9mcmFnOjFjOWViMDlkMTM1MjRiNGNiYzE0ZDRjMjM3ZjE4MmExL3RleHRyZWdpb246MWM5ZWIwOWQxMzUyNGI0Y2JjMTRkNGMyMzdmMTgyYTFfMjg5Ng_e28e5298-f8a5-4d49-8830-693b20c8cb08" unitRef="shares"> 47000 </us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
<us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights contextRef="ibd144d9728004cf9863b6ae5054c6f3b_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81NS9mcmFnOjFjOWViMDlkMTM1MjRiNGNiYzE0ZDRjMjM3ZjE4MmExL3RleHRyZWdpb246MWM5ZWIwOWQxMzUyNGI0Y2JjMTRkNGMyMzdmMTgyYTFfMjk5Mg_f8d7ad96-d44e-49e3-a660-9582e6f202f5" unitRef="shares"> 33000 </us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
<us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights contextRef="i088e1c2b87224f69a5e28490a4d4c18b_I20220630" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81NS9mcmFnOjFjOWViMDlkMTM1MjRiNGNiYzE0ZDRjMjM3ZjE4MmExL3RleHRyZWdpb246MWM5ZWIwOWQxMzUyNGI0Y2JjMTRkNGMyMzdmMTgyYTFfMjk5OQ_8faced84-09d5-41d7-bbab-f1cea24f654d" unitRef="shares"> 700000 </us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
<opk:NoncontrollingInterestSharesIssued contextRef="ife44f423be0e44ba9c693b730c6ecddf_D20210914-20210914" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81NS9mcmFnOjFjOWViMDlkMTM1MjRiNGNiYzE0ZDRjMjM3ZjE4MmExL3RleHRyZWdpb246MWM5ZWIwOWQxMzUyNGI0Y2JjMTRkNGMyMzdmMTgyYTFfNDQ2NQ_f81ec7db-e6c3-4727-8e3f-ba43ff97dc20" unitRef="shares"> 4703 </opk:NoncontrollingInterestSharesIssued>
<us-gaap:MinorityInterestOwnershipPercentageByParent contextRef="i1d617d723c3b4354a0819a2ba6169cbe_I20210914" decimals="2" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81NS9mcmFnOjFjOWViMDlkMTM1MjRiNGNiYzE0ZDRjMjM3ZjE4MmExL3RleHRyZWdpb246MWM5ZWIwOWQxMzUyNGI0Y2JjMTRkNGMyMzdmMTgyYTFfNDQ3NQ_53bcaef0-1ebc-4a7c-9070-0209de3f65d2" unitRef="number"> 0.47 </us-gaap:MinorityInterestOwnershipPercentageByParent>
<us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="i9df475336f4742019be80be30aa8e211_D20210914-20210914" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81NS9mcmFnOjFjOWViMDlkMTM1MjRiNGNiYzE0ZDRjMjM3ZjE4MmExL3RleHRyZWdpb246MWM5ZWIwOWQxMzUyNGI0Y2JjMTRkNGMyMzdmMTgyYTFfNDU2Ng_52c6fa2f-69bb-4b2d-ae3c-64566893ea96" unitRef="usd"> 1000000 </us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
<us-gaap:InvestmentOwnedBalanceShares contextRef="i2ba27a001dea4cc59d62f4a7ffee8b4f_I20220630" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81NS9mcmFnOjFjOWViMDlkMTM1MjRiNGNiYzE0ZDRjMjM3ZjE4MmExL3RleHRyZWdpb246MWM5ZWIwOWQxMzUyNGI0Y2JjMTRkNGMyMzdmMTgyYTFfNzUzOA_07e7a7c9-8e72-482c-806a-f6399c4ba099" unitRef="shares"> 1260000 </us-gaap:InvestmentOwnedBalanceShares>
<opk:SharesReceivedAsGift contextRef="i3b7a2e82c132485bba44954c33dc0a80_D20220101-20220630" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81NS9mcmFnOjFjOWViMDlkMTM1MjRiNGNiYzE0ZDRjMjM3ZjE4MmExL3RleHRyZWdpb246MWM5ZWIwOWQxMzUyNGI0Y2JjMTRkNGMyMzdmMTgyYTFfNzU4OA_8cceb07e-b116-47a1-ae3d-21df78b5b9d1" unitRef="shares"> 900000 </opk:SharesReceivedAsGift>
<us-gaap:EquityMethodInvestmentOwnershipPercentage contextRef="i0044bb7665294ec49393bbdcb93e676c_I20220630" decimals="2" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81NS9mcmFnOjFjOWViMDlkMTM1MjRiNGNiYzE0ZDRjMjM3ZjE4MmExL3RleHRyZWdpb246MWM5ZWIwOWQxMzUyNGI0Y2JjMTRkNGMyMzdmMTgyYTFfNzY0Mg_d514b279-88c3-48d6-82eb-e68d6c37d368" unitRef="number"> 0.29 </us-gaap:EquityMethodInvestmentOwnershipPercentage>
<us-gaap:DebtDisclosureTextBlock contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81OC9mcmFnOjdlMWE2NDBlMDg3ODQ4MjA5MjY1Y2QwY2E4ZTlhYTg0L3RleHRyZWdpb246N2UxYTY0MGUwODc4NDgyMDkyNjVjZDBjYThlOWFhODRfMTgxMzQ_5e64fedf-13fa-4415-b86d-71287eee4524">
DEBT    <div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June 30, 2022 and December 31, 2021, our debt consisted of the following:</span></div><div style="margin-top:9pt;text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.104%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.005%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.007%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">June 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2025 Notes</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">141,537 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">119,360 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023 Convertible Notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">66,889 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">65,525 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2033 Senior Notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,050 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,050 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">JP Morgan Chase</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,867 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Chilean and Spanish lines of credit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,351 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,672 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current portion of notes payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">771 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,022 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long term portion of notes payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,984 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,642 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">232,449 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">205,272 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance sheet captions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Convertible Notes</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">211,477 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">187,935 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current portion of lines of credit and notes payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,989 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,695 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">LT notes payable included in long-term liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,984 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,642 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">232,449 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">205,272 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:4pt;text-indent:22.5pt"><span><br/></span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2019, we issued $200.0 million aggregate principal amount of Convertible Senior Notes due 2025 (the “2025 Notes”) in an underwritten public offering. The 2025 Notes bear interest at a rate of 4.50% per year, payable semiannually in arrears on February 15 and August 15 of each year. The notes mature on February 15, 2025, unless earlier repurchased, redeemed or converted. </span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holders may convert their 2025 Notes into shares of Common Stock at their option at any time prior to the close of business on the business day immediately preceding November 15, 2024 only under the following circumstances: (1) during any calendar quarter commencing after the calendar quarter ended March 31, 2019 (and only during such calendar quarter), if the last reported sale price of our Common Stock for at least 20 trading days (whether or not consecutive) during a period of 30 consecutive trading days ending on the last trading day of the immediately preceding calendar quarter is greater than or equal to 130% of the conversion price on each applicable trading day; (2) during the five business day period after any five consecutive trading day period (the “measurement period”) in which the trading price per $1,000 principal amount of 2025 Notes for each trading day of the measurement period was less than 98% of the product of the last reported sale price of our Common Stock and the conversion rate on each such trading day; (3) if we call any or all of the 2025 Notes for redemption, at any time prior to the close of business on the scheduled trading day immediately preceding the redemption date; or (4) upon the occurrence of specified corporate events set forth in the indenture governing the 2025 Notes. On or after November 15, 2024, until the close of business on the business day immediately preceding the maturity date, holders of the 2025 Notes may convert their notes at any time, regardless of the foregoing conditions. Upon conversion, we will pay or deliver, as the case may be, cash, shares of our Common Stock, or a combination of cash and shares of our Common Stock, at our election.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The initial and current conversion rate for the 2025 Notes is 236.7424 shares of Common Stock per $1,000 principal amount of 2025 Notes (equivalent to a conversion price of approximately $4.22 per share of Common Stock). The conversion rate for the 2025 Notes is subject to adjustment in certain events but will not be adjusted for any accrued and unpaid interest. In addition, following certain corporate events that occur prior to the maturity date of the 2025 Notes or if we deliver a notice of redemption, in certain circumstances the indenture governing the 2025 Notes requires an increase in the conversion rate of the 2025 Notes for a holder who elects to convert its notes in connection with such a corporate event or notice of redemption, as the case may be.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may not redeem the 2025 Notes prior to February 15, 2022. We may redeem for cash any or all of the 2025 Notes, at our option, on or after February 15, 2022, if the last reported sale price of our Common Stock has been at least 130% of the then current conversion price for the notes for at least 20 trading days (whether or not consecutive) during any 30 consecutive trading day period (including the last trading day of such period) ending on, and including, the trading day immediately preceding the date on which we provide notice of redemption at a redemption price equal to 100% of the principal amount of the notes to be redeemed, plus accrued and unpaid interest to, but excluding, the redemption date. No sinking fund is provided for the 2025 Notes.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we undergo a fundamental change, as defined in the indenture governing the 2025 Notes, prior to the maturity date of the 2025 Notes, holders may require us to repurchase for cash all or any portion of their notes at a repurchase price equal to 100% of the principal amount of the notes to be repurchased, plus accrued and unpaid interest to, but excluding, the fundamental change repurchase date. The 2025 Notes are our senior unsecured obligations and rank senior in right of payment to any of our indebtedness that is expressly subordinated in right of payment to the 2025 Notes; equal in right of payment to any of our existing and future liabilities that are not so subordinated; effectively junior in right of payment to any of our secured indebtedness to the extent of the value of the assets securing such indebtedness; and structurally junior to all indebtedness and other liabilities (including trade payables) of our current or future subsidiaries.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2021, we entered into exchange agreements with certain holders of the 2025 Notes, pursuant to which the holders exchanged $55.4 million in aggregate principal amount of the outstanding 2025 Notes for 19,051,270 shares of our Common Stock (the “Exchange”). We recorded an $11.1 million non-cash loss related to the Exchange during the second quarter of 2021.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In conjunction with the issuance of the 2025 Notes, we agreed to loan up to 30,000,000 shares of our Common Stock to affiliates of the underwriter in order to assist investors in the 2025 Notes to hedge their position. Following consummation of the Exchange, the number of outstanding borrowed shares of Common Stock was reduced by approximately 8,105,175 shares. As of June 30, 2022 and December 31, 2021, a total of 21,144,825 and 21,144,825 shares remained outstanding under the share lending arrangement, respectively. We will not receive any of the proceeds from the sale of the borrowed shares, but we received a one-time nominal fee of $0.3 million for the newly issued shares. Shares of our Common Stock outstanding under the share lending arrangement are excluded from the calculation of basic and diluted earnings per share. See Note 4.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth information related to the 2025 Notes which is included in our Condensed Consolidated Balance Sheet as of June 30, 2022:</span></div><div style="margin-top:14pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:52.779%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.880%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.880%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.880%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.885%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2025 Senior Notes</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Discount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Debt Issuance Cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at December 31, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">144,580 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(22,747)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,473)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">119,360 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization of debt discount and debt issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">534 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">534 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adoption of ASU 2020-06</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,747 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,104)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21,643 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at June 30, 2022</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">144,580 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,043)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">141,537 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, the FASB issued ASU No. 2020-06, “Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity's Own Equity (Subtopic 815-40).” ASU 2020-06 simplifies the accounting for convertible instruments by reducing the number of accounting models for convertible debt instruments and convertible preferred stock. The ASU is effective for public entities for fiscal years beginning after December 15, 2021, with early adoption permitted. As required, we adopted ASU 2020-06 on January 1, 2022 and used the modified retrospective approach for all convertible debt instruments at the beginning of the period of adoptions. Results for reporting periods beginning January 1, 2022 are presented under ASU 2020-06, while prior period amounts were not adjusted and continue to be reported in accordance with historic accounting guidance. </span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the modified approach, entities will apply the guidance to all financial instruments that are outstanding as of the beginning of the year of adoption with the cumulative effect recognized as an adjustment to the opening balance of retained earnings. ASU 2020-06 eliminates the cash conversion and beneficial conversion feature models in ASC 470-20 that require an issuer of certain convertible debt and preferred stock to separately account for embedded conversion features as a component of equity. The adoption of ASU 2020-06 at January 1, 2022 resulted in an increase of the Convertible notes of $21.6 million, a reduction of the Accumulated deficit of $17.5 million and a reduction of Additional paid-in capital of $39.1 million.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2018, we issued a series of 5% Convertible Promissory Notes (the “2023 Convertible Notes”) in the aggregate principal amount of $55.0 million. The 2023 Convertible Notes mature five years following the date of issuance. Each holder of a 2023 Convertible Note has the option, from time to time, to convert all or any portion of the outstanding principal balance of such 2023 Convertible Note, together with accrued and unpaid interest thereon, into shares of our Common </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock at a conversion price of $5.00 per share. We may redeem all or any part of the then issued and outstanding 2023 Convertible Notes, together with accrued and unpaid interest thereon, pro rata among the holders, upon no fewer than 30 days, and no more than 60 days, notice to the holders. The 2023 Convertible Notes contain customary events of default and representations and warranties of OPKO. </span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Purchasers of the 2023 Convertible Notes included an affiliate of Dr. Phillip Frost, M.D., our Chairman and Chief Executive Officer, and Dr. Jane H. Hsiao, Ph.D., MBA, our Vice-Chairman and Chief Technical Officer. </span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2013, we entered into note purchase agreements with respect to the issuance and sale of our 3.0% Senior Notes due 2033 (the “2033 Senior Notes”) in a private placement exempt from registration under the Securities Act. We issued the 2033 Senior Notes on January 30, 2013. The 2033 Senior Notes, which totaled $175.0 million in original principal amount, bear interest at the rate of 3.0% per year, payable semiannually on February 1 and August 1 of each year. The 2033 Senior Notes mature on February 1, 2033, unless earlier repurchased, redeemed or converted. Upon a fundamental change, as defined in the indenture governing the 2033 Senior Notes, subject to certain exceptions, the holders may require us to repurchase all or any portion of their 2033 Senior Notes for cash at a repurchase price equal to 100% of the principal amount of the 2033 Senior Notes being repurchased, plus any accrued and unpaid interest to, but not including, the related fundamental change repurchase date.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From 2013 to 2016, holders of the 2033 Senior Notes converted $143.2 million in aggregate principal amount into an aggregate of 21,539,873 shares of Common Stock. On February 1, 2019, approximately $28.8 million aggregate principal amount of 2033 Senior Notes were tendered by holders pursuant to such holders’ option to require us to repurchase the 2033 Senior Notes as set forth in the indenture, governing the 2033 Senior Notes, following which repurchase only $3.0 million aggregate principal amount of the 2033 Senior Notes remained outstanding. Holders of the remaining $3.0 million principal amount of the 2033 Senior Notes may require us to repurchase such notes for 100% of their principal amount, plus accrued and unpaid interest, on February 1, 2023, on February 1, 2028, or following the occurrence of a fundamental change as described above. </span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The terms of the 2033 Senior Notes, include, among others: (i) rights to convert the notes into shares of our Common Stock, including upon a fundamental change; and (ii) a coupon make-whole payment in the event of a conversion by the holders of the 2033 Senior Notes on or after February 1, 2017 but prior to February 1, 2019. We determined that these specific terms were embedded derivatives. Embedded derivatives are required to be separated from the host contract, the 2033 Senior Notes, and carried at fair value when: (a) the embedded derivative possesses economic characteristics that are not clearly and closely related to the economic characteristics of the host contract; and (b) a separate, stand-alone instrument with the same terms would qualify as a derivative instrument. We concluded that the embedded derivatives within the 2033 Senior Notes met these criteria and, as such, were valued separate and apart from the 2033 Senior Notes and recorded at fair value each reporting period.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For accounting and financial reporting purposes, we combined these embedded derivatives and valued them together as one unit of accounting. In 2017, certain terms of the embedded derivatives expired pursuant to the original agreement and the embedded derivatives no longer met the criteria to be separated from the host contract and, as a result, the embedded derivatives were no longer required to be valued separate and apart from the 2033 Senior Notes and were reclassified to additional paid in capital. </span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2015, BioReference and certain of its subsidiaries entered into a credit agreement with JPMorgan Chase Bank, N.A. (“CB”), as lender and administrative agent, as amended (the “Credit Agreement”). As amended, the Credit Agreement provides for a $75.0 million secured revolving credit facility and includes a $20.0 million sub-facility for swingline loans and a $20.0 million sub-facility for the issuance of letters of credit. </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Credit Agreement is guaranteed by all of BioReference’s domestic subsidiaries and is also secured by substantially all assets of BioReference and its domestic subsidiaries, as well as a non-recourse pledge by us of our equity interest in BioReference. Availability under the Credit Agreement is based on a borrowing base composed of eligible accounts receivables of BioReference and certain of its subsidiaries, as specified therein. As of June 30, 2022, $53.1 million remained available for borrowing under the Credit Agreement. Principal under the Credit Agreement is due upon maturity on August 30, 2024. </span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">At BioReference’s option, borrowings under the Credit Agreement (other than swingline loans) bear interest at (i) the CB floating rate (defined as the higher of (a) the prime rate and (b) the LIBOR rate (adjusted for statutory reserve requirements for Eurocurrency liabilities) for an interest period of one month plus 2.50%) plus an applicable margin of 0.75% or (ii) the LIBOR rate (adjusted for statutory reserve requirements for Eurocurrency liabilities) plus an applicable margin of 1.75%. Swingline loans will bear interest at the CB floating rate plus the applicable margin. The Credit Agreement also calls for other customary </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">fees and charges, including an unused commitment fee of 0.375% if the average quarterly availability is 50% or more of the revolving commitment, or 0.25% if the average quarterly availability is less than or equal to 50% of the revolving commitments. </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">As of June 30, 2022 and December 31, 2021, $2.9 million and no amount, respectively, was outstanding under the Credit Agreement.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Credit Agreement contains customary covenants and restrictions, including, without limitation, covenants that require BioReference and its subsidiaries to maintain a minimum fixed charge coverage ratio if availability under the new credit facility falls below a specified amount and to comply with laws and restrictions on the ability of BioReference and its subsidiaries to incur additional indebtedness or to pay dividends and make certain other distributions to the Company, subject to certain exceptions as specified therein. Failure to comply with these covenants would constitute an event of default under the Credit Agreement, notwithstanding the ability of BioReference to meet its debt service obligations. The Credit Agreement also includes various customary remedies for the lenders following an event of default, including the acceleration of repayment of outstanding amounts under the Credit Agreement and execution upon the collateral securing obligations under the Credit Agreement. Substantially all the assets of BioReference and its subsidiaries are restricted from sale, transfer, lease, disposal or distributions to the Company, subject to certain exceptions. As of June 30, 2022, BioReference and its subsidiaries had net assets of approximately $680.0 million, which included goodwill of $283.0 million and intangible assets of $195.9 million.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On April 29, 2022, the Credit Agreement was amended to, among other things, (i) waive specified defaults under the Credit Agreement resulting from certain internal reorganization transactions that resulted in both BioReference and GeneDx changing their respective forms of organization from New Jersey corporations to Delaware limited liability companies, (ii) provide for the disposition of GeneDx pursuant to the transactions contemplated by the GeneDx Merger Agreement, (iii) amend certain reporting requirements under the Credit Agreement and (iv) provide that the borrowers under the Credit Agreement may effect certain restricted payments to the extent necessary for their parent entities to pay income tax in respect of income earned by the borrowers. </span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the Credit Agreement, we had line of credit agreements with thirteen other financial institutions as of June 30, 2022 and eleven other financial institutions as of December 31, 2021 in the U.S., Chile and Spain. These lines of credit are used primarily as sources of working capital for inventory purchases.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the amounts outstanding under the BioReference, Chilean and Spanish lines of credit:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:39.575%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.996%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.996%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.996%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.001%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(Dollars in thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> Balance Outstanding</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Lender</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest rate on borrowings at June 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Credit line<br/>capacity</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">June 30,<br/>2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">JPMorgan Chase</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.25%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">75,000 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,867 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Itau Bank</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.50%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,900 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,293 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,603 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Bank of Chile</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.60%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,500 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,452 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,048 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">BICE Bank</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.50%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,500 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,499 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">850 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Scotiabank</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.00%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,500 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,560 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">567 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Santander Bank</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.50%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,000 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,467 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">503 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Security Bank</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.50%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,400 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,111 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Estado Bank</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.50%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,000 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,682 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,540 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">BCI Bank</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.00%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,500 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,400 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,515 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Corpbanca</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.00%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,935 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">International Bank</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.50%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,500 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">845 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Consoorcio Bank</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.00%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,000 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,151 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Banco De Sabadell</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.75%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">522 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Santander Bank</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.15%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">522 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">104,844 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,218 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,672 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:4pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For both June 30, 2022 and December 31, 2021, the weighted average interest rate on our lines of credit was approximately 5.4%.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At June 30, 2022 and December 31, 2021, we had notes payable and other debt (excluding the 2033 Senior Notes, the 2023 Convertible Notes, the 2025 Notes, the Credit Agreement and amounts outstanding under lines of credit described above) as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:59.163%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.401%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.403%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">June 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of notes payable</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">771 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,022 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,984 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,642 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,755 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,664 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>The notes and other debt mature at various dates ranging from 2022 through 2026, bearing variable interest rates from 0.7% up to 3.8%. The weighted average interest rate on the notes and other debt was 1.5% on both June 30, 2022 and December 31, 2021. The notes are partially secured by our office space in Barcelona.
</us-gaap:DebtDisclosureTextBlock>
<us-gaap:ScheduleOfDebtTableTextBlock contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81OC9mcmFnOjdlMWE2NDBlMDg3ODQ4MjA5MjY1Y2QwY2E4ZTlhYTg0L3RleHRyZWdpb246N2UxYTY0MGUwODc4NDgyMDkyNjVjZDBjYThlOWFhODRfMTgxNDQ_6a79ff8e-b468-4a5e-a8e8-87c8ee8a0937">
<div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June 30, 2022 and December 31, 2021, our debt consisted of the following:</span></div><div style="margin-top:9pt;text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.104%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.005%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.007%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">June 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2025 Notes</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">141,537 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">119,360 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023 Convertible Notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">66,889 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">65,525 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2033 Senior Notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,050 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,050 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">JP Morgan Chase</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,867 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Chilean and Spanish lines of credit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,351 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,672 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current portion of notes payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">771 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,022 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long term portion of notes payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,984 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,642 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">232,449 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">205,272 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance sheet captions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Convertible Notes</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">211,477 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">187,935 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current portion of lines of credit and notes payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,989 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,695 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">LT notes payable included in long-term liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,984 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,642 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">232,449 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">205,272 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>
</us-gaap:ScheduleOfDebtTableTextBlock>
<us-gaap:LongTermDebt contextRef="i151ab0dd04b3481fb9699222fcf20168_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81OC9mcmFnOjdlMWE2NDBlMDg3ODQ4MjA5MjY1Y2QwY2E4ZTlhYTg0L3RhYmxlOjAzZjQ2ZjFkMTQ5NTQ2MTY4NWFjM2VjNWIyMmUzNzRhL3RhYmxlcmFuZ2U6MDNmNDZmMWQxNDk1NDYxNjg1YWMzZWM1YjIyZTM3NGFfMS0xLTEtMS00ODE2NA_66ad18ef-46b2-45c1-a51c-1513b1b8de54" unitRef="usd"> 141537000 </us-gaap:LongTermDebt>
<us-gaap:LongTermDebt contextRef="i4efdf654d84c4d7688276f9207347029_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81OC9mcmFnOjdlMWE2NDBlMDg3ODQ4MjA5MjY1Y2QwY2E4ZTlhYTg0L3RhYmxlOjAzZjQ2ZjFkMTQ5NTQ2MTY4NWFjM2VjNWIyMmUzNzRhL3RhYmxlcmFuZ2U6MDNmNDZmMWQxNDk1NDYxNjg1YWMzZWM1YjIyZTM3NGFfMS0zLTEtMS00ODE2NA_41bf99fa-3e48-4ad5-9244-b2ecc9d8ecf1" unitRef="usd"> 119360000 </us-gaap:LongTermDebt>
<us-gaap:LongTermDebt contextRef="i545b69ea550943f383e91660d1351a32_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81OC9mcmFnOjdlMWE2NDBlMDg3ODQ4MjA5MjY1Y2QwY2E4ZTlhYTg0L3RhYmxlOjAzZjQ2ZjFkMTQ5NTQ2MTY4NWFjM2VjNWIyMmUzNzRhL3RhYmxlcmFuZ2U6MDNmNDZmMWQxNDk1NDYxNjg1YWMzZWM1YjIyZTM3NGFfMi0xLTEtMS00ODE2NA_ee070aa7-3ae2-411c-a3f5-a4e47496c214" unitRef="usd"> 66889000 </us-gaap:LongTermDebt>
<us-gaap:LongTermDebt contextRef="id441ab2a289c4a5d92325001746be946_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81OC9mcmFnOjdlMWE2NDBlMDg3ODQ4MjA5MjY1Y2QwY2E4ZTlhYTg0L3RhYmxlOjAzZjQ2ZjFkMTQ5NTQ2MTY4NWFjM2VjNWIyMmUzNzRhL3RhYmxlcmFuZ2U6MDNmNDZmMWQxNDk1NDYxNjg1YWMzZWM1YjIyZTM3NGFfMi0zLTEtMS00ODE2NA_c15ca2a1-c30a-4668-bd4a-1bb63bafe225" unitRef="usd"> 65525000 </us-gaap:LongTermDebt>
<us-gaap:LongTermDebt contextRef="iaa9313f365864c73929898dbbfd8cc12_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81OC9mcmFnOjdlMWE2NDBlMDg3ODQ4MjA5MjY1Y2QwY2E4ZTlhYTg0L3RhYmxlOjAzZjQ2ZjFkMTQ5NTQ2MTY4NWFjM2VjNWIyMmUzNzRhL3RhYmxlcmFuZ2U6MDNmNDZmMWQxNDk1NDYxNjg1YWMzZWM1YjIyZTM3NGFfMy0xLTEtMS00ODE2NA_c6ce5798-0516-4ce0-8bb4-0cd11535de47" unitRef="usd"> 3050000 </us-gaap:LongTermDebt>
<us-gaap:LongTermDebt contextRef="i5e346875c2a14be79c94a0ea3d5b0ec1_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81OC9mcmFnOjdlMWE2NDBlMDg3ODQ4MjA5MjY1Y2QwY2E4ZTlhYTg0L3RhYmxlOjAzZjQ2ZjFkMTQ5NTQ2MTY4NWFjM2VjNWIyMmUzNzRhL3RhYmxlcmFuZ2U6MDNmNDZmMWQxNDk1NDYxNjg1YWMzZWM1YjIyZTM3NGFfMy0zLTEtMS00ODE2NA_fd16c747-b048-45f4-91be-7a6292a0a7d1" unitRef="usd"> 3050000 </us-gaap:LongTermDebt>
<us-gaap:LongTermDebt contextRef="ic9f69debfc1749da97c5998f7384fdc1_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81OC9mcmFnOjdlMWE2NDBlMDg3ODQ4MjA5MjY1Y2QwY2E4ZTlhYTg0L3RhYmxlOjAzZjQ2ZjFkMTQ5NTQ2MTY4NWFjM2VjNWIyMmUzNzRhL3RhYmxlcmFuZ2U6MDNmNDZmMWQxNDk1NDYxNjg1YWMzZWM1YjIyZTM3NGFfNC0xLTEtMS00ODE2NA_b4a1a5b8-65dd-4a54-a534-6aa856667a64" unitRef="usd"> 2867000 </us-gaap:LongTermDebt>
<us-gaap:LongTermDebt contextRef="id62e921fa70e48b8bcd0517e930bbf99_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81OC9mcmFnOjdlMWE2NDBlMDg3ODQ4MjA5MjY1Y2QwY2E4ZTlhYTg0L3RhYmxlOjAzZjQ2ZjFkMTQ5NTQ2MTY4NWFjM2VjNWIyMmUzNzRhL3RhYmxlcmFuZ2U6MDNmNDZmMWQxNDk1NDYxNjg1YWMzZWM1YjIyZTM3NGFfNC0zLTEtMS00ODE2NA_a5090164-3318-4d6d-87c0-633835a5e6ed" unitRef="usd"> 0 </us-gaap:LongTermDebt>
<us-gaap:LongTermDebt contextRef="ic0a23d2a2b9748de8fc661ffee37ea8e_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81OC9mcmFnOjdlMWE2NDBlMDg3ODQ4MjA5MjY1Y2QwY2E4ZTlhYTg0L3RhYmxlOjAzZjQ2ZjFkMTQ5NTQ2MTY4NWFjM2VjNWIyMmUzNzRhL3RhYmxlcmFuZ2U6MDNmNDZmMWQxNDk1NDYxNjg1YWMzZWM1YjIyZTM3NGFfNS0xLTEtMS00ODE2NA_1e00634f-5c5f-4ad9-aa3c-2b10267813cc" unitRef="usd"> 15351000 </us-gaap:LongTermDebt>
<us-gaap:LongTermDebt contextRef="ifc4a073257294a89b0fae4e5d964a900_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81OC9mcmFnOjdlMWE2NDBlMDg3ODQ4MjA5MjY1Y2QwY2E4ZTlhYTg0L3RhYmxlOjAzZjQ2ZjFkMTQ5NTQ2MTY4NWFjM2VjNWIyMmUzNzRhL3RhYmxlcmFuZ2U6MDNmNDZmMWQxNDk1NDYxNjg1YWMzZWM1YjIyZTM3NGFfNS0zLTEtMS00ODE2NA_ff6237d5-8c53-40d4-bc44-d4a9b5711af2" unitRef="usd"> 13672000 </us-gaap:LongTermDebt>
<us-gaap:LongTermDebtCurrent contextRef="ia01691970d624340948847c83273440d_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81OC9mcmFnOjdlMWE2NDBlMDg3ODQ4MjA5MjY1Y2QwY2E4ZTlhYTg0L3RhYmxlOjAzZjQ2ZjFkMTQ5NTQ2MTY4NWFjM2VjNWIyMmUzNzRhL3RhYmxlcmFuZ2U6MDNmNDZmMWQxNDk1NDYxNjg1YWMzZWM1YjIyZTM3NGFfNi0xLTEtMS00ODE2NA_f896273d-c40d-44f3-9eb9-39c9880e458c" unitRef="usd"> 771000 </us-gaap:LongTermDebtCurrent>
<us-gaap:LongTermDebtCurrent contextRef="i6c8fc69a7d8d49cf8d3016e333b33f00_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81OC9mcmFnOjdlMWE2NDBlMDg3ODQ4MjA5MjY1Y2QwY2E4ZTlhYTg0L3RhYmxlOjAzZjQ2ZjFkMTQ5NTQ2MTY4NWFjM2VjNWIyMmUzNzRhL3RhYmxlcmFuZ2U6MDNmNDZmMWQxNDk1NDYxNjg1YWMzZWM1YjIyZTM3NGFfNi0zLTEtMS00ODE2NA_f0f1c667-ca1d-4acd-851d-7092470858b1" unitRef="usd"> 1022000 </us-gaap:LongTermDebtCurrent>
<us-gaap:LongTermDebtNoncurrent contextRef="ia01691970d624340948847c83273440d_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81OC9mcmFnOjdlMWE2NDBlMDg3ODQ4MjA5MjY1Y2QwY2E4ZTlhYTg0L3RhYmxlOjAzZjQ2ZjFkMTQ5NTQ2MTY4NWFjM2VjNWIyMmUzNzRhL3RhYmxlcmFuZ2U6MDNmNDZmMWQxNDk1NDYxNjg1YWMzZWM1YjIyZTM3NGFfNy0xLTEtMS00ODE2NA_9ea87054-e3ee-4f3e-8f00-10358536a3d3" unitRef="usd"> 1984000 </us-gaap:LongTermDebtNoncurrent>
<us-gaap:LongTermDebtNoncurrent contextRef="i6c8fc69a7d8d49cf8d3016e333b33f00_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81OC9mcmFnOjdlMWE2NDBlMDg3ODQ4MjA5MjY1Y2QwY2E4ZTlhYTg0L3RhYmxlOjAzZjQ2ZjFkMTQ5NTQ2MTY4NWFjM2VjNWIyMmUzNzRhL3RhYmxlcmFuZ2U6MDNmNDZmMWQxNDk1NDYxNjg1YWMzZWM1YjIyZTM3NGFfNy0zLTEtMS00ODE2NA_ccb9890e-f155-43d6-80fe-f16516082099" unitRef="usd"> 2642000 </us-gaap:LongTermDebtNoncurrent>
<us-gaap:LongTermDebt contextRef="i4768f885851b49f986857a2a956f9162_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81OC9mcmFnOjdlMWE2NDBlMDg3ODQ4MjA5MjY1Y2QwY2E4ZTlhYTg0L3RhYmxlOjAzZjQ2ZjFkMTQ5NTQ2MTY4NWFjM2VjNWIyMmUzNzRhL3RhYmxlcmFuZ2U6MDNmNDZmMWQxNDk1NDYxNjg1YWMzZWM1YjIyZTM3NGFfOC0xLTEtMS00ODE2NA_e88eb718-cefb-4ea6-a64a-7644455b4b94" unitRef="usd"> 232449000 </us-gaap:LongTermDebt>
<us-gaap:LongTermDebt contextRef="i7e0f479bead144b0bdbcc71082db627b_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81OC9mcmFnOjdlMWE2NDBlMDg3ODQ4MjA5MjY1Y2QwY2E4ZTlhYTg0L3RhYmxlOjAzZjQ2ZjFkMTQ5NTQ2MTY4NWFjM2VjNWIyMmUzNzRhL3RhYmxlcmFuZ2U6MDNmNDZmMWQxNDk1NDYxNjg1YWMzZWM1YjIyZTM3NGFfOC0zLTEtMS00ODE2NA_66b50ff4-a25c-430c-9e33-0face919615a" unitRef="usd"> 205272000 </us-gaap:LongTermDebt>
<us-gaap:LongTermDebt contextRef="i2bc99c77452b4f53ba5c749761fbfb98_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81OC9mcmFnOjdlMWE2NDBlMDg3ODQ4MjA5MjY1Y2QwY2E4ZTlhYTg0L3RhYmxlOjAzZjQ2ZjFkMTQ5NTQ2MTY4NWFjM2VjNWIyMmUzNzRhL3RhYmxlcmFuZ2U6MDNmNDZmMWQxNDk1NDYxNjg1YWMzZWM1YjIyZTM3NGFfMTEtMS0xLTEtNDgxNjQ_047ddebb-ce34-491f-bb09-4563e8ebd850" unitRef="usd"> 211477000 </us-gaap:LongTermDebt>
<us-gaap:LongTermDebt contextRef="i286b350a85e94dbda1c1fbe93da8ec3f_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81OC9mcmFnOjdlMWE2NDBlMDg3ODQ4MjA5MjY1Y2QwY2E4ZTlhYTg0L3RhYmxlOjAzZjQ2ZjFkMTQ5NTQ2MTY4NWFjM2VjNWIyMmUzNzRhL3RhYmxlcmFuZ2U6MDNmNDZmMWQxNDk1NDYxNjg1YWMzZWM1YjIyZTM3NGFfMTEtMy0xLTEtNDgxNjQ_17ee820f-2aa8-44ba-b320-8d0bc0f6d6d4" unitRef="usd"> 187935000 </us-gaap:LongTermDebt>
<us-gaap:LongTermDebt contextRef="i08bce415af5648368d40c1e9504721af_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81OC9mcmFnOjdlMWE2NDBlMDg3ODQ4MjA5MjY1Y2QwY2E4ZTlhYTg0L3RhYmxlOjAzZjQ2ZjFkMTQ5NTQ2MTY4NWFjM2VjNWIyMmUzNzRhL3RhYmxlcmFuZ2U6MDNmNDZmMWQxNDk1NDYxNjg1YWMzZWM1YjIyZTM3NGFfMTItMS0xLTEtNDgxNjQ_ae328073-aac7-4604-ac93-b7e097b73143" unitRef="usd"> 18989000 </us-gaap:LongTermDebt>
<us-gaap:LongTermDebt contextRef="i2f7ea3469cb440b494ef76cac5c2e8b7_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81OC9mcmFnOjdlMWE2NDBlMDg3ODQ4MjA5MjY1Y2QwY2E4ZTlhYTg0L3RhYmxlOjAzZjQ2ZjFkMTQ5NTQ2MTY4NWFjM2VjNWIyMmUzNzRhL3RhYmxlcmFuZ2U6MDNmNDZmMWQxNDk1NDYxNjg1YWMzZWM1YjIyZTM3NGFfMTItMy0xLTEtNDgxNjQ_8ead3693-1d31-4bd4-a198-b1210498b46a" unitRef="usd"> 14695000 </us-gaap:LongTermDebt>
<us-gaap:LongTermDebt contextRef="i9527c584ee6e460bb59b851ee6b2385d_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81OC9mcmFnOjdlMWE2NDBlMDg3ODQ4MjA5MjY1Y2QwY2E4ZTlhYTg0L3RhYmxlOjAzZjQ2ZjFkMTQ5NTQ2MTY4NWFjM2VjNWIyMmUzNzRhL3RhYmxlcmFuZ2U6MDNmNDZmMWQxNDk1NDYxNjg1YWMzZWM1YjIyZTM3NGFfMTMtMS0xLTEtNDgxNjQ_c6a20825-e515-4a5c-b47a-36326fd278c7" unitRef="usd"> 1984000 </us-gaap:LongTermDebt>
<us-gaap:LongTermDebt contextRef="icd2fa1bdbc054e5ca0d1119b9283489e_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81OC9mcmFnOjdlMWE2NDBlMDg3ODQ4MjA5MjY1Y2QwY2E4ZTlhYTg0L3RhYmxlOjAzZjQ2ZjFkMTQ5NTQ2MTY4NWFjM2VjNWIyMmUzNzRhL3RhYmxlcmFuZ2U6MDNmNDZmMWQxNDk1NDYxNjg1YWMzZWM1YjIyZTM3NGFfMTMtMy0xLTEtNDgxNjQ_c6f91013-7eba-42de-9d57-bf5ce9a8b898" unitRef="usd"> 2642000 </us-gaap:LongTermDebt>
<us-gaap:LongTermDebt contextRef="i4768f885851b49f986857a2a956f9162_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81OC9mcmFnOjdlMWE2NDBlMDg3ODQ4MjA5MjY1Y2QwY2E4ZTlhYTg0L3RhYmxlOjAzZjQ2ZjFkMTQ5NTQ2MTY4NWFjM2VjNWIyMmUzNzRhL3RhYmxlcmFuZ2U6MDNmNDZmMWQxNDk1NDYxNjg1YWMzZWM1YjIyZTM3NGFfMTQtMS0xLTEtNDgxNjQ_3168e833-5c5a-439e-8a88-4f755225bb02" unitRef="usd"> 232449000 </us-gaap:LongTermDebt>
<us-gaap:LongTermDebt contextRef="i7e0f479bead144b0bdbcc71082db627b_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81OC9mcmFnOjdlMWE2NDBlMDg3ODQ4MjA5MjY1Y2QwY2E4ZTlhYTg0L3RhYmxlOjAzZjQ2ZjFkMTQ5NTQ2MTY4NWFjM2VjNWIyMmUzNzRhL3RhYmxlcmFuZ2U6MDNmNDZmMWQxNDk1NDYxNjg1YWMzZWM1YjIyZTM3NGFfMTQtMy0xLTEtNDgxNjQ_bb557230-4da1-4e82-99fa-7f0b561fbc91" unitRef="usd"> 205272000 </us-gaap:LongTermDebt>
<us-gaap:DebtInstrumentFaceAmount contextRef="i074565638db14b50ae97acdfc5c6aeaf_I20190228" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81OC9mcmFnOjdlMWE2NDBlMDg3ODQ4MjA5MjY1Y2QwY2E4ZTlhYTg0L3RleHRyZWdpb246N2UxYTY0MGUwODc4NDgyMDkyNjVjZDBjYThlOWFhODRfNTA1_4770b0b3-4d75-4960-8933-0e07d52e8583" unitRef="usd"> 200000000 </us-gaap:DebtInstrumentFaceAmount>
<us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="iacae9f4f1fed4a7d9cbb734bd178394b_I20190228" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81OC9mcmFnOjdlMWE2NDBlMDg3ODQ4MjA5MjY1Y2QwY2E4ZTlhYTg0L3RleHRyZWdpb246N2UxYTY0MGUwODc4NDgyMDkyNjVjZDBjYThlOWFhODRfNjcw_e1f08f56-2639-40ad-b3a3-be14ef4a767f" unitRef="number"> 0.0450 </us-gaap:DebtInstrumentInterestRateStatedPercentage>
<us-gaap:DebtInstrumentConvertibleThresholdTradingDays contextRef="ic7549257a4ef4d1a96574093d9e6df03_D20190201-20190228" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81OC9mcmFnOjdlMWE2NDBlMDg3ODQ4MjA5MjY1Y2QwY2E4ZTlhYTg0L3RleHRyZWdpb246N2UxYTY0MGUwODc4NDgyMDkyNjVjZDBjYThlOWFhODRfMTI3Mw_1391be3a-f164-48ac-b274-780c7cabe20d" unitRef="day"> 20 </us-gaap:DebtInstrumentConvertibleThresholdTradingDays>
<us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1 contextRef="i8494b4ff6e2f4657b1504a0722acf6ce_D20190201-20190228" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81OC9mcmFnOjdlMWE2NDBlMDg3ODQ4MjA5MjY1Y2QwY2E4ZTlhYTg0L3RleHRyZWdpb246N2UxYTY0MGUwODc4NDgyMDkyNjVjZDBjYThlOWFhODRfMTMzNw_9444e871-473d-4375-a967-011225e8a205" unitRef="day"> 30 </us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1>
<us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger contextRef="ia36206cec58a422eafdbb64775321560_D20190201-20190228" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81OC9mcmFnOjdlMWE2NDBlMDg3ODQ4MjA5MjY1Y2QwY2E4ZTlhYTg0L3RleHRyZWdpb246N2UxYTY0MGUwODc4NDgyMDkyNjVjZDBjYThlOWFhODRfMTQ3MA_4a14141d-5634-4d80-bf77-0222e45ac9a9" unitRef="number"> 1.30 </us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger>
<us-gaap:DebtInstrumentConvertibleThresholdTradingDays contextRef="ibfa24f105ca34a13bfb968d16a59e767_D20190201-20190228" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81OC9mcmFnOjdlMWE2NDBlMDg3ODQ4MjA5MjY1Y2QwY2E4ZTlhYTg0L3RleHRyZWdpb246N2UxYTY0MGUwODc4NDgyMDkyNjVjZDBjYThlOWFhODRfMTU0NA_268fc4a8-6e95-458d-abe3-59736f9e1233" unitRef="day"> 5 </us-gaap:DebtInstrumentConvertibleThresholdTradingDays>
<us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1 contextRef="ieea8bcf2f45a48698e5815a155f81004_D20190201-20190228" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81OC9mcmFnOjdlMWE2NDBlMDg3ODQ4MjA5MjY1Y2QwY2E4ZTlhYTg0L3RleHRyZWdpb246N2UxYTY0MGUwODc4NDgyMDkyNjVjZDBjYThlOWFhODRfMTU3Nw_3029bf71-7c4d-45cf-af3c-40b787d8ced4" unitRef="day"> 5 </us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1>
<us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger contextRef="ie3d1c7fac426448cb3f3648f46054f60_D20190201-20190228" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81OC9mcmFnOjdlMWE2NDBlMDg3ODQ4MjA5MjY1Y2QwY2E4ZTlhYTg0L3RleHRyZWdpb246N2UxYTY0MGUwODc4NDgyMDkyNjVjZDBjYThlOWFhODRfMTc2OA_af0b69e2-b13b-4e0f-a7f6-a0baa1463723" unitRef="number"> 0.98 </us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger>
<us-gaap:DebtInstrumentConvertibleConversionPrice1 contextRef="i074565638db14b50ae97acdfc5c6aeaf_I20190228" decimals="2" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81OC9mcmFnOjdlMWE2NDBlMDg3ODQ4MjA5MjY1Y2QwY2E4ZTlhYTg0L3RleHRyZWdpb246N2UxYTY0MGUwODc4NDgyMDkyNjVjZDBjYThlOWFhODRfMjc0NA_383c8a68-412a-428e-94ef-2cd876190a63" unitRef="usdPerShare"> 4.22 </us-gaap:DebtInstrumentConvertibleConversionPrice1>
<us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger contextRef="i7dcec7dfdeae4be998d97f1b318f9433_D20220101-20220630" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81OC9mcmFnOjdlMWE2NDBlMDg3ODQ4MjA5MjY1Y2QwY2E4ZTlhYTg0L3RleHRyZWdpb246N2UxYTY0MGUwODc4NDgyMDkyNjVjZDBjYThlOWFhODRfMzU1NQ_22f27a7b-1568-41da-9093-cabbf96f44dd" unitRef="number"> 1.30 </us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger>
<us-gaap:DebtInstrumentConvertibleThresholdTradingDays contextRef="i22f25b04b85c4d44bbe55e3c2bf93530_D20220101-20220630" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81OC9mcmFnOjdlMWE2NDBlMDg3ODQ4MjA5MjY1Y2QwY2E4ZTlhYTg0L3RleHRyZWdpb246N2UxYTY0MGUwODc4NDgyMDkyNjVjZDBjYThlOWFhODRfMzYyMg_9a5dec4a-25d6-4821-bd2d-bb7edca9f9c0" unitRef="day"> 20 </us-gaap:DebtInstrumentConvertibleThresholdTradingDays>
<us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1 contextRef="i2df390f6e40342238875ab8db49600de_D20220101-20220630" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81OC9mcmFnOjdlMWE2NDBlMDg3ODQ4MjA5MjY1Y2QwY2E4ZTlhYTg0L3RleHRyZWdpb246N2UxYTY0MGUwODc4NDgyMDkyNjVjZDBjYThlOWFhODRfMzY3OA_932badb9-2c34-4d5a-9ac6-efc031a11130" unitRef="day"> 30 </us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1>
<us-gaap:DebtInstrumentRedemptionPricePercentage contextRef="i7dcec7dfdeae4be998d97f1b318f9433_D20220101-20220630" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81OC9mcmFnOjdlMWE2NDBlMDg3ODQ4MjA5MjY1Y2QwY2E4ZTlhYTg0L3RleHRyZWdpb246N2UxYTY0MGUwODc4NDgyMDkyNjVjZDBjYThlOWFhODRfMzkwNQ_72a50acd-b685-4490-9175-b092ddd0bac9" unitRef="number"> 1 </us-gaap:DebtInstrumentRedemptionPricePercentage>
<us-gaap:DebtInstrumentRedemptionPricePercentage contextRef="ia36206cec58a422eafdbb64775321560_D20190201-20190228" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81OC9mcmFnOjdlMWE2NDBlMDg3ODQ4MjA5MjY1Y2QwY2E4ZTlhYTg0L3RleHRyZWdpb246N2UxYTY0MGUwODc4NDgyMDkyNjVjZDBjYThlOWFhODRfNDMzMA_1f346800-af6c-45b4-86dd-10d1e03a0593" unitRef="number"> 1 </us-gaap:DebtInstrumentRedemptionPricePercentage>
<us-gaap:DebtConversionConvertedInstrumentAmount1 contextRef="i04b77a20c73249288e12d7cc6ab35d1e_D20210501-20210531" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81OC9mcmFnOjdlMWE2NDBlMDg3ODQ4MjA5MjY1Y2QwY2E4ZTlhYTg0L3RleHRyZWdpb246N2UxYTY0MGUwODc4NDgyMDkyNjVjZDBjYThlOWFhODRfNTE3Mw_c3568a49-e964-4bd0-a69c-f9d34e27ee13" unitRef="usd"> 55400000 </us-gaap:DebtConversionConvertedInstrumentAmount1>
<us-gaap:DebtConversionConvertedInstrumentSharesIssued1 contextRef="i04b77a20c73249288e12d7cc6ab35d1e_D20210501-20210531" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81OC9mcmFnOjdlMWE2NDBlMDg3ODQ4MjA5MjY1Y2QwY2E4ZTlhYTg0L3RleHRyZWdpb246N2UxYTY0MGUwODc4NDgyMDkyNjVjZDBjYThlOWFhODRfNTI0MA_ac0b2ef9-25b4-4022-b71d-2b49a26885b0" unitRef="shares"> 19051270 </us-gaap:DebtConversionConvertedInstrumentSharesIssued1>
<opk:GainLossOnConversionOfDebt contextRef="i04b77a20c73249288e12d7cc6ab35d1e_D20210501-20210531" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81OC9mcmFnOjdlMWE2NDBlMDg3ODQ4MjA5MjY1Y2QwY2E4ZTlhYTg0L3RleHRyZWdpb246N2UxYTY0MGUwODc4NDgyMDkyNjVjZDBjYThlOWFhODRfNTMwMw_75a47e1b-8f90-4d84-8f0f-ae4674de1c46" unitRef="usd"> -11100000 </opk:GainLossOnConversionOfDebt>
<opk:DebtInstrumentConvertibleDebtMaximumSharesIssuable contextRef="i074565638db14b50ae97acdfc5c6aeaf_I20190228" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81OC9mcmFnOjdlMWE2NDBlMDg3ODQ4MjA5MjY1Y2QwY2E4ZTlhYTg0L3RleHRyZWdpb246N2UxYTY0MGUwODc4NDgyMDkyNjVjZDBjYThlOWFhODRfNTQ1NQ_ce23c9a2-47bc-469b-84b8-a494dca5209e" unitRef="shares"> 30000000 </opk:DebtInstrumentConvertibleDebtMaximumSharesIssuable>
<opk:DebtInstrumentConvertibleDebtIncreaseDecreaseInMaximumSharesIssuable contextRef="i04b77a20c73249288e12d7cc6ab35d1e_D20210501-20210531" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81OC9mcmFnOjdlMWE2NDBlMDg3ODQ4MjA5MjY1Y2QwY2E4ZTlhYTg0L3RleHRyZWdpb246N2UxYTY0MGUwODc4NDgyMDkyNjVjZDBjYThlOWFhODRfNTcxNw_b99cbad8-6e65-4766-8437-15fe0ef2d42f" unitRef="shares"> -8105175 </opk:DebtInstrumentConvertibleDebtIncreaseDecreaseInMaximumSharesIssuable>
<us-gaap:DebtConversionConvertedInstrumentSharesIssued1 contextRef="ic07e78aa482c4bbc874a70c2e542f37e_D20220101-20220630" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81OC9mcmFnOjdlMWE2NDBlMDg3ODQ4MjA5MjY1Y2QwY2E4ZTlhYTg0L3RleHRyZWdpb246N2UxYTY0MGUwODc4NDgyMDkyNjVjZDBjYThlOWFhODRfNTc3MQ_a874a4c1-9590-4b03-ab48-c042ab535afe" unitRef="shares"> 21144825 </us-gaap:DebtConversionConvertedInstrumentSharesIssued1>
<us-gaap:DebtConversionConvertedInstrumentSharesIssued1 contextRef="i5fc13571b11d4722895953bcfbe46938_D20210101-20211231" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81OC9mcmFnOjdlMWE2NDBlMDg3ODQ4MjA5MjY1Y2QwY2E4ZTlhYTg0L3RleHRyZWdpb246N2UxYTY0MGUwODc4NDgyMDkyNjVjZDBjYThlOWFhODRfNTc3OA_566a841f-6189-4684-8f5b-f4fc1ccb05e1" unitRef="shares"> 21144825 </us-gaap:DebtConversionConvertedInstrumentSharesIssued1>
<opk:ProceedsFromConvertibleDebtConversionFee contextRef="ic07e78aa482c4bbc874a70c2e542f37e_D20220101-20220630" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81OC9mcmFnOjdlMWE2NDBlMDg3ODQ4MjA5MjY1Y2QwY2E4ZTlhYTg0L3RleHRyZWdpb246N2UxYTY0MGUwODc4NDgyMDkyNjVjZDBjYThlOWFhODRfNTk4MA_569448e6-278f-467e-b48a-ead64925a8ba" unitRef="usd"> 300000 </opk:ProceedsFromConvertibleDebtConversionFee>
<us-gaap:ScheduleOfDebtInstrumentsTextBlock contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81OC9mcmFnOjdlMWE2NDBlMDg3ODQ4MjA5MjY1Y2QwY2E4ZTlhYTg0L3RleHRyZWdpb246N2UxYTY0MGUwODc4NDgyMDkyNjVjZDBjYThlOWFhODRfMTgxNDE_ec207d52-197b-4e4f-a3ed-0fcb4bef7a76">
<div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth information related to the 2025 Notes which is included in our Condensed Consolidated Balance Sheet as of June 30, 2022:</span></div><div style="margin-top:14pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:52.779%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.880%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.880%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.880%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.885%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2025 Senior Notes</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Discount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Debt Issuance Cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at December 31, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">144,580 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(22,747)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,473)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">119,360 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization of debt discount and debt issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">534 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">534 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adoption of ASU 2020-06</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,747 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,104)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21,643 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at June 30, 2022</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">144,580 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,043)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">141,537 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At June 30, 2022 and December 31, 2021, we had notes payable and other debt (excluding the 2033 Senior Notes, the 2023 Convertible Notes, the 2025 Notes, the Credit Agreement and amounts outstanding under lines of credit described above) as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:59.163%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.401%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.403%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">June 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of notes payable</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">771 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,022 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,984 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,642 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,755 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,664 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>
</us-gaap:ScheduleOfDebtInstrumentsTextBlock>
<us-gaap:DebtInstrumentCarryingAmount contextRef="i066796790696499cb2b9834b409c969e_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81OC9mcmFnOjdlMWE2NDBlMDg3ODQ4MjA5MjY1Y2QwY2E4ZTlhYTg0L3RhYmxlOjgzZGUzOTA5NTc1NjQ2NDE4M2IzMDNjYjc0M2M4YzdhL3RhYmxlcmFuZ2U6ODNkZTM5MDk1NzU2NDY0MTgzYjMwM2NiNzQzYzhjN2FfMS0xLTEtMS00ODE2NA_a2203b5e-61e9-416e-a59c-87b5c7ac798e" unitRef="usd"> 144580000 </us-gaap:DebtInstrumentCarryingAmount>
<us-gaap:DebtInstrumentUnamortizedDiscount contextRef="i066796790696499cb2b9834b409c969e_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81OC9mcmFnOjdlMWE2NDBlMDg3ODQ4MjA5MjY1Y2QwY2E4ZTlhYTg0L3RhYmxlOjgzZGUzOTA5NTc1NjQ2NDE4M2IzMDNjYjc0M2M4YzdhL3RhYmxlcmFuZ2U6ODNkZTM5MDk1NzU2NDY0MTgzYjMwM2NiNzQzYzhjN2FfMS0zLTEtMS00ODE2NA_9537f548-7e8c-49ec-9ec8-4c972f136c7f" unitRef="usd"> 22747000 </us-gaap:DebtInstrumentUnamortizedDiscount>
<us-gaap:DeferredFinanceCostsNet contextRef="i066796790696499cb2b9834b409c969e_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81OC9mcmFnOjdlMWE2NDBlMDg3ODQ4MjA5MjY1Y2QwY2E4ZTlhYTg0L3RhYmxlOjgzZGUzOTA5NTc1NjQ2NDE4M2IzMDNjYjc0M2M4YzdhL3RhYmxlcmFuZ2U6ODNkZTM5MDk1NzU2NDY0MTgzYjMwM2NiNzQzYzhjN2FfMS01LTEtMS00ODE2NA_ca5edfbf-474a-4769-93bb-de177699ba20" unitRef="usd"> 2473000 </us-gaap:DeferredFinanceCostsNet>
<us-gaap:LongTermDebt contextRef="i066796790696499cb2b9834b409c969e_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81OC9mcmFnOjdlMWE2NDBlMDg3ODQ4MjA5MjY1Y2QwY2E4ZTlhYTg0L3RhYmxlOjgzZGUzOTA5NTc1NjQ2NDE4M2IzMDNjYjc0M2M4YzdhL3RhYmxlcmFuZ2U6ODNkZTM5MDk1NzU2NDY0MTgzYjMwM2NiNzQzYzhjN2FfMS03LTEtMS00ODE2NA_0f23c924-d416-4318-9ef9-4c92e170140b" unitRef="usd"> 119360000 </us-gaap:LongTermDebt>
<us-gaap:AmortizationOfDebtDiscountPremium contextRef="i40a7fd1ae9844d22adbba23face78713_D20220101-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81OC9mcmFnOjdlMWE2NDBlMDg3ODQ4MjA5MjY1Y2QwY2E4ZTlhYTg0L3RhYmxlOjgzZGUzOTA5NTc1NjQ2NDE4M2IzMDNjYjc0M2M4YzdhL3RhYmxlcmFuZ2U6ODNkZTM5MDk1NzU2NDY0MTgzYjMwM2NiNzQzYzhjN2FfMy0zLTEtMS00ODE2NA_4bcdc058-7113-45e0-9092-b99bc40dbfb2" unitRef="usd"> 0 </us-gaap:AmortizationOfDebtDiscountPremium>
<us-gaap:AmortizationOfFinancingCosts contextRef="i40a7fd1ae9844d22adbba23face78713_D20220101-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81OC9mcmFnOjdlMWE2NDBlMDg3ODQ4MjA5MjY1Y2QwY2E4ZTlhYTg0L3RhYmxlOjgzZGUzOTA5NTc1NjQ2NDE4M2IzMDNjYjc0M2M4YzdhL3RhYmxlcmFuZ2U6ODNkZTM5MDk1NzU2NDY0MTgzYjMwM2NiNzQzYzhjN2FfMy01LTEtMS00ODE2NA_a81fd9dd-2eae-4ce9-a44f-bf75c2eb25d0" unitRef="usd"> 534000 </us-gaap:AmortizationOfFinancingCosts>
<us-gaap:AmortizationOfFinancingCostsAndDiscounts contextRef="i40a7fd1ae9844d22adbba23face78713_D20220101-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81OC9mcmFnOjdlMWE2NDBlMDg3ODQ4MjA5MjY1Y2QwY2E4ZTlhYTg0L3RhYmxlOjgzZGUzOTA5NTc1NjQ2NDE4M2IzMDNjYjc0M2M4YzdhL3RhYmxlcmFuZ2U6ODNkZTM5MDk1NzU2NDY0MTgzYjMwM2NiNzQzYzhjN2FfMy03LTEtMS00ODE2NA_1c2e65d8-dacb-4767-98f7-b1a40470901a" unitRef="usd"> 534000 </us-gaap:AmortizationOfFinancingCostsAndDiscounts>
<us-gaap:DebtInstrumentCarryingAmount contextRef="icf03735524d949168f73504e648fc104_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81OC9mcmFnOjdlMWE2NDBlMDg3ODQ4MjA5MjY1Y2QwY2E4ZTlhYTg0L3RhYmxlOjgzZGUzOTA5NTc1NjQ2NDE4M2IzMDNjYjc0M2M4YzdhL3RhYmxlcmFuZ2U6ODNkZTM5MDk1NzU2NDY0MTgzYjMwM2NiNzQzYzhjN2FfNS0xLTEtMS00ODE2NA_c2d60779-ad88-4252-9c7e-aa852f20cb02" unitRef="usd"> 0 </us-gaap:DebtInstrumentCarryingAmount>
<us-gaap:DebtInstrumentUnamortizedDiscount contextRef="icf03735524d949168f73504e648fc104_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81OC9mcmFnOjdlMWE2NDBlMDg3ODQ4MjA5MjY1Y2QwY2E4ZTlhYTg0L3RhYmxlOjgzZGUzOTA5NTc1NjQ2NDE4M2IzMDNjYjc0M2M4YzdhL3RhYmxlcmFuZ2U6ODNkZTM5MDk1NzU2NDY0MTgzYjMwM2NiNzQzYzhjN2FfNS0zLTEtMS00ODE2NA_19b49fa2-15eb-4ea3-ad88-3aaa3b7b8e4d" unitRef="usd"> -22747000 </us-gaap:DebtInstrumentUnamortizedDiscount>
<us-gaap:DeferredFinanceCostsNet contextRef="icf03735524d949168f73504e648fc104_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81OC9mcmFnOjdlMWE2NDBlMDg3ODQ4MjA5MjY1Y2QwY2E4ZTlhYTg0L3RhYmxlOjgzZGUzOTA5NTc1NjQ2NDE4M2IzMDNjYjc0M2M4YzdhL3RhYmxlcmFuZ2U6ODNkZTM5MDk1NzU2NDY0MTgzYjMwM2NiNzQzYzhjN2FfNS01LTEtMS00ODE2NA_b0c3de19-d59a-42b6-8b49-66f59d1df223" unitRef="usd"> 1104000 </us-gaap:DeferredFinanceCostsNet>
<us-gaap:LongTermDebt contextRef="icf03735524d949168f73504e648fc104_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81OC9mcmFnOjdlMWE2NDBlMDg3ODQ4MjA5MjY1Y2QwY2E4ZTlhYTg0L3RhYmxlOjgzZGUzOTA5NTc1NjQ2NDE4M2IzMDNjYjc0M2M4YzdhL3RhYmxlcmFuZ2U6ODNkZTM5MDk1NzU2NDY0MTgzYjMwM2NiNzQzYzhjN2FfNS03LTEtMS00ODE2NA_60a5c6cc-fe3d-434a-b220-3308a838f609" unitRef="usd"> 21643000 </us-gaap:LongTermDebt>
<us-gaap:DebtInstrumentCarryingAmount contextRef="i2f8779c083c44285914f38702ee04ee0_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81OC9mcmFnOjdlMWE2NDBlMDg3ODQ4MjA5MjY1Y2QwY2E4ZTlhYTg0L3RhYmxlOjgzZGUzOTA5NTc1NjQ2NDE4M2IzMDNjYjc0M2M4YzdhL3RhYmxlcmFuZ2U6ODNkZTM5MDk1NzU2NDY0MTgzYjMwM2NiNzQzYzhjN2FfNi0xLTEtMS00ODE2NA_28386333-ea21-45a2-94f2-61b9c795980d" unitRef="usd"> 144580000 </us-gaap:DebtInstrumentCarryingAmount>
<us-gaap:DebtInstrumentUnamortizedDiscount contextRef="i2f8779c083c44285914f38702ee04ee0_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81OC9mcmFnOjdlMWE2NDBlMDg3ODQ4MjA5MjY1Y2QwY2E4ZTlhYTg0L3RhYmxlOjgzZGUzOTA5NTc1NjQ2NDE4M2IzMDNjYjc0M2M4YzdhL3RhYmxlcmFuZ2U6ODNkZTM5MDk1NzU2NDY0MTgzYjMwM2NiNzQzYzhjN2FfNi0zLTEtMS00ODE2NA_87dee707-3fab-4709-8b7c-c2b30afcc161" unitRef="usd"> 0 </us-gaap:DebtInstrumentUnamortizedDiscount>
<us-gaap:DeferredFinanceCostsNet contextRef="i2f8779c083c44285914f38702ee04ee0_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81OC9mcmFnOjdlMWE2NDBlMDg3ODQ4MjA5MjY1Y2QwY2E4ZTlhYTg0L3RhYmxlOjgzZGUzOTA5NTc1NjQ2NDE4M2IzMDNjYjc0M2M4YzdhL3RhYmxlcmFuZ2U6ODNkZTM5MDk1NzU2NDY0MTgzYjMwM2NiNzQzYzhjN2FfNi01LTEtMS00ODE2NA_cc3cab21-5c41-4762-b7b5-ed42f12df244" unitRef="usd"> 3043000 </us-gaap:DeferredFinanceCostsNet>
<us-gaap:LongTermDebt contextRef="i2f8779c083c44285914f38702ee04ee0_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81OC9mcmFnOjdlMWE2NDBlMDg3ODQ4MjA5MjY1Y2QwY2E4ZTlhYTg0L3RhYmxlOjgzZGUzOTA5NTc1NjQ2NDE4M2IzMDNjYjc0M2M4YzdhL3RhYmxlcmFuZ2U6ODNkZTM5MDk1NzU2NDY0MTgzYjMwM2NiNzQzYzhjN2FfNi03LTEtMS00ODE2NA_82ecc097-ac84-4932-86ab-274a1453e8b7" unitRef="usd"> 141537000 </us-gaap:LongTermDebt>
<us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="ie684d614568d45eb9bcce4fd63aa5077_I20220101" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81OC9mcmFnOjdlMWE2NDBlMDg3ODQ4MjA5MjY1Y2QwY2E4ZTlhYTg0L3RleHRyZWdpb246N2UxYTY0MGUwODc4NDgyMDkyNjVjZDBjYThlOWFhODRfODM2Nw_418e4e63-d602-4c0e-98f2-451e333c03b9" unitRef="usd"> 21600000 </us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
<us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="i17f6d7edfe2d4cfd97bd8bf85038b376_I20220101" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81OC9mcmFnOjdlMWE2NDBlMDg3ODQ4MjA5MjY1Y2QwY2E4ZTlhYTg0L3RleHRyZWdpb246N2UxYTY0MGUwODc4NDgyMDkyNjVjZDBjYThlOWFhODRfODQxMw_c6279bed-c5ba-49f4-9508-4984555c49ad" unitRef="usd"> 17500000 </us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
<us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="i2e013f06489447d0b09e5fcc88390e38_I20220101" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81OC9mcmFnOjdlMWE2NDBlMDg3ODQ4MjA5MjY1Y2QwY2E4ZTlhYTg0L3RleHRyZWdpb246N2UxYTY0MGUwODc4NDgyMDkyNjVjZDBjYThlOWFhODRfODQ2NQ_2bb8a987-aeba-4ed8-b586-44b53e1e9bb1" unitRef="usd"> -39100000 </us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
<us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="ib1eb3cc9d65e4d7d91eacb3270347554_I20180228" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81OC9mcmFnOjdlMWE2NDBlMDg3ODQ4MjA5MjY1Y2QwY2E4ZTlhYTg0L3RleHRyZWdpb246N2UxYTY0MGUwODc4NDgyMDkyNjVjZDBjYThlOWFhODRfODUwOQ_b99d7c63-604c-49d5-af32-f19db1d801ad" unitRef="number"> 0.05 </us-gaap:DebtInstrumentInterestRateStatedPercentage>
<us-gaap:DebtInstrumentFaceAmount contextRef="ib1eb3cc9d65e4d7d91eacb3270347554_I20180228" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81OC9mcmFnOjdlMWE2NDBlMDg3ODQ4MjA5MjY1Y2QwY2E4ZTlhYTg0L3RleHRyZWdpb246N2UxYTY0MGUwODc4NDgyMDkyNjVjZDBjYThlOWFhODRfODYwOQ_9b3cef3f-a5ed-4df6-a0b4-7713e4e719ca" unitRef="usd"> 55000000 </us-gaap:DebtInstrumentFaceAmount>
<us-gaap:DebtInstrumentTerm contextRef="i40ed7e7b6fdb443f812627efa4fbe8b7_D20180201-20180228" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81OC9mcmFnOjdlMWE2NDBlMDg3ODQ4MjA5MjY1Y2QwY2E4ZTlhYTg0L3RleHRyZWdpb246N2UxYTY0MGUwODc4NDgyMDkyNjVjZDBjYThlOWFhODRfODY0OA_67a57c73-5953-4bf3-8755-26d94d571f5b"> P5Y </us-gaap:DebtInstrumentTerm>
<us-gaap:DebtInstrumentConvertibleConversionPrice1 contextRef="ib1eb3cc9d65e4d7d91eacb3270347554_I20180228" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81OC9mcmFnOjdlMWE2NDBlMDg3ODQ4MjA5MjY1Y2QwY2E4ZTlhYTg0L3RleHRyZWdpb246N2UxYTY0MGUwODc4NDgyMDkyNjVjZDBjYThlOWFhODRfODk2NA_7bf7e20f-cba9-4f22-9e83-abcaf6a4b8ad" unitRef="usdPerShare"> 5.00 </us-gaap:DebtInstrumentConvertibleConversionPrice1>
<opk:DebtInstrumentConvertibleConversionNoticeThresholdMinimum contextRef="i40ed7e7b6fdb443f812627efa4fbe8b7_D20180201-20180228" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81OC9mcmFnOjdlMWE2NDBlMDg3ODQ4MjA5MjY1Y2QwY2E4ZTlhYTg0L3RleHRyZWdpb246N2UxYTY0MGUwODc4NDgyMDkyNjVjZDBjYThlOWFhODRfOTE2Ng_0c16782a-1b4d-4da0-9081-70af767b55ff"> P30D </opk:DebtInstrumentConvertibleConversionNoticeThresholdMinimum>
<opk:DebtInstrumentConvertibleConversionNoticeThresholdMaximum contextRef="i40ed7e7b6fdb443f812627efa4fbe8b7_D20180201-20180228" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81OC9mcmFnOjdlMWE2NDBlMDg3ODQ4MjA5MjY1Y2QwY2E4ZTlhYTg0L3RleHRyZWdpb246N2UxYTY0MGUwODc4NDgyMDkyNjVjZDBjYThlOWFhODRfOTE5Mg_24e4bde0-cf02-48be-b712-bd3423657f55"> P60D </opk:DebtInstrumentConvertibleConversionNoticeThresholdMaximum>
<us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="i5e2069d0507747518c38c942dba9afb2_I20130130" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81OC9mcmFnOjdlMWE2NDBlMDg3ODQ4MjA5MjY1Y2QwY2E4ZTlhYTg0L3RleHRyZWdpb246N2UxYTY0MGUwODc4NDgyMDkyNjVjZDBjYThlOWFhODRfOTY1NA_98c17524-ddfe-44c2-aa6d-729c060a6ddb" unitRef="number"> 0.030 </us-gaap:DebtInstrumentInterestRateStatedPercentage>
<us-gaap:DebtInstrumentFaceAmount contextRef="i5e2069d0507747518c38c942dba9afb2_I20130130" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81OC9mcmFnOjdlMWE2NDBlMDg3ODQ4MjA5MjY1Y2QwY2E4ZTlhYTg0L3RleHRyZWdpb246N2UxYTY0MGUwODc4NDgyMDkyNjVjZDBjYThlOWFhODRfOTg3MQ_458b8667-2a45-4661-9b8f-22b168391b90" unitRef="usd"> 175000000 </us-gaap:DebtInstrumentFaceAmount>
<us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="i5e2069d0507747518c38c942dba9afb2_I20130130" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81OC9mcmFnOjdlMWE2NDBlMDg3ODQ4MjA5MjY1Y2QwY2E4ZTlhYTg0L3RleHRyZWdpb246N2UxYTY0MGUwODc4NDgyMDkyNjVjZDBjYThlOWFhODRfOTkzMw_35c7a6e5-6541-42f6-8abc-5f52d12c7609" unitRef="number"> 0.030 </us-gaap:DebtInstrumentInterestRateStatedPercentage>
<us-gaap:DebtInstrumentRedemptionPricePercentage contextRef="i9ea765d456714acaa37e12d880184a34_D20130130-20130130" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81OC9mcmFnOjdlMWE2NDBlMDg3ODQ4MjA5MjY1Y2QwY2E4ZTlhYTg0L3RleHRyZWdpb246N2UxYTY0MGUwODc4NDgyMDkyNjVjZDBjYThlOWFhODRfMTAzNTc_e7205854-f184-4fda-9326-305afe1e711e" unitRef="number"> 1 </us-gaap:DebtInstrumentRedemptionPricePercentage>
<us-gaap:DebtConversionConvertedInstrumentAmount1 contextRef="i3998285cf79345bf85e2e3c20bed4e2b_D20130101-20161231" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81OC9mcmFnOjdlMWE2NDBlMDg3ODQ4MjA5MjY1Y2QwY2E4ZTlhYTg0L3RleHRyZWdpb246N2UxYTY0MGUwODc4NDgyMDkyNjVjZDBjYThlOWFhODRfMTA1OTg_01670e64-c9e1-4721-a784-c0aae3aed656" unitRef="usd"> 143200000 </us-gaap:DebtConversionConvertedInstrumentAmount1>
<us-gaap:DebtConversionConvertedInstrumentSharesIssued1 contextRef="i6ed1d5ceb104456c81e7bea1dc044cd5_D20130101-20161231" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81OC9mcmFnOjdlMWE2NDBlMDg3ODQ4MjA5MjY1Y2QwY2E4ZTlhYTg0L3RleHRyZWdpb246N2UxYTY0MGUwODc4NDgyMDkyNjVjZDBjYThlOWFhODRfMTA2NTI_10c887b6-3ccc-49ed-913b-d6d840cc692f" unitRef="shares"> 21539873 </us-gaap:DebtConversionConvertedInstrumentSharesIssued1>
<us-gaap:DebtInstrumentRepurchaseAmount contextRef="id987f0ef8a464c24a3e364f9b084a2db_I20190201" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81OC9mcmFnOjdlMWE2NDBlMDg3ODQ4MjA5MjY1Y2QwY2E4ZTlhYTg0L3RleHRyZWdpb246N2UxYTY0MGUwODc4NDgyMDkyNjVjZDBjYThlOWFhODRfMTA3MTQ_318bdaa1-352f-4cf5-899a-390073a29ac7" unitRef="usd"> 28800000 </us-gaap:DebtInstrumentRepurchaseAmount>
<us-gaap:LongTermDebt contextRef="id987f0ef8a464c24a3e364f9b084a2db_I20190201" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81OC9mcmFnOjdlMWE2NDBlMDg3ODQ4MjA5MjY1Y2QwY2E4ZTlhYTg0L3RleHRyZWdpb246N2UxYTY0MGUwODc4NDgyMDkyNjVjZDBjYThlOWFhODRfMTA5Njk_3daac71d-0310-42bb-a3a1-537f5143bdc5" unitRef="usd"> 3000000 </us-gaap:LongTermDebt>
<us-gaap:LongTermDebt contextRef="id987f0ef8a464c24a3e364f9b084a2db_I20190201" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81OC9mcmFnOjdlMWE2NDBlMDg3ODQ4MjA5MjY1Y2QwY2E4ZTlhYTg0L3RleHRyZWdpb246N2UxYTY0MGUwODc4NDgyMDkyNjVjZDBjYThlOWFhODRfMTEwNzI_8751df59-5838-4ab7-b502-9174eb17466a" unitRef="usd"> 3000000 </us-gaap:LongTermDebt>
<us-gaap:DebtInstrumentRedemptionPricePercentage contextRef="i8137f42862c24bce826ee0380e613886_D20130101-20130131" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81OC9mcmFnOjdlMWE2NDBlMDg3ODQ4MjA5MjY1Y2QwY2E4ZTlhYTg0L3RleHRyZWdpb246N2UxYTY0MGUwODc4NDgyMDkyNjVjZDBjYThlOWFhODRfMTExNjE_2b6c0768-7d72-4b6a-8b06-5ebc842b5f3b" unitRef="number"> 1 </us-gaap:DebtInstrumentRedemptionPricePercentage>
<us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="i533360515fa240e397a47831e256567b_I20151130" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81OC9mcmFnOjdlMWE2NDBlMDg3ODQ4MjA5MjY1Y2QwY2E4ZTlhYTg0L3RleHRyZWdpb246N2UxYTY0MGUwODc4NDgyMDkyNjVjZDBjYThlOWFhODRfMTMwOTc_554bdaa4-d203-44e2-bc94-36898c02c50f" unitRef="usd"> 75000000 </us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
<us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="ia43ec42737404e39a71e997f75a42a7d_I20151130" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81OC9mcmFnOjdlMWE2NDBlMDg3ODQ4MjA5MjY1Y2QwY2E4ZTlhYTg0L3RleHRyZWdpb246N2UxYTY0MGUwODc4NDgyMDkyNjVjZDBjYThlOWFhODRfMTMxNDk_64587ffb-04d4-4c99-8956-2ae327bb5ea6" unitRef="usd"> 20000000 </us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
<us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="i88d19b39fa04431a872085f065eb25f7_I20151130" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81OC9mcmFnOjdlMWE2NDBlMDg3ODQ4MjA5MjY1Y2QwY2E4ZTlhYTg0L3RleHRyZWdpb246N2UxYTY0MGUwODc4NDgyMDkyNjVjZDBjYThlOWFhODRfMTMxOTE_069c6c78-89a0-4730-9d5d-8b585006a512" unitRef="usd"> 20000000 </us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
<us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity contextRef="ic9f69debfc1749da97c5998f7384fdc1_I20220630" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81OC9mcmFnOjdlMWE2NDBlMDg3ODQ4MjA5MjY1Y2QwY2E4ZTlhYTg0L3RleHRyZWdpb246N2UxYTY0MGUwODc4NDgyMDkyNjVjZDBjYThlOWFhODRfMTM4MjU_95290b10-69ff-448b-afbf-489a98a94425" unitRef="usd"> 53100000 </us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity>
<us-gaap:DebtInstrumentBasisSpreadOnVariableRate1 contextRef="ic515d09273fb4eb9a043d9e55756833a_D20151101-20151130" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81OC9mcmFnOjdlMWE2NDBlMDg3ODQ4MjA5MjY1Y2QwY2E4ZTlhYTg0L3RleHRyZWdpb246N2UxYTY0MGUwODc4NDgyMDkyNjVjZDBjYThlOWFhODRfMTQyOTc_9f2caec8-d972-453c-a309-5786174d2f79" unitRef="number"> 0.0250 </us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
<us-gaap:DebtInstrumentBasisSpreadOnVariableRate1 contextRef="i2546e962b7a444f49aae29ce581c6605_D20151101-20151130" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81OC9mcmFnOjdlMWE2NDBlMDg3ODQ4MjA5MjY1Y2QwY2E4ZTlhYTg0L3RleHRyZWdpb246N2UxYTY0MGUwODc4NDgyMDkyNjVjZDBjYThlOWFhODRfMTQzMzA_6c7d0bbd-8a06-4a7e-baf0-761ed38c7fdd" unitRef="number"> 0.0075 </us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
<us-gaap:DebtInstrumentBasisSpreadOnVariableRate1 contextRef="ib337a97b28244b6f8323a94c9849538c_D20151101-20151130" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81OC9mcmFnOjdlMWE2NDBlMDg3ODQ4MjA5MjY1Y2QwY2E4ZTlhYTg0L3RleHRyZWdpb246N2UxYTY0MGUwODc4NDgyMDkyNjVjZDBjYThlOWFhODRfMTQ0NjA_c54648f1-48c4-40a3-ae97-5e0b17ef58c2" unitRef="number"> 0.0175 </us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
<us-gaap:LineOfCreditFacilityCommitmentFeePercentage contextRef="if7609ec898974cd2bb37b42f63ea1c14_D20151101-20151130" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81OC9mcmFnOjdlMWE2NDBlMDg3ODQ4MjA5MjY1Y2QwY2E4ZTlhYTg0L3RleHRyZWdpb246N2UxYTY0MGUwODc4NDgyMDkyNjVjZDBjYThlOWFhODRfMTQ2NjU_a719f16e-e399-4baa-98d8-2c1205f92ff6" unitRef="number"> 0.00375 </us-gaap:LineOfCreditFacilityCommitmentFeePercentage>
<us-gaap:LineOfCreditFacilityCommitmentFeePercentage contextRef="i90097e8f2e3d48f39d40078004a70570_D20151101-20151130" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81OC9mcmFnOjdlMWE2NDBlMDg3ODQ4MjA5MjY1Y2QwY2E4ZTlhYTg0L3RleHRyZWdpb246N2UxYTY0MGUwODc4NDgyMDkyNjVjZDBjYThlOWFhODRfMTQ3NTI_a9a90aae-d18a-4e26-9bd1-c12e0d121833" unitRef="number"> 0.0025 </us-gaap:LineOfCreditFacilityCommitmentFeePercentage>
<us-gaap:LongTermLineOfCredit contextRef="ic9f69debfc1749da97c5998f7384fdc1_I20220630" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81OC9mcmFnOjdlMWE2NDBlMDg3ODQ4MjA5MjY1Y2QwY2E4ZTlhYTg0L3RleHRyZWdpb246N2UxYTY0MGUwODc4NDgyMDkyNjVjZDBjYThlOWFhODRfMTQ4OTg_d8ae558f-6184-4301-adb7-79bfd17d6270" unitRef="usd"> 2900000 </us-gaap:LongTermLineOfCredit>
<us-gaap:LongTermLineOfCredit contextRef="id62e921fa70e48b8bcd0517e930bbf99_I20211231" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81OC9mcmFnOjdlMWE2NDBlMDg3ODQ4MjA5MjY1Y2QwY2E4ZTlhYTg0L3RleHRyZWdpb246N2UxYTY0MGUwODc4NDgyMDkyNjVjZDBjYThlOWFhODRfMjE5OTAyMzI3NTAyMQ_8bef295a-482f-49ba-8ea7-df6aa6a6778f" unitRef="usd"> 0 </us-gaap:LongTermLineOfCredit>
<us-gaap:StockholdersEquity contextRef="ib66e75fd6c1047b58f966338304821dd_I20220630" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81OC9mcmFnOjdlMWE2NDBlMDg3ODQ4MjA5MjY1Y2QwY2E4ZTlhYTg0L3RleHRyZWdpb246N2UxYTY0MGUwODc4NDgyMDkyNjVjZDBjYThlOWFhODRfMjc0ODc3OTA4NzY3MA_55a0d66d-7f2a-45bf-87a2-5574d170a391" unitRef="usd"> 680000000 </us-gaap:StockholdersEquity>
<us-gaap:Goodwill contextRef="ib66e75fd6c1047b58f966338304821dd_I20220630" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81OC9mcmFnOjdlMWE2NDBlMDg3ODQ4MjA5MjY1Y2QwY2E4ZTlhYTg0L3RleHRyZWdpb246N2UxYTY0MGUwODc4NDgyMDkyNjVjZDBjYThlOWFhODRfMjc0ODc3OTA4NzY2NA_88054d43-657e-4af7-9d77-d65e52889152" unitRef="usd"> 283000000 </us-gaap:Goodwill>
<us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="ib66e75fd6c1047b58f966338304821dd_I20220630" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81OC9mcmFnOjdlMWE2NDBlMDg3ODQ4MjA5MjY1Y2QwY2E4ZTlhYTg0L3RleHRyZWdpb246N2UxYTY0MGUwODc4NDgyMDkyNjVjZDBjYThlOWFhODRfMjc0ODc3OTA4NzYzNQ_60ff9671-e075-4d36-9507-1d2e08f05920" unitRef="usd"> 195900000 </us-gaap:IntangibleAssetsNetExcludingGoodwill>
<opk:DebtInstrumentsNumberofFinancialInstitutions contextRef="i4768f885851b49f986857a2a956f9162_I20220630" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81OC9mcmFnOjdlMWE2NDBlMDg3ODQ4MjA5MjY1Y2QwY2E4ZTlhYTg0L3RleHRyZWdpb246N2UxYTY0MGUwODc4NDgyMDkyNjVjZDBjYThlOWFhODRfMTcxNzE_4409b42d-25b7-4a6e-ab74-42efaa9176dc" unitRef="institution"> 13 </opk:DebtInstrumentsNumberofFinancialInstitutions>
<opk:DebtInstrumentsNumberofFinancialInstitutions contextRef="i7e0f479bead144b0bdbcc71082db627b_I20211231" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81OC9mcmFnOjdlMWE2NDBlMDg3ODQ4MjA5MjY1Y2QwY2E4ZTlhYTg0L3RleHRyZWdpb246N2UxYTY0MGUwODc4NDgyMDkyNjVjZDBjYThlOWFhODRfMTcyMTY_133b5037-718a-4160-b7d7-7dd536eb7492" unitRef="institution"> 11 </opk:DebtInstrumentsNumberofFinancialInstitutions>
<us-gaap:ScheduleOfLineOfCreditFacilitiesTextBlock contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81OC9mcmFnOjdlMWE2NDBlMDg3ODQ4MjA5MjY1Y2QwY2E4ZTlhYTg0L3RleHRyZWdpb246N2UxYTY0MGUwODc4NDgyMDkyNjVjZDBjYThlOWFhODRfMTgxNjI_f1f84e89-727f-4f95-94bf-5f26fdf70b24">
<div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the amounts outstanding under the BioReference, Chilean and Spanish lines of credit:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:39.575%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.996%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.996%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.996%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.001%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(Dollars in thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> Balance Outstanding</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Lender</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest rate on borrowings at June 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Credit line<br/>capacity</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">June 30,<br/>2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">JPMorgan Chase</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.25%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">75,000 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,867 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Itau Bank</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.50%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,900 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,293 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,603 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Bank of Chile</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.60%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,500 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,452 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,048 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">BICE Bank</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.50%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,500 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,499 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">850 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Scotiabank</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.00%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,500 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,560 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">567 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Santander Bank</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.50%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,000 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,467 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">503 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Security Bank</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.50%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,400 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,111 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Estado Bank</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.50%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,000 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,682 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,540 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">BCI Bank</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.00%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,500 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,400 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,515 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Corpbanca</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.00%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,935 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">International Bank</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.50%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,500 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">845 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Consoorcio Bank</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.00%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,000 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,151 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Banco De Sabadell</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.75%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">522 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Santander Bank</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.15%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">522 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">104,844 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,218 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,672 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>
</us-gaap:ScheduleOfLineOfCreditFacilitiesTextBlock>
<us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd contextRef="i56807793c69c4ec9a634208091e94279_I20220630" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81OC9mcmFnOjdlMWE2NDBlMDg3ODQ4MjA5MjY1Y2QwY2E4ZTlhYTg0L3RhYmxlOjAxMDEwODc5NTM3YjRkOWZhYzQ4ZTEwZWU5NTQ3ODZlL3RhYmxlcmFuZ2U6MDEwMTA4Nzk1MzdiNGQ5ZmFjNDhlMTBlZTk1NDc4NmVfMi0yLTEtMS00ODE2NA_b4ce2a84-0d40-406c-bdc3-625373bee24c" unitRef="number"> 0.0325 </us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd>
<us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="i56807793c69c4ec9a634208091e94279_I20220630" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81OC9mcmFnOjdlMWE2NDBlMDg3ODQ4MjA5MjY1Y2QwY2E4ZTlhYTg0L3RhYmxlOjAxMDEwODc5NTM3YjRkOWZhYzQ4ZTEwZWU5NTQ3ODZlL3RhYmxlcmFuZ2U6MDEwMTA4Nzk1MzdiNGQ5ZmFjNDhlMTBlZTk1NDc4NmVfMi00LTEtMS00ODE2NA_d2b7807b-9e6d-43f5-b2f4-cbef016013e5" unitRef="usd"> 75000000 </us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
<us-gaap:LineOfCredit contextRef="i56807793c69c4ec9a634208091e94279_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81OC9mcmFnOjdlMWE2NDBlMDg3ODQ4MjA5MjY1Y2QwY2E4ZTlhYTg0L3RhYmxlOjAxMDEwODc5NTM3YjRkOWZhYzQ4ZTEwZWU5NTQ3ODZlL3RhYmxlcmFuZ2U6MDEwMTA4Nzk1MzdiNGQ5ZmFjNDhlMTBlZTk1NDc4NmVfMi02LTEtMS00ODE2NA_8d0e77d3-d91e-4e3e-b741-ed59edeb1d69" unitRef="usd"> 2867000 </us-gaap:LineOfCredit>
<us-gaap:LineOfCredit contextRef="i2344a50075bf4971aa6e540623c2c620_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81OC9mcmFnOjdlMWE2NDBlMDg3ODQ4MjA5MjY1Y2QwY2E4ZTlhYTg0L3RhYmxlOjAxMDEwODc5NTM3YjRkOWZhYzQ4ZTEwZWU5NTQ3ODZlL3RhYmxlcmFuZ2U6MDEwMTA4Nzk1MzdiNGQ5ZmFjNDhlMTBlZTk1NDc4NmVfMi04LTEtMS00ODE2NA_882b2c07-bc1c-4f71-b2c2-0712ffe3b652" unitRef="usd"> 0 </us-gaap:LineOfCredit>
<us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd contextRef="ice0af0cb7369458d8f7c448eba85ffeb_I20220630" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81OC9mcmFnOjdlMWE2NDBlMDg3ODQ4MjA5MjY1Y2QwY2E4ZTlhYTg0L3RhYmxlOjAxMDEwODc5NTM3YjRkOWZhYzQ4ZTEwZWU5NTQ3ODZlL3RhYmxlcmFuZ2U6MDEwMTA4Nzk1MzdiNGQ5ZmFjNDhlMTBlZTk1NDc4NmVfMy0yLTEtMS00ODE2NA_5ad99dfa-a45f-47a2-a2be-fae7138cea31" unitRef="number"> 0.0550 </us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd>
<us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="ice0af0cb7369458d8f7c448eba85ffeb_I20220630" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81OC9mcmFnOjdlMWE2NDBlMDg3ODQ4MjA5MjY1Y2QwY2E4ZTlhYTg0L3RhYmxlOjAxMDEwODc5NTM3YjRkOWZhYzQ4ZTEwZWU5NTQ3ODZlL3RhYmxlcmFuZ2U6MDEwMTA4Nzk1MzdiNGQ5ZmFjNDhlMTBlZTk1NDc4NmVfMy00LTEtMS00ODE2NA_e887049f-4b66-4455-855a-fb810917c0ee" unitRef="usd"> 1900000 </us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
<us-gaap:LineOfCredit contextRef="ice0af0cb7369458d8f7c448eba85ffeb_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81OC9mcmFnOjdlMWE2NDBlMDg3ODQ4MjA5MjY1Y2QwY2E4ZTlhYTg0L3RhYmxlOjAxMDEwODc5NTM3YjRkOWZhYzQ4ZTEwZWU5NTQ3ODZlL3RhYmxlcmFuZ2U6MDEwMTA4Nzk1MzdiNGQ5ZmFjNDhlMTBlZTk1NDc4NmVfMy02LTEtMS00ODE2NA_98224605-24e7-4653-a7be-0c24484f1180" unitRef="usd"> 1293000 </us-gaap:LineOfCredit>
<us-gaap:LineOfCredit contextRef="i49ecd9df98ab40aaa2b8d33dd8ee5c51_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81OC9mcmFnOjdlMWE2NDBlMDg3ODQ4MjA5MjY1Y2QwY2E4ZTlhYTg0L3RhYmxlOjAxMDEwODc5NTM3YjRkOWZhYzQ4ZTEwZWU5NTQ3ODZlL3RhYmxlcmFuZ2U6MDEwMTA4Nzk1MzdiNGQ5ZmFjNDhlMTBlZTk1NDc4NmVfMy04LTEtMS00ODE2NA_72f754cd-213d-4844-92c0-87746a65450e" unitRef="usd"> 1603000 </us-gaap:LineOfCredit>
<us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd contextRef="i52523bea912c40b9938f4d706c10e999_I20220630" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81OC9mcmFnOjdlMWE2NDBlMDg3ODQ4MjA5MjY1Y2QwY2E4ZTlhYTg0L3RhYmxlOjAxMDEwODc5NTM3YjRkOWZhYzQ4ZTEwZWU5NTQ3ODZlL3RhYmxlcmFuZ2U6MDEwMTA4Nzk1MzdiNGQ5ZmFjNDhlMTBlZTk1NDc4NmVfNC0yLTEtMS00ODE2NA_6e805b96-2933-4c25-9a10-40a08abc7709" unitRef="number"> 0.0660 </us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd>
<us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="i52523bea912c40b9938f4d706c10e999_I20220630" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81OC9mcmFnOjdlMWE2NDBlMDg3ODQ4MjA5MjY1Y2QwY2E4ZTlhYTg0L3RhYmxlOjAxMDEwODc5NTM3YjRkOWZhYzQ4ZTEwZWU5NTQ3ODZlL3RhYmxlcmFuZ2U6MDEwMTA4Nzk1MzdiNGQ5ZmFjNDhlMTBlZTk1NDc4NmVfNC00LTEtMS00ODE2NA_917a180f-5a59-4360-8bec-4c5da21e0ce6" unitRef="usd"> 2500000 </us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
<us-gaap:LineOfCredit contextRef="i52523bea912c40b9938f4d706c10e999_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81OC9mcmFnOjdlMWE2NDBlMDg3ODQ4MjA5MjY1Y2QwY2E4ZTlhYTg0L3RhYmxlOjAxMDEwODc5NTM3YjRkOWZhYzQ4ZTEwZWU5NTQ3ODZlL3RhYmxlcmFuZ2U6MDEwMTA4Nzk1MzdiNGQ5ZmFjNDhlMTBlZTk1NDc4NmVfNC02LTEtMS00ODE2NA_b099e4d0-6a37-4f3d-832e-c3cf72efe617" unitRef="usd"> 1452000 </us-gaap:LineOfCredit>
<us-gaap:LineOfCredit contextRef="i52c0ae43e5d24cc68b9582d04cb605f9_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81OC9mcmFnOjdlMWE2NDBlMDg3ODQ4MjA5MjY1Y2QwY2E4ZTlhYTg0L3RhYmxlOjAxMDEwODc5NTM3YjRkOWZhYzQ4ZTEwZWU5NTQ3ODZlL3RhYmxlcmFuZ2U6MDEwMTA4Nzk1MzdiNGQ5ZmFjNDhlMTBlZTk1NDc4NmVfNC04LTEtMS00ODE2NA_a6a657d1-217f-492c-bf1c-b1e5aeace390" unitRef="usd"> 1048000 </us-gaap:LineOfCredit>
<us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd contextRef="i60b61041434f419394d47f328f70ec2c_I20220630" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81OC9mcmFnOjdlMWE2NDBlMDg3ODQ4MjA5MjY1Y2QwY2E4ZTlhYTg0L3RhYmxlOjAxMDEwODc5NTM3YjRkOWZhYzQ4ZTEwZWU5NTQ3ODZlL3RhYmxlcmFuZ2U6MDEwMTA4Nzk1MzdiNGQ5ZmFjNDhlMTBlZTk1NDc4NmVfNS0yLTEtMS00ODE2NA_d21c19c1-16c5-4993-aa7f-cb4c813de430" unitRef="number"> 0.0550 </us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd>
<us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="i60b61041434f419394d47f328f70ec2c_I20220630" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81OC9mcmFnOjdlMWE2NDBlMDg3ODQ4MjA5MjY1Y2QwY2E4ZTlhYTg0L3RhYmxlOjAxMDEwODc5NTM3YjRkOWZhYzQ4ZTEwZWU5NTQ3ODZlL3RhYmxlcmFuZ2U6MDEwMTA4Nzk1MzdiNGQ5ZmFjNDhlMTBlZTk1NDc4NmVfNS00LTEtMS00ODE2NA_021442a4-c8c4-468d-9fe1-314a2684ef0e" unitRef="usd"> 2500000 </us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
<us-gaap:LineOfCredit contextRef="i60b61041434f419394d47f328f70ec2c_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81OC9mcmFnOjdlMWE2NDBlMDg3ODQ4MjA5MjY1Y2QwY2E4ZTlhYTg0L3RhYmxlOjAxMDEwODc5NTM3YjRkOWZhYzQ4ZTEwZWU5NTQ3ODZlL3RhYmxlcmFuZ2U6MDEwMTA4Nzk1MzdiNGQ5ZmFjNDhlMTBlZTk1NDc4NmVfNS02LTEtMS00ODE2NA_e8d4a1ac-8471-4a11-ac31-40e913345cc6" unitRef="usd"> 1499000 </us-gaap:LineOfCredit>
<us-gaap:LineOfCredit contextRef="i16d500ea31cb4f2789f1f3ef7ec22d7e_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81OC9mcmFnOjdlMWE2NDBlMDg3ODQ4MjA5MjY1Y2QwY2E4ZTlhYTg0L3RhYmxlOjAxMDEwODc5NTM3YjRkOWZhYzQ4ZTEwZWU5NTQ3ODZlL3RhYmxlcmFuZ2U6MDEwMTA4Nzk1MzdiNGQ5ZmFjNDhlMTBlZTk1NDc4NmVfNS04LTEtMS00ODE2NA_2a609d1f-84dc-4435-9f46-ff8024b1c155" unitRef="usd"> 850000 </us-gaap:LineOfCredit>
<us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd contextRef="ie72f8d56489f4905a1971d13983ffac7_I20220630" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81OC9mcmFnOjdlMWE2NDBlMDg3ODQ4MjA5MjY1Y2QwY2E4ZTlhYTg0L3RhYmxlOjAxMDEwODc5NTM3YjRkOWZhYzQ4ZTEwZWU5NTQ3ODZlL3RhYmxlcmFuZ2U6MDEwMTA4Nzk1MzdiNGQ5ZmFjNDhlMTBlZTk1NDc4NmVfNi0yLTEtMS00ODE2NA_1c4a0985-f3ed-4441-900a-f4d9b8c381b4" unitRef="number"> 0.0500 </us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd>
<us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="ie72f8d56489f4905a1971d13983ffac7_I20220630" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81OC9mcmFnOjdlMWE2NDBlMDg3ODQ4MjA5MjY1Y2QwY2E4ZTlhYTg0L3RhYmxlOjAxMDEwODc5NTM3YjRkOWZhYzQ4ZTEwZWU5NTQ3ODZlL3RhYmxlcmFuZ2U6MDEwMTA4Nzk1MzdiNGQ5ZmFjNDhlMTBlZTk1NDc4NmVfNi00LTEtMS00ODE2NA_5904d0ab-60a2-4f73-87a5-0c896dd79875" unitRef="usd"> 5500000 </us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
<us-gaap:LineOfCredit contextRef="ie72f8d56489f4905a1971d13983ffac7_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81OC9mcmFnOjdlMWE2NDBlMDg3ODQ4MjA5MjY1Y2QwY2E4ZTlhYTg0L3RhYmxlOjAxMDEwODc5NTM3YjRkOWZhYzQ4ZTEwZWU5NTQ3ODZlL3RhYmxlcmFuZ2U6MDEwMTA4Nzk1MzdiNGQ5ZmFjNDhlMTBlZTk1NDc4NmVfNi02LTEtMS00ODE2NA_6e5f0bd0-d645-48c0-aa06-ff3b365a174b" unitRef="usd"> 1560000 </us-gaap:LineOfCredit>
<us-gaap:LineOfCredit contextRef="i255535a8ace24b70829bdf68bfe2e690_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81OC9mcmFnOjdlMWE2NDBlMDg3ODQ4MjA5MjY1Y2QwY2E4ZTlhYTg0L3RhYmxlOjAxMDEwODc5NTM3YjRkOWZhYzQ4ZTEwZWU5NTQ3ODZlL3RhYmxlcmFuZ2U6MDEwMTA4Nzk1MzdiNGQ5ZmFjNDhlMTBlZTk1NDc4NmVfNi04LTEtMS00ODE2NA_d7ce7598-1024-4b32-bca3-00776b86f750" unitRef="usd"> 567000 </us-gaap:LineOfCredit>
<us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd contextRef="i1a1f3fd7481e4dd6a1c53610266dcf0a_I20220630" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81OC9mcmFnOjdlMWE2NDBlMDg3ODQ4MjA5MjY1Y2QwY2E4ZTlhYTg0L3RhYmxlOjAxMDEwODc5NTM3YjRkOWZhYzQ4ZTEwZWU5NTQ3ODZlL3RhYmxlcmFuZ2U6MDEwMTA4Nzk1MzdiNGQ5ZmFjNDhlMTBlZTk1NDc4NmVfNy0yLTEtMS00ODE2NA_c1e1f8e9-0967-406b-a401-1f76ac5d4036" unitRef="number"> 0.0550 </us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd>
<us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="i1a1f3fd7481e4dd6a1c53610266dcf0a_I20220630" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81OC9mcmFnOjdlMWE2NDBlMDg3ODQ4MjA5MjY1Y2QwY2E4ZTlhYTg0L3RhYmxlOjAxMDEwODc5NTM3YjRkOWZhYzQ4ZTEwZWU5NTQ3ODZlL3RhYmxlcmFuZ2U6MDEwMTA4Nzk1MzdiNGQ5ZmFjNDhlMTBlZTk1NDc4NmVfNy00LTEtMS00ODE2NA_0f81a599-8b46-4d66-be7c-d3310de40988" unitRef="usd"> 5000000 </us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
<us-gaap:LineOfCredit contextRef="i1a1f3fd7481e4dd6a1c53610266dcf0a_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81OC9mcmFnOjdlMWE2NDBlMDg3ODQ4MjA5MjY1Y2QwY2E4ZTlhYTg0L3RhYmxlOjAxMDEwODc5NTM3YjRkOWZhYzQ4ZTEwZWU5NTQ3ODZlL3RhYmxlcmFuZ2U6MDEwMTA4Nzk1MzdiNGQ5ZmFjNDhlMTBlZTk1NDc4NmVfNy02LTEtMS00ODE2NA_5a2cc3b2-98c4-4a2a-8f5c-519f6fc97587" unitRef="usd"> 2467000 </us-gaap:LineOfCredit>
<us-gaap:LineOfCredit contextRef="i2712915f41d44376bdc9fd4e0d28de41_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81OC9mcmFnOjdlMWE2NDBlMDg3ODQ4MjA5MjY1Y2QwY2E4ZTlhYTg0L3RhYmxlOjAxMDEwODc5NTM3YjRkOWZhYzQ4ZTEwZWU5NTQ3ODZlL3RhYmxlcmFuZ2U6MDEwMTA4Nzk1MzdiNGQ5ZmFjNDhlMTBlZTk1NDc4NmVfNy04LTEtMS00ODE2NA_2ed85d87-b82b-40ed-8784-5edd5540b7d9" unitRef="usd"> 503000 </us-gaap:LineOfCredit>
<us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd contextRef="ib70c4920bea74eeca7f56555043a32a3_I20220630" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81OC9mcmFnOjdlMWE2NDBlMDg3ODQ4MjA5MjY1Y2QwY2E4ZTlhYTg0L3RhYmxlOjAxMDEwODc5NTM3YjRkOWZhYzQ4ZTEwZWU5NTQ3ODZlL3RhYmxlcmFuZ2U6MDEwMTA4Nzk1MzdiNGQ5ZmFjNDhlMTBlZTk1NDc4NmVfOC0yLTEtMS00ODE2NA_4444be87-cd70-48c3-8d4c-920085694444" unitRef="number"> 0.0550 </us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd>
<us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="ib70c4920bea74eeca7f56555043a32a3_I20220630" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81OC9mcmFnOjdlMWE2NDBlMDg3ODQ4MjA5MjY1Y2QwY2E4ZTlhYTg0L3RhYmxlOjAxMDEwODc5NTM3YjRkOWZhYzQ4ZTEwZWU5NTQ3ODZlL3RhYmxlcmFuZ2U6MDEwMTA4Nzk1MzdiNGQ5ZmFjNDhlMTBlZTk1NDc4NmVfOC00LTEtMS00ODE2NA_fccc4358-56a7-4427-aea3-0ea7ac27b87a" unitRef="usd"> 1400000 </us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
<us-gaap:LineOfCredit contextRef="ib70c4920bea74eeca7f56555043a32a3_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81OC9mcmFnOjdlMWE2NDBlMDg3ODQ4MjA5MjY1Y2QwY2E4ZTlhYTg0L3RhYmxlOjAxMDEwODc5NTM3YjRkOWZhYzQ4ZTEwZWU5NTQ3ODZlL3RhYmxlcmFuZ2U6MDEwMTA4Nzk1MzdiNGQ5ZmFjNDhlMTBlZTk1NDc4NmVfOC02LTEtMS00ODE2NA_05cd6fbb-52a0-422e-9b98-0e4885ed7182" unitRef="usd"> 2000 </us-gaap:LineOfCredit>
<us-gaap:LineOfCredit contextRef="ide3f5554e53c4dab98cc2c73c680f90f_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81OC9mcmFnOjdlMWE2NDBlMDg3ODQ4MjA5MjY1Y2QwY2E4ZTlhYTg0L3RhYmxlOjAxMDEwODc5NTM3YjRkOWZhYzQ4ZTEwZWU5NTQ3ODZlL3RhYmxlcmFuZ2U6MDEwMTA4Nzk1MzdiNGQ5ZmFjNDhlMTBlZTk1NDc4NmVfOC04LTEtMS00ODE2NA_8c0ca75e-1183-43f0-b37d-e7cbf2548a67" unitRef="usd"> 1111000 </us-gaap:LineOfCredit>
<us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd contextRef="id66fd4396bb54240a254a860ef3e5240_I20220630" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81OC9mcmFnOjdlMWE2NDBlMDg3ODQ4MjA5MjY1Y2QwY2E4ZTlhYTg0L3RhYmxlOjAxMDEwODc5NTM3YjRkOWZhYzQ4ZTEwZWU5NTQ3ODZlL3RhYmxlcmFuZ2U6MDEwMTA4Nzk1MzdiNGQ5ZmFjNDhlMTBlZTk1NDc4NmVfOS0yLTEtMS00ODE2NA_47701018-463a-449e-b17f-dccf374d7eec" unitRef="number"> 0.0550 </us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd>
<us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="id66fd4396bb54240a254a860ef3e5240_I20220630" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81OC9mcmFnOjdlMWE2NDBlMDg3ODQ4MjA5MjY1Y2QwY2E4ZTlhYTg0L3RhYmxlOjAxMDEwODc5NTM3YjRkOWZhYzQ4ZTEwZWU5NTQ3ODZlL3RhYmxlcmFuZ2U6MDEwMTA4Nzk1MzdiNGQ5ZmFjNDhlMTBlZTk1NDc4NmVfOS00LTEtMS00ODE2NA_8d857243-b63d-43e3-b32f-a964738203d9" unitRef="usd"> 4000000 </us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
<us-gaap:LineOfCredit contextRef="id66fd4396bb54240a254a860ef3e5240_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81OC9mcmFnOjdlMWE2NDBlMDg3ODQ4MjA5MjY1Y2QwY2E4ZTlhYTg0L3RhYmxlOjAxMDEwODc5NTM3YjRkOWZhYzQ4ZTEwZWU5NTQ3ODZlL3RhYmxlcmFuZ2U6MDEwMTA4Nzk1MzdiNGQ5ZmFjNDhlMTBlZTk1NDc4NmVfOS02LTEtMS00ODE2NA_7602a4f0-ca1f-4ffd-931f-2dd0d0e081f5" unitRef="usd"> 2682000 </us-gaap:LineOfCredit>
<us-gaap:LineOfCredit contextRef="ib8c7ae40d2d749828e9af1f579d12fb2_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81OC9mcmFnOjdlMWE2NDBlMDg3ODQ4MjA5MjY1Y2QwY2E4ZTlhYTg0L3RhYmxlOjAxMDEwODc5NTM3YjRkOWZhYzQ4ZTEwZWU5NTQ3ODZlL3RhYmxlcmFuZ2U6MDEwMTA4Nzk1MzdiNGQ5ZmFjNDhlMTBlZTk1NDc4NmVfOS04LTEtMS00ODE2NA_f9d8d5df-0d64-4432-8071-82817723735c" unitRef="usd"> 2540000 </us-gaap:LineOfCredit>
<us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd contextRef="i5637acfcd63249cd82d7154c4c0f12f0_I20220630" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81OC9mcmFnOjdlMWE2NDBlMDg3ODQ4MjA5MjY1Y2QwY2E4ZTlhYTg0L3RhYmxlOjAxMDEwODc5NTM3YjRkOWZhYzQ4ZTEwZWU5NTQ3ODZlL3RhYmxlcmFuZ2U6MDEwMTA4Nzk1MzdiNGQ5ZmFjNDhlMTBlZTk1NDc4NmVfMTAtMi0xLTEtNDgxNjQ_662fc9ed-a950-4bc2-a2b4-01c1ba143baa" unitRef="number"> 0.0500 </us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd>
<us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="i5637acfcd63249cd82d7154c4c0f12f0_I20220630" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81OC9mcmFnOjdlMWE2NDBlMDg3ODQ4MjA5MjY1Y2QwY2E4ZTlhYTg0L3RhYmxlOjAxMDEwODc5NTM3YjRkOWZhYzQ4ZTEwZWU5NTQ3ODZlL3RhYmxlcmFuZ2U6MDEwMTA4Nzk1MzdiNGQ5ZmFjNDhlMTBlZTk1NDc4NmVfMTAtNC0xLTEtNDgxNjQ_0130228f-4b3c-4860-8b6a-6902f38f3f65" unitRef="usd"> 2500000 </us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
<us-gaap:LineOfCredit contextRef="i5637acfcd63249cd82d7154c4c0f12f0_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81OC9mcmFnOjdlMWE2NDBlMDg3ODQ4MjA5MjY1Y2QwY2E4ZTlhYTg0L3RhYmxlOjAxMDEwODc5NTM3YjRkOWZhYzQ4ZTEwZWU5NTQ3ODZlL3RhYmxlcmFuZ2U6MDEwMTA4Nzk1MzdiNGQ5ZmFjNDhlMTBlZTk1NDc4NmVfMTAtNi0xLTEtNDgxNjQ_6cb93575-4fb4-4ada-82b5-5ed0d56cee4b" unitRef="usd"> 2400000 </us-gaap:LineOfCredit>
<us-gaap:LineOfCredit contextRef="id1567ec7311643dd88397949786c9b43_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81OC9mcmFnOjdlMWE2NDBlMDg3ODQ4MjA5MjY1Y2QwY2E4ZTlhYTg0L3RhYmxlOjAxMDEwODc5NTM3YjRkOWZhYzQ4ZTEwZWU5NTQ3ODZlL3RhYmxlcmFuZ2U6MDEwMTA4Nzk1MzdiNGQ5ZmFjNDhlMTBlZTk1NDc4NmVfMTAtOC0xLTEtNDgxNjQ_40d6e1a9-e46d-4be1-8b6b-5118bca36893" unitRef="usd"> 2515000 </us-gaap:LineOfCredit>
<us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd contextRef="ie2ccd76b30e140c48c99c770483b6f5c_I20220630" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81OC9mcmFnOjdlMWE2NDBlMDg3ODQ4MjA5MjY1Y2QwY2E4ZTlhYTg0L3RhYmxlOjAxMDEwODc5NTM3YjRkOWZhYzQ4ZTEwZWU5NTQ3ODZlL3RhYmxlcmFuZ2U6MDEwMTA4Nzk1MzdiNGQ5ZmFjNDhlMTBlZTk1NDc4NmVfMTEtMi0xLTEtNDgxNjQ_6b1b1d23-d166-4a58-892d-6ce2ea92a93d" unitRef="number"> 0.0500 </us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd>
<us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="ie2ccd76b30e140c48c99c770483b6f5c_I20220630" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81OC9mcmFnOjdlMWE2NDBlMDg3ODQ4MjA5MjY1Y2QwY2E4ZTlhYTg0L3RhYmxlOjAxMDEwODc5NTM3YjRkOWZhYzQ4ZTEwZWU5NTQ3ODZlL3RhYmxlcmFuZ2U6MDEwMTA4Nzk1MzdiNGQ5ZmFjNDhlMTBlZTk1NDc4NmVfMTEtNC0xLTEtNDgxNjQ_f905a16b-d74d-42b0-9c24-5fb38d6426bc" unitRef="usd"> 0 </us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
<us-gaap:LineOfCredit contextRef="ie2ccd76b30e140c48c99c770483b6f5c_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81OC9mcmFnOjdlMWE2NDBlMDg3ODQ4MjA5MjY1Y2QwY2E4ZTlhYTg0L3RhYmxlOjAxMDEwODc5NTM3YjRkOWZhYzQ4ZTEwZWU5NTQ3ODZlL3RhYmxlcmFuZ2U6MDEwMTA4Nzk1MzdiNGQ5ZmFjNDhlMTBlZTk1NDc4NmVfMTEtNi0xLTEtNDgxNjQ_6bfafcdd-7aa1-4e35-ad0c-36b8ec26bb0d" unitRef="usd"> 0 </us-gaap:LineOfCredit>
<us-gaap:LineOfCredit contextRef="ie3458844527444f38fbe8ba9edb158c6_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81OC9mcmFnOjdlMWE2NDBlMDg3ODQ4MjA5MjY1Y2QwY2E4ZTlhYTg0L3RhYmxlOjAxMDEwODc5NTM3YjRkOWZhYzQ4ZTEwZWU5NTQ3ODZlL3RhYmxlcmFuZ2U6MDEwMTA4Nzk1MzdiNGQ5ZmFjNDhlMTBlZTk1NDc4NmVfMTEtOC0xLTEtNDgxNjQ_6e4bdef0-f194-4e8e-a6b6-1bd26c790d26" unitRef="usd"> 2935000 </us-gaap:LineOfCredit>
<us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd contextRef="id58289e26ef94850ac4a7fc7f7ebd663_I20220630" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81OC9mcmFnOjdlMWE2NDBlMDg3ODQ4MjA5MjY1Y2QwY2E4ZTlhYTg0L3RhYmxlOjAxMDEwODc5NTM3YjRkOWZhYzQ4ZTEwZWU5NTQ3ODZlL3RhYmxlcmFuZ2U6MDEwMTA4Nzk1MzdiNGQ5ZmFjNDhlMTBlZTk1NDc4NmVfMTItMi0xLTEtNDgxNjQ_1f73c81a-73ed-42fd-9a62-585b9c87c059" unitRef="number"> 0.0550 </us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd>
<us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="id58289e26ef94850ac4a7fc7f7ebd663_I20220630" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81OC9mcmFnOjdlMWE2NDBlMDg3ODQ4MjA5MjY1Y2QwY2E4ZTlhYTg0L3RhYmxlOjAxMDEwODc5NTM3YjRkOWZhYzQ4ZTEwZWU5NTQ3ODZlL3RhYmxlcmFuZ2U6MDEwMTA4Nzk1MzdiNGQ5ZmFjNDhlMTBlZTk1NDc4NmVfMTItNC0xLTEtNDgxNjQ_f2420e5e-dbcd-4448-9e75-9fb524990fe7" unitRef="usd"> 1500000 </us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
<us-gaap:LineOfCredit contextRef="id58289e26ef94850ac4a7fc7f7ebd663_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81OC9mcmFnOjdlMWE2NDBlMDg3ODQ4MjA5MjY1Y2QwY2E4ZTlhYTg0L3RhYmxlOjAxMDEwODc5NTM3YjRkOWZhYzQ4ZTEwZWU5NTQ3ODZlL3RhYmxlcmFuZ2U6MDEwMTA4Nzk1MzdiNGQ5ZmFjNDhlMTBlZTk1NDc4NmVfMTItNi0xLTEtNDgxNjQ_ce68f2df-0f66-4f0b-9a57-8485b3b13711" unitRef="usd"> 845000 </us-gaap:LineOfCredit>
<us-gaap:LineOfCredit contextRef="i04b9f66f168143bd90f0da006fed8821_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81OC9mcmFnOjdlMWE2NDBlMDg3ODQ4MjA5MjY1Y2QwY2E4ZTlhYTg0L3RhYmxlOjAxMDEwODc5NTM3YjRkOWZhYzQ4ZTEwZWU5NTQ3ODZlL3RhYmxlcmFuZ2U6MDEwMTA4Nzk1MzdiNGQ5ZmFjNDhlMTBlZTk1NDc4NmVfMTItOC0xLTEtNDgxNjQ_54a20aae-34cb-46f3-84c7-9fd67e96264a" unitRef="usd"> 0 </us-gaap:LineOfCredit>
<us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd contextRef="i1718a3744fce467e9d6d675f095bd492_I20220630" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81OC9mcmFnOjdlMWE2NDBlMDg3ODQ4MjA5MjY1Y2QwY2E4ZTlhYTg0L3RhYmxlOjAxMDEwODc5NTM3YjRkOWZhYzQ4ZTEwZWU5NTQ3ODZlL3RhYmxlcmFuZ2U6MDEwMTA4Nzk1MzdiNGQ5ZmFjNDhlMTBlZTk1NDc4NmVfMTMtMi0xLTEtNDgxNjQ_02f36a95-fb84-49cd-9902-4fd731caa539" unitRef="number"> 0.0500 </us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd>
<us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="i1718a3744fce467e9d6d675f095bd492_I20220630" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81OC9mcmFnOjdlMWE2NDBlMDg3ODQ4MjA5MjY1Y2QwY2E4ZTlhYTg0L3RhYmxlOjAxMDEwODc5NTM3YjRkOWZhYzQ4ZTEwZWU5NTQ3ODZlL3RhYmxlcmFuZ2U6MDEwMTA4Nzk1MzdiNGQ5ZmFjNDhlMTBlZTk1NDc4NmVfMTMtNC0xLTEtNDgxNjQ_db2d89e5-87cd-465c-a4db-411b16fd7568" unitRef="usd"> 2000000 </us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
<us-gaap:LineOfCredit contextRef="i1718a3744fce467e9d6d675f095bd492_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81OC9mcmFnOjdlMWE2NDBlMDg3ODQ4MjA5MjY1Y2QwY2E4ZTlhYTg0L3RhYmxlOjAxMDEwODc5NTM3YjRkOWZhYzQ4ZTEwZWU5NTQ3ODZlL3RhYmxlcmFuZ2U6MDEwMTA4Nzk1MzdiNGQ5ZmFjNDhlMTBlZTk1NDc4NmVfMTMtNi0xLTEtNDgxNjQ_717ba0b4-ae90-43cb-825b-308fa9e8c827" unitRef="usd"> 1151000 </us-gaap:LineOfCredit>
<us-gaap:LineOfCredit contextRef="i6ba73a1704414fdb8410cf207c73c0c1_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81OC9mcmFnOjdlMWE2NDBlMDg3ODQ4MjA5MjY1Y2QwY2E4ZTlhYTg0L3RhYmxlOjAxMDEwODc5NTM3YjRkOWZhYzQ4ZTEwZWU5NTQ3ODZlL3RhYmxlcmFuZ2U6MDEwMTA4Nzk1MzdiNGQ5ZmFjNDhlMTBlZTk1NDc4NmVfMTMtOC0xLTEtNDgxNjQ_158ea737-fb9b-4ab1-909f-79b67b548c3f" unitRef="usd"> 0 </us-gaap:LineOfCredit>
<us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd contextRef="i05bc4a7a182945a580aa3920bde0e0b3_I20220630" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81OC9mcmFnOjdlMWE2NDBlMDg3ODQ4MjA5MjY1Y2QwY2E4ZTlhYTg0L3RhYmxlOjAxMDEwODc5NTM3YjRkOWZhYzQ4ZTEwZWU5NTQ3ODZlL3RhYmxlcmFuZ2U6MDEwMTA4Nzk1MzdiNGQ5ZmFjNDhlMTBlZTk1NDc4NmVfMTQtMi0xLTEtNDgxNjQ_5064e242-9a60-4cd9-ab64-e993efc973e6" unitRef="number"> 0.0175 </us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd>
<us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="i05bc4a7a182945a580aa3920bde0e0b3_I20220630" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81OC9mcmFnOjdlMWE2NDBlMDg3ODQ4MjA5MjY1Y2QwY2E4ZTlhYTg0L3RhYmxlOjAxMDEwODc5NTM3YjRkOWZhYzQ4ZTEwZWU5NTQ3ODZlL3RhYmxlcmFuZ2U6MDEwMTA4Nzk1MzdiNGQ5ZmFjNDhlMTBlZTk1NDc4NmVfMTQtNC0xLTEtNDgxNjQ_c137aca7-eaf6-471e-b4ea-7221b9e5d6d1" unitRef="usd"> 522000 </us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
<us-gaap:LineOfCredit contextRef="i05bc4a7a182945a580aa3920bde0e0b3_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81OC9mcmFnOjdlMWE2NDBlMDg3ODQ4MjA5MjY1Y2QwY2E4ZTlhYTg0L3RhYmxlOjAxMDEwODc5NTM3YjRkOWZhYzQ4ZTEwZWU5NTQ3ODZlL3RhYmxlcmFuZ2U6MDEwMTA4Nzk1MzdiNGQ5ZmFjNDhlMTBlZTk1NDc4NmVfMTQtNi0xLTEtNDgxNjQ_0ecf154e-164d-46b4-8002-26c5cb55710e" unitRef="usd"> 0 </us-gaap:LineOfCredit>
<us-gaap:LineOfCredit contextRef="i6783b43b6eb6425fa7d452652473e794_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81OC9mcmFnOjdlMWE2NDBlMDg3ODQ4MjA5MjY1Y2QwY2E4ZTlhYTg0L3RhYmxlOjAxMDEwODc5NTM3YjRkOWZhYzQ4ZTEwZWU5NTQ3ODZlL3RhYmxlcmFuZ2U6MDEwMTA4Nzk1MzdiNGQ5ZmFjNDhlMTBlZTk1NDc4NmVfMTQtOC0xLTEtNDgxNjQ_5ff29725-8db8-49ad-8aeb-842c246c1e2c" unitRef="usd"> 0 </us-gaap:LineOfCredit>
<us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd contextRef="i597fd23d185f4f11835243b671f72ad8_I20220630" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81OC9mcmFnOjdlMWE2NDBlMDg3ODQ4MjA5MjY1Y2QwY2E4ZTlhYTg0L3RhYmxlOjAxMDEwODc5NTM3YjRkOWZhYzQ4ZTEwZWU5NTQ3ODZlL3RhYmxlcmFuZ2U6MDEwMTA4Nzk1MzdiNGQ5ZmFjNDhlMTBlZTk1NDc4NmVfMTUtMi0xLTEtNDgxNjQ_151b12b7-f688-4a1d-984a-fbaa7aaf8bab" unitRef="number"> 0.0215 </us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd>
<us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="i597fd23d185f4f11835243b671f72ad8_I20220630" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81OC9mcmFnOjdlMWE2NDBlMDg3ODQ4MjA5MjY1Y2QwY2E4ZTlhYTg0L3RhYmxlOjAxMDEwODc5NTM3YjRkOWZhYzQ4ZTEwZWU5NTQ3ODZlL3RhYmxlcmFuZ2U6MDEwMTA4Nzk1MzdiNGQ5ZmFjNDhlMTBlZTk1NDc4NmVfMTUtNC0xLTEtNDgxNjQ_cfe4eeed-9fa4-43d6-9635-d7d39b5f39a2" unitRef="usd"> 522000 </us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
<us-gaap:LineOfCredit contextRef="i597fd23d185f4f11835243b671f72ad8_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81OC9mcmFnOjdlMWE2NDBlMDg3ODQ4MjA5MjY1Y2QwY2E4ZTlhYTg0L3RhYmxlOjAxMDEwODc5NTM3YjRkOWZhYzQ4ZTEwZWU5NTQ3ODZlL3RhYmxlcmFuZ2U6MDEwMTA4Nzk1MzdiNGQ5ZmFjNDhlMTBlZTk1NDc4NmVfMTUtNi0xLTEtNDgxNjQ_01854233-b229-46a4-8584-950f736a257c" unitRef="usd"> 0 </us-gaap:LineOfCredit>
<us-gaap:LineOfCredit contextRef="i6b5d01d98bd541cd86e2d77e9037086a_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81OC9mcmFnOjdlMWE2NDBlMDg3ODQ4MjA5MjY1Y2QwY2E4ZTlhYTg0L3RhYmxlOjAxMDEwODc5NTM3YjRkOWZhYzQ4ZTEwZWU5NTQ3ODZlL3RhYmxlcmFuZ2U6MDEwMTA4Nzk1MzdiNGQ5ZmFjNDhlMTBlZTk1NDc4NmVfMTUtOC0xLTEtNDgxNjQ_e163f22b-7a39-4fb4-b8db-42b100dd2df1" unitRef="usd"> 0 </us-gaap:LineOfCredit>
<us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="i4768f885851b49f986857a2a956f9162_I20220630" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81OC9mcmFnOjdlMWE2NDBlMDg3ODQ4MjA5MjY1Y2QwY2E4ZTlhYTg0L3RhYmxlOjAxMDEwODc5NTM3YjRkOWZhYzQ4ZTEwZWU5NTQ3ODZlL3RhYmxlcmFuZ2U6MDEwMTA4Nzk1MzdiNGQ5ZmFjNDhlMTBlZTk1NDc4NmVfMTctNC0xLTEtNDgxNjQ_5ea087d1-3761-4e31-acc9-7b42dd34305b" unitRef="usd"> 104844000 </us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
<us-gaap:LineOfCredit contextRef="i4768f885851b49f986857a2a956f9162_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81OC9mcmFnOjdlMWE2NDBlMDg3ODQ4MjA5MjY1Y2QwY2E4ZTlhYTg0L3RhYmxlOjAxMDEwODc5NTM3YjRkOWZhYzQ4ZTEwZWU5NTQ3ODZlL3RhYmxlcmFuZ2U6MDEwMTA4Nzk1MzdiNGQ5ZmFjNDhlMTBlZTk1NDc4NmVfMTctNi0xLTEtNDgxNjQ_37f944a7-1264-40d6-bfb3-fa05757f6197" unitRef="usd"> 18218000 </us-gaap:LineOfCredit>
<us-gaap:LineOfCredit contextRef="i7e0f479bead144b0bdbcc71082db627b_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81OC9mcmFnOjdlMWE2NDBlMDg3ODQ4MjA5MjY1Y2QwY2E4ZTlhYTg0L3RhYmxlOjAxMDEwODc5NTM3YjRkOWZhYzQ4ZTEwZWU5NTQ3ODZlL3RhYmxlcmFuZ2U6MDEwMTA4Nzk1MzdiNGQ5ZmFjNDhlMTBlZTk1NDc4NmVfMTctOC0xLTEtNDgxNjQ_6b034efa-92c6-49f1-861e-46088fc11d12" unitRef="usd"> 13672000 </us-gaap:LineOfCredit>
<us-gaap:DebtWeightedAverageInterestRate contextRef="ifc4a073257294a89b0fae4e5d964a900_I20211231" decimals="4" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81OC9mcmFnOjdlMWE2NDBlMDg3ODQ4MjA5MjY1Y2QwY2E4ZTlhYTg0L3RleHRyZWdpb246N2UxYTY0MGUwODc4NDgyMDkyNjVjZDBjYThlOWFhODRfMTc1OTM_2c0c598c-d806-42b3-a4d8-e939c83e04b7" unitRef="number"> 0.054 </us-gaap:DebtWeightedAverageInterestRate>
<us-gaap:DebtWeightedAverageInterestRate contextRef="ic0a23d2a2b9748de8fc661ffee37ea8e_I20220630" decimals="4" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81OC9mcmFnOjdlMWE2NDBlMDg3ODQ4MjA5MjY1Y2QwY2E4ZTlhYTg0L3RleHRyZWdpb246N2UxYTY0MGUwODc4NDgyMDkyNjVjZDBjYThlOWFhODRfMTc1OTM_ead3d603-ac95-4f2b-84c5-a2759b023e00" unitRef="number"> 0.054 </us-gaap:DebtWeightedAverageInterestRate>
<us-gaap:LongTermDebtCurrent contextRef="i5ed93df026694b52bdb270cb2e2bba15_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81OC9mcmFnOjdlMWE2NDBlMDg3ODQ4MjA5MjY1Y2QwY2E4ZTlhYTg0L3RhYmxlOjEzNWI1OGQwNWY4ZDRlZWM4ZDVkODY4MjUxMWFlYmMxL3RhYmxlcmFuZ2U6MTM1YjU4ZDA1ZjhkNGVlYzhkNWQ4NjgyNTExYWViYzFfMS0xLTEtMS00ODE2NA_64d9959a-696c-4aec-bebd-d96cc51e449d" unitRef="usd"> 771000 </us-gaap:LongTermDebtCurrent>
<us-gaap:LongTermDebtCurrent contextRef="i393cb528c2304024a2d3dab1c70aa562_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81OC9mcmFnOjdlMWE2NDBlMDg3ODQ4MjA5MjY1Y2QwY2E4ZTlhYTg0L3RhYmxlOjEzNWI1OGQwNWY4ZDRlZWM4ZDVkODY4MjUxMWFlYmMxL3RhYmxlcmFuZ2U6MTM1YjU4ZDA1ZjhkNGVlYzhkNWQ4NjgyNTExYWViYzFfMS0zLTEtMS00ODE2NA_0c33a689-5a68-4b1d-8a39-850e43c8a210" unitRef="usd"> 1022000 </us-gaap:LongTermDebtCurrent>
<us-gaap:OtherLiabilitiesNoncurrent contextRef="i5ed93df026694b52bdb270cb2e2bba15_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81OC9mcmFnOjdlMWE2NDBlMDg3ODQ4MjA5MjY1Y2QwY2E4ZTlhYTg0L3RhYmxlOjEzNWI1OGQwNWY4ZDRlZWM4ZDVkODY4MjUxMWFlYmMxL3RhYmxlcmFuZ2U6MTM1YjU4ZDA1ZjhkNGVlYzhkNWQ4NjgyNTExYWViYzFfMi0xLTEtMS00ODE2NA_c7735825-77e5-4476-b44b-2484100787f5" unitRef="usd"> 1984000 </us-gaap:OtherLiabilitiesNoncurrent>
<us-gaap:OtherLiabilitiesNoncurrent contextRef="i393cb528c2304024a2d3dab1c70aa562_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81OC9mcmFnOjdlMWE2NDBlMDg3ODQ4MjA5MjY1Y2QwY2E4ZTlhYTg0L3RhYmxlOjEzNWI1OGQwNWY4ZDRlZWM4ZDVkODY4MjUxMWFlYmMxL3RhYmxlcmFuZ2U6MTM1YjU4ZDA1ZjhkNGVlYzhkNWQ4NjgyNTExYWViYzFfMi0zLTEtMS00ODE2NA_2f8c4460-72c0-4d06-a545-a05339ecd4c6" unitRef="usd"> 2642000 </us-gaap:OtherLiabilitiesNoncurrent>
<us-gaap:LongTermDebt contextRef="i5ed93df026694b52bdb270cb2e2bba15_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81OC9mcmFnOjdlMWE2NDBlMDg3ODQ4MjA5MjY1Y2QwY2E4ZTlhYTg0L3RhYmxlOjEzNWI1OGQwNWY4ZDRlZWM4ZDVkODY4MjUxMWFlYmMxL3RhYmxlcmFuZ2U6MTM1YjU4ZDA1ZjhkNGVlYzhkNWQ4NjgyNTExYWViYzFfMy0xLTEtMS00ODE2NA_a87c50fd-15c1-4f7f-90f1-ea84a4629888" unitRef="usd"> 2755000 </us-gaap:LongTermDebt>
<us-gaap:LongTermDebt contextRef="i393cb528c2304024a2d3dab1c70aa562_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81OC9mcmFnOjdlMWE2NDBlMDg3ODQ4MjA5MjY1Y2QwY2E4ZTlhYTg0L3RhYmxlOjEzNWI1OGQwNWY4ZDRlZWM4ZDVkODY4MjUxMWFlYmMxL3RhYmxlcmFuZ2U6MTM1YjU4ZDA1ZjhkNGVlYzhkNWQ4NjgyNTExYWViYzFfMy0zLTEtMS00ODE2NA_d7046a18-b2b2-4ee5-843c-92362c282e57" unitRef="usd"> 3664000 </us-gaap:LongTermDebt>
<us-gaap:LongTermDebtPercentageBearingVariableInterestRate contextRef="i28c749cd61f5444e8a8e514d12554ce0_I20220630" decimals="3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81OC9mcmFnOjdlMWE2NDBlMDg3ODQ4MjA5MjY1Y2QwY2E4ZTlhYTg0L3RleHRyZWdpb246N2UxYTY0MGUwODc4NDgyMDkyNjVjZDBjYThlOWFhODRfMTc5NjI_f2abcd2c-bdbb-4058-8487-a3f81f221d6d" unitRef="number"> 0.007 </us-gaap:LongTermDebtPercentageBearingVariableInterestRate>
<us-gaap:LongTermDebtPercentageBearingVariableInterestRate contextRef="i15d550a3788a46098959eb013a63ace4_I20220630" decimals="3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81OC9mcmFnOjdlMWE2NDBlMDg3ODQ4MjA5MjY1Y2QwY2E4ZTlhYTg0L3RleHRyZWdpb246N2UxYTY0MGUwODc4NDgyMDkyNjVjZDBjYThlOWFhODRfMTc5NzE_427c59eb-d5fb-4171-b0d0-447811ba4418" unitRef="number"> 0.038 </us-gaap:LongTermDebtPercentageBearingVariableInterestRate>
<us-gaap:DebtWeightedAverageInterestRate contextRef="if8ff0b6e8f3a4561b6661e6b9d97aaea_I20211231" decimals="3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81OC9mcmFnOjdlMWE2NDBlMDg3ODQ4MjA5MjY1Y2QwY2E4ZTlhYTg0L3RleHRyZWdpb246N2UxYTY0MGUwODc4NDgyMDkyNjVjZDBjYThlOWFhODRfMTgwNDM_030b146c-9ddb-4edc-9635-3cae81c9c04b" unitRef="number"> 0.015 </us-gaap:DebtWeightedAverageInterestRate>
<us-gaap:DebtWeightedAverageInterestRate contextRef="i092cd0d4f9f24c7e85aa4253a35b7074_I20220630" decimals="3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml81OC9mcmFnOjdlMWE2NDBlMDg3ODQ4MjA5MjY1Y2QwY2E4ZTlhYTg0L3RleHRyZWdpb246N2UxYTY0MGUwODc4NDgyMDkyNjVjZDBjYThlOWFhODRfMTgwNDM_51c17b61-7ef7-4bdd-bc1c-64f23265b9bc" unitRef="number"> 0.015 </us-gaap:DebtWeightedAverageInterestRate>
<us-gaap:ComprehensiveIncomeNoteTextBlock contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml82NC9mcmFnOjY2OGExMzJmMjE3YTRjMjU4ZThlOGRhNGRhOWU5YTliL3RleHRyZWdpb246NjY4YTEzMmYyMTdhNGMyNThlOGU4ZGE0ZGE5ZTlhOWJfMTQz_ecaafd27-6713-4b63-ba4d-ac1cca792d6a">
ACCUMULATED OTHER COMPREHENSIVE LOSS<div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the six months ended June 30, 2022, changes in Accumulated other comprehensive loss, net of tax, were as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:85.430%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.370%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign<br/>currency<br/>translation</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30,495)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:20.25pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18,676)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at June 30, 2022</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(49,171)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div>
</us-gaap:ComprehensiveIncomeNoteTextBlock>
<us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml82NC9mcmFnOjY2OGExMzJmMjE3YTRjMjU4ZThlOGRhNGRhOWU5YTliL3RleHRyZWdpb246NjY4YTEzMmYyMTdhNGMyNThlOGU4ZGE0ZGE5ZTlhOWJfMTQw_6a2f09c9-98bd-4aed-9901-232129727754">
<div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the six months ended June 30, 2022, changes in Accumulated other comprehensive loss, net of tax, were as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:85.430%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.370%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign<br/>currency<br/>translation</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30,495)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:20.25pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18,676)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at June 30, 2022</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(49,171)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div>
</us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
<us-gaap:StockholdersEquity contextRef="i303bb35bf09d4dc7856750f6db40b282_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml82NC9mcmFnOjY2OGExMzJmMjE3YTRjMjU4ZThlOGRhNGRhOWU5YTliL3RhYmxlOjY5MjBiZmNiNjhhNDQwMzc4ZWNkY2FlYzk4MzI5M2QwL3RhYmxlcmFuZ2U6NjkyMGJmY2I2OGE0NDAzNzhlY2RjYWVjOTgzMjkzZDBfMS0xLTEtMS00ODE2NA_9a0ee71e-392b-4c8e-ba55-ca45152e6cb1" unitRef="usd"> -30495000 </us-gaap:StockholdersEquity>
<us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="i8653f039aac143078e56b57e5a08417b_D20220101-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml82NC9mcmFnOjY2OGExMzJmMjE3YTRjMjU4ZThlOGRhNGRhOWU5YTliL3RhYmxlOjY5MjBiZmNiNjhhNDQwMzc4ZWNkY2FlYzk4MzI5M2QwL3RhYmxlcmFuZ2U6NjkyMGJmY2I2OGE0NDAzNzhlY2RjYWVjOTgzMjkzZDBfMi0xLTEtMS00ODE2NA_3536ad74-c135-4071-9422-2c198218aa96" unitRef="usd"> -18676000 </us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
<us-gaap:StockholdersEquity contextRef="if3554448f2d343a8844430991e28c3a6_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml82NC9mcmFnOjY2OGExMzJmMjE3YTRjMjU4ZThlOGRhNGRhOWU5YTliL3RhYmxlOjY5MjBiZmNiNjhhNDQwMzc4ZWNkY2FlYzk4MzI5M2QwL3RhYmxlcmFuZ2U6NjkyMGJmY2I2OGE0NDAzNzhlY2RjYWVjOTgzMjkzZDBfNS0xLTEtMS00ODE2NA_05dd1c82-bf16-4fb6-8ab8-a2898e870a2b" unitRef="usd"> -49171000 </us-gaap:StockholdersEquity>
<us-gaap:FairValueDisclosuresTextBlock contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml82Ny9mcmFnOjgzMTNlZWQwYzRhMTQ2OTg4NzIwNmI3MTgxZjUwMDNjL3RleHRyZWdpb246ODMxM2VlZDBjNGExNDY5ODg3MjA2YjcxODFmNTAwM2NfMzIzNg_66210aa4-aa6e-4630-9de9-aa25b47c289c">
FAIR VALUE MEASUREMENTS<div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We record fair values at an exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. As such, fair value is a market-based measurement determined based on assumptions that market participants would use in pricing an asset or liability. We utilize a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. These tiers are: Level 1, defined as observable inputs such as quoted prices in active markets; Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable; and Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June 30, 2022, we had equity securities and an equity method fair value option (refer to Note 6), forward foreign currency exchange contracts for inventory purchases (refer to Note 10) and contingent consideration related to the acquisitions of CURNA, OPKO Diagnostics and OPKO Renal that are required to be measured at fair value on a recurring basis. In addition, in connection with our investment and our consulting agreement with BioCardia, we record the related BioCardia options at fair value as well as the warrants from COCP.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our financial assets and liabilities measured at fair value on a recurring basis are as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:45.752%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.641%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fair value measurements as of June 30, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Quoted<br/>prices in<br/>active<br/>markets for<br/>identical<br/>assets<br/>(Level 1)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Significant<br/>other<br/>observable<br/>inputs<br/>(Level 2)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Significant<br/>unobservable<br/>inputs<br/>(Level 3)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131,658 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131,658 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,508 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,508 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity Method - FV option</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100,800 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100,800 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock options/warrants</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">434 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">434 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">233,966 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">445 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">234,411 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,903 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,903 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,903 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,903 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:45.752%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.641%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fair value measurements as of December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Quoted<br/>prices in<br/>active<br/>markets for<br/>identical<br/>assets<br/>(Level 1)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Significant<br/>other<br/>observable<br/>inputs<br/>(Level 2)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Significant<br/>unobservable<br/>inputs<br/>(Level 3)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,226 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,226 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock options/warrants</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,226 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,364 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,837 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,837 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,837 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,837 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying amount and estimated fair value of our 2025 Notes, as well as the applicable fair value hierarchy tiers, are contained in the table below. The fair value of the 2025 Notes is determined using inputs other than quoted prices in active markets that are directly observable.</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.297%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.870%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="27" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 30, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carrying<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total<br/>Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 3</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025 Notes</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141,537 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145,163 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145,163 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:4pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been no transfers between Level 1 and Level 2 and no transfers to or from Level 3 of the fair value hierarchy.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June 30, 2022 and December 31, 2021, the carrying value of our other financial instrument assets approximates their fair value due to their short-term nature or variable rate of interest.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table reconciles the beginning and ending balances of our Level 3 assets and liabilities as of June 30, 2022:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:79.398%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.402%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">June 30, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Contingent<br/>consideration</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2021</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,837 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Included in results of operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency impact</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at June 30, 2022</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,903 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:4pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated fair values of our financial instruments have been determined by using available market information and what we believe to be appropriate valuation methodologies. We use the following methods and assumptions in estimating fair value:</span></div>Contingent consideration – We estimate the fair value of the contingent consideration utilizing a discounted cash flow model for the expected payments based on estimated timing and expected revenues. We use several discount rates depending on each type of contingent consideration related to OPKO Diagnostics, CURNA and OPKO Renal transactions. As of June 30, 2022, of the $2.9 million of contingent consideration, $0.5 million was recorded in Accrued expenses and $2.4 million was recorded in Other long-term liabilities. As of December 31, 2021, of the $2.8 million of contingent consideration, $0.5 million was recorded in Accrued expenses and $2.3 million was recorded in Other long-term liabilities. As a result of our execution of the CAMP4 Agreement (as defined in Note 14), we will have to pay a percentage of any payments received under the CAMP4 Agreement to the former CURNA stockholders.
</us-gaap:FairValueDisclosuresTextBlock>
<us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml82Ny9mcmFnOjgzMTNlZWQwYzRhMTQ2OTg4NzIwNmI3MTgxZjUwMDNjL3RleHRyZWdpb246ODMxM2VlZDBjNGExNDY5ODg3MjA2YjcxODFmNTAwM2NfMzIyMw_abd4d702-81d2-4960-9b9e-f59284bd9092">
<div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our financial assets and liabilities measured at fair value on a recurring basis are as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:45.752%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.641%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fair value measurements as of June 30, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Quoted<br/>prices in<br/>active<br/>markets for<br/>identical<br/>assets<br/>(Level 1)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Significant<br/>other<br/>observable<br/>inputs<br/>(Level 2)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Significant<br/>unobservable<br/>inputs<br/>(Level 3)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131,658 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131,658 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,508 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,508 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity Method - FV option</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100,800 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100,800 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock options/warrants</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">434 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">434 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">233,966 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">445 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">234,411 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,903 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,903 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,903 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,903 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:45.752%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.641%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fair value measurements as of December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Quoted<br/>prices in<br/>active<br/>markets for<br/>identical<br/>assets<br/>(Level 1)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Significant<br/>other<br/>observable<br/>inputs<br/>(Level 2)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Significant<br/>unobservable<br/>inputs<br/>(Level 3)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,226 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,226 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock options/warrants</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,226 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,364 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,837 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,837 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,837 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,837 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>
</us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock>
<us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="ibfea464ded6448aca552adef980e0da4_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml82Ny9mcmFnOjgzMTNlZWQwYzRhMTQ2OTg4NzIwNmI3MTgxZjUwMDNjL3RhYmxlOjkzMTRkM2JlYWIyNzQwMzc4MTgwYzM1MmZiODQ5M2YwL3RhYmxlcmFuZ2U6OTMxNGQzYmVhYjI3NDAzNzgxODBjMzUyZmI4NDkzZjBfMy0xLTEtMS00ODE2NA_31185cb9-82cc-4336-b93c-ec9769597e54" unitRef="usd"> 131658000 </us-gaap:CashAndCashEquivalentsFairValueDisclosure>
<us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="i72fd1c49a8474b988e35665a53082217_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml82Ny9mcmFnOjgzMTNlZWQwYzRhMTQ2OTg4NzIwNmI3MTgxZjUwMDNjL3RhYmxlOjkzMTRkM2JlYWIyNzQwMzc4MTgwYzM1MmZiODQ5M2YwL3RhYmxlcmFuZ2U6OTMxNGQzYmVhYjI3NDAzNzgxODBjMzUyZmI4NDkzZjBfMy0zLTEtMS00ODE2NA_004c424b-f2a3-4d70-9a1e-479944f1b623" unitRef="usd"> 0 </us-gaap:CashAndCashEquivalentsFairValueDisclosure>
<us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="i0fc88df2a18e4450acfcd643aba9ccf2_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml82Ny9mcmFnOjgzMTNlZWQwYzRhMTQ2OTg4NzIwNmI3MTgxZjUwMDNjL3RhYmxlOjkzMTRkM2JlYWIyNzQwMzc4MTgwYzM1MmZiODQ5M2YwL3RhYmxlcmFuZ2U6OTMxNGQzYmVhYjI3NDAzNzgxODBjMzUyZmI4NDkzZjBfMy01LTEtMS00ODE2NA_aff574af-ab6a-4e14-a7bd-b169bd3c182b" unitRef="usd"> 0 </us-gaap:CashAndCashEquivalentsFairValueDisclosure>
<us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="i4768f885851b49f986857a2a956f9162_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml82Ny9mcmFnOjgzMTNlZWQwYzRhMTQ2OTg4NzIwNmI3MTgxZjUwMDNjL3RhYmxlOjkzMTRkM2JlYWIyNzQwMzc4MTgwYzM1MmZiODQ5M2YwL3RhYmxlcmFuZ2U6OTMxNGQzYmVhYjI3NDAzNzgxODBjMzUyZmI4NDkzZjBfMy03LTEtMS00ODE2NA_53add546-36c1-489b-936c-d2b3254f8f67" unitRef="usd"> 131658000 </us-gaap:CashAndCashEquivalentsFairValueDisclosure>
<us-gaap:EquitySecuritiesFvNi contextRef="ibfea464ded6448aca552adef980e0da4_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml82Ny9mcmFnOjgzMTNlZWQwYzRhMTQ2OTg4NzIwNmI3MTgxZjUwMDNjL3RhYmxlOjkzMTRkM2JlYWIyNzQwMzc4MTgwYzM1MmZiODQ5M2YwL3RhYmxlcmFuZ2U6OTMxNGQzYmVhYjI3NDAzNzgxODBjMzUyZmI4NDkzZjBfNS0xLTEtMS00ODE2NA_c9448dab-09eb-4938-ab51-c228f1e90d45" unitRef="usd"> 1508000 </us-gaap:EquitySecuritiesFvNi>
<us-gaap:EquitySecuritiesFvNi contextRef="i72fd1c49a8474b988e35665a53082217_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml82Ny9mcmFnOjgzMTNlZWQwYzRhMTQ2OTg4NzIwNmI3MTgxZjUwMDNjL3RhYmxlOjkzMTRkM2JlYWIyNzQwMzc4MTgwYzM1MmZiODQ5M2YwL3RhYmxlcmFuZ2U6OTMxNGQzYmVhYjI3NDAzNzgxODBjMzUyZmI4NDkzZjBfNS0zLTEtMS00ODE2NA_7072ee3e-273c-4514-8846-a61dfae7cd42" unitRef="usd"> 0 </us-gaap:EquitySecuritiesFvNi>
<us-gaap:EquitySecuritiesFvNi contextRef="i0fc88df2a18e4450acfcd643aba9ccf2_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml82Ny9mcmFnOjgzMTNlZWQwYzRhMTQ2OTg4NzIwNmI3MTgxZjUwMDNjL3RhYmxlOjkzMTRkM2JlYWIyNzQwMzc4MTgwYzM1MmZiODQ5M2YwL3RhYmxlcmFuZ2U6OTMxNGQzYmVhYjI3NDAzNzgxODBjMzUyZmI4NDkzZjBfNS01LTEtMS00ODE2NA_5d62946b-6a84-400f-b062-774b7a7130b7" unitRef="usd"> 0 </us-gaap:EquitySecuritiesFvNi>
<us-gaap:EquitySecuritiesFvNi contextRef="i4768f885851b49f986857a2a956f9162_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml82Ny9mcmFnOjgzMTNlZWQwYzRhMTQ2OTg4NzIwNmI3MTgxZjUwMDNjL3RhYmxlOjkzMTRkM2JlYWIyNzQwMzc4MTgwYzM1MmZiODQ5M2YwL3RhYmxlcmFuZ2U6OTMxNGQzYmVhYjI3NDAzNzgxODBjMzUyZmI4NDkzZjBfNS03LTEtMS00ODE2NA_5eb592d0-8722-4340-bc4f-1804a4d443cf" unitRef="usd"> 1508000 </us-gaap:EquitySecuritiesFvNi>
<us-gaap:EquityMethodInvestmentsFairValueDisclosure contextRef="ibfea464ded6448aca552adef980e0da4_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml82Ny9mcmFnOjgzMTNlZWQwYzRhMTQ2OTg4NzIwNmI3MTgxZjUwMDNjL3RhYmxlOjkzMTRkM2JlYWIyNzQwMzc4MTgwYzM1MmZiODQ5M2YwL3RhYmxlcmFuZ2U6OTMxNGQzYmVhYjI3NDAzNzgxODBjMzUyZmI4NDkzZjBfNi0xLTEtMS01NTEzNw_e8089490-4181-48b3-af59-5970abaff5b9" unitRef="usd"> 100800000 </us-gaap:EquityMethodInvestmentsFairValueDisclosure>
<us-gaap:EquityMethodInvestmentsFairValueDisclosure contextRef="i72fd1c49a8474b988e35665a53082217_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml82Ny9mcmFnOjgzMTNlZWQwYzRhMTQ2OTg4NzIwNmI3MTgxZjUwMDNjL3RhYmxlOjkzMTRkM2JlYWIyNzQwMzc4MTgwYzM1MmZiODQ5M2YwL3RhYmxlcmFuZ2U6OTMxNGQzYmVhYjI3NDAzNzgxODBjMzUyZmI4NDkzZjBfNi0zLTEtMS01NTEzNw_d4dd27d5-efc2-4325-a06e-950ec9a13c8f" unitRef="usd"> 0 </us-gaap:EquityMethodInvestmentsFairValueDisclosure>
<us-gaap:EquityMethodInvestmentsFairValueDisclosure contextRef="i0fc88df2a18e4450acfcd643aba9ccf2_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml82Ny9mcmFnOjgzMTNlZWQwYzRhMTQ2OTg4NzIwNmI3MTgxZjUwMDNjL3RhYmxlOjkzMTRkM2JlYWIyNzQwMzc4MTgwYzM1MmZiODQ5M2YwL3RhYmxlcmFuZ2U6OTMxNGQzYmVhYjI3NDAzNzgxODBjMzUyZmI4NDkzZjBfNi01LTEtMS01NTEzNw_bcf0b73b-23e9-450e-bf00-5fc9d078238d" unitRef="usd"> 0 </us-gaap:EquityMethodInvestmentsFairValueDisclosure>
<us-gaap:EquityMethodInvestmentsFairValueDisclosure contextRef="i4768f885851b49f986857a2a956f9162_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml82Ny9mcmFnOjgzMTNlZWQwYzRhMTQ2OTg4NzIwNmI3MTgxZjUwMDNjL3RhYmxlOjkzMTRkM2JlYWIyNzQwMzc4MTgwYzM1MmZiODQ5M2YwL3RhYmxlcmFuZ2U6OTMxNGQzYmVhYjI3NDAzNzgxODBjMzUyZmI4NDkzZjBfNi03LTEtMS01NTEzNw_4acd6c93-7117-491d-8799-393a6fa88cf4" unitRef="usd"> 100800000 </us-gaap:EquityMethodInvestmentsFairValueDisclosure>
<us-gaap:DerivativeAssets contextRef="ie0dc6128eb0c40be9f94448bec95076d_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml82Ny9mcmFnOjgzMTNlZWQwYzRhMTQ2OTg4NzIwNmI3MTgxZjUwMDNjL3RhYmxlOjkzMTRkM2JlYWIyNzQwMzc4MTgwYzM1MmZiODQ5M2YwL3RhYmxlcmFuZ2U6OTMxNGQzYmVhYjI3NDAzNzgxODBjMzUyZmI4NDkzZjBfNi0xLTEtMS00ODE2NA_af25fc88-261a-4895-942b-5cfc4064bfce" unitRef="usd"> 0 </us-gaap:DerivativeAssets>
<us-gaap:DerivativeAssets contextRef="i9a020d7596b24ac89b62d0eb67e8c866_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml82Ny9mcmFnOjgzMTNlZWQwYzRhMTQ2OTg4NzIwNmI3MTgxZjUwMDNjL3RhYmxlOjkzMTRkM2JlYWIyNzQwMzc4MTgwYzM1MmZiODQ5M2YwL3RhYmxlcmFuZ2U6OTMxNGQzYmVhYjI3NDAzNzgxODBjMzUyZmI4NDkzZjBfNi0zLTEtMS00ODE2NA_838cc106-9b30-49e7-a1ef-19a24fa520e1" unitRef="usd"> 11000 </us-gaap:DerivativeAssets>
<us-gaap:DerivativeAssets contextRef="i6d3eb36da42c4da58345c85c97b23dd6_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml82Ny9mcmFnOjgzMTNlZWQwYzRhMTQ2OTg4NzIwNmI3MTgxZjUwMDNjL3RhYmxlOjkzMTRkM2JlYWIyNzQwMzc4MTgwYzM1MmZiODQ5M2YwL3RhYmxlcmFuZ2U6OTMxNGQzYmVhYjI3NDAzNzgxODBjMzUyZmI4NDkzZjBfNi01LTEtMS00ODE2NA_ebbc0fc5-c874-4579-8292-82ab019be3b4" unitRef="usd"> 0 </us-gaap:DerivativeAssets>
<us-gaap:DerivativeAssets contextRef="i76b9d049162140ef8b8eabf4c02dfee2_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml82Ny9mcmFnOjgzMTNlZWQwYzRhMTQ2OTg4NzIwNmI3MTgxZjUwMDNjL3RhYmxlOjkzMTRkM2JlYWIyNzQwMzc4MTgwYzM1MmZiODQ5M2YwL3RhYmxlcmFuZ2U6OTMxNGQzYmVhYjI3NDAzNzgxODBjMzUyZmI4NDkzZjBfNi03LTEtMS00ODE2NA_49400830-d0c8-465b-b34e-2eddc3589c66" unitRef="usd"> 11000 </us-gaap:DerivativeAssets>
<us-gaap:DerivativeAssets contextRef="i224bb3923e45495e9ce69f0beac16ec0_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml82Ny9mcmFnOjgzMTNlZWQwYzRhMTQ2OTg4NzIwNmI3MTgxZjUwMDNjL3RhYmxlOjkzMTRkM2JlYWIyNzQwMzc4MTgwYzM1MmZiODQ5M2YwL3RhYmxlcmFuZ2U6OTMxNGQzYmVhYjI3NDAzNzgxODBjMzUyZmI4NDkzZjBfNy0xLTEtMS00ODE2NA_7bb9bad4-c536-4b4f-85c6-5bb33f59bbf1" unitRef="usd"> 0 </us-gaap:DerivativeAssets>
<us-gaap:DerivativeAssets contextRef="i37f76838f367409e8e4e168dcd0a01d0_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml82Ny9mcmFnOjgzMTNlZWQwYzRhMTQ2OTg4NzIwNmI3MTgxZjUwMDNjL3RhYmxlOjkzMTRkM2JlYWIyNzQwMzc4MTgwYzM1MmZiODQ5M2YwL3RhYmxlcmFuZ2U6OTMxNGQzYmVhYjI3NDAzNzgxODBjMzUyZmI4NDkzZjBfNy0zLTEtMS00ODE2NA_82133eb5-fcf5-4d72-86ef-b6ff5b56055b" unitRef="usd"> 434000 </us-gaap:DerivativeAssets>
<us-gaap:DerivativeAssets contextRef="i4f45baa5bfd249ffbb20b64a82f05cbf_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml82Ny9mcmFnOjgzMTNlZWQwYzRhMTQ2OTg4NzIwNmI3MTgxZjUwMDNjL3RhYmxlOjkzMTRkM2JlYWIyNzQwMzc4MTgwYzM1MmZiODQ5M2YwL3RhYmxlcmFuZ2U6OTMxNGQzYmVhYjI3NDAzNzgxODBjMzUyZmI4NDkzZjBfNy01LTEtMS00ODE2NA_6eab0585-bcd4-40ee-9c69-c5706ec04e12" unitRef="usd"> 0 </us-gaap:DerivativeAssets>
<us-gaap:DerivativeAssets contextRef="i6c79f94c7c804d89a36e480b424e57c0_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml82Ny9mcmFnOjgzMTNlZWQwYzRhMTQ2OTg4NzIwNmI3MTgxZjUwMDNjL3RhYmxlOjkzMTRkM2JlYWIyNzQwMzc4MTgwYzM1MmZiODQ5M2YwL3RhYmxlcmFuZ2U6OTMxNGQzYmVhYjI3NDAzNzgxODBjMzUyZmI4NDkzZjBfNy03LTEtMS00ODE2NA_fb8ea9db-93e2-4163-9f25-a871222d9dbc" unitRef="usd"> 434000 </us-gaap:DerivativeAssets>
<us-gaap:AssetsFairValueDisclosure contextRef="ibfea464ded6448aca552adef980e0da4_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml82Ny9mcmFnOjgzMTNlZWQwYzRhMTQ2OTg4NzIwNmI3MTgxZjUwMDNjL3RhYmxlOjkzMTRkM2JlYWIyNzQwMzc4MTgwYzM1MmZiODQ5M2YwL3RhYmxlcmFuZ2U6OTMxNGQzYmVhYjI3NDAzNzgxODBjMzUyZmI4NDkzZjBfOC0xLTEtMS00ODE2NA_34c438cf-9d8c-4420-84c2-7c9076f54cc8" unitRef="usd"> 233966000 </us-gaap:AssetsFairValueDisclosure>
<us-gaap:AssetsFairValueDisclosure contextRef="i72fd1c49a8474b988e35665a53082217_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml82Ny9mcmFnOjgzMTNlZWQwYzRhMTQ2OTg4NzIwNmI3MTgxZjUwMDNjL3RhYmxlOjkzMTRkM2JlYWIyNzQwMzc4MTgwYzM1MmZiODQ5M2YwL3RhYmxlcmFuZ2U6OTMxNGQzYmVhYjI3NDAzNzgxODBjMzUyZmI4NDkzZjBfOC0zLTEtMS00ODE2NA_920d13b2-6864-4c89-a8e9-060505aed54b" unitRef="usd"> 445000 </us-gaap:AssetsFairValueDisclosure>
<us-gaap:AssetsFairValueDisclosure contextRef="i0fc88df2a18e4450acfcd643aba9ccf2_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml82Ny9mcmFnOjgzMTNlZWQwYzRhMTQ2OTg4NzIwNmI3MTgxZjUwMDNjL3RhYmxlOjkzMTRkM2JlYWIyNzQwMzc4MTgwYzM1MmZiODQ5M2YwL3RhYmxlcmFuZ2U6OTMxNGQzYmVhYjI3NDAzNzgxODBjMzUyZmI4NDkzZjBfOC01LTEtMS00ODE2NA_742fb559-d6e9-4cd0-b226-8bd8c2bdc52e" unitRef="usd"> 0 </us-gaap:AssetsFairValueDisclosure>
<us-gaap:AssetsFairValueDisclosure contextRef="i4768f885851b49f986857a2a956f9162_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml82Ny9mcmFnOjgzMTNlZWQwYzRhMTQ2OTg4NzIwNmI3MTgxZjUwMDNjL3RhYmxlOjkzMTRkM2JlYWIyNzQwMzc4MTgwYzM1MmZiODQ5M2YwL3RhYmxlcmFuZ2U6OTMxNGQzYmVhYjI3NDAzNzgxODBjMzUyZmI4NDkzZjBfOC03LTEtMS00ODE2NA_2b7e2ad0-38da-4ea0-8e1a-b2e5b4fb8b15" unitRef="usd"> 234411000 </us-gaap:AssetsFairValueDisclosure>
<us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="ibfea464ded6448aca552adef980e0da4_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml82Ny9mcmFnOjgzMTNlZWQwYzRhMTQ2OTg4NzIwNmI3MTgxZjUwMDNjL3RhYmxlOjkzMTRkM2JlYWIyNzQwMzc4MTgwYzM1MmZiODQ5M2YwL3RhYmxlcmFuZ2U6OTMxNGQzYmVhYjI3NDAzNzgxODBjMzUyZmI4NDkzZjBfMTMtMS0xLTEtNDgxNjQ_6f094e8c-d015-44f5-b102-29460343095b" unitRef="usd"> 0 </us-gaap:BusinessCombinationContingentConsiderationLiability>
<us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="i72fd1c49a8474b988e35665a53082217_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml82Ny9mcmFnOjgzMTNlZWQwYzRhMTQ2OTg4NzIwNmI3MTgxZjUwMDNjL3RhYmxlOjkzMTRkM2JlYWIyNzQwMzc4MTgwYzM1MmZiODQ5M2YwL3RhYmxlcmFuZ2U6OTMxNGQzYmVhYjI3NDAzNzgxODBjMzUyZmI4NDkzZjBfMTMtMy0xLTEtNDgxNjQ_7bd53b6d-dc4f-4d20-beb1-7ecccf810eaf" unitRef="usd"> 0 </us-gaap:BusinessCombinationContingentConsiderationLiability>
<us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="i0fc88df2a18e4450acfcd643aba9ccf2_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml82Ny9mcmFnOjgzMTNlZWQwYzRhMTQ2OTg4NzIwNmI3MTgxZjUwMDNjL3RhYmxlOjkzMTRkM2JlYWIyNzQwMzc4MTgwYzM1MmZiODQ5M2YwL3RhYmxlcmFuZ2U6OTMxNGQzYmVhYjI3NDAzNzgxODBjMzUyZmI4NDkzZjBfMTMtNS0xLTEtNDgxNjQ_8dadb9e1-9aec-4686-8306-6c95a7b5e3e8" unitRef="usd"> 2903000 </us-gaap:BusinessCombinationContingentConsiderationLiability>
<us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="i4768f885851b49f986857a2a956f9162_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml82Ny9mcmFnOjgzMTNlZWQwYzRhMTQ2OTg4NzIwNmI3MTgxZjUwMDNjL3RhYmxlOjkzMTRkM2JlYWIyNzQwMzc4MTgwYzM1MmZiODQ5M2YwL3RhYmxlcmFuZ2U6OTMxNGQzYmVhYjI3NDAzNzgxODBjMzUyZmI4NDkzZjBfMTMtNy0xLTEtNDgxNjQ_e2f07524-6d81-4f92-bb69-f5df456d41c5" unitRef="usd"> 2903000 </us-gaap:BusinessCombinationContingentConsiderationLiability>
<us-gaap:LiabilitiesFairValueDisclosure contextRef="ibfea464ded6448aca552adef980e0da4_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml82Ny9mcmFnOjgzMTNlZWQwYzRhMTQ2OTg4NzIwNmI3MTgxZjUwMDNjL3RhYmxlOjkzMTRkM2JlYWIyNzQwMzc4MTgwYzM1MmZiODQ5M2YwL3RhYmxlcmFuZ2U6OTMxNGQzYmVhYjI3NDAzNzgxODBjMzUyZmI4NDkzZjBfMTQtMS0xLTEtNDgxNjQ_602d7dec-7965-4a53-b30f-0320fd277435" unitRef="usd"> 0 </us-gaap:LiabilitiesFairValueDisclosure>
<us-gaap:LiabilitiesFairValueDisclosure contextRef="i72fd1c49a8474b988e35665a53082217_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml82Ny9mcmFnOjgzMTNlZWQwYzRhMTQ2OTg4NzIwNmI3MTgxZjUwMDNjL3RhYmxlOjkzMTRkM2JlYWIyNzQwMzc4MTgwYzM1MmZiODQ5M2YwL3RhYmxlcmFuZ2U6OTMxNGQzYmVhYjI3NDAzNzgxODBjMzUyZmI4NDkzZjBfMTQtMy0xLTEtNDgxNjQ_445992e9-0290-4b9d-8699-5be414794455" unitRef="usd"> 0 </us-gaap:LiabilitiesFairValueDisclosure>
<us-gaap:LiabilitiesFairValueDisclosure contextRef="i0fc88df2a18e4450acfcd643aba9ccf2_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml82Ny9mcmFnOjgzMTNlZWQwYzRhMTQ2OTg4NzIwNmI3MTgxZjUwMDNjL3RhYmxlOjkzMTRkM2JlYWIyNzQwMzc4MTgwYzM1MmZiODQ5M2YwL3RhYmxlcmFuZ2U6OTMxNGQzYmVhYjI3NDAzNzgxODBjMzUyZmI4NDkzZjBfMTQtNS0xLTEtNDgxNjQ_0de45725-0f4d-40a2-9e0b-de764bbc1175" unitRef="usd"> 2903000 </us-gaap:LiabilitiesFairValueDisclosure>
<us-gaap:LiabilitiesFairValueDisclosure contextRef="i4768f885851b49f986857a2a956f9162_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml82Ny9mcmFnOjgzMTNlZWQwYzRhMTQ2OTg4NzIwNmI3MTgxZjUwMDNjL3RhYmxlOjkzMTRkM2JlYWIyNzQwMzc4MTgwYzM1MmZiODQ5M2YwL3RhYmxlcmFuZ2U6OTMxNGQzYmVhYjI3NDAzNzgxODBjMzUyZmI4NDkzZjBfMTQtNy0xLTEtNDgxNjQ_bd616f0e-3674-4098-867e-a59024ebb239" unitRef="usd"> 2903000 </us-gaap:LiabilitiesFairValueDisclosure>
<us-gaap:EquitySecuritiesFvNi contextRef="i6a5748dbc7a446c1964b3d4f2f126e82_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml82Ny9mcmFnOjgzMTNlZWQwYzRhMTQ2OTg4NzIwNmI3MTgxZjUwMDNjL3RhYmxlOjcyMzU1ZTUyMWMxNzQ1YzRiN2I4ZGY0NmQ1ZDhlYjAwL3RhYmxlcmFuZ2U6NzIzNTVlNTIxYzE3NDVjNGI3YjhkZjQ2ZDVkOGViMDBfNi0xLTEtMS00ODE2NA_3e8eea42-888f-4ed3-9eec-1b1d06ce0ac0" unitRef="usd"> 4226000 </us-gaap:EquitySecuritiesFvNi>
<us-gaap:EquitySecuritiesFvNi contextRef="i88bc132bdde94d76820fbb0d52c10d79_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml82Ny9mcmFnOjgzMTNlZWQwYzRhMTQ2OTg4NzIwNmI3MTgxZjUwMDNjL3RhYmxlOjcyMzU1ZTUyMWMxNzQ1YzRiN2I4ZGY0NmQ1ZDhlYjAwL3RhYmxlcmFuZ2U6NzIzNTVlNTIxYzE3NDVjNGI3YjhkZjQ2ZDVkOGViMDBfNi0zLTEtMS00ODE2NA_808188ff-dacc-4fbd-a4ab-293e655e051a" unitRef="usd"> 0 </us-gaap:EquitySecuritiesFvNi>
<us-gaap:EquitySecuritiesFvNi contextRef="i582ac628f05e4953b9ccd2fab6e714a6_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml82Ny9mcmFnOjgzMTNlZWQwYzRhMTQ2OTg4NzIwNmI3MTgxZjUwMDNjL3RhYmxlOjcyMzU1ZTUyMWMxNzQ1YzRiN2I4ZGY0NmQ1ZDhlYjAwL3RhYmxlcmFuZ2U6NzIzNTVlNTIxYzE3NDVjNGI3YjhkZjQ2ZDVkOGViMDBfNi01LTEtMS00ODE2NA_f0b979f9-dbb1-4108-8c43-94871c5808fb" unitRef="usd"> 0 </us-gaap:EquitySecuritiesFvNi>
<us-gaap:EquitySecuritiesFvNi contextRef="i7e0f479bead144b0bdbcc71082db627b_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml82Ny9mcmFnOjgzMTNlZWQwYzRhMTQ2OTg4NzIwNmI3MTgxZjUwMDNjL3RhYmxlOjcyMzU1ZTUyMWMxNzQ1YzRiN2I4ZGY0NmQ1ZDhlYjAwL3RhYmxlcmFuZ2U6NzIzNTVlNTIxYzE3NDVjNGI3YjhkZjQ2ZDVkOGViMDBfNi03LTEtMS00ODE2NA_ebb85248-c52d-449a-802a-72dcd01125e4" unitRef="usd"> 4226000 </us-gaap:EquitySecuritiesFvNi>
<us-gaap:DerivativeAssets contextRef="i36a7a2d12b9748f2aca5ab5d89b03eb6_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml82Ny9mcmFnOjgzMTNlZWQwYzRhMTQ2OTg4NzIwNmI3MTgxZjUwMDNjL3RhYmxlOjcyMzU1ZTUyMWMxNzQ1YzRiN2I4ZGY0NmQ1ZDhlYjAwL3RhYmxlcmFuZ2U6NzIzNTVlNTIxYzE3NDVjNGI3YjhkZjQ2ZDVkOGViMDBfNy0xLTEtMS00ODE2NA_4a4a5a13-40d1-4639-b3ed-55ed336e77d1" unitRef="usd"> 0 </us-gaap:DerivativeAssets>
<us-gaap:DerivativeAssets contextRef="i55ec0a6131f24494b7123673340c96ce_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml82Ny9mcmFnOjgzMTNlZWQwYzRhMTQ2OTg4NzIwNmI3MTgxZjUwMDNjL3RhYmxlOjcyMzU1ZTUyMWMxNzQ1YzRiN2I4ZGY0NmQ1ZDhlYjAwL3RhYmxlcmFuZ2U6NzIzNTVlNTIxYzE3NDVjNGI3YjhkZjQ2ZDVkOGViMDBfNy0zLTEtMS00ODE2NA_574f706b-2bdd-4a86-b970-0bc2a2580dbb" unitRef="usd"> 16000 </us-gaap:DerivativeAssets>
<us-gaap:DerivativeAssets contextRef="i1fd3c9f461504a349a8f742d36f61319_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml82Ny9mcmFnOjgzMTNlZWQwYzRhMTQ2OTg4NzIwNmI3MTgxZjUwMDNjL3RhYmxlOjcyMzU1ZTUyMWMxNzQ1YzRiN2I4ZGY0NmQ1ZDhlYjAwL3RhYmxlcmFuZ2U6NzIzNTVlNTIxYzE3NDVjNGI3YjhkZjQ2ZDVkOGViMDBfNy01LTEtMS00ODE2NA_10f8ff64-d683-4dd3-b5c0-9d1c64542c3f" unitRef="usd"> 0 </us-gaap:DerivativeAssets>
<us-gaap:DerivativeAssets contextRef="i70ea49e1b5564a3999a159525ab40e66_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml82Ny9mcmFnOjgzMTNlZWQwYzRhMTQ2OTg4NzIwNmI3MTgxZjUwMDNjL3RhYmxlOjcyMzU1ZTUyMWMxNzQ1YzRiN2I4ZGY0NmQ1ZDhlYjAwL3RhYmxlcmFuZ2U6NzIzNTVlNTIxYzE3NDVjNGI3YjhkZjQ2ZDVkOGViMDBfNy03LTEtMS00ODE2NA_a6429e4d-8b3a-482d-8ece-624993844a3f" unitRef="usd"> 16000 </us-gaap:DerivativeAssets>
<us-gaap:DerivativeAssets contextRef="ie9a939f96724436881465c6a9d817aef_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml82Ny9mcmFnOjgzMTNlZWQwYzRhMTQ2OTg4NzIwNmI3MTgxZjUwMDNjL3RhYmxlOjcyMzU1ZTUyMWMxNzQ1YzRiN2I4ZGY0NmQ1ZDhlYjAwL3RhYmxlcmFuZ2U6NzIzNTVlNTIxYzE3NDVjNGI3YjhkZjQ2ZDVkOGViMDBfOC0xLTEtMS00ODE2NA_f4a2bc5f-3c6f-4c95-b7fe-2fe927552a73" unitRef="usd"> 0 </us-gaap:DerivativeAssets>
<us-gaap:DerivativeAssets contextRef="iae1118f31b46442ab3feff33e0fe8bec_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml82Ny9mcmFnOjgzMTNlZWQwYzRhMTQ2OTg4NzIwNmI3MTgxZjUwMDNjL3RhYmxlOjcyMzU1ZTUyMWMxNzQ1YzRiN2I4ZGY0NmQ1ZDhlYjAwL3RhYmxlcmFuZ2U6NzIzNTVlNTIxYzE3NDVjNGI3YjhkZjQ2ZDVkOGViMDBfOC0zLTEtMS00ODE2NA_e4203f27-9fd7-4a3b-90ca-85764d887e33" unitRef="usd"> 122000 </us-gaap:DerivativeAssets>
<us-gaap:DerivativeAssets contextRef="iacfe781a9cc44b3ca00b4513c457db51_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml82Ny9mcmFnOjgzMTNlZWQwYzRhMTQ2OTg4NzIwNmI3MTgxZjUwMDNjL3RhYmxlOjcyMzU1ZTUyMWMxNzQ1YzRiN2I4ZGY0NmQ1ZDhlYjAwL3RhYmxlcmFuZ2U6NzIzNTVlNTIxYzE3NDVjNGI3YjhkZjQ2ZDVkOGViMDBfOC01LTEtMS00ODE2NA_675af009-71db-4de0-8339-b67f73623ff8" unitRef="usd"> 0 </us-gaap:DerivativeAssets>
<us-gaap:DerivativeAssets contextRef="ie3e8b63088884c56bcfc29948f65e463_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml82Ny9mcmFnOjgzMTNlZWQwYzRhMTQ2OTg4NzIwNmI3MTgxZjUwMDNjL3RhYmxlOjcyMzU1ZTUyMWMxNzQ1YzRiN2I4ZGY0NmQ1ZDhlYjAwL3RhYmxlcmFuZ2U6NzIzNTVlNTIxYzE3NDVjNGI3YjhkZjQ2ZDVkOGViMDBfOC03LTEtMS00ODE2NA_f11cf4a2-15f1-4596-b843-8e2b01b2bb7d" unitRef="usd"> 122000 </us-gaap:DerivativeAssets>
<us-gaap:AssetsFairValueDisclosure contextRef="i6a5748dbc7a446c1964b3d4f2f126e82_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml82Ny9mcmFnOjgzMTNlZWQwYzRhMTQ2OTg4NzIwNmI3MTgxZjUwMDNjL3RhYmxlOjcyMzU1ZTUyMWMxNzQ1YzRiN2I4ZGY0NmQ1ZDhlYjAwL3RhYmxlcmFuZ2U6NzIzNTVlNTIxYzE3NDVjNGI3YjhkZjQ2ZDVkOGViMDBfOS0xLTEtMS00ODE2NA_f94c7b8f-68f7-470b-a2c2-826acec6c8a6" unitRef="usd"> 4226000 </us-gaap:AssetsFairValueDisclosure>
<us-gaap:AssetsFairValueDisclosure contextRef="i88bc132bdde94d76820fbb0d52c10d79_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml82Ny9mcmFnOjgzMTNlZWQwYzRhMTQ2OTg4NzIwNmI3MTgxZjUwMDNjL3RhYmxlOjcyMzU1ZTUyMWMxNzQ1YzRiN2I4ZGY0NmQ1ZDhlYjAwL3RhYmxlcmFuZ2U6NzIzNTVlNTIxYzE3NDVjNGI3YjhkZjQ2ZDVkOGViMDBfOS0zLTEtMS00ODE2NA_d2ea4258-7cf9-4c11-a709-a51bf8ad197a" unitRef="usd"> 138000 </us-gaap:AssetsFairValueDisclosure>
<us-gaap:AssetsFairValueDisclosure contextRef="i582ac628f05e4953b9ccd2fab6e714a6_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml82Ny9mcmFnOjgzMTNlZWQwYzRhMTQ2OTg4NzIwNmI3MTgxZjUwMDNjL3RhYmxlOjcyMzU1ZTUyMWMxNzQ1YzRiN2I4ZGY0NmQ1ZDhlYjAwL3RhYmxlcmFuZ2U6NzIzNTVlNTIxYzE3NDVjNGI3YjhkZjQ2ZDVkOGViMDBfOS01LTEtMS00ODE2NA_7aed2a06-3d36-49e2-bd78-b5dd88319aac" unitRef="usd"> 0 </us-gaap:AssetsFairValueDisclosure>
<us-gaap:AssetsFairValueDisclosure contextRef="i7e0f479bead144b0bdbcc71082db627b_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml82Ny9mcmFnOjgzMTNlZWQwYzRhMTQ2OTg4NzIwNmI3MTgxZjUwMDNjL3RhYmxlOjcyMzU1ZTUyMWMxNzQ1YzRiN2I4ZGY0NmQ1ZDhlYjAwL3RhYmxlcmFuZ2U6NzIzNTVlNTIxYzE3NDVjNGI3YjhkZjQ2ZDVkOGViMDBfOS03LTEtMS00ODE2NA_aa9e90ad-dd69-4a9e-b3fb-5ff7e0668025" unitRef="usd"> 4364000 </us-gaap:AssetsFairValueDisclosure>
<us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="i6a5748dbc7a446c1964b3d4f2f126e82_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml82Ny9mcmFnOjgzMTNlZWQwYzRhMTQ2OTg4NzIwNmI3MTgxZjUwMDNjL3RhYmxlOjcyMzU1ZTUyMWMxNzQ1YzRiN2I4ZGY0NmQ1ZDhlYjAwL3RhYmxlcmFuZ2U6NzIzNTVlNTIxYzE3NDVjNGI3YjhkZjQ2ZDVkOGViMDBfMTQtMS0xLTEtNDgxNjQ_74a256ba-4826-40f4-9db3-2f5d3d3340fc" unitRef="usd"> 0 </us-gaap:BusinessCombinationContingentConsiderationLiability>
<us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="i88bc132bdde94d76820fbb0d52c10d79_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml82Ny9mcmFnOjgzMTNlZWQwYzRhMTQ2OTg4NzIwNmI3MTgxZjUwMDNjL3RhYmxlOjcyMzU1ZTUyMWMxNzQ1YzRiN2I4ZGY0NmQ1ZDhlYjAwL3RhYmxlcmFuZ2U6NzIzNTVlNTIxYzE3NDVjNGI3YjhkZjQ2ZDVkOGViMDBfMTQtMy0xLTEtNDgxNjQ_e5708ab1-4752-4fd1-8d4a-58f084fb5690" unitRef="usd"> 0 </us-gaap:BusinessCombinationContingentConsiderationLiability>
<us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="i582ac628f05e4953b9ccd2fab6e714a6_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml82Ny9mcmFnOjgzMTNlZWQwYzRhMTQ2OTg4NzIwNmI3MTgxZjUwMDNjL3RhYmxlOjcyMzU1ZTUyMWMxNzQ1YzRiN2I4ZGY0NmQ1ZDhlYjAwL3RhYmxlcmFuZ2U6NzIzNTVlNTIxYzE3NDVjNGI3YjhkZjQ2ZDVkOGViMDBfMTQtNS0xLTEtNDgxNjQ_e57f6988-468d-476d-8164-7255c9f74cf9" unitRef="usd"> 2837000 </us-gaap:BusinessCombinationContingentConsiderationLiability>
<us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="i7e0f479bead144b0bdbcc71082db627b_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml82Ny9mcmFnOjgzMTNlZWQwYzRhMTQ2OTg4NzIwNmI3MTgxZjUwMDNjL3RhYmxlOjcyMzU1ZTUyMWMxNzQ1YzRiN2I4ZGY0NmQ1ZDhlYjAwL3RhYmxlcmFuZ2U6NzIzNTVlNTIxYzE3NDVjNGI3YjhkZjQ2ZDVkOGViMDBfMTQtNy0xLTEtNDgxNjQ_cb77cd38-1b8f-4295-b4ac-b762ef0ec6f5" unitRef="usd"> 2837000 </us-gaap:BusinessCombinationContingentConsiderationLiability>
<us-gaap:LiabilitiesFairValueDisclosure contextRef="i6a5748dbc7a446c1964b3d4f2f126e82_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml82Ny9mcmFnOjgzMTNlZWQwYzRhMTQ2OTg4NzIwNmI3MTgxZjUwMDNjL3RhYmxlOjcyMzU1ZTUyMWMxNzQ1YzRiN2I4ZGY0NmQ1ZDhlYjAwL3RhYmxlcmFuZ2U6NzIzNTVlNTIxYzE3NDVjNGI3YjhkZjQ2ZDVkOGViMDBfMTUtMS0xLTEtNDgxNjQ_0d2776e1-7661-483c-b0be-44bebeff965e" unitRef="usd"> 0 </us-gaap:LiabilitiesFairValueDisclosure>
<us-gaap:LiabilitiesFairValueDisclosure contextRef="i88bc132bdde94d76820fbb0d52c10d79_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml82Ny9mcmFnOjgzMTNlZWQwYzRhMTQ2OTg4NzIwNmI3MTgxZjUwMDNjL3RhYmxlOjcyMzU1ZTUyMWMxNzQ1YzRiN2I4ZGY0NmQ1ZDhlYjAwL3RhYmxlcmFuZ2U6NzIzNTVlNTIxYzE3NDVjNGI3YjhkZjQ2ZDVkOGViMDBfMTUtMy0xLTEtNDgxNjQ_0c9fdd60-089d-4df4-8542-a37a4d9e708e" unitRef="usd"> 0 </us-gaap:LiabilitiesFairValueDisclosure>
<us-gaap:LiabilitiesFairValueDisclosure contextRef="i582ac628f05e4953b9ccd2fab6e714a6_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml82Ny9mcmFnOjgzMTNlZWQwYzRhMTQ2OTg4NzIwNmI3MTgxZjUwMDNjL3RhYmxlOjcyMzU1ZTUyMWMxNzQ1YzRiN2I4ZGY0NmQ1ZDhlYjAwL3RhYmxlcmFuZ2U6NzIzNTVlNTIxYzE3NDVjNGI3YjhkZjQ2ZDVkOGViMDBfMTUtNS0xLTEtNDgxNjQ_486894a4-439b-4024-8271-79b3fed8b08b" unitRef="usd"> 2837000 </us-gaap:LiabilitiesFairValueDisclosure>
<us-gaap:LiabilitiesFairValueDisclosure contextRef="i7e0f479bead144b0bdbcc71082db627b_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml82Ny9mcmFnOjgzMTNlZWQwYzRhMTQ2OTg4NzIwNmI3MTgxZjUwMDNjL3RhYmxlOjcyMzU1ZTUyMWMxNzQ1YzRiN2I4ZGY0NmQ1ZDhlYjAwL3RhYmxlcmFuZ2U6NzIzNTVlNTIxYzE3NDVjNGI3YjhkZjQ2ZDVkOGViMDBfMTUtNy0xLTEtNDgxNjQ_9bc78573-4ce8-4470-830f-78fee8b14de5" unitRef="usd"> 2837000 </us-gaap:LiabilitiesFairValueDisclosure>
<us-gaap:FairValueByBalanceSheetGroupingTextBlock contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml82Ny9mcmFnOjgzMTNlZWQwYzRhMTQ2OTg4NzIwNmI3MTgxZjUwMDNjL3RleHRyZWdpb246ODMxM2VlZDBjNGExNDY5ODg3MjA2YjcxODFmNTAwM2NfMzI0MQ_3cf8c1fb-936b-4469-9d28-e8dad1819f34">
<div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying amount and estimated fair value of our 2025 Notes, as well as the applicable fair value hierarchy tiers, are contained in the table below. The fair value of the 2025 Notes is determined using inputs other than quoted prices in active markets that are directly observable.</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.297%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.870%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="27" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 30, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carrying<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total<br/>Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 3</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025 Notes</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141,537 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145,163 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145,163 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div>
</us-gaap:FairValueByBalanceSheetGroupingTextBlock>
<us-gaap:NotesPayableFairValueDisclosure contextRef="ia33981192edd41b59027684f379a1ab3_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml82Ny9mcmFnOjgzMTNlZWQwYzRhMTQ2OTg4NzIwNmI3MTgxZjUwMDNjL3RhYmxlOmE1YjhjZjMxNDg0YzQ4ODY4MzIwNDJjOTgxYWZkZGRjL3RhYmxlcmFuZ2U6YTViOGNmMzE0ODRjNDg4NjgzMjA0MmM5ODFhZmRkZGNfMi0xLTEtMS00ODE2NA_107fe402-5339-4cc8-80d5-2e52c12bdc7c" unitRef="usd"> 141537000 </us-gaap:NotesPayableFairValueDisclosure>
<us-gaap:NotesPayableFairValueDisclosure contextRef="i28b0014b24b8439fa52208ad6b809311_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml82Ny9mcmFnOjgzMTNlZWQwYzRhMTQ2OTg4NzIwNmI3MTgxZjUwMDNjL3RhYmxlOmE1YjhjZjMxNDg0YzQ4ODY4MzIwNDJjOTgxYWZkZGRjL3RhYmxlcmFuZ2U6YTViOGNmMzE0ODRjNDg4NjgzMjA0MmM5ODFhZmRkZGNfMi0zLTEtMS00ODE2NA_0c7354c6-d1dc-444e-91cc-60ab0c2c7761" unitRef="usd"> 145163000 </us-gaap:NotesPayableFairValueDisclosure>
<us-gaap:NotesPayableFairValueDisclosure contextRef="i06767b8ced884b4ca516f64257f3a9f5_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml82Ny9mcmFnOjgzMTNlZWQwYzRhMTQ2OTg4NzIwNmI3MTgxZjUwMDNjL3RhYmxlOmE1YjhjZjMxNDg0YzQ4ODY4MzIwNDJjOTgxYWZkZGRjL3RhYmxlcmFuZ2U6YTViOGNmMzE0ODRjNDg4NjgzMjA0MmM5ODFhZmRkZGNfMi01LTEtMS00ODE2NA_bdbea3d7-0eb4-4cd3-a880-53683b073d53" unitRef="usd"> 0 </us-gaap:NotesPayableFairValueDisclosure>
<us-gaap:NotesPayableFairValueDisclosure contextRef="ia6da14e46e95405a8e44c6fba822c6a4_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml82Ny9mcmFnOjgzMTNlZWQwYzRhMTQ2OTg4NzIwNmI3MTgxZjUwMDNjL3RhYmxlOmE1YjhjZjMxNDg0YzQ4ODY4MzIwNDJjOTgxYWZkZGRjL3RhYmxlcmFuZ2U6YTViOGNmMzE0ODRjNDg4NjgzMjA0MmM5ODFhZmRkZGNfMi03LTEtMS00ODE2NA_644de917-3bc3-4a2a-b289-568c4df54282" unitRef="usd"> 145163000 </us-gaap:NotesPayableFairValueDisclosure>
<us-gaap:NotesPayableFairValueDisclosure contextRef="i8d292d3ca8cd41e4aeaa2d9ee4f153ba_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml82Ny9mcmFnOjgzMTNlZWQwYzRhMTQ2OTg4NzIwNmI3MTgxZjUwMDNjL3RhYmxlOmE1YjhjZjMxNDg0YzQ4ODY4MzIwNDJjOTgxYWZkZGRjL3RhYmxlcmFuZ2U6YTViOGNmMzE0ODRjNDg4NjgzMjA0MmM5ODFhZmRkZGNfMi05LTEtMS00ODE2NA_956f1e42-cfe6-4eb0-8c30-4c5f02e705fa" unitRef="usd"> 0 </us-gaap:NotesPayableFairValueDisclosure>
<us-gaap:FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml82Ny9mcmFnOjgzMTNlZWQwYzRhMTQ2OTg4NzIwNmI3MTgxZjUwMDNjL3RleHRyZWdpb246ODMxM2VlZDBjNGExNDY5ODg3MjA2YjcxODFmNTAwM2NfMzIxNw_d8672997-551f-4dc1-97a1-9c4c255e6953">
The following table reconciles the beginning and ending balances of our Level 3 assets and liabilities as of June 30, 2022:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:79.398%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.402%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">June 30, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Contingent<br/>consideration</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2021</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,837 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Included in results of operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency impact</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at June 30, 2022</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,903 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table>
</us-gaap:FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock>
<us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml82Ny9mcmFnOjgzMTNlZWQwYzRhMTQ2OTg4NzIwNmI3MTgxZjUwMDNjL3RleHRyZWdpb246ODMxM2VlZDBjNGExNDY5ODg3MjA2YjcxODFmNTAwM2NfMzIzNQ_af2ddc33-1816-477d-bf52-57951e2deb6d">
The following table reconciles the beginning and ending balances of our Level 3 assets and liabilities as of June 30, 2022:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:79.398%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.402%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">June 30, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Contingent<br/>consideration</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2021</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,837 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Included in results of operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency impact</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at June 30, 2022</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,903 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table>
</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock>
<us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue contextRef="i59e36a43bbbe44558e75fc9e6cfa6012_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml82Ny9mcmFnOjgzMTNlZWQwYzRhMTQ2OTg4NzIwNmI3MTgxZjUwMDNjL3RhYmxlOmZlOTZhZmM0NTFiNzRmODNhNjY5ZjZjMTc1MDExNGY5L3RhYmxlcmFuZ2U6ZmU5NmFmYzQ1MWI3NGY4M2E2NjlmNmMxNzUwMTE0ZjlfMi0xLTEtMS00ODE2NA_82d97694-e22c-4a29-aa7e-346141728f2d" unitRef="usd"> 2837000 </us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
<us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings contextRef="i65a0b049acb747c29820329d4e8557c9_D20220101-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml82Ny9mcmFnOjgzMTNlZWQwYzRhMTQ2OTg4NzIwNmI3MTgxZjUwMDNjL3RhYmxlOmZlOTZhZmM0NTFiNzRmODNhNjY5ZjZjMTc1MDExNGY5L3RhYmxlcmFuZ2U6ZmU5NmFmYzQ1MWI3NGY4M2E2NjlmNmMxNzUwMTE0ZjlfNS0xLTEtMS00ODE2NA_8419444e-f5be-48bc-8db5-1102d3aba2b8" unitRef="usd"> 69000 </us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
<opk:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityForeignCurrencyImpact contextRef="i65a0b049acb747c29820329d4e8557c9_D20220101-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml82Ny9mcmFnOjgzMTNlZWQwYzRhMTQ2OTg4NzIwNmI3MTgxZjUwMDNjL3RhYmxlOmZlOTZhZmM0NTFiNzRmODNhNjY5ZjZjMTc1MDExNGY5L3RhYmxlcmFuZ2U6ZmU5NmFmYzQ1MWI3NGY4M2E2NjlmNmMxNzUwMTE0ZjlfNi0xLTEtMS00ODE2NA_c335acd2-c75f-4924-aa13-13d86aefe675" unitRef="usd"> -3000 </opk:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityForeignCurrencyImpact>
<us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue contextRef="i6d6bd1d1a436445e9d4d16e321631499_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml82Ny9mcmFnOjgzMTNlZWQwYzRhMTQ2OTg4NzIwNmI3MTgxZjUwMDNjL3RhYmxlOmZlOTZhZmM0NTFiNzRmODNhNjY5ZjZjMTc1MDExNGY5L3RhYmxlcmFuZ2U6ZmU5NmFmYzQ1MWI3NGY4M2E2NjlmNmMxNzUwMTE0ZjlfOS0xLTEtMS00ODE2NA_02c01837-d17b-49d8-b4b0-09bd120aec19" unitRef="usd"> 2903000 </us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
<us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="i4768f885851b49f986857a2a956f9162_I20220630" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml82Ny9mcmFnOjgzMTNlZWQwYzRhMTQ2OTg4NzIwNmI3MTgxZjUwMDNjL3RleHRyZWdpb246ODMxM2VlZDBjNGExNDY5ODg3MjA2YjcxODFmNTAwM2NfMjc2Mw_98b4b4d5-2e38-4590-906e-257b890b956c" unitRef="usd"> 2900000 </us-gaap:BusinessCombinationContingentConsiderationLiability>
<us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="i9f2a6258e98049439883dbcb99e01f29_I20220630" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml82Ny9mcmFnOjgzMTNlZWQwYzRhMTQ2OTg4NzIwNmI3MTgxZjUwMDNjL3RleHRyZWdpb246ODMxM2VlZDBjNGExNDY5ODg3MjA2YjcxODFmNTAwM2NfMjc5NQ_cb6c70c4-a752-4c20-985b-2c28a28d4e6c" unitRef="usd"> 500000 </us-gaap:BusinessCombinationContingentConsiderationLiability>
<us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="i9527c584ee6e460bb59b851ee6b2385d_I20220630" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml82Ny9mcmFnOjgzMTNlZWQwYzRhMTQ2OTg4NzIwNmI3MTgxZjUwMDNjL3RleHRyZWdpb246ODMxM2VlZDBjNGExNDY5ODg3MjA2YjcxODFmNTAwM2NfMjgzNQ_6708fede-2caa-406d-995e-516b6acb82a8" unitRef="usd"> 2400000 </us-gaap:BusinessCombinationContingentConsiderationLiability>
<us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="i7e0f479bead144b0bdbcc71082db627b_I20211231" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml82Ny9mcmFnOjgzMTNlZWQwYzRhMTQ2OTg4NzIwNmI3MTgxZjUwMDNjL3RleHRyZWdpb246ODMxM2VlZDBjNGExNDY5ODg3MjA2YjcxODFmNTAwM2NfMjkwMQ_f9989eaa-65d3-4834-9e56-b04a15331b4b" unitRef="usd"> 2800000 </us-gaap:BusinessCombinationContingentConsiderationLiability>
<us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="i65efe3dd9bdc415c805cfd2726799008_I20211231" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml82Ny9mcmFnOjgzMTNlZWQwYzRhMTQ2OTg4NzIwNmI3MTgxZjUwMDNjL3RleHRyZWdpb246ODMxM2VlZDBjNGExNDY5ODg3MjA2YjcxODFmNTAwM2NfMjkzMw_95f55157-6fcf-47f1-a9d8-664b38362e59" unitRef="usd"> 500000 </us-gaap:BusinessCombinationContingentConsiderationLiability>
<us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="icd2fa1bdbc054e5ca0d1119b9283489e_I20211231" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml82Ny9mcmFnOjgzMTNlZWQwYzRhMTQ2OTg4NzIwNmI3MTgxZjUwMDNjL3RleHRyZWdpb246ODMxM2VlZDBjNGExNDY5ODg3MjA2YjcxODFmNTAwM2NfMjk3Mw_81db7128-78cd-45ab-83c7-f2f80c58eadd" unitRef="usd"> 2300000 </us-gaap:BusinessCombinationContingentConsiderationLiability>
<us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml83MC9mcmFnOmEwNjgwOGFjNDU3NTRlNmNhZDczN2JlZTE5ZWI0YjcyL3RleHRyZWdpb246YTA2ODA4YWM0NTc1NGU2Y2FkNzM3YmVlMTllYjRiNzJfMTE5Nw_5943bbce-913d-46c8-9e82-d2c77f1ded1d">
DERIVATIVE CONTRACTS<div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the fair values and the presentation of our derivative financial instruments in the Condensed Consolidated Balance Sheets:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:36.491%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:38.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance Sheet Component</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">June 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative financial instruments:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common Stock options/warrants</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized gains on forward contracts are recorded in Other current assets and prepaid expenses. Unrealized (losses) on forward contracts are recorded in Accrued expenses.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">434 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div style="margin-top:4pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We enter into foreign currency forward exchange contracts with respect to the risk of exposure to exchange rate differences arising from inventory purchases on letters of credit. Under these forward contracts, for any rate above or below the fixed rate, we receive or pay the difference between the spot rate and the fixed rate for the given amount at the settlement date. </span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To qualify the derivative instrument as a hedge, we are required to meet strict hedge effectiveness and contemporaneous documentation requirements at the initiation of the hedge and assess the hedge effectiveness on an ongoing basis over the life of the hedge. At June 30, 2022 and December 31, 2021, our derivative financial instruments did not meet the documentation requirements to be designated as hedges. Accordingly, we recognize the changes in Fair value of derivative instruments, net in our Condensed Consolidated Statement of Operations. The following table summarizes the losses and gains recorded for the three and six months ended June 30, 2022 and 2021:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:43.198%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.207%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three months ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Six months ended June 30,</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative gain (loss):</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common Stock options/warrants </span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">342 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(246)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">211 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(705)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">338 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(272)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">206 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(711)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>
</us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock>
<us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml83MC9mcmFnOmEwNjgwOGFjNDU3NTRlNmNhZDczN2JlZTE5ZWI0YjcyL3RleHRyZWdpb246YTA2ODA4YWM0NTc1NGU2Y2FkNzM3YmVlMTllYjRiNzJfMTIwNA_f21863ac-a857-4250-ba9c-d7e436cd8489">
<div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the fair values and the presentation of our derivative financial instruments in the Condensed Consolidated Balance Sheets:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:36.491%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:38.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance Sheet Component</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">June 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative financial instruments:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common Stock options/warrants</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized gains on forward contracts are recorded in Other current assets and prepaid expenses. Unrealized (losses) on forward contracts are recorded in Accrued expenses.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">434 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div>
</us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock>
<us-gaap:DerivativeFairValueOfDerivativeAsset contextRef="ib02175831f164aafbfaa698c482e0a71_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml83MC9mcmFnOmEwNjgwOGFjNDU3NTRlNmNhZDczN2JlZTE5ZWI0YjcyL3RhYmxlOjNmMTUzNzFiMzI2ODQxNWE5YzljNzk2ZGUyOWFmOWU5L3RhYmxlcmFuZ2U6M2YxNTM3MWIzMjY4NDE1YTljOWM3OTZkZTI5YWY5ZTlfMy0zLTEtMS00ODE2NA_a0ba3b6e-cd42-4ac7-8390-3dc51dd727e3" unitRef="usd"> 11000 </us-gaap:DerivativeFairValueOfDerivativeAsset>
<us-gaap:DerivativeFairValueOfDerivativeAsset contextRef="i75d42ed8c77d46dc983e5330c62b3740_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml83MC9mcmFnOmEwNjgwOGFjNDU3NTRlNmNhZDczN2JlZTE5ZWI0YjcyL3RhYmxlOjNmMTUzNzFiMzI2ODQxNWE5YzljNzk2ZGUyOWFmOWU5L3RhYmxlcmFuZ2U6M2YxNTM3MWIzMjY4NDE1YTljOWM3OTZkZTI5YWY5ZTlfMy01LTEtMS00ODE2NA_f3053f70-c6dc-44b0-b3c2-4a6462c9bc08" unitRef="usd"> 16000 </us-gaap:DerivativeFairValueOfDerivativeAsset>
<us-gaap:DerivativeFairValueOfDerivativeAsset contextRef="i215af1b905a347d8ac401994928e236c_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml83MC9mcmFnOmEwNjgwOGFjNDU3NTRlNmNhZDczN2JlZTE5ZWI0YjcyL3RhYmxlOjNmMTUzNzFiMzI2ODQxNWE5YzljNzk2ZGUyOWFmOWU5L3RhYmxlcmFuZ2U6M2YxNTM3MWIzMjY4NDE1YTljOWM3OTZkZTI5YWY5ZTlfNS0zLTEtMS00ODE2NA_cdfc36a6-83de-4041-8b0a-a3bc53e6961c" unitRef="usd"> 434000 </us-gaap:DerivativeFairValueOfDerivativeAsset>
<us-gaap:DerivativeFairValueOfDerivativeAsset contextRef="i9a6eb9ed46e64435be8fba557735d4d7_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml83MC9mcmFnOmEwNjgwOGFjNDU3NTRlNmNhZDczN2JlZTE5ZWI0YjcyL3RhYmxlOjNmMTUzNzFiMzI2ODQxNWE5YzljNzk2ZGUyOWFmOWU5L3RhYmxlcmFuZ2U6M2YxNTM3MWIzMjY4NDE1YTljOWM3OTZkZTI5YWY5ZTlfNS01LTEtMS00ODE2NA_0a91c211-50f1-4ed4-99e4-d5a4451a9c35" unitRef="usd"> 122000 </us-gaap:DerivativeFairValueOfDerivativeAsset>
<us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml83MC9mcmFnOmEwNjgwOGFjNDU3NTRlNmNhZDczN2JlZTE5ZWI0YjcyL3RleHRyZWdpb246YTA2ODA4YWM0NTc1NGU2Y2FkNzM3YmVlMTllYjRiNzJfMTE5MQ_946b2b8f-6c76-4ad4-b42e-b74cf7d71706">
The following table summarizes the losses and gains recorded for the three and six months ended June 30, 2022 and 2021:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:43.198%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.207%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three months ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Six months ended June 30,</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative gain (loss):</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common Stock options/warrants </span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">342 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(246)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">211 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(705)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">338 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(272)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">206 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(711)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table>
</us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock>
<us-gaap:DerivativeGainLossOnDerivativeNet contextRef="i9fe4947833b24a4ca64cc0f859ec1795_D20220401-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml83MC9mcmFnOmEwNjgwOGFjNDU3NTRlNmNhZDczN2JlZTE5ZWI0YjcyL3RhYmxlOjcwNDMyZmUyYWRlODQzOTlhMDZiYTM0Njk2NmYyMjk5L3RhYmxlcmFuZ2U6NzA0MzJmZTJhZGU4NDM5OWEwNmJhMzQ2OTY2ZjIyOTlfNC0xLTEtMS00ODE2NA_4fb96bfd-3910-46ec-b1c4-5e27061326db" unitRef="usd"> -4000 </us-gaap:DerivativeGainLossOnDerivativeNet>
<us-gaap:DerivativeGainLossOnDerivativeNet contextRef="i57ec4d548aff49f3b1f854d388eb755a_D20210401-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml83MC9mcmFnOmEwNjgwOGFjNDU3NTRlNmNhZDczN2JlZTE5ZWI0YjcyL3RhYmxlOjcwNDMyZmUyYWRlODQzOTlhMDZiYTM0Njk2NmYyMjk5L3RhYmxlcmFuZ2U6NzA0MzJmZTJhZGU4NDM5OWEwNmJhMzQ2OTY2ZjIyOTlfNC0zLTEtMS00ODE2NA_30c497e2-ae6a-42ba-9fe0-8e02e21352aa" unitRef="usd"> -26000 </us-gaap:DerivativeGainLossOnDerivativeNet>
<us-gaap:DerivativeGainLossOnDerivativeNet contextRef="ie2a3239bdd9d4c728245bea98e009d26_D20220101-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml83MC9mcmFnOmEwNjgwOGFjNDU3NTRlNmNhZDczN2JlZTE5ZWI0YjcyL3RhYmxlOjcwNDMyZmUyYWRlODQzOTlhMDZiYTM0Njk2NmYyMjk5L3RhYmxlcmFuZ2U6NzA0MzJmZTJhZGU4NDM5OWEwNmJhMzQ2OTY2ZjIyOTlfNC02LTEtMS00ODE2NA_bf1d7706-5bbc-47ff-9a66-e833c9d8719d" unitRef="usd"> -5000 </us-gaap:DerivativeGainLossOnDerivativeNet>
<us-gaap:DerivativeGainLossOnDerivativeNet contextRef="i4316d86be62847d29b15b6cebf47ae09_D20210101-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml83MC9mcmFnOmEwNjgwOGFjNDU3NTRlNmNhZDczN2JlZTE5ZWI0YjcyL3RhYmxlOjcwNDMyZmUyYWRlODQzOTlhMDZiYTM0Njk2NmYyMjk5L3RhYmxlcmFuZ2U6NzA0MzJmZTJhZGU4NDM5OWEwNmJhMzQ2OTY2ZjIyOTlfNC04LTEtMS00ODE2NA_2a0b2dc5-01d5-45cd-9c75-006c04df9486" unitRef="usd"> -6000 </us-gaap:DerivativeGainLossOnDerivativeNet>
<us-gaap:DerivativeGainLossOnDerivativeNet contextRef="ia55be08871dc4a009ceb35ae7fb8f266_D20220401-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml83MC9mcmFnOmEwNjgwOGFjNDU3NTRlNmNhZDczN2JlZTE5ZWI0YjcyL3RhYmxlOjcwNDMyZmUyYWRlODQzOTlhMDZiYTM0Njk2NmYyMjk5L3RhYmxlcmFuZ2U6NzA0MzJmZTJhZGU4NDM5OWEwNmJhMzQ2OTY2ZjIyOTlfNi0xLTEtMS00ODE2NA_db9b6829-7e62-4a65-8bd2-3427cf695960" unitRef="usd"> 342000 </us-gaap:DerivativeGainLossOnDerivativeNet>
<us-gaap:DerivativeGainLossOnDerivativeNet contextRef="i9bf8a7f7eb234ea5a19f7687de9e9813_D20210401-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml83MC9mcmFnOmEwNjgwOGFjNDU3NTRlNmNhZDczN2JlZTE5ZWI0YjcyL3RhYmxlOjcwNDMyZmUyYWRlODQzOTlhMDZiYTM0Njk2NmYyMjk5L3RhYmxlcmFuZ2U6NzA0MzJmZTJhZGU4NDM5OWEwNmJhMzQ2OTY2ZjIyOTlfNi0zLTEtMS00ODE2NA_85e55808-6354-4843-9e69-c6542e8da212" unitRef="usd"> -246000 </us-gaap:DerivativeGainLossOnDerivativeNet>
<us-gaap:DerivativeGainLossOnDerivativeNet contextRef="if20244744d774e6398b6bae428452264_D20220101-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml83MC9mcmFnOmEwNjgwOGFjNDU3NTRlNmNhZDczN2JlZTE5ZWI0YjcyL3RhYmxlOjcwNDMyZmUyYWRlODQzOTlhMDZiYTM0Njk2NmYyMjk5L3RhYmxlcmFuZ2U6NzA0MzJmZTJhZGU4NDM5OWEwNmJhMzQ2OTY2ZjIyOTlfNi02LTEtMS00ODE2NA_9087b1f1-5d50-481d-8862-1480d484d540" unitRef="usd"> 211000 </us-gaap:DerivativeGainLossOnDerivativeNet>
<us-gaap:DerivativeGainLossOnDerivativeNet contextRef="i2aced1f8a06c428bb238f003fd83ae71_D20210101-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml83MC9mcmFnOmEwNjgwOGFjNDU3NTRlNmNhZDczN2JlZTE5ZWI0YjcyL3RhYmxlOjcwNDMyZmUyYWRlODQzOTlhMDZiYTM0Njk2NmYyMjk5L3RhYmxlcmFuZ2U6NzA0MzJmZTJhZGU4NDM5OWEwNmJhMzQ2OTY2ZjIyOTlfNi04LTEtMS00ODE2NA_cf63f446-5807-43fc-bde9-5f5f70417690" unitRef="usd"> -705000 </us-gaap:DerivativeGainLossOnDerivativeNet>
<us-gaap:DerivativeGainLossOnDerivativeNet contextRef="iee6e65958638450585afc60d10fbd82b_D20220401-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml83MC9mcmFnOmEwNjgwOGFjNDU3NTRlNmNhZDczN2JlZTE5ZWI0YjcyL3RhYmxlOjcwNDMyZmUyYWRlODQzOTlhMDZiYTM0Njk2NmYyMjk5L3RhYmxlcmFuZ2U6NzA0MzJmZTJhZGU4NDM5OWEwNmJhMzQ2OTY2ZjIyOTlfNy0xLTEtMS00ODE2NA_77558976-c4f2-41d1-a6d6-856c6d0f7c27" unitRef="usd"> 338000 </us-gaap:DerivativeGainLossOnDerivativeNet>
<us-gaap:DerivativeGainLossOnDerivativeNet contextRef="ie4f941de7d37464b935e1e24982cf735_D20210401-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml83MC9mcmFnOmEwNjgwOGFjNDU3NTRlNmNhZDczN2JlZTE5ZWI0YjcyL3RhYmxlOjcwNDMyZmUyYWRlODQzOTlhMDZiYTM0Njk2NmYyMjk5L3RhYmxlcmFuZ2U6NzA0MzJmZTJhZGU4NDM5OWEwNmJhMzQ2OTY2ZjIyOTlfNy0zLTEtMS00ODE2NA_36dacadb-0305-48d2-bfff-a5125da0ec13" unitRef="usd"> -272000 </us-gaap:DerivativeGainLossOnDerivativeNet>
<us-gaap:DerivativeGainLossOnDerivativeNet contextRef="i3e4dd7f6b70f47caa8ffd853fab9de85_D20220101-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml83MC9mcmFnOmEwNjgwOGFjNDU3NTRlNmNhZDczN2JlZTE5ZWI0YjcyL3RhYmxlOjcwNDMyZmUyYWRlODQzOTlhMDZiYTM0Njk2NmYyMjk5L3RhYmxlcmFuZ2U6NzA0MzJmZTJhZGU4NDM5OWEwNmJhMzQ2OTY2ZjIyOTlfNy02LTEtMS00ODE2NA_4f17bd79-a7c0-488a-b915-c58a6f5d37c0" unitRef="usd"> 206000 </us-gaap:DerivativeGainLossOnDerivativeNet>
<us-gaap:DerivativeGainLossOnDerivativeNet contextRef="if0247590b7594ea9a15bd401f6de3a00_D20210101-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml83MC9mcmFnOmEwNjgwOGFjNDU3NTRlNmNhZDczN2JlZTE5ZWI0YjcyL3RhYmxlOjcwNDMyZmUyYWRlODQzOTlhMDZiYTM0Njk2NmYyMjk5L3RhYmxlcmFuZ2U6NzA0MzJmZTJhZGU4NDM5OWEwNmJhMzQ2OTY2ZjIyOTlfNy04LTEtMS00ODE2NA_9ed6b94c-0f9d-4e3d-993d-1ff721b9c853" unitRef="usd"> -711000 </us-gaap:DerivativeGainLossOnDerivativeNet>
<us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml83My9mcmFnOmQ3YzhhNTA0ZDllMTRiZDdhMGM1MzdlYTc2M2VlZDVlL3RleHRyZWdpb246ZDdjOGE1MDRkOWUxNGJkN2EwYzUzN2VhNzYzZWVkNWVfNjU5NzA2OTc3MDg1OA_412f74cd-5360-4199-8437-8664d6cd964f">
RELATED PARTY TRANSACTIONS<div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In August 2020, GeneDx entered into an agreement with Mednax Services, Inc. (“Mednax Services”), a subsidiary of MEDNAX, Inc., (“MEDNAX”) pursuant to which the parties formed a joint venture under the brand Detect Genomix. GeneDx’s initial capital investment in Detect Genomix was $245,000 for which GeneDx received a 49% ownership interest in Detect Genomix, and Mednax Services contributed $255,000 in exchange for a 51% ownership interest in Detect Genomix. Adam Logal, the Company’s CFO, was the chair and sat on the Board of Managers of the joint venture. Mednax Services provided administrative services to the joint venture pursuant to an administrative services agreement. GeneDx provided laboratory services to the joint venture. Dr. Roger Medel, a director of the Company, is the former Chief Executive Officer of MEDNAX and Mednax Services. Dr. Medel continues to serve on the board of MEDNAX. The joint venture was dissolved in January 2022.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 29, 2022, upon consummation of the GeneDx Transaction, the Company entered into a Transition Services Agreement, dated as of April 29, 2022 (the “Transition Services Agreement”), with GeneDx (now a wholly owned subsidiary of Sema4), pursuant to which OPKO has agreed to provide, at cost, certain customary support services in respect of GeneDx’s business through December 31, 2022, subject to certain limited exceptions, with such services being in order to facilitate the GeneDx Transactions, including human resources, information technology support, and finance and accounting. As of June 30, 2022, the Company had incurred aggregate expenses of $335.3 thousand for services rendered under the Transition Services Agreement, for which the Company has an offsetting receivable of $167.2 thousand payable to the Company by GeneDx in accordance with the terms of the Transition Services Agreement.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company owns approximately 9% of Pharmsynthez and Pharmsynthez is Xenetic’s largest and controlling stockholder. Dr. Richard Lerner, a director of the Company until his death on December 2, 2021, was a co-inventor of Xenetic’s technology and received 31,240 shares of Xenetic upon the closing of the Xenetic transactions described above. Adam Logal, our Senior Vice President and Chief Financial Officer, is a director of Xenetic. </span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We hold investments in Zebra (ownership 29%), Neovasc (1%), ChromaDex Corporation (0.1%), COCP (3%), NIMS (1%), Eloxx (1%), BioCardia (1%) and LeaderMed Health Group Limited (47%). These investments were considered related party transactions as a result of our executive management’s ownership interests and/or board representation in these entities. See further discussion of our investments in Note 6. </span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We lease office space from Frost Real Estate Holdings, LLC (“Frost Holdings”) in Miami, Florida, where our principal executive offices are located. Effective August 1, 2019, we entered into an amendment to our lease agreement with Frost Holdings. The lease, as amended, is for approximately 29,500 square feet of space. The lease provides for payments of approximately $89 thousand per month in the first year increasing annually to $101 thousand per month in the fifth year, plus applicable sales tax. The rent is inclusive of operating expenses, property taxes and parking. </span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dr. Elias Zerhouni, our Vice Chairman and President, sits on the board of directors of Danaher Corporation (“Danaher”). Our subsidiary, BioReference, routinely procures products and services from several subsidiaries of Danaher, including Beckman Coulter, Integrated DNA Technologies Inc., and Leica Microsystems Inc., to which BioReference has paid $1.7 million, $0.1 million, and $0.3 million, respectively, through June 30, 2022.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BioReference purchases and uses certain products acquired from InCellDx, a company in which we hold a 29% minority interest. </span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We reimburse Dr. Frost for Company-related use by Dr. Frost and our other executives of an airplane owned by a company that is beneficially owned by Dr. Frost. We reimburse Dr. Frost for out-of-pocket operating costs for the use of the airplane by Dr. Frost or Company executives for Company-related business. We do not reimburse Dr. Frost for personal use of the airplane by Dr. Frost or any other executive. For the three and six months ended June 30, 2022, we reimbursed approximately $0 thousand and $30 thousand, respectively, for Company-related travel by Dr. Frost and other OPKO executives. For the three and six months ended June 30, 2021, we reimbursed approximately $0 thousand and $43 thousand, respectively, for Company-related travel by Dr. Frost and other OPKO executives.</span></div>
</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
<us-gaap:PaymentsToAcquireEquityMethodInvestments contextRef="ia7a3c018e543418cafcd9447f550bae3_D20200801-20200831" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml83My9mcmFnOmQ3YzhhNTA0ZDllMTRiZDdhMGM1MzdlYTc2M2VlZDVlL3RleHRyZWdpb246ZDdjOGE1MDRkOWUxNGJkN2EwYzUzN2VhNzYzZWVkNWVfNDIwNw_a14d667d-85f7-469c-b12b-4152b9dcd266" unitRef="usd"> 245000 </us-gaap:PaymentsToAcquireEquityMethodInvestments>
<us-gaap:EquityMethodInvestmentOwnershipPercentage contextRef="i0d7891d8150144dd97ca108bf7292e46_I20200831" decimals="2" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml83My9mcmFnOmQ3YzhhNTA0ZDllMTRiZDdhMGM1MzdlYTc2M2VlZDVlL3RleHRyZWdpb246ZDdjOGE1MDRkOWUxNGJkN2EwYzUzN2VhNzYzZWVkNWVfNDIxMQ_973dab84-eb39-49b4-b314-936261b750b1" unitRef="number"> 0.49 </us-gaap:EquityMethodInvestmentOwnershipPercentage>
<us-gaap:PaymentsToAcquireEquityMethodInvestments contextRef="i4017b4d7760c4bf599661ff8eca425ac_D20200801-20200831" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml83My9mcmFnOmQ3YzhhNTA0ZDllMTRiZDdhMGM1MzdlYTc2M2VlZDVlL3RleHRyZWdpb246ZDdjOGE1MDRkOWUxNGJkN2EwYzUzN2VhNzYzZWVkNWVfNDI3_2ad59935-e03a-422f-896b-71d115216335" unitRef="usd"> 255000 </us-gaap:PaymentsToAcquireEquityMethodInvestments>
<us-gaap:EquityMethodInvestmentOwnershipPercentage contextRef="idf1a2a8d8a014959b4fbfdb9c285551d_I20200831" decimals="2" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml83My9mcmFnOmQ3YzhhNTA0ZDllMTRiZDdhMGM1MzdlYTc2M2VlZDVlL3RleHRyZWdpb246ZDdjOGE1MDRkOWUxNGJkN2EwYzUzN2VhNzYzZWVkNWVfNDQ4_6afd3734-dd2d-46b1-a2ad-698762105897" unitRef="number"> 0.51 </us-gaap:EquityMethodInvestmentOwnershipPercentage>
<us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty contextRef="i6b2fc03757264304b6d7b20379ad54df_D20220101-20220630" decimals="-2" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml83My9mcmFnOmQ3YzhhNTA0ZDllMTRiZDdhMGM1MzdlYTc2M2VlZDVlL3RleHRyZWdpb246ZDdjOGE1MDRkOWUxNGJkN2EwYzUzN2VhNzYzZWVkNWVfMjE5OTAyMzI2NTY5MA_29789219-9c0e-411b-bf2b-344e4ce522e5" unitRef="usd"> 335300 </us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty>
<us-gaap:DueFromAffiliates contextRef="id6c8824b84b940149de9701215df8749_I20220630" decimals="-2" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml83My9mcmFnOmQ3YzhhNTA0ZDllMTRiZDdhMGM1MzdlYTc2M2VlZDVlL3RleHRyZWdpb246ZDdjOGE1MDRkOWUxNGJkN2EwYzUzN2VhNzYzZWVkNWVfMjE5OTAyMzI2NTgxMQ_a6682f92-3e84-4831-9dac-ba2c30031832" unitRef="usd"> 167200 </us-gaap:DueFromAffiliates>
<us-gaap:EquityMethodInvestmentOwnershipPercentage contextRef="iccb7ebf892d04d5bad4a79423d427821_I20220630" decimals="2" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml83My9mcmFnOmQ3YzhhNTA0ZDllMTRiZDdhMGM1MzdlYTc2M2VlZDVlL3RleHRyZWdpb246ZDdjOGE1MDRkOWUxNGJkN2EwYzUzN2VhNzYzZWVkNWVfMTQ1Mw_b35ac6be-3630-49a5-a81c-cb6cb38c8d6c" unitRef="number"> 0.09 </us-gaap:EquityMethodInvestmentOwnershipPercentage>
<opk:RelatedPartyTransactionShares contextRef="if907ce6e11c94b43a96b7cfe0ea19f49_I20220630" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml83My9mcmFnOmQ3YzhhNTA0ZDllMTRiZDdhMGM1MzdlYTc2M2VlZDVlL3RleHRyZWdpb246ZDdjOGE1MDRkOWUxNGJkN2EwYzUzN2VhNzYzZWVkNWVfMTY3Nw_152625c5-39a1-4adc-b3dc-a02d80f35511" unitRef="shares"> 31240 </opk:RelatedPartyTransactionShares>
<us-gaap:VariableInterestEntityOwnershipPercentage contextRef="i16b541229b024da08f7daa48c380124d_D20220101-20220630" decimals="2" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml83My9mcmFnOmQ3YzhhNTA0ZDllMTRiZDdhMGM1MzdlYTc2M2VlZDVlL3RleHRyZWdpb246ZDdjOGE1MDRkOWUxNGJkN2EwYzUzN2VhNzYzZWVkNWVfMTg5Nw_c68a81cd-449a-40d3-95dc-3393272739ea" unitRef="number"> 0.29 </us-gaap:VariableInterestEntityOwnershipPercentage>
<us-gaap:EquityMethodInvestmentOwnershipPercentage contextRef="i638893db4b744380bbf4fe4b1c4c34cb_I20220630" decimals="2" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml83My9mcmFnOmQ3YzhhNTA0ZDllMTRiZDdhMGM1MzdlYTc2M2VlZDVlL3RleHRyZWdpb246ZDdjOGE1MDRkOWUxNGJkN2EwYzUzN2VhNzYzZWVkNWVfMTkxMQ_b958c4ea-e7b0-46cb-a092-d7aff8e03333" unitRef="number"> 0.01 </us-gaap:EquityMethodInvestmentOwnershipPercentage>
<opk:EquitySecurityFVNIOwnershipPercent contextRef="i64c7c96871b341d99d80d66a62fbcdf5_I20220630" decimals="3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml83My9mcmFnOmQ3YzhhNTA0ZDllMTRiZDdhMGM1MzdlYTc2M2VlZDVlL3RleHRyZWdpb246ZDdjOGE1MDRkOWUxNGJkN2EwYzUzN2VhNzYzZWVkNWVfMTkzOQ_d14a2d90-3695-433f-85dc-0aac5cd65e3a" unitRef="number"> 0.001 </opk:EquitySecurityFVNIOwnershipPercent>
<us-gaap:EquityMethodInvestmentOwnershipPercentage contextRef="ibd144d9728004cf9863b6ae5054c6f3b_I20220630" decimals="2" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml83My9mcmFnOmQ3YzhhNTA0ZDllMTRiZDdhMGM1MzdlYTc2M2VlZDVlL3RleHRyZWdpb246ZDdjOGE1MDRkOWUxNGJkN2EwYzUzN2VhNzYzZWVkNWVfMTk1MA_0988d565-7245-4eba-b07c-61d9541c3b2f" unitRef="number"> 0.03 </us-gaap:EquityMethodInvestmentOwnershipPercentage>
<opk:EquitySecurityFVNIOwnershipPercent contextRef="i822b73267c824562bdff0073abf69c90_I20220630" decimals="2" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml83My9mcmFnOmQ3YzhhNTA0ZDllMTRiZDdhMGM1MzdlYTc2M2VlZDVlL3RleHRyZWdpb246ZDdjOGE1MDRkOWUxNGJkN2EwYzUzN2VhNzYzZWVkNWVfMTk2MQ_890b44ab-501d-4245-a10a-3437391ebc88" unitRef="number"> 0.01 </opk:EquitySecurityFVNIOwnershipPercent>
<opk:EquitySecurityFVNIOwnershipPercent contextRef="i4b9df4ff9c4d4da3ad49058716ae72e7_I20220630" decimals="2" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml83My9mcmFnOmQ3YzhhNTA0ZDllMTRiZDdhMGM1MzdlYTc2M2VlZDVlL3RleHRyZWdpb246ZDdjOGE1MDRkOWUxNGJkN2EwYzUzN2VhNzYzZWVkNWVfMTk3Mw_0fd627b5-1cff-4cc7-a10f-287c311e6433" unitRef="number"> 0.01 </opk:EquitySecurityFVNIOwnershipPercent>
<opk:EquitySecurityFVNIOwnershipPercent contextRef="ica61dbae6de944cbb0951857c4df1f1c_I20220630" decimals="2" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml83My9mcmFnOmQ3YzhhNTA0ZDllMTRiZDdhMGM1MzdlYTc2M2VlZDVlL3RleHRyZWdpb246ZDdjOGE1MDRkOWUxNGJkN2EwYzUzN2VhNzYzZWVkNWVfMTk4OQ_6254afae-5753-4e80-915e-c9209fdf4125" unitRef="number"> 0.01 </opk:EquitySecurityFVNIOwnershipPercent>
<us-gaap:VariableInterestEntityOwnershipPercentage contextRef="i4aa0e748cf164fbebe8ea96fb98f0800_D20220101-20220630" decimals="2" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml83My9mcmFnOmQ3YzhhNTA0ZDllMTRiZDdhMGM1MzdlYTc2M2VlZDVlL3RleHRyZWdpb246ZDdjOGE1MDRkOWUxNGJkN2EwYzUzN2VhNzYzZWVkNWVfMjAyOQ_f619dc79-a14a-41df-a72a-49a476b08337" unitRef="number"> 0.47 </us-gaap:VariableInterestEntityOwnershipPercentage>
<us-gaap:AreaOfRealEstateProperty contextRef="i9943940092354c79b00f75f6a1a4d840_I20190801" decimals="-2" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml83My9mcmFnOmQ3YzhhNTA0ZDllMTRiZDdhMGM1MzdlYTc2M2VlZDVlL3RleHRyZWdpb246ZDdjOGE1MDRkOWUxNGJkN2EwYzUzN2VhNzYzZWVkNWVfMzAxNA_0bd25884-8f8a-4231-a422-76d0d69240bb" unitRef="sqft"> 29500 </us-gaap:AreaOfRealEstateProperty>
<opk:OperatingLeasesMonthlyPaymentsYearOne contextRef="i9943940092354c79b00f75f6a1a4d840_I20190801" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml83My9mcmFnOmQ3YzhhNTA0ZDllMTRiZDdhMGM1MzdlYTc2M2VlZDVlL3RleHRyZWdpb246ZDdjOGE1MDRkOWUxNGJkN2EwYzUzN2VhNzYzZWVkNWVfMzA4OQ_2a6bc95d-f6de-4edc-b79c-080a58fa1f2a" unitRef="usd"> 89000 </opk:OperatingLeasesMonthlyPaymentsYearOne>
<opk:OperatingLeasesMonthlyPaymentsYearFive contextRef="i9943940092354c79b00f75f6a1a4d840_I20190801" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml83My9mcmFnOmQ3YzhhNTA0ZDllMTRiZDdhMGM1MzdlYTc2M2VlZDVlL3RleHRyZWdpb246ZDdjOGE1MDRkOWUxNGJkN2EwYzUzN2VhNzYzZWVkNWVfMzE0Mw_13221382-58ee-4e07-92af-3dd3c1b2d33d" unitRef="usd"> 101000 </opk:OperatingLeasesMonthlyPaymentsYearFive>
<us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty contextRef="i338cafba600248e69d11f39d67c116f5_D20220101-20220630" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml83My9mcmFnOmQ3YzhhNTA0ZDllMTRiZDdhMGM1MzdlYTc2M2VlZDVlL3RleHRyZWdpb246ZDdjOGE1MDRkOWUxNGJkN2EwYzUzN2VhNzYzZWVkNWVfMjE5OTAyMzI2ODI5NQ_f9c1e35c-1a95-4741-af5e-be202831f34c" unitRef="usd"> 1700000 </us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty>
<us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty contextRef="i7a7dbbd3653743e989676feff6ad0792_D20220101-20220630" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml83My9mcmFnOmQ3YzhhNTA0ZDllMTRiZDdhMGM1MzdlYTc2M2VlZDVlL3RleHRyZWdpb246ZDdjOGE1MDRkOWUxNGJkN2EwYzUzN2VhNzYzZWVkNWVfMjE5OTAyMzI2ODMwOQ_3ce598aa-36b1-4cde-aa52-fcd4e5fd5b9e" unitRef="usd"> 100000 </us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty>
<us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty contextRef="i5355afa387de46198fcac5ce089f240e_D20220101-20220630" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml83My9mcmFnOmQ3YzhhNTA0ZDllMTRiZDdhMGM1MzdlYTc2M2VlZDVlL3RleHRyZWdpb246ZDdjOGE1MDRkOWUxNGJkN2EwYzUzN2VhNzYzZWVkNWVfMjE5OTAyMzI2ODMyMw_cf3c7197-bcbc-4047-9eb6-829bea98ff6b" unitRef="usd"> 300000 </us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty>
<us-gaap:EquityMethodInvestmentOwnershipPercentage contextRef="i088e1c2b87224f69a5e28490a4d4c18b_I20220630" decimals="2" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml83My9mcmFnOmQ3YzhhNTA0ZDllMTRiZDdhMGM1MzdlYTc2M2VlZDVlL3RleHRyZWdpb246ZDdjOGE1MDRkOWUxNGJkN2EwYzUzN2VhNzYzZWVkNWVfMzM4MQ_b5133896-c5ba-4372-baf4-c615ebcf8740" unitRef="number"> 0.29 </us-gaap:EquityMethodInvestmentOwnershipPercentage>
<us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty contextRef="i50aa2eea9a6446b6ad796d994509b1ad_D20220401-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml83My9mcmFnOmQ3YzhhNTA0ZDllMTRiZDdhMGM1MzdlYTc2M2VlZDVlL3RleHRyZWdpb246ZDdjOGE1MDRkOWUxNGJkN2EwYzUzN2VhNzYzZWVkNWVfMzg2Nw_ec4c227f-cafc-4de5-a45a-93cd03b27556" unitRef="usd"> 0 </us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty>
<us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml83My9mcmFnOmQ3YzhhNTA0ZDllMTRiZDdhMGM1MzdlYTc2M2VlZDVlL3RleHRyZWdpb246ZDdjOGE1MDRkOWUxNGJkN2EwYzUzN2VhNzYzZWVkNWVfMjc0ODc3OTA3MzYyNg_01e328ce-c800-45f6-bad4-e81af082c0f8" unitRef="usd"> 30000 </us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty>
<us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty contextRef="if2a6207b6732465a921fe019a2a0f048_D20210401-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml83My9mcmFnOmQ3YzhhNTA0ZDllMTRiZDdhMGM1MzdlYTc2M2VlZDVlL3RleHRyZWdpb246ZDdjOGE1MDRkOWUxNGJkN2EwYzUzN2VhNzYzZWVkNWVfMjE5OTAyMzI1OTgyNw_e824f165-2aca-4e7e-8886-de5bce8e88d5" unitRef="usd"> 0 </us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty>
<us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty contextRef="i420e18e30084498a98510d48880063cd_D20210101-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml83My9mcmFnOmQ3YzhhNTA0ZDllMTRiZDdhMGM1MzdlYTc2M2VlZDVlL3RleHRyZWdpb246ZDdjOGE1MDRkOWUxNGJkN2EwYzUzN2VhNzYzZWVkNWVfMzg3NA_4b8f1842-34c7-4e64-9e0e-b80fe2361084" unitRef="usd"> 43000 </us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty>
<us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml83Ni9mcmFnOjI4MmVmZGU5ZTg4ZDRhZDY4ZDQ1ZGQ2YzFlYzAwMWIzL3RleHRyZWdpb246MjgyZWZkZTllODhkNGFkNjhkNDVkZDZjMWVjMDAxYjNfOTE0Ng_7405f034-8b28-4e8c-8c68-d29b528d2cd0">
COMMITMENTS AND CONTINGENCIES<div style="margin-bottom:9pt;margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with our acquisitions of CURNA, OPKO Diagnostics and OPKO Renal, we agreed to pay future consideration to the sellers upon the achievement of certain events. As a result, as of June 30, 2022, we recorded $2.9 million as contingent consideration, with $0.5 million recorded within Accrued expenses and $2.4 million recorded within Other long-term liabilities in the accompanying Condensed Consolidated Balance Sheets. Refer to Note 5 and Note 17.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 1, 2019, the Company received a Civil Investigative Demand (“CID”) from the U.S. Department of Justice (“DOJ”), Washington, DC. The CID sets forth document requests and interrogatories in connection with allegations that the Company and certain of its affiliates violated the False Claims Act and/or the Anti-Kickback Statute. On January 13, 2022, the Federal Government notified the U.S.D.C., Middle District Florida, Jacksonville Division, that it is declining to intervene in the matter but retains the right, via the Attorney General, to consent to any proposed dismissal of the action by the Court. On February 9, 2022, the States of Florida, Georgia, and Commonwealth of Massachusetts notified the U.S.D.C., Middle District Florida, Jacksonville Division, that they are declining to intervene in the matter. Notwithstanding the above declinations, on February 17, 2022, the Company was served with the Relator’s Summons and Complaint (“Complaint”), which had been previously sealed. The complaint alleges violations of the False Claims Act, the California Fraud Preventions Act, the Florida False Claims Act, the Massachusetts False Claims Act, the Georgia False Medicaid Claims Act, and illegal kickbacks. The Company is reviewing and assessing the allegations made in the Complaint and, at this point, has not determined whether there is any merit to these claims nor can it determine the extent of any potential liability. While management cannot predict the outcome of these matters at this time, the ultimate outcome could be material to our business, financial condition, results of operations, and cash flows.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> As previously reported, BioReference receives and is routinely required to respond to CIDs in the ordinary course of business. On November 26, 2019, BioReference received a CID from the DOJ. The CID stated that the DOJ was investigating whether BioReference paid unlawful remuneration to health care practitioners in violation of the Anti-Kickback Statute or Stark law and thus submitted or caused to be submitted false claims to government health care programs in violation of the False Claims Act. The time period covered by the DOJ’s requests was January 1, 2011 through November 26, 2019. BioReference has fully cooperated with the DOJ by submitting the requested information and making current employees available for interviews, and the DOJ made a presentation to BioReference regarding its position. The parties have reached an agreement on the settlement amount, which is approximately $10 million, excluding attorney fees (refer to Note 17). As of June 30, 2022 and December 31, 2021, $10.5 million and $10.0 million was recorded in Accrued expenses, respectively.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 8, 2019, MabVax Therapeutics Holdings, Inc. filed a lawsuit in the Superior Court of California, County of San Diego against a number of individuals and entities, including the Company, Dr. Frost, Steven Rubin, the Company’s Executive Vice President-Administration, and an entity affiliated with Dr. Frost, based on the allegations raised in the SEC Complaint. The lawsuit seeks an award for actual and punitive damages, pre- and post-judgment interest; that the defendants be required to make full disclosure and accounting of their interests and transactions in plaintiff’s securities; costs of the suit, and reasonable attorney’s fees; and such other legal and equitable relief as the Court may deem proper under the circumstances. On January 31, 2022, plaintiffs entered into a confidential mutual release and settlement agreement with the Company, Dr. Frost, Frost Gamma Investment Trust, and Steve Rubin, which has been approved by the United States Bankruptcy Court for the District of Delaware.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 5, 2019, former shareholders of Claros Diagnostics, Inc. filed a complaint in the Chancery Court of Delaware against the Company, alleging among other things, that the Company breached the Agreement and Plan of Merger dated October 13, 2011 by and among the Company, Claros Merger Subsidiary, LLC and Claros Diagnostics, Inc. (the “Claros Merger Agreement”): (i) by failing to make a milestone payment of $2.375 million (payable in OPKO Common Stock) upon obtaining FDA approval of the Claros PSA test; and (ii) by repudiating its obligations to make additional future milestone payments as required under the Claros Merger Agreement. In January 2021, the Company and the shareholder representative entered into a settlement agreement providing, among other things, that the Company pay the shareholders $1.2 million, which the Company has paid in full.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2017, the Civil Division of the United States Attorney’s Office for the Southern District of New York (the “SDNY”) informed BioReference that it believed that, from 2008 to 2012, BioReference had, in violation of the False Claims Act, improperly billed Medicare and TRICARE (both are federal government healthcare programs) for clinical laboratory services provided to hospital inpatient beneficiaries at certain hospitals. In April 2019, the SDNY also informed BioReference that it believed that BioReference provided physicians subsidies for electronic health record systems prior to 2012 that violated regulations adopted by HHS in 2006 which allowed laboratories to provide these donations under certain conditions. BioReference and the SDNY reached a settlement with respect to these matters and a final settlement and release, including BioReference’s payment of an approximately $11.5 million settlement amount, was approved on September 22, 2020. The settlement amount has been paid. The amount of relator attorneys’ fees is currently being negotiated.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, we may receive inquiries, document requests, CIDs or subpoenas from the Department of Justice, OCR, CMS, various payors and fiscal intermediaries, and other state and federal regulators regarding investigations, audits and reviews. In addition to the matters discussed in this note, we are currently responding to CIDs, subpoenas, payor audits, and document requests for various matters relating to our laboratory operations. Some pending or threatened proceedings against us may involve potentially substantial amounts as well as the possibility of civil, criminal, or administrative fines, penalties, or other sanctions, which could be material. Settlements of suits involving the types of issues that we routinely confront may require monetary payments as well as corporate integrity agreements. Additionally, qui tam or “whistleblower” actions initiated under the civil False Claims Act may be pending but placed under seal by the court to comply with the False Claims Act’s requirements for filing such suits. Also, from time to time, we may detect issues of non-compliance with federal healthcare laws pertaining to claims submission and reimbursement practices and/or financial relationships with physicians, among other things. We may avail ourselves of various mechanisms to address these issues, including participation in voluntary disclosure protocols. Participating in voluntary disclosure protocols can have the potential for significant settlement obligations or even enforcement action. The Company generally has cooperated, and intends to continue to cooperate, with appropriate regulatory authorities as and when investigations, audits and inquiries arise. </span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a party to other litigation in the ordinary course of business. While we cannot predict the ultimate outcome of legal matters, we accrue a liability for legal contingencies when we believe that it is both probable that a liability has been incurred and that we can reasonably estimate the amount of the loss. It’s reasonably possible the ultimate liability could exceed amounts currently estimated and we review established accruals and adjust them to reflect ongoing negotiations, settlements, rulings, advice of legal counsel and other relevant information. To the extent new information is obtained and our views on the probable outcomes of claims, suits, assessments, investigations or legal proceedings change, changes in our accrued liabilities would be recorded in the period in which such determination is made. Because of the high degree of judgment involved in establishing loss estimates, the ultimate outcome of such matters will differ from our estimates and such differences may be material to our business, financial condition, results of operations, and cash flows.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At June 30, 2022, we were committed to make future purchases for inventory and other items in 2022 that occur in the ordinary course of business under various purchase arrangements with fixed purchase provisions aggregating approximately $197.2 million.</span></div>
</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
<us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="i4768f885851b49f986857a2a956f9162_I20220630" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml83Ni9mcmFnOjI4MmVmZGU5ZTg4ZDRhZDY4ZDQ1ZGQ2YzFlYzAwMWIzL3RleHRyZWdpb246MjgyZWZkZTllODhkNGFkNjhkNDVkZDZjMWVjMDAxYjNfMjQ1_c8717bab-c70e-4fa2-802e-56a5d61a4319" unitRef="usd"> 2900000 </us-gaap:BusinessCombinationContingentConsiderationLiability>
<us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="i9f2a6258e98049439883dbcb99e01f29_I20220630" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml83Ni9mcmFnOjI4MmVmZGU5ZTg4ZDRhZDY4ZDQ1ZGQ2YzFlYzAwMWIzL3RleHRyZWdpb246MjgyZWZkZTllODhkNGFkNjhkNDVkZDZjMWVjMDAxYjNfMjgy_ff474a72-9d6b-42ac-891b-42936ddd0903" unitRef="usd"> 500000 </us-gaap:BusinessCombinationContingentConsiderationLiability>
<us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="i9527c584ee6e460bb59b851ee6b2385d_I20220630" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml83Ni9mcmFnOjI4MmVmZGU5ZTg4ZDRhZDY4ZDQ1ZGQ2YzFlYzAwMWIzL3RleHRyZWdpb246MjgyZWZkZTllODhkNGFkNjhkNDVkZDZjMWVjMDAxYjNfMzIy_34cff718-59e9-4637-a280-2a3a73c13233" unitRef="usd"> 2400000 </us-gaap:BusinessCombinationContingentConsiderationLiability>
<us-gaap:LitigationSettlementAmountAwardedToOtherParty contextRef="i47726716d3bd4c8593b1d488649813a3_D20220101-20220630" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml83Ni9mcmFnOjI4MmVmZGU5ZTg4ZDRhZDY4ZDQ1ZGQ2YzFlYzAwMWIzL3RleHRyZWdpb246MjgyZWZkZTllODhkNGFkNjhkNDVkZDZjMWVjMDAxYjNfMzAzNg_071e8676-c782-41a5-82aa-e73273aa07f0" unitRef="usd"> 10000000 </us-gaap:LitigationSettlementAmountAwardedToOtherParty>
<us-gaap:LitigationReserveCurrent contextRef="i7e1df4373dd046b89578b1be8e91e5ea_I20220630" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml83Ni9mcmFnOjI4MmVmZGU5ZTg4ZDRhZDY4ZDQ1ZGQ2YzFlYzAwMWIzL3RleHRyZWdpb246MjgyZWZkZTllODhkNGFkNjhkNDVkZDZjMWVjMDAxYjNfMzA5Nw_cdbc97bf-017b-40bf-8fe0-12a6ca8b1bb1" unitRef="usd"> 10500000 </us-gaap:LitigationReserveCurrent>
<us-gaap:LitigationReserveCurrent contextRef="icc3fe055809a40779843b63725072220_I20211231" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml83Ni9mcmFnOjI4MmVmZGU5ZTg4ZDRhZDY4ZDQ1ZGQ2YzFlYzAwMWIzL3RleHRyZWdpb246MjgyZWZkZTllODhkNGFkNjhkNDVkZDZjMWVjMDAxYjNfMzEwNA_8193a2fc-0fb3-4bf7-a57d-3334b47f66b2" unitRef="usd"> 10000000 </us-gaap:LitigationReserveCurrent>
<opk:LossContingencyMilestonePayment contextRef="if50ac22ea363492e8881a12b69f412df_I20190405" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml83Ni9mcmFnOjI4MmVmZGU5ZTg4ZDRhZDY4ZDQ1ZGQ2YzFlYzAwMWIzL3RleHRyZWdpb246MjgyZWZkZTllODhkNGFkNjhkNDVkZDZjMWVjMDAxYjNfNDYzMA_cd6fc401-c073-47dc-9050-c3b892e2dd33" unitRef="usd"> 2375000 </opk:LossContingencyMilestonePayment>
<us-gaap:LitigationSettlementAmountAwardedToOtherParty contextRef="i834a9a4eb5f145048be6d98d14a1f2d0_D20210101-20210131" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml83Ni9mcmFnOjI4MmVmZGU5ZTg4ZDRhZDY4ZDQ1ZGQ2YzFlYzAwMWIzL3RleHRyZWdpb246MjgyZWZkZTllODhkNGFkNjhkNDVkZDZjMWVjMDAxYjNfNTAxNw_f193caf5-778a-494e-acd6-7fb07b96cf28" unitRef="usd"> 1200000 </us-gaap:LitigationSettlementAmountAwardedToOtherParty>
<us-gaap:LitigationSettlementAmountAwardedToOtherParty contextRef="i557a3a4d196441c3b5affd3d0bb5e05e_D20200922-20200922" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml83Ni9mcmFnOjI4MmVmZGU5ZTg4ZDRhZDY4ZDQ1ZGQ2YzFlYzAwMWIzL3RleHRyZWdpb246MjgyZWZkZTllODhkNGFkNjhkNDVkZDZjMWVjMDAxYjNfNTk1NA_6b83f826-6edd-4f15-a4d5-c439d590381b" unitRef="usd"> 11500000 </us-gaap:LitigationSettlementAmountAwardedToOtherParty>
<us-gaap:PurchaseObligation contextRef="i4768f885851b49f986857a2a956f9162_I20220630" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml83Ni9mcmFnOjI4MmVmZGU5ZTg4ZDRhZDY4ZDQ1ZGQ2YzFlYzAwMWIzL3RleHRyZWdpb246MjgyZWZkZTllODhkNGFkNjhkNDVkZDZjMWVjMDAxYjNfOTE0Mg_6d9e1593-37b1-4d0c-b086-895108e5cec9" unitRef="usd"> 197200000 </us-gaap:PurchaseObligation>
<us-gaap:RevenueFromContractWithCustomerTextBlock contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml83OS9mcmFnOjVmOTBlN2YxYTViZjQ4YjJiYjMzYmJhY2YzY2U0YzAwL3RleHRyZWdpb246NWY5MGU3ZjFhNWJmNDhiMmJiMzNiYmFjZjNjZTRjMDBfMTU1OTM_c642d729-c2ec-43b4-b19b-04f9ab00659e">
REVENUE RECOGNITION<div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We generate revenues from services, products and intellectual property as follows:</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue from services</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue for laboratory services is recognized at the time test results are reported, which approximates when services are provided and the performance obligations are satisfied. Services are provided to patients covered by various third-party payor programs including various managed care organizations, as well as the Medicare and Medicaid programs. Billings for services are included in revenue net of allowances for contractual discounts, allowances for differences between the amounts billed and estimated program payment amounts, and implicit price concessions provided to uninsured patients which are all elements of variable consideration. </span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following are descriptions of our payors for laboratory services:</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Healthcare Insurers. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reimbursements from healthcare insurers are based on negotiated fee-for-service schedules. Revenues consist of amounts billed, net of contractual allowances for differences between amounts billed and the estimated consideration we expect to receive from such payors, which considers historical denial and collection experience and the terms of our contractual arrangements. Adjustments to the allowances, based on actual receipts from the third-party payors, are recorded upon settlement. </span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Government Payors. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reimbursements from government payors are based on fee-for-service schedules set by governmental authorities, including traditional Medicare and Medicaid. Revenues consist of amounts billed, net of contractual allowances for differences between amounts billed and the estimated consideration we expect to receive from such payors, which considers historical denial and collection experience and the terms of our contractual arrangements. Adjustments to the allowances, based on actual receipts from the government payors, are recorded upon settlement.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Client Payors. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Client payors include physicians, hospitals, employers, and other institutions for which services are performed on a wholesale basis, and are billed and recognized as revenue based on negotiated fee schedules. Client payors also include cities, states and companies for which BioReference provides COVID-19 testing services. </span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Patients. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Uninsured patients are billed based on established patient fee schedules or fees negotiated with physicians on behalf of their patients. Insured patients (including amounts for coinsurance and deductible responsibilities) are billed based on fees negotiated with healthcare insurers. Collection of billings from patients is subject to credit risk and ability of the patients to pay. Revenues consist of amounts billed net of discounts provided to uninsured patients in accordance with our policies and implicit price concessions. Implicit price concessions represent differences between amounts billed and the estimated consideration that we expect to receive from patients, which considers historical collection experience and other factors including current market conditions. Adjustments to the estimated allowances, based on actual receipts from the patients, are recorded upon settlement. </span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The complexities and ambiguities of billing, reimbursement regulations and claims processing, as well as considerations unique to Medicare and Medicaid programs, require us to estimate the potential for retroactive adjustments as an element of variable consideration in the recognition of revenue in the period the related services are rendered. Actual amounts are adjusted in the period those adjustments become known. For the six months ended June 30, 2022, negative revenue adjustments due to changes in estimates of implicit price concessions for performance obligations satisfied in prior periods of $21.2 million were recognized. Revenue adjustments for the six months ended June 30, 2022 were primarily due to lower COVID-19 test reimbursement estimates. For the six months ended June 30, 2021, positive revenue adjustments due to changes in estimates of implicit price concessions for performance obligations satisfied in prior periods of $28.5 million were recognized. Revenue adjustments for the six months ended June 30, 2021 were primarily due to an increase in COVID-19 test reimbursement estimates.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Third-party payors, including government programs, may decide to deny payment or recoup payments for testing they contend were improperly billed or not medically necessary, against their coverage determinations, or for which they believe they have otherwise overpaid (including as a result of their own error), and we may be required to refund payments already received. Our revenues may be subject to retroactive adjustment as a result of these factors among others, including without limitation, differing interpretations of billing and coding guidance and changes by government agencies and payors in interpretations, requirements, and “conditions of participation” in various programs. We have processed requests for recoupment from third-party payors in the ordinary course of our business, and it is likely that we will continue to do so in the future. If a third-party payor denies payment for testing or recoups money from us in a later period, reimbursement for our testing could decline. </span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As an integral part of our billing compliance program, we periodically assess our billing and coding practices, respond to payor audits on a routine basis, and investigate reported failures or suspected failures to comply with federal and state healthcare reimbursement requirements, as well as overpayment claims which may arise from time to time without fault on the part of the Company. We may have an obligation to reimburse Medicare, Medicaid, and third-party payors for overpayments regardless of fault. We have periodically identified and reported overpayments, reimbursed payors for overpayments and taken appropriate corrective action. </span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Settlements with third-party payors for retroactive adjustments due to audits, reviews or investigations are also considered variable consideration and are included in the determination of the estimated transaction price for providing services. These settlements are estimated based on the terms of the payment agreement with the payor, correspondence from the payor and our historical settlement activity, including an assessment of the probability a significant reversal of cumulative revenue recognized will occur when the uncertainty is subsequently resolved. Estimated settlements are adjusted in future periods as adjustments become known (that is, new information becomes available), or as years are settled or are no longer subject to such audits, reviews, and investigations. As of June 30, 2022 and December 31, 2021, we had liabilities of approximately $1.5 million and $5.0 million, respectively, within Accrued expenses and Other long-term liabilities related to reimbursements for payor overpayments.</span></div><div style="margin-bottom:5pt;margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The composition of revenue from services by payor for the three and six months ended June 30, 2022 and 2021 was as follows:</span></div><div style="margin-bottom:5pt;margin-top:14pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:40.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.935%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.935%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.935%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.939%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three months ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Six months ended June 30,</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Healthcare insurers</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76,442 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109,084 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172,269 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">273,913 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government payers</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,659 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,611 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,263 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131,269 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Client payers</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80,931 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">225,936 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">240,021 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">488,845 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patients</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,772 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,566 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,849 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,122 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">186,804 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">397,197 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">473,402 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">904,149 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:5pt;margin-top:4pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue from products</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize revenue from product sales when a customer obtains control of promised goods or services. The amount of revenue that is recorded reflects the consideration that we expect to receive in exchange for those goods or services. Our estimates for sales returns and allowances are based upon the historical patterns of product returns and allowances taken, matched against the sales from which they originated, and our evaluation of specific factors that may increase or decrease the risk of product returns. Product revenues are recorded net of estimated rebates, chargebacks, discounts, co-pay assistance and other deductions (collectively, “Sales Deductions”) as well as estimated product returns which are all elements of variable consideration. Allowances are recorded as a reduction of revenue at the time product revenues are recognized. The actual amounts of consideration ultimately received may differ from our estimates. If actual results in the future vary from our estimates, we will adjust these estimates, which would affect Revenue from products in the period such variances become known.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Rayaldee</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> is distributed in the U.S. principally through the retail pharmacy channel, which initiates with the largest wholesalers in the U.S. (collectively, “</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Rayaldee</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Customers”). In addition to distribution agreements with </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Rayaldee </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Customers, we have entered into arrangements with many healthcare providers and payors that provide for government-mandated and/or privately-negotiated rebates, chargebacks and discounts with respect to the purchase of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Rayaldee</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:5pt;margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize revenue for shipments of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Rayaldee</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> at the time of delivery to customers after estimating Sales Deductions and product returns as elements of variable consideration utilizing historical information and market research projections. For the three and six months ended June 30, 2022, we recognized $6.2 million and $11.3 million, respectively, in net product revenue from sales of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Rayaldee</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. For the three and six months ended June 30, 2021, we recognized $5.0 million and $10.8 million, respectively, in net product revenue from sales of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Rayaldee</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span></div><div style="margin-bottom:5pt;margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents an analysis of product sales allowances and accruals for the three and six months ended June 30, 2022 and 2021:</span></div><div style="margin-bottom:5pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.005%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.554%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.554%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.554%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.554%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Chargebacks, discounts, rebates and fees</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Governmental </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Returns</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,588 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,282 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,333 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,203 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  Provision related to current period sales</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,411 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,442 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">308 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,161 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  Credits or payments made</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,330)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,235)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,023)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,588)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at June 30, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,669 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,489 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,618 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,776 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total gross </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Rayaldee</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> sales</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,382 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Rayaldee</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> sales allowances and accruals as a percentage of gross </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Rayaldee</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> sales</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60%</span></td></tr></table></div><div style="margin-bottom:5pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.005%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.554%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.554%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.554%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.554%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Chargebacks, discounts, rebates and fees</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Governmental </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Returns</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,014 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,499 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,639 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,152 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  Provision related to current period sales</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,626 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,311 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">577 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,514 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  Credits or payments made</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,971)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,321)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,598)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17,890)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at June 30, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,669 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,489 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,618 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,776 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total gross </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Rayaldee</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> sales</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,861 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Rayaldee</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> sales allowances and accruals as a percentage of gross </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Rayaldee</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> sales</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61%</span></td></tr></table></div><div style="margin-bottom:5pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.005%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.554%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.554%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.554%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.554%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Chargebacks, discounts, rebates and fees</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Governmental </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Returns</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,693 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,209 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,487 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,389 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  Provision related to current period sales</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,724 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,061 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">322 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,107 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  Credits or payments made</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,716)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,684)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(485)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,885)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at June 30, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,701 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,586 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,324 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,611 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total gross </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Rayaldee</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> sales</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,122 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Rayaldee</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> sales allowances and accruals as a percentage of gross </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Rayaldee</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> sales</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69%</span></td></tr></table></div><div style="margin-bottom:5pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.005%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.554%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.554%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.554%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.554%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Chargebacks, discounts, rebates and fees</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Governmental </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Returns</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,332 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,812 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,593 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,737 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  Provision related to current period sales</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,539 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,755 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">635 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,929 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  Credits or payments made</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,170)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,981)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(904)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20,055)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at June 30, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,701 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,586 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,324 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,611 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total gross </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Rayaldee</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> sales</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,767 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Rayaldee</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> sales allowances and accruals as a percentage of gross </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Rayaldee</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> sales</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66%</span></td></tr></table></div><div style="margin-bottom:5pt;margin-top:9pt"><span><br/></span></div><div style="margin-bottom:5pt;margin-top:4pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Taxes collected from customers related to revenues from services and revenues from products are excluded from revenues.</span></div><div style="margin-bottom:5pt;margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue from intellectual property and other</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize revenues from the transfer of intellectual property generated through license, development, collaboration and/or commercialization agreements. The terms of these agreements typically include payment to us for one or more of the following: non-refundable, up-front license fees; development and commercialization milestone payments; funding of research and/or development activities; and royalties on sales of licensed products. Revenue is recognized upon satisfaction of a performance obligation by transferring control of a good or service to the customer. </span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For research, development and/or commercialization agreements that result in revenues, we identify all material performance obligations, which may include a license to intellectual property and know-how, and research and development activities. In order to determine the transaction price, in addition to any upfront payment, we estimate the amount of variable consideration at the outset of the contract either utilizing the expected value or most likely amount method, depending on the facts and circumstances relative to the contract. We constrain (reduce) our estimates of variable consideration such that it is probable that a significant reversal of previously recognized revenue will not occur throughout the life of the contract. When determining if variable consideration should be constrained, we consider whether there are factors outside of our control that could result in a significant reversal of revenue. In making these assessments, we consider the likelihood and magnitude of a potential reversal of revenue. These estimates are re-assessed each reporting period as required. </span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upfront License Fees: If a license to our intellectual property is determined to be functional intellectual property distinct from the other performance obligations identified in the arrangement, we recognize revenue from nonrefundable, upfront license fees based on the relative value prescribed to the license compared to the total value of the arrangement. The revenue is recognized when the license is transferred to the customer and the customer is able to use and benefit from the license. For licenses that are not distinct from other obligations identified in the arrangement, we utilize judgment to assess the nature of the combined performance obligation to determine whether the combined performance obligation is satisfied over time or at a point in time. If the combined performance obligation is satisfied over time, we apply an appropriate method of measuring progress for purposes of recognizing revenue from nonrefundable, upfront license fees. We evaluate the measure of progress each reporting period and, if necessary, adjust the measure of performance and related revenue recognition.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Development and Regulatory Milestone Payments: Depending on facts and circumstances, we may conclude that it is appropriate to include the milestone in the estimated transaction price or that it is appropriate to fully constrain the milestone. A milestone payment is included in the transaction price in the reporting period that we conclude that it is probable that recording revenue in the period will not result in a significant reversal in amounts recognized in future periods. We may record revenues from certain milestones in a reporting period before the milestone is achieved if we conclude that achievement of the milestone is probable and that recognition of revenue related to the milestone will not result in a significant reversal in amounts recognized in future periods. We record a corresponding contract asset when this conclusion is reached. Milestone payments that have been fully constrained are not included in the transaction price to date. These milestones remain fully constrained until we conclude that achievement of the milestone is probable and that recognition of revenue related to the milestone will not result in a significant reversal in amounts recognized in future periods. We re-evaluate the probability of achievement of such development milestones and any related constraint each reporting period. We adjust our estimate of the overall transaction price, including the amount of revenue recorded, if necessary.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and Development Activities: If we are entitled to reimbursement from our customers for specified research and development expenses, we account for them as separate performance obligations if distinct. We also determine whether the research and development funding would result in revenues or an offset to research and development expenses in accordance with provisions of gross or net revenue presentation. The corresponding revenues or offset to research and development expenses are recognized as the related performance obligations are satisfied.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sales-based Milestone and Royalty Payments: Our customers may be required to pay us sales-based milestone payments or royalties on future sales of commercial products. We recognize revenues related to sales-based milestone and royalty payments upon the later to occur of (i) achievement of the customer’s underlying sales or (ii) satisfaction of any performance obligation(s) related to these sales, in each case assuming the license to our intellectual property is deemed to be the predominant item to which the sales-based milestones and/or royalties relate.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other Potential Products and Services: Arrangements may include an option for license rights, future supply of drug substance or drug product for either clinical development or commercial supply at the licensee’s election. We assess if these options provide a material right to the licensee and if so, they are accounted for as separate performance obligations at the inception of the contract and revenue is recognized only if the option is exercised and products or services are subsequently delivered or when the rights expire. If the promise is based on market terms and not considered a material right, the option is accounted for if and when exercised. If we are entitled to additional payments when the licensee exercises these options, any additional payments are generally recorded in license or other revenues when the licensee obtains control of the goods, which is upon delivery.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three and six months ended June 30, 2022, revenue from transfer of intellectual property and other reflects $2.3 million and $4.5 million of revenue related to the Pfizer Transaction (as defined below) and a $85.0 million regulatory milestone payments from Pfizer due from the commencement of sales from NGENLA (Somatrogon) in Europe and Japan. For the six months ended June 30, 2022, revenue from transfer of intellectual property and other includes $3.0 million related to a sales milestone from VFMCRP (as defined below). For the three and six months ended June 30, 2021, revenue from transfer of intellectual property principally reflects $2.8 million and $5.6 million of revenue, respectively, related to the Pfizer Transaction and a $5.0 million non-refundable upfront payment we have received under the Nicoya Agreement (as defined below).</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contract liabilities relate to cash consideration that OPKO receives in advance of satisfying the related performance obligations. Changes in the contractual liabilities balance during the six months ended June 30, 2022 are as follows:</span></div><div style="margin-top:9pt;text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.859%"><tr><td style="width:1.0%"/><td style="width:76.002%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.798%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">466 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at June 30, 2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">449 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue recognized in the period from:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts included in contracts liability at the beginning of the period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div>
</us-gaap:RevenueFromContractWithCustomerTextBlock>
<us-gaap:ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml83OS9mcmFnOjVmOTBlN2YxYTViZjQ4YjJiYjMzYmJhY2YzY2U0YzAwL3RleHRyZWdpb246NWY5MGU3ZjFhNWJmNDhiMmJiMzNiYmFjZjNjZTRjMDBfMzc5MQ_aafb5c17-61c5-48d0-be8b-671b294d694a" unitRef="usd"> 21200000 </us-gaap:ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod>
<us-gaap:ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod contextRef="i420e18e30084498a98510d48880063cd_D20210101-20210630" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml83OS9mcmFnOjVmOTBlN2YxYTViZjQ4YjJiYjMzYmJhY2YzY2U0YzAwL3RleHRyZWdpb246NWY5MGU3ZjFhNWJmNDhiMmJiMzNiYmFjZjNjZTRjMDBfMzc5OA_01f9002a-9b44-44bb-9f88-1b242a406f17" unitRef="usd"> 28500000 </us-gaap:ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod>
<opk:AccruedExpensePayorOverpaymentReimbursementLiability contextRef="i4768f885851b49f986857a2a956f9162_I20220630" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml83OS9mcmFnOjVmOTBlN2YxYTViZjQ4YjJiYjMzYmJhY2YzY2U0YzAwL3RleHRyZWdpb246NWY5MGU3ZjFhNWJmNDhiMmJiMzNiYmFjZjNjZTRjMDBfNjMyNQ_b110cbcf-4489-4435-9352-56a13d621723" unitRef="usd"> 1500000 </opk:AccruedExpensePayorOverpaymentReimbursementLiability>
<opk:AccruedExpensePayorOverpaymentReimbursementLiability contextRef="i7e0f479bead144b0bdbcc71082db627b_I20211231" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml83OS9mcmFnOjVmOTBlN2YxYTViZjQ4YjJiYjMzYmJhY2YzY2U0YzAwL3RleHRyZWdpb246NWY5MGU3ZjFhNWJmNDhiMmJiMzNiYmFjZjNjZTRjMDBfNjMzMg_9b7630fd-a0c9-4514-a5ca-6ee67cd5f179" unitRef="usd"> 5000000 </opk:AccruedExpensePayorOverpaymentReimbursementLiability>
<us-gaap:DisaggregationOfRevenueTableTextBlock contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml83OS9mcmFnOjVmOTBlN2YxYTViZjQ4YjJiYjMzYmJhY2YzY2U0YzAwL3RleHRyZWdpb246NWY5MGU3ZjFhNWJmNDhiMmJiMzNiYmFjZjNjZTRjMDBfMTU1OTU_e5b81e16-21a0-46a6-81b5-53471d106f53">
<div style="margin-bottom:5pt;margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The composition of revenue from services by payor for the three and six months ended June 30, 2022 and 2021 was as follows:</span></div><div style="margin-bottom:5pt;margin-top:14pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:40.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.935%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.935%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.935%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.939%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three months ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Six months ended June 30,</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Healthcare insurers</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76,442 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109,084 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172,269 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">273,913 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government payers</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,659 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,611 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,263 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131,269 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Client payers</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80,931 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">225,936 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">240,021 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">488,845 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patients</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,772 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,566 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,849 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,122 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">186,804 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">397,197 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">473,402 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">904,149 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>
</us-gaap:DisaggregationOfRevenueTableTextBlock>
<us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="i6bb5c2adbf0542a3aca179aa23bb6ae7_D20220401-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml83OS9mcmFnOjVmOTBlN2YxYTViZjQ4YjJiYjMzYmJhY2YzY2U0YzAwL3RhYmxlOjVhOTM4MGMwZGUxNTQxY2ZiNmZkYWVmMTVmNGRjNGZiL3RhYmxlcmFuZ2U6NWE5MzgwYzBkZTE1NDFjZmI2ZmRhZWYxNWY0ZGM0ZmJfMi0xLTEtMS00ODE2NA_13177645-43ef-4b5c-94fa-310ea93766b8" unitRef="usd"> 76442000 </us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
<us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="idc2dbc0d17014b3b852db13d3e1a4057_D20210401-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml83OS9mcmFnOjVmOTBlN2YxYTViZjQ4YjJiYjMzYmJhY2YzY2U0YzAwL3RhYmxlOjVhOTM4MGMwZGUxNTQxY2ZiNmZkYWVmMTVmNGRjNGZiL3RhYmxlcmFuZ2U6NWE5MzgwYzBkZTE1NDFjZmI2ZmRhZWYxNWY0ZGM0ZmJfMi0zLTEtMS00ODE2NA_73622578-2c3c-4cbc-9855-30c690f08e7e" unitRef="usd"> 109084000 </us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
<us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="ic2e7e867f4b44c73ac8edb9086cbf1af_D20220101-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml83OS9mcmFnOjVmOTBlN2YxYTViZjQ4YjJiYjMzYmJhY2YzY2U0YzAwL3RhYmxlOjVhOTM4MGMwZGUxNTQxY2ZiNmZkYWVmMTVmNGRjNGZiL3RhYmxlcmFuZ2U6NWE5MzgwYzBkZTE1NDFjZmI2ZmRhZWYxNWY0ZGM0ZmJfMi01LTEtMS00ODE2NA_164281ae-e0bc-4529-89c5-de5f0985fd8c" unitRef="usd"> 172269000 </us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
<us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="i4f0143a4a10e47a4ba818e759bfb700d_D20210101-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml83OS9mcmFnOjVmOTBlN2YxYTViZjQ4YjJiYjMzYmJhY2YzY2U0YzAwL3RhYmxlOjVhOTM4MGMwZGUxNTQxY2ZiNmZkYWVmMTVmNGRjNGZiL3RhYmxlcmFuZ2U6NWE5MzgwYzBkZTE1NDFjZmI2ZmRhZWYxNWY0ZGM0ZmJfMi03LTEtMS00ODE2NA_11a01639-39da-417c-a622-5bd85b6ca0cb" unitRef="usd"> 273913000 </us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
<us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="ia7f60d6c17c74ef0aea353cfcb26e682_D20220401-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml83OS9mcmFnOjVmOTBlN2YxYTViZjQ4YjJiYjMzYmJhY2YzY2U0YzAwL3RhYmxlOjVhOTM4MGMwZGUxNTQxY2ZiNmZkYWVmMTVmNGRjNGZiL3RhYmxlcmFuZ2U6NWE5MzgwYzBkZTE1NDFjZmI2ZmRhZWYxNWY0ZGM0ZmJfMy0xLTEtMS00ODE2NA_abb0bb23-53e6-4107-b77e-29f4dd034c41" unitRef="usd"> 25659000 </us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
<us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="ie851abf1a45b4637b3015e54ab1c0454_D20210401-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml83OS9mcmFnOjVmOTBlN2YxYTViZjQ4YjJiYjMzYmJhY2YzY2U0YzAwL3RhYmxlOjVhOTM4MGMwZGUxNTQxY2ZiNmZkYWVmMTVmNGRjNGZiL3RhYmxlcmFuZ2U6NWE5MzgwYzBkZTE1NDFjZmI2ZmRhZWYxNWY0ZGM0ZmJfMy0zLTEtMS00ODE2NA_b24fc914-cc4d-454e-892a-774e967ab83a" unitRef="usd"> 57611000 </us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
<us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="ic5af5a8651384732a5e6104062d9073e_D20220101-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml83OS9mcmFnOjVmOTBlN2YxYTViZjQ4YjJiYjMzYmJhY2YzY2U0YzAwL3RhYmxlOjVhOTM4MGMwZGUxNTQxY2ZiNmZkYWVmMTVmNGRjNGZiL3RhYmxlcmFuZ2U6NWE5MzgwYzBkZTE1NDFjZmI2ZmRhZWYxNWY0ZGM0ZmJfMy01LTEtMS00ODE2NA_df9392ed-a5a7-4bd2-a744-41fcda4063b8" unitRef="usd"> 53263000 </us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
<us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="i6ba426be3e6248f6a2f174a0369b8b19_D20210101-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml83OS9mcmFnOjVmOTBlN2YxYTViZjQ4YjJiYjMzYmJhY2YzY2U0YzAwL3RhYmxlOjVhOTM4MGMwZGUxNTQxY2ZiNmZkYWVmMTVmNGRjNGZiL3RhYmxlcmFuZ2U6NWE5MzgwYzBkZTE1NDFjZmI2ZmRhZWYxNWY0ZGM0ZmJfMy03LTEtMS00ODE2NA_c4746d56-6b19-4470-a93d-fb28428c0a0b" unitRef="usd"> 131269000 </us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
<us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="i1ab1365924f1495b8be46a46d65c2278_D20220401-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml83OS9mcmFnOjVmOTBlN2YxYTViZjQ4YjJiYjMzYmJhY2YzY2U0YzAwL3RhYmxlOjVhOTM4MGMwZGUxNTQxY2ZiNmZkYWVmMTVmNGRjNGZiL3RhYmxlcmFuZ2U6NWE5MzgwYzBkZTE1NDFjZmI2ZmRhZWYxNWY0ZGM0ZmJfNC0xLTEtMS00ODE2NA_de33401f-e307-4d1b-a21b-edbcf3be721c" unitRef="usd"> 80931000 </us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
<us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="ia7b1375110964abc93b30e830fa5b992_D20210401-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml83OS9mcmFnOjVmOTBlN2YxYTViZjQ4YjJiYjMzYmJhY2YzY2U0YzAwL3RhYmxlOjVhOTM4MGMwZGUxNTQxY2ZiNmZkYWVmMTVmNGRjNGZiL3RhYmxlcmFuZ2U6NWE5MzgwYzBkZTE1NDFjZmI2ZmRhZWYxNWY0ZGM0ZmJfNC0zLTEtMS00ODE2NA_6c948c3b-e63c-4477-965e-db08a5225bf1" unitRef="usd"> 225936000 </us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
<us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="i14984c435d404fafbacb8be50aebf8ff_D20220101-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml83OS9mcmFnOjVmOTBlN2YxYTViZjQ4YjJiYjMzYmJhY2YzY2U0YzAwL3RhYmxlOjVhOTM4MGMwZGUxNTQxY2ZiNmZkYWVmMTVmNGRjNGZiL3RhYmxlcmFuZ2U6NWE5MzgwYzBkZTE1NDFjZmI2ZmRhZWYxNWY0ZGM0ZmJfNC01LTEtMS00ODE2NA_f93f0bd8-de6a-4b84-b113-4505c4572574" unitRef="usd"> 240021000 </us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
<us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="i042dff45e2104ae1833cb6868607adf0_D20210101-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml83OS9mcmFnOjVmOTBlN2YxYTViZjQ4YjJiYjMzYmJhY2YzY2U0YzAwL3RhYmxlOjVhOTM4MGMwZGUxNTQxY2ZiNmZkYWVmMTVmNGRjNGZiL3RhYmxlcmFuZ2U6NWE5MzgwYzBkZTE1NDFjZmI2ZmRhZWYxNWY0ZGM0ZmJfNC03LTEtMS00ODE2NA_d08d48d5-b28d-4efc-8532-73f8244878f0" unitRef="usd"> 488845000 </us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
<us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="ib56a9313041e44fab2a2830a8b058ec3_D20220401-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml83OS9mcmFnOjVmOTBlN2YxYTViZjQ4YjJiYjMzYmJhY2YzY2U0YzAwL3RhYmxlOjVhOTM4MGMwZGUxNTQxY2ZiNmZkYWVmMTVmNGRjNGZiL3RhYmxlcmFuZ2U6NWE5MzgwYzBkZTE1NDFjZmI2ZmRhZWYxNWY0ZGM0ZmJfNS0xLTEtMS00ODE2NA_b5d59e5f-4270-44ca-95e2-9c2f0867d4b7" unitRef="usd"> 3772000 </us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
<us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="ie2d7cbc3727d4b6f8a7e93840976603b_D20210401-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml83OS9mcmFnOjVmOTBlN2YxYTViZjQ4YjJiYjMzYmJhY2YzY2U0YzAwL3RhYmxlOjVhOTM4MGMwZGUxNTQxY2ZiNmZkYWVmMTVmNGRjNGZiL3RhYmxlcmFuZ2U6NWE5MzgwYzBkZTE1NDFjZmI2ZmRhZWYxNWY0ZGM0ZmJfNS0zLTEtMS00ODE2NA_4ca21d04-a3e3-4a20-ab53-e6f22985e7c3" unitRef="usd"> 4566000 </us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
<us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="i0e3cfc7a7a4f4555a055e51ca671291c_D20220101-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml83OS9mcmFnOjVmOTBlN2YxYTViZjQ4YjJiYjMzYmJhY2YzY2U0YzAwL3RhYmxlOjVhOTM4MGMwZGUxNTQxY2ZiNmZkYWVmMTVmNGRjNGZiL3RhYmxlcmFuZ2U6NWE5MzgwYzBkZTE1NDFjZmI2ZmRhZWYxNWY0ZGM0ZmJfNS01LTEtMS00ODE2NA_cc9057d3-7f9a-454d-89e4-2c46fc6c8d38" unitRef="usd"> 7849000 </us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
<us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="i26b22c38d09e4e989bfde7f05a03aa9d_D20210101-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml83OS9mcmFnOjVmOTBlN2YxYTViZjQ4YjJiYjMzYmJhY2YzY2U0YzAwL3RhYmxlOjVhOTM4MGMwZGUxNTQxY2ZiNmZkYWVmMTVmNGRjNGZiL3RhYmxlcmFuZ2U6NWE5MzgwYzBkZTE1NDFjZmI2ZmRhZWYxNWY0ZGM0ZmJfNS03LTEtMS00ODE2NA_79167273-d444-4e15-a918-043fd77f28c3" unitRef="usd"> 10122000 </us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
<us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="idf5be29147e94b809d0f3f67415ce0b1_D20220401-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml83OS9mcmFnOjVmOTBlN2YxYTViZjQ4YjJiYjMzYmJhY2YzY2U0YzAwL3RhYmxlOjVhOTM4MGMwZGUxNTQxY2ZiNmZkYWVmMTVmNGRjNGZiL3RhYmxlcmFuZ2U6NWE5MzgwYzBkZTE1NDFjZmI2ZmRhZWYxNWY0ZGM0ZmJfNi0xLTEtMS00ODE2NA_29e8053d-a376-4c27-b718-44cc9130db52" unitRef="usd"> 186804000 </us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
<us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="i3f3fc0cd0f02481481f1bb2345313999_D20210401-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml83OS9mcmFnOjVmOTBlN2YxYTViZjQ4YjJiYjMzYmJhY2YzY2U0YzAwL3RhYmxlOjVhOTM4MGMwZGUxNTQxY2ZiNmZkYWVmMTVmNGRjNGZiL3RhYmxlcmFuZ2U6NWE5MzgwYzBkZTE1NDFjZmI2ZmRhZWYxNWY0ZGM0ZmJfNi0zLTEtMS00ODE2NA_01a7d285-926d-423f-834c-b204e947b319" unitRef="usd"> 397197000 </us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
<us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="i8b5aa09d29044d42bbfdc68d86a7e9a3_D20220101-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml83OS9mcmFnOjVmOTBlN2YxYTViZjQ4YjJiYjMzYmJhY2YzY2U0YzAwL3RhYmxlOjVhOTM4MGMwZGUxNTQxY2ZiNmZkYWVmMTVmNGRjNGZiL3RhYmxlcmFuZ2U6NWE5MzgwYzBkZTE1NDFjZmI2ZmRhZWYxNWY0ZGM0ZmJfNi01LTEtMS00ODE2NA_5fd3000e-8d84-4fdb-ac42-ac04bde622b6" unitRef="usd"> 473402000 </us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
<us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="i80b516e519b848f8a55bf1affb1fc020_D20210101-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml83OS9mcmFnOjVmOTBlN2YxYTViZjQ4YjJiYjMzYmJhY2YzY2U0YzAwL3RhYmxlOjVhOTM4MGMwZGUxNTQxY2ZiNmZkYWVmMTVmNGRjNGZiL3RhYmxlcmFuZ2U6NWE5MzgwYzBkZTE1NDFjZmI2ZmRhZWYxNWY0ZGM0ZmJfNi03LTEtMS00ODE2NA_11042a76-aab8-41b5-bb3b-f461aab827f6" unitRef="usd"> 904149000 </us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
<us-gaap:ContractWithCustomerLiabilityRevenueRecognized contextRef="if8f23b3b6d824e96b4de7bfae5af2e49_D20220401-20220630" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml83OS9mcmFnOjVmOTBlN2YxYTViZjQ4YjJiYjMzYmJhY2YzY2U0YzAwL3RleHRyZWdpb246NWY5MGU3ZjFhNWJmNDhiMmJiMzNiYmFjZjNjZTRjMDBfODQyMw_e329e9e6-adfb-4c26-8fde-963ed081423a" unitRef="usd"> 6200000 </us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
<us-gaap:ContractWithCustomerLiabilityRevenueRecognized contextRef="ibe1ed031e1284ea7821dad180688ecc8_D20220101-20220630" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml83OS9mcmFnOjVmOTBlN2YxYTViZjQ4YjJiYjMzYmJhY2YzY2U0YzAwL3RleHRyZWdpb246NWY5MGU3ZjFhNWJmNDhiMmJiMzNiYmFjZjNjZTRjMDBfMjE5OTAyMzI3MTE4NQ_12fa0877-673d-4973-a89b-943333dd8f7d" unitRef="usd"> 11300000 </us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
<us-gaap:ContractWithCustomerLiabilityRevenueRecognized contextRef="i564e75108a164e5aa777de7fd2247e9b_D20210401-20210630" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml83OS9mcmFnOjVmOTBlN2YxYTViZjQ4YjJiYjMzYmJhY2YzY2U0YzAwL3RleHRyZWdpb246NWY5MGU3ZjFhNWJmNDhiMmJiMzNiYmFjZjNjZTRjMDBfODQzMA_055779e9-90ec-4281-9798-3a889959646c" unitRef="usd"> 5000000 </us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
<us-gaap:ContractWithCustomerLiabilityRevenueRecognized contextRef="ia33f8e8ebe3940b9a6803c8dfd6f8d8f_D20210101-20210630" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml83OS9mcmFnOjVmOTBlN2YxYTViZjQ4YjJiYjMzYmJhY2YzY2U0YzAwL3RleHRyZWdpb246NWY5MGU3ZjFhNWJmNDhiMmJiMzNiYmFjZjNjZTRjMDBfMjE5OTAyMzI3MTMzNA_aeae7354-c0b1-497b-b3cf-527e95570961" unitRef="usd"> 10800000 </us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
<opk:ScheduleOfProductSalesAllowancesAndAccrualsTableTextBlock contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml83OS9mcmFnOjVmOTBlN2YxYTViZjQ4YjJiYjMzYmJhY2YzY2U0YzAwL3RleHRyZWdpb246NWY5MGU3ZjFhNWJmNDhiMmJiMzNiYmFjZjNjZTRjMDBfMTU1ODQ_de6fc0d0-7113-432b-bf97-eb5237f300c1">
The following table presents an analysis of product sales allowances and accruals for the three and six months ended June 30, 2022 and 2021:<div style="margin-bottom:5pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.005%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.554%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.554%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.554%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.554%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Chargebacks, discounts, rebates and fees</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Governmental </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Returns</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,588 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,282 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,333 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,203 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  Provision related to current period sales</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,411 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,442 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">308 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,161 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  Credits or payments made</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,330)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,235)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,023)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,588)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at June 30, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,669 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,489 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,618 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,776 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total gross </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Rayaldee</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> sales</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,382 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Rayaldee</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> sales allowances and accruals as a percentage of gross </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Rayaldee</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> sales</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60%</span></td></tr></table></div><div style="margin-bottom:5pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.005%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.554%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.554%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.554%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.554%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Chargebacks, discounts, rebates and fees</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Governmental </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Returns</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,014 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,499 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,639 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,152 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  Provision related to current period sales</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,626 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,311 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">577 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,514 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  Credits or payments made</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,971)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,321)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,598)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17,890)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at June 30, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,669 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,489 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,618 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,776 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total gross </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Rayaldee</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> sales</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,861 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Rayaldee</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> sales allowances and accruals as a percentage of gross </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Rayaldee</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> sales</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61%</span></td></tr></table></div><div style="margin-bottom:5pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.005%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.554%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.554%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.554%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.554%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Chargebacks, discounts, rebates and fees</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Governmental </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Returns</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,693 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,209 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,487 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,389 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  Provision related to current period sales</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,724 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,061 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">322 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,107 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  Credits or payments made</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,716)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,684)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(485)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,885)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at June 30, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,701 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,586 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,324 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,611 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total gross </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Rayaldee</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> sales</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,122 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Rayaldee</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> sales allowances and accruals as a percentage of gross </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Rayaldee</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> sales</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69%</span></td></tr></table></div><div style="margin-bottom:5pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.005%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.554%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.554%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.554%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.554%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Chargebacks, discounts, rebates and fees</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Governmental </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Returns</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,332 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,812 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,593 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,737 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  Provision related to current period sales</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,539 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,755 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">635 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,929 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  Credits or payments made</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,170)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,981)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(904)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20,055)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at June 30, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,701 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,586 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,324 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,611 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total gross </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Rayaldee</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> sales</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,767 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Rayaldee</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> sales allowances and accruals as a percentage of gross </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Rayaldee</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> sales</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66%</span></td></tr></table></div>
</opk:ScheduleOfProductSalesAllowancesAndAccrualsTableTextBlock>
<us-gaap:AllowanceForDoubtfulAccountsReceivable contextRef="ic1087ac8d7514474b2cac40fdc6bce07_I20220331" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml83OS9mcmFnOjVmOTBlN2YxYTViZjQ4YjJiYjMzYmJhY2YzY2U0YzAwL3RhYmxlOjFjMDBlN2VjZTJhZjQyYTZiNzliMjhiNWJhZmRjNmVkL3RhYmxlcmFuZ2U6MWMwMGU3ZWNlMmFmNDJhNmI3OWIyOGI1YmFmZGM2ZWRfMS0yLTEtMS00ODE2NA_59ddb75b-43e0-46c1-bb0f-9bac3521532e" unitRef="usd"> 1588000 </us-gaap:AllowanceForDoubtfulAccountsReceivable>
<us-gaap:AllowanceForDoubtfulAccountsReceivable contextRef="iccdfcf68105c4872a57cb3412df9b1eb_I20220331" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml83OS9mcmFnOjVmOTBlN2YxYTViZjQ4YjJiYjMzYmJhY2YzY2U0YzAwL3RhYmxlOjFjMDBlN2VjZTJhZjQyYTZiNzliMjhiNWJhZmRjNmVkL3RhYmxlcmFuZ2U6MWMwMGU3ZWNlMmFmNDJhNmI3OWIyOGI1YmFmZGM2ZWRfMS00LTEtMS00ODE2NA_e5a34ae2-dc39-4495-9c1d-6047c4131c96" unitRef="usd"> 5282000 </us-gaap:AllowanceForDoubtfulAccountsReceivable>
<us-gaap:AllowanceForDoubtfulAccountsReceivable contextRef="i8345f727b97746f4b228735fddfc5c08_I20220331" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml83OS9mcmFnOjVmOTBlN2YxYTViZjQ4YjJiYjMzYmJhY2YzY2U0YzAwL3RhYmxlOjFjMDBlN2VjZTJhZjQyYTZiNzliMjhiNWJhZmRjNmVkL3RhYmxlcmFuZ2U6MWMwMGU3ZWNlMmFmNDJhNmI3OWIyOGI1YmFmZGM2ZWRfMS02LTEtMS00ODE2NA_5da13ef7-b98c-429c-a78c-7ad4e9e49fc0" unitRef="usd"> 2333000 </us-gaap:AllowanceForDoubtfulAccountsReceivable>
<us-gaap:AllowanceForDoubtfulAccountsReceivable contextRef="ie710435ef69c4a1a8c49d15fc6acce34_I20220331" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml83OS9mcmFnOjVmOTBlN2YxYTViZjQ4YjJiYjMzYmJhY2YzY2U0YzAwL3RhYmxlOjFjMDBlN2VjZTJhZjQyYTZiNzliMjhiNWJhZmRjNmVkL3RhYmxlcmFuZ2U6MWMwMGU3ZWNlMmFmNDJhNmI3OWIyOGI1YmFmZGM2ZWRfMS04LTEtMS00ODE2NA_e0067ca1-6f3e-43b5-9099-5f7f23ae660a" unitRef="usd"> 9203000 </us-gaap:AllowanceForDoubtfulAccountsReceivable>
<us-gaap:ProvisionForDoubtfulAccounts contextRef="i48e11b8eeace403f82bfd20fb1c0b226_D20220401-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml83OS9mcmFnOjVmOTBlN2YxYTViZjQ4YjJiYjMzYmJhY2YzY2U0YzAwL3RhYmxlOjFjMDBlN2VjZTJhZjQyYTZiNzliMjhiNWJhZmRjNmVkL3RhYmxlcmFuZ2U6MWMwMGU3ZWNlMmFmNDJhNmI3OWIyOGI1YmFmZGM2ZWRfMi0yLTEtMS00ODE2NA_efca922d-0941-4441-92d5-e408d2ddfc60" unitRef="usd"> 3411000 </us-gaap:ProvisionForDoubtfulAccounts>
<us-gaap:ProvisionForDoubtfulAccounts contextRef="i9192452aae374b5b8060a5f9b4a10f7c_D20220401-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml83OS9mcmFnOjVmOTBlN2YxYTViZjQ4YjJiYjMzYmJhY2YzY2U0YzAwL3RhYmxlOjFjMDBlN2VjZTJhZjQyYTZiNzliMjhiNWJhZmRjNmVkL3RhYmxlcmFuZ2U6MWMwMGU3ZWNlMmFmNDJhNmI3OWIyOGI1YmFmZGM2ZWRfMi00LTEtMS00ODE2NA_dbe09f4f-99fe-4d2f-bd9d-6809353e8fdf" unitRef="usd"> 5442000 </us-gaap:ProvisionForDoubtfulAccounts>
<us-gaap:ProvisionForDoubtfulAccounts contextRef="i45442e11dab0461d9e9ecd4e3dbe877c_D20220401-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml83OS9mcmFnOjVmOTBlN2YxYTViZjQ4YjJiYjMzYmJhY2YzY2U0YzAwL3RhYmxlOjFjMDBlN2VjZTJhZjQyYTZiNzliMjhiNWJhZmRjNmVkL3RhYmxlcmFuZ2U6MWMwMGU3ZWNlMmFmNDJhNmI3OWIyOGI1YmFmZGM2ZWRfMi02LTEtMS00ODE2NA_886869e1-812a-4843-9299-f8552f854fc0" unitRef="usd"> 308000 </us-gaap:ProvisionForDoubtfulAccounts>
<us-gaap:ProvisionForDoubtfulAccounts contextRef="if8f23b3b6d824e96b4de7bfae5af2e49_D20220401-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml83OS9mcmFnOjVmOTBlN2YxYTViZjQ4YjJiYjMzYmJhY2YzY2U0YzAwL3RhYmxlOjFjMDBlN2VjZTJhZjQyYTZiNzliMjhiNWJhZmRjNmVkL3RhYmxlcmFuZ2U6MWMwMGU3ZWNlMmFmNDJhNmI3OWIyOGI1YmFmZGM2ZWRfMi04LTEtMS00ODE2NA_30d755af-26be-456b-abf1-6a816ecbd780" unitRef="usd"> 9161000 </us-gaap:ProvisionForDoubtfulAccounts>
<opk:AllowanceForDoubtfulAccountsReceivableDecreaseCreditsOrPayments contextRef="i48e11b8eeace403f82bfd20fb1c0b226_D20220401-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml83OS9mcmFnOjVmOTBlN2YxYTViZjQ4YjJiYjMzYmJhY2YzY2U0YzAwL3RhYmxlOjFjMDBlN2VjZTJhZjQyYTZiNzliMjhiNWJhZmRjNmVkL3RhYmxlcmFuZ2U6MWMwMGU3ZWNlMmFmNDJhNmI3OWIyOGI1YmFmZGM2ZWRfNC0yLTEtMS00ODE2NA_0c443cc7-e86b-4514-b76d-bc7f6842b051" unitRef="usd"> 3330000 </opk:AllowanceForDoubtfulAccountsReceivableDecreaseCreditsOrPayments>
<opk:AllowanceForDoubtfulAccountsReceivableDecreaseCreditsOrPayments contextRef="i9192452aae374b5b8060a5f9b4a10f7c_D20220401-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml83OS9mcmFnOjVmOTBlN2YxYTViZjQ4YjJiYjMzYmJhY2YzY2U0YzAwL3RhYmxlOjFjMDBlN2VjZTJhZjQyYTZiNzliMjhiNWJhZmRjNmVkL3RhYmxlcmFuZ2U6MWMwMGU3ZWNlMmFmNDJhNmI3OWIyOGI1YmFmZGM2ZWRfNC00LTEtMS00ODE2NA_5314c7d7-8180-4692-9cbf-46857349956a" unitRef="usd"> 4235000 </opk:AllowanceForDoubtfulAccountsReceivableDecreaseCreditsOrPayments>
<opk:AllowanceForDoubtfulAccountsReceivableDecreaseCreditsOrPayments contextRef="i45442e11dab0461d9e9ecd4e3dbe877c_D20220401-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml83OS9mcmFnOjVmOTBlN2YxYTViZjQ4YjJiYjMzYmJhY2YzY2U0YzAwL3RhYmxlOjFjMDBlN2VjZTJhZjQyYTZiNzliMjhiNWJhZmRjNmVkL3RhYmxlcmFuZ2U6MWMwMGU3ZWNlMmFmNDJhNmI3OWIyOGI1YmFmZGM2ZWRfNC02LTEtMS00ODE2NA_9f537a0d-0a2e-4575-88ce-fab9f310e85c" unitRef="usd"> 1023000 </opk:AllowanceForDoubtfulAccountsReceivableDecreaseCreditsOrPayments>
<opk:AllowanceForDoubtfulAccountsReceivableDecreaseCreditsOrPayments contextRef="if8f23b3b6d824e96b4de7bfae5af2e49_D20220401-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml83OS9mcmFnOjVmOTBlN2YxYTViZjQ4YjJiYjMzYmJhY2YzY2U0YzAwL3RhYmxlOjFjMDBlN2VjZTJhZjQyYTZiNzliMjhiNWJhZmRjNmVkL3RhYmxlcmFuZ2U6MWMwMGU3ZWNlMmFmNDJhNmI3OWIyOGI1YmFmZGM2ZWRfNC04LTEtMS00ODE2NA_481b7c6b-43c7-409a-878d-8447769501dd" unitRef="usd"> 8588000 </opk:AllowanceForDoubtfulAccountsReceivableDecreaseCreditsOrPayments>
<us-gaap:AllowanceForDoubtfulAccountsReceivable contextRef="i8450d55aab1847daa919e89902d7e12b_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml83OS9mcmFnOjVmOTBlN2YxYTViZjQ4YjJiYjMzYmJhY2YzY2U0YzAwL3RhYmxlOjFjMDBlN2VjZTJhZjQyYTZiNzliMjhiNWJhZmRjNmVkL3RhYmxlcmFuZ2U6MWMwMGU3ZWNlMmFmNDJhNmI3OWIyOGI1YmFmZGM2ZWRfNS0yLTEtMS00ODE2NA_45626343-3bae-4e3b-b422-c8390d97b211" unitRef="usd"> 1669000 </us-gaap:AllowanceForDoubtfulAccountsReceivable>
<us-gaap:AllowanceForDoubtfulAccountsReceivable contextRef="i4d6fe13bb5ea4edd9ac036805619ec63_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml83OS9mcmFnOjVmOTBlN2YxYTViZjQ4YjJiYjMzYmJhY2YzY2U0YzAwL3RhYmxlOjFjMDBlN2VjZTJhZjQyYTZiNzliMjhiNWJhZmRjNmVkL3RhYmxlcmFuZ2U6MWMwMGU3ZWNlMmFmNDJhNmI3OWIyOGI1YmFmZGM2ZWRfNS00LTEtMS00ODE2NA_b517a623-1fa8-4a84-8f70-7f6d30a2a661" unitRef="usd"> 6489000 </us-gaap:AllowanceForDoubtfulAccountsReceivable>
<us-gaap:AllowanceForDoubtfulAccountsReceivable contextRef="idd9e352e5df04547a80bc7424fa123c0_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml83OS9mcmFnOjVmOTBlN2YxYTViZjQ4YjJiYjMzYmJhY2YzY2U0YzAwL3RhYmxlOjFjMDBlN2VjZTJhZjQyYTZiNzliMjhiNWJhZmRjNmVkL3RhYmxlcmFuZ2U6MWMwMGU3ZWNlMmFmNDJhNmI3OWIyOGI1YmFmZGM2ZWRfNS02LTEtMS00ODE2NA_23e391f0-7cab-4f2b-8068-b544594dd634" unitRef="usd"> 1618000 </us-gaap:AllowanceForDoubtfulAccountsReceivable>
<us-gaap:AllowanceForDoubtfulAccountsReceivable contextRef="i77e5ed43e89b438ba48256bf157d2827_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml83OS9mcmFnOjVmOTBlN2YxYTViZjQ4YjJiYjMzYmJhY2YzY2U0YzAwL3RhYmxlOjFjMDBlN2VjZTJhZjQyYTZiNzliMjhiNWJhZmRjNmVkL3RhYmxlcmFuZ2U6MWMwMGU3ZWNlMmFmNDJhNmI3OWIyOGI1YmFmZGM2ZWRfNS04LTEtMS00ODE2NA_fc8f86fa-cce7-4fe4-9b47-df8165e1a347" unitRef="usd"> 9776000 </us-gaap:AllowanceForDoubtfulAccountsReceivable>
<us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="if8f23b3b6d824e96b4de7bfae5af2e49_D20220401-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml83OS9mcmFnOjVmOTBlN2YxYTViZjQ4YjJiYjMzYmJhY2YzY2U0YzAwL3RhYmxlOjFjMDBlN2VjZTJhZjQyYTZiNzliMjhiNWJhZmRjNmVkL3RhYmxlcmFuZ2U6MWMwMGU3ZWNlMmFmNDJhNmI3OWIyOGI1YmFmZGM2ZWRfNy04LTEtMS00ODE2NA_63ea08ca-d8e2-4cdd-9f67-625ee7d175e0" unitRef="usd"> 15382000 </us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
<opk:AllowanceForDoubtfulAccountsProvisionForAllowanceAsPercentOfGrossSales contextRef="if8f23b3b6d824e96b4de7bfae5af2e49_D20220401-20220630" decimals="2" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml83OS9mcmFnOjVmOTBlN2YxYTViZjQ4YjJiYjMzYmJhY2YzY2U0YzAwL3RhYmxlOjFjMDBlN2VjZTJhZjQyYTZiNzliMjhiNWJhZmRjNmVkL3RhYmxlcmFuZ2U6MWMwMGU3ZWNlMmFmNDJhNmI3OWIyOGI1YmFmZGM2ZWRfOC04LTEtMS00ODE2NA_a6e5fc15-98c9-49eb-b12e-f4fe8e5661e3" unitRef="number"> 0.60 </opk:AllowanceForDoubtfulAccountsProvisionForAllowanceAsPercentOfGrossSales>
<us-gaap:AllowanceForDoubtfulAccountsReceivable contextRef="ie6ed48530fc54f78a4c9d3dab331d6ee_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml83OS9mcmFnOjVmOTBlN2YxYTViZjQ4YjJiYjMzYmJhY2YzY2U0YzAwL3RhYmxlOjc4M2Q3ODRkYjY1OTQ2NWNhMmUyMmM1NzBhZmRhMjllL3RhYmxlcmFuZ2U6NzgzZDc4NGRiNjU5NDY1Y2EyZTIyYzU3MGFmZGEyOWVfMS0yLTEtMS01MzA5Nw_559361c4-6a1e-4d7f-9d13-e4f8ce873f52" unitRef="usd"> 2014000 </us-gaap:AllowanceForDoubtfulAccountsReceivable>
<us-gaap:AllowanceForDoubtfulAccountsReceivable contextRef="i17b67f61ce8b41ee922405c19c92394f_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml83OS9mcmFnOjVmOTBlN2YxYTViZjQ4YjJiYjMzYmJhY2YzY2U0YzAwL3RhYmxlOjc4M2Q3ODRkYjY1OTQ2NWNhMmUyMmM1NzBhZmRhMjllL3RhYmxlcmFuZ2U6NzgzZDc4NGRiNjU5NDY1Y2EyZTIyYzU3MGFmZGEyOWVfMS00LTEtMS01MzA5Nw_c56d7b11-bb98-430f-83e4-2cc8aef5149f" unitRef="usd"> 5499000 </us-gaap:AllowanceForDoubtfulAccountsReceivable>
<us-gaap:AllowanceForDoubtfulAccountsReceivable contextRef="i51774ab1ca0f413aadcd0edf0cbeef64_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml83OS9mcmFnOjVmOTBlN2YxYTViZjQ4YjJiYjMzYmJhY2YzY2U0YzAwL3RhYmxlOjc4M2Q3ODRkYjY1OTQ2NWNhMmUyMmM1NzBhZmRhMjllL3RhYmxlcmFuZ2U6NzgzZDc4NGRiNjU5NDY1Y2EyZTIyYzU3MGFmZGEyOWVfMS02LTEtMS01MzA5Nw_1afdd008-d7ff-47ad-89d2-71ba9a1b2a1c" unitRef="usd"> 2639000 </us-gaap:AllowanceForDoubtfulAccountsReceivable>
<us-gaap:AllowanceForDoubtfulAccountsReceivable contextRef="icce105d5b0ba43438ae9521fa03df5f4_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml83OS9mcmFnOjVmOTBlN2YxYTViZjQ4YjJiYjMzYmJhY2YzY2U0YzAwL3RhYmxlOjc4M2Q3ODRkYjY1OTQ2NWNhMmUyMmM1NzBhZmRhMjllL3RhYmxlcmFuZ2U6NzgzZDc4NGRiNjU5NDY1Y2EyZTIyYzU3MGFmZGEyOWVfMS04LTEtMS01MzA5Nw_3b2b0fef-b683-4949-a7e8-b8154ff475d0" unitRef="usd"> 10152000 </us-gaap:AllowanceForDoubtfulAccountsReceivable>
<us-gaap:ProvisionForDoubtfulAccounts contextRef="i2c9cbb57ea79457c9cda0bbd7952fe4e_D20220101-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml83OS9mcmFnOjVmOTBlN2YxYTViZjQ4YjJiYjMzYmJhY2YzY2U0YzAwL3RhYmxlOjc4M2Q3ODRkYjY1OTQ2NWNhMmUyMmM1NzBhZmRhMjllL3RhYmxlcmFuZ2U6NzgzZDc4NGRiNjU5NDY1Y2EyZTIyYzU3MGFmZGEyOWVfMi0yLTEtMS01MzA5Nw_680052fc-f2d4-403f-a203-5efc0106c495" unitRef="usd"> 6626000 </us-gaap:ProvisionForDoubtfulAccounts>
<us-gaap:ProvisionForDoubtfulAccounts contextRef="ia1d6d63f2e0c4327a51f20037d56e598_D20220101-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml83OS9mcmFnOjVmOTBlN2YxYTViZjQ4YjJiYjMzYmJhY2YzY2U0YzAwL3RhYmxlOjc4M2Q3ODRkYjY1OTQ2NWNhMmUyMmM1NzBhZmRhMjllL3RhYmxlcmFuZ2U6NzgzZDc4NGRiNjU5NDY1Y2EyZTIyYzU3MGFmZGEyOWVfMi00LTEtMS01MzA5Nw_457ae66d-aa91-42f9-baf3-eb4eb098f101" unitRef="usd"> 10311000 </us-gaap:ProvisionForDoubtfulAccounts>
<us-gaap:ProvisionForDoubtfulAccounts contextRef="id0ae536198124007a138924bb2785af2_D20220101-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml83OS9mcmFnOjVmOTBlN2YxYTViZjQ4YjJiYjMzYmJhY2YzY2U0YzAwL3RhYmxlOjc4M2Q3ODRkYjY1OTQ2NWNhMmUyMmM1NzBhZmRhMjllL3RhYmxlcmFuZ2U6NzgzZDc4NGRiNjU5NDY1Y2EyZTIyYzU3MGFmZGEyOWVfMi02LTEtMS01MzA5Nw_93de7030-714d-4d9c-bec7-90c1cbb8b69d" unitRef="usd"> 577000 </us-gaap:ProvisionForDoubtfulAccounts>
<us-gaap:ProvisionForDoubtfulAccounts contextRef="ibe1ed031e1284ea7821dad180688ecc8_D20220101-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml83OS9mcmFnOjVmOTBlN2YxYTViZjQ4YjJiYjMzYmJhY2YzY2U0YzAwL3RhYmxlOjc4M2Q3ODRkYjY1OTQ2NWNhMmUyMmM1NzBhZmRhMjllL3RhYmxlcmFuZ2U6NzgzZDc4NGRiNjU5NDY1Y2EyZTIyYzU3MGFmZGEyOWVfMi04LTEtMS01MzA5Nw_f78cd5ee-e33d-4053-a906-2fc53d63a27a" unitRef="usd"> 17514000 </us-gaap:ProvisionForDoubtfulAccounts>
<opk:AllowanceForDoubtfulAccountsReceivableDecreaseCreditsOrPayments contextRef="i2c9cbb57ea79457c9cda0bbd7952fe4e_D20220101-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml83OS9mcmFnOjVmOTBlN2YxYTViZjQ4YjJiYjMzYmJhY2YzY2U0YzAwL3RhYmxlOjc4M2Q3ODRkYjY1OTQ2NWNhMmUyMmM1NzBhZmRhMjllL3RhYmxlcmFuZ2U6NzgzZDc4NGRiNjU5NDY1Y2EyZTIyYzU3MGFmZGEyOWVfNC0yLTEtMS01MzA5Nw_ddc326ec-6ff9-4bde-b406-0d815b7e6bed" unitRef="usd"> 6971000 </opk:AllowanceForDoubtfulAccountsReceivableDecreaseCreditsOrPayments>
<opk:AllowanceForDoubtfulAccountsReceivableDecreaseCreditsOrPayments contextRef="ia1d6d63f2e0c4327a51f20037d56e598_D20220101-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml83OS9mcmFnOjVmOTBlN2YxYTViZjQ4YjJiYjMzYmJhY2YzY2U0YzAwL3RhYmxlOjc4M2Q3ODRkYjY1OTQ2NWNhMmUyMmM1NzBhZmRhMjllL3RhYmxlcmFuZ2U6NzgzZDc4NGRiNjU5NDY1Y2EyZTIyYzU3MGFmZGEyOWVfNC00LTEtMS01MzA5Nw_1f539751-a88b-4a3e-8cc7-94fbca36c6c7" unitRef="usd"> 9321000 </opk:AllowanceForDoubtfulAccountsReceivableDecreaseCreditsOrPayments>
<opk:AllowanceForDoubtfulAccountsReceivableDecreaseCreditsOrPayments contextRef="id0ae536198124007a138924bb2785af2_D20220101-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml83OS9mcmFnOjVmOTBlN2YxYTViZjQ4YjJiYjMzYmJhY2YzY2U0YzAwL3RhYmxlOjc4M2Q3ODRkYjY1OTQ2NWNhMmUyMmM1NzBhZmRhMjllL3RhYmxlcmFuZ2U6NzgzZDc4NGRiNjU5NDY1Y2EyZTIyYzU3MGFmZGEyOWVfNC02LTEtMS01MzA5Nw_95bbb54e-dad8-45d1-868f-256c536aec3c" unitRef="usd"> 1598000 </opk:AllowanceForDoubtfulAccountsReceivableDecreaseCreditsOrPayments>
<opk:AllowanceForDoubtfulAccountsReceivableDecreaseCreditsOrPayments contextRef="ibe1ed031e1284ea7821dad180688ecc8_D20220101-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml83OS9mcmFnOjVmOTBlN2YxYTViZjQ4YjJiYjMzYmJhY2YzY2U0YzAwL3RhYmxlOjc4M2Q3ODRkYjY1OTQ2NWNhMmUyMmM1NzBhZmRhMjllL3RhYmxlcmFuZ2U6NzgzZDc4NGRiNjU5NDY1Y2EyZTIyYzU3MGFmZGEyOWVfNC04LTEtMS01MzA5Nw_97947659-b036-4fff-bc27-71924e0f41a6" unitRef="usd"> 17890000 </opk:AllowanceForDoubtfulAccountsReceivableDecreaseCreditsOrPayments>
<us-gaap:AllowanceForDoubtfulAccountsReceivable contextRef="i8450d55aab1847daa919e89902d7e12b_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml83OS9mcmFnOjVmOTBlN2YxYTViZjQ4YjJiYjMzYmJhY2YzY2U0YzAwL3RhYmxlOjc4M2Q3ODRkYjY1OTQ2NWNhMmUyMmM1NzBhZmRhMjllL3RhYmxlcmFuZ2U6NzgzZDc4NGRiNjU5NDY1Y2EyZTIyYzU3MGFmZGEyOWVfNS0yLTEtMS01MzA5Nw_a5738b42-1e32-4b1e-b24f-da62ee9920f9" unitRef="usd"> 1669000 </us-gaap:AllowanceForDoubtfulAccountsReceivable>
<us-gaap:AllowanceForDoubtfulAccountsReceivable contextRef="i4d6fe13bb5ea4edd9ac036805619ec63_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml83OS9mcmFnOjVmOTBlN2YxYTViZjQ4YjJiYjMzYmJhY2YzY2U0YzAwL3RhYmxlOjc4M2Q3ODRkYjY1OTQ2NWNhMmUyMmM1NzBhZmRhMjllL3RhYmxlcmFuZ2U6NzgzZDc4NGRiNjU5NDY1Y2EyZTIyYzU3MGFmZGEyOWVfNS00LTEtMS01MzA5Nw_63d26fb9-681c-438a-b8f7-b59d34f293be" unitRef="usd"> 6489000 </us-gaap:AllowanceForDoubtfulAccountsReceivable>
<us-gaap:AllowanceForDoubtfulAccountsReceivable contextRef="idd9e352e5df04547a80bc7424fa123c0_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml83OS9mcmFnOjVmOTBlN2YxYTViZjQ4YjJiYjMzYmJhY2YzY2U0YzAwL3RhYmxlOjc4M2Q3ODRkYjY1OTQ2NWNhMmUyMmM1NzBhZmRhMjllL3RhYmxlcmFuZ2U6NzgzZDc4NGRiNjU5NDY1Y2EyZTIyYzU3MGFmZGEyOWVfNS02LTEtMS01MzA5Nw_41c507a6-7e8b-4450-8de3-d7ecbed5ea68" unitRef="usd"> 1618000 </us-gaap:AllowanceForDoubtfulAccountsReceivable>
<us-gaap:AllowanceForDoubtfulAccountsReceivable contextRef="i77e5ed43e89b438ba48256bf157d2827_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml83OS9mcmFnOjVmOTBlN2YxYTViZjQ4YjJiYjMzYmJhY2YzY2U0YzAwL3RhYmxlOjc4M2Q3ODRkYjY1OTQ2NWNhMmUyMmM1NzBhZmRhMjllL3RhYmxlcmFuZ2U6NzgzZDc4NGRiNjU5NDY1Y2EyZTIyYzU3MGFmZGEyOWVfNS04LTEtMS01MzA5Nw_68872c5e-5b0a-46f1-a109-d163b970a65e" unitRef="usd"> 9776000 </us-gaap:AllowanceForDoubtfulAccountsReceivable>
<us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="ibe1ed031e1284ea7821dad180688ecc8_D20220101-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml83OS9mcmFnOjVmOTBlN2YxYTViZjQ4YjJiYjMzYmJhY2YzY2U0YzAwL3RhYmxlOjc4M2Q3ODRkYjY1OTQ2NWNhMmUyMmM1NzBhZmRhMjllL3RhYmxlcmFuZ2U6NzgzZDc4NGRiNjU5NDY1Y2EyZTIyYzU3MGFmZGEyOWVfNy04LTEtMS01MzA5Nw_af946b29-cce5-40c9-afbc-730b0596846f" unitRef="usd"> 28861000 </us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
<opk:AllowanceForDoubtfulAccountsProvisionForAllowanceAsPercentOfGrossSales contextRef="ibe1ed031e1284ea7821dad180688ecc8_D20220101-20220630" decimals="2" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml83OS9mcmFnOjVmOTBlN2YxYTViZjQ4YjJiYjMzYmJhY2YzY2U0YzAwL3RhYmxlOjc4M2Q3ODRkYjY1OTQ2NWNhMmUyMmM1NzBhZmRhMjllL3RhYmxlcmFuZ2U6NzgzZDc4NGRiNjU5NDY1Y2EyZTIyYzU3MGFmZGEyOWVfOC04LTEtMS01MzEwMw_6f95b9f9-ffb7-4f96-a69c-53a045cbb0c1" unitRef="number"> 0.61 </opk:AllowanceForDoubtfulAccountsProvisionForAllowanceAsPercentOfGrossSales>
<us-gaap:AllowanceForDoubtfulAccountsReceivable contextRef="ib1a0d40d77bd4e56a647aee31b3fe14d_I20210331" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml83OS9mcmFnOjVmOTBlN2YxYTViZjQ4YjJiYjMzYmJhY2YzY2U0YzAwL3RhYmxlOjg2OGQ3ZGM2MzFjNDRjMjdiNDFmNjRkMWQ0NDdiOTk4L3RhYmxlcmFuZ2U6ODY4ZDdkYzYzMWM0NGMyN2I0MWY2NGQxZDQ0N2I5OThfMS0yLTEtMS01MzEwNQ_0abb6aaf-513a-4538-bc24-46db85d2b4c6" unitRef="usd"> 1693000 </us-gaap:AllowanceForDoubtfulAccountsReceivable>
<us-gaap:AllowanceForDoubtfulAccountsReceivable contextRef="if6ae0f23b98f4df9a60f04854a743234_I20210331" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml83OS9mcmFnOjVmOTBlN2YxYTViZjQ4YjJiYjMzYmJhY2YzY2U0YzAwL3RhYmxlOjg2OGQ3ZGM2MzFjNDRjMjdiNDFmNjRkMWQ0NDdiOTk4L3RhYmxlcmFuZ2U6ODY4ZDdkYzYzMWM0NGMyN2I0MWY2NGQxZDQ0N2I5OThfMS00LTEtMS01MzEwNQ_9960618b-165d-47f3-a198-8905cf306c84" unitRef="usd"> 6209000 </us-gaap:AllowanceForDoubtfulAccountsReceivable>
<us-gaap:AllowanceForDoubtfulAccountsReceivable contextRef="ifd5482e2bc32410fbb7288435951888b_I20210331" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml83OS9mcmFnOjVmOTBlN2YxYTViZjQ4YjJiYjMzYmJhY2YzY2U0YzAwL3RhYmxlOjg2OGQ3ZGM2MzFjNDRjMjdiNDFmNjRkMWQ0NDdiOTk4L3RhYmxlcmFuZ2U6ODY4ZDdkYzYzMWM0NGMyN2I0MWY2NGQxZDQ0N2I5OThfMS02LTEtMS01MzEwNQ_987f6dcd-1c6f-4253-a4a9-496457a76816" unitRef="usd"> 3487000 </us-gaap:AllowanceForDoubtfulAccountsReceivable>
<us-gaap:AllowanceForDoubtfulAccountsReceivable contextRef="i2d850dbda35d4530baf0f0a13b7f8692_I20210331" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml83OS9mcmFnOjVmOTBlN2YxYTViZjQ4YjJiYjMzYmJhY2YzY2U0YzAwL3RhYmxlOjg2OGQ3ZGM2MzFjNDRjMjdiNDFmNjRkMWQ0NDdiOTk4L3RhYmxlcmFuZ2U6ODY4ZDdkYzYzMWM0NGMyN2I0MWY2NGQxZDQ0N2I5OThfMS04LTEtMS01MzEwNQ_453aab54-d5ae-4a03-935a-98dc7cf5bd5a" unitRef="usd"> 11389000 </us-gaap:AllowanceForDoubtfulAccountsReceivable>
<us-gaap:ProvisionForDoubtfulAccounts contextRef="i642c89b963764feeb85667307d3f80f9_D20210401-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml83OS9mcmFnOjVmOTBlN2YxYTViZjQ4YjJiYjMzYmJhY2YzY2U0YzAwL3RhYmxlOjg2OGQ3ZGM2MzFjNDRjMjdiNDFmNjRkMWQ0NDdiOTk4L3RhYmxlcmFuZ2U6ODY4ZDdkYzYzMWM0NGMyN2I0MWY2NGQxZDQ0N2I5OThfMi0yLTEtMS01MzEwNQ_08179d03-0efd-47d8-8f08-4fa57bb563cb" unitRef="usd"> 3724000 </us-gaap:ProvisionForDoubtfulAccounts>
<us-gaap:ProvisionForDoubtfulAccounts contextRef="i96dc7f6dbba346e684fb855b1e0e93a0_D20210401-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml83OS9mcmFnOjVmOTBlN2YxYTViZjQ4YjJiYjMzYmJhY2YzY2U0YzAwL3RhYmxlOjg2OGQ3ZGM2MzFjNDRjMjdiNDFmNjRkMWQ0NDdiOTk4L3RhYmxlcmFuZ2U6ODY4ZDdkYzYzMWM0NGMyN2I0MWY2NGQxZDQ0N2I5OThfMi00LTEtMS01MzEwNQ_6f65deb3-d0be-4983-8379-ce2265809d1b" unitRef="usd"> 7061000 </us-gaap:ProvisionForDoubtfulAccounts>
<us-gaap:ProvisionForDoubtfulAccounts contextRef="ibc5a694894544ec183e96c6e03276765_D20210401-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml83OS9mcmFnOjVmOTBlN2YxYTViZjQ4YjJiYjMzYmJhY2YzY2U0YzAwL3RhYmxlOjg2OGQ3ZGM2MzFjNDRjMjdiNDFmNjRkMWQ0NDdiOTk4L3RhYmxlcmFuZ2U6ODY4ZDdkYzYzMWM0NGMyN2I0MWY2NGQxZDQ0N2I5OThfMi02LTEtMS01MzEwNQ_4264c4d1-8f80-477d-baa8-57853152797c" unitRef="usd"> 322000 </us-gaap:ProvisionForDoubtfulAccounts>
<us-gaap:ProvisionForDoubtfulAccounts contextRef="i564e75108a164e5aa777de7fd2247e9b_D20210401-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml83OS9mcmFnOjVmOTBlN2YxYTViZjQ4YjJiYjMzYmJhY2YzY2U0YzAwL3RhYmxlOjg2OGQ3ZGM2MzFjNDRjMjdiNDFmNjRkMWQ0NDdiOTk4L3RhYmxlcmFuZ2U6ODY4ZDdkYzYzMWM0NGMyN2I0MWY2NGQxZDQ0N2I5OThfMi04LTEtMS01MzEwNQ_56421607-fc5f-4595-b0a4-9687ce21f950" unitRef="usd"> 11107000 </us-gaap:ProvisionForDoubtfulAccounts>
<opk:AllowanceForDoubtfulAccountsReceivableDecreaseCreditsOrPayments contextRef="i642c89b963764feeb85667307d3f80f9_D20210401-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml83OS9mcmFnOjVmOTBlN2YxYTViZjQ4YjJiYjMzYmJhY2YzY2U0YzAwL3RhYmxlOjg2OGQ3ZGM2MzFjNDRjMjdiNDFmNjRkMWQ0NDdiOTk4L3RhYmxlcmFuZ2U6ODY4ZDdkYzYzMWM0NGMyN2I0MWY2NGQxZDQ0N2I5OThfNC0yLTEtMS01MzEwNQ_aa3ea92f-e507-4086-ad7f-0a781dfee5c0" unitRef="usd"> 3716000 </opk:AllowanceForDoubtfulAccountsReceivableDecreaseCreditsOrPayments>
<opk:AllowanceForDoubtfulAccountsReceivableDecreaseCreditsOrPayments contextRef="i96dc7f6dbba346e684fb855b1e0e93a0_D20210401-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml83OS9mcmFnOjVmOTBlN2YxYTViZjQ4YjJiYjMzYmJhY2YzY2U0YzAwL3RhYmxlOjg2OGQ3ZGM2MzFjNDRjMjdiNDFmNjRkMWQ0NDdiOTk4L3RhYmxlcmFuZ2U6ODY4ZDdkYzYzMWM0NGMyN2I0MWY2NGQxZDQ0N2I5OThfNC00LTEtMS01MzEwNQ_b884b5d4-5087-4fcf-9490-911f0e5f779d" unitRef="usd"> 5684000 </opk:AllowanceForDoubtfulAccountsReceivableDecreaseCreditsOrPayments>
<opk:AllowanceForDoubtfulAccountsReceivableDecreaseCreditsOrPayments contextRef="ibc5a694894544ec183e96c6e03276765_D20210401-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml83OS9mcmFnOjVmOTBlN2YxYTViZjQ4YjJiYjMzYmJhY2YzY2U0YzAwL3RhYmxlOjg2OGQ3ZGM2MzFjNDRjMjdiNDFmNjRkMWQ0NDdiOTk4L3RhYmxlcmFuZ2U6ODY4ZDdkYzYzMWM0NGMyN2I0MWY2NGQxZDQ0N2I5OThfNC02LTEtMS01MzEwNQ_05d18c72-a145-43d4-9361-8960b64312ae" unitRef="usd"> 485000 </opk:AllowanceForDoubtfulAccountsReceivableDecreaseCreditsOrPayments>
<opk:AllowanceForDoubtfulAccountsReceivableDecreaseCreditsOrPayments contextRef="i564e75108a164e5aa777de7fd2247e9b_D20210401-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml83OS9mcmFnOjVmOTBlN2YxYTViZjQ4YjJiYjMzYmJhY2YzY2U0YzAwL3RhYmxlOjg2OGQ3ZGM2MzFjNDRjMjdiNDFmNjRkMWQ0NDdiOTk4L3RhYmxlcmFuZ2U6ODY4ZDdkYzYzMWM0NGMyN2I0MWY2NGQxZDQ0N2I5OThfNC04LTEtMS01MzEwNQ_739e9d5c-d414-4c6e-b41b-3fd3f5b919db" unitRef="usd"> 9885000 </opk:AllowanceForDoubtfulAccountsReceivableDecreaseCreditsOrPayments>
<us-gaap:AllowanceForDoubtfulAccountsReceivable contextRef="i6f90e15c7d5b44cf8e02d2e5edaf7e46_I20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml83OS9mcmFnOjVmOTBlN2YxYTViZjQ4YjJiYjMzYmJhY2YzY2U0YzAwL3RhYmxlOjg2OGQ3ZGM2MzFjNDRjMjdiNDFmNjRkMWQ0NDdiOTk4L3RhYmxlcmFuZ2U6ODY4ZDdkYzYzMWM0NGMyN2I0MWY2NGQxZDQ0N2I5OThfNS0yLTEtMS01MzEwNQ_f7ef9af3-c72f-4d34-9e4f-9b49d67916a7" unitRef="usd"> 1701000 </us-gaap:AllowanceForDoubtfulAccountsReceivable>
<us-gaap:AllowanceForDoubtfulAccountsReceivable contextRef="ide0b5e05384b4a9ab9b3b8347df937c9_I20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml83OS9mcmFnOjVmOTBlN2YxYTViZjQ4YjJiYjMzYmJhY2YzY2U0YzAwL3RhYmxlOjg2OGQ3ZGM2MzFjNDRjMjdiNDFmNjRkMWQ0NDdiOTk4L3RhYmxlcmFuZ2U6ODY4ZDdkYzYzMWM0NGMyN2I0MWY2NGQxZDQ0N2I5OThfNS00LTEtMS01MzEwNQ_4c857637-3bf8-4c5b-b070-b6ed8ed91454" unitRef="usd"> 7586000 </us-gaap:AllowanceForDoubtfulAccountsReceivable>
<us-gaap:AllowanceForDoubtfulAccountsReceivable contextRef="i531a7c098ac44b75ac7b3a46c34b6c3c_I20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml83OS9mcmFnOjVmOTBlN2YxYTViZjQ4YjJiYjMzYmJhY2YzY2U0YzAwL3RhYmxlOjg2OGQ3ZGM2MzFjNDRjMjdiNDFmNjRkMWQ0NDdiOTk4L3RhYmxlcmFuZ2U6ODY4ZDdkYzYzMWM0NGMyN2I0MWY2NGQxZDQ0N2I5OThfNS02LTEtMS01MzEwNQ_cb461b37-da63-45f7-8cbc-37906e38cc59" unitRef="usd"> 3324000 </us-gaap:AllowanceForDoubtfulAccountsReceivable>
<us-gaap:AllowanceForDoubtfulAccountsReceivable contextRef="i4036f7150eba4a0ea41bb7f703001989_I20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml83OS9mcmFnOjVmOTBlN2YxYTViZjQ4YjJiYjMzYmJhY2YzY2U0YzAwL3RhYmxlOjg2OGQ3ZGM2MzFjNDRjMjdiNDFmNjRkMWQ0NDdiOTk4L3RhYmxlcmFuZ2U6ODY4ZDdkYzYzMWM0NGMyN2I0MWY2NGQxZDQ0N2I5OThfNS04LTEtMS01MzEwNQ_00b6745e-1668-4a2a-8141-c6865bd46875" unitRef="usd"> 12611000 </us-gaap:AllowanceForDoubtfulAccountsReceivable>
<us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="i564e75108a164e5aa777de7fd2247e9b_D20210401-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml83OS9mcmFnOjVmOTBlN2YxYTViZjQ4YjJiYjMzYmJhY2YzY2U0YzAwL3RhYmxlOjg2OGQ3ZGM2MzFjNDRjMjdiNDFmNjRkMWQ0NDdiOTk4L3RhYmxlcmFuZ2U6ODY4ZDdkYzYzMWM0NGMyN2I0MWY2NGQxZDQ0N2I5OThfNy04LTEtMS01MzEwNQ_e186a752-81ca-4092-88be-1fc94c1d4e38" unitRef="usd"> 16122000 </us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
<opk:AllowanceForDoubtfulAccountsProvisionForAllowanceAsPercentOfGrossSales contextRef="i564e75108a164e5aa777de7fd2247e9b_D20210401-20210630" decimals="2" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml83OS9mcmFnOjVmOTBlN2YxYTViZjQ4YjJiYjMzYmJhY2YzY2U0YzAwL3RhYmxlOjg2OGQ3ZGM2MzFjNDRjMjdiNDFmNjRkMWQ0NDdiOTk4L3RhYmxlcmFuZ2U6ODY4ZDdkYzYzMWM0NGMyN2I0MWY2NGQxZDQ0N2I5OThfOC04LTEtMS01MzEwNQ_ff04583e-c616-4fbc-a4b7-f26070e2efc7" unitRef="number"> 0.69 </opk:AllowanceForDoubtfulAccountsProvisionForAllowanceAsPercentOfGrossSales>
<us-gaap:AllowanceForDoubtfulAccountsReceivable contextRef="i5830191e5eb8467d9591373c448d909d_I20201231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml83OS9mcmFnOjVmOTBlN2YxYTViZjQ4YjJiYjMzYmJhY2YzY2U0YzAwL3RhYmxlOjJhNzI3MWVlZjIyYzRkMTc4ZjMzNjljZGJmMDMxNGY2L3RhYmxlcmFuZ2U6MmE3MjcxZWVmMjJjNGQxNzhmMzM2OWNkYmYwMzE0ZjZfMS0yLTEtMS00ODE2NA_84c3b5f0-2b81-4650-b24f-cb1b5b9ede67" unitRef="usd"> 2332000 </us-gaap:AllowanceForDoubtfulAccountsReceivable>
<us-gaap:AllowanceForDoubtfulAccountsReceivable contextRef="if3f8c9be18594f1fb1986265d45d0995_I20201231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml83OS9mcmFnOjVmOTBlN2YxYTViZjQ4YjJiYjMzYmJhY2YzY2U0YzAwL3RhYmxlOjJhNzI3MWVlZjIyYzRkMTc4ZjMzNjljZGJmMDMxNGY2L3RhYmxlcmFuZ2U6MmE3MjcxZWVmMjJjNGQxNzhmMzM2OWNkYmYwMzE0ZjZfMS00LTEtMS00ODE2NA_0384f22e-a5aa-4847-a7f3-d872ca6922a0" unitRef="usd"> 5812000 </us-gaap:AllowanceForDoubtfulAccountsReceivable>
<us-gaap:AllowanceForDoubtfulAccountsReceivable contextRef="if10c9dad621f41f4a9fa3879ae3e8d8e_I20201231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml83OS9mcmFnOjVmOTBlN2YxYTViZjQ4YjJiYjMzYmJhY2YzY2U0YzAwL3RhYmxlOjJhNzI3MWVlZjIyYzRkMTc4ZjMzNjljZGJmMDMxNGY2L3RhYmxlcmFuZ2U6MmE3MjcxZWVmMjJjNGQxNzhmMzM2OWNkYmYwMzE0ZjZfMS02LTEtMS00ODE2NA_201cda0f-701b-4e8a-8078-7be1a70de76a" unitRef="usd"> 3593000 </us-gaap:AllowanceForDoubtfulAccountsReceivable>
<us-gaap:AllowanceForDoubtfulAccountsReceivable contextRef="i15f7393e7e034cd58a3084cd59485b60_I20201231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml83OS9mcmFnOjVmOTBlN2YxYTViZjQ4YjJiYjMzYmJhY2YzY2U0YzAwL3RhYmxlOjJhNzI3MWVlZjIyYzRkMTc4ZjMzNjljZGJmMDMxNGY2L3RhYmxlcmFuZ2U6MmE3MjcxZWVmMjJjNGQxNzhmMzM2OWNkYmYwMzE0ZjZfMS04LTEtMS00ODE2NA_0bc5252a-1ad0-46d4-a465-331ec2228c1d" unitRef="usd"> 11737000 </us-gaap:AllowanceForDoubtfulAccountsReceivable>
<us-gaap:ProvisionForDoubtfulAccounts contextRef="i340df3deb1144777bab4f9be295ee50a_D20210101-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml83OS9mcmFnOjVmOTBlN2YxYTViZjQ4YjJiYjMzYmJhY2YzY2U0YzAwL3RhYmxlOjJhNzI3MWVlZjIyYzRkMTc4ZjMzNjljZGJmMDMxNGY2L3RhYmxlcmFuZ2U6MmE3MjcxZWVmMjJjNGQxNzhmMzM2OWNkYmYwMzE0ZjZfMi0yLTEtMS00ODE2NA_b55f976a-b3fb-4286-ae14-d62ce2cf89ed" unitRef="usd"> 7539000 </us-gaap:ProvisionForDoubtfulAccounts>
<us-gaap:ProvisionForDoubtfulAccounts contextRef="ia9fd561b004d41d78905c8c99e7b8a69_D20210101-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml83OS9mcmFnOjVmOTBlN2YxYTViZjQ4YjJiYjMzYmJhY2YzY2U0YzAwL3RhYmxlOjJhNzI3MWVlZjIyYzRkMTc4ZjMzNjljZGJmMDMxNGY2L3RhYmxlcmFuZ2U6MmE3MjcxZWVmMjJjNGQxNzhmMzM2OWNkYmYwMzE0ZjZfMi00LTEtMS00ODE2NA_89b6337b-c536-41b2-af6b-f73c00bc6901" unitRef="usd"> 12755000 </us-gaap:ProvisionForDoubtfulAccounts>
<us-gaap:ProvisionForDoubtfulAccounts contextRef="i227c10653be445e0b26f1e13bea67679_D20210101-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml83OS9mcmFnOjVmOTBlN2YxYTViZjQ4YjJiYjMzYmJhY2YzY2U0YzAwL3RhYmxlOjJhNzI3MWVlZjIyYzRkMTc4ZjMzNjljZGJmMDMxNGY2L3RhYmxlcmFuZ2U6MmE3MjcxZWVmMjJjNGQxNzhmMzM2OWNkYmYwMzE0ZjZfMi02LTEtMS00ODE2NA_93701f43-d83d-4ad1-927b-145cd9ae8bdd" unitRef="usd"> 635000 </us-gaap:ProvisionForDoubtfulAccounts>
<us-gaap:ProvisionForDoubtfulAccounts contextRef="ia33f8e8ebe3940b9a6803c8dfd6f8d8f_D20210101-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml83OS9mcmFnOjVmOTBlN2YxYTViZjQ4YjJiYjMzYmJhY2YzY2U0YzAwL3RhYmxlOjJhNzI3MWVlZjIyYzRkMTc4ZjMzNjljZGJmMDMxNGY2L3RhYmxlcmFuZ2U6MmE3MjcxZWVmMjJjNGQxNzhmMzM2OWNkYmYwMzE0ZjZfMi04LTEtMS00ODE2NA_a7e8d417-2bf0-4481-9fb7-091a9063c472" unitRef="usd"> 20929000 </us-gaap:ProvisionForDoubtfulAccounts>
<opk:AllowanceForDoubtfulAccountsReceivableDecreaseCreditsOrPayments contextRef="i340df3deb1144777bab4f9be295ee50a_D20210101-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml83OS9mcmFnOjVmOTBlN2YxYTViZjQ4YjJiYjMzYmJhY2YzY2U0YzAwL3RhYmxlOjJhNzI3MWVlZjIyYzRkMTc4ZjMzNjljZGJmMDMxNGY2L3RhYmxlcmFuZ2U6MmE3MjcxZWVmMjJjNGQxNzhmMzM2OWNkYmYwMzE0ZjZfNC0yLTEtMS00ODE2NA_0960041a-5017-4897-ba1f-56c64850d236" unitRef="usd"> 8170000 </opk:AllowanceForDoubtfulAccountsReceivableDecreaseCreditsOrPayments>
<opk:AllowanceForDoubtfulAccountsReceivableDecreaseCreditsOrPayments contextRef="ia9fd561b004d41d78905c8c99e7b8a69_D20210101-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml83OS9mcmFnOjVmOTBlN2YxYTViZjQ4YjJiYjMzYmJhY2YzY2U0YzAwL3RhYmxlOjJhNzI3MWVlZjIyYzRkMTc4ZjMzNjljZGJmMDMxNGY2L3RhYmxlcmFuZ2U6MmE3MjcxZWVmMjJjNGQxNzhmMzM2OWNkYmYwMzE0ZjZfNC00LTEtMS00ODE2NA_bdb1d3e1-32be-4338-ba28-4de8485d12c0" unitRef="usd"> 10981000 </opk:AllowanceForDoubtfulAccountsReceivableDecreaseCreditsOrPayments>
<opk:AllowanceForDoubtfulAccountsReceivableDecreaseCreditsOrPayments contextRef="i227c10653be445e0b26f1e13bea67679_D20210101-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml83OS9mcmFnOjVmOTBlN2YxYTViZjQ4YjJiYjMzYmJhY2YzY2U0YzAwL3RhYmxlOjJhNzI3MWVlZjIyYzRkMTc4ZjMzNjljZGJmMDMxNGY2L3RhYmxlcmFuZ2U6MmE3MjcxZWVmMjJjNGQxNzhmMzM2OWNkYmYwMzE0ZjZfNC02LTEtMS00ODE2NA_e8df615f-ab89-4d50-978e-0d2f9c6d7432" unitRef="usd"> 904000 </opk:AllowanceForDoubtfulAccountsReceivableDecreaseCreditsOrPayments>
<opk:AllowanceForDoubtfulAccountsReceivableDecreaseCreditsOrPayments contextRef="ia33f8e8ebe3940b9a6803c8dfd6f8d8f_D20210101-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml83OS9mcmFnOjVmOTBlN2YxYTViZjQ4YjJiYjMzYmJhY2YzY2U0YzAwL3RhYmxlOjJhNzI3MWVlZjIyYzRkMTc4ZjMzNjljZGJmMDMxNGY2L3RhYmxlcmFuZ2U6MmE3MjcxZWVmMjJjNGQxNzhmMzM2OWNkYmYwMzE0ZjZfNC04LTEtMS00ODE2NA_798cf0de-6c3b-4233-87cb-1b608ed9f688" unitRef="usd"> 20055000 </opk:AllowanceForDoubtfulAccountsReceivableDecreaseCreditsOrPayments>
<us-gaap:AllowanceForDoubtfulAccountsReceivable contextRef="i6f90e15c7d5b44cf8e02d2e5edaf7e46_I20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml83OS9mcmFnOjVmOTBlN2YxYTViZjQ4YjJiYjMzYmJhY2YzY2U0YzAwL3RhYmxlOjJhNzI3MWVlZjIyYzRkMTc4ZjMzNjljZGJmMDMxNGY2L3RhYmxlcmFuZ2U6MmE3MjcxZWVmMjJjNGQxNzhmMzM2OWNkYmYwMzE0ZjZfNS0yLTEtMS00ODE2NA_85be8859-ff3f-4b1c-abda-26b46562c407" unitRef="usd"> 1701000 </us-gaap:AllowanceForDoubtfulAccountsReceivable>
<us-gaap:AllowanceForDoubtfulAccountsReceivable contextRef="ide0b5e05384b4a9ab9b3b8347df937c9_I20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml83OS9mcmFnOjVmOTBlN2YxYTViZjQ4YjJiYjMzYmJhY2YzY2U0YzAwL3RhYmxlOjJhNzI3MWVlZjIyYzRkMTc4ZjMzNjljZGJmMDMxNGY2L3RhYmxlcmFuZ2U6MmE3MjcxZWVmMjJjNGQxNzhmMzM2OWNkYmYwMzE0ZjZfNS00LTEtMS00ODE2NA_a54de998-4b62-407a-b361-355fb5e25bce" unitRef="usd"> 7586000 </us-gaap:AllowanceForDoubtfulAccountsReceivable>
<us-gaap:AllowanceForDoubtfulAccountsReceivable contextRef="i531a7c098ac44b75ac7b3a46c34b6c3c_I20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml83OS9mcmFnOjVmOTBlN2YxYTViZjQ4YjJiYjMzYmJhY2YzY2U0YzAwL3RhYmxlOjJhNzI3MWVlZjIyYzRkMTc4ZjMzNjljZGJmMDMxNGY2L3RhYmxlcmFuZ2U6MmE3MjcxZWVmMjJjNGQxNzhmMzM2OWNkYmYwMzE0ZjZfNS02LTEtMS00ODE2NA_cdd71b13-296b-4bad-b4ef-309a18895bcf" unitRef="usd"> 3324000 </us-gaap:AllowanceForDoubtfulAccountsReceivable>
<us-gaap:AllowanceForDoubtfulAccountsReceivable contextRef="i4036f7150eba4a0ea41bb7f703001989_I20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml83OS9mcmFnOjVmOTBlN2YxYTViZjQ4YjJiYjMzYmJhY2YzY2U0YzAwL3RhYmxlOjJhNzI3MWVlZjIyYzRkMTc4ZjMzNjljZGJmMDMxNGY2L3RhYmxlcmFuZ2U6MmE3MjcxZWVmMjJjNGQxNzhmMzM2OWNkYmYwMzE0ZjZfNS04LTEtMS00ODE2NA_7f35786c-94a7-4eda-86a9-1172722be9db" unitRef="usd"> 12611000 </us-gaap:AllowanceForDoubtfulAccountsReceivable>
<us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="ia33f8e8ebe3940b9a6803c8dfd6f8d8f_D20210101-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml83OS9mcmFnOjVmOTBlN2YxYTViZjQ4YjJiYjMzYmJhY2YzY2U0YzAwL3RhYmxlOjJhNzI3MWVlZjIyYzRkMTc4ZjMzNjljZGJmMDMxNGY2L3RhYmxlcmFuZ2U6MmE3MjcxZWVmMjJjNGQxNzhmMzM2OWNkYmYwMzE0ZjZfNy04LTEtMS00ODE2NA_f2d2ff96-c428-4dbf-9064-80f07f5837ac" unitRef="usd"> 31767000 </us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
<opk:AllowanceForDoubtfulAccountsProvisionForAllowanceAsPercentOfGrossSales contextRef="ia33f8e8ebe3940b9a6803c8dfd6f8d8f_D20210101-20210630" decimals="2" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml83OS9mcmFnOjVmOTBlN2YxYTViZjQ4YjJiYjMzYmJhY2YzY2U0YzAwL3RhYmxlOjJhNzI3MWVlZjIyYzRkMTc4ZjMzNjljZGJmMDMxNGY2L3RhYmxlcmFuZ2U6MmE3MjcxZWVmMjJjNGQxNzhmMzM2OWNkYmYwMzE0ZjZfOC04LTEtMS00ODE2NA_6b28ee89-b0b9-4e82-a951-351f2a3bf765" unitRef="number"> 0.66 </opk:AllowanceForDoubtfulAccountsProvisionForAllowanceAsPercentOfGrossSales>
<us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="i12f96520f0de445889e85c1dcc4a5537_D20220401-20220630" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml83OS9mcmFnOjVmOTBlN2YxYTViZjQ4YjJiYjMzYmJhY2YzY2U0YzAwL3RleHRyZWdpb246NWY5MGU3ZjFhNWJmNDhiMmJiMzNiYmFjZjNjZTRjMDBfMjc0ODc3OTA4NzIxNg_18de2b27-dd3c-47ce-a3f2-30ab4de850fa" unitRef="usd"> 2300000 </us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
<us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="i304ac2eceb1c429fbab5ca387b688dd3_D20220101-20220630" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml83OS9mcmFnOjVmOTBlN2YxYTViZjQ4YjJiYjMzYmJhY2YzY2U0YzAwL3RleHRyZWdpb246NWY5MGU3ZjFhNWJmNDhiMmJiMzNiYmFjZjNjZTRjMDBfMjc0ODc3OTA4NzIxMA_972cdead-e4b4-4852-8ca1-511686452bff" unitRef="usd"> 4500000 </us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
<opk:CollaborativeArrangementMaximumMilestonePayments contextRef="i304ac2eceb1c429fbab5ca387b688dd3_D20220101-20220630" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml83OS9mcmFnOjVmOTBlN2YxYTViZjQ4YjJiYjMzYmJhY2YzY2U0YzAwL3RleHRyZWdpb246NWY5MGU3ZjFhNWJmNDhiMmJiMzNiYmFjZjNjZTRjMDBfMjE5OTAyMzI3NDYzNA_b8448e71-9ad6-4bce-8e6d-17e299544b8d" unitRef="usd"> 85000000 </opk:CollaborativeArrangementMaximumMilestonePayments>
<us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="ic2d25e88030844d6a45bcc6dd738ee08_D20220101-20220630" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml83OS9mcmFnOjVmOTBlN2YxYTViZjQ4YjJiYjMzYmJhY2YzY2U0YzAwL3RleHRyZWdpb246NWY5MGU3ZjFhNWJmNDhiMmJiMzNiYmFjZjNjZTRjMDBfMTUzMTA_61252a98-97bf-4327-9fc1-d2beb49ebc9c" unitRef="usd"> 3000000 </us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
<us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="if52d9a96555d4b6a9061cd14d69ebbca_D20210401-20210630" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml83OS9mcmFnOjVmOTBlN2YxYTViZjQ4YjJiYjMzYmJhY2YzY2U0YzAwL3RleHRyZWdpb246NWY5MGU3ZjFhNWJmNDhiMmJiMzNiYmFjZjNjZTRjMDBfMjc0ODc3OTA4ODQ1NQ_f5bc4ab2-c833-4479-b4c3-30944283f825" unitRef="usd"> 2800000 </us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
<us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="icd5b0c4e08564d34af78f3a6a18a7869_D20210101-20210630" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml83OS9mcmFnOjVmOTBlN2YxYTViZjQ4YjJiYjMzYmJhY2YzY2U0YzAwL3RleHRyZWdpb246NWY5MGU3ZjFhNWJmNDhiMmJiMzNiYmFjZjNjZTRjMDBfMjc0ODc3OTA4ODQ3MA_2bd34135-ca0c-4719-915d-df3dc7a70f99" unitRef="usd"> 5600000 </us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
<opk:CollaborativeArrangementUpfrontPayment contextRef="ia0ce8c6ac0e84c49b0f1d84de3584480_D20220101-20220630" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml83OS9mcmFnOjVmOTBlN2YxYTViZjQ4YjJiYjMzYmJhY2YzY2U0YzAwL3RleHRyZWdpb246NWY5MGU3ZjFhNWJmNDhiMmJiMzNiYmFjZjNjZTRjMDBfMjc0ODc3OTA4ODQ4OQ_719659de-0c30-45bb-ab0a-31fdebc0b7a9" unitRef="usd"> 5000000 </opk:CollaborativeArrangementUpfrontPayment>
<us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml83OS9mcmFnOjVmOTBlN2YxYTViZjQ4YjJiYjMzYmJhY2YzY2U0YzAwL3RleHRyZWdpb246NWY5MGU3ZjFhNWJmNDhiMmJiMzNiYmFjZjNjZTRjMDBfMTU1ODU_fa28fdfc-a97c-4156-82ee-53722f91e2cb">
Changes in the contractual liabilities balance during the six months ended June 30, 2022 are as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.859%"><tr><td style="width:1.0%"/><td style="width:76.002%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.798%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">466 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at June 30, 2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">449 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue recognized in the period from:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts included in contracts liability at the beginning of the period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table>
</us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock>
<us-gaap:ContractWithCustomerLiability contextRef="i7e0f479bead144b0bdbcc71082db627b_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml83OS9mcmFnOjVmOTBlN2YxYTViZjQ4YjJiYjMzYmJhY2YzY2U0YzAwL3RhYmxlOmVmMmYzNzczYjU0YzRmNzc4YmE1N2VhYmViZDU4ZTEyL3RhYmxlcmFuZ2U6ZWYyZjM3NzNiNTRjNGY3NzhiYTU3ZWFiZWJkNThlMTJfMS0xLTEtMS00ODE2NA_0df23ad9-6f86-44a4-ae85-29d201ba861c" unitRef="usd"> 466000 </us-gaap:ContractWithCustomerLiability>
<us-gaap:ContractWithCustomerLiability contextRef="i4768f885851b49f986857a2a956f9162_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml83OS9mcmFnOjVmOTBlN2YxYTViZjQ4YjJiYjMzYmJhY2YzY2U0YzAwL3RhYmxlOmVmMmYzNzczYjU0YzRmNzc4YmE1N2VhYmViZDU4ZTEyL3RhYmxlcmFuZ2U6ZWYyZjM3NzNiNTRjNGY3NzhiYTU3ZWFiZWJkNThlMTJfMi0xLTEtMS00ODE2NA_cc3123f9-9410-4d47-91fb-34b387fe0f73" unitRef="usd"> 449000 </us-gaap:ContractWithCustomerLiability>
<us-gaap:ContractWithCustomerLiabilityRevenueRecognized contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml83OS9mcmFnOjVmOTBlN2YxYTViZjQ4YjJiYjMzYmJhY2YzY2U0YzAwL3RhYmxlOmVmMmYzNzczYjU0YzRmNzc4YmE1N2VhYmViZDU4ZTEyL3RhYmxlcmFuZ2U6ZWYyZjM3NzNiNTRjNGY3NzhiYTU3ZWFiZWJkNThlMTJfNC0xLTEtMS00ODE2NA_a6931c74-612b-4f2d-bae3-0d3b332f730d" unitRef="usd"> 17000 </us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
<opk:StrategicAlliancesTextBlock contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84Mi9mcmFnOjJkMGNlOThmOTU5YTQ4OTRiM2M3NWU5ODljNzJhMDFkL3RleHRyZWdpb246MmQwY2U5OGY5NTlhNDg5NGIzYzc1ZTk4OWM3MmEwMWRfMTU2Nzg_aafc753b-2e3f-45cb-bb98-89e831978fc9">
STRATEGIC ALLIANCES<div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">LeaderMed</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 14, 2021, we and LeaderMed Health Group Limited (“LeaderMed”), a pharmaceutical development company with operations based in Asia, announced the formation of a joint venture to develop, manufacture and commercialize two of OPKO’s clinical stage, long-acting drug products in Greater China and eight other Asian territories. </span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the terms of the agreements, we have granted the joint venture exclusive rights to develop, manufacture and commercialize (a) OPK88003, an oxyntomodulin analog being developed for the treatment of obesity and diabetes, and (b) Factor VIIa-CTP, a novel long-acting coagulation factor being developed to treat hemophilia, in exchange for a 47% ownership interest in the joint venture. In addition, we received an upfront payment of $1 million and will be reimbursed for clinical trial material and technical support we provide the joint venture. We recognized the upfront payment of $1 million as revenue from transfer of intellectual property and other during the year ended December 31, 2021.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">LeaderMed has agreed to be responsible for funding the joint venture’s operations, development and commercialization efforts and, together with its syndicate partners, initially invested $11 million in exchange for a 53% ownership interest. We retain full rights to oxyntomodulin and Factor VIIa-CTP in all other geographies.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">CAMP4 Therapeutics</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 6, 2021, we entered into an exclusive license agreement (the “CAMP4 Agreement”) with CAMP4, pursuant to which we granted to CAMP4 an exclusive license to develop, manufacture, commercialize or improve therapeutics utilizing the AntagoNAT technology, an oligonucleotide platform developed under OPKO CURNA, which includes the molecule for the treatment of Dravet syndrome, together with any derivative or modification thereof (the “Licensed Compound”) and any pharmaceutical product that comprises or contains the Licensed Compound, alone or in combination with one or more other active ingredients (“Licensed Product”), worldwide. The CAMP4 Agreement grant covers human pharmaceutical, prophylactic, and therapeutic and certain diagnostic uses.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We received an initial upfront payment of $1.5 million and 3,373,008 shares of CAMP4’s Series A Prime Preferred Stock (“Preferred Stock”), which equates to approximately 9% of the outstanding shares of CAMP4, and we are eligible to receive up to $3.5 million in development milestone payments for Dravet syndrome products, and $4 million for non-Dravet syndrome products, as well as sales milestones of up to $90 million for Dravet syndrome products and up to $90 million for non-Dravet syndrome products. We may also receive double digit royalty payments on the net sales of royalty bearing products, subject to adjustment. In addition, upon achievement of certain development milestones, we will be eligible to receive equity consideration of up to 5,782,299 shares of Preferred Stock in connection with Dravet syndrome products and up to 1,082,248 shares of Preferred Stock in connection with non-Dravet syndrome products. In connection with our acquisition of CURNA, we agreed to pay future consideration to the sellers upon the achievement of certain events. As a result of our execution of the CAMP4 Agreement, we will have to pay a percentage of any payments received under the CAMP4 Agreement to the former CURNA stockholders. </span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless earlier terminated, the CAMP4 Agreement will remain in effect on a Licensed Product-by-Licensed Product and country by-country basis until such time as the royalty term expires for a Licensed Product in a country, and expires in its entirety upon the expiration of the royalty term for the last Licensed Product in the last country. CAMP4’s royalty obligations expire on the later of (i) the expiration, invalidation or abandonment date of the last patent right in connection with the royalty bearing product, or (ii) ten (10) years after a royalty bearing product’s first commercial sale in a country. In addition to termination rights for material breach and bankruptcy, CAMP4 is permitted to terminate the Agreement after a specified notice period.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">NICOYA Macau Limited</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 18, 2021, EirGen, our wholly owned subsidiary, and NICOYA Macau Limited (“Nicoya”), a Macau corporation and an affiliate of NICOYA Therapeutics, entered into a Development and License Agreement (the “Nicoya Agreement”) granting Nicoya the exclusive rights for the development and commercialization of extended release calcifediol (the “Nicoya Product”) in Greater China, which includes mainland China, Hong Kong, Macau, and Taiwan (collectively, the “Nicoya Territory”). Extended release calcifediol is marketed in the U.S. by OPKO under the tradename </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Rayaldee</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The license grant to Nicoya covers the therapeutic and preventative use of the Nicoya Product for SHPT in non-dialysis and hemodialysis chronic kidney disease patients (the “Nicoya Field”).</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">EirGen has received an initial upfront payment of $5 million and is eligible to receive an additional $5 million upon the first to occur of (A) a predetermined milestone and (B) the first anniversary of the effective date. EirGen is also eligible to receive up to an additional aggregate amount of $115 million upon the achievement of certain development, regulatory and sales-based milestones by Nicoya for the Nicoya Product in the Nicoya Territory. EirGen will also receive tiered, double digit royalty payments at rates in the low double digits on net product sales within the Nicoya Territory and in the Nicoya Field.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Nicoya will, at its sole cost and expense, be responsible for performing all development activities necessary to obtain all regulatory approvals for the Nicoya Product in the Nicoya Territory and for all commercial activities pertaining to the Nicoya Product in the Nicoya Territory.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless earlier terminated, the Nicoya Agreement will remain in effect until such time as all royalty payment terms and extended payment terms have expired, and Nicoya shall have no further payment obligations to EirGen under the terms of the Nicoya Agreement. Nicoya’s royalty obligations expire on the later of (i) expiration of the last to expire valid patent claim covering the Nicoya Product sold in the Nicoya Territory, (ii) expiration of all regulatory and data exclusivity applicable to the Nicoya Product in the Nicoya Territory, and (iii) on a product-by-product basis, ten (10) years after such Nicoya Product’s first commercial sale in the Nicoya Territory. In addition to termination rights for material breach and bankruptcy, Nicoya is permitted to terminate the Nicoya Agreement after a specified notice period.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Vifor Fresenius Medical Care Renal Pharma Ltd</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2016, EirGen and Vifor Fresenius Medical Care Renal Pharma Ltd. (“VFMCRP”) entered into a Development and License Agreement (the “VFMCRP Agreement”) for the development and commercialization of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Rayaldee</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (the “Product”) worldwide, except for (i) the U.S., (ii) any country in Central America or South America (including Mexico), (iii) Russia, (iv) China, (v) South Korea, (vi) Ukraine, (vii) Belorussia, (viii) Azerbaijan, (ix) Kazakhstan, (x) Taiwan (xi) the Middle East, and (xii) all countries of Africa (the “VFMCRP Territory”), as amended. The license to VFMCRP potentially covers all therapeutic and prophylactic uses of the Product in human patients (the “VFMCRP Field”), provided that initially the license is for the use of the Product for the treatment or prevention of SHPT related to patients with CKD and vitamin D insufficiency/deficiency (the “VFMCRP Initial Indication”).</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the six months ended June 30, 2022 we recognized a milestone payment of $3.0 million in revenue from transfer of intellectual property and other for the first sale of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Rayaldee</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in Europe.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective May 23, 2021, we entered into an amendment to the VFMCRP Agreement pursuant to which the parties thereto agreed to include Japan as part of the VFMCRP Territory.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective May 5, 2020, we entered into an amendment to the VFMCRP Agreement pursuant to which the parties agreed to exclude Mexico, South Korea, the Middle East and all of the countries of Africa from the VFMCRP Territory. In addition, the parties agreed to certain amendments to the milestone structure and to reduce minimum royalties payable. As revised, the Company has received a $3 million payment triggered by the first marketing approval of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Rayaldee</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in Europe and is eligible to receive up to an additional $17 million in regulatory milestones and $207 million in milestone payments tied to launch, pricing and sales of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Rayaldee</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and tiered, double-digit royalties. </span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We plan to share responsibility with VFMCRP for the conduct of trials specified within an agreed-upon development plan, with each company leading certain activities within the plan. EirGen will lead the manufacturing activities within and outside the VFMCRP Territory and the commercialization activities outside the VFMCRP Territory and outside the VFMCRP Field in the VFMCRP Territory and VFMCRP will lead the commercialization activities in the VFMCRP Territory and the VFMCRP Field. For the initial development plan, the companies have agreed to certain cost sharing arrangements. VFMCRP will be responsible for all other development costs that VFMCRP considers necessary to develop the Product for the use of the Product for the VFMCRP Initial Indication in the VFMCRP Territory in the VFMCRP Field except as otherwise provided in the VFMCRP Agreement. The first of the clinical studies provided for in the development activities commenced in September 2018. </span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the VFMCRP Agreement, the parties entered into a letter agreement pursuant to which EirGen granted to VFMCRP an exclusive option (the “Option”) to acquire an exclusive license under certain EirGen patents and technology to use, import, offer for sale, sell, distribute and commercialize the Product in the U.S. solely for the treatment of SHPT in dialysis patients with CKD and vitamin D insufficiency (the “Dialysis Indication”). Upon exercise of the Option, VFMCRP will reimburse EirGen for all of the development costs incurred by EirGen with respect to the Product for the Dialysis Indication in the U.S. VFMCRP would also pay EirGen up to an additional aggregate amount of $555 million of sales-based milestones upon the achievement of certain milestones and would be obligated to pay royalties at percentage rates that range from the mid-teens to the mid-twenties on sales of the Product in the U.S. for the Dialysis Indication. To date, VFMCRP has not exercised its option.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Payments received for regulatory milestones and sales milestones are non-refundable. The regulatory milestones are payable if and when VFMCRP obtains approval from certain regulatory authorities and will be recognized as revenue in the period in which the associated milestone is achieved, assuming all other revenue recognition criteria are met. We account for the sales milestones as royalties and sales milestones payments will be recognized as revenue in the period in which the associated milestone is achieved or sales occur, assuming all other revenue recognition criteria are met. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pfizer Inc.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2014, we entered into an exclusive worldwide agreement (the “Pfizer Agreement”) with Pfizer for the development and commercialization of our long-acting Somatrogon (hGH-CTP) for the treatment of growth hormone deficiency (“GHD”) in adults and children, as well as for the treatment of growth failure in children born small for gestational age (the “Pfizer Transaction”). </span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In early 2022, the European Commission and Ministry of Health, Labour and Welfare in Japan approved the next-generation long-acting recombinant human growth hormone NGENLA (Somatrogon), a once-weekly injection to treat pediatric growth hormone deficiency, and we received pricing approvals in Germany and Japan. With the achievement of these milestones, we received $85.0 million in milestone payments during the second quarter of 2022. Further, Canada and Australia approved NGENLA in October and November of 2021, respectively.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2022, the FDA issued a Complete Response Letter for the BLA for Somatrogon (hGH-CTP). Pfizer and OPKO are evaluating the FDA’s comments and will work with the agency to determine the best path forward for Somatrogon (hGH-CTP) in the United States.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2020, we entered into an Amended and Restated Development and Commercialization License Agreement (the “Restated Pfizer Agreement”) with Pfizer, effective January 1, 2020, pursuant to which the parties agreed, among other things, to share all costs for Manufacturing Activities, as defined in the Restated Pfizer Agreement, for developing a licensed product for the three indications included in the Restated Pfizer Agreement.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 21, 2019, we and Pfizer announced that the global phase 3 trial evaluating Somatrogon dosed once-weekly in prepubertal children with GHD met its primary endpoint of non-inferiority to daily Genotropin® (somatropin) for injection, as measured by annual height velocity at 12 months.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the terms of the Pfizer Transaction, as restated, we received non-refundable and non-creditable upfront payments of $295.0 million and are eligible to receive up to an additional $275.0 million upon the achievement of certain regulatory milestones. Pfizer received the exclusive license to commercialize Somatrogon worldwide. In addition, we are eligible to receive initial tiered royalty payments associated with the commercialization of Somatrogon for adult GHD with percentage rates ranging from the high teens to mid-twenties. Upon the launch of Somatrogon for pediatric GHD in certain major markets, the royalties will transition to regional, tiered gross profit sharing for both Somatrogon and Pfizer’s Genotropin®.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The agreement with Pfizer will remain in effect until the last sale of the licensed product, unless earlier terminated as permitted under the Pfizer Agreement. In addition to termination rights for material breach and bankruptcy, Pfizer is permitted </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to terminate the Pfizer Agreement in its entirety, or with respect to one or more world regions, without cause after a specified notice period. If the Pfizer Agreement is terminated by us for Pfizer’s uncured material breach, or by Pfizer without cause, provision has been made for transition of product and product responsibilities to us for the terminated regions, as well as continued supply of product by Pfizer or transfer of supply to us in order to support the terminated regions. </span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognized the non-refundable $295.0 million upfront payments as revenue as the research and development services were completed and as of both June 30, 2022 and December 31, 2021, we had no contract liabilities related to the Pfizer Transaction.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Pfizer Transaction includes milestone payments of $275.0 million upon the achievement of certain milestones. The milestones range from $20.0 million to $90.0 million each and are based on achievement of regulatory approval in the U.S. and regulatory approval and price approval in other major markets. The milestone payments will be recognized as revenue in the period in which the associated milestone is achieved, assuming all other revenue recognition criteria are met. To date, $85.0 million of revenue has been recognized related to the achievement of the milestones.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have completed strategic deals with numerous institutions and commercial partners. In connection with these agreements, upon the achievement of certain milestones we are obligated to make certain payments and have royalty obligations upon sales of products developed under the license agreements. At this time, we are unable to estimate the timing and amounts of payments as the obligations are based on future development of the licensed products.</span></div>
</opk:StrategicAlliancesTextBlock>
<us-gaap:MinorityInterestOwnershipPercentageByParent contextRef="i1d617d723c3b4354a0819a2ba6169cbe_I20210914" decimals="2" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84Mi9mcmFnOjJkMGNlOThmOTU5YTQ4OTRiM2M3NWU5ODljNzJhMDFkL3RleHRyZWdpb246MmQwY2U5OGY5NTlhNDg5NGIzYzc1ZTk4OWM3MmEwMWRfNzI1_d187e7f0-43c2-48c6-b6a7-1275997b7442" unitRef="number"> 0.47 </us-gaap:MinorityInterestOwnershipPercentageByParent>
<us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="i9df475336f4742019be80be30aa8e211_D20210914-20210914" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84Mi9mcmFnOjJkMGNlOThmOTU5YTQ4OTRiM2M3NWU5ODljNzJhMDFkL3RleHRyZWdpb246MmQwY2U5OGY5NTlhNDg5NGIzYzc1ZTk4OWM3MmEwMWRfODE2_554d140b-048f-401f-babf-e920fb4c1267" unitRef="usd"> 1000000 </us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
<us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="icd13b5cdff764ac1b6da33756463ad81_D20210101-20211231" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84Mi9mcmFnOjJkMGNlOThmOTU5YTQ4OTRiM2M3NWU5ODljNzJhMDFkL3RleHRyZWdpb246MmQwY2U5OGY5NTlhNDg5NGIzYzc1ZTk4OWM3MmEwMWRfOTU5_b34f2d02-88d1-425b-bbdb-2d1d14e354fb" unitRef="usd"> 1000000 </us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
<us-gaap:PaymentsToAcquireInterestInJointVenture contextRef="ife44f423be0e44ba9c693b730c6ecddf_D20210914-20210914" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84Mi9mcmFnOjJkMGNlOThmOTU5YTQ4OTRiM2M3NWU5ODljNzJhMDFkL3RleHRyZWdpb246MmQwY2U5OGY5NTlhNDg5NGIzYzc1ZTk4OWM3MmEwMWRfMTI1MA_159fa3ff-e97d-43c8-ab33-7eed0ca35188" unitRef="usd"> 11000000 </us-gaap:PaymentsToAcquireInterestInJointVenture>
<us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners contextRef="i1d617d723c3b4354a0819a2ba6169cbe_I20210914" decimals="3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84Mi9mcmFnOjJkMGNlOThmOTU5YTQ4OTRiM2M3NWU5ODljNzJhMDFkL3RleHRyZWdpb246MmQwY2U5OGY5NTlhNDg5NGIzYzc1ZTk4OWM3MmEwMWRfMTI3MQ_f8f3b967-e71b-4ae2-bc5a-950036c56ba8" unitRef="number"> 0.53 </us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners>
<us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="i5701e9389a3b45f09bc25710565808e4_D20210706-20210706" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84Mi9mcmFnOjJkMGNlOThmOTU5YTQ4OTRiM2M3NWU5ODljNzJhMDFkL3RleHRyZWdpb246MmQwY2U5OGY5NTlhNDg5NGIzYzc1ZTk4OWM3MmEwMWRfMjE5Mw_6298bf70-7a72-45a0-9a2b-6dd05070c052" unitRef="usd"> 1500000 </us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
<opk:CollaborativeArrangementUpfrontPaymentShares contextRef="i66c40505624f4271a9330c0a7af1652b_D20210706-20210706" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84Mi9mcmFnOjJkMGNlOThmOTU5YTQ4OTRiM2M3NWU5ODljNzJhMDFkL3RleHRyZWdpb246MmQwY2U5OGY5NTlhNDg5NGIzYzc1ZTk4OWM3MmEwMWRfMjIwMA_899e3e09-487c-48d1-8d8a-be30a3f28069" unitRef="shares"> 3373008 </opk:CollaborativeArrangementUpfrontPaymentShares>
<opk:CollaborativeArrangementPercentOfOutstandingShares contextRef="i66c40505624f4271a9330c0a7af1652b_D20210706-20210706" decimals="2" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84Mi9mcmFnOjJkMGNlOThmOTU5YTQ4OTRiM2M3NWU5ODljNzJhMDFkL3RleHRyZWdpb246MmQwY2U5OGY5NTlhNDg5NGIzYzc1ZTk4OWM3MmEwMWRfMjMwNA_7e0c5e62-9279-4950-a3b1-dd7f0fcc22a8" unitRef="number"> 0.09 </opk:CollaborativeArrangementPercentOfOutstandingShares>
<opk:CollaborativeArrangementDevelopmentMilestonePayment contextRef="i04b1fea4c63a4013a107d1f6e8c2b898_D20210706-20210706" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84Mi9mcmFnOjJkMGNlOThmOTU5YTQ4OTRiM2M3NWU5ODljNzJhMDFkL3RleHRyZWdpb246MmQwY2U5OGY5NTlhNDg5NGIzYzc1ZTk4OWM3MmEwMWRfMjM4MA_684cb586-1752-44da-bb5d-bcc471c47372" unitRef="usd"> 3500000 </opk:CollaborativeArrangementDevelopmentMilestonePayment>
<opk:CollaborativeArrangementDevelopmentMilestonePayment contextRef="i09e19371951f43cc9dc8c74c84e2251c_D20210706-20210706" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84Mi9mcmFnOjJkMGNlOThmOTU5YTQ4OTRiM2M3NWU5ODljNzJhMDFkL3RleHRyZWdpb246MmQwY2U5OGY5NTlhNDg5NGIzYzc1ZTk4OWM3MmEwMWRfMjQ1MQ_697bc526-854e-4b61-8f11-8d2330337620" unitRef="usd"> 4000000 </opk:CollaborativeArrangementDevelopmentMilestonePayment>
<opk:CollaborativeArrangementSalesMilestonePayment contextRef="i04b1fea4c63a4013a107d1f6e8c2b898_D20210706-20210706" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84Mi9mcmFnOjJkMGNlOThmOTU5YTQ4OTRiM2M3NWU5ODljNzJhMDFkL3RleHRyZWdpb246MmQwY2U5OGY5NTlhNDg5NGIzYzc1ZTk4OWM3MmEwMWRfMjUyNQ_f92ede91-531e-478f-af32-e5231df0b99d" unitRef="usd"> 90000000 </opk:CollaborativeArrangementSalesMilestonePayment>
<opk:CollaborativeArrangementSalesMilestonePayment contextRef="i09e19371951f43cc9dc8c74c84e2251c_D20210706-20210706" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84Mi9mcmFnOjJkMGNlOThmOTU5YTQ4OTRiM2M3NWU5ODljNzJhMDFkL3RleHRyZWdpb246MmQwY2U5OGY5NTlhNDg5NGIzYzc1ZTk4OWM3MmEwMWRfMjU2Nw_84e21a81-c0ce-438f-9b52-b400745df885" unitRef="usd"> 90000000 </opk:CollaborativeArrangementSalesMilestonePayment>
<opk:CollaborativeArrangementDevelopmentMilestonePaymentShares contextRef="i04b1fea4c63a4013a107d1f6e8c2b898_D20210706-20210706" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84Mi9mcmFnOjJkMGNlOThmOTU5YTQ4OTRiM2M3NWU5ODljNzJhMDFkL3RleHRyZWdpb246MmQwY2U5OGY5NTlhNDg5NGIzYzc1ZTk4OWM3MmEwMWRfMjg0OQ_2deb2cfb-d92c-473e-9bb4-4435c8aa6bfe" unitRef="shares"> 5782299 </opk:CollaborativeArrangementDevelopmentMilestonePaymentShares>
<opk:CollaborativeArrangementDevelopmentMilestonePaymentShares contextRef="i09e19371951f43cc9dc8c74c84e2251c_D20210706-20210706" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84Mi9mcmFnOjJkMGNlOThmOTU5YTQ4OTRiM2M3NWU5ODljNzJhMDFkL3RleHRyZWdpb246MmQwY2U5OGY5NTlhNDg5NGIzYzc1ZTk4OWM3MmEwMWRfMjkzMg_0cb03b7b-9542-47dc-9130-8421021cfa09" unitRef="shares"> 1082248 </opk:CollaborativeArrangementDevelopmentMilestonePaymentShares>
<opk:CollaborativeArrangementPeriodFollowingFirstCommercialSale contextRef="i66c40505624f4271a9330c0a7af1652b_D20210706-20210706" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84Mi9mcmFnOjJkMGNlOThmOTU5YTQ4OTRiM2M3NWU5ODljNzJhMDFkL3RleHRyZWdpb246MmQwY2U5OGY5NTlhNDg5NGIzYzc1ZTk4OWM3MmEwMWRfMzg1MA_2d80f671-5829-41f5-99df-94e66f7bbe2d"> P10Y </opk:CollaborativeArrangementPeriodFollowingFirstCommercialSale>
<opk:ProceedsFromDevelopmentAndLicenseAgreementUpfrontPayment contextRef="icdd8457f597346fca02a9a713337a3a0_D20210618-20210618" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84Mi9mcmFnOjJkMGNlOThmOTU5YTQ4OTRiM2M3NWU5ODljNzJhMDFkL3RleHRyZWdpb246MmQwY2U5OGY5NTlhNDg5NGIzYzc1ZTk4OWM3MmEwMWRfNDkxMA_936b5cc0-66fc-4d71-9b04-f3142d3b412f" unitRef="usd"> 5000000 </opk:ProceedsFromDevelopmentAndLicenseAgreementUpfrontPayment>
<opk:ProceedsFromDevelopmentAndLicenseAgreementUpfrontPayment contextRef="ic13084132a834365a6e31b71c6450cc0_D20210618-20210618" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84Mi9mcmFnOjJkMGNlOThmOTU5YTQ4OTRiM2M3NWU5ODljNzJhMDFkL3RleHRyZWdpb246MmQwY2U5OGY5NTlhNDg5NGIzYzc1ZTk4OWM3MmEwMWRfNDk1NA_1686f491-53cd-42bd-a490-30b267c84e5e" unitRef="usd"> 5000000 </opk:ProceedsFromDevelopmentAndLicenseAgreementUpfrontPayment>
<opk:ProceedsFromDevelopmentAndLicenseAgreementMilestonePayment contextRef="ic7b48d7ef14a4478b86806c11aae1766_D20210618-20210618" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84Mi9mcmFnOjJkMGNlOThmOTU5YTQ4OTRiM2M3NWU5ODljNzJhMDFkL3RleHRyZWdpb246MmQwY2U5OGY5NTlhNDg5NGIzYzc1ZTk4OWM3MmEwMWRfNTE0Mg_5922cdf0-71d3-4938-86b9-73a24dfd82c4" unitRef="usd"> 115000000 </opk:ProceedsFromDevelopmentAndLicenseAgreementMilestonePayment>
<opk:CollaborativeArrangementPeriodAfterFirstCommercialSale contextRef="icdd8457f597346fca02a9a713337a3a0_D20210618-20210618" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84Mi9mcmFnOjJkMGNlOThmOTU5YTQ4OTRiM2M3NWU5ODljNzJhMDFkL3RleHRyZWdpb246MmQwY2U5OGY5NTlhNDg5NGIzYzc1ZTk4OWM3MmEwMWRfNjMyNg_d32963d7-5804-467b-8d09-0574933862f6"> P10Y </opk:CollaborativeArrangementPeriodAfterFirstCommercialSale>
<us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="ic2d25e88030844d6a45bcc6dd738ee08_D20220101-20220630" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84Mi9mcmFnOjJkMGNlOThmOTU5YTQ4OTRiM2M3NWU5ODljNzJhMDFkL3RleHRyZWdpb246MmQwY2U5OGY5NTlhNDg5NGIzYzc1ZTk4OWM3MmEwMWRfNzU4OQ_61252a98-97bf-4327-9fc1-d2beb49ebc9c" unitRef="usd"> 3000000 </us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
<us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="i0528eeb931cb48febe1e55ac6c2120ea_D20200505-20200505" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84Mi9mcmFnOjJkMGNlOThmOTU5YTQ4OTRiM2M3NWU5ODljNzJhMDFkL3RleHRyZWdpb246MmQwY2U5OGY5NTlhNDg5NGIzYzc1ZTk4OWM3MmEwMWRfODI1Mg_73d6efea-5b16-46b3-a682-92375a5047c1" unitRef="usd"> 3000000 </us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
<opk:CollaborativeArrangementMaximumMilestonePayments contextRef="i242ab26482294826b358ac46a25dc0de_D20200505-20200505" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84Mi9mcmFnOjJkMGNlOThmOTU5YTQ4OTRiM2M3NWU5ODljNzJhMDFkL3RleHRyZWdpb246MmQwY2U5OGY5NTlhNDg5NGIzYzc1ZTk4OWM3MmEwMWRfODM3NA_79496797-aa1b-4270-86e7-cf669fe485ef" unitRef="usd"> 17000000 </opk:CollaborativeArrangementMaximumMilestonePayments>
<opk:CollaborativeArrangementMaximumMilestonePayments contextRef="i919d82ffaa2242fab66ebd562eb3b0b8_D20200505-20200505" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84Mi9mcmFnOjJkMGNlOThmOTU5YTQ4OTRiM2M3NWU5ODljNzJhMDFkL3RleHRyZWdpb246MmQwY2U5OGY5NTlhNDg5NGIzYzc1ZTk4OWM3MmEwMWRfODQwNg_78124e2e-9feb-42fb-a633-e1c1319d1a23" unitRef="usd"> 207000000 </opk:CollaborativeArrangementMaximumMilestonePayments>
<opk:CollaborativeArrangementMaximumMilestonePayments contextRef="i7e6ec43259f2432fac1dab4a788f474c_D20160501-20160531" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84Mi9mcmFnOjJkMGNlOThmOTU5YTQ4OTRiM2M3NWU5ODljNzJhMDFkL3RleHRyZWdpb246MmQwY2U5OGY5NTlhNDg5NGIzYzc1ZTk4OWM3MmEwMWRfMTAxODU_7a153e6a-7d12-434e-872e-f8727afeea05" unitRef="usd"> 555000000 </opk:CollaborativeArrangementMaximumMilestonePayments>
<opk:CollaborativeArrangementMilestonePayment contextRef="ibeccc485dd5f4f1f9697ea28a6c31669_D20220401-20220630" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84Mi9mcmFnOjJkMGNlOThmOTU5YTQ4OTRiM2M3NWU5ODljNzJhMDFkL3RleHRyZWdpb246MmQwY2U5OGY5NTlhNDg5NGIzYzc1ZTk4OWM3MmEwMWRfMTE4Njg_12985cfe-2616-4706-8f96-889c0857fab1" unitRef="usd"> 85000000 </opk:CollaborativeArrangementMilestonePayment>
<opk:CollaborativeArrangementAnnualHeightVelocityatPointinTime contextRef="i6b34b696fb8f49d6a2693caeeef93ba5_D20191021-20191021" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84Mi9mcmFnOjJkMGNlOThmOTU5YTQ4OTRiM2M3NWU5ODljNzJhMDFkL3RleHRyZWdpb246MmQwY2U5OGY5NTlhNDg5NGIzYzc1ZTk4OWM3MmEwMWRfMTI5NTU_2aeb6290-941f-4036-b0e5-6d657816a257"> P12M </opk:CollaborativeArrangementAnnualHeightVelocityatPointinTime>
<opk:CollaborativeArrangementUpfrontPayment contextRef="ia376fcbbc1d54e0abbe47b991bd1ca15_D20150101-20150131" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84Mi9mcmFnOjJkMGNlOThmOTU5YTQ4OTRiM2M3NWU5ODljNzJhMDFkL3RleHRyZWdpb246MmQwY2U5OGY5NTlhNDg5NGIzYzc1ZTk4OWM3MmEwMWRfMTMwODE_b6073b13-1088-4780-81d1-aa98c46e5e3c" unitRef="usd"> 295000000 </opk:CollaborativeArrangementUpfrontPayment>
<opk:CollaborativeAgreementAdditionalMilestonePayment contextRef="ia376fcbbc1d54e0abbe47b991bd1ca15_D20150101-20150131" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84Mi9mcmFnOjJkMGNlOThmOTU5YTQ4OTRiM2M3NWU5ODljNzJhMDFkL3RleHRyZWdpb246MmQwY2U5OGY5NTlhNDg5NGIzYzc1ZTk4OWM3MmEwMWRfMTMxMzI_b0e2977e-2273-414c-a72a-eba07036f6de" unitRef="usd"> 275000000 </opk:CollaborativeAgreementAdditionalMilestonePayment>
<opk:CollaborativeArrangementUpfrontPayment contextRef="ia376fcbbc1d54e0abbe47b991bd1ca15_D20150101-20150131" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84Mi9mcmFnOjJkMGNlOThmOTU5YTQ4OTRiM2M3NWU5ODljNzJhMDFkL3RleHRyZWdpb246MmQwY2U5OGY5NTlhNDg5NGIzYzc1ZTk4OWM3MmEwMWRfMTQ0NDY_ea61d7eb-3073-423e-934b-08e4f8013b3b" unitRef="usd"> 295000000 </opk:CollaborativeArrangementUpfrontPayment>
<opk:CollaborativeArrangementMaximumMilestonePayments contextRef="ia376fcbbc1d54e0abbe47b991bd1ca15_D20150101-20150131" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84Mi9mcmFnOjJkMGNlOThmOTU5YTQ4OTRiM2M3NWU5ODljNzJhMDFkL3RleHRyZWdpb246MmQwY2U5OGY5NTlhNDg5NGIzYzc1ZTk4OWM3MmEwMWRfMTQ3MDY_7e728e84-36ae-4deb-b93e-0c55349e9c05" unitRef="usd"> 275000000 </opk:CollaborativeArrangementMaximumMilestonePayments>
<opk:CollaborativeArrangementMilestonePayment contextRef="i4a877793ea6e40bcb4412fb871d8a4a6_D20150101-20150131" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84Mi9mcmFnOjJkMGNlOThmOTU5YTQ4OTRiM2M3NWU5ODljNzJhMDFkL3RleHRyZWdpb246MmQwY2U5OGY5NTlhNDg5NGIzYzc1ZTk4OWM3MmEwMWRfMTQ3ODA_ed618273-83c0-4d41-aa89-0e12cde54e96" unitRef="usd"> 20000000 </opk:CollaborativeArrangementMilestonePayment>
<opk:CollaborativeArrangementMilestonePayment contextRef="i1e36deb038794b318844f6bf06c5a436_D20150101-20150131" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84Mi9mcmFnOjJkMGNlOThmOTU5YTQ4OTRiM2M3NWU5ODljNzJhMDFkL3RleHRyZWdpb246MmQwY2U5OGY5NTlhNDg5NGIzYzc1ZTk4OWM3MmEwMWRfMTQ3ODY_a6214dd4-521c-47ea-ad7b-98a64c04f95c" unitRef="usd"> 90000000 </opk:CollaborativeArrangementMilestonePayment>
<us-gaap:ContractWithCustomerLiabilityRevenueRecognized contextRef="i6744a2487a2a4da4bd87bdb6700db729_D20150101-20220630" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84Mi9mcmFnOjJkMGNlOThmOTU5YTQ4OTRiM2M3NWU5ODljNzJhMDFkL3RleHRyZWdpb246MmQwY2U5OGY5NTlhNDg5NGIzYzc1ZTk4OWM3MmEwMWRfMTUxMDc_28a89181-01e2-43a5-998f-40397069475a" unitRef="usd"> 85000000 </us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
<us-gaap:SegmentReportingDisclosureTextBlock contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84NS9mcmFnOjNjNWFkNzUyZDgyNjRhODE5ODkwOWY1N2NhOTQxY2Q4L3RleHRyZWdpb246M2M1YWQ3NTJkODI2NGE4MTk4OTA5ZjU3Y2E5NDFjZDhfMTAxMw_f3e8c93a-f46a-4541-a896-646be09ba58e">
SEGMENTS<div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We manage our operations in two reportable segments, pharmaceutical and diagnostics. The pharmaceutical segment consists of our pharmaceutical operations in Chile, Mexico, Ireland, Israel and Spain, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Rayaldee</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> product sales and our pharmaceutical research and development. The diagnostics segment primarily consists of our clinical and genomics laboratory operations through BioReference and our point-of-care operations. There are no significant inter-segment sales. We evaluate the performance of each segment based on operating profit or loss. There is no inter-segment allocation of interest expense and income taxes.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information regarding our operations and assets for our operating segments and the unallocated corporate operations as well as geographic information are as follows:</span></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:40.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.935%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.935%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.935%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.939%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">For the three months ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">For the six months ended June 30,</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue from services:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmaceutical</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">186,804 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">397,197 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">473,402 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">904,149 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">186,804 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">397,197 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">473,402 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">904,149 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue from products:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmaceutical</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,892 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,663 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,550 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,608 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,892 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,663 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,550 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,608 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue from transfer of intellectual property and other: </span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmaceutical</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87,197 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,548 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93,159 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,816 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87,197 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,548 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93,159 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,816 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income (loss):</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmaceutical</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,435 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,710)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,327 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32,868)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(57,543)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,000 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(101,092)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97,014 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,631)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,719)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19,399)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20,138)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,739)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,571 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(83,164)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,008 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmaceutical</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,840 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,007 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,242 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,420 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,155 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,566 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,567 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,141 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,995 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,573 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,809 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,561 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from investment in investees:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmaceutical</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(268)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(67)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(316)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(110)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(268)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(67)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(316)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(110)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">193,105 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">402,291 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">484,913 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">915,163 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ireland</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89,177 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,088 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97,638 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,218 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chile</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,804 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,657 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,143 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,809 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Spain</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,696 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,437 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,805 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,356 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Israel</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,854 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">724 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,412 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,235 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mexico</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,055 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,039 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,805 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,457 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">202 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">395 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">335 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">309,893 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">442,408 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">639,111 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">987,573 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.081%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.443%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.446%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">June 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmaceutical</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,354,058 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,114,460 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">748,165 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,238,583 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">267,379 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,672 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,369,602 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,399,715 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmaceutical</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">295,820 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">237,576 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">283,025 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">283,025 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">578,845 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">520,601 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table>No customer represented more than 10% of our total consolidated revenue during the six months ended June 30, 2022 and 2021. As of June 30, 2022 and December 31, 2021, no customer represented more than 10% of our accounts receivable balance.
</us-gaap:SegmentReportingDisclosureTextBlock>
<us-gaap:NumberOfReportableSegments contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84NS9mcmFnOjNjNWFkNzUyZDgyNjRhODE5ODkwOWY1N2NhOTQxY2Q4L3RleHRyZWdpb246M2M1YWQ3NTJkODI2NGE4MTk4OTA5ZjU3Y2E5NDFjZDhfNTA_8e76907d-ee8b-4451-9148-0b9ad84ff8a5" unitRef="segment"> 2 </us-gaap:NumberOfReportableSegments>
<us-gaap:Revenues contextRef="id76c5069be644220983f7e66c6dc51c4_D20220101-20220630" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84NS9mcmFnOjNjNWFkNzUyZDgyNjRhODE5ODkwOWY1N2NhOTQxY2Q4L3RleHRyZWdpb246M2M1YWQ3NTJkODI2NGE4MTk4OTA5ZjU3Y2E5NDFjZDhfNDU0_80493319-3d59-48ea-99b4-71b4d2ae2904" unitRef="usd"> 0 </us-gaap:Revenues>
<us-gaap:InterestExpense contextRef="id76c5069be644220983f7e66c6dc51c4_D20220101-20220630" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84NS9mcmFnOjNjNWFkNzUyZDgyNjRhODE5ODkwOWY1N2NhOTQxY2Q4L3RleHRyZWdpb246M2M1YWQ3NTJkODI2NGE4MTk4OTA5ZjU3Y2E5NDFjZDhfNTgw_6cd21e20-e6fb-4ec5-a1ad-6e8272dbcdb9" unitRef="usd"> 0 </us-gaap:InterestExpense>
<us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84NS9mcmFnOjNjNWFkNzUyZDgyNjRhODE5ODkwOWY1N2NhOTQxY2Q4L3RleHRyZWdpb246M2M1YWQ3NTJkODI2NGE4MTk4OTA5ZjU3Y2E5NDFjZDhfMTAwOQ_88f9af86-e017-464a-a5f3-afb97144e5ca">
Information regarding our operations and assets for our operating segments and the unallocated corporate operations as well as geographic information are as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:40.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.935%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.935%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.935%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.939%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">For the three months ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">For the six months ended June 30,</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue from services:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmaceutical</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">186,804 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">397,197 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">473,402 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">904,149 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">186,804 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">397,197 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">473,402 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">904,149 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue from products:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmaceutical</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,892 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,663 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,550 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,608 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,892 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,663 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,550 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,608 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue from transfer of intellectual property and other: </span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmaceutical</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87,197 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,548 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93,159 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,816 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87,197 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,548 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93,159 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,816 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income (loss):</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmaceutical</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,435 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,710)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,327 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32,868)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(57,543)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,000 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(101,092)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97,014 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,631)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,719)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19,399)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20,138)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,739)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,571 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(83,164)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,008 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmaceutical</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,840 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,007 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,242 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,420 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,155 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,566 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,567 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,141 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,995 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,573 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,809 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,561 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from investment in investees:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmaceutical</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(268)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(67)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(316)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(110)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(268)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(67)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(316)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(110)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">193,105 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">402,291 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">484,913 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">915,163 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ireland</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89,177 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,088 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97,638 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,218 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chile</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,804 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,657 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,143 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,809 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Spain</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,696 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,437 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,805 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,356 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Israel</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,854 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">724 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,412 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,235 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mexico</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,055 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,039 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,805 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,457 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">202 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">395 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">335 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">309,893 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">442,408 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">639,111 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">987,573 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.081%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.443%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.446%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">June 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmaceutical</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,354,058 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,114,460 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">748,165 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,238,583 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">267,379 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,672 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,369,602 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,399,715 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmaceutical</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">295,820 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">237,576 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">283,025 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">283,025 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">578,845 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">520,601 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table>
</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
<us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="id81dc8b2bd404b568174fdb62e57917a_D20220401-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84NS9mcmFnOjNjNWFkNzUyZDgyNjRhODE5ODkwOWY1N2NhOTQxY2Q4L3RhYmxlOjhkMTYzYTFmZTc0ZDQzYjFiMzNiNjJjOTE1NGU4ZmU0L3RhYmxlcmFuZ2U6OGQxNjNhMWZlNzRkNDNiMWIzM2I2MmM5MTU0ZThmZTRfMy0xLTEtMS00ODE2NA_dd5782f2-d4f1-4305-902e-a5fcc039216d" unitRef="usd"> 0 </us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
<us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="i33bb3aa9d57f4468993f60c3d830894d_D20210401-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84NS9mcmFnOjNjNWFkNzUyZDgyNjRhODE5ODkwOWY1N2NhOTQxY2Q4L3RhYmxlOjhkMTYzYTFmZTc0ZDQzYjFiMzNiNjJjOTE1NGU4ZmU0L3RhYmxlcmFuZ2U6OGQxNjNhMWZlNzRkNDNiMWIzM2I2MmM5MTU0ZThmZTRfMy0zLTEtMS00ODE2NA_41a6a07c-af0d-409d-bd55-cf715768d3ed" unitRef="usd"> 0 </us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
<us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="ie9c4962f367a4a68b8a8f28ed7d49d6d_D20220101-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84NS9mcmFnOjNjNWFkNzUyZDgyNjRhODE5ODkwOWY1N2NhOTQxY2Q4L3RhYmxlOjhkMTYzYTFmZTc0ZDQzYjFiMzNiNjJjOTE1NGU4ZmU0L3RhYmxlcmFuZ2U6OGQxNjNhMWZlNzRkNDNiMWIzM2I2MmM5MTU0ZThmZTRfMy01LTEtMS00ODE2NA_2f6dfdb2-2b59-45c2-adf2-27801cc31cc5" unitRef="usd"> 0 </us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
<us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="ie63cc25623604f1193acdc474450358c_D20210101-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84NS9mcmFnOjNjNWFkNzUyZDgyNjRhODE5ODkwOWY1N2NhOTQxY2Q4L3RhYmxlOjhkMTYzYTFmZTc0ZDQzYjFiMzNiNjJjOTE1NGU4ZmU0L3RhYmxlcmFuZ2U6OGQxNjNhMWZlNzRkNDNiMWIzM2I2MmM5MTU0ZThmZTRfMy03LTEtMS00ODE2NA_eb5d668e-7f79-4c0a-8b10-0bff243e11ff" unitRef="usd"> 0 </us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
<us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="i0e5138f6fdda4c458a34b95b545a8605_D20220401-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84NS9mcmFnOjNjNWFkNzUyZDgyNjRhODE5ODkwOWY1N2NhOTQxY2Q4L3RhYmxlOjhkMTYzYTFmZTc0ZDQzYjFiMzNiNjJjOTE1NGU4ZmU0L3RhYmxlcmFuZ2U6OGQxNjNhMWZlNzRkNDNiMWIzM2I2MmM5MTU0ZThmZTRfNC0xLTEtMS00ODE2NA_3125d2f8-219d-4d2f-8f89-361dcaa567d5" unitRef="usd"> 186804000 </us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
<us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="if590b0262e2c4555bb7bf92a24775d9a_D20210401-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84NS9mcmFnOjNjNWFkNzUyZDgyNjRhODE5ODkwOWY1N2NhOTQxY2Q4L3RhYmxlOjhkMTYzYTFmZTc0ZDQzYjFiMzNiNjJjOTE1NGU4ZmU0L3RhYmxlcmFuZ2U6OGQxNjNhMWZlNzRkNDNiMWIzM2I2MmM5MTU0ZThmZTRfNC0zLTEtMS00ODE2NA_bec2ba6f-9692-426b-8836-18597f56aa6d" unitRef="usd"> 397197000 </us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
<us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="i3f090dc87cae49b09a37d54a17fdab88_D20220101-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84NS9mcmFnOjNjNWFkNzUyZDgyNjRhODE5ODkwOWY1N2NhOTQxY2Q4L3RhYmxlOjhkMTYzYTFmZTc0ZDQzYjFiMzNiNjJjOTE1NGU4ZmU0L3RhYmxlcmFuZ2U6OGQxNjNhMWZlNzRkNDNiMWIzM2I2MmM5MTU0ZThmZTRfNC01LTEtMS00ODE2NA_68961a1f-cf02-4022-8d17-49e940347c8a" unitRef="usd"> 473402000 </us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
<us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="idab50ba28b814a40b2fec95f4c955688_D20210101-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84NS9mcmFnOjNjNWFkNzUyZDgyNjRhODE5ODkwOWY1N2NhOTQxY2Q4L3RhYmxlOjhkMTYzYTFmZTc0ZDQzYjFiMzNiNjJjOTE1NGU4ZmU0L3RhYmxlcmFuZ2U6OGQxNjNhMWZlNzRkNDNiMWIzM2I2MmM5MTU0ZThmZTRfNC03LTEtMS00ODE2NA_8079e6a8-8aef-466b-8af0-e481b3f305d4" unitRef="usd"> 904149000 </us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
<us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="i477488176c1a43798f507e64450a4728_D20220401-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84NS9mcmFnOjNjNWFkNzUyZDgyNjRhODE5ODkwOWY1N2NhOTQxY2Q4L3RhYmxlOjhkMTYzYTFmZTc0ZDQzYjFiMzNiNjJjOTE1NGU4ZmU0L3RhYmxlcmFuZ2U6OGQxNjNhMWZlNzRkNDNiMWIzM2I2MmM5MTU0ZThmZTRfNS0xLTEtMS00ODE2NA_ee9698a6-f047-4960-a546-156cb08e1669" unitRef="usd"> 0 </us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
<us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="i2d9c598c7d6440bd90adc66fc4563e7a_D20210401-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84NS9mcmFnOjNjNWFkNzUyZDgyNjRhODE5ODkwOWY1N2NhOTQxY2Q4L3RhYmxlOjhkMTYzYTFmZTc0ZDQzYjFiMzNiNjJjOTE1NGU4ZmU0L3RhYmxlcmFuZ2U6OGQxNjNhMWZlNzRkNDNiMWIzM2I2MmM5MTU0ZThmZTRfNS0zLTEtMS00ODE2NA_d2a968a3-4462-4944-b5d8-e789e161d4e4" unitRef="usd"> 0 </us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
<us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="idcf14c4cdb9e480cab7cf4394d1ebefd_D20220101-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84NS9mcmFnOjNjNWFkNzUyZDgyNjRhODE5ODkwOWY1N2NhOTQxY2Q4L3RhYmxlOjhkMTYzYTFmZTc0ZDQzYjFiMzNiNjJjOTE1NGU4ZmU0L3RhYmxlcmFuZ2U6OGQxNjNhMWZlNzRkNDNiMWIzM2I2MmM5MTU0ZThmZTRfNS01LTEtMS00ODE2NA_13d513dd-f1b0-4804-a805-1cd0e1d0e625" unitRef="usd"> 0 </us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
<us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="id668f805e3494978b808ca3a5edae187_D20210101-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84NS9mcmFnOjNjNWFkNzUyZDgyNjRhODE5ODkwOWY1N2NhOTQxY2Q4L3RhYmxlOjhkMTYzYTFmZTc0ZDQzYjFiMzNiNjJjOTE1NGU4ZmU0L3RhYmxlcmFuZ2U6OGQxNjNhMWZlNzRkNDNiMWIzM2I2MmM5MTU0ZThmZTRfNS03LTEtMS00ODE2NA_ea78f551-38ec-446e-b77e-889de197cd13" unitRef="usd"> 0 </us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
<us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="idf5be29147e94b809d0f3f67415ce0b1_D20220401-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84NS9mcmFnOjNjNWFkNzUyZDgyNjRhODE5ODkwOWY1N2NhOTQxY2Q4L3RhYmxlOjhkMTYzYTFmZTc0ZDQzYjFiMzNiNjJjOTE1NGU4ZmU0L3RhYmxlcmFuZ2U6OGQxNjNhMWZlNzRkNDNiMWIzM2I2MmM5MTU0ZThmZTRfNi0xLTEtMS00ODE2NA_eb39bedc-88a1-472e-9f0f-dac7d5fbfff9" unitRef="usd"> 186804000 </us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
<us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="i3f3fc0cd0f02481481f1bb2345313999_D20210401-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84NS9mcmFnOjNjNWFkNzUyZDgyNjRhODE5ODkwOWY1N2NhOTQxY2Q4L3RhYmxlOjhkMTYzYTFmZTc0ZDQzYjFiMzNiNjJjOTE1NGU4ZmU0L3RhYmxlcmFuZ2U6OGQxNjNhMWZlNzRkNDNiMWIzM2I2MmM5MTU0ZThmZTRfNi0zLTEtMS00ODE2NA_6527ac37-8d45-4acd-b7c7-a10e940f1c2f" unitRef="usd"> 397197000 </us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
<us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="i8b5aa09d29044d42bbfdc68d86a7e9a3_D20220101-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84NS9mcmFnOjNjNWFkNzUyZDgyNjRhODE5ODkwOWY1N2NhOTQxY2Q4L3RhYmxlOjhkMTYzYTFmZTc0ZDQzYjFiMzNiNjJjOTE1NGU4ZmU0L3RhYmxlcmFuZ2U6OGQxNjNhMWZlNzRkNDNiMWIzM2I2MmM5MTU0ZThmZTRfNi01LTEtMS00ODE2NA_1a3c3cb4-8a4d-404f-b2ff-19a0e96138ab" unitRef="usd"> 473402000 </us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
<us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="i80b516e519b848f8a55bf1affb1fc020_D20210101-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84NS9mcmFnOjNjNWFkNzUyZDgyNjRhODE5ODkwOWY1N2NhOTQxY2Q4L3RhYmxlOjhkMTYzYTFmZTc0ZDQzYjFiMzNiNjJjOTE1NGU4ZmU0L3RhYmxlcmFuZ2U6OGQxNjNhMWZlNzRkNDNiMWIzM2I2MmM5MTU0ZThmZTRfNi03LTEtMS00ODE2NA_109bb02b-f2d9-473b-90d8-359291c2af0b" unitRef="usd"> 904149000 </us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
<us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="iaf914158d38b4cdd9b64cc48fe6941e7_D20220401-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84NS9mcmFnOjNjNWFkNzUyZDgyNjRhODE5ODkwOWY1N2NhOTQxY2Q4L3RhYmxlOjhkMTYzYTFmZTc0ZDQzYjFiMzNiNjJjOTE1NGU4ZmU0L3RhYmxlcmFuZ2U6OGQxNjNhMWZlNzRkNDNiMWIzM2I2MmM5MTU0ZThmZTRfOC0xLTEtMS00ODE2NA_e8f9fc6f-37ab-4316-a1a4-3674b8fbe947" unitRef="usd"> 35892000 </us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
<us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="i5df0e8ab75c84f8b9d413b10a337a431_D20210401-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84NS9mcmFnOjNjNWFkNzUyZDgyNjRhODE5ODkwOWY1N2NhOTQxY2Q4L3RhYmxlOjhkMTYzYTFmZTc0ZDQzYjFiMzNiNjJjOTE1NGU4ZmU0L3RhYmxlcmFuZ2U6OGQxNjNhMWZlNzRkNDNiMWIzM2I2MmM5MTU0ZThmZTRfOC0zLTEtMS00ODE2NA_1f325deb-ea22-4475-b7b8-3e0488c86e9b" unitRef="usd"> 35663000 </us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
<us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="i30f11fb9d1c8437f8f8cec1e76f2db37_D20220101-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84NS9mcmFnOjNjNWFkNzUyZDgyNjRhODE5ODkwOWY1N2NhOTQxY2Q4L3RhYmxlOjhkMTYzYTFmZTc0ZDQzYjFiMzNiNjJjOTE1NGU4ZmU0L3RhYmxlcmFuZ2U6OGQxNjNhMWZlNzRkNDNiMWIzM2I2MmM5MTU0ZThmZTRfOC01LTEtMS00ODE2NA_3600e9d1-f05a-4c9e-a0dd-1c52c536ac60" unitRef="usd"> 72550000 </us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
<us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="i143e53c0033b4a5aa1cc3194a84e2ba5_D20210101-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84NS9mcmFnOjNjNWFkNzUyZDgyNjRhODE5ODkwOWY1N2NhOTQxY2Q4L3RhYmxlOjhkMTYzYTFmZTc0ZDQzYjFiMzNiNjJjOTE1NGU4ZmU0L3RhYmxlcmFuZ2U6OGQxNjNhMWZlNzRkNDNiMWIzM2I2MmM5MTU0ZThmZTRfOC03LTEtMS00ODE2NA_319cc388-04f6-4d63-819b-e3156951e1e8" unitRef="usd"> 69608000 </us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
<us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="i47c6f21fd59f4c408b59de9ac7a7f482_D20220401-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84NS9mcmFnOjNjNWFkNzUyZDgyNjRhODE5ODkwOWY1N2NhOTQxY2Q4L3RhYmxlOjhkMTYzYTFmZTc0ZDQzYjFiMzNiNjJjOTE1NGU4ZmU0L3RhYmxlcmFuZ2U6OGQxNjNhMWZlNzRkNDNiMWIzM2I2MmM5MTU0ZThmZTRfOS0xLTEtMS00ODE2NA_4b71b1c4-4046-4166-ad8a-bfdc8b9f7003" unitRef="usd"> 0 </us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
<us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="i38e2d74e7a5746139ec93cdf2caaa373_D20210401-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84NS9mcmFnOjNjNWFkNzUyZDgyNjRhODE5ODkwOWY1N2NhOTQxY2Q4L3RhYmxlOjhkMTYzYTFmZTc0ZDQzYjFiMzNiNjJjOTE1NGU4ZmU0L3RhYmxlcmFuZ2U6OGQxNjNhMWZlNzRkNDNiMWIzM2I2MmM5MTU0ZThmZTRfOS0zLTEtMS00ODE2NA_1a4c43e9-ef01-4f15-b594-3f5d519fbc17" unitRef="usd"> 0 </us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
<us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="ie12b9c2d9c4e403fa1ad251ba931d7c2_D20220101-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84NS9mcmFnOjNjNWFkNzUyZDgyNjRhODE5ODkwOWY1N2NhOTQxY2Q4L3RhYmxlOjhkMTYzYTFmZTc0ZDQzYjFiMzNiNjJjOTE1NGU4ZmU0L3RhYmxlcmFuZ2U6OGQxNjNhMWZlNzRkNDNiMWIzM2I2MmM5MTU0ZThmZTRfOS01LTEtMS00ODE2NA_5f69a2cc-a965-4841-beec-e0265f1c0c91" unitRef="usd"> 0 </us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
<us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="i1d13f5bd721944f586124a6e82d9b758_D20210101-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84NS9mcmFnOjNjNWFkNzUyZDgyNjRhODE5ODkwOWY1N2NhOTQxY2Q4L3RhYmxlOjhkMTYzYTFmZTc0ZDQzYjFiMzNiNjJjOTE1NGU4ZmU0L3RhYmxlcmFuZ2U6OGQxNjNhMWZlNzRkNDNiMWIzM2I2MmM5MTU0ZThmZTRfOS03LTEtMS00ODE2NA_373db777-e716-4622-9de1-090920372aed" unitRef="usd"> 0 </us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
<us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="i63babcfc181b470d90de1cc42164afdc_D20220401-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84NS9mcmFnOjNjNWFkNzUyZDgyNjRhODE5ODkwOWY1N2NhOTQxY2Q4L3RhYmxlOjhkMTYzYTFmZTc0ZDQzYjFiMzNiNjJjOTE1NGU4ZmU0L3RhYmxlcmFuZ2U6OGQxNjNhMWZlNzRkNDNiMWIzM2I2MmM5MTU0ZThmZTRfMTAtMS0xLTEtNDgxNjQ_b06f2240-ec78-4d64-821c-04570314725d" unitRef="usd"> 0 </us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
<us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="i358ba31eb83948c3b5ba3c16bc6031b1_D20210401-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84NS9mcmFnOjNjNWFkNzUyZDgyNjRhODE5ODkwOWY1N2NhOTQxY2Q4L3RhYmxlOjhkMTYzYTFmZTc0ZDQzYjFiMzNiNjJjOTE1NGU4ZmU0L3RhYmxlcmFuZ2U6OGQxNjNhMWZlNzRkNDNiMWIzM2I2MmM5MTU0ZThmZTRfMTAtMy0xLTEtNDgxNjQ_0847a11e-12d8-4050-9c30-8433bb03020a" unitRef="usd"> 0 </us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
<us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="ie80ebdf1ac004a0fbc6f8158b6409b28_D20220101-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84NS9mcmFnOjNjNWFkNzUyZDgyNjRhODE5ODkwOWY1N2NhOTQxY2Q4L3RhYmxlOjhkMTYzYTFmZTc0ZDQzYjFiMzNiNjJjOTE1NGU4ZmU0L3RhYmxlcmFuZ2U6OGQxNjNhMWZlNzRkNDNiMWIzM2I2MmM5MTU0ZThmZTRfMTAtNS0xLTEtNDgxNjQ_f7a61930-02ed-4a7d-aa00-c46ce7276bb8" unitRef="usd"> 0 </us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
<us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="i687618916e7f41789dc16990c9d03470_D20210101-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84NS9mcmFnOjNjNWFkNzUyZDgyNjRhODE5ODkwOWY1N2NhOTQxY2Q4L3RhYmxlOjhkMTYzYTFmZTc0ZDQzYjFiMzNiNjJjOTE1NGU4ZmU0L3RhYmxlcmFuZ2U6OGQxNjNhMWZlNzRkNDNiMWIzM2I2MmM5MTU0ZThmZTRfMTAtNy0xLTEtNDgxNjQ_ed41a6c3-63e8-420f-b6bf-700fd9b0c801" unitRef="usd"> 0 </us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
<us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="if2238695b80a4a5f903fa54aa9e93ad7_D20220401-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84NS9mcmFnOjNjNWFkNzUyZDgyNjRhODE5ODkwOWY1N2NhOTQxY2Q4L3RhYmxlOjhkMTYzYTFmZTc0ZDQzYjFiMzNiNjJjOTE1NGU4ZmU0L3RhYmxlcmFuZ2U6OGQxNjNhMWZlNzRkNDNiMWIzM2I2MmM5MTU0ZThmZTRfMTEtMS0xLTEtNDgxNjQ_0d9cb5c1-ec4f-4813-a048-f541b1662429" unitRef="usd"> 35892000 </us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
<us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="ie9994295e2b2433795782a98077e22b5_D20210401-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84NS9mcmFnOjNjNWFkNzUyZDgyNjRhODE5ODkwOWY1N2NhOTQxY2Q4L3RhYmxlOjhkMTYzYTFmZTc0ZDQzYjFiMzNiNjJjOTE1NGU4ZmU0L3RhYmxlcmFuZ2U6OGQxNjNhMWZlNzRkNDNiMWIzM2I2MmM5MTU0ZThmZTRfMTEtMy0xLTEtNDgxNjQ_4f795d15-1fb0-418b-b556-77e04bfed7c1" unitRef="usd"> 35663000 </us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
<us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="ib67a5f67884e4812a29dfbb65739778f_D20220101-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84NS9mcmFnOjNjNWFkNzUyZDgyNjRhODE5ODkwOWY1N2NhOTQxY2Q4L3RhYmxlOjhkMTYzYTFmZTc0ZDQzYjFiMzNiNjJjOTE1NGU4ZmU0L3RhYmxlcmFuZ2U6OGQxNjNhMWZlNzRkNDNiMWIzM2I2MmM5MTU0ZThmZTRfMTEtNS0xLTEtNDgxNjQ_19a8f14e-1ba7-447f-8dff-bd382c030865" unitRef="usd"> 72550000 </us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
<us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="ia894264b8eea4bb0bd7d5a5dbc6ab9cd_D20210101-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84NS9mcmFnOjNjNWFkNzUyZDgyNjRhODE5ODkwOWY1N2NhOTQxY2Q4L3RhYmxlOjhkMTYzYTFmZTc0ZDQzYjFiMzNiNjJjOTE1NGU4ZmU0L3RhYmxlcmFuZ2U6OGQxNjNhMWZlNzRkNDNiMWIzM2I2MmM5MTU0ZThmZTRfMTEtNy0xLTEtNDgxNjQ_cdba90ae-c46a-4fbf-9532-3699dd0218a6" unitRef="usd"> 69608000 </us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
<us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="ic0587d2cd33b40af8987451f56f4aa29_D20220401-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84NS9mcmFnOjNjNWFkNzUyZDgyNjRhODE5ODkwOWY1N2NhOTQxY2Q4L3RhYmxlOjhkMTYzYTFmZTc0ZDQzYjFiMzNiNjJjOTE1NGU4ZmU0L3RhYmxlcmFuZ2U6OGQxNjNhMWZlNzRkNDNiMWIzM2I2MmM5MTU0ZThmZTRfMTMtMS0xLTEtNDgxNjQ_7849e059-232d-449d-bed6-ef09f85df86f" unitRef="usd"> 87197000 </us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
<us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="icfe2fb47c0064a28a23505dd76762dcf_D20210401-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84NS9mcmFnOjNjNWFkNzUyZDgyNjRhODE5ODkwOWY1N2NhOTQxY2Q4L3RhYmxlOjhkMTYzYTFmZTc0ZDQzYjFiMzNiNjJjOTE1NGU4ZmU0L3RhYmxlcmFuZ2U6OGQxNjNhMWZlNzRkNDNiMWIzM2I2MmM5MTU0ZThmZTRfMTMtMy0xLTEtNDgxNjQ_f635f7bf-2709-495d-86aa-b7ed069907a1" unitRef="usd"> 9548000 </us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
<us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="ifb617d99ae244ec3b284b078d19e6d36_D20220101-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84NS9mcmFnOjNjNWFkNzUyZDgyNjRhODE5ODkwOWY1N2NhOTQxY2Q4L3RhYmxlOjhkMTYzYTFmZTc0ZDQzYjFiMzNiNjJjOTE1NGU4ZmU0L3RhYmxlcmFuZ2U6OGQxNjNhMWZlNzRkNDNiMWIzM2I2MmM5MTU0ZThmZTRfMTMtNS0xLTEtNDgxNjQ_a1961b42-0f84-4ebe-af82-725113a663e9" unitRef="usd"> 93159000 </us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
<us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="ic5a6747ed795423d89d2f37e93c1ca03_D20210101-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84NS9mcmFnOjNjNWFkNzUyZDgyNjRhODE5ODkwOWY1N2NhOTQxY2Q4L3RhYmxlOjhkMTYzYTFmZTc0ZDQzYjFiMzNiNjJjOTE1NGU4ZmU0L3RhYmxlcmFuZ2U6OGQxNjNhMWZlNzRkNDNiMWIzM2I2MmM5MTU0ZThmZTRfMTMtNy0xLTEtNDgxNjQ_994be3f5-5cef-412e-ac00-ba5a16ee064d" unitRef="usd"> 13816000 </us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
<us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="i64bf1c05f86346148dfa9e35e5ff6f4f_D20220401-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84NS9mcmFnOjNjNWFkNzUyZDgyNjRhODE5ODkwOWY1N2NhOTQxY2Q4L3RhYmxlOjhkMTYzYTFmZTc0ZDQzYjFiMzNiNjJjOTE1NGU4ZmU0L3RhYmxlcmFuZ2U6OGQxNjNhMWZlNzRkNDNiMWIzM2I2MmM5MTU0ZThmZTRfMTQtMS0xLTEtNDgxNjQ_b01446a9-b5eb-450c-83bc-4e7e9f1dc767" unitRef="usd"> 0 </us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
<us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="i58965460c46b4eb0b0466c3a3733f92f_D20210401-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84NS9mcmFnOjNjNWFkNzUyZDgyNjRhODE5ODkwOWY1N2NhOTQxY2Q4L3RhYmxlOjhkMTYzYTFmZTc0ZDQzYjFiMzNiNjJjOTE1NGU4ZmU0L3RhYmxlcmFuZ2U6OGQxNjNhMWZlNzRkNDNiMWIzM2I2MmM5MTU0ZThmZTRfMTQtMy0xLTEtNDgxNjQ_e3370489-8323-4529-beb8-5b7fa5b77a9f" unitRef="usd"> 0 </us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
<us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="icc4efd4200064acd9f3e6a3fbda11da1_D20220101-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84NS9mcmFnOjNjNWFkNzUyZDgyNjRhODE5ODkwOWY1N2NhOTQxY2Q4L3RhYmxlOjhkMTYzYTFmZTc0ZDQzYjFiMzNiNjJjOTE1NGU4ZmU0L3RhYmxlcmFuZ2U6OGQxNjNhMWZlNzRkNDNiMWIzM2I2MmM5MTU0ZThmZTRfMTQtNS0xLTEtNDgxNjQ_f5ac5256-6100-4a43-b555-0e6a2388fe1d" unitRef="usd"> 0 </us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
<us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="i42fd684665a6467db64af378fa447780_D20210101-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84NS9mcmFnOjNjNWFkNzUyZDgyNjRhODE5ODkwOWY1N2NhOTQxY2Q4L3RhYmxlOjhkMTYzYTFmZTc0ZDQzYjFiMzNiNjJjOTE1NGU4ZmU0L3RhYmxlcmFuZ2U6OGQxNjNhMWZlNzRkNDNiMWIzM2I2MmM5MTU0ZThmZTRfMTQtNy0xLTEtNDgxNjQ_f3d37ba2-6b78-4174-b048-82af941e1fa9" unitRef="usd"> 0 </us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
<us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="ib7415debee114057bb13f6ad72b27bab_D20220401-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84NS9mcmFnOjNjNWFkNzUyZDgyNjRhODE5ODkwOWY1N2NhOTQxY2Q4L3RhYmxlOjhkMTYzYTFmZTc0ZDQzYjFiMzNiNjJjOTE1NGU4ZmU0L3RhYmxlcmFuZ2U6OGQxNjNhMWZlNzRkNDNiMWIzM2I2MmM5MTU0ZThmZTRfMTUtMS0xLTEtNDgxNjQ_774da7d6-4547-4389-ab81-bb22382a8eca" unitRef="usd"> 0 </us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
<us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="i6731b7acc16d4873b3c7bcf4e8ea381e_D20210401-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84NS9mcmFnOjNjNWFkNzUyZDgyNjRhODE5ODkwOWY1N2NhOTQxY2Q4L3RhYmxlOjhkMTYzYTFmZTc0ZDQzYjFiMzNiNjJjOTE1NGU4ZmU0L3RhYmxlcmFuZ2U6OGQxNjNhMWZlNzRkNDNiMWIzM2I2MmM5MTU0ZThmZTRfMTUtMy0xLTEtNDgxNjQ_7090e969-4852-497b-b257-7e6204c49a82" unitRef="usd"> 0 </us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
<us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="i4103386cd19941e088e1dd35c635673e_D20220101-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84NS9mcmFnOjNjNWFkNzUyZDgyNjRhODE5ODkwOWY1N2NhOTQxY2Q4L3RhYmxlOjhkMTYzYTFmZTc0ZDQzYjFiMzNiNjJjOTE1NGU4ZmU0L3RhYmxlcmFuZ2U6OGQxNjNhMWZlNzRkNDNiMWIzM2I2MmM5MTU0ZThmZTRfMTUtNS0xLTEtNDgxNjQ_cd50e6cf-def6-4299-9616-61993860dda3" unitRef="usd"> 0 </us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
<us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="ic201d669422e446186ae5521d4bf67b4_D20210101-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84NS9mcmFnOjNjNWFkNzUyZDgyNjRhODE5ODkwOWY1N2NhOTQxY2Q4L3RhYmxlOjhkMTYzYTFmZTc0ZDQzYjFiMzNiNjJjOTE1NGU4ZmU0L3RhYmxlcmFuZ2U6OGQxNjNhMWZlNzRkNDNiMWIzM2I2MmM5MTU0ZThmZTRfMTUtNy0xLTEtNDgxNjQ_9a4fdfc6-1def-4953-8c21-214caab87679" unitRef="usd"> 0 </us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
<us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="i2dbee62a623a4004a055434064bcdd46_D20220401-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84NS9mcmFnOjNjNWFkNzUyZDgyNjRhODE5ODkwOWY1N2NhOTQxY2Q4L3RhYmxlOjhkMTYzYTFmZTc0ZDQzYjFiMzNiNjJjOTE1NGU4ZmU0L3RhYmxlcmFuZ2U6OGQxNjNhMWZlNzRkNDNiMWIzM2I2MmM5MTU0ZThmZTRfMTYtMS0xLTEtNDgxNjQ_a678d4a7-9e07-4ef5-8058-fe4c21f39c4a" unitRef="usd"> 87197000 </us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
<us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="ia406b4879e9a4c2cadf973464d173c63_D20210401-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84NS9mcmFnOjNjNWFkNzUyZDgyNjRhODE5ODkwOWY1N2NhOTQxY2Q4L3RhYmxlOjhkMTYzYTFmZTc0ZDQzYjFiMzNiNjJjOTE1NGU4ZmU0L3RhYmxlcmFuZ2U6OGQxNjNhMWZlNzRkNDNiMWIzM2I2MmM5MTU0ZThmZTRfMTYtMy0xLTEtNDgxNjQ_eb8a227e-2b6b-4ad5-82e4-333599ed1091" unitRef="usd"> 9548000 </us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
<us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="i504cf7154fff4123a500b2c26e04b6d9_D20220101-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84NS9mcmFnOjNjNWFkNzUyZDgyNjRhODE5ODkwOWY1N2NhOTQxY2Q4L3RhYmxlOjhkMTYzYTFmZTc0ZDQzYjFiMzNiNjJjOTE1NGU4ZmU0L3RhYmxlcmFuZ2U6OGQxNjNhMWZlNzRkNDNiMWIzM2I2MmM5MTU0ZThmZTRfMTYtNS0xLTEtNDgxNjQ_b347c7cf-da23-417c-a9fd-730c269e4019" unitRef="usd"> 93159000 </us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
<us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="i32f2af0f2c1f4fee9b8639b2a0a7823b_D20210101-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84NS9mcmFnOjNjNWFkNzUyZDgyNjRhODE5ODkwOWY1N2NhOTQxY2Q4L3RhYmxlOjhkMTYzYTFmZTc0ZDQzYjFiMzNiNjJjOTE1NGU4ZmU0L3RhYmxlcmFuZ2U6OGQxNjNhMWZlNzRkNDNiMWIzM2I2MmM5MTU0ZThmZTRfMTYtNy0xLTEtNDgxNjQ_09b9c7e6-2882-48e4-ab33-fba07b5a1712" unitRef="usd"> 13816000 </us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
<us-gaap:OperatingIncomeLoss contextRef="i957434db983c4190b847e4637fef04f9_D20220401-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84NS9mcmFnOjNjNWFkNzUyZDgyNjRhODE5ODkwOWY1N2NhOTQxY2Q4L3RhYmxlOjhkMTYzYTFmZTc0ZDQzYjFiMzNiNjJjOTE1NGU4ZmU0L3RhYmxlcmFuZ2U6OGQxNjNhMWZlNzRkNDNiMWIzM2I2MmM5MTU0ZThmZTRfMTgtMS0xLTEtNDgxNjQ_bc986643-2252-4ef6-9f5b-136b15cdccd4" unitRef="usd"> 55435000 </us-gaap:OperatingIncomeLoss>
<us-gaap:OperatingIncomeLoss contextRef="i96ca08fd8d9945cb99bcf89ed9b4cd72_D20210401-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84NS9mcmFnOjNjNWFkNzUyZDgyNjRhODE5ODkwOWY1N2NhOTQxY2Q4L3RhYmxlOjhkMTYzYTFmZTc0ZDQzYjFiMzNiNjJjOTE1NGU4ZmU0L3RhYmxlcmFuZ2U6OGQxNjNhMWZlNzRkNDNiMWIzM2I2MmM5MTU0ZThmZTRfMTgtMy0xLTEtNDgxNjQ_71b53d59-1ffb-407d-9a29-322a729b0549" unitRef="usd"> -13710000 </us-gaap:OperatingIncomeLoss>
<us-gaap:OperatingIncomeLoss contextRef="i041fd017f3924fc3800fd697bfd128d1_D20220101-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84NS9mcmFnOjNjNWFkNzUyZDgyNjRhODE5ODkwOWY1N2NhOTQxY2Q4L3RhYmxlOjhkMTYzYTFmZTc0ZDQzYjFiMzNiNjJjOTE1NGU4ZmU0L3RhYmxlcmFuZ2U6OGQxNjNhMWZlNzRkNDNiMWIzM2I2MmM5MTU0ZThmZTRfMTgtNS0xLTEtNDgxNjQ_dc408a23-f0a2-4bb2-a085-330ac804ed37" unitRef="usd"> 37327000 </us-gaap:OperatingIncomeLoss>
<us-gaap:OperatingIncomeLoss contextRef="i4b4c0e12ce634eecbb1e11e846d447b5_D20210101-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84NS9mcmFnOjNjNWFkNzUyZDgyNjRhODE5ODkwOWY1N2NhOTQxY2Q4L3RhYmxlOjhkMTYzYTFmZTc0ZDQzYjFiMzNiNjJjOTE1NGU4ZmU0L3RhYmxlcmFuZ2U6OGQxNjNhMWZlNzRkNDNiMWIzM2I2MmM5MTU0ZThmZTRfMTgtNy0xLTEtNDgxNjQ_abb11c66-e729-4758-9ece-6e0644053ae5" unitRef="usd"> -32868000 </us-gaap:OperatingIncomeLoss>
<us-gaap:OperatingIncomeLoss contextRef="i7fde44ebde9341789ddff40144143c2f_D20220401-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84NS9mcmFnOjNjNWFkNzUyZDgyNjRhODE5ODkwOWY1N2NhOTQxY2Q4L3RhYmxlOjhkMTYzYTFmZTc0ZDQzYjFiMzNiNjJjOTE1NGU4ZmU0L3RhYmxlcmFuZ2U6OGQxNjNhMWZlNzRkNDNiMWIzM2I2MmM5MTU0ZThmZTRfMTktMS0xLTEtNDgxNjQ_1e9a3516-d53d-4bde-85dd-d3d164b19d18" unitRef="usd"> -57543000 </us-gaap:OperatingIncomeLoss>
<us-gaap:OperatingIncomeLoss contextRef="icce0e81024e2406b803d4529ed0c015c_D20210401-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84NS9mcmFnOjNjNWFkNzUyZDgyNjRhODE5ODkwOWY1N2NhOTQxY2Q4L3RhYmxlOjhkMTYzYTFmZTc0ZDQzYjFiMzNiNjJjOTE1NGU4ZmU0L3RhYmxlcmFuZ2U6OGQxNjNhMWZlNzRkNDNiMWIzM2I2MmM5MTU0ZThmZTRfMTktMy0xLTEtNDgxNjQ_ab4ad5c1-b781-4ffc-9535-7207d673bcf2" unitRef="usd"> 30000000 </us-gaap:OperatingIncomeLoss>
<us-gaap:OperatingIncomeLoss contextRef="ia5c9d668ef7340748d80ff87edaf4173_D20220101-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84NS9mcmFnOjNjNWFkNzUyZDgyNjRhODE5ODkwOWY1N2NhOTQxY2Q4L3RhYmxlOjhkMTYzYTFmZTc0ZDQzYjFiMzNiNjJjOTE1NGU4ZmU0L3RhYmxlcmFuZ2U6OGQxNjNhMWZlNzRkNDNiMWIzM2I2MmM5MTU0ZThmZTRfMTktNS0xLTEtNDgxNjQ_23faca1b-e433-4336-b408-3e14a7c69384" unitRef="usd"> -101092000 </us-gaap:OperatingIncomeLoss>
<us-gaap:OperatingIncomeLoss contextRef="i21b7f98f9a12463da100915dc502484b_D20210101-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84NS9mcmFnOjNjNWFkNzUyZDgyNjRhODE5ODkwOWY1N2NhOTQxY2Q4L3RhYmxlOjhkMTYzYTFmZTc0ZDQzYjFiMzNiNjJjOTE1NGU4ZmU0L3RhYmxlcmFuZ2U6OGQxNjNhMWZlNzRkNDNiMWIzM2I2MmM5MTU0ZThmZTRfMTktNy0xLTEtNDgxNjQ_8aa80e43-ce90-485d-84ef-fdcbb545754b" unitRef="usd"> 97014000 </us-gaap:OperatingIncomeLoss>
<us-gaap:OperatingIncomeLoss contextRef="i8c23b2342c5f4f99bbfd7e108dea19ec_D20220401-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84NS9mcmFnOjNjNWFkNzUyZDgyNjRhODE5ODkwOWY1N2NhOTQxY2Q4L3RhYmxlOjhkMTYzYTFmZTc0ZDQzYjFiMzNiNjJjOTE1NGU4ZmU0L3RhYmxlcmFuZ2U6OGQxNjNhMWZlNzRkNDNiMWIzM2I2MmM5MTU0ZThmZTRfMjAtMS0xLTEtNDgxNjQ_cc33f9cf-b883-48f6-b723-653aaa7318a7" unitRef="usd"> -8631000 </us-gaap:OperatingIncomeLoss>
<us-gaap:OperatingIncomeLoss contextRef="ib557e685194f428ea1c938b7ea46759d_D20210401-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84NS9mcmFnOjNjNWFkNzUyZDgyNjRhODE5ODkwOWY1N2NhOTQxY2Q4L3RhYmxlOjhkMTYzYTFmZTc0ZDQzYjFiMzNiNjJjOTE1NGU4ZmU0L3RhYmxlcmFuZ2U6OGQxNjNhMWZlNzRkNDNiMWIzM2I2MmM5MTU0ZThmZTRfMjAtMy0xLTEtNDgxNjQ_3a6a1575-2a65-4a79-b15b-b1c148944f60" unitRef="usd"> -10719000 </us-gaap:OperatingIncomeLoss>
<us-gaap:OperatingIncomeLoss contextRef="i0828e7ef8a584b5b8ff47b0f0506ad32_D20220101-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84NS9mcmFnOjNjNWFkNzUyZDgyNjRhODE5ODkwOWY1N2NhOTQxY2Q4L3RhYmxlOjhkMTYzYTFmZTc0ZDQzYjFiMzNiNjJjOTE1NGU4ZmU0L3RhYmxlcmFuZ2U6OGQxNjNhMWZlNzRkNDNiMWIzM2I2MmM5MTU0ZThmZTRfMjAtNS0xLTEtNDgxNjQ_f9f085ac-64e6-4408-9408-3b871b481bae" unitRef="usd"> -19399000 </us-gaap:OperatingIncomeLoss>
<us-gaap:OperatingIncomeLoss contextRef="i49a8829d28bd44178eb1108e0ef77637_D20210101-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84NS9mcmFnOjNjNWFkNzUyZDgyNjRhODE5ODkwOWY1N2NhOTQxY2Q4L3RhYmxlOjhkMTYzYTFmZTc0ZDQzYjFiMzNiNjJjOTE1NGU4ZmU0L3RhYmxlcmFuZ2U6OGQxNjNhMWZlNzRkNDNiMWIzM2I2MmM5MTU0ZThmZTRfMjAtNy0xLTEtNDgxNjQ_c88f61c2-baef-4274-a54b-0cceae9e3f73" unitRef="usd"> -20138000 </us-gaap:OperatingIncomeLoss>
<us-gaap:OperatingIncomeLoss contextRef="i50aa2eea9a6446b6ad796d994509b1ad_D20220401-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84NS9mcmFnOjNjNWFkNzUyZDgyNjRhODE5ODkwOWY1N2NhOTQxY2Q4L3RhYmxlOjhkMTYzYTFmZTc0ZDQzYjFiMzNiNjJjOTE1NGU4ZmU0L3RhYmxlcmFuZ2U6OGQxNjNhMWZlNzRkNDNiMWIzM2I2MmM5MTU0ZThmZTRfMjItMS0xLTEtNDgxNjQ_48a817e8-b4d3-4ff7-a679-3dfebb839c1d" unitRef="usd"> -10739000 </us-gaap:OperatingIncomeLoss>
<us-gaap:OperatingIncomeLoss contextRef="if2a6207b6732465a921fe019a2a0f048_D20210401-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84NS9mcmFnOjNjNWFkNzUyZDgyNjRhODE5ODkwOWY1N2NhOTQxY2Q4L3RhYmxlOjhkMTYzYTFmZTc0ZDQzYjFiMzNiNjJjOTE1NGU4ZmU0L3RhYmxlcmFuZ2U6OGQxNjNhMWZlNzRkNDNiMWIzM2I2MmM5MTU0ZThmZTRfMjItMy0xLTEtNDgxNjQ_a48800f1-03d6-4f1e-adb6-ec5f213b00f3" unitRef="usd"> 5571000 </us-gaap:OperatingIncomeLoss>
<us-gaap:OperatingIncomeLoss contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84NS9mcmFnOjNjNWFkNzUyZDgyNjRhODE5ODkwOWY1N2NhOTQxY2Q4L3RhYmxlOjhkMTYzYTFmZTc0ZDQzYjFiMzNiNjJjOTE1NGU4ZmU0L3RhYmxlcmFuZ2U6OGQxNjNhMWZlNzRkNDNiMWIzM2I2MmM5MTU0ZThmZTRfMjItNS0xLTEtNDgxNjQ_b6f2975b-54b7-4ef5-be03-5e059b82ff60" unitRef="usd"> -83164000 </us-gaap:OperatingIncomeLoss>
<us-gaap:OperatingIncomeLoss contextRef="i420e18e30084498a98510d48880063cd_D20210101-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84NS9mcmFnOjNjNWFkNzUyZDgyNjRhODE5ODkwOWY1N2NhOTQxY2Q4L3RhYmxlOjhkMTYzYTFmZTc0ZDQzYjFiMzNiNjJjOTE1NGU4ZmU0L3RhYmxlcmFuZ2U6OGQxNjNhMWZlNzRkNDNiMWIzM2I2MmM5MTU0ZThmZTRfMjItNy0xLTEtNDgxNjQ_0b035f77-fac2-4c4f-9f5e-f050d3fde3e9" unitRef="usd"> 44008000 </us-gaap:OperatingIncomeLoss>
<us-gaap:DepreciationDepletionAndAmortization contextRef="i957434db983c4190b847e4637fef04f9_D20220401-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84NS9mcmFnOjNjNWFkNzUyZDgyNjRhODE5ODkwOWY1N2NhOTQxY2Q4L3RhYmxlOjhkMTYzYTFmZTc0ZDQzYjFiMzNiNjJjOTE1NGU4ZmU0L3RhYmxlcmFuZ2U6OGQxNjNhMWZlNzRkNDNiMWIzM2I2MmM5MTU0ZThmZTRfMjQtMS0xLTEtNDgxNjQ_833a70e3-f0d8-4175-9c32-c7b3cba30ce4" unitRef="usd"> 17840000 </us-gaap:DepreciationDepletionAndAmortization>
<us-gaap:DepreciationDepletionAndAmortization contextRef="i96ca08fd8d9945cb99bcf89ed9b4cd72_D20210401-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84NS9mcmFnOjNjNWFkNzUyZDgyNjRhODE5ODkwOWY1N2NhOTQxY2Q4L3RhYmxlOjhkMTYzYTFmZTc0ZDQzYjFiMzNiNjJjOTE1NGU4ZmU0L3RhYmxlcmFuZ2U6OGQxNjNhMWZlNzRkNDNiMWIzM2I2MmM5MTU0ZThmZTRfMjQtMy0xLTEtNDgxNjQ_604952b1-f0db-4999-a3b7-7016264fd82b" unitRef="usd"> 7007000 </us-gaap:DepreciationDepletionAndAmortization>
<us-gaap:DepreciationDepletionAndAmortization contextRef="i041fd017f3924fc3800fd697bfd128d1_D20220101-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84NS9mcmFnOjNjNWFkNzUyZDgyNjRhODE5ODkwOWY1N2NhOTQxY2Q4L3RhYmxlOjhkMTYzYTFmZTc0ZDQzYjFiMzNiNjJjOTE1NGU4ZmU0L3RhYmxlcmFuZ2U6OGQxNjNhMWZlNzRkNDNiMWIzM2I2MmM5MTU0ZThmZTRfMjQtNS0xLTEtNDgxNjQ_f8c27f9f-e30d-44fb-a791-7f59bdb7711d" unitRef="usd"> 33242000 </us-gaap:DepreciationDepletionAndAmortization>
<us-gaap:DepreciationDepletionAndAmortization contextRef="i4b4c0e12ce634eecbb1e11e846d447b5_D20210101-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84NS9mcmFnOjNjNWFkNzUyZDgyNjRhODE5ODkwOWY1N2NhOTQxY2Q4L3RhYmxlOjhkMTYzYTFmZTc0ZDQzYjFiMzNiNjJjOTE1NGU4ZmU0L3RhYmxlcmFuZ2U6OGQxNjNhMWZlNzRkNDNiMWIzM2I2MmM5MTU0ZThmZTRfMjQtNy0xLTEtNDgxNjQ_2cd42765-34ee-45ee-9b8e-c57d8b22f1d7" unitRef="usd"> 14420000 </us-gaap:DepreciationDepletionAndAmortization>
<us-gaap:DepreciationDepletionAndAmortization contextRef="i7fde44ebde9341789ddff40144143c2f_D20220401-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84NS9mcmFnOjNjNWFkNzUyZDgyNjRhODE5ODkwOWY1N2NhOTQxY2Q4L3RhYmxlOjhkMTYzYTFmZTc0ZDQzYjFiMzNiNjJjOTE1NGU4ZmU0L3RhYmxlcmFuZ2U6OGQxNjNhMWZlNzRkNDNiMWIzM2I2MmM5MTU0ZThmZTRfMjUtMS0xLTEtNDgxNjQ_8166d2e0-54f0-410d-9373-a2aab94edcf1" unitRef="usd"> 10155000 </us-gaap:DepreciationDepletionAndAmortization>
<us-gaap:DepreciationDepletionAndAmortization contextRef="icce0e81024e2406b803d4529ed0c015c_D20210401-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84NS9mcmFnOjNjNWFkNzUyZDgyNjRhODE5ODkwOWY1N2NhOTQxY2Q4L3RhYmxlOjhkMTYzYTFmZTc0ZDQzYjFiMzNiNjJjOTE1NGU4ZmU0L3RhYmxlcmFuZ2U6OGQxNjNhMWZlNzRkNDNiMWIzM2I2MmM5MTU0ZThmZTRfMjUtMy0xLTEtNDgxNjQ_36317f94-6edd-4f7b-a538-5c772671fa88" unitRef="usd"> 13566000 </us-gaap:DepreciationDepletionAndAmortization>
<us-gaap:DepreciationDepletionAndAmortization contextRef="ia5c9d668ef7340748d80ff87edaf4173_D20220101-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84NS9mcmFnOjNjNWFkNzUyZDgyNjRhODE5ODkwOWY1N2NhOTQxY2Q4L3RhYmxlOjhkMTYzYTFmZTc0ZDQzYjFiMzNiNjJjOTE1NGU4ZmU0L3RhYmxlcmFuZ2U6OGQxNjNhMWZlNzRkNDNiMWIzM2I2MmM5MTU0ZThmZTRfMjUtNS0xLTEtNDgxNjQ_4d4cb458-b4d3-4b92-8246-37a898f40b5b" unitRef="usd"> 22567000 </us-gaap:DepreciationDepletionAndAmortization>
<us-gaap:DepreciationDepletionAndAmortization contextRef="i21b7f98f9a12463da100915dc502484b_D20210101-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84NS9mcmFnOjNjNWFkNzUyZDgyNjRhODE5ODkwOWY1N2NhOTQxY2Q4L3RhYmxlOjhkMTYzYTFmZTc0ZDQzYjFiMzNiNjJjOTE1NGU4ZmU0L3RhYmxlcmFuZ2U6OGQxNjNhMWZlNzRkNDNiMWIzM2I2MmM5MTU0ZThmZTRfMjUtNy0xLTEtNDgxNjQ_047bd832-3a18-4063-8a3e-c7830fdbf5ef" unitRef="usd"> 26141000 </us-gaap:DepreciationDepletionAndAmortization>
<us-gaap:DepreciationDepletionAndAmortization contextRef="i8c23b2342c5f4f99bbfd7e108dea19ec_D20220401-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84NS9mcmFnOjNjNWFkNzUyZDgyNjRhODE5ODkwOWY1N2NhOTQxY2Q4L3RhYmxlOjhkMTYzYTFmZTc0ZDQzYjFiMzNiNjJjOTE1NGU4ZmU0L3RhYmxlcmFuZ2U6OGQxNjNhMWZlNzRkNDNiMWIzM2I2MmM5MTU0ZThmZTRfMjYtMS0xLTEtNDgxNjQ_be80d94e-5340-44ab-95e8-08952900d730" unitRef="usd"> 0 </us-gaap:DepreciationDepletionAndAmortization>
<us-gaap:DepreciationDepletionAndAmortization contextRef="ib557e685194f428ea1c938b7ea46759d_D20210401-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84NS9mcmFnOjNjNWFkNzUyZDgyNjRhODE5ODkwOWY1N2NhOTQxY2Q4L3RhYmxlOjhkMTYzYTFmZTc0ZDQzYjFiMzNiNjJjOTE1NGU4ZmU0L3RhYmxlcmFuZ2U6OGQxNjNhMWZlNzRkNDNiMWIzM2I2MmM5MTU0ZThmZTRfMjYtMy0xLTEtNDgxNjQ_0a4ad960-48c2-488b-b275-dc169c863aab" unitRef="usd"> 0 </us-gaap:DepreciationDepletionAndAmortization>
<us-gaap:DepreciationDepletionAndAmortization contextRef="i0828e7ef8a584b5b8ff47b0f0506ad32_D20220101-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84NS9mcmFnOjNjNWFkNzUyZDgyNjRhODE5ODkwOWY1N2NhOTQxY2Q4L3RhYmxlOjhkMTYzYTFmZTc0ZDQzYjFiMzNiNjJjOTE1NGU4ZmU0L3RhYmxlcmFuZ2U6OGQxNjNhMWZlNzRkNDNiMWIzM2I2MmM5MTU0ZThmZTRfMjYtNS0xLTEtNDgxNjQ_526029c9-5012-445b-9c19-ba90289e4615" unitRef="usd"> 0 </us-gaap:DepreciationDepletionAndAmortization>
<us-gaap:DepreciationDepletionAndAmortization contextRef="i49a8829d28bd44178eb1108e0ef77637_D20210101-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84NS9mcmFnOjNjNWFkNzUyZDgyNjRhODE5ODkwOWY1N2NhOTQxY2Q4L3RhYmxlOjhkMTYzYTFmZTc0ZDQzYjFiMzNiNjJjOTE1NGU4ZmU0L3RhYmxlcmFuZ2U6OGQxNjNhMWZlNzRkNDNiMWIzM2I2MmM5MTU0ZThmZTRfMjYtNy0xLTEtNDgxNjQ_de3763ec-ac28-4883-b54c-0982ad3a0643" unitRef="usd"> 0 </us-gaap:DepreciationDepletionAndAmortization>
<us-gaap:DepreciationDepletionAndAmortization contextRef="i50aa2eea9a6446b6ad796d994509b1ad_D20220401-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84NS9mcmFnOjNjNWFkNzUyZDgyNjRhODE5ODkwOWY1N2NhOTQxY2Q4L3RhYmxlOjhkMTYzYTFmZTc0ZDQzYjFiMzNiNjJjOTE1NGU4ZmU0L3RhYmxlcmFuZ2U6OGQxNjNhMWZlNzRkNDNiMWIzM2I2MmM5MTU0ZThmZTRfMjctMS0xLTEtNDgxNjQ_b6b0ce15-2cb5-47c9-aa76-4bf1c57a55dc" unitRef="usd"> 27995000 </us-gaap:DepreciationDepletionAndAmortization>
<us-gaap:DepreciationDepletionAndAmortization contextRef="if2a6207b6732465a921fe019a2a0f048_D20210401-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84NS9mcmFnOjNjNWFkNzUyZDgyNjRhODE5ODkwOWY1N2NhOTQxY2Q4L3RhYmxlOjhkMTYzYTFmZTc0ZDQzYjFiMzNiNjJjOTE1NGU4ZmU0L3RhYmxlcmFuZ2U6OGQxNjNhMWZlNzRkNDNiMWIzM2I2MmM5MTU0ZThmZTRfMjctMy0xLTEtNDgxNjQ_01dffb1c-d8ee-434e-90fa-e4a33da08336" unitRef="usd"> 20573000 </us-gaap:DepreciationDepletionAndAmortization>
<us-gaap:DepreciationDepletionAndAmortization contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84NS9mcmFnOjNjNWFkNzUyZDgyNjRhODE5ODkwOWY1N2NhOTQxY2Q4L3RhYmxlOjhkMTYzYTFmZTc0ZDQzYjFiMzNiNjJjOTE1NGU4ZmU0L3RhYmxlcmFuZ2U6OGQxNjNhMWZlNzRkNDNiMWIzM2I2MmM5MTU0ZThmZTRfMjctNS0xLTEtNDgxNjQ_74127abe-a7c4-40ab-a82a-9158cb2f17cf" unitRef="usd"> 55809000 </us-gaap:DepreciationDepletionAndAmortization>
<us-gaap:DepreciationDepletionAndAmortization contextRef="i420e18e30084498a98510d48880063cd_D20210101-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84NS9mcmFnOjNjNWFkNzUyZDgyNjRhODE5ODkwOWY1N2NhOTQxY2Q4L3RhYmxlOjhkMTYzYTFmZTc0ZDQzYjFiMzNiNjJjOTE1NGU4ZmU0L3RhYmxlcmFuZ2U6OGQxNjNhMWZlNzRkNDNiMWIzM2I2MmM5MTU0ZThmZTRfMjctNy0xLTEtNDgxNjQ_64e19d6d-43a0-42ee-b9fa-9c3746d6661e" unitRef="usd"> 40561000 </us-gaap:DepreciationDepletionAndAmortization>
<us-gaap:GainLossOnInvestments contextRef="i957434db983c4190b847e4637fef04f9_D20220401-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84NS9mcmFnOjNjNWFkNzUyZDgyNjRhODE5ODkwOWY1N2NhOTQxY2Q4L3RhYmxlOjhkMTYzYTFmZTc0ZDQzYjFiMzNiNjJjOTE1NGU4ZmU0L3RhYmxlcmFuZ2U6OGQxNjNhMWZlNzRkNDNiMWIzM2I2MmM5MTU0ZThmZTRfMjktMS0xLTEtNDgxNjQ_030223ee-8141-4309-ae05-76adf4e17784" unitRef="usd"> -268000 </us-gaap:GainLossOnInvestments>
<us-gaap:GainLossOnInvestments contextRef="i96ca08fd8d9945cb99bcf89ed9b4cd72_D20210401-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84NS9mcmFnOjNjNWFkNzUyZDgyNjRhODE5ODkwOWY1N2NhOTQxY2Q4L3RhYmxlOjhkMTYzYTFmZTc0ZDQzYjFiMzNiNjJjOTE1NGU4ZmU0L3RhYmxlcmFuZ2U6OGQxNjNhMWZlNzRkNDNiMWIzM2I2MmM5MTU0ZThmZTRfMjktMy0xLTEtNDgxNjQ_711bec99-3524-4814-a825-2b5ffb636762" unitRef="usd"> -67000 </us-gaap:GainLossOnInvestments>
<us-gaap:GainLossOnInvestments contextRef="i041fd017f3924fc3800fd697bfd128d1_D20220101-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84NS9mcmFnOjNjNWFkNzUyZDgyNjRhODE5ODkwOWY1N2NhOTQxY2Q4L3RhYmxlOjhkMTYzYTFmZTc0ZDQzYjFiMzNiNjJjOTE1NGU4ZmU0L3RhYmxlcmFuZ2U6OGQxNjNhMWZlNzRkNDNiMWIzM2I2MmM5MTU0ZThmZTRfMjktNS0xLTEtNDgxNjQ_00f4be4f-e7ff-4a78-a985-ae996284d8a3" unitRef="usd"> -316000 </us-gaap:GainLossOnInvestments>
<us-gaap:GainLossOnInvestments contextRef="i4b4c0e12ce634eecbb1e11e846d447b5_D20210101-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84NS9mcmFnOjNjNWFkNzUyZDgyNjRhODE5ODkwOWY1N2NhOTQxY2Q4L3RhYmxlOjhkMTYzYTFmZTc0ZDQzYjFiMzNiNjJjOTE1NGU4ZmU0L3RhYmxlcmFuZ2U6OGQxNjNhMWZlNzRkNDNiMWIzM2I2MmM5MTU0ZThmZTRfMjktNy0xLTEtNDgxNjQ_f5fed316-97a3-4231-92a9-f3f6554ef4b8" unitRef="usd"> -110000 </us-gaap:GainLossOnInvestments>
<us-gaap:GainLossOnInvestments contextRef="i7fde44ebde9341789ddff40144143c2f_D20220401-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84NS9mcmFnOjNjNWFkNzUyZDgyNjRhODE5ODkwOWY1N2NhOTQxY2Q4L3RhYmxlOjhkMTYzYTFmZTc0ZDQzYjFiMzNiNjJjOTE1NGU4ZmU0L3RhYmxlcmFuZ2U6OGQxNjNhMWZlNzRkNDNiMWIzM2I2MmM5MTU0ZThmZTRfMzAtMS0xLTEtNDgxNjQ_6b1ec98e-8121-4094-9bd6-184d43b8d437" unitRef="usd"> 0 </us-gaap:GainLossOnInvestments>
<us-gaap:GainLossOnInvestments contextRef="icce0e81024e2406b803d4529ed0c015c_D20210401-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84NS9mcmFnOjNjNWFkNzUyZDgyNjRhODE5ODkwOWY1N2NhOTQxY2Q4L3RhYmxlOjhkMTYzYTFmZTc0ZDQzYjFiMzNiNjJjOTE1NGU4ZmU0L3RhYmxlcmFuZ2U6OGQxNjNhMWZlNzRkNDNiMWIzM2I2MmM5MTU0ZThmZTRfMzAtMy0xLTEtNDgxNjQ_c3e5a311-0fb0-4b7e-a434-3511cb1b4a04" unitRef="usd"> 0 </us-gaap:GainLossOnInvestments>
<us-gaap:GainLossOnInvestments contextRef="ia5c9d668ef7340748d80ff87edaf4173_D20220101-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84NS9mcmFnOjNjNWFkNzUyZDgyNjRhODE5ODkwOWY1N2NhOTQxY2Q4L3RhYmxlOjhkMTYzYTFmZTc0ZDQzYjFiMzNiNjJjOTE1NGU4ZmU0L3RhYmxlcmFuZ2U6OGQxNjNhMWZlNzRkNDNiMWIzM2I2MmM5MTU0ZThmZTRfMzAtNS0xLTEtNDgxNjQ_4fb796e4-f63e-44f2-a1c9-a1eaad255456" unitRef="usd"> 0 </us-gaap:GainLossOnInvestments>
<us-gaap:GainLossOnInvestments contextRef="i21b7f98f9a12463da100915dc502484b_D20210101-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84NS9mcmFnOjNjNWFkNzUyZDgyNjRhODE5ODkwOWY1N2NhOTQxY2Q4L3RhYmxlOjhkMTYzYTFmZTc0ZDQzYjFiMzNiNjJjOTE1NGU4ZmU0L3RhYmxlcmFuZ2U6OGQxNjNhMWZlNzRkNDNiMWIzM2I2MmM5MTU0ZThmZTRfMzAtNy0xLTEtNDgxNjQ_38fd6466-311f-4305-8cf4-4a90658e6e42" unitRef="usd"> 0 </us-gaap:GainLossOnInvestments>
<us-gaap:GainLossOnInvestments contextRef="i8c23b2342c5f4f99bbfd7e108dea19ec_D20220401-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84NS9mcmFnOjNjNWFkNzUyZDgyNjRhODE5ODkwOWY1N2NhOTQxY2Q4L3RhYmxlOjhkMTYzYTFmZTc0ZDQzYjFiMzNiNjJjOTE1NGU4ZmU0L3RhYmxlcmFuZ2U6OGQxNjNhMWZlNzRkNDNiMWIzM2I2MmM5MTU0ZThmZTRfMzEtMS0xLTEtNDgxNjQ_674309e0-90f9-421c-8387-7492662c9b19" unitRef="usd"> 0 </us-gaap:GainLossOnInvestments>
<us-gaap:GainLossOnInvestments contextRef="ib557e685194f428ea1c938b7ea46759d_D20210401-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84NS9mcmFnOjNjNWFkNzUyZDgyNjRhODE5ODkwOWY1N2NhOTQxY2Q4L3RhYmxlOjhkMTYzYTFmZTc0ZDQzYjFiMzNiNjJjOTE1NGU4ZmU0L3RhYmxlcmFuZ2U6OGQxNjNhMWZlNzRkNDNiMWIzM2I2MmM5MTU0ZThmZTRfMzEtMy0xLTEtNDgxNjQ_212f14fb-0db2-4389-866e-5c4281fa8161" unitRef="usd"> 0 </us-gaap:GainLossOnInvestments>
<us-gaap:GainLossOnInvestments contextRef="i0828e7ef8a584b5b8ff47b0f0506ad32_D20220101-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84NS9mcmFnOjNjNWFkNzUyZDgyNjRhODE5ODkwOWY1N2NhOTQxY2Q4L3RhYmxlOjhkMTYzYTFmZTc0ZDQzYjFiMzNiNjJjOTE1NGU4ZmU0L3RhYmxlcmFuZ2U6OGQxNjNhMWZlNzRkNDNiMWIzM2I2MmM5MTU0ZThmZTRfMzEtNS0xLTEtNDgxNjQ_f6a4556f-d939-4b9b-a266-82af430a1075" unitRef="usd"> 0 </us-gaap:GainLossOnInvestments>
<us-gaap:GainLossOnInvestments contextRef="i49a8829d28bd44178eb1108e0ef77637_D20210101-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84NS9mcmFnOjNjNWFkNzUyZDgyNjRhODE5ODkwOWY1N2NhOTQxY2Q4L3RhYmxlOjhkMTYzYTFmZTc0ZDQzYjFiMzNiNjJjOTE1NGU4ZmU0L3RhYmxlcmFuZ2U6OGQxNjNhMWZlNzRkNDNiMWIzM2I2MmM5MTU0ZThmZTRfMzEtNy0xLTEtNDgxNjQ_14a40e02-b31f-48f0-ac31-94c883c3e1bc" unitRef="usd"> 0 </us-gaap:GainLossOnInvestments>
<us-gaap:GainLossOnInvestments contextRef="i50aa2eea9a6446b6ad796d994509b1ad_D20220401-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84NS9mcmFnOjNjNWFkNzUyZDgyNjRhODE5ODkwOWY1N2NhOTQxY2Q4L3RhYmxlOjhkMTYzYTFmZTc0ZDQzYjFiMzNiNjJjOTE1NGU4ZmU0L3RhYmxlcmFuZ2U6OGQxNjNhMWZlNzRkNDNiMWIzM2I2MmM5MTU0ZThmZTRfMzItMS0xLTEtNDgxNjQ_0d8daa16-1d31-43e7-820a-dc4ce2d6ab26" unitRef="usd"> -268000 </us-gaap:GainLossOnInvestments>
<us-gaap:GainLossOnInvestments contextRef="if2a6207b6732465a921fe019a2a0f048_D20210401-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84NS9mcmFnOjNjNWFkNzUyZDgyNjRhODE5ODkwOWY1N2NhOTQxY2Q4L3RhYmxlOjhkMTYzYTFmZTc0ZDQzYjFiMzNiNjJjOTE1NGU4ZmU0L3RhYmxlcmFuZ2U6OGQxNjNhMWZlNzRkNDNiMWIzM2I2MmM5MTU0ZThmZTRfMzItMy0xLTEtNDgxNjQ_34348563-c895-49a9-831a-c53398a3f4ad" unitRef="usd"> -67000 </us-gaap:GainLossOnInvestments>
<us-gaap:GainLossOnInvestments contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84NS9mcmFnOjNjNWFkNzUyZDgyNjRhODE5ODkwOWY1N2NhOTQxY2Q4L3RhYmxlOjhkMTYzYTFmZTc0ZDQzYjFiMzNiNjJjOTE1NGU4ZmU0L3RhYmxlcmFuZ2U6OGQxNjNhMWZlNzRkNDNiMWIzM2I2MmM5MTU0ZThmZTRfMzItNS0xLTEtNDgxNjQ_0ee6c00c-82a9-4936-a3fd-2a51ea1f6bf2" unitRef="usd"> -316000 </us-gaap:GainLossOnInvestments>
<us-gaap:GainLossOnInvestments contextRef="i420e18e30084498a98510d48880063cd_D20210101-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84NS9mcmFnOjNjNWFkNzUyZDgyNjRhODE5ODkwOWY1N2NhOTQxY2Q4L3RhYmxlOjhkMTYzYTFmZTc0ZDQzYjFiMzNiNjJjOTE1NGU4ZmU0L3RhYmxlcmFuZ2U6OGQxNjNhMWZlNzRkNDNiMWIzM2I2MmM5MTU0ZThmZTRfMzItNy0xLTEtNDgxNjQ_39f137df-0bfb-4b7d-9007-8072f72aa606" unitRef="usd"> -110000 </us-gaap:GainLossOnInvestments>
<us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="i0dd68860a1a146e597f3770be5653eb1_D20220401-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84NS9mcmFnOjNjNWFkNzUyZDgyNjRhODE5ODkwOWY1N2NhOTQxY2Q4L3RhYmxlOjhkMTYzYTFmZTc0ZDQzYjFiMzNiNjJjOTE1NGU4ZmU0L3RhYmxlcmFuZ2U6OGQxNjNhMWZlNzRkNDNiMWIzM2I2MmM5MTU0ZThmZTRfMzQtMS0xLTEtNDgxNjQ_b4c4682c-db65-4d70-8123-6c7b53ed02c5" unitRef="usd"> 193105000 </us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
<us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="ie9fa8a7fa3bd4c838a417101afd89478_D20210401-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84NS9mcmFnOjNjNWFkNzUyZDgyNjRhODE5ODkwOWY1N2NhOTQxY2Q4L3RhYmxlOjhkMTYzYTFmZTc0ZDQzYjFiMzNiNjJjOTE1NGU4ZmU0L3RhYmxlcmFuZ2U6OGQxNjNhMWZlNzRkNDNiMWIzM2I2MmM5MTU0ZThmZTRfMzQtMy0xLTEtNDgxNjQ_f749c73b-e419-4f3d-9f99-37c6ec5adf2a" unitRef="usd"> 402291000 </us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
<us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="i7206f4294559439da9e04af14912ea95_D20220101-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84NS9mcmFnOjNjNWFkNzUyZDgyNjRhODE5ODkwOWY1N2NhOTQxY2Q4L3RhYmxlOjhkMTYzYTFmZTc0ZDQzYjFiMzNiNjJjOTE1NGU4ZmU0L3RhYmxlcmFuZ2U6OGQxNjNhMWZlNzRkNDNiMWIzM2I2MmM5MTU0ZThmZTRfMzQtNS0xLTEtNDgxNjQ_6b102127-5ebe-4ffe-809c-4dfdda083522" unitRef="usd"> 484913000 </us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
<us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="i4e306ebc1a4841ccb1a9a48201229d45_D20210101-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84NS9mcmFnOjNjNWFkNzUyZDgyNjRhODE5ODkwOWY1N2NhOTQxY2Q4L3RhYmxlOjhkMTYzYTFmZTc0ZDQzYjFiMzNiNjJjOTE1NGU4ZmU0L3RhYmxlcmFuZ2U6OGQxNjNhMWZlNzRkNDNiMWIzM2I2MmM5MTU0ZThmZTRfMzQtNy0xLTEtNDgxNjQ_04a1a51f-04f9-40b9-b37c-f058f69ec887" unitRef="usd"> 915163000 </us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
<us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="ic7edf2f37b144b5b98cbd8824f6e8284_D20220401-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84NS9mcmFnOjNjNWFkNzUyZDgyNjRhODE5ODkwOWY1N2NhOTQxY2Q4L3RhYmxlOjhkMTYzYTFmZTc0ZDQzYjFiMzNiNjJjOTE1NGU4ZmU0L3RhYmxlcmFuZ2U6OGQxNjNhMWZlNzRkNDNiMWIzM2I2MmM5MTU0ZThmZTRfMzUtMS0xLTEtNDgxNjQ_8f88634f-0a5b-47ca-b29b-25c575fcfe12" unitRef="usd"> 89177000 </us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
<us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="i559f4f01f3f54b08aa1043b5256116a6_D20210401-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84NS9mcmFnOjNjNWFkNzUyZDgyNjRhODE5ODkwOWY1N2NhOTQxY2Q4L3RhYmxlOjhkMTYzYTFmZTc0ZDQzYjFiMzNiNjJjOTE1NGU4ZmU0L3RhYmxlcmFuZ2U6OGQxNjNhMWZlNzRkNDNiMWIzM2I2MmM5MTU0ZThmZTRfMzUtMy0xLTEtNDgxNjQ_6ba0cc42-2083-4a47-87a4-dc57ae8c8cef" unitRef="usd"> 12088000 </us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
<us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="i23061402e7ce43fe9914532b20d7ae5b_D20220101-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84NS9mcmFnOjNjNWFkNzUyZDgyNjRhODE5ODkwOWY1N2NhOTQxY2Q4L3RhYmxlOjhkMTYzYTFmZTc0ZDQzYjFiMzNiNjJjOTE1NGU4ZmU0L3RhYmxlcmFuZ2U6OGQxNjNhMWZlNzRkNDNiMWIzM2I2MmM5MTU0ZThmZTRfMzUtNS0xLTEtNDgxNjQ_847993d1-cdc8-4311-8c6b-cef8b4044701" unitRef="usd"> 97638000 </us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
<us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="ibd7b1018233641c5b70bfa7cac55e364_D20210101-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84NS9mcmFnOjNjNWFkNzUyZDgyNjRhODE5ODkwOWY1N2NhOTQxY2Q4L3RhYmxlOjhkMTYzYTFmZTc0ZDQzYjFiMzNiNjJjOTE1NGU4ZmU0L3RhYmxlcmFuZ2U6OGQxNjNhMWZlNzRkNDNiMWIzM2I2MmM5MTU0ZThmZTRfMzUtNy0xLTEtNDgxNjQ_159236a2-8d59-43b7-86b7-16998f92112b" unitRef="usd"> 19218000 </us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
<us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="i8dac6979b49c411b86a6cb7570c61721_D20220401-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84NS9mcmFnOjNjNWFkNzUyZDgyNjRhODE5ODkwOWY1N2NhOTQxY2Q4L3RhYmxlOjhkMTYzYTFmZTc0ZDQzYjFiMzNiNjJjOTE1NGU4ZmU0L3RhYmxlcmFuZ2U6OGQxNjNhMWZlNzRkNDNiMWIzM2I2MmM5MTU0ZThmZTRfMzYtMS0xLTEtNDgxNjQ_ff771f66-753d-439c-a492-bf69d06b928d" unitRef="usd"> 15804000 </us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
<us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="ieffe8ce34d68444b965ba0946cec3044_D20210401-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84NS9mcmFnOjNjNWFkNzUyZDgyNjRhODE5ODkwOWY1N2NhOTQxY2Q4L3RhYmxlOjhkMTYzYTFmZTc0ZDQzYjFiMzNiNjJjOTE1NGU4ZmU0L3RhYmxlcmFuZ2U6OGQxNjNhMWZlNzRkNDNiMWIzM2I2MmM5MTU0ZThmZTRfMzYtMy0xLTEtNDgxNjQ_0995ec33-bf57-46c1-a33f-2ad2370594fe" unitRef="usd"> 18657000 </us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
<us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="ie5ffa3525ae44756824f1afcc5fd1ae5_D20220101-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84NS9mcmFnOjNjNWFkNzUyZDgyNjRhODE5ODkwOWY1N2NhOTQxY2Q4L3RhYmxlOjhkMTYzYTFmZTc0ZDQzYjFiMzNiNjJjOTE1NGU4ZmU0L3RhYmxlcmFuZ2U6OGQxNjNhMWZlNzRkNDNiMWIzM2I2MmM5MTU0ZThmZTRfMzYtNS0xLTEtNDgxNjQ_e1b1ec3b-8248-4e94-8b2c-6f6da1b486a4" unitRef="usd"> 32143000 </us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
<us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="i64298a8ce6294c5690549751d5987f73_D20210101-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84NS9mcmFnOjNjNWFkNzUyZDgyNjRhODE5ODkwOWY1N2NhOTQxY2Q4L3RhYmxlOjhkMTYzYTFmZTc0ZDQzYjFiMzNiNjJjOTE1NGU4ZmU0L3RhYmxlcmFuZ2U6OGQxNjNhMWZlNzRkNDNiMWIzM2I2MmM5MTU0ZThmZTRfMzYtNy0xLTEtNDgxNjQ_34fc3b19-0bc4-4881-b080-f046f999d6da" unitRef="usd"> 32809000 </us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
<us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="i7aa5b108802144fe8eb984c17fe037fd_D20220401-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84NS9mcmFnOjNjNWFkNzUyZDgyNjRhODE5ODkwOWY1N2NhOTQxY2Q4L3RhYmxlOjhkMTYzYTFmZTc0ZDQzYjFiMzNiNjJjOTE1NGU4ZmU0L3RhYmxlcmFuZ2U6OGQxNjNhMWZlNzRkNDNiMWIzM2I2MmM5MTU0ZThmZTRfMzctMS0xLTEtNDgxNjQ_ff90d2c2-32de-4791-b76c-90aea38a9a71" unitRef="usd"> 5696000 </us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
<us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="i041fa117876d43e49ec1c4ed358d285c_D20210401-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84NS9mcmFnOjNjNWFkNzUyZDgyNjRhODE5ODkwOWY1N2NhOTQxY2Q4L3RhYmxlOjhkMTYzYTFmZTc0ZDQzYjFiMzNiNjJjOTE1NGU4ZmU0L3RhYmxlcmFuZ2U6OGQxNjNhMWZlNzRkNDNiMWIzM2I2MmM5MTU0ZThmZTRfMzctMy0xLTEtNDgxNjQ_eca7f69f-0ef9-4f8c-a5b4-99f1a67e7407" unitRef="usd"> 5437000 </us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
<us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="i9904c2a5cd304f36be9a34e8057e705c_D20220101-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84NS9mcmFnOjNjNWFkNzUyZDgyNjRhODE5ODkwOWY1N2NhOTQxY2Q4L3RhYmxlOjhkMTYzYTFmZTc0ZDQzYjFiMzNiNjJjOTE1NGU4ZmU0L3RhYmxlcmFuZ2U6OGQxNjNhMWZlNzRkNDNiMWIzM2I2MmM5MTU0ZThmZTRfMzctNS0xLTEtNDgxNjQ_f6c54e52-d9ba-4235-b602-8b29c085e954" unitRef="usd"> 12805000 </us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
<us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="i69cccf9eda114612893f98381b1b9ad4_D20210101-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84NS9mcmFnOjNjNWFkNzUyZDgyNjRhODE5ODkwOWY1N2NhOTQxY2Q4L3RhYmxlOjhkMTYzYTFmZTc0ZDQzYjFiMzNiNjJjOTE1NGU4ZmU0L3RhYmxlcmFuZ2U6OGQxNjNhMWZlNzRkNDNiMWIzM2I2MmM5MTU0ZThmZTRfMzctNy0xLTEtNDgxNjQ_a1f1aceb-5226-42f4-85c3-26419c45b9a6" unitRef="usd"> 11356000 </us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
<us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="i52877188041549d1b37d940b442390a0_D20220401-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84NS9mcmFnOjNjNWFkNzUyZDgyNjRhODE5ODkwOWY1N2NhOTQxY2Q4L3RhYmxlOjhkMTYzYTFmZTc0ZDQzYjFiMzNiNjJjOTE1NGU4ZmU0L3RhYmxlcmFuZ2U6OGQxNjNhMWZlNzRkNDNiMWIzM2I2MmM5MTU0ZThmZTRfMzgtMS0xLTEtNDgxNjQ_49b05bd7-2723-443d-aeff-b3255d41f794" unitRef="usd"> 1854000 </us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
<us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="i9019381f808348f6ad7cfc9e735c809d_D20210401-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84NS9mcmFnOjNjNWFkNzUyZDgyNjRhODE5ODkwOWY1N2NhOTQxY2Q4L3RhYmxlOjhkMTYzYTFmZTc0ZDQzYjFiMzNiNjJjOTE1NGU4ZmU0L3RhYmxlcmFuZ2U6OGQxNjNhMWZlNzRkNDNiMWIzM2I2MmM5MTU0ZThmZTRfMzgtMy0xLTEtNDgxNjQ_4288a354-ae02-40d5-9b88-f728b4476689" unitRef="usd"> 724000 </us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
<us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="ie8a826331d5041c9bdeca1a432bb4357_D20220101-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84NS9mcmFnOjNjNWFkNzUyZDgyNjRhODE5ODkwOWY1N2NhOTQxY2Q4L3RhYmxlOjhkMTYzYTFmZTc0ZDQzYjFiMzNiNjJjOTE1NGU4ZmU0L3RhYmxlcmFuZ2U6OGQxNjNhMWZlNzRkNDNiMWIzM2I2MmM5MTU0ZThmZTRfMzgtNS0xLTEtNDgxNjQ_c21855b4-01cd-4d26-9525-d5b704a5155e" unitRef="usd"> 3412000 </us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
<us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="i0dee503c427a4762a66dfd2b2d3935f9_D20210101-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84NS9mcmFnOjNjNWFkNzUyZDgyNjRhODE5ODkwOWY1N2NhOTQxY2Q4L3RhYmxlOjhkMTYzYTFmZTc0ZDQzYjFiMzNiNjJjOTE1NGU4ZmU0L3RhYmxlcmFuZ2U6OGQxNjNhMWZlNzRkNDNiMWIzM2I2MmM5MTU0ZThmZTRfMzgtNy0xLTEtNDgxNjQ_72570e23-09b6-4ea9-a55a-357abea1d64e" unitRef="usd"> 3235000 </us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
<us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="i3e6c38e0293e4599bb8e99803d1d651a_D20220401-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84NS9mcmFnOjNjNWFkNzUyZDgyNjRhODE5ODkwOWY1N2NhOTQxY2Q4L3RhYmxlOjhkMTYzYTFmZTc0ZDQzYjFiMzNiNjJjOTE1NGU4ZmU0L3RhYmxlcmFuZ2U6OGQxNjNhMWZlNzRkNDNiMWIzM2I2MmM5MTU0ZThmZTRfMzktMS0xLTEtNDgxNjQ_806c3432-7048-4b85-819d-70cacdbb6bc9" unitRef="usd"> 4055000 </us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
<us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="i562959c388b94bf9bf9ab9007634c7ad_D20210401-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84NS9mcmFnOjNjNWFkNzUyZDgyNjRhODE5ODkwOWY1N2NhOTQxY2Q4L3RhYmxlOjhkMTYzYTFmZTc0ZDQzYjFiMzNiNjJjOTE1NGU4ZmU0L3RhYmxlcmFuZ2U6OGQxNjNhMWZlNzRkNDNiMWIzM2I2MmM5MTU0ZThmZTRfMzktMy0xLTEtNDgxNjQ_f72fcafa-d91b-40ba-b00a-ba3c5c2464d9" unitRef="usd"> 3039000 </us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
<us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="i758f56d85bcf452b9cf2e86887b92cd9_D20220101-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84NS9mcmFnOjNjNWFkNzUyZDgyNjRhODE5ODkwOWY1N2NhOTQxY2Q4L3RhYmxlOjhkMTYzYTFmZTc0ZDQzYjFiMzNiNjJjOTE1NGU4ZmU0L3RhYmxlcmFuZ2U6OGQxNjNhMWZlNzRkNDNiMWIzM2I2MmM5MTU0ZThmZTRfMzktNS0xLTEtNDgxNjQ_ffb0eb41-46d5-4277-8185-af21d4e89c57" unitRef="usd"> 7805000 </us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
<us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="i780db68c2bb843e3bf05d5ed66b1e04c_D20210101-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84NS9mcmFnOjNjNWFkNzUyZDgyNjRhODE5ODkwOWY1N2NhOTQxY2Q4L3RhYmxlOjhkMTYzYTFmZTc0ZDQzYjFiMzNiNjJjOTE1NGU4ZmU0L3RhYmxlcmFuZ2U6OGQxNjNhMWZlNzRkNDNiMWIzM2I2MmM5MTU0ZThmZTRfMzktNy0xLTEtNDgxNjQ_bb35bf91-0afc-44d9-bc6c-b9a1cda7d630" unitRef="usd"> 5457000 </us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
<us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="iee88e88ad393482c9fc5f2515351701d_D20220401-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84NS9mcmFnOjNjNWFkNzUyZDgyNjRhODE5ODkwOWY1N2NhOTQxY2Q4L3RhYmxlOjhkMTYzYTFmZTc0ZDQzYjFiMzNiNjJjOTE1NGU4ZmU0L3RhYmxlcmFuZ2U6OGQxNjNhMWZlNzRkNDNiMWIzM2I2MmM5MTU0ZThmZTRfNDAtMS0xLTEtNDgxNjQ_8938a0db-cc8a-4514-9edf-24cf914673ba" unitRef="usd"> 202000 </us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
<us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="i1e8f0ff787414bcb9de2b88966bcfc3f_D20210401-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84NS9mcmFnOjNjNWFkNzUyZDgyNjRhODE5ODkwOWY1N2NhOTQxY2Q4L3RhYmxlOjhkMTYzYTFmZTc0ZDQzYjFiMzNiNjJjOTE1NGU4ZmU0L3RhYmxlcmFuZ2U6OGQxNjNhMWZlNzRkNDNiMWIzM2I2MmM5MTU0ZThmZTRfNDAtMy0xLTEtNDgxNjQ_92a9f2bc-28e2-4cb8-aaca-4d92fd6647f6" unitRef="usd"> 172000 </us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
<us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="ie3a530a9b17f4c679451829961773739_D20220101-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84NS9mcmFnOjNjNWFkNzUyZDgyNjRhODE5ODkwOWY1N2NhOTQxY2Q4L3RhYmxlOjhkMTYzYTFmZTc0ZDQzYjFiMzNiNjJjOTE1NGU4ZmU0L3RhYmxlcmFuZ2U6OGQxNjNhMWZlNzRkNDNiMWIzM2I2MmM5MTU0ZThmZTRfNDAtNS0xLTEtNDgxNjQ_404590cc-144b-4a5d-b5db-b09d60f73e94" unitRef="usd"> 395000 </us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
<us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="iec818c36643649748e099a09b924ca36_D20210101-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84NS9mcmFnOjNjNWFkNzUyZDgyNjRhODE5ODkwOWY1N2NhOTQxY2Q4L3RhYmxlOjhkMTYzYTFmZTc0ZDQzYjFiMzNiNjJjOTE1NGU4ZmU0L3RhYmxlcmFuZ2U6OGQxNjNhMWZlNzRkNDNiMWIzM2I2MmM5MTU0ZThmZTRfNDAtNy0xLTEtNDgxNjQ_d3ecf2a7-7b29-476d-8c16-18cbf2866a37" unitRef="usd"> 335000 </us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
<us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="i50aa2eea9a6446b6ad796d994509b1ad_D20220401-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84NS9mcmFnOjNjNWFkNzUyZDgyNjRhODE5ODkwOWY1N2NhOTQxY2Q4L3RhYmxlOjhkMTYzYTFmZTc0ZDQzYjFiMzNiNjJjOTE1NGU4ZmU0L3RhYmxlcmFuZ2U6OGQxNjNhMWZlNzRkNDNiMWIzM2I2MmM5MTU0ZThmZTRfNDEtMS0xLTEtNDgxNjQ_cb02742c-1d36-4ab9-b65d-33835e647c23" unitRef="usd"> 309893000 </us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
<us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="if2a6207b6732465a921fe019a2a0f048_D20210401-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84NS9mcmFnOjNjNWFkNzUyZDgyNjRhODE5ODkwOWY1N2NhOTQxY2Q4L3RhYmxlOjhkMTYzYTFmZTc0ZDQzYjFiMzNiNjJjOTE1NGU4ZmU0L3RhYmxlcmFuZ2U6OGQxNjNhMWZlNzRkNDNiMWIzM2I2MmM5MTU0ZThmZTRfNDEtMy0xLTEtNDgxNjQ_fb432536-785c-4d59-a734-0d5c89e9bed6" unitRef="usd"> 442408000 </us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
<us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84NS9mcmFnOjNjNWFkNzUyZDgyNjRhODE5ODkwOWY1N2NhOTQxY2Q4L3RhYmxlOjhkMTYzYTFmZTc0ZDQzYjFiMzNiNjJjOTE1NGU4ZmU0L3RhYmxlcmFuZ2U6OGQxNjNhMWZlNzRkNDNiMWIzM2I2MmM5MTU0ZThmZTRfNDEtNS0xLTEtNDgxNjQ_ce8cbe66-4f75-4f88-a4ae-20022ce29556" unitRef="usd"> 639111000 </us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
<us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="i420e18e30084498a98510d48880063cd_D20210101-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84NS9mcmFnOjNjNWFkNzUyZDgyNjRhODE5ODkwOWY1N2NhOTQxY2Q4L3RhYmxlOjhkMTYzYTFmZTc0ZDQzYjFiMzNiNjJjOTE1NGU4ZmU0L3RhYmxlcmFuZ2U6OGQxNjNhMWZlNzRkNDNiMWIzM2I2MmM5MTU0ZThmZTRfNDEtNy0xLTEtNDgxNjQ_04054ff1-7480-4709-8cfb-e60e68399d03" unitRef="usd"> 987573000 </us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
<us-gaap:Assets contextRef="i932964789b874d07b8eb7aa207be7426_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84NS9mcmFnOjNjNWFkNzUyZDgyNjRhODE5ODkwOWY1N2NhOTQxY2Q4L3RhYmxlOjdhNmYzMDg2ZGYwYTQ4NmM5Njk1Yjc0MDUzNzk5MjA3L3RhYmxlcmFuZ2U6N2E2ZjMwODZkZjBhNDg2Yzk2OTViNzQwNTM3OTkyMDdfMi0xLTEtMS00ODE2NA_b3d9f1be-4aee-4a95-873e-4f379dcb61bf" unitRef="usd"> 1354058000 </us-gaap:Assets>
<us-gaap:Assets contextRef="id98380ff851c4e8c863f5e14df564350_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84NS9mcmFnOjNjNWFkNzUyZDgyNjRhODE5ODkwOWY1N2NhOTQxY2Q4L3RhYmxlOjdhNmYzMDg2ZGYwYTQ4NmM5Njk1Yjc0MDUzNzk5MjA3L3RhYmxlcmFuZ2U6N2E2ZjMwODZkZjBhNDg2Yzk2OTViNzQwNTM3OTkyMDdfMi0zLTEtMS00ODE2NA_25541791-8766-40f8-910f-67a8bdefc07c" unitRef="usd"> 1114460000 </us-gaap:Assets>
<us-gaap:Assets contextRef="i3e0f809fdadc46b8bd186df746a3bd3c_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84NS9mcmFnOjNjNWFkNzUyZDgyNjRhODE5ODkwOWY1N2NhOTQxY2Q4L3RhYmxlOjdhNmYzMDg2ZGYwYTQ4NmM5Njk1Yjc0MDUzNzk5MjA3L3RhYmxlcmFuZ2U6N2E2ZjMwODZkZjBhNDg2Yzk2OTViNzQwNTM3OTkyMDdfMy0xLTEtMS00ODE2NA_68ce622f-f089-4b6c-bf5d-291b24038d0e" unitRef="usd"> 748165000 </us-gaap:Assets>
<us-gaap:Assets contextRef="ifd9c316e7e6345e8b7856cd774fb64c3_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84NS9mcmFnOjNjNWFkNzUyZDgyNjRhODE5ODkwOWY1N2NhOTQxY2Q4L3RhYmxlOjdhNmYzMDg2ZGYwYTQ4NmM5Njk1Yjc0MDUzNzk5MjA3L3RhYmxlcmFuZ2U6N2E2ZjMwODZkZjBhNDg2Yzk2OTViNzQwNTM3OTkyMDdfMy0zLTEtMS00ODE2NA_6bab4215-36a7-4b51-b128-e328172b5ca6" unitRef="usd"> 1238583000 </us-gaap:Assets>
<us-gaap:Assets contextRef="i1411dda547cd4a0ebd23a90a746f9e70_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84NS9mcmFnOjNjNWFkNzUyZDgyNjRhODE5ODkwOWY1N2NhOTQxY2Q4L3RhYmxlOjdhNmYzMDg2ZGYwYTQ4NmM5Njk1Yjc0MDUzNzk5MjA3L3RhYmxlcmFuZ2U6N2E2ZjMwODZkZjBhNDg2Yzk2OTViNzQwNTM3OTkyMDdfNC0xLTEtMS00ODE2NA_99a4086d-4ba1-4f4b-9c57-ce1ce7182231" unitRef="usd"> 267379000 </us-gaap:Assets>
<us-gaap:Assets contextRef="i265cf472105c4444a2536dc3fa84c305_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84NS9mcmFnOjNjNWFkNzUyZDgyNjRhODE5ODkwOWY1N2NhOTQxY2Q4L3RhYmxlOjdhNmYzMDg2ZGYwYTQ4NmM5Njk1Yjc0MDUzNzk5MjA3L3RhYmxlcmFuZ2U6N2E2ZjMwODZkZjBhNDg2Yzk2OTViNzQwNTM3OTkyMDdfNC0zLTEtMS00ODE2NA_984f9040-0b91-4639-aa62-d1a8473b80f1" unitRef="usd"> 46672000 </us-gaap:Assets>
<us-gaap:Assets contextRef="i4768f885851b49f986857a2a956f9162_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84NS9mcmFnOjNjNWFkNzUyZDgyNjRhODE5ODkwOWY1N2NhOTQxY2Q4L3RhYmxlOjdhNmYzMDg2ZGYwYTQ4NmM5Njk1Yjc0MDUzNzk5MjA3L3RhYmxlcmFuZ2U6N2E2ZjMwODZkZjBhNDg2Yzk2OTViNzQwNTM3OTkyMDdfNS0xLTEtMS00ODE2NA_7b3f35b0-346d-47fb-9654-ae929e22fdce" unitRef="usd"> 2369602000 </us-gaap:Assets>
<us-gaap:Assets contextRef="i7e0f479bead144b0bdbcc71082db627b_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84NS9mcmFnOjNjNWFkNzUyZDgyNjRhODE5ODkwOWY1N2NhOTQxY2Q4L3RhYmxlOjdhNmYzMDg2ZGYwYTQ4NmM5Njk1Yjc0MDUzNzk5MjA3L3RhYmxlcmFuZ2U6N2E2ZjMwODZkZjBhNDg2Yzk2OTViNzQwNTM3OTkyMDdfNS0zLTEtMS00ODE2NA_89d862a3-3da7-4c0c-b6f3-e0509dd6d4a9" unitRef="usd"> 2399715000 </us-gaap:Assets>
<us-gaap:Goodwill contextRef="i932964789b874d07b8eb7aa207be7426_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84NS9mcmFnOjNjNWFkNzUyZDgyNjRhODE5ODkwOWY1N2NhOTQxY2Q4L3RhYmxlOjdhNmYzMDg2ZGYwYTQ4NmM5Njk1Yjc0MDUzNzk5MjA3L3RhYmxlcmFuZ2U6N2E2ZjMwODZkZjBhNDg2Yzk2OTViNzQwNTM3OTkyMDdfNy0xLTEtMS00ODE2NA_9485f181-36d4-4d1f-90f3-e36353b6161e" unitRef="usd"> 295820000 </us-gaap:Goodwill>
<us-gaap:Goodwill contextRef="id98380ff851c4e8c863f5e14df564350_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84NS9mcmFnOjNjNWFkNzUyZDgyNjRhODE5ODkwOWY1N2NhOTQxY2Q4L3RhYmxlOjdhNmYzMDg2ZGYwYTQ4NmM5Njk1Yjc0MDUzNzk5MjA3L3RhYmxlcmFuZ2U6N2E2ZjMwODZkZjBhNDg2Yzk2OTViNzQwNTM3OTkyMDdfNy0zLTEtMS00ODE2NA_6d17fd7c-e058-40a5-bde4-a87d5252f568" unitRef="usd"> 237576000 </us-gaap:Goodwill>
<us-gaap:Goodwill contextRef="i3e0f809fdadc46b8bd186df746a3bd3c_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84NS9mcmFnOjNjNWFkNzUyZDgyNjRhODE5ODkwOWY1N2NhOTQxY2Q4L3RhYmxlOjdhNmYzMDg2ZGYwYTQ4NmM5Njk1Yjc0MDUzNzk5MjA3L3RhYmxlcmFuZ2U6N2E2ZjMwODZkZjBhNDg2Yzk2OTViNzQwNTM3OTkyMDdfOC0xLTEtMS00ODE2NA_eb89535e-d984-418f-b33c-bf93021c0455" unitRef="usd"> 283025000 </us-gaap:Goodwill>
<us-gaap:Goodwill contextRef="ifd9c316e7e6345e8b7856cd774fb64c3_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84NS9mcmFnOjNjNWFkNzUyZDgyNjRhODE5ODkwOWY1N2NhOTQxY2Q4L3RhYmxlOjdhNmYzMDg2ZGYwYTQ4NmM5Njk1Yjc0MDUzNzk5MjA3L3RhYmxlcmFuZ2U6N2E2ZjMwODZkZjBhNDg2Yzk2OTViNzQwNTM3OTkyMDdfOC0zLTEtMS00ODE2NA_d44b6181-8b78-4894-aa22-b3f393640da5" unitRef="usd"> 283025000 </us-gaap:Goodwill>
<us-gaap:Goodwill contextRef="i4768f885851b49f986857a2a956f9162_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84NS9mcmFnOjNjNWFkNzUyZDgyNjRhODE5ODkwOWY1N2NhOTQxY2Q4L3RhYmxlOjdhNmYzMDg2ZGYwYTQ4NmM5Njk1Yjc0MDUzNzk5MjA3L3RhYmxlcmFuZ2U6N2E2ZjMwODZkZjBhNDg2Yzk2OTViNzQwNTM3OTkyMDdfMTAtMS0xLTEtNDgxNjQ_ccc8d4b4-2dd9-479f-ad13-c2f18417ad22" unitRef="usd"> 578845000 </us-gaap:Goodwill>
<us-gaap:Goodwill contextRef="i7e0f479bead144b0bdbcc71082db627b_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84NS9mcmFnOjNjNWFkNzUyZDgyNjRhODE5ODkwOWY1N2NhOTQxY2Q4L3RhYmxlOjdhNmYzMDg2ZGYwYTQ4NmM5Njk1Yjc0MDUzNzk5MjA3L3RhYmxlcmFuZ2U6N2E2ZjMwODZkZjBhNDg2Yzk2OTViNzQwNTM3OTkyMDdfMTAtMy0xLTEtNDgxNjQ_3a46f550-2269-4c6b-8f1a-07bea61d6419" unitRef="usd"> 520601000 </us-gaap:Goodwill>
<us-gaap:LesseeOperatingLeasesTextBlock contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84OC9mcmFnOmYwYmRmNjU2NjU4ODRlZTRhODlhNGU1NTA2ZDk4YTBhL3RleHRyZWdpb246ZjBiZGY2NTY2NTg4NGVlNGE4OWE0ZTU1MDZkOThhMGFfMjQ3OQ_c737b272-6489-48ab-888f-e7f13b715683">
LEASES<div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have operating leases for office space, laboratory operations, research and development facilities, manufacturing locations, warehouses and certain equipment. We determine if a contract contains a lease at inception or modification of a contract. Our leases generally do not provide an implicit interest rate, and we therefore use our incremental borrowing rate as the discount rate when measuring operating lease liabilities. The incremental borrowing rate represents an estimate of the interest rate we would incur at lease commencement to borrow an amount equal to the lease payments on a collateralized basis over the term of the lease within a particular currency environment. We used the incremental borrowing rates as of January 1, 2019 for operating leases that commenced prior to that date. Many of our leases contain rental escalation, renewal options and/or termination options that are factored into our determination of lease payments as appropriate. Variable lease payment amounts that cannot be determined at the commencement of the lease are not included in the right-to-use assets or liabilities. </span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We elected the use of permitted practical expedients of not recording leases on our Consolidated Balance Sheet when the leases have terms of 12 months or less, and we elected not to separate nonlease components from lease components and instead account for each separate lease component and the nonlease components associated with that lease component as a single lease component.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the lease balances within the Condensed Consolidated Balance Sheet as of June 30, 2022 and December 31, 2021:</span></div><div style="margin-top:14pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:33.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:33.549%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.085%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Classification on the Balance Sheet</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">42,412 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">44,228 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84OC9mcmFnOmYwYmRmNjU2NjU4ODRlZTRhODlhNGU1NTA2ZDk4YTBhL3RhYmxlOmFhNTZiZTdkNzE4YjQ2OTE5ODAzYjE5YTg1NjA4ZWRhL3RhYmxlcmFuZ2U6YWE1NmJlN2Q3MThiNDY5MTk4MDNiMTlhODU2MDhlZGFfMy0wLTEtMS00ODE2NA_9c5b9bae-c0e0-43d9-ba85-b128a4c8eafa">Finance lease assets</span></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,213 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,181 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current maturities of operating leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,122 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,624 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current maturities of finance leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,625 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,257 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30,876 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33,097 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finance lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,588 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,924 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average remaining lease term</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.4 years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.2 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.2 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.4 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average discount rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:4pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table reconciles the undiscounted future minimum lease payments (displayed by year and in the aggregate) under noncancelable operating leases with terms of more than one year to the total operating lease liabilities recognized on our Condensed Consolidated Balance Sheet as of June 30, 2022:</span></div><div style="margin-top:14pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:70.894%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.536%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.537%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Operating</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Finance</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">July 1, 2022 through December 31, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,322 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,528 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,399 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,430 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,025 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,829 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,541 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,291 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,654 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">636 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,493 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total undiscounted future minimum lease payments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">47,434 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,716 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: Difference between lease payments and discounted lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,436 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">503 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">42,998 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,213 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:4pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expense under operating leases and finance leases was $8.4 million and $1.9 million, respectively, for the six months ended June 30, 2022, which includes $1.3 million of variable lease costs. Expense under operating leases and finance leases was $9.1 million and $1.1 million, respectively, for the six months ended June 30, 2021, which includes $1.4 million of variable lease costs. Operating lease costs and finance lease costs are included within Operating loss in the Condensed Consolidated Statement of Operations. Short-term lease costs were not material. </span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental cash flow information is as follows:</span></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:70.600%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.536%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.831%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in thousands)</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">For the six months ended June 30,</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash out flows from operating leases</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,327 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,484 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash out flows from finance leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing cash out flows from finance leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">724 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">769 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,103 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,298 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table>
</us-gaap:LesseeOperatingLeasesTextBlock>
<us-gaap:LesseeFinanceLeasesTextBlock contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84OC9mcmFnOmYwYmRmNjU2NjU4ODRlZTRhODlhNGU1NTA2ZDk4YTBhL3RleHRyZWdpb246ZjBiZGY2NTY2NTg4NGVlNGE4OWE0ZTU1MDZkOThhMGFfMjQ3Ng_03a048f1-a776-4b36-ae69-64fb380337d7">
LEASES<div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have operating leases for office space, laboratory operations, research and development facilities, manufacturing locations, warehouses and certain equipment. We determine if a contract contains a lease at inception or modification of a contract. Our leases generally do not provide an implicit interest rate, and we therefore use our incremental borrowing rate as the discount rate when measuring operating lease liabilities. The incremental borrowing rate represents an estimate of the interest rate we would incur at lease commencement to borrow an amount equal to the lease payments on a collateralized basis over the term of the lease within a particular currency environment. We used the incremental borrowing rates as of January 1, 2019 for operating leases that commenced prior to that date. Many of our leases contain rental escalation, renewal options and/or termination options that are factored into our determination of lease payments as appropriate. Variable lease payment amounts that cannot be determined at the commencement of the lease are not included in the right-to-use assets or liabilities. </span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We elected the use of permitted practical expedients of not recording leases on our Consolidated Balance Sheet when the leases have terms of 12 months or less, and we elected not to separate nonlease components from lease components and instead account for each separate lease component and the nonlease components associated with that lease component as a single lease component.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the lease balances within the Condensed Consolidated Balance Sheet as of June 30, 2022 and December 31, 2021:</span></div><div style="margin-top:14pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:33.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:33.549%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.085%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Classification on the Balance Sheet</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">42,412 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">44,228 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84OC9mcmFnOmYwYmRmNjU2NjU4ODRlZTRhODlhNGU1NTA2ZDk4YTBhL3RhYmxlOmFhNTZiZTdkNzE4YjQ2OTE5ODAzYjE5YTg1NjA4ZWRhL3RhYmxlcmFuZ2U6YWE1NmJlN2Q3MThiNDY5MTk4MDNiMTlhODU2MDhlZGFfMy0wLTEtMS00ODE2NA_9c5b9bae-c0e0-43d9-ba85-b128a4c8eafa">Finance lease assets</span></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,213 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,181 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current maturities of operating leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,122 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,624 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current maturities of finance leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,625 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,257 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30,876 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33,097 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finance lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,588 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,924 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average remaining lease term</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.4 years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.2 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.2 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.4 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average discount rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:4pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table reconciles the undiscounted future minimum lease payments (displayed by year and in the aggregate) under noncancelable operating leases with terms of more than one year to the total operating lease liabilities recognized on our Condensed Consolidated Balance Sheet as of June 30, 2022:</span></div><div style="margin-top:14pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:70.894%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.536%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.537%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Operating</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Finance</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">July 1, 2022 through December 31, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,322 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,528 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,399 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,430 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,025 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,829 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,541 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,291 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,654 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">636 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,493 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total undiscounted future minimum lease payments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">47,434 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,716 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: Difference between lease payments and discounted lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,436 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">503 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">42,998 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,213 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:4pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expense under operating leases and finance leases was $8.4 million and $1.9 million, respectively, for the six months ended June 30, 2022, which includes $1.3 million of variable lease costs. Expense under operating leases and finance leases was $9.1 million and $1.1 million, respectively, for the six months ended June 30, 2021, which includes $1.4 million of variable lease costs. Operating lease costs and finance lease costs are included within Operating loss in the Condensed Consolidated Statement of Operations. Short-term lease costs were not material. </span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental cash flow information is as follows:</span></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:70.600%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.536%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.831%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in thousands)</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">For the six months ended June 30,</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash out flows from operating leases</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,327 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,484 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash out flows from finance leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing cash out flows from finance leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">724 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">769 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,103 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,298 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table>
</us-gaap:LesseeFinanceLeasesTextBlock>
<opk:AssetsAndLiabilitiesLesseeTableTextBlock contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84OC9mcmFnOmYwYmRmNjU2NjU4ODRlZTRhODlhNGU1NTA2ZDk4YTBhL3RleHRyZWdpb246ZjBiZGY2NTY2NTg4NGVlNGE4OWE0ZTU1MDZkOThhMGFfMjQ5Mw_52b81dff-1ecd-4505-9f74-125c7ce95be5">
The following table presents the lease balances within the Condensed Consolidated Balance Sheet as of June 30, 2022 and December 31, 2021:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:33.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:33.549%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.085%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Classification on the Balance Sheet</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">42,412 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">44,228 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84OC9mcmFnOmYwYmRmNjU2NjU4ODRlZTRhODlhNGU1NTA2ZDk4YTBhL3RhYmxlOmFhNTZiZTdkNzE4YjQ2OTE5ODAzYjE5YTg1NjA4ZWRhL3RhYmxlcmFuZ2U6YWE1NmJlN2Q3MThiNDY5MTk4MDNiMTlhODU2MDhlZGFfMy0wLTEtMS00ODE2NA_9c5b9bae-c0e0-43d9-ba85-b128a4c8eafa">Finance lease assets</span></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,213 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,181 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current maturities of operating leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,122 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,624 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current maturities of finance leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,625 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,257 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30,876 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33,097 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finance lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,588 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,924 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average remaining lease term</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.4 years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.2 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.2 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.4 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average discount rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table>
</opk:AssetsAndLiabilitiesLesseeTableTextBlock>
<us-gaap:OperatingLeaseRightOfUseAsset contextRef="i4768f885851b49f986857a2a956f9162_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84OC9mcmFnOmYwYmRmNjU2NjU4ODRlZTRhODlhNGU1NTA2ZDk4YTBhL3RhYmxlOmFhNTZiZTdkNzE4YjQ2OTE5ODAzYjE5YTg1NjA4ZWRhL3RhYmxlcmFuZ2U6YWE1NmJlN2Q3MThiNDY5MTk4MDNiMTlhODU2MDhlZGFfMi00LTEtMS00ODE2NA_f7d14b44-3648-43f4-8235-49bdebaeb557" unitRef="usd"> 42412000 </us-gaap:OperatingLeaseRightOfUseAsset>
<us-gaap:OperatingLeaseRightOfUseAsset contextRef="i7e0f479bead144b0bdbcc71082db627b_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84OC9mcmFnOmYwYmRmNjU2NjU4ODRlZTRhODlhNGU1NTA2ZDk4YTBhL3RhYmxlOmFhNTZiZTdkNzE4YjQ2OTE5ODAzYjE5YTg1NjA4ZWRhL3RhYmxlcmFuZ2U6YWE1NmJlN2Q3MThiNDY5MTk4MDNiMTlhODU2MDhlZGFfMi02LTEtMS00ODE2NA_32dcd379-2c53-4d43-93a1-cb242762e971" unitRef="usd"> 44228000 </us-gaap:OperatingLeaseRightOfUseAsset>
<us-gaap:FinanceLeaseRightOfUseAsset contextRef="i4768f885851b49f986857a2a956f9162_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84OC9mcmFnOmYwYmRmNjU2NjU4ODRlZTRhODlhNGU1NTA2ZDk4YTBhL3RhYmxlOmFhNTZiZTdkNzE4YjQ2OTE5ODAzYjE5YTg1NjA4ZWRhL3RhYmxlcmFuZ2U6YWE1NmJlN2Q3MThiNDY5MTk4MDNiMTlhODU2MDhlZGFfMy00LTEtMS00ODE2NA_28228e56-df9a-4384-acc6-36499c582f24" unitRef="usd"> 7213000 </us-gaap:FinanceLeaseRightOfUseAsset>
<us-gaap:FinanceLeaseRightOfUseAsset contextRef="i7e0f479bead144b0bdbcc71082db627b_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84OC9mcmFnOmYwYmRmNjU2NjU4ODRlZTRhODlhNGU1NTA2ZDk4YTBhL3RhYmxlOmFhNTZiZTdkNzE4YjQ2OTE5ODAzYjE5YTg1NjA4ZWRhL3RhYmxlcmFuZ2U6YWE1NmJlN2Q3MThiNDY5MTk4MDNiMTlhODU2MDhlZGFfMy02LTEtMS00ODE2NA_7808bc9a-fb33-4302-9c3e-575fc8d241d5" unitRef="usd"> 5181000 </us-gaap:FinanceLeaseRightOfUseAsset>
<us-gaap:OperatingLeaseLiabilityCurrent contextRef="i4768f885851b49f986857a2a956f9162_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84OC9mcmFnOmYwYmRmNjU2NjU4ODRlZTRhODlhNGU1NTA2ZDk4YTBhL3RhYmxlOmFhNTZiZTdkNzE4YjQ2OTE5ODAzYjE5YTg1NjA4ZWRhL3RhYmxlcmFuZ2U6YWE1NmJlN2Q3MThiNDY5MTk4MDNiMTlhODU2MDhlZGFfNy00LTEtMS00ODE2NA_220d40b2-25c8-4c3c-91fa-b62a4813d7db" unitRef="usd"> 12122000 </us-gaap:OperatingLeaseLiabilityCurrent>
<us-gaap:OperatingLeaseLiabilityCurrent contextRef="i7e0f479bead144b0bdbcc71082db627b_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84OC9mcmFnOmYwYmRmNjU2NjU4ODRlZTRhODlhNGU1NTA2ZDk4YTBhL3RhYmxlOmFhNTZiZTdkNzE4YjQ2OTE5ODAzYjE5YTg1NjA4ZWRhL3RhYmxlcmFuZ2U6YWE1NmJlN2Q3MThiNDY5MTk4MDNiMTlhODU2MDhlZGFfNy02LTEtMS00ODE2NA_28d3b878-d7ef-4304-b2ff-b0f74747f1eb" unitRef="usd"> 11624000 </us-gaap:OperatingLeaseLiabilityCurrent>
<us-gaap:FinanceLeaseLiabilityCurrent contextRef="i4768f885851b49f986857a2a956f9162_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84OC9mcmFnOmYwYmRmNjU2NjU4ODRlZTRhODlhNGU1NTA2ZDk4YTBhL3RhYmxlOmFhNTZiZTdkNzE4YjQ2OTE5ODAzYjE5YTg1NjA4ZWRhL3RhYmxlcmFuZ2U6YWE1NmJlN2Q3MThiNDY5MTk4MDNiMTlhODU2MDhlZGFfOC00LTEtMS00ODE2NA_fef7bb2d-8869-48a3-af00-d2983aae872f" unitRef="usd"> 2625000 </us-gaap:FinanceLeaseLiabilityCurrent>
<us-gaap:FinanceLeaseLiabilityCurrent contextRef="i7e0f479bead144b0bdbcc71082db627b_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84OC9mcmFnOmYwYmRmNjU2NjU4ODRlZTRhODlhNGU1NTA2ZDk4YTBhL3RhYmxlOmFhNTZiZTdkNzE4YjQ2OTE5ODAzYjE5YTg1NjA4ZWRhL3RhYmxlcmFuZ2U6YWE1NmJlN2Q3MThiNDY5MTk4MDNiMTlhODU2MDhlZGFfOC02LTEtMS00ODE2NA_c23e8547-c44e-446c-95d9-8d528eeb2049" unitRef="usd"> 2257000 </us-gaap:FinanceLeaseLiabilityCurrent>
<us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="i4768f885851b49f986857a2a956f9162_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84OC9mcmFnOmYwYmRmNjU2NjU4ODRlZTRhODlhNGU1NTA2ZDk4YTBhL3RhYmxlOmFhNTZiZTdkNzE4YjQ2OTE5ODAzYjE5YTg1NjA4ZWRhL3RhYmxlcmFuZ2U6YWE1NmJlN2Q3MThiNDY5MTk4MDNiMTlhODU2MDhlZGFfMTAtNC0xLTEtNDgxNjQ_e9a9d2e9-f3d6-464a-be6e-36c950b64437" unitRef="usd"> 30876000 </us-gaap:OperatingLeaseLiabilityNoncurrent>
<us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="i7e0f479bead144b0bdbcc71082db627b_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84OC9mcmFnOmYwYmRmNjU2NjU4ODRlZTRhODlhNGU1NTA2ZDk4YTBhL3RhYmxlOmFhNTZiZTdkNzE4YjQ2OTE5ODAzYjE5YTg1NjA4ZWRhL3RhYmxlcmFuZ2U6YWE1NmJlN2Q3MThiNDY5MTk4MDNiMTlhODU2MDhlZGFfMTAtNi0xLTEtNDgxNjQ_921b4acc-6ed0-4fb3-8e64-337c079344ba" unitRef="usd"> 33097000 </us-gaap:OperatingLeaseLiabilityNoncurrent>
<us-gaap:FinanceLeaseLiabilityNoncurrent contextRef="i4768f885851b49f986857a2a956f9162_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84OC9mcmFnOmYwYmRmNjU2NjU4ODRlZTRhODlhNGU1NTA2ZDk4YTBhL3RhYmxlOmFhNTZiZTdkNzE4YjQ2OTE5ODAzYjE5YTg1NjA4ZWRhL3RhYmxlcmFuZ2U6YWE1NmJlN2Q3MThiNDY5MTk4MDNiMTlhODU2MDhlZGFfMTEtNC0xLTEtNDgxNjQ_cd3f1203-75f0-4b40-8007-9670038bde6a" unitRef="usd"> 4588000 </us-gaap:FinanceLeaseLiabilityNoncurrent>
<us-gaap:FinanceLeaseLiabilityNoncurrent contextRef="i7e0f479bead144b0bdbcc71082db627b_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84OC9mcmFnOmYwYmRmNjU2NjU4ODRlZTRhODlhNGU1NTA2ZDk4YTBhL3RhYmxlOmFhNTZiZTdkNzE4YjQ2OTE5ODAzYjE5YTg1NjA4ZWRhL3RhYmxlcmFuZ2U6YWE1NmJlN2Q3MThiNDY5MTk4MDNiMTlhODU2MDhlZGFfMTEtNi0xLTEtNDgxNjQ_a0db1a73-b4f3-4d0d-aa1a-f17ce02e39f1" unitRef="usd"> 2924000 </us-gaap:FinanceLeaseLiabilityNoncurrent>
<us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1 contextRef="i4768f885851b49f986857a2a956f9162_I20220630" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84OC9mcmFnOmYwYmRmNjU2NjU4ODRlZTRhODlhNGU1NTA2ZDk4YTBhL3RhYmxlOmFhNTZiZTdkNzE4YjQ2OTE5ODAzYjE5YTg1NjA4ZWRhL3RhYmxlcmFuZ2U6YWE1NmJlN2Q3MThiNDY5MTk4MDNiMTlhODU2MDhlZGFfMTQtNC0xLTEtNDgxNjQ_5a15f51c-dc6f-4999-a5f1-ea8d229318ab"> P6Y4M24D </us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
<us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1 contextRef="i7e0f479bead144b0bdbcc71082db627b_I20211231" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84OC9mcmFnOmYwYmRmNjU2NjU4ODRlZTRhODlhNGU1NTA2ZDk4YTBhL3RhYmxlOmFhNTZiZTdkNzE4YjQ2OTE5ODAzYjE5YTg1NjA4ZWRhL3RhYmxlcmFuZ2U6YWE1NmJlN2Q3MThiNDY5MTk4MDNiMTlhODU2MDhlZGFfMTQtNi0xLTEtNDgxNjQ_b78129ab-7098-4010-b401-80856a36fd39"> P7Y2M12D </us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
<us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1 contextRef="i4768f885851b49f986857a2a956f9162_I20220630" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84OC9mcmFnOmYwYmRmNjU2NjU4ODRlZTRhODlhNGU1NTA2ZDk4YTBhL3RhYmxlOmFhNTZiZTdkNzE4YjQ2OTE5ODAzYjE5YTg1NjA4ZWRhL3RhYmxlcmFuZ2U6YWE1NmJlN2Q3MThiNDY5MTk4MDNiMTlhODU2MDhlZGFfMTUtNC0xLTEtNDgxNjQ_abcd2045-6f0d-4d8e-b7fc-9d856e4704f0"> P3Y2M12D </us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1>
<us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1 contextRef="i7e0f479bead144b0bdbcc71082db627b_I20211231" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84OC9mcmFnOmYwYmRmNjU2NjU4ODRlZTRhODlhNGU1NTA2ZDk4YTBhL3RhYmxlOmFhNTZiZTdkNzE4YjQ2OTE5ODAzYjE5YTg1NjA4ZWRhL3RhYmxlcmFuZ2U6YWE1NmJlN2Q3MThiNDY5MTk4MDNiMTlhODU2MDhlZGFfMTUtNi0xLTEtNDgxNjQ_f6d99233-5d1d-454c-adbd-eb06ffac3c3e"> P2Y4M24D </us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1>
<us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent contextRef="i4768f885851b49f986857a2a956f9162_I20220630" decimals="3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84OC9mcmFnOmYwYmRmNjU2NjU4ODRlZTRhODlhNGU1NTA2ZDk4YTBhL3RhYmxlOmFhNTZiZTdkNzE4YjQ2OTE5ODAzYjE5YTg1NjA4ZWRhL3RhYmxlcmFuZ2U6YWE1NmJlN2Q3MThiNDY5MTk4MDNiMTlhODU2MDhlZGFfMTctNC0xLTEtNDgxNjQ_68510437-088a-4c2c-b5b6-2448017e1820" unitRef="number"> 0.037 </us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
<us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent contextRef="i7e0f479bead144b0bdbcc71082db627b_I20211231" decimals="3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84OC9mcmFnOmYwYmRmNjU2NjU4ODRlZTRhODlhNGU1NTA2ZDk4YTBhL3RhYmxlOmFhNTZiZTdkNzE4YjQ2OTE5ODAzYjE5YTg1NjA4ZWRhL3RhYmxlcmFuZ2U6YWE1NmJlN2Q3MThiNDY5MTk4MDNiMTlhODU2MDhlZGFfMTctNi0xLTEtNDgxNjQ_d2617fb4-4d40-4e5d-a5d8-b53c1b1937cf" unitRef="number"> 0.046 </us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
<us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent contextRef="i4768f885851b49f986857a2a956f9162_I20220630" decimals="3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84OC9mcmFnOmYwYmRmNjU2NjU4ODRlZTRhODlhNGU1NTA2ZDk4YTBhL3RhYmxlOmFhNTZiZTdkNzE4YjQ2OTE5ODAzYjE5YTg1NjA4ZWRhL3RhYmxlcmFuZ2U6YWE1NmJlN2Q3MThiNDY5MTk4MDNiMTlhODU2MDhlZGFfMTgtNC0xLTEtNDgxNjQ_9fd1deed-9ed5-4814-83a8-ea5edc554263" unitRef="number"> 0.070 </us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent>
<us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent contextRef="i7e0f479bead144b0bdbcc71082db627b_I20211231" decimals="3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84OC9mcmFnOmYwYmRmNjU2NjU4ODRlZTRhODlhNGU1NTA2ZDk4YTBhL3RhYmxlOmFhNTZiZTdkNzE4YjQ2OTE5ODAzYjE5YTg1NjA4ZWRhL3RhYmxlcmFuZ2U6YWE1NmJlN2Q3MThiNDY5MTk4MDNiMTlhODU2MDhlZGFfMTgtNi0xLTEtNDgxNjQ_13f9c8d3-cf49-47dc-9065-0791456f795a" unitRef="number"> 0.048 </us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent>
<us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84OC9mcmFnOmYwYmRmNjU2NjU4ODRlZTRhODlhNGU1NTA2ZDk4YTBhL3RleHRyZWdpb246ZjBiZGY2NTY2NTg4NGVlNGE4OWE0ZTU1MDZkOThhMGFfMjQ4Mg_870f2862-c877-412b-b2d9-97e0f51d64b8">
<div style="margin-top:4pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table reconciles the undiscounted future minimum lease payments (displayed by year and in the aggregate) under noncancelable operating leases with terms of more than one year to the total operating lease liabilities recognized on our Condensed Consolidated Balance Sheet as of June 30, 2022:</span></div><div style="margin-top:14pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:70.894%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.536%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.537%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Operating</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Finance</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">July 1, 2022 through December 31, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,322 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,528 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,399 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,430 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,025 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,829 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,541 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,291 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,654 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">636 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,493 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total undiscounted future minimum lease payments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">47,434 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,716 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: Difference between lease payments and discounted lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,436 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">503 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">42,998 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,213 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>
</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
<us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84OC9mcmFnOmYwYmRmNjU2NjU4ODRlZTRhODlhNGU1NTA2ZDk4YTBhL3RleHRyZWdpb246ZjBiZGY2NTY2NTg4NGVlNGE4OWE0ZTU1MDZkOThhMGFfMjQ4Mw_c4a5bf51-f62f-409b-aabd-a1e5a274eaef">
<div style="margin-top:4pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table reconciles the undiscounted future minimum lease payments (displayed by year and in the aggregate) under noncancelable operating leases with terms of more than one year to the total operating lease liabilities recognized on our Condensed Consolidated Balance Sheet as of June 30, 2022:</span></div><div style="margin-top:14pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:70.894%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.536%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.537%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Operating</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Finance</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">July 1, 2022 through December 31, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,322 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,528 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,399 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,430 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,025 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,829 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,541 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,291 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,654 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">636 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,493 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total undiscounted future minimum lease payments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">47,434 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,716 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: Difference between lease payments and discounted lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,436 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">503 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">42,998 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,213 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>
</us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock>
<us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear contextRef="i4768f885851b49f986857a2a956f9162_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84OC9mcmFnOmYwYmRmNjU2NjU4ODRlZTRhODlhNGU1NTA2ZDk4YTBhL3RhYmxlOmE5MjY5ODIzNTdjMzRhYWFhNDIzMWZlMjhhZjM1NGVlL3RhYmxlcmFuZ2U6YTkyNjk4MjM1N2MzNGFhYWE0MjMxZmUyOGFmMzU0ZWVfMS0xLTEtMS00ODE2NA_27a8ae66-75b2-4847-bbc5-6ceaf71f27b4" unitRef="usd"> 6322000 </us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear>
<us-gaap:FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear contextRef="i4768f885851b49f986857a2a956f9162_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84OC9mcmFnOmYwYmRmNjU2NjU4ODRlZTRhODlhNGU1NTA2ZDk4YTBhL3RhYmxlOmE5MjY5ODIzNTdjMzRhYWFhNDIzMWZlMjhhZjM1NGVlL3RhYmxlcmFuZ2U6YTkyNjk4MjM1N2MzNGFhYWE0MjMxZmUyOGFmMzU0ZWVfMS0zLTEtMS00ODE2NA_038dda37-d9c6-4d80-91ec-6f3fe73d6c91" unitRef="usd"> 1528000 </us-gaap:FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear>
<us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths contextRef="i4768f885851b49f986857a2a956f9162_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84OC9mcmFnOmYwYmRmNjU2NjU4ODRlZTRhODlhNGU1NTA2ZDk4YTBhL3RhYmxlOmE5MjY5ODIzNTdjMzRhYWFhNDIzMWZlMjhhZjM1NGVlL3RhYmxlcmFuZ2U6YTkyNjk4MjM1N2MzNGFhYWE0MjMxZmUyOGFmMzU0ZWVfMi0xLTEtMS00ODE2NA_651c2750-68d3-46ac-b7ab-03ea0448059b" unitRef="usd"> 10399000 </us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
<us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths contextRef="i4768f885851b49f986857a2a956f9162_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84OC9mcmFnOmYwYmRmNjU2NjU4ODRlZTRhODlhNGU1NTA2ZDk4YTBhL3RhYmxlOmE5MjY5ODIzNTdjMzRhYWFhNDIzMWZlMjhhZjM1NGVlL3RhYmxlcmFuZ2U6YTkyNjk4MjM1N2MzNGFhYWE0MjMxZmUyOGFmMzU0ZWVfMi0zLTEtMS00ODE2NA_730c536e-22d6-4f57-8ef6-b642565e9ecb" unitRef="usd"> 2430000 </us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths>
<us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo contextRef="i4768f885851b49f986857a2a956f9162_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84OC9mcmFnOmYwYmRmNjU2NjU4ODRlZTRhODlhNGU1NTA2ZDk4YTBhL3RhYmxlOmE5MjY5ODIzNTdjMzRhYWFhNDIzMWZlMjhhZjM1NGVlL3RhYmxlcmFuZ2U6YTkyNjk4MjM1N2MzNGFhYWE0MjMxZmUyOGFmMzU0ZWVfMy0xLTEtMS00ODE2NA_903ecff8-82a2-4bb3-86a2-34a77710888a" unitRef="usd"> 7025000 </us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
<us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo contextRef="i4768f885851b49f986857a2a956f9162_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84OC9mcmFnOmYwYmRmNjU2NjU4ODRlZTRhODlhNGU1NTA2ZDk4YTBhL3RhYmxlOmE5MjY5ODIzNTdjMzRhYWFhNDIzMWZlMjhhZjM1NGVlL3RhYmxlcmFuZ2U6YTkyNjk4MjM1N2MzNGFhYWE0MjMxZmUyOGFmMzU0ZWVfMy0zLTEtMS00ODE2NA_56430265-1e10-4369-b578-0d4ef7ec62ef" unitRef="usd"> 1829000 </us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo>
<us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree contextRef="i4768f885851b49f986857a2a956f9162_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84OC9mcmFnOmYwYmRmNjU2NjU4ODRlZTRhODlhNGU1NTA2ZDk4YTBhL3RhYmxlOmE5MjY5ODIzNTdjMzRhYWFhNDIzMWZlMjhhZjM1NGVlL3RhYmxlcmFuZ2U6YTkyNjk4MjM1N2MzNGFhYWE0MjMxZmUyOGFmMzU0ZWVfNC0xLTEtMS00ODE2NA_e323f63f-646e-4d37-85ef-56b62942c5d2" unitRef="usd"> 4541000 </us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
<us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree contextRef="i4768f885851b49f986857a2a956f9162_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84OC9mcmFnOmYwYmRmNjU2NjU4ODRlZTRhODlhNGU1NTA2ZDk4YTBhL3RhYmxlOmE5MjY5ODIzNTdjMzRhYWFhNDIzMWZlMjhhZjM1NGVlL3RhYmxlcmFuZ2U6YTkyNjk4MjM1N2MzNGFhYWE0MjMxZmUyOGFmMzU0ZWVfNC0zLTEtMS00ODE2NA_3f3f10c1-7a97-459e-918f-1381ef9aedaf" unitRef="usd"> 1291000 </us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree>
<us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour contextRef="i4768f885851b49f986857a2a956f9162_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84OC9mcmFnOmYwYmRmNjU2NjU4ODRlZTRhODlhNGU1NTA2ZDk4YTBhL3RhYmxlOmE5MjY5ODIzNTdjMzRhYWFhNDIzMWZlMjhhZjM1NGVlL3RhYmxlcmFuZ2U6YTkyNjk4MjM1N2MzNGFhYWE0MjMxZmUyOGFmMzU0ZWVfNS0xLTEtMS00ODE2NA_af00b603-588a-4423-b1ad-588557e4535a" unitRef="usd"> 3654000 </us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
<us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour contextRef="i4768f885851b49f986857a2a956f9162_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84OC9mcmFnOmYwYmRmNjU2NjU4ODRlZTRhODlhNGU1NTA2ZDk4YTBhL3RhYmxlOmE5MjY5ODIzNTdjMzRhYWFhNDIzMWZlMjhhZjM1NGVlL3RhYmxlcmFuZ2U6YTkyNjk4MjM1N2MzNGFhYWE0MjMxZmUyOGFmMzU0ZWVfNS0zLTEtMS00ODE2NA_16e8f504-9f03-4f88-b14a-bffb22ca5b8a" unitRef="usd"> 636000 </us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour>
<opk:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour contextRef="i4768f885851b49f986857a2a956f9162_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84OC9mcmFnOmYwYmRmNjU2NjU4ODRlZTRhODlhNGU1NTA2ZDk4YTBhL3RhYmxlOmE5MjY5ODIzNTdjMzRhYWFhNDIzMWZlMjhhZjM1NGVlL3RhYmxlcmFuZ2U6YTkyNjk4MjM1N2MzNGFhYWE0MjMxZmUyOGFmMzU0ZWVfNi0xLTEtMS00ODE2NA_6939c431-61d0-4865-85ef-855f89050cb1" unitRef="usd"> 15493000 </opk:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour>
<opk:FinanceLeaseLiabilityPaymentsDueAfterYearFour contextRef="i4768f885851b49f986857a2a956f9162_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84OC9mcmFnOmYwYmRmNjU2NjU4ODRlZTRhODlhNGU1NTA2ZDk4YTBhL3RhYmxlOmE5MjY5ODIzNTdjMzRhYWFhNDIzMWZlMjhhZjM1NGVlL3RhYmxlcmFuZ2U6YTkyNjk4MjM1N2MzNGFhYWE0MjMxZmUyOGFmMzU0ZWVfNi0zLTEtMS00ODE2NA_024e1af8-27e5-4e60-8a3d-e1bf865e8c87" unitRef="usd"> 2000 </opk:FinanceLeaseLiabilityPaymentsDueAfterYearFour>
<us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue contextRef="i4768f885851b49f986857a2a956f9162_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84OC9mcmFnOmYwYmRmNjU2NjU4ODRlZTRhODlhNGU1NTA2ZDk4YTBhL3RhYmxlOmE5MjY5ODIzNTdjMzRhYWFhNDIzMWZlMjhhZjM1NGVlL3RhYmxlcmFuZ2U6YTkyNjk4MjM1N2MzNGFhYWE0MjMxZmUyOGFmMzU0ZWVfNy0xLTEtMS00ODE2NA_0406b133-1872-4071-9c9b-b5a1680168ac" unitRef="usd"> 47434000 </us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
<us-gaap:FinanceLeaseLiabilityPaymentsDue contextRef="i4768f885851b49f986857a2a956f9162_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84OC9mcmFnOmYwYmRmNjU2NjU4ODRlZTRhODlhNGU1NTA2ZDk4YTBhL3RhYmxlOmE5MjY5ODIzNTdjMzRhYWFhNDIzMWZlMjhhZjM1NGVlL3RhYmxlcmFuZ2U6YTkyNjk4MjM1N2MzNGFhYWE0MjMxZmUyOGFmMzU0ZWVfNy0zLTEtMS00ODE2NA_d2c30c60-d607-46c6-83dd-edbffc3d5ec8" unitRef="usd"> 7716000 </us-gaap:FinanceLeaseLiabilityPaymentsDue>
<us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount contextRef="i4768f885851b49f986857a2a956f9162_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84OC9mcmFnOmYwYmRmNjU2NjU4ODRlZTRhODlhNGU1NTA2ZDk4YTBhL3RhYmxlOmE5MjY5ODIzNTdjMzRhYWFhNDIzMWZlMjhhZjM1NGVlL3RhYmxlcmFuZ2U6YTkyNjk4MjM1N2MzNGFhYWE0MjMxZmUyOGFmMzU0ZWVfOC0xLTEtMS00ODE2NA_3ec7b008-de3c-442c-9ab2-ab517f314c82" unitRef="usd"> 4436000 </us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
<us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount contextRef="i4768f885851b49f986857a2a956f9162_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84OC9mcmFnOmYwYmRmNjU2NjU4ODRlZTRhODlhNGU1NTA2ZDk4YTBhL3RhYmxlOmE5MjY5ODIzNTdjMzRhYWFhNDIzMWZlMjhhZjM1NGVlL3RhYmxlcmFuZ2U6YTkyNjk4MjM1N2MzNGFhYWE0MjMxZmUyOGFmMzU0ZWVfOC0zLTEtMS00ODE2NA_c35aa6f9-e407-4281-89e3-13d98bc7828f" unitRef="usd"> 503000 </us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount>
<us-gaap:OperatingLeaseLiability contextRef="i4768f885851b49f986857a2a956f9162_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84OC9mcmFnOmYwYmRmNjU2NjU4ODRlZTRhODlhNGU1NTA2ZDk4YTBhL3RhYmxlOmE5MjY5ODIzNTdjMzRhYWFhNDIzMWZlMjhhZjM1NGVlL3RhYmxlcmFuZ2U6YTkyNjk4MjM1N2MzNGFhYWE0MjMxZmUyOGFmMzU0ZWVfOS0xLTEtMS00ODE2NA_73babf01-5c9f-4c7f-8c1d-3f6e6f617a10" unitRef="usd"> 42998000 </us-gaap:OperatingLeaseLiability>
<us-gaap:FinanceLeaseLiability contextRef="i4768f885851b49f986857a2a956f9162_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84OC9mcmFnOmYwYmRmNjU2NjU4ODRlZTRhODlhNGU1NTA2ZDk4YTBhL3RhYmxlOmE5MjY5ODIzNTdjMzRhYWFhNDIzMWZlMjhhZjM1NGVlL3RhYmxlcmFuZ2U6YTkyNjk4MjM1N2MzNGFhYWE0MjMxZmUyOGFmMzU0ZWVfOS0zLTEtMS00ODE2NA_63968338-863c-4580-8ee3-28c6e0644f2d" unitRef="usd"> 7213000 </us-gaap:FinanceLeaseLiability>
<us-gaap:OperatingLeaseCost contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84OC9mcmFnOmYwYmRmNjU2NjU4ODRlZTRhODlhNGU1NTA2ZDk4YTBhL3RleHRyZWdpb246ZjBiZGY2NTY2NTg4NGVlNGE4OWE0ZTU1MDZkOThhMGFfMjAzMQ_110e6f91-9bd7-4785-813d-9265af95cb3d" unitRef="usd"> 8400000 </us-gaap:OperatingLeaseCost>
<us-gaap:FinanceLeaseInterestExpense contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84OC9mcmFnOmYwYmRmNjU2NjU4ODRlZTRhODlhNGU1NTA2ZDk4YTBhL3RleHRyZWdpb246ZjBiZGY2NTY2NTg4NGVlNGE4OWE0ZTU1MDZkOThhMGFfMjAzOA_e9ef36e1-d9c5-4ff3-8d2f-e97c50941be0" unitRef="usd"> 1900000 </us-gaap:FinanceLeaseInterestExpense>
<us-gaap:VariableLeaseCost contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84OC9mcmFnOmYwYmRmNjU2NjU4ODRlZTRhODlhNGU1NTA2ZDk4YTBhL3RleHRyZWdpb246ZjBiZGY2NTY2NTg4NGVlNGE4OWE0ZTU1MDZkOThhMGFfMjA4Mw_c55ad633-bac2-456d-90c9-d388e77ae8e8" unitRef="usd"> 1300000 </us-gaap:VariableLeaseCost>
<us-gaap:OperatingLeaseCost contextRef="i420e18e30084498a98510d48880063cd_D20210101-20210630" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84OC9mcmFnOmYwYmRmNjU2NjU4ODRlZTRhODlhNGU1NTA2ZDk4YTBhL3RleHRyZWdpb246ZjBiZGY2NTY2NTg4NGVlNGE4OWE0ZTU1MDZkOThhMGFfMjE2NQ_d46a985b-161c-4408-b2d0-b14c8a476dc8" unitRef="usd"> 9100000 </us-gaap:OperatingLeaseCost>
<us-gaap:FinanceLeaseInterestExpense contextRef="i420e18e30084498a98510d48880063cd_D20210101-20210630" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84OC9mcmFnOmYwYmRmNjU2NjU4ODRlZTRhODlhNGU1NTA2ZDk4YTBhL3RleHRyZWdpb246ZjBiZGY2NTY2NTg4NGVlNGE4OWE0ZTU1MDZkOThhMGFfMjE3Mg_c4f479fb-b052-43f6-aaa6-240ceec16631" unitRef="usd"> 1100000 </us-gaap:FinanceLeaseInterestExpense>
<us-gaap:VariableLeaseCost contextRef="i420e18e30084498a98510d48880063cd_D20210101-20210630" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84OC9mcmFnOmYwYmRmNjU2NjU4ODRlZTRhODlhNGU1NTA2ZDk4YTBhL3RleHRyZWdpb246ZjBiZGY2NTY2NTg4NGVlNGE4OWE0ZTU1MDZkOThhMGFfMjIxNw_e6b5238c-2263-46d7-a6ba-72cb83f94085" unitRef="usd"> 1400000 </us-gaap:VariableLeaseCost>
<us-gaap:LeaseCostTableTextBlock contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84OC9mcmFnOmYwYmRmNjU2NjU4ODRlZTRhODlhNGU1NTA2ZDk4YTBhL3RleHRyZWdpb246ZjBiZGY2NTY2NTg4NGVlNGE4OWE0ZTU1MDZkOThhMGFfMjQ4Ng_7ed4b866-c0b9-4333-9315-e4514c0a2255">
Supplemental cash flow information is as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:70.600%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.536%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.831%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in thousands)</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">For the six months ended June 30,</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash out flows from operating leases</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,327 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,484 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash out flows from finance leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing cash out flows from finance leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">724 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">769 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,103 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,298 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table>
</us-gaap:LeaseCostTableTextBlock>
<us-gaap:OperatingLeasePayments contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84OC9mcmFnOmYwYmRmNjU2NjU4ODRlZTRhODlhNGU1NTA2ZDk4YTBhL3RhYmxlOjg2ZTg0NDFiYWIxNTQ3MzBhNzZmMmE2YzUwNjg2ZDI5L3RhYmxlcmFuZ2U6ODZlODQ0MWJhYjE1NDczMGE3NmYyYTZjNTA2ODZkMjlfMi0xLTEtMS00ODE2NA_9fb29238-0c8e-4008-930d-4f293b5991ab" unitRef="usd"> 8327000 </us-gaap:OperatingLeasePayments>
<us-gaap:OperatingLeasePayments contextRef="i420e18e30084498a98510d48880063cd_D20210101-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84OC9mcmFnOmYwYmRmNjU2NjU4ODRlZTRhODlhNGU1NTA2ZDk4YTBhL3RhYmxlOjg2ZTg0NDFiYWIxNTQ3MzBhNzZmMmE2YzUwNjg2ZDI5L3RhYmxlcmFuZ2U6ODZlODQ0MWJhYjE1NDczMGE3NmYyYTZjNTA2ODZkMjlfMi0zLTEtMS00ODE2NA_2a140f05-8d17-4878-8ed9-bc83379b3e31" unitRef="usd"> 6484000 </us-gaap:OperatingLeasePayments>
<us-gaap:FinanceLeaseInterestPaymentOnLiability contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84OC9mcmFnOmYwYmRmNjU2NjU4ODRlZTRhODlhNGU1NTA2ZDk4YTBhL3RhYmxlOjg2ZTg0NDFiYWIxNTQ3MzBhNzZmMmE2YzUwNjg2ZDI5L3RhYmxlcmFuZ2U6ODZlODQ0MWJhYjE1NDczMGE3NmYyYTZjNTA2ODZkMjlfMy0xLTEtMS00ODE2NA_1fa8f494-65fd-4451-a350-1e6dfa35f31b" unitRef="usd"> 52000 </us-gaap:FinanceLeaseInterestPaymentOnLiability>
<us-gaap:FinanceLeaseInterestPaymentOnLiability contextRef="i420e18e30084498a98510d48880063cd_D20210101-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84OC9mcmFnOmYwYmRmNjU2NjU4ODRlZTRhODlhNGU1NTA2ZDk4YTBhL3RhYmxlOjg2ZTg0NDFiYWIxNTQ3MzBhNzZmMmE2YzUwNjg2ZDI5L3RhYmxlcmFuZ2U6ODZlODQ0MWJhYjE1NDczMGE3NmYyYTZjNTA2ODZkMjlfMy0zLTEtMS00ODE2NA_68995e0f-3e5b-4c0d-88f6-2b77a1ec9f2a" unitRef="usd"> 45000 </us-gaap:FinanceLeaseInterestPaymentOnLiability>
<us-gaap:FinanceLeasePrincipalPayments contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84OC9mcmFnOmYwYmRmNjU2NjU4ODRlZTRhODlhNGU1NTA2ZDk4YTBhL3RhYmxlOjg2ZTg0NDFiYWIxNTQ3MzBhNzZmMmE2YzUwNjg2ZDI5L3RhYmxlcmFuZ2U6ODZlODQ0MWJhYjE1NDczMGE3NmYyYTZjNTA2ODZkMjlfNC0xLTEtMS00ODE2NA_0e678430-ab42-43a6-930f-d5384e1b3cb9" unitRef="usd"> 724000 </us-gaap:FinanceLeasePrincipalPayments>
<us-gaap:FinanceLeasePrincipalPayments contextRef="i420e18e30084498a98510d48880063cd_D20210101-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84OC9mcmFnOmYwYmRmNjU2NjU4ODRlZTRhODlhNGU1NTA2ZDk4YTBhL3RhYmxlOjg2ZTg0NDFiYWIxNTQ3MzBhNzZmMmE2YzUwNjg2ZDI5L3RhYmxlcmFuZ2U6ODZlODQ0MWJhYjE1NDczMGE3NmYyYTZjNTA2ODZkMjlfNC0zLTEtMS00ODE2NA_ebc15657-a272-4508-8c36-7907631d37fb" unitRef="usd"> 769000 </us-gaap:FinanceLeasePrincipalPayments>
<opk:PaymentsForLeases contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84OC9mcmFnOmYwYmRmNjU2NjU4ODRlZTRhODlhNGU1NTA2ZDk4YTBhL3RhYmxlOjg2ZTg0NDFiYWIxNTQ3MzBhNzZmMmE2YzUwNjg2ZDI5L3RhYmxlcmFuZ2U6ODZlODQ0MWJhYjE1NDczMGE3NmYyYTZjNTA2ODZkMjlfNS0xLTEtMS00ODE2NA_56179710-c404-49a8-9d66-cc49942af406" unitRef="usd"> 9103000 </opk:PaymentsForLeases>
<opk:PaymentsForLeases contextRef="i420e18e30084498a98510d48880063cd_D20210101-20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml84OC9mcmFnOmYwYmRmNjU2NjU4ODRlZTRhODlhNGU1NTA2ZDk4YTBhL3RhYmxlOjg2ZTg0NDFiYWIxNTQ3MzBhNzZmMmE2YzUwNjg2ZDI5L3RhYmxlcmFuZ2U6ODZlODQ0MWJhYjE1NDczMGE3NmYyYTZjNTA2ODZkMjlfNS0zLTEtMS00ODE2NA_de1b8a1e-5b72-42b4-8340-d561da97c5f5" unitRef="usd"> 7298000 </opk:PaymentsForLeases>
<us-gaap:SubsequentEventsTextBlock contextRef="i6c0217e60ff543c3975b93aa8e6baa72_D20220101-20220630" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml85NC9mcmFnOjI1ODhmYTYzOWI0OTQ0Nzc4ZTBkOTI2NWI2YzExMjAyL3RleHRyZWdpb246MjU4OGZhNjM5YjQ5NDQ3NzhlMGQ5MjY1YjZjMTEyMDJfMjgxNg_fc166574-80fb-45b0-8f91-e03aabdd8f44">
SUBSEQUENT EVENTS<div style="margin-top:4pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company and BioReference entered into (i) a settlement agreement (the “Settlement Agreement”), effective July 14, 2022, with the United States of America, acting through the United States Department of Justice and on behalf of the Office of Inspector General of the Department of Health and Human Services (“OIG-HHS”), and the Defense Health Agency, acting on behalf of the TRICARE Program (collectively, the “United States”), the Commonwealth of Massachusetts (the “Commonwealth”), the State of Connecticut, (“Connecticut”), and the relator identified therein (“Relator”), and (ii) a Corporate Integrity Agreement, effective July 14, 2022 (the “CIA”), with the OIG-HHS, to resolve the investigation and related civil action concerning alleged fee-for-service claims for payment to the Medicare Program, the Medicaid Program, and the TRICARE Program (collectively, the “Federal Health Care Programs”).</span></div><div style="margin-top:4pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Settlement Agreement, the Company and BioReference admitted only to having made payments to certain physicians and physicians’ groups for office space rentals for amounts that exceeded fair market value, and that it did not report or return any such overpayments to the Federal Health Care Programs (the “Covered Conduct”). The Covered Conduct had commenced prior to the Company’s acquisition of BioReference in 2015. With the exception of the Covered Conduct, the Company and BioReference expressly deny the allegations of the Relator as set forth in her civil action. The Company has agreed to pay a total of $10,000,000 plus accrued interest from September 24, 2021 at a rate of 1.5% per annum (the “Settlement Amount”). The Settlement Amount consists of $9,853,958 payable to the United States, $141,041 payable to the Commonwealth and $5,001 payable to Connecticut, in each case plus interest and paid on July 18th, 2022. Conditioned upon payment of the Settlement Amount, the United States, the Commonwealth and Connecticut have agreed to release the Company and BioReference from any civil or administrative monetarily liability arising from the Covered Conduct. Upon payment of the Settlement Amount and the amount due under a separate agreement with the Relator, the Relator has agreed to release the Company and BioReference from any and all claims and potential claims. Further, in consideration of the obligations of the Company and BioReference in the Settlement Agreement and the CIA, the OIG-HHS has agreed to release and refrain from instituting any administrative action seeking to exclude the Company or BioReference from participating in Medicare, Medicaid or other Federal health care programs as a result of the Covered Conduct.</span></div><div style="margin-top:4pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the CIA, which has a term of 5 years, BioReference is required to, among other things: (i) maintain a Compliance Officer, a Compliance Committee, board review and oversight of certain federal healthcare compliance matters, compliance programs, and disclosure programs; (ii) provide management certifications and compliance training and education; (iii) establish written compliance policies and procedures to meet federal health care program requirements; (iv) create procedures designed to ensure compliance with the Anti-Kickback Statute and/or Stark Law; (v) engage an independent review organization to conduct a thorough review of BioReference’ s systems, policies, processes and procedures related to certain arrangements; (vi) implement a risk assessment and internal review process; (vii) establish a disclosure program for whistleblowers; and (viii) report or disclose certain events and physician payments. The Company’s or BioReference’s failure to comply with its obligations under the CIA could result in monetary penalties and the exclusion from participation in Federal Health Care Programs. The CIA does not apply to any of the Company’s subsidiaries other than BioReference, and its scope is generally limited to “focus arrangements”, which are those “arrangements” (as defined in the CIA) (i) between BioReference and any actual source or recipient of health care business or referrals and involves, directly or indirectly, the offer, payment, or provision of anything of value, or (ii) is between BioReference and any physician (or a physician’s immediate family member). Most of these measures have already been implemented at BioReference. Following its acquisition of BioReference, the Company and BioReference implemented robust compliance measures that substantially align with those actions required under the CIA.</span></div>
</us-gaap:SubsequentEventsTextBlock>
<us-gaap:LitigationSettlementAmountAwardedToOtherParty contextRef="iaaab35e2a69742aba58b3bce061ca59d_D20220714-20220714" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml85NC9mcmFnOjI1ODhmYTYzOWI0OTQ0Nzc4ZTBkOTI2NWI2YzExMjAyL3RleHRyZWdpb246MjU4OGZhNjM5YjQ5NDQ3NzhlMGQ5MjY1YjZjMTEyMDJfMzg0ODI5MDcxMTk5NQ_24373d6a-5e31-4ecb-b3eb-67b86e7f3f5a" unitRef="usd"> 10000000 </us-gaap:LitigationSettlementAmountAwardedToOtherParty>
<opk:LitigationSettlementInterestRate contextRef="i159bb5353b604ef8bcf714d747bd6227_I20220714" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml85NC9mcmFnOjI1ODhmYTYzOWI0OTQ0Nzc4ZTBkOTI2NWI2YzExMjAyL3RleHRyZWdpb246MjU4OGZhNjM5YjQ5NDQ3NzhlMGQ5MjY1YjZjMTEyMDJfMzg0ODI5MDcxMjAwOA_63eaf91b-20ef-4303-88a6-e6b1517cea17" unitRef="number"> 0.015 </opk:LitigationSettlementInterestRate>
<us-gaap:LitigationSettlementAmountAwardedToOtherParty contextRef="if1f7b317f2664ce48cd8bed9f09bd628_D20220714-20220714" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml85NC9mcmFnOjI1ODhmYTYzOWI0OTQ0Nzc4ZTBkOTI2NWI2YzExMjAyL3RleHRyZWdpb246MjU4OGZhNjM5YjQ5NDQ3NzhlMGQ5MjY1YjZjMTEyMDJfMzg0ODI5MDcxMjAxNA_78d2c6ab-453a-4bfa-99be-8db65a09fe07" unitRef="usd"> 9853958 </us-gaap:LitigationSettlementAmountAwardedToOtherParty>
<us-gaap:LitigationSettlementAmountAwardedToOtherParty contextRef="i7fc497baca3b45b883c778a446f221b4_D20220714-20220714" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml85NC9mcmFnOjI1ODhmYTYzOWI0OTQ0Nzc4ZTBkOTI2NWI2YzExMjAyL3RleHRyZWdpb246MjU4OGZhNjM5YjQ5NDQ3NzhlMGQ5MjY1YjZjMTEyMDJfMzg0ODI5MDcxMjAyNg_0861e4a8-eb93-47d7-9006-eb74028e4129" unitRef="usd"> 141041 </us-gaap:LitigationSettlementAmountAwardedToOtherParty>
<us-gaap:LitigationSettlementAmountAwardedToOtherParty contextRef="if38b8c04509b49968e85bee0a732b229_D20220714-20220714" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml85NC9mcmFnOjI1ODhmYTYzOWI0OTQ0Nzc4ZTBkOTI2NWI2YzExMjAyL3RleHRyZWdpb246MjU4OGZhNjM5YjQ5NDQ3NzhlMGQ5MjY1YjZjMTEyMDJfMzg0ODI5MDcxMjAzNg_1c54990c-a13a-456b-990e-dc61ce30155b" unitRef="usd"> 5001 </us-gaap:LitigationSettlementAmountAwardedToOtherParty>
<opk:LitigationSettlementCorporateIntegrityAgreementTerm contextRef="idd10fd8a8e37462facbaef8483be3234_D20220714-20220714" id="id3VybDovL2RvY3MudjEvZG9jOjMxMmMzZjc4Y2ZmZDQxNzNhZDU4ZGY4Y2VhYWMyMTYyL3NlYzozMTJjM2Y3OGNmZmQ0MTczYWQ1OGRmOGNlYWFjMjE2Ml85NC9mcmFnOjI1ODhmYTYzOWI0OTQ0Nzc4ZTBkOTI2NWI2YzExMjAyL3RleHRyZWdpb246MjU4OGZhNjM5YjQ5NDQ3NzhlMGQ5MjY1YjZjMTEyMDJfMzg0ODI5MDcxNjkwNA_9b3ae005-a559-45a2-8516-0bc7b4014251"> P5Y </opk:LitigationSettlementCorporateIntegrityAgreementTerm>
</xbrl>

2 Previous Filings that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 5/13/22  Opko Health, Inc.                 8-K:1,3,5,9 5/09/22   14:1.3M
 5/04/22  Opko Health, Inc.                 8-K:1,8,9   4/29/22    2:145K
↑Top
Filing Submission 0000944809-22-000038   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)
Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
About — Privacy — Redactions — Help — Thu., May 2, 6:26:00.3am ET